<SEC-DOCUMENT>0001193125-18-126970.txt : 20180423
<SEC-HEADER>0001193125-18-126970.hdr.sgml : 20180423
<ACCEPTANCE-DATETIME>20180423171722
ACCESSION NUMBER:		0001193125-18-126970
CONFORMED SUBMISSION TYPE:	S-4
PUBLIC DOCUMENT COUNT:		29
FILED AS OF DATE:		20180423
DATE AS OF CHANGE:		20180423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORTHOFIX INTERNATIONAL N V
		CENTRAL INDEX KEY:			0000884624
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-224407
		FILM NUMBER:		18769539

	BUSINESS ADDRESS:	
		STREET 1:		7 ABRAHAM DE VEERSTRAAT
		STREET 2:		CURACAO
		CITY:			NETHERLANDS ANTILLES
		STATE:			P8
		ZIP:			00000
		BUSINESS PHONE:		214-937-2000

	MAIL ADDRESS:	
		STREET 1:		3451 PLANO PARKWAY
		CITY:			LEWISVILLE
		STATE:			TX
		ZIP:			75056
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4
<SEQUENCE>1
<FILENAME>d571963ds4.htm
<DESCRIPTION>S-4
<TEXT>
<HTML><HEAD>
<TITLE>S-4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on April&nbsp;23, 2018 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration
No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-4</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF&nbsp;1933 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Orthofix International N.V.* </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Cura&ccedil;ao*</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">0-19961</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">98-1340767</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(State&nbsp;or&nbsp;Other&nbsp;Jurisdiction&nbsp;of<BR>Incorporation&nbsp;or&nbsp;Organization)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Primary Standard Industrial<BR>Classification Code Number)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(IRS Employer<BR>Identification Number)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7 Abraham de Veerstraat, Cura&ccedil;ao </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">599-9-4658525</FONT></FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code, and telephone number, including area code, of registrant&#146;s principal executive offices) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Kimberley A. Elting </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chief Legal and Administrative Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>3451 Plano Parkway </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Lewisville, Texas 75056 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(214) <FONT STYLE="white-space:nowrap">937-2000</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>With a Copy to: </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Joseph E. Gilligan </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Brian
C. O&#146;Fahey </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Paul D. Manca </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Hogan Lovells US&nbsp;LLP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Columbia Square </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>555
Thirteenth Street, N.W. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, DC 20004 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">(202)&nbsp;637-5600</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Approximate date of commencement of proposed sale of the securities to the public: As soon as practicable after this registration statement is
declared effective and all other conditions to the domestication described in the enclosed proxy statement/prospectus have been satisfied or waived. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the
securities being registered on this Form are being offered in connection with the formation of a holding company and there is compliance with General Instruction&nbsp;G, check the following box:&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule&nbsp;462(b) under the Securities Act, check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
<FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148;
and &#147;emerging growth company&#148; in <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;&nbsp;&nbsp;(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Exchange Act <FONT STYLE="white-space:nowrap">Rule&nbsp;13e-4(i)</FONT> (Cross-Border Issuer Tender Offer)&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Exchange Act <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-1(d)</FONT> (Cross-Border Third-Party Tender Offer)&nbsp;&nbsp;&#9744; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Title of each class of securities<BR>to be registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount to be<BR>registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed maximum<BR>offering price per<BR>unit<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed maximum<BR>aggregate offering<BR>price<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount of<BR>registration fee</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares of Common Stock, $0.10 par value<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19,382,784</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$1,143,002,773</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$142,304</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">In connection with the domestication of Orthofix International N.V. as a Delaware corporation, each common share of Orthofix International N.V. will be converted into one share of common stock of Orthofix Medical Inc.
Orthofix International N.V.&#146;s common shares are listed on the Nasdaq Global Select Market (&#147;Nasdaq&#148;) under the symbol &#147;OFIX.&#148; Orthofix Medical Inc. common stock will continue to be listed on Nasdaq under the symbol
&#147;OFIX&#148; following the domestication. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the common shares of Orthofix International N.V. on Nasdaq on April 20, 2018 ($58.97 per share),
in accordance with Rule 457(f)(1). </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">In connection with the consummation of the domestication described herein, Orthofix International N.V. intends to change its jurisdiction of organization from a limited liability company (<I>naamloze vennootschap</I>)
organized under the laws of Cura&ccedil;ao to a corporation organized under the laws of the State of Delaware in accordance with the conversion procedures of Articles 304 and 305 of Book 2 of the Cura&ccedil;ao Civil Code and the domestication
procedures of Section&nbsp;388 of the Delaware General Corporation Law. In connection with the domestication, the registrant intends to change its name to Orthofix Medical Inc. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act or until this registration statement shall become
effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#ff4338"><B>The information in this preliminary proxy statement/prospectus is subject to completion
and amendment. The registrant may not sell the securities described herein until the registration statement filed with the United States Securities and Exchange Commission is declared effective. This preliminary proxy statement/prospectus is not an
offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>PRELIMINARY PROXY STATEMENT/PROSPECTUS &#150; SUBJECT TO COMPLETION, DATED APRIL&nbsp;23, 2018 </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT FOR ANNUAL GENERAL MEETING OF ORTHOFIX INTERNATIONAL N.V. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS FOR SHARES OF COMMON STOCK OF ORTHOFIX MEDICAL INC. (AFTER ITS DOMESTICATION AS A CORPORATION IN DELAWARE) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Shareholders: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cordially invited to attend the 2018
Annual General Meeting of Shareholders (the &#147;Annual General Meeting&#148;) of Orthofix International N.V., a limited liability company (<I>naamloze vennootschap</I>) operating under the laws of Cura&ccedil;ao (&#147;Orthofix,&#148; the
&#147;Company,&#148; &#147;we,&#148; &#147;us&#148; or &#147;our&#148;), which will be held on June 18, 2018 at 11:00 a.m. Atlantic Standard Time (AST) at Orthofix&#146;s offices, located at 7 Abraham de Veerstraat, Cura&ccedil;ao. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Domestication Proposal. </I>The board of directors (the &#147;Board&#148;) of Orthofix has unanimously approved a plan to change the Company&#146;s
jurisdiction of organization from Cura&ccedil;ao to the State of Delaware (the &#147;domestication&#148;), and has unanimously resolved to submit a proposal to the Company&#146;s shareholders asking that they vote to adopt a shareholders&#146;
resolution that authorizes the domestication (the &#147;domestication resolution&#148;). If the shareholders vote to adopt the domestication resolution, and the other conditions to completion of the domestication are satisfied, the Company
anticipates that, on or prior to January&nbsp;1, 2019, it will complete the domestication in accordance with the conversion procedures of Articles 304 and 305 of Book 2 of the Cura&ccedil;ao Civil Code and the domestication procedures of
Section&nbsp;388 of the Delaware General Corporation Law. Following the domestication, the Company will be renamed &#147;Orthofix Medical Inc.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If
the domestication resolution is adopted by the requisite vote of our shareholders, the number of shares of common stock that you will own in Orthofix Medical Inc. on the effective date of the domestication will be the same as the number of common
shares you held in Orthofix International N.V. immediately prior to the effectuation of the domestication. Orthofix Medical Inc.&#146;s common stock will continue to be traded on the Nasdaq Global Select Market under the symbol &#147;OFIX.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board believes that the domestication will provide potential strategic opportunities and benefits, including: aligning our incorporation with our
primary business operations in the United States, improving operational and financial flexibility by simplifying our corporate structure, which will allow for improved cash management capabilities and increased business efficiencies, benefiting from
the prominence, predictability and flexibility of Delaware law and a well-established corporate governance regime and positioning the Company to better respond to global tax developments. <B>The domestication cannot be completed without satisfying
certain conditions, the most important of which is the adoption of the domestication resolution by the affirmative vote of holders representing an absolute majority of the outstanding common shares of Orthofix as of the record date.</B> </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Annual General Meeting Proposals. </I>In addition to the proposal to adopt the domestication resolution,
Orthofix shareholders will be asked to vote on other proposals at the Annual General Meeting, including: (i)&nbsp;the election of nine directors to the Board, (ii)&nbsp;the approval of the Company&#146;s consolidated balance sheet and consolidated
statement of operations for the fiscal year ended December&nbsp;31, 2017, (iii) the approval, on an advisory and <FONT STYLE="white-space:nowrap">non-binding</FONT> basis, of the compensation of the Company&#146;s named executive officers,
(iv)&nbsp;the approval of an amendment and restatement of the Company&#146;s 2012 Long-Term Incentive Plan (the &#147;Amended and Restated 2012 Plan&#148;), (v) the approval of Amendment No.&nbsp;1 to the Company&#146;s Second Amended and Restated
Stock Purchase Plan (the &#147;SPP&#148;) to increase the number of shares subject to awards under the SPP (the &#147;SPP Amendment&#148;) and (vi)&nbsp;the ratification of the appointment of Ernst&nbsp;&amp; Young LLP (&#147;EY&#148;) as the
Company&#146;s independent registered accounting firm for the year ending December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders of record of Orthofix as of the close of
business on April&nbsp;24, 2018 have the right to attend the Annual General Meeting and vote their Orthofix common shares, or may grant a proxy to vote on the proposals included in this proxy statement/prospectus. <B>Whether or not you plan to
attend the Annual General Meeting, please sign, date and return the proxy voting card in the accompanying envelope. Your vote is important no matter how many common shares you own. The Board has unanimously approved the domestication and recommends
that you vote &#147;FOR&#148; the adoption of the domestication resolution, &#147;FOR&#148; the election of each of the director nominees, &#147;FOR&#148; the approval of the financial statements, &#147;FOR&#148; the approval, on a <FONT
STYLE="white-space:nowrap">non-binding</FONT> advisory basis, of the compensation of the Company&#146;s named executive officers, &#147;FOR&#148; the approval of the Amended and Restated 2012 Plan, &#147;FOR&#148; the approval of the SPP Amendment
and &#147;FOR&#148; the ratification of EY. You are urged to join Orthofix in supporting these important proposals. </B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This proxy
statement/prospectus provides you with detailed information about the domestication and other matters to be considered at the Annual General Meeting. We urge you to carefully read this entire document and the documents incorporated herein by
reference. You should also carefully consider the risk factors described in &#147;</B><B><I><A HREF="#tx571963_33">Risk Factors</A></I></B><B>&#148; beginning on page 13 of this proxy statement/prospectus. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the transactions described in this proxy
statement/prospectus or passed upon the adequacy or accuracy of this proxy statement/prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">This proxy
statement/prospectus is dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2018, and is first being mailed to Orthofix shareholders on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2018. </P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:30pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#004a97"><B>Orthofix International N.V. </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>7 Abraham de Veerstraat </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cura&ccedil;ao </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE
OF ANNUAL GENERAL MEETING OF SHAREHOLDERS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held On June 18, 2018 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Shareholders: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will hold the 2018 Annual General Meeting
of Shareholders (the &#147;Annual General Meeting&#148;) of Orthofix International N.V. (&#147;Orthofix,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; or &#147;our&#148;) on June 18, 2018 at 11:00 a.m. Atlantic Standard Time (AST) at
Orthofix&#146;s offices, located at 7 Abraham de Veerstraat, Cura&ccedil;ao, for the following purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719631a.jpg" ALT="LOGO">
</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B>Adoption of the Domestication Resolution. </B>Shareholders will be asked to adopt a resolution to change the jurisdiction of organization of the Company from Cura&ccedil;ao to the State of Delaware, subject to
the conditions set forth in such resolution (the &#147;domestication resolution&#148;). If the domestication resolution is adopted by the requisite vote of our shareholders and the other conditions to the completion of the domestication are
satisfied, Orthofix will change its jurisdiction of organization from Cura&ccedil;ao to the State of Delaware in accordance with the conversion procedures of Articles 304 and 305 of Book 2 of the Cura&ccedil;ao Civil Code and the domestication
procedures of Section&nbsp;388 of the Delaware General Corporation Law (the &#147;domestication&#148;). Following the domestication, the Company will be renamed &#147;Orthofix Medical Inc.&#148; The Board of Directors (the &#147;Board&#148;)
unanimously recommends that shareholders vote &#147;FOR&#148; the proposal to adopt the domestication resolution. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719632a.jpg" ALT="LOGO">
</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B>Election of Directors. </B>Shareholders will be asked to elect the following persons to the Board: Luke Faulstick, James F. Hinrichs, Alexis V. Lukianov, Lilly Marks, Bradley R. Mason, Ronald A. Matricaria,
Michael E. Paolucci, Maria Sainz and John Sicard. The Board unanimously recommends that shareholders vote &#147;FOR&#148; each of the foregoing director nominees. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719633a.jpg" ALT="LOGO">
</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B>Approval of Financial Statements for the Fiscal Year Ended December</B><B></B><B>&nbsp;31, 2017. </B><B></B>As required by Cura&ccedil;ao law, shareholders will be asked to approve the consolidated balance
sheet and consolidated statement of operations at and for the fiscal year ended December&nbsp;31, 2017.&nbsp;The Board unanimously recommends that shareholders vote &#147;FOR&#148; the proposal to approve the consolidated balance sheet and
consolidated statement of operations at and for the fiscal year ended December&nbsp;31, 2017. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719634a.jpg" ALT="LOGO">
</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B>Advisory and <FONT STYLE="white-space:nowrap">Non-Binding</FONT> Resolution to Approve Executive Compensation. </B>Shareholders will be asked to approve an advisory and
<FONT STYLE="white-space:nowrap">non-binding</FONT> resolution on the compensation of the Company&#146;s named executive officers, as described in the &#147;<I>Management&#151;Compensation Discussion and Analysi</I>s&#148; and the related
compensation tables beginning on&nbsp;page 49 of this proxy statement/prospectus. The Board values shareholders&#146; opinions, and the Compensation Committee of the Board will take into account the outcome of the advisory vote when considering
future executive compensation decisions. The Board unanimously recommends that shareholders vote &#147;FOR&#148; the proposal to approve the advisory and <FONT STYLE="white-space:nowrap">non-binding</FONT> resolution on executive compensation.
</TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719635a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B></B><B>Approval of the Amended and Restated 2012 Plan. </B><B></B>Shareholders will be asked to approve an amendment and restatement of the Company&#146;s 2012 Long-Term Incentive Plan (the &#147;Amended and
Restated 2012 Plan&#148;).&nbsp;The Board unanimously recommends that shareholders vote &#147;FOR&#148; the proposal to approve the Amended and Restated 2012 Plan. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719636a.jpg" ALT="LOGO">
</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B>Approval of Amendment to the SPP. </B><B></B>Shareholders will be asked to approve Amendment No.&nbsp;1 to the Company&#146;s Second Amended and Restated Stock Purchase Plan (the &#147;SPP&#148;) to increase
the number of shares subject to awards under the SPP (the &#147;SPP Amendment&#148;).&nbsp;The Board unanimously recommends that shareholders vote &#147;FOR&#148; the proposal to amend the SPP. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719637a.jpg" ALT="LOGO">
</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B>Ratification of the Selection of EY. </B><B></B>Shareholders will be asked to approve a resolution to ratify the selection of Ernst&nbsp;&amp; Young LLP (&#147;EY&#148;) as the independent registered public
accounting firm for Orthofix and its subsidiaries for the fiscal year ending December&nbsp;31, 2018.&nbsp;The Board unanimously recommends that shareholders vote &#147;FOR&#148; the proposal to ratify the selection of EY as the independent
registered public accounting firm. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719638a.jpg" ALT="LOGO">
</B><B></B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B>Miscellaneous. </B><B></B>Shareholders will be asked to transact such other business as may come before the Annual General Meeting or any adjournment or postponement thereof. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing proposals are more fully described in the proxy statement/prospectus accompanying this notice. Please give your attention to all of the
information in the accompanying proxy statement/prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All record holders of Orthofix common shares at the close of business on April&nbsp;24, 2018
are being sent this notice and will be entitled to vote at the Annual General Meeting. Each record holder on such date is entitled to cast one vote per common share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are sending the proxy statement/prospectus to shareholders on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018, together with
an accompanying proxy voting card and the Orthofix Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2017. A copy of the consolidated financial statements for the fiscal year ended
December&nbsp;31, 2017 have been filed at the offices of Orthofix at 7 Abraham de Veerstraat, Cura&ccedil;ao and are available for inspection by shareholders until the conclusion of the Annual General Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you have any questions regarding the proxy statement/prospectus, you may contact Mark Quick, Investor Relations, by calling (214) 937-2924 or Saratoga
Proxy Consulting LLC, our proxy solicitor, by calling toll-free at (888) <FONT STYLE="white-space:nowrap">368-0379.</FONT><SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your vote is important. Please refer to the proxy voting card or other voting instructions included with these proxy materials for information on how to vote
by proxy or in person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g571963g0420113918240.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ronald A. Matricaria </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chairman of the Board </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SHAREHOLDERS MEETING TO BE HELD ON JUNE&nbsp;18, 2018: A COPY OF THIS PROXY
STATEMENT, PROXY VOTING CARD AND THE ORTHOFIX ANNUAL REPORT ON FORM <FONT STYLE="white-space:nowrap">10-K</FONT> FOR THE YEAR ENDED DECEMBER&nbsp;31, 2017 ARE AVAILABLE AT <U>WWW.PROXYDOCS.COM/OFIX</U>. </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Additional Information</FONT></B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus incorporates important business and financial information about Orthofix International N.V.
(&#147;Orthofix,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; or &#147;our&#148;) from other documents that are not included in or delivered with this proxy statement/prospectus. This information is available to you without charge
upon your written or oral request. You can obtain the documents incorporated by reference into this proxy statement/prospectus by requesting them from Orthofix by writing to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Orthofix International N.V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">c/o
Orthofix Holdings, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3451 Plano Parkway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Lewisville, Texas 75056 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention:&nbsp;Mr.&nbsp;Mark Quick, Investor Relations </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may also contact Mr.&nbsp;Quick at (214) <FONT STYLE="white-space:nowrap">937-2924</FONT> or at <U>MarkQuick@orthofix.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may also contact Saratoga Proxy Consulting LLC, our proxy solicitor, at the following address and phone number: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Saratoga Proxy Consulting LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">520
8th Avenue, 14th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, New York 10018 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(212) <FONT STYLE="white-space:nowrap">257-1311</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(888) <FONT STYLE="white-space:nowrap">368-0379</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If you would like to request any documents that are incorporated by reference into this proxy statement/prospectus, please do so at least five business
days before the Annual General Meeting of Shareholders to be held on June 18, 2018 (the &#147;Annual General Meeting&#148;), or by June 17, 2018, in order to receive them before the Annual General Meeting. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This information is also available for you to review at the U.S. Securities and Exchange Commission&#146;s (the &#147;SEC&#148;) public reference room located
at 100 F Street, N.E., Room 1580, Washington, D.C. 20549, and through the SEC&#146;s website at <U>www.sec.gov</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information, see
&#147;<I>Where You Can Find More Information and Incorporation by Reference</I>&#148; beginning on page 104 of this proxy statement/prospectus. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">About this Proxy Statement/Prospectus</FONT></B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus, which forms part of a registration statement on Form
<FONT STYLE="white-space:nowrap">S-4</FONT> (Registration Statement No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ) filed by Orthofix with the SEC, constitutes a prospectus of Orthofix for purposes of the Securities Act of 1933, as
amended (the &#147;Securities Act&#148;), with respect to the shares of common stock of Orthofix Medical Inc. to be issued in exchange for common shares of Orthofix International N.V. in connection with the change of the Company&#146;s jurisdiction
of organization from Cura&ccedil;ao to the State of Delaware in accordance with the conversion procedures of Articles 304 and 305 of Book 2 of the Cura&ccedil;ao Civil Code and the domestication procedures of Section&nbsp;388 of the Delaware General
Corporation Law (the &#147;domestication&#148;). This proxy statement/prospectus also constitutes a proxy statement for Orthofix for purposes of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;). In addition, it
constitutes a notice of annual meeting with respect to the Company&#146;s Annual General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained or
incorporated by reference in this proxy statement/prospectus. No one has been authorized to provide you with information that is different from that contained in, or incorporated by reference into, this proxy statement/prospectus. This proxy
statement/prospectus is dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018. You should not assume that the information contained in, or
incorporated by reference into, this proxy statement/prospectus is accurate as of any date other than that date. Neither the mailing of this proxy statement/prospectus to Orthofix&#146;s shareholders nor the domestication of the Company as a
Delaware corporation will create any implication to the contrary. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus does not constitute an offer to sell, or a solicitation of an offer to buy, any
securities, or the solicitation of a proxy, in any jurisdiction in which or to any person to whom it is unlawful to make any such offer or solicitation in such jurisdiction. Information contained in this proxy statement/prospectus regarding Orthofix
has been provided by Orthofix. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">Cautionary Statement Regarding Forward-Looking Statements</FONT></B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus and the annexes attached hereto contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section&nbsp;21E of the Exchange Act, and Section&nbsp;27A of the Securities Act, relating to our business and financial outlook, which are based on our current beliefs, assumptions, expectations,
estimates, forecasts and projections. In some cases, you can identify forward-looking statements by terminology such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;expects,&#148; &#147;plans,&#148; &#147;anticipates,&#148;
&#147;believes,&#148; &#147;estimates,&#148; &#147;projects,&#148; &#147;intends,&#148; &#147;predicts,&#148; &#147;potential,&#148; or &#147;continue&#148; or other words, phrases or expressions of similar import, or the negative of such words or
phrases or other words or expressions of similar meaning, including statements regarding the benefits of the domestication and related transactions or the future financial condition, results of operation and business of the Company. Without limiting
the generality of the preceding sentence, certain information contained in the sections &#147;<I>Proposal 1: Domestication in Delaware</I>&#148; and &#147;<I>Comparison of Corporate Governance and Shareholder Rights</I>&#148; constitute forward
looking statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We based these forward-looking statements on particular assumptions that we have made in light of our industry experience, as well as
our perception of historical trends, current conditions, expected future developments and other factors that we believe are appropriate under the circumstances. These forward-looking statements are not guarantees of our future performance and
involve risks, uncertainties, estimates and assumptions that are difficult to predict. Therefore, our actual outcomes and results may differ materially from those expressed in these forward-looking statements. In addition to other factors and
matters contained in this proxy statement/prospectus, including those disclosed under &#147;<I>Risk Factors</I>&#148; beginning on page 13, these forward-looking statements are subject to risks, uncertainties and other factors, including, among
others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to obtain the required shareholder vote to adopt the domestication proposal at the Annual General Meeting; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the satisfaction of other conditions to the domestication; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the outcome of any legal proceedings that may be instituted against us following announcement of the domestication and related transactions; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to maintain the listing of our common stock on the Nasdaq Global Select Market following the domestication; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to take advantage of the potential strategic opportunities provided by, and realize the potential benefits of, the domestication; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the risk that the domestication disrupts current plans and operations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the risk that shareholders may recognize gain or other income with respect to their shares at the effective time of the domestication; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the future financial performance of the Company following the domestication, including our anticipated growth rate and market opportunity; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in shareholders&#146; rights as a result of the domestication; </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to adapt to operating under the laws of the State of Delaware; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">business uncertainties while the domestication is pending; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the risk that the Board may defer or abandon the domestication; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">costs related to the domestication; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in general political, economic and competitive conditions and specific market conditions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">adverse changes in the medical device industry; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">other risks detailed in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2017 filed by the Company with the SEC and incorporated herein by reference. See also
&#147;<I>Where You Can Find More Information and Incorporation by Reference</I>&#148; on page 104 of this proxy statement/prospectus. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be
inaccurate, and therefore there can be no assurance that such statements included in this proxy statement/prospectus will prove to be accurate. As you read and consider the information in this proxy statement/prospectus, you are cautioned to not
place undue reliance on these forward-looking statements. These statements are not guarantees of performance or results and speak only as of the date of this proxy statement/prospectus, in the case of forward-looking statements contained in this
proxy statement/prospectus, or the dates of the documents incorporated by reference or attached as annexes to this proxy statement/prospectus, in the case of forward-looking statements made in those documents. We undertake no obligation to update or
revise any forward-looking statements, whether as a result of new information or developments, future events or otherwise, except as required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by the Company or any other person that the results or conditions
described in such statements or the objectives and plans expressed will be achieved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All forward-looking statements, expressed or implied, included in
this proxy statement/prospectus are expressly qualified in their entirety by this cautionary statement. This cautionary statement should also be considered in connection with any subsequent written or oral forward-looking statements that we or any
persons acting on our behalf may issue. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_1">QUESTIONS AND ANSWERS ABOUT THE ANNUAL GENERAL MEETING AND THE
DOMESTICATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_2">When and where is the Annual General Meeting?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_3">What matters will be voted on at the Annual General Meeting?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_4">How does the Board recommend that I vote on the proposals?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_5">What is the proposed domestication transaction?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_6">How will shareholders be affected by the domestication?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_7">Why is Orthofix proposing the domestication?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_8">Are there any conditions to the domestication?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_9">If the domestication resolution is adopted, when is the domestication expected
 to be completed?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_10">Are there risks associated with the domestication that I should consider in deciding
how to vote?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_11">What are the material U.S. federal income tax consequences of the domestication
 to U.S. shareholders?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_12">Who is entitled to vote at the Annual General Meeting?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_13">What constitutes a quorum for the Annual General Meeting?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_14">What vote is required for shareholders to approve the
proposals?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_15">How are votes counted?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_16">How do I vote?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_17">How can I revoke or change my vote?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_18">What else do I need to know?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_19">Who can answer my questions?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_20">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_21">The Company</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_22">The Annual General Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_23">The Domestication</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_24">Comparison of Corporate Governance and Shareholder Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_25">Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_26">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_27">Material U.S. Federal Income Tax Considerations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_28">SELECTED HISTORICAL FINANCIAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_29">MARKET PRICES AND DIVIDEND INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_30">Market Price for Common Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_31">Holders of Record</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_32">Dividends</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_33">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_34">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_35">THE ANNUAL GENERAL MEETING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_36">Date, Time and Place</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_37">Purpose of the Annual General Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_38">Record Date</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_39">Quorum, Vote Required</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_40">Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_41">Voting is Confidential</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_42">The Costs of Soliciting These Proxies and Who Will Pay for
Them</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_43">The Voting Results</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_44">Obtaining an Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT>
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_45">Whom to Call if you have any Questions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_46">Important Notice Regarding the Availability of Proxy Materials for the Annual
 General Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_47">PROPOSAL 1: DOMESTICATION IN DELAWARE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_48">Overview</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_49">Reasons for the Domestication</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_50">The Domestication Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_51">Conditions to Completion of the Domestication</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_52">Regulatory Approvals Related to the Domestication</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_53">Exchange of Shares</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_54">No Dissenters&#146; Rights of Appraisal in the Domestication</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_55">Termination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_56">Orthofix Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_57">Interests of Certain Persons in the Domestication</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_58">Anticipated Accounting Treatment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_59">Material U.S. Federal Income Tax Considerations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_60">Vote Required for Adoption</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_61">Resolution to be Voted Upon</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_62">DESCRIPTION OF ORTHOFIX CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_63">General</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_64">Authorized Share Capital</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_65">Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_66">Dividends</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="97%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_67">Certain Anti-Takeover Provisions of Delaware Law and the Proposed Organizational
 Documents</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_68">Listing of Securities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_69">Transfer Agent</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_70">COMPARISON OF CORPORATE GOVERNANCE AND SHAREHOLDER RIGHTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_71">MATERIAL TAX CONSIDERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_72">Material U.S. Federal Income Tax Considerations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_73">U.S. Shareholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_74"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Shareholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom571963_74a">Information Reporting and Backup Withholding </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom571963_74b">Foreign Account Tax Compliance Act </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_75">MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_76">Corporate Governance Highlights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_77">Executive Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_78">The Board and Committees of the Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_79">Section&nbsp;16(a) Beneficial Ownership Reporting Compliance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_80">Compensation Discussion and Analysis</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_81">Report of the Compensation Committee</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_82">Summary Compensation Table</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_83">Grants of Plan-Based Awards</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_84">Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End
</FONT></A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_85">Option Exercises and Stock Vested</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_86">Deferred Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_87">Potential Payments upon Termination or Change in Control</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_88">Pay Ratio Disclosure</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_89">Director Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_90">Equity Compensation Plan Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_91">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_92">Compensation Committee Interlocks and Insider Participation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_93">Approval of Related Person Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_94">Transactions with Related Persons</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_95">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_96">Who are the principal owners of Orthofix common shares?</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_97">Common shares owned by Orthofix&#146;s directors and executive
officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_98">PROPOSAL 2:&nbsp;ELECTION OF DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_99">Current Directors (and Directors Standing for Election at the Annual General Meeting)
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_100">PROPOSAL 3: APPROVAL OF FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER&nbsp;31,
 2017</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_101">PROPOSAL 4:&nbsp;
ADVISORY AND <FONT STYLE="white-space:nowrap">NON-BINDING</FONT> VOTE ON EXECUTIVE COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_102">PROPOSAL 5: APPROVAL OF THE AMENDED AND RESTATED 2012 LONG-TERM INCENTIVE PLAN
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_103">Description of the Plan</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_104">Federal Income Tax Consequences</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_105">New Plan Benefits</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_106">PROPOSAL 6: APPROVAL OF AMENDMENT NO.&nbsp;
1 TO THE SECOND AMENDED AND RESTATED STOCK PURCHASE PLAN</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom571963_120">Description of the SPP </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><A HREF="#tx571963_107">PROPOSAL 7: RATIFICATION OF THE SELECTION OF EY AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2018</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_108">Principal Accountant Fees and Services</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_109">Audit Fees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_110">Audit-Related Fees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_111">Tax Fees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_112">All Other Fees</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_113"><FONT STYLE="white-space:nowrap">Pre-Approval</FONT> Policies and Procedures
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_114">REPORT OF THE AUDIT AND FINANCE COMMITTEE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_115">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_116">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_117">INFORMATION ABOUT SHAREHOLDER PROPOSALS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_118">MULTIPLE SHAREHOLDERS SHARING ONE ADDRESS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx571963_119">WHERE YOU CAN FIND MORE INFORMATION AND INCORPORATION BY
REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><A HREF="#rom571963_125">ANNEX A: Proposed Orthofix Medical Inc. Certificate of Incorporation </A> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><A HREF="#rom571963_126">ANNEX B: Proposed Orthofix Medical Inc. Bylaws </A> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><A HREF="#rom571963_127">ANNEX C: Amended and Restated 2012 Long-Term Incentive Plan </A> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><A HREF="#rom571963_128">ANNEX D: Second Amended and Restated Stock Purchase Plan&nbsp;&amp; Amendment No.&nbsp;1 Thereto </A> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iv </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_1"></A></FONT>QUESTIONS AND ANSWERS ABOUT THE ANNUAL GENERAL MEETING AND THE DOMESTICATION </B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following questions and answers are intended to address briefly some commonly asked questions regarding Orthofix
International N.V.&#146;s intent to change its jurisdiction of organization from Cura&ccedil;ao to the State of Delaware (the &#147;domestication&#148;) and the Annual General Meeting of Shareholders to be held on June&nbsp;18, 2018 (the
&#147;Annual General Meeting&#148;). These questions and answers may not address all questions that may be important to you. Please refer to the more detailed information contained elsewhere in this proxy statement/prospectus, its annexes and the
documents referred to or incorporated by reference in this proxy statement/prospectus for more information. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Unless the context otherwise requires,
the terms the &#147;Company,&#148; &#147;Orthofix,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to Orthofix International N.V. as it currently exists under Cura&ccedil;ao law and will continue under Delaware law after the
domestication. The term &#147;Orthofix Cura&ccedil;ao&#148; refers to the Company prior to the domestication and the term &#147;Orthofix Delaware&#148; refers to the Company after the domestication. We refer to holders of our securities as our
&#147;shareholders.&#148; Our shareholders will hold Orthofix Cura&ccedil;ao common shares prior to the domestication and shares of Orthofix Delaware common stock after the domestication. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_2"></A>When and where is the Annual General Meeting? </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Annual General Meeting will be held on June 18, 2018 at 11:00 a.m. Atlantic Standard Time (AST) at Orthofix&#146;s offices, located at 7 Abraham de
Veerstraat, Cura&ccedil;ao. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_3"></A>What matters will be voted on at the Annual General Meeting?
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be asked to consider and vote on the following proposals: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719631a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to adopt a shareholders&#146; resolution to change the jurisdiction of organization of Orthofix from Cura&ccedil;ao to the State of Delaware (the &#147;domestication resolution&#148;); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719632a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to elect the nine nominees named in this proxy statement/prospectus to the Board of Directors of Orthofix (the &#147;Board&#148;); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719633a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to approve the consolidated balance sheet and consolidated statement of operations at and for the fiscal year ended December&nbsp;31, 2017; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719634a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to approve an advisory and <FONT STYLE="white-space:nowrap">non-binding</FONT> resolution on the compensation of Orthofix&#146;s named executive officers as disclosed in this proxy statement/prospectus;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719635a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to approve the Company&#146;s Amended and Restated 2012 Long-Term Incentive Plan (the &#147;Amended and Restated 2012 Plan&#148;); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719636a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to approve Amendment No.&nbsp;1 to the Company&#146;s Stock Purchase Plan (the &#147;SPP&#148;) to increase the number of shares subject to awards under the SPP (the &#147;SPP Amendment&#148;); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719637a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to ratify the selection of Ernst&nbsp;&amp; Young LLP (&#147;EY&#148;) as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December&nbsp;31, 2018; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719638a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to transact such other business as may come before the Annual General Meeting or any adjournment or postponement thereof. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_4"></A>How does the Board recommend that I vote on the proposals?
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After careful consideration, the Board has unanimously determined that the domestication and related transactions are advisable and in the
best interest of the shareholders and has unanimously approved the domestication and related transactions, subject to the adoption of the domestication resolution by the requisite vote of our shareholders. <B>The</B> <B>domestication resolution must
be adopted by the affirmative vote of holders representing an absolute majority of the outstanding common shares as of the Record Date (as defined below) in order for the Company to be able to effectuate the domestication. The Board urges
shareholders to join Orthofix in supporting this important proposal and unanimously recommends that you vote &#147;FOR&#148; the proposal to adopt the domestication resolution. </B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Board also unanimously recommends that you vote &#147;FOR&#148; each of the other items at the Annual General Meeting: &#147;FOR&#148; the election of
each of the director nominees, &#147;FOR&#148; the approval of the financial statements, &#147;FOR&#148; the approval, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, of the compensation of the Company&#146;s named executive
officers, &#147;FOR&#148; the approval of the Amended and Restated 2012 Plan, &#147;FOR&#148; the approval of the SPP Amendment and &#147;FOR&#148; the ratification of EY. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_5"></A>What is the proposed domestication transaction? </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposed domestication is a transaction whereby the Company will change its jurisdiction of organization from a Cura&ccedil;ao limited liability company
(<I>naamloze vennootschap</I>) to a Delaware corporation in accordance with the conversion procedures of Articles 304 and 305 of Book 2 of the Cura&ccedil;ao Civil Code (the &#147;CCC&#148;) and the domestication procedures of Section&nbsp;388 of
the Delaware General Corporation Law (the &#147;DGCL&#148;). The domestication will only be completed if the domestication resolution is adopted by the requisite vote of our shareholders at the Annual General Meeting and all other conditions to the
domestication are satisfied. Following the domestication, the Company will be renamed &#147;Orthofix Medical Inc.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_6">
</A>How will shareholders be affected by the domestication? </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the domestication resolution is adopted by the requisite vote of our
shareholders, the number of shares of common stock that you will own in Orthofix Delaware on the effective date of the domestication will be the same as the number of common shares of Orthofix Cura&ccedil;ao that you held immediately prior to the
effectuation of the domestication. Orthofix Delaware&#146;s common stock will continue to be traded on Nasdaq under the symbol &#147;OFIX.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currently, your rights as a shareholder of the Company arise under the laws of Cura&ccedil;ao, as well as our current Articles of Association of the Company
(the &#147;Existing Articles of Association&#148;). Upon the effectiveness of the domestication, your rights as a shareholder of the Company will arise under Delaware law and our proposed Certificate of Incorporation, attached as Annex A to this
proxy statement/prospectus (the &#147;Proposed Certificate of Incorporation&#148;) and proposed Bylaws, attached as Annex B to this proxy statement/prospectus (the &#147;Proposed Bylaws,&#148; and, together with the Proposed Certificate of
Incorporation, the &#147;Proposed Organizational Documents&#148;). Delaware law and the Proposed Organizational Documents contain provisions that differ in certain respects from Cura&ccedil;ao law and our Existing Articles of Association and,
therefore, some of your rights as a shareholder will change. For a description of your rights following the domestication and how they may differ from your current rights, please see &#147;<I>Comparison of Corporate Governance and Shareholder
Rights</I>&#148; beginning on page 29. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_7"></A>Why is Orthofix proposing the domestication?
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board believes that the domestication will provide a number of significant potential strategic opportunities and benefits, including,
among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">aligning our incorporation with our primary business operations, which are in the United States; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">improving operational and financial flexibility by simplifying our corporate structure, which will allow for improved cash management capabilities and increased business efficiencies; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">benefiting from the prominence, predictability and flexibility of Delaware law and a well-established corporate governance regime; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">positioning the Company to better respond to global tax developments. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has unanimously determined
that the domestication is advisable and in the best interests of the Company and its shareholders and has unanimously approved the domestication and related transactions. To review the reasons for the domestication in greater detail, please see
&#147;<I>Proposal 1: Domestication in Delaware&#151;Reasons for the Domestication</I>&#148; beginning on page 20. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_8">
</A>Are there any conditions to the domestication?<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yes. In addition to the adoption
of the domestication resolution by the shareholders of the Company, as described herein, we must satisfy certain other conditions in order to effectuate the domestication, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Company has published certain notices in Cura&ccedil;ao newspapers announcing its intent to change its jurisdiction of organization from Cura&ccedil;ao to the State of Delaware, as required by Cura&ccedil;ao law,
and has completed related procedures, as further described in &#147;<I>Proposal 1: Domestication in Delaware&#151;Conditions to Completion of the Domestication</I>&#148; beginning on page 20; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Board has determined the effective date and time of the domestication, such effective date to be on or prior to January&nbsp;1, 2019, and has confirmed that the domestication should not be delayed or abandoned;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the SEC has declared the registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> that includes this proxy statement/prospectus effective, and no stop order with respect thereto is in effect;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Nasdaq Global Select Market (&#147;Nasdaq&#148;) has approved the Orthofix Delaware common stock for listing; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Orthofix is not subject to any decree, order or injunction that prohibits the consummation of the domestication. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_9"></A>If the domestication resolution is adopted, when is the domestication expected to be completed?
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the domestication resolution is adopted by the requisite vote of our shareholders and all other conditions to the domestication are
satisfied, we expect the domestication to occur on or before January&nbsp;1, 2019. If the domestication is not effectuated on or before January&nbsp;1, 2019, for whatever reason, we would need to ask shareholders to adopt a new domestication
resolution in order to pursue a domestication transaction. For a description of the steps required to consummate the domestication, including timing, please see &#147;<I>Proposal 1: Domestication in Delaware&#151;The Domestication
Transactions</I>&#148; beginning on page 20. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_10"></A>Are there risks associated with the domestication that
I should consider in deciding how to vote? </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yes. There are a number of risks related to the domestication that are discussed in this proxy
statement/prospectus described in the section entitled &#147;<I>Risk Factors</I>&#148; beginning on page 13. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_11">
</A>What are the material U.S. federal income tax consequences of the domestication to U.S. shareholders? </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. shareholders (as defined in
&#147;<I>Material Tax Considerations&#151;U.S. Shareholders</I>&#148; below) may be subject to U.S. federal income tax as a result of the domestication. Please see the section entitled &#147;<I>Material Tax Considerations</I>&#148; beginning on page
34 for a discussion of material U.S. federal income tax consequences of the domestication. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You should consult your tax advisors with respect to the application of U.S. federal tax laws to your
particular situation, as well as any tax consequences arising under the laws of any state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_12"></A>Who is entitled to vote at the Annual General Meeting? </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All record holders of Orthofix Cura&ccedil;ao common shares at the close of business on April&nbsp;24, 2018 (the &#147;Record Date&#148;) are being sent this
proxy statement/prospectus and will be entitled to vote at the Annual General Meeting. Each record holder on such date is entitled to cast one vote per common share. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_13"></A>What constitutes a quorum for the Annual General Meeting? </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The presence, in person or by proxy, of the holders of at least 50% of Orthofix Cura&ccedil;ao common shares outstanding on the Record Date is required to
constitute a quorum at the Annual General Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_14"></A>What vote is required for shareholders to
approve the proposals? </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The affirmative vote of the holders representing an absolute majority of the outstanding common shares as of the
Record Date will be required in order to adopt the domestication resolution (Proposal 1) at the Annual General Meeting. Assuming a quorum is present, the nominees for election as directors in Proposal 2 will be elected upon the affirmative vote of a
plurality of all votes cast at the Annual General Meeting. Assuming a quorum is present, the approval of the holders of a majority of the votes cast on Proposals 3, 4, 5, 6 and 7 at the Annual General Meeting will be required to approve each of
these Proposals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_15"></A>How are votes counted? </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Abstentions and &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;</FONT> are counted as shares that are present and entitled to vote on the
proposals for purposes of determining the presence of a quorum. A broker <FONT STYLE="white-space:nowrap">&#147;non-vote&#148;</FONT> occurs when a broker holding shares for a beneficial owner does not vote on a particular proposal because the
broker does not have discretionary voting power for that particular item and has not received instructions from the beneficial owner. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have the effect of a vote
&#147;against&#148; Proposal 1. Neither abstentions nor broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have any effect on the outcome of voting on Proposals 2, 3, 4, 5, 6 and 7. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_16"></A>How do I vote? </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a record holder, you may cast your vote at <U>https://www.proxypush.com/ofix</U>. See your proxy voting card for your online control number in order
to vote. If your common shares are held in &#147;street name,&#148; you will receive instructions from your broker, bank or other nominee that you must follow in order to have your common shares voted. All votes must be cast and received by 5:00
p.m., Eastern Daylight Time (EDT), on June 17, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_17"></A>How can I revoke or change my vote?
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any proxy given pursuant to this solicitation may be revoked by the person giving it at any time before it is voted. Proxies may be revoked
by (1)&nbsp;filing with Orthofix, at or before the taking of the vote at the Annual General Meeting, a written notice of revocation bearing a later date than the proxy, or (2)&nbsp;duly executing a subsequent proxy relating to the same common shares
and delivering it to Orthofix before the Annual General Meeting. Attending the Annual General Meeting will not in and of itself constitute the revocation of a proxy. Any written notice of revocation or subsequent proxy should be sent so as to be
delivered to: Orthofix International N.V., 7 Abraham de Veerstraat, Cura&ccedil;ao, at or before the taking of the vote at the Annual General Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_18"></A>What else do I need to know? </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are urged to read this proxy statement/prospectus carefully and in its entirety, including its annexes. You are also urged to consider how the
domestication affects you, including any application of U.S. federal tax laws, as well as any tax consequences arising under the laws of any state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction. Even if you plan to attend
the Annual General Meeting, if you hold your common shares in your own name as the shareholder of record, please vote your shares by completing, signing, dating and returning the enclosed proxy voting card. You can also attend the Annual General
Meeting and vote, or change your prior vote, in person. If you hold your shares in &#147;street name&#148; through a bank, broker or other nominee, then you should have received this proxy statement/prospectus from that nominee, along with that
nominee&#146;s proxy voting card, which includes voting instructions and instructions on how to change your vote. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_19">
</A>Who can answer my questions? </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you have any questions about the domestication or the other matters to be voted on at the Annual
General Meeting or how to submit your proxy or need additional copies of this proxy statement/prospectus, the enclosed proxy voting card or voting instructions, please contact Saratoga Proxy Consulting, LLC (&#147;Saratoga&#148;), our proxy
solicitor, at the following address and phone numbers: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Saratoga Proxy Consulting LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">520 8th Avenue, 14th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New
York, New York 10018 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(212) <FONT STYLE="white-space:nowrap">257-1311</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(888) <FONT STYLE="white-space:nowrap">368-0379</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may also contact Orthofix directly by writing to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Orthofix International N.V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">c/o
Orthofix Holdings, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3451 Plano Parkway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Lewisville, Texas 75056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention:
Mr.&nbsp;Mark Quick, Investor Relations </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may also contact Mr.&nbsp;Quick at (214) <FONT STYLE="white-space:nowrap">937-2924</FONT> or at
<U>MarkQuick@orthofix.com</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_20"></A>SUMMARY</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information from this proxy statement/prospectus and does not contain all of the
information that is important to you</I>. <I>You should read carefully this entire proxy statement/prospectus, including the annexes, to fully understand the proposals to be voted on at the Annual General Meeting, including the proposal to adopt the
domestication resolution. Please see the section entitled &#147;Where You Can Find More Information and Incorporation by Reference&#148; beginning on page 104 of this proxy statement/prospectus. </I> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_21"></A>The Company (Page 16) </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently a limited liability company (<I>naamloze vennootschap</I>) operating under the laws of Cura&ccedil;ao. We are a global medical device company
focused on musculoskeletal healing products and value-added services. We have four strategic business units (&#147;SBUs&#148;) that are also our reporting segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. Our products are
distributed by our sales representatives and distributors in over 60 countries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our offices in Cura&ccedil;ao are located at 7 Abraham de Veerstraat,
Cura&ccedil;ao and our U.S. headquarters are located at 3451 Plano Parkway, Lewisville, Texas 75056. We intend to relocate our offices in Cura&ccedil;ao to our corporate headquarters in Lewisville, Texas following the domestication. Our phone
numbers at these respective locations are <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">599-9-4658525</FONT></FONT> and (214) <FONT STYLE="white-space:nowrap">937-2000,</FONT> respectively, and our website is available at
<U>www.orthofix.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_22"></A>The Annual General Meeting (Page 17) </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Date, Time and Place. </I></B>The Annual General Meeting will be held on June 18, 2018 at 11:00 a.m. Atlantic Standard Time (AST) at Orthofix&#146;s
offices, located at 7 Abraham de Veerstraat, Cura&ccedil;ao. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Purpose. </I></B>At the Annual General Meeting, you will be asked to consider and vote
on: (1)&nbsp;the adoption of the domestication resolution to change the jurisdiction of organization of the Company from Cura&ccedil;ao to the State of Delaware, (2)&nbsp;the election of nine directors to the Board, (3)&nbsp;the approval of the
Company&#146;s consolidated balance sheet and consolidated statement of operations for the fiscal year ended December&nbsp;31, 2017, (4) the approval, on an advisory and <FONT STYLE="white-space:nowrap">non-binding</FONT> basis, of the compensation
of the Company&#146;s named executive officers, (5)&nbsp;the approval of the Company&#146;s Amended and Restated 2012 Plan, (6)&nbsp;the approval of the SPP Amendment and (7)&nbsp;the ratification of the appointment of EY as the Company&#146;s
independent registered accounting firm for the year ending December&nbsp;31, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Board has unanimously approved the domestication and the other
proposals described in this proxy statement/prospectus and has unanimously resolved to submit such proposals to the Company&#146;s shareholders. The Board recommends that you vote &#147;FOR&#148; the adoption of the domestication resolution,
&#147;FOR&#148; the election of each of the director nominees, &#147;FOR&#148; the approval of the financial statements, &#147;FOR&#148; the approval, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, of the compensation of
the Company&#146;s named executive officers, &#147;FOR&#148; the approval of the Amended and Restated 2012 Plan, &#147;FOR&#148; the approval of the SPP Amendment and &#147;FOR&#148; the ratification of EY. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Record Date; Voting Rights. </I></B>Orthofix Cura&ccedil;ao&#146;s shareholders of record as of the close of business on April&nbsp;24, 2018, the Record
Date, will be entitled to vote at the Annual General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Quorum</I></B>. The presence, in person or by proxy, of the holders of at least 50%
of Orthofix Cura&ccedil;ao common shares outstanding on the Record Date is required to constitute a quorum at the Annual General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Required
Vote. </I></B>The affirmative vote of the holders representing an absolute majority of the outstanding common shares as of the Record Date will be required in order to adopt the domestication resolution at the Annual General Meeting. Assuming a
quorum is present, the nominees for election as directors in Proposal 2 will be elected upon the affirmative vote of a plurality of all votes cast at the Annual General Meeting. Assuming a quorum is present, the approval of the holders of a majority
of the votes cast on Proposals 3, 4, 5, 6 and 7 at the Annual General Meeting will be required to approve each of these Proposals. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_23"></A>The Domestication (Page 20) </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are asking our shareholders to adopt the
domestication resolution to change the jurisdiction of organization of the Company from Cura&ccedil;ao to the State of Delaware. If the shareholders vote to adopt the domestication resolution, and the other conditions to completion of the
domestication are satisfied, the Company anticipates that, on or prior to January&nbsp;1, 2019, it will complete the domestication in accordance with the conversion procedures of Articles 304 and 305 of Book 2 of the Cura&ccedil;ao Civil Code and
the domestication procedures of Section&nbsp;388 of the Delaware General Corporation Law. On April&nbsp;23, 2018, the Board unanimously approved the domestication and related transactions and unanimously resolved to propose the domestication
resolution to the shareholders for adoption. The Board urges shareholders to join in supporting this important proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the domestication resolution
is adopted by the requisite vote of our shareholders and the domestication is completed, the number of shares of common stock that you will own in Orthofix Delaware on the effective date of the domestication will be the same as the number of common
shares you held in Orthofix Cura&ccedil;ao immediately prior to the effectuation of the domestication. Orthofix Delaware&#146;s common stock will continue to be traded on Nasdaq under the symbol &#147;OFIX.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for the Domestication </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board believes that
the domestication will provide a number of significant potential strategic opportunities and benefits, including, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">aligning our incorporation with our primary business operations, which are in the United States; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">improving operational and financial flexibility by simplifying our corporate structure, which will allow for improved cash management capabilities and increased business efficiencies; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">benefiting from the prominence, predictability and flexibility of Delaware law and a well-established corporate governance regime; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">positioning the Company to better respond to global tax developments. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Domestication Transactions
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the domestication resolution is adopted by the requisite vote of our shareholders at the Annual General Meeting and the other conditions to the
domestication are satisfied, we anticipate the domestication will be completed on or before January&nbsp;1, 2019. There are several principal steps to effect the domestication: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Shareholders of Orthofix will vote on whether to adopt the domestication resolution at the Annual General Meeting. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If the domestication resolution is adopted by the requisite vote of our shareholders, then a notarial deed of conversion documenting the domestication resolution will be executed in Cura&ccedil;ao. The notarial deed of
conversion will contain conditions precedent (<I>opschortende voorwaarden</I>), such that (i)&nbsp;the Board must determine the effective date and time of the domestication, such effective date to be on or prior to January 1, 2019, and confirm that
the domestication should not be delayed or abandoned and (ii)&nbsp;the conversion of Orthofix Cura&ccedil;ao pursuant to Articles 304 and 305 of Book 2 of the CCC will be effective only upon the acceptance and effectiveness of the Proposed
Certificate of Incorporation and a certificate of corporate domestication by the Secretary of State of the State of Delaware (the &#147;Delaware SOS&#148;). </TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Following adoption of the domestication resolution at the Annual General Meeting, and subject to satisfaction of the other conditions to completion of the domestication, as described under &#147;<I>Proposal 1:
Domestication in Delaware&#151;Conditions to Completion of the Domestication</I>,&#148; the Proposed Certificate of Incorporation and a certificate of corporate domestication will be filed with the Delaware SOS and, upon acceptance of the filings
(or such later time as is specified in the filings), Orthofix Delaware will exist as a Delaware corporation. These filings with the Delaware SOS are anticipated to be made and become effective on or before January&nbsp;1, 2019, on such date as is
determined by the Board. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As soon as possible following acceptance and effectiveness of the filings by the Delaware SOS, the notarial deed of conversion will be registered with the Cura&ccedil;ao Commercial Register. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exchange of Orthofix Cura&ccedil;ao common shares into shares of Orthofix Delaware common stock will occur automatically upon acceptance and effectiveness
of the filings by the Delaware SOS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conditions to Completion of the Domestication </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the Annual General Meeting, Orthofix is required to publish an announcement of its intent to change its jurisdiction of organization from
Cura&ccedil;ao to the State of Delaware in a daily newspaper in Cura&ccedil;ao and in the Cura&ccedil;ao Gazette (<I>Cura&ccedil;aosche Courant</I>) (collectively, the &#147;Publications&#148;). Creditors and certain contracting parties of Orthofix
have the right to object to the domestication by filing an opposition with a Cura&ccedil;ao court within one month of the Publications. Following the expiration of the <FONT STYLE="white-space:nowrap">one-month</FONT> period, the Company must obtain
a declaration from a Cura&ccedil;ao court confirming that no opposition was filed (the &#147;Cura&ccedil;ao Declaration&#148;). The notarial deed of conversion cannot be executed and the domestication cannot be completed until the Company has
received the Cura&ccedil;ao Declaration, or until opposition proceedings, if any, have been settled or dismissed. The Publications were completed on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018. Assuming there are no objections, we expect to receive the Cura&ccedil;ao Declaration prior to
the Annual General Meeting. If a creditor or contracting party objects to the domestication, it may adversely impact the timing of the domestication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
addition to receipt of the Cura&ccedil;ao Declaration, the Company&#146;s ability to initiate the filings in Delaware necessary to effectuate the domestication is conditioned on the following matters: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Board has determined the effective date and time of the domestication, such effective date to be on or prior to January&nbsp;1, 2019, and has confirmed that the domestication should not be delayed or abandoned;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the SEC has declared the registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> that includes this proxy statement/prospectus effective, and no stop order with respect thereto is in effect;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Nasdaq has approved the Orthofix Delaware common stock for listing; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Orthofix is not subject to any decree, order or injunction that prohibits the consummation of the domestication. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of these conditions are not satisfied or waived by the Board, then the domestication will not be effectuated and the Proposed Organizational Documents
will not become effective. In addition, the expected timing for the completion of the domestication may be impacted by these or other conditions described in this proxy statement/prospectus. We cannot be certain when, or if, the conditions to the
domestication will be satisfied or waived, or that the domestication will be completed. As set forth in the domestication resolution, the Board is also authorized to delay or abandon the domestication at any time prior to the initiation of the
filings in Delaware. In addition, if the domestication is not effectuated on or before January&nbsp;1, 2019, we would need to ask shareholders to adopt a new domestication resolution in order to pursue a domestication transaction. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Regulatory Approvals Related to the Domestication </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix is not aware of any material regulatory approvals or actions that are required for completion of the domestication, other than as described above in
&#147;&#151;<I>The Domestication Transactions</I>&#148; and &#147;&#151;<I>Conditions to Completion of the Domestication</I>.&#148; It is presently contemplated that if any such additional regulatory approvals or actions are required, those
approvals or actions will be sought. There can be no assurance, however, that any additional approvals or actions will be obtained. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No
Dissenters&#146; Rights of Appraisal in the Domestication </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Cura&ccedil;ao and Delaware law and our Existing Articles of Association, our
shareholders do not have statutory dissenters&#146; rights of appraisal or any other appraisal rights as a result of the domestication. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interests of
Certain Persons in the Domestication </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not believe that any of our directors or executive officers has an interest in the domestication that is
different from the interests of our shareholders generally. No change in control payments or additional compensation will be payable to our directors or executive officers in connection with the domestication. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_24"></A>Comparison of Corporate Governance and Shareholder Rights (Page 29) </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The domestication will change our jurisdiction of organization from Cura&ccedil;ao to the State of Delaware and, as a result, our organizational documents will
change and will be governed by Delaware law rather than Cura&ccedil;ao law. The Proposed Organizational Documents and Delaware law contain provisions that may differ in certain respects from those in our Existing Articles of Association and
Cura&ccedil;ao law. For a description of your rights following the domestication and how they may differ from your current rights, please see &#147;<I>Comparison of Corporate Governance and Shareholder Rights</I>&#148; beginning on page 29. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_25"></A>Management (Page 42) </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not anticipate any changes to our Board or management team in connection with the domestication. See &#147;<I>Management</I>&#148; on page 42 of this
proxy statement/prospectus for more information regarding our corporate governance, executive officers and Board, as well as detailed information regarding compensation of our named executive officers. At the Annual General Meeting, our shareholders
will be asked to consider and vote on the election of nine directors to the Board, as well as the approval, on an advisory and <FONT STYLE="white-space:nowrap">non-binding</FONT> basis, of the compensation of the Company&#146;s named executive
officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_26"></A>Risk Factors (Page 13) </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should carefully consider all of the risk factors together with all of the other information included in this proxy statement/prospectus before deciding
how to vote. The risks related to the domestication and the related transactions are described under the section &#147;<I>Risk Factors</I>&#148; beginning on page 13. We also urge you to review other risks detailed in our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2017 (the &#147;2017 Form <FONT STYLE="white-space:nowrap">10-K&#148;)</FONT> filed by the Company with the SEC and incorporated herein by reference. See also &#147;<I>Where
You Can Find More Information and Incorporation by Reference</I>&#148; on page 105 of this proxy statement/prospectus. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_27"></A>Material U.S. Federal Income Tax Considerations (Page
34) </I></B></FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. shareholders (as defined in &#147;<I>Material Tax Considerations&#151;U.S. Shareholders</I>&#148; below) may be subject to U.S.
federal income tax as a result of the domestication. See &#147;<I>Material Tax Considerations</I>&#148; on page 34 of this proxy statement/prospectus for more information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You should consult your tax advisors with respect to the application of U.S. federal tax laws to your particular situation, as well as any tax consequences
arising under the laws of any state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction. </B></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_28"></A>SELECTED HISTORICAL FINANCIAL INFORMATION</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following selected historical financial information for each of the years during the five-year period ended
December&nbsp;31, 2017 and the selected balance sheet data as of December&nbsp;31 for each of the years in the five-year period ended December&nbsp;31, 2017 have been derived from the Company&#146;s audited consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read the selected historical financial information below together with the consolidated financial statements and related notes thereto and
management&#146;s discussion and analysis of financial condition and results of operations included in the 2017 Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed by the Company with the SEC and incorporated herein by reference. A copy of the
2017 Form <FONT STYLE="white-space:nowrap">10-K</FONT> is also contained in the materials that we are sending you along with this proxy statement/prospectus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:212.50pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>(U.S. Dollars, in thousands, except margin and per share
data)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated operating results</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">433,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">409,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">396,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">402,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">397,611</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">340,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">321,935</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">309,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">303,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross margin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating income (loss)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,192</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss) from continuing operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,342</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,744</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(18,205</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss from discontinued operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,068</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(441</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(467</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,793</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,607</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,809</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8,537</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(28,812</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net income (loss) per common share &#150; basic</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss) from continuing operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.97</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss from discontinued operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.06</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.57</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.46</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.54</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net income (loss) per common share &#150; diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss) from continuing operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.20</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.97</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss from discontinued operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.05</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.03</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.26</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.57</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income (loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.46</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.54</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Includes the following: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Legal, accounting, and other professional fees incurred in 2017, 2016, 2015, 2014, and 2013 of $3.4&nbsp;million, $2.0&nbsp;million, $9.1&nbsp;million and $15.6&nbsp;million, and $12.9&nbsp;million, respectively, in
connection with the accounting review and restatements through March 2015 and legal fees associated with the SEC Investigation, Securities Class&nbsp;Action Complaint and Brazil subsidiary compliance review. In addition, the Company received an
insurance settlement related to these matters of approximately $6&nbsp;million in 2017 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Charges related to U.S. Government resolutions in 2016 of $14.4&nbsp;million </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Goodwill impairment charge in 2013 of $19.2&nbsp;million </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Dividends have not been paid in any of the years presented. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:93.70pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>(U.S. Dollars, in thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated financial position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">405,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">372,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">400,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">392,956</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">411,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shareholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">296,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">290,311</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">295,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_29"></A>MARKET PRICES AND DIVIDEND INFORMATION</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_30"></A>Market Price for Common Shares </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s common shares are currently listed on Nasdaq under the symbol &#147;OFIX.&#148; The following table presents trading information for the
Company&#146;s common shares on February&nbsp;23, 2018, the business date preceding the announcement that the Company was in the final stages of evaluating the domestication, and
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018, the latest practicable trading day before the date of this proxy statement/prospectus, as reported by Nasdaq. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:16.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Close</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">February&nbsp;23, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">54.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth, for the periods indicated, the reported high and low sales prices of the Company&#146;s common
shares as reported on Nasdaq and the quarterly cash dividends declared per share for each period. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Dividend</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>2016</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">41.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">36.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">46.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">36.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">43.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth Quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">55.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix Delaware common stock will continue to be traded on Nasdaq following the completion of the domestication. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_31"></A>Holders of Record </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the Record Date, there were approximately&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; holders of record of the Company&#146;s
common shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_32"></A>Dividends </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not paid dividends to holders of our common shares in the past and have no present intention to pay dividends in the foreseeable future. We currently
intend to retain all of our consolidated earnings to finance the continued growth of our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that we decide to pay a dividend to
holders of our common stock following the domestication with dividends received from our subsidiaries, we may, based on prevailing rates of taxation, be required to pay additional withholding and income tax on such amounts. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_33"></A>RISK FACTORS</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>In addition to other information included elsewhere in this proxy statement/prospectus and in the annexes to this proxy
statement/prospectus, including the matters addressed in the section entitled &#147;Cautionary Statement Regarding Forward-Looking Statements,&#148; you should carefully consider the following risk factors in deciding whether to vote for the
proposal to adopt the domestication resolution. In addition, you should read and consider the risks associated with the business of Orthofix. These risks can be found in the 2017 Form <FONT STYLE="white-space:nowrap">10-K,</FONT> which report is
incorporated by reference into this proxy statement/prospectus and a copy of which accompanies this proxy statement/prospectus. You should also read and consider other information in this proxy statement/prospectus and the other documents
incorporated by reference into this proxy statement/prospectus. Please also see &#147;Where you can Find More Information&#148; on page 105. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if the domestication qualifies as a reorganization under Section&nbsp;368(a) of the Internal Revenue Code, a U.S. shareholder may still recognize
gain or other income with respect to their shares at the effective time of the domestication. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. shareholders (as defined in &#147;<I>Material
</I><I>Tax Considerations</I>&#151;<I>U.S. Shareholders</I>&#148; below) may be subject to U.S. federal income tax as a result of the domestication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A
U.S. shareholder who on the effective date of the domestication beneficially owns (actually or constructively) shares with a fair market value of $50,000 or more, but less than 10% of the total value or voting power of Orthofix common shares,
generally will recognize gain (but not loss) in respect of the domestication as if such holder exchanged its Orthofix Cura&ccedil;ao shares for Orthofix Delaware shares in a taxable transaction, unless such U.S. shareholder elects in accordance with
applicable Treasury regulations to include in income the &#147;all earnings and profits amount&#148; (as defined in the Treasury regulations) attributable to the Orthofix common shares held directly by such holder. The date shares were acquired by a
U.S. shareholder will impact whether such shareholder will have a positive or negative &#147;all earnings and profits amount&#148; in respect of such shares. See the section entitled &#147;<I>Material Tax Considerations</I>&#151;<I>U.S.
Shareholders</I>&#151;<I>U.S. Shareholders That Own Less Than 10% Percent of Orthofix</I><I>&#148;</I><I> </I>for a more detailed discussion of the &#147;all earnings and profits amount&#148; as it relates to U.S. shareholders who own (actually or
constructively) shares with a fair market value of $50,000 or more, but less than 10% of the total value or voting power of Orthofix shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S.
shareholder who on the effective date of the domestication owns (actually or constructively) 10% or more of the total value or voting power of Orthofix common shares will be required to include in income the &#147;all earnings and profits
amount&#148; attributable to the Orthofix common shares held directly by such holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. shareholder who on the effective date of the domestication
beneficially owns (actually or constructively) shares with a fair market value of less than $50,000 should not be required to recognize any gain or loss under Section&nbsp;367(b) of the Code in connection with the domestication, and generally should
not be required to include any part of the all earnings and profits amount in income. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>YOU SHOULD CONSULT YOUR TAX ADVISORS WITH RESPECT TO THE
APPLICATION OF U.S. FEDERAL TAX LAWS TO YOUR PARTICULAR SITUATION, AS WELL AS ANY TAX CONSEQUENCES ARISING UNDER THE LAWS OF ANY STATE, LOCAL OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> JURISDICTION. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The domestication resolution must be adopted by holders representing an absolute majority of the outstanding Orthofix common shares as of the Record Date
in order to complete the domestication. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The domestication cannot be completed unless the Orthofix shareholders adopt the domestication resolution
by the affirmative vote of holders of an absolute majority of the outstanding Orthofix common shares as of the Record Date. If the shareholders of Orthofix do not adopt the domestication resolution by the requisite shareholder vote, the
domestication and related transactions cannot be completed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Your rights as a shareholder will change as a result of the domestication</I></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currently, your rights as a shareholder of the Company arise under the laws of Cura&ccedil;ao, as well as the Existing Articles of Association. Upon
effectiveness of the domestication, your rights as a shareholder of the Company will arise under Delaware law, as well as the Proposed Organizational Documents. The Proposed Organizational Documents and Delaware law contain provisions that differ in
certain respects from those in our Existing Articles of Association and Cura&ccedil;ao law and, therefore, some of your rights as a shareholder will change. For a description of your rights following the domestication and how they may differ from
your current rights, please see &#147;<I>Comparison of Corporate Governance and Shareholder Rights</I>&#148; beginning on page 29. The forms of the Proposed Organizational Documents are attached hereto as Annex A and Annex B. We urge you to read
them, as well. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We expect to incur transaction costs in connection with the completion of the domestication and related transactions, some of which
will be incurred whether or not the domestication is completed</I></B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect to incur significant transaction costs in connection with the
domestication and related transactions. The substantial majority of these costs will be incurred regardless of whether the domestication is completed and prior to your vote to adopt the domestication resolution at the Annual General Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may choose to or need to defer the domestication, or we may abandon the domestication</I></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board may decide to defer or abandon the domestication at any time prior to the completion of the domestication. In addition, after the domestication
resolution is adopted by shareholders, we will not effect the domestication if one of the conditions to the domestication fails to be satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further,
we are required to publish an announcement of our intent to change our jurisdiction of organization from Cura&ccedil;ao to the State of Delaware in certain Cura&ccedil;ao newspapers no more than three months and no less than five weeks prior to
executing the notarial deed of conversion, which is necessary to effect the domestication. Following such Publications, our creditors and certain contracting parties have the right to object to the domestication by filing an opposition with a
Cura&ccedil;ao court. If a creditor files such an objection, we may be unable to complete the domestication until the opposition proceedings, if any, have been settled or resolved. This could result in a delay in the completion of the domestication
or our Board may decide to abandon the domestication. Further, if no objections are filed, we must obtain the Cura&ccedil;ao Declaration, a declaration from a Cura&ccedil;ao court confirming that no objection was made. We may experience delays in
obtaining the Cura&ccedil;ao Declaration, which may delay completion of the domestication itself. If the domestication is delayed for this or any other reason, as described in &#147;<I>Proposal 1: Domestication in Delaware&#151;Conditions to
Completion of the Domestication</I>,&#148; we may be required to <FONT STYLE="white-space:nowrap">re-publish</FONT> the announcements in Cura&ccedil;ao newspapers, which will again require us to comply with the Cura&ccedil;ao publication
requirements referenced above, and may provide our creditors and other contracting parties with another opportunity to file an objection. In addition, the domestication resolution provides that the domestication will be effectuated, if at all, on or
before January&nbsp;1, 2019. If the domestication has not been effectuated by this time, for whatever reason, we would need to ask shareholders to adopt a new domestication resolution in order to pursue a domestication transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Anti-takeover provisions in our Proposed Organizational Documents and under Delaware law could make an acquisition of us more difficult and limit
attempts by our shareholders to replace or remove our current management. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Both the Existing Organizational Documents and Proposed Organizational
Documents contain anti-takeover provisions that may have the effect of delaying or preventing a change in control or changes in our management. The Proposed Organizational Documents, which will be effective following the effectiveness of the
domestication, include the following anti-takeover provisions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability of our shareholders to act without a meeting of the shareholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">rules regarding how shareholders may present proposals or nominate directors for election at shareholder meetings; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability of our directors, and not shareholders, to fill vacancies on the Board. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a comparison of how
these provisions may differ from your current rights, please see &#147;<I>Comparison of Corporate Governance and Shareholder Rights</I>&#148; beginning on page 29. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These provisions may frustrate or prevent any attempts by our shareholders to replace or remove our current management by making it more difficult for
shareholders to replace members of our Board, which is responsible for appointing the members of our management, and may discourage, delay or prevent a transaction involving a change in control of the Company that is in the best interest of our
minority shareholders. Even in the absence of a takeover attempt, the existence of these provisions may adversely affect the prevailing market price of our common stock if shareholders view them as discouraging future takeover attempts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, following the domestication, we will be subject to provisions of Delaware law, including Section&nbsp;203 of the DGCL, which may prohibit certain
stockholders holding 15% or more of Orthofix&#146;s outstanding capital stock from engaging in certain business combinations with us for a specified period of time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><I>The Proposed Organizational Documents designate the state courts in the State of Delaware or, if no state court located within the State of
Delaware has jurisdiction, the federal court for the District of Delaware, as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our shareholders, which could discourage lawsuits against us and our
directors and officers</I></B><B>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cura&ccedil;ao law provides that the Cura&ccedil;ao Court of First Instance (<I>Rechter in Eerste Aanleg</I>) shall
generally be the sole and exclusive forum for actions, suits or proceedings brought against the Company or any director, officer or other employee for breach of fiduciary duty. Delaware law does not specify an exclusive forum in this manner.
However, the Proposed Bylaws, which would become effective upon completion of the domestication, provide that unless the Board otherwise determines, the state courts in the State of Delaware or, if no state court located within the State of Delaware
has jurisdiction, the federal court for the District of Delaware, will be the sole and exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a claim of breach of a fiduciary duty owed by any of our
directors or officers to the company or our shareholders, any action asserting a claim against us or any of our directors or officers arising pursuant to any provision of the DGCL or Orthofix&#146;s governing documents, or any action asserting a
claim against us or any of our directors or officers governed by the internal affairs doctrine. This exclusive forum provision may limit the ability of our shareholders to bring a claim in a judicial forum that such shareholders find favorable for
disputes with us or our directors or officers, which may discourage such lawsuits against us and our directors and officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_34"></A>THE COMPANY</FONT></B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix Cura&ccedil;ao was formed in 1987 as a limited liability company operating under the laws of the Netherlands Antilles,
and we now operate under the laws of Cura&ccedil;ao. Our offices in Cura&ccedil;ao are located at 7 Abraham de Veerstraat, Cura&ccedil;ao and our U.S. headquarters are located at 3451 Plano Parkway, Lewisville, Texas 75056. We intend to relocate our
offices in Cura&ccedil;ao to our corporate headquarters in Lewisville, Texas following the domestication. Our phone numbers at these respective locations are
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">599-9-4658525</FONT></FONT> and (214) <FONT STYLE="white-space:nowrap">937-2000,</FONT> respectively, and our website is available at <U>www.orthofix.com</U>. Our common stock is
traded on Nasdaq under the symbol &#147;OFIX.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2017, our primary business strategy was to accelerate our organic topline growth rate while
maintaining Adjusted EBITDA margins. We believe that this strategy proved effective and resulted in us exceeding our growth expectations for the year. We are currently focused on continuing our organic growth momentum, expanding margins and actively
pursuing value-accretive inorganic opportunities to further accelerate growth. We believe that we remain well-positioned to execute on both organic and inorganic strategic opportunities focused on accelerating shareholder value creation. Notable
highlights and accomplishments in 2017 include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Net sales were $433.8&nbsp;million, an increase of 5.9% on a reported basis and 5.5% on a constant currency basis; as net sales increased for each of our SBUs. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Net income from continuing operations was $7.3&nbsp;million, an increase of 108.5% from the prior year. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Net margin, an internal metric that we define as gross profit less sales and marketing expense, was $142.4&nbsp;million, an increase of 1.3% from the prior year.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We manage our business by our four SBUs: BioStim, Extremity Fixation, Spine Fixation and Biologics, which accounted for 43%, 24%, 19%, and
14%, respectively, of our total net sales in 2017. The chart below presents net sales, which includes product sales and marketing service fees, by SBU for each of the years ended December&nbsp;31, 2017, 2016, and 2015. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g571963g0420113918568.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Over the three-year period ending December&nbsp;31, 2017, Orthofix delivered total shareholder return of 82%, with an
annual compound shareholder return of 22% during that same period. A $100 investment in Orthofix&#146;s common stock at the beginning of 2015 would have grown to $182 at the end of 2017, more than doubling the return of the S&amp;P&nbsp;500 over the
same period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_35"></A>THE ANNUAL GENERAL MEETING </B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus is being furnished in connection with the solicitation of proxies from Orthofix shareholders
for use at the Orthofix Annual General Meeting. This proxy statement/prospectus and accompanying form of proxy are first being mailed to Orthofix shareholders on or about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018. This proxy
statement/prospectus provides Orthofix&#146;s shareholders with information they need to know to be able to vote or instruct their vote to be cast at the Annual General Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_36"></A>Date, Time and Place </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Annual General Meeting will be held on June 18, 2018, at 11:00 a.m. Atlantic Standard Time (AST), at Orthofix&#146;s offices, located at 7 Abraham de
Veerstraat, Cura&ccedil;ao. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_37"></A>Purpose of the Annual General Meeting </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the Annual General Meeting, the Board will ask shareholders to vote on the following proposals: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719631a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to adopt the domestication resolution, a shareholders&#146; resolution to change the jurisdiction of organization of Orthofix from Cura&ccedil;ao to Delaware; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719632a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to elect the nine nominees named in this proxy statement/prospectus to the Board; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719633a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to approve the consolidated balance sheet and consolidated statement of operations at and for the fiscal year ended December&nbsp;31, 2017; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719634a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to approve an advisory and <FONT STYLE="white-space:nowrap">non-binding</FONT> resolution on the compensation of Orthofix&#146;s named executive officers as disclosed in this proxy statement/prospectus;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719635a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to approve the Amended and Restated 2012 Plan; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719636a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to approve the SPP Amendment; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719637a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to ratify the selection of EY as the independent registered public accounting firm for Orthofix and its subsidiaries for the fiscal year ending December&nbsp;31, 2018; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g5719638a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top">to transact such other business as may come before the Annual General Meeting or any adjournment or postponement thereof. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Board has unanimously approved the domestication and has unanimously resolved to propose the domestication resolution to the Company&#146;s
shareholders for adoption. The domestication resolution must be adopted by the affirmative vote of holders representing an absolute majority of the outstanding common shares on the Record Date in order for the Company to be able to effectuate the
domestication. The Board urges shareholders to join Orthofix in supporting this important proposal and unanimously recommends that you vote &#147;FOR&#148; the proposal to adopt the domestication resolution. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Board also unanimously recommends that you vote &#147;FOR&#148; the election of each of the director nominees, &#147;FOR&#148; the approval of the
financial statements, &#147;FOR&#148; the approval, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, of the compensation of the Company&#146;s named executive officers, &#147;FOR&#148; the approval of the Amended and Restated
2012 Plan, &#147;FOR&#148; the approval of the SPP Amendment and &#147;FOR&#148; the ratification of EY. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_38"></A>Record Date </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All record holders of Orthofix common shares at the close of business on April&nbsp;24, 2018, the Record Date, are being sent this proxy statement/prospectus
and will be entitled to vote at the Annual General Meeting. Each record holder on such date is entitled to cast one vote per common share. As of the Record Date, there were Orthofix common shares outstanding. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_39"></A>Quorum, Vote Required </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The presence, in person or by proxy, of the holders of at least 50% of Orthofix Cura&ccedil;ao common shares outstanding on the Record Date is required to
constitute a quorum at the Annual General Meeting. The affirmative vote of the holders representing an absolute majority of the outstanding common shares as of the Record Date will be required in order to adopt the domestication resolution (Proposal
1) at the Annual General Meeting. Assuming a quorum is present, the nominees for election as directors in Proposal 2 will be elected upon the affirmative vote of a plurality of all votes cast at the Annual General Meeting. Assuming a quorum is
present, the approval of the holders of a majority of the votes cast on Proposals 3, 4, 5, 6, and 7 at the Annual General Meeting will be required to approve each of these Proposals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Abstentions and &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;</FONT> are counted as shares that are present and entitled to vote on the
proposals for purposes of determining the presence of a quorum. A broker <FONT STYLE="white-space:nowrap">&#147;non-vote&#148;</FONT> occurs when a broker holding shares for a beneficial owner does not vote on a particular proposal because the
broker does not have discretionary voting power for that particular item and has not received instructions from the beneficial owner. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have the effect of a vote
&#147;against&#148; Proposal 1. Neither abstentions nor broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have any effect on the outcome of voting on Proposals 2, 3, 4, 5, 6 and 7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a record holder, you may cast your vote at <U>https://www.proxypush.com/ofix</U>. See your proxy voting card for your online control number in
order to vote. If your common shares are held in &#147;street name,&#148; you will receive instructions from your broker, bank or other nominee that you must follow in order to have your common shares voted. All votes must be cast and received by
5:00 p.m., Eastern Daylight Time (EDT), on June 17, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_40"></A>Proxies </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus is being furnished to holders of Orthofix common shares in connection with the solicitation of proxies by and on behalf of the
Board for use at the Annual General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All Orthofix common shares that are represented at the Annual General Meeting by properly executed proxies
received prior to or at the Annual General Meeting and which are not validly revoked, will be voted at the Annual General Meeting in accordance with the instructions indicated on such proxies. If no instructions are indicated on a properly executed
proxy, such proxy will be voted in favor of each of the proposals. The Board does not know of any other matters that are to be presented for consideration at the Annual General Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any proxy given pursuant to this solicitation may be revoked by the person giving it at any time before it is voted. Proxies may be revoked by (1)&nbsp;filing
with Orthofix, at or before the taking of the vote at the Annual General Meeting, a written notice of revocation bearing a later date than the proxy, or (2)&nbsp;duly executing a subsequent proxy relating to the same common shares and delivering it
to Orthofix before the Annual General Meeting. Attending the Annual General Meeting will not in and of itself constitute the revocation of a proxy. Any written notice of revocation or subsequent proxy should be sent so as to be delivered to:
Orthofix International N.V., 7 Abraham de Veerstraat, Cura&ccedil;ao, at or before the taking of the vote at the Annual General Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_41"></A>Voting is Confidential </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain a policy of keeping all proxies and ballots confidential. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_42"></A>The Costs of Soliciting These Proxies and Who Will Pay for Them </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will pay all the costs of soliciting these proxies, including reimbursing banks, brokers, nominees and other fiduciaries for the expenses they incur in
forwarding the proxy materials to you. Although we are mailing these proxy materials, our directors and employees may also solicit proxies by telephone, fax or other electronic means of communication, or in person. We have engaged Saratoga to assist
it in the solicitation of proxies. We estimate that we will pay Saratoga a fee of up to approximately $20,000 for the services to be performed. We have also agreed to reimburse Saratoga for reasonable <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses and disbursements incurred in connection with the proxy solicitation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
 COLOR="#004a97"><B><I><A NAME="tx571963_43"></A>The Voting Results </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will publish the voting results from the Annual General Meeting in a
Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> which we will file with the SEC after the conclusion of the meeting. You will also be able to find the Form <FONT STYLE="white-space:nowrap">8-K</FONT> on our website at
<U>www.orthofix.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_44"></A>Obtaining an Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have filed our 2017 Form <FONT STYLE="white-space:nowrap">10-K</FONT> with the SEC. A copy
of the 2017 Form <FONT STYLE="white-space:nowrap">10-K</FONT> is contained in the materials that we are sending you along with this proxy statement/prospectus. The 2017 Form <FONT STYLE="white-space:nowrap">10-K</FONT> is also available on our
website at <U>www.orthofix.com</U>. If you would like to receive an additional copy of the 2017 Form <FONT STYLE="white-space:nowrap">10-K,</FONT> we will send you one free of charge. Please write to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Orthofix International N.V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">c/o
Orthofix Holdings, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3451 Plano Parkway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Lewisville, Texas 75056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention:
Mr.&nbsp;Mark Quick, Investor Relations </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may also contact Mr.&nbsp;Quick at (214) <FONT STYLE="white-space:nowrap">937-2924</FONT> or at
<U>MarkQuick@orthofix.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_45"></A>Whom to Call if You Have Any Questions </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you have any questions about the Annual General Meeting, voting or your ownership of Orthofix common shares, please contact Saratoga, our proxy solicitor,
by calling toll-free at (888) <FONT STYLE="white-space:nowrap">368-0379.</FONT> You may also contact Mr.&nbsp;Quick at (214) <FONT STYLE="white-space:nowrap">937-2924</FONT> or at <U>MarkQuick@orthofix.com</U>. Directions to the meeting can be found
at <U>http://www.proxydocs.com/ofix</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_46"></A>Important Notice Regarding the Availability of Proxy
Materials for the Annual General Meeting </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus, your proxy voting card and the 2017 Form <FONT
STYLE="white-space:nowrap">10-K</FONT> are available at <U>http://www.proxydocs.com/ofix</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_47"></A></FONT>PROPOSAL 1: DOMESTICATION IN DELAWARE</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_48"></A>Overview </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are asking our shareholders to adopt the domestication resolution to change the Company&#146;s jurisdiction of organization from Cura&ccedil;ao to the State
of Delaware. If the shareholders vote to adopt the domestication resolution and the other conditions to the domestication are satisfied, the Company anticipates that, on or prior to January&nbsp;1, 2019, it will complete the domestication in
accordance with the conversion procedures of Articles 304 and 305 of Book 2 of the CCC and the domestication procedures of Section&nbsp;388 of the DGCL. We refer to this as the domestication. Following the domestication, the Company will be renamed
&#147;Orthofix Medical Inc.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;23, 2018, the Board unanimously approved the domestication and related transactions and unanimously
resolved to propose the domestication resolution to the shareholders for adoption. The Board believes that the domestication will provide potential strategic opportunities and benefits, including: (i)&nbsp;aligning our incorporation with our primary
business operations in the United States, (ii)&nbsp;improving operational and financial flexibility by simplifying our corporate structure, which will allow for improved cash management capabilities and increased business efficiencies,
(iii)&nbsp;benefiting from the prominence, predictability and flexibility of Delaware law and a well-established corporate governance regime and (iv)&nbsp;positioning the Company to better respond to global tax developments. The Board urges
shareholders to join in supporting this important proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the domestication resolution is adopted by the requisite vote of our shareholders and the
other conditions to the domestication are satisfied, then, in connection with the domestication, Orthofix will replace the Existing Articles of Association, which are governed by Cura&ccedil;ao law, with the Proposed Organizational Documents, which
will be governed by Delaware law. The Proposed Organizational Documents differ in certain respects from the Existing Articles of Association. We urge shareholders to carefully consider the information set out under &#147;<I>Comparison of Corporate
Governance and Shareholder Rights</I>,&#148; as well as the Proposed Organizational Documents, attached hereto as Annex A and Annex B. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the
domestication resolution is adopted by the requisite vote of our shareholders and the other conditions to the domestication are satisfied, the number of shares of common stock that you will own in Orthofix Delaware on the effective date of the
domestication will be the same as the number of common shares of Orthofix Cura&ccedil;ao that you held immediately prior to the effectuation of the domestication. Orthofix Delaware&#146;s common stock will continue to be traded on Nasdaq under the
symbol &#147;OFIX.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_49"></A>Reasons for the Domestication </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board believes that there are significant potential strategic opportunities and benefits to Orthofix and our shareholders that will arise as a result of a
change of domicile to Delaware, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Alignment with our U.S. Operations</I></B>. A significant portion of our business operations, including our headquarters, are located in the United States. Our common shares have been listed on Nasdaq for over 25
years, and most of our shareholders reside in the United States. Despite this connection with the United States, we believe we are not uniformly perceived by investors, customers, lenders, employees or potential strategic partners as a U.S. company.
Our Board believes that the absence of a clear U.S. identity may prevent us from maximizing the opportunities and relationships with investors, existing and potential customers, lenders and potential partners, many of whom prefer to engage in
business with a U.S. entity. By changing our jurisdiction of organization from Cura&ccedil;ao to the State of Delaware, we will firmly and unambiguously establish ourselves as a U.S. corporation. This will level the playing field with our principal
competitors, many of whom are U.S. corporations. In addition, we intend to relocate our offices in Cura&ccedil;ao to our corporate headquarters in Lewisville, Texas following the domestication. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Simplified Corporate Structure, Improved Cash Management Capabilities and Increased Business Efficiencies. </I></B>We believe that the domestication will result in a simplified corporate structure, which will
improve our operational and financial flexibility. In connection with the change of jurisdiction to Delaware, we intend to eliminate redundant legal entities and activities in our corporate structure in order to maximize legal, administrative and
other efficiencies associated with a more streamlined U.S.-based corporate governance structure. We believe that these changes will also allow us to improve our cash management capabilities and make our business more efficient primarily by
eliminating unnecessary administrative cash management procedures and minimizing the costs associated with intercompany cash flows. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Prominence, Predictability and Flexibility of Delaware Law.</I></B> For many years, Delaware has followed a policy of encouraging incorporation in its state and, in furtherance of that policy, has been a leader in
adopting, construing, and implementing comprehensive, flexible corporate laws responsive to the legal and business needs of corporations organized under its laws. Many corporations have chosen Delaware initially as a state of incorporation or have
subsequently changed corporate domicile to Delaware. Because of Delaware&#146;s prominence as the state of incorporation for many major corporations, both the legislature and courts in Delaware have demonstrated the ability and a willingness to act
quickly and effectively to meet changing business needs. The DGCL is frequently revised and updated to accommodate changing legal and business needs and is more comprehensive, widely used and interpreted than other state corporate laws. This
favorable corporate and regulatory environment is attractive to businesses such as ours. Based on publicly available data, over half of publicly-traded corporations in the United States and over 60% of all Fortune 500 companies are incorporated in
Delaware. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Well-Established Principles of Corporate Governance.</I></B> There is substantial judicial precedent in the Delaware courts as to the legal principles applicable to measures that may be taken by a corporation and
to the conduct of a corporation&#146;s board of directors, such as under the business judgment rule and other standards. Because the judicial system is based largely on legal precedents, the abundance of Delaware case law provides clarity and
predictability to many areas of corporate law. Such clarity would be advantageous to Orthofix, its Board and its management to make corporate decisions and take corporate actions with greater assurance as to the validity and consequences of those
decisions and actions. Further, investors and securities professionals are generally more familiar with Delaware corporations, and the laws governing such corporations, increasing their level of comfort with Delaware corporations relative to other
jurisdictions. The Delaware courts have developed considerable expertise in dealing with corporate issues, and a substantial body of case law has developed construing Delaware law and establishing public policies with respect to corporate legal
affairs. Moreover, Delaware&#146;s vast body of law on the fiduciary duties of directors provides appropriate protection for Orthofix&#146;s shareholders from possible abuses by directors and officers. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Positioned to Better Respond to Global Tax Developments</I></B>. Recent global tax developments, particularly legislative and regulatory activity stemming from the Organisation for Economic Cooperation and
Development&#146;s (&#147;OECD&#148;) Base Erosion and Profit Shifting initiative, have given rise to increased focus on companies&#146; global tax footprints.&nbsp;The initiative suggests a range of new approaches that national governments might
adopt when taxing the activities of multinational enterprises. As a result of the OECD project and other international initiatives, tax laws that currently apply to our business may be amended by the relevant authorities or interpreted differently
by them, and these changes may present risks to our Company. By better aligning our corporate structure with our primary business functions, we believe that we will more fully benefit from the expenses borne in our US operations, which will improve
our effective tax rate; also with this improved alignment, we may be able to reduce risks associated with tax authority challenges stemming from these and other potential changes. Further, the United States recently adopted tax reform legislation
commonly known as the Tax Cuts and Jobs Act (the &#147;Tax Act&#148;), which we expect will positively impact our global effective tax rate and <FONT STYLE="white-space:nowrap">after-tax</FONT> earnings in the United States, resulting in increased
cash flow and enhanced ability to centralize cash for more efficient deployment.&nbsp;The Tax Act was signed into law on December&nbsp;22, 2017, and reduces the federal corporate tax rate in the United States from 35% to 21%, effective
January&nbsp;1, 2018. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the foregoing advantages of domestication in Delaware, the Board believes that the domestication
will generally improve the Company&#146;s operational and financial flexibility and provide for a more efficient corporate structure to achieve strategic and financial goals. Further, the Board believes that any direct benefit that the domestication
in Delaware provides to the Company also indirectly benefits the shareholders, who are the owners of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_50">
</A>The Domestication Transactions </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the domestication resolution is adopted by the requisite vote of our shareholders at the Annual
General Meeting and the other conditions to the domestication are satisfied, we anticipate the domestication will be completed on or before January&nbsp;1, 2019. There are several principal steps to effect the domestication: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Shareholders of Orthofix will vote on whether to adopt the domestication resolution at the Annual General Meeting. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If the domestication resolution is adopted by the requisite vote of our shareholders at the Annual General Meeting, then a notarial deed of conversion documenting the domestication resolution will be executed in
Cura&ccedil;ao, together with certain required documentation attached, including (i)&nbsp;the Proposed Certificate of Incorporation, (ii)&nbsp;a legal opinion from Delaware counsel confirming the continued existence of Orthofix as a Delaware entity
following the domestication, (iii)&nbsp;copies of the Publications, (iv)&nbsp;the domestication resolution and (v)&nbsp;the Cura&ccedil;ao Declaration. The notarial deed of conversion cannot be executed until the completion of the Publications and
receipt of the Cura&ccedil;ao Declaration, as discussed below in &#147;&#151;<I>Conditions to Completion of the Domestication</I>.&#148; The notarial deed of conversion will contain conditions precedent (<I>opschortende voorwaarden</I>), such that
(i)&nbsp;the Board must determine the effective date and time of the domestication, such effective date to be on or prior to January&nbsp;1, 2019, and confirm that the domestication should not be delayed or abandoned and (ii)&nbsp;the conversion of
Orthofix Cura&ccedil;ao pursuant to Articles 304 and 305 of Book 2 of the CCC will be effective only upon the acceptance and effectiveness of the Proposed Certificate of Incorporation and a certificate of corporate domestication by the Delaware SOS.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Following adoption of the domestication resolution at the Annual General Meeting, and subject to satisfaction of the conditions to completion of the domestication, as described under &#147;<I>&#151;Conditions to
Completion of the Domestication</I>,&#148; the Proposed Certificate of Incorporation and a certificate of corporate domestication will be filed with the Delaware SOS and, subject to acceptance and effectiveness of the filings, Orthofix Delaware will
exist as a Delaware corporation. These filings with the Delaware SOS are anticipated to be made on or before January&nbsp;1, 2019, on such date as is determined by the Board. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As soon as possible following acceptance of the filings by the Delaware SOS and their becoming effective, the notarial deed of conversion will be registered with the Cura&ccedil;ao Commercial Register.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Upon submission of the notarial deed of conversion and related documentation to the Cura&ccedil;ao Commercial Register, the Cura&ccedil;ao Commercial Register will reflect the domestication. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the foregoing, shareholders of Orthofix Cura&ccedil;ao will become shareholders of Orthofix Delaware and their rights will be governed by the
DGCL and the Proposed Organizational Documents. The exchange of Orthofix Cura&ccedil;ao common shares into shares of Orthofix Delaware common stock will occur automatically at the effective time of the filings with the Delaware SOS. See
&#147;&#151;<I>Exchange of Shares</I>&#148; below for additional information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board may decide to abandon the domestication at any time prior to
consummation of the domestication, in which case we will not undertake to complete the domestication transactions described above. See &#147;&#151;<I>Termination</I>&#148; below for additional information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_51"></A>Conditions to Completion of the Domestication
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the Annual General Meeting, Orthofix is required to publish the Publications announcing its intent to change its jurisdiction of
organization from Cura&ccedil;ao to the State of Delaware. Creditors and certain contracting parties of Orthofix have the right to object to the domestication by filing an opposition with a Cura&ccedil;ao court within one month of the Publications.
Following the expiration of the <FONT STYLE="white-space:nowrap">one-month</FONT> period, the Company must obtain a declaration from a Cura&ccedil;ao court confirming that no opposition was filed, which we refer to as the Cura&ccedil;ao Declaration.
The notarial deed of conversion cannot be executed, and therefore the domestication cannot be completed, until the Company has received the Cura&ccedil;ao Declaration, or until opposition proceedings, if any, have been settled or dismissed. The
Publications were completed on&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , 2018. Assuming there are no objections, we expect to receive the Cura&ccedil;ao Declaration prior to the Annual General
Meeting. If a creditor or contracting party objects to the domestication, it may adversely impact the timing of the domestication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to receipt
of the Cura&ccedil;ao Declaration, the Company&#146;s ability to initiate the filings in Delaware necessary to effectuate the domestication is also conditioned on the following matters: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Board has determined the effective date and time of the domestication, such effective date to be on or prior to January&nbsp;1, 2019, and has confirmed that the domestication should not be delayed or abandoned;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the SEC has declared the registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> that includes this proxy statement/prospectus effective, and no stop order with respect thereto is in effect;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Nasdaq has approved the Orthofix Delaware common stock for listing; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Orthofix is not subject to any decree, order or injunction that prohibits the consummation of the domestication. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of these conditions are not satisfied or waived by the Board, then the domestication will not be effectuated and the Proposed Organizational Documents
will not become effective. In addition, the expected timing for the completion of the domestication may be impacted by these or other conditions described in this proxy statement/prospectus. We cannot be certain when, or if, the conditions to the
domestication will be satisfied or waived, or that the domestication will be completed. As set forth in the domestication resolution, the Board is also authorized to delay or abandon the domestication at any time prior to the initiation of the
filings in Delaware. In addition, if the domestication is not effectuated on or before January&nbsp;1, 2019, we would need to ask shareholders to adopt a new domestication resolution in order to pursue a domestication transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_52"></A>Regulatory Approvals Related to the Domestication </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix is not aware of any material regulatory approvals or actions that are required for completion of the domestication, other than as described above in
&#147;&#151;<I>The Domestication Transactions</I>&#148; and &#147;&#151;<I>Conditions to Completion of the Domestication.</I>&#148; It is presently contemplated that if any such additional regulatory approvals or actions are required, those
approvals or actions will be sought. There can be no assurance, however, that any additional approvals or actions will be obtained. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_53"></A>Exchange of Shares </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exchange of Orthofix Cura&ccedil;ao common shares into shares of Orthofix Delaware common stock will occur automatically upon the effectiveness of the
filing of the Proposed Certificate of Incorporation and a certificate of corporate domestication with the Delaware SOS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficial holders of shares held
in &#147;street name&#148; through a bank, broker or other nominee and record owners of shares held in book-entry form will not be required to take any action. Your ownership of Orthofix Delaware common stock will be recorded in book-entry form by
your nominee (for shares held in &#147;street name&#148;) or by our transfer agent (for shares held by record owners in book-entry form), without the need for any additional action on your part. Holders of record who hold their shares in book-entry
form will receive a statement of their holdings in Orthofix Delaware after the domestication. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock certificates representing Orthofix Cura&ccedil;ao common shares will, at the effective time of the
domestication, automatically represent the same number of shares of Orthofix Delaware common stock. You will not be required to exchange your stock certificates as a result of the domestication. If you desire to sell some or all of your Orthofix
Cura&ccedil;ao common shares after the effective time of the domestication, delivery of the stock certificate or certificates which previously represented Orthofix Cura&ccedil;ao common shares will be sufficient. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the domestication, certificates bearing the name of Orthofix Delaware will be issued in the normal course upon surrender of outstanding Orthofix
Cura&ccedil;ao certificates for transfer or exchange. Holders who submit Orthofix Cura&ccedil;ao certificates for transfer or exchange following the domestication will receive shares of Orthofix Delaware common stock in book-entry form unless
otherwise requested. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_54"></A>No Dissenters&#146; Rights of Appraisal in the Domestication
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Cura&ccedil;ao and Delaware law and our Existing Articles of Association, our shareholders do not have statutory dissenters&#146;
rights of appraisal or any other appraisal rights as a result of the domestication. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_55"></A>Termination
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the domestication resolution is adopted by the requisite vote of our shareholders, the Board will be authorized to delay or abandon the
domestication at any time prior to the initiation of the filings in Delaware. In addition, the domestication resolution provides that the domestication will be effectuated on or before January&nbsp;1, 2019, on such date as determined by the Board.
If the domestication has not been effectuated by this time, for whatever reason, we would need to ask shareholders to adopt a new domestication resolution in order to pursue a domestication transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_56"></A>Orthofix Management </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not anticipate any changes to the Board or management in connection with the domestication. Please see &#147;<I>Management</I>&#148; beginning on page 42
for more detailed information about our directors and executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_57"></A>Interests of Certain
Persons in the Domestication </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not believe that any of our directors or executive officers has an interest in the domestication that is
different from the interests of our shareholders generally. No change in control payments or additional compensation will be payable to our directors or executive officers in connection with the domestication. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_58"></A>Anticipated Accounting Treatment </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There will be no accounting effect or change in the carrying amount of the consolidated assets and liabilities of Orthofix as a result of domestication. The
business, capitalization, assets and liabilities and financial statements of Orthofix immediately following the domestication will be the same as those of Orthofix immediately prior to the domestication. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_59"></A>Material U.S. Federal Income Tax Considerations </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please see the section entitled &#147;<I>Material </I><I>Tax Considerations</I>&#148; beginning on page 34 for a discussion of material U.S. federal income tax
consequences of the domestication. Notably, U.S. shareholders (as defined in &#147;<I>Material </I><I>Tax Considerations</I>&#151;<I>U.S. Shareholders</I>&#148; below) may be subject to U.S. federal income tax as a result of the domestication. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. shareholder who on the effective date of the domestication beneficially owns (actually or constructively)
shares with a fair market value of less than $50,000 should not be required to recognize any gain or loss under Section&nbsp;367(b) of the Code in connection with the domestication, and generally should not be required to include any part of the all
earnings and profits amount in income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. shareholder who on the effective date of the domestication beneficially owns (actually or constructively)
shares with a fair market value of $50,000 or more, but less than 10% of the total value or voting power of Orthofix shares, generally will recognize gain (but not loss) in respect of the domestication as if such holder exchanged its Orthofix
Cura&ccedil;ao shares for Orthofix Delaware shares in a taxable transaction, unless such U.S. shareholder elects in accordance with applicable Treasury regulations to include in income the &#147;all earnings and profits amount&#148; (as defined in
the Treasury regulations) attributable to the Orthofix shares held directly by such holder. See the section entitled &#147;<I>Material Tax Considerations</I>&#151;<I>U.S. Shareholders</I>&#151;<I>U.S. Shareholders That Own Less Than 10% Percent of
Orthofix&#148; </I>for a more detailed discussion of the &#147;all earnings and profits amount&#148; as it relates to U.S. shareholders who own (actually or constructively) shares with a fair market value of $50,000 or more, but less than 10% of the
total value or voting power of Orthofix shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. shareholder who on the effective date of the domestication owns (actually or constructively) 10%
or more of the total value or voting power of Orthofix shares will be required to include in income the &#147;all earnings and profits amount&#148; attributable to the Orthofix shares held directly by such holder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>YOU SHOULD CONSULT YOUR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF U.S. FEDERAL TAX LAWS TO YOUR PARTICULAR SITUATION, AS WELL AS ANY TAX CONSEQUENCES
ARISING UNDER THE LAWS OF ANY STATE, LOCAL OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> JURISDICTION. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_60">
</A>Vote Required for Adoption </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The adoption of the domestication resolution requires the affirmative vote of holders representing an
absolute majority of the outstanding common shares as of the Record Date. Abstentions and &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;</FONT> are counted as votes &#147;against&#148; Proposal 1. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_61"></A>Resolution to be Voted Upon </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the foregoing, the Board unanimously recommends that shareholders vote in favor of the domestication resolution, to be adopted in the following form:
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>&#147;RESOLVED, (1)&nbsp;to convert Orthofix International N.V. (the &#147;Company&#148;) from a Cura&ccedil;ao limited liability company into a
Delaware corporation (the &#147;Conversion&#148;) on or prior to January&nbsp;1, 2019 (on such date as determined by the board of directors of the Company (the &#147;Board&#148;)), subject to: (i)&nbsp;the condition precedent of the filing of a
certificate of corporate domestication and certificate of incorporation (the &#147;Delaware Documentation&#148;) with the Secretary of State of the State of Delaware (the &#147;Delaware SOS&#148;) (the Conversion to be effective as of such filing of
the Delaware Documentation or at such later effective time as may be specified in the Delaware Documentation) in accordance with Section&nbsp;388 and other applicable provisions of the Delaware General Corporation Law; and (ii)&nbsp;the condition
precedent of the Board having confirmed not to see any reason to delay or abandon the Conversion at any time prior to the filing of the Delaware Documentation with the Delaware SOS; and (2)&nbsp;authorize each employee working at STvB Advocaten,
both jointly and severally, to sign the notarial deed of conversion relating to the Conversion before a Cura&ccedil;ao notary.&#148; </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">The Board unanimously recommends that you vote &#147;FOR&#148;
the proposal</FONT></B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">to adopt the domestication
resolution.</FONT></B></FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_62"></A></FONT>DESCRIPTION OF ORTHOFIX CAPITAL STOCK</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following description of the Orthofix Delaware common stock reflects our common stock as it will exist upon completion
of the domestication, as governed by our new certificate of incorporation and bylaws and by Delaware law. This description is a summary. We urge you to read the forms of our Proposed Certificate of Incorporation and Proposed Bylaws in their
entirety, which are attached as Annex A and Annex B, respectively, to the proxy statement/prospectus. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_63">
</A>General </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were formed in 1987 as a limited liability company operating under the laws of the Netherlands Antilles, and we now operate
under the laws of Cura&ccedil;ao. If the domestication resolution is adopted by the requisite vote of our shareholders, we will change our organization and jurisdiction from a limited liability company (<I>naamloze vennootschap</I>) organized under
the laws of Cura&ccedil;ao to a corporation organized in the State of Delaware, and will replace the Existing Articles of Association, which are governed by Cura&ccedil;ao law, with the Proposed Organizational Documents, which will be governed by
Delaware law. Upon our Proposed Certificate of Incorporation and the certificate of domestication becoming effective in Delaware, our existence shall be deemed to have commenced on the date we commenced our existence under the laws of
Cura&ccedil;ao. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_64"></A>Authorized Share Capital </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Until the effective time of the domestication, Orthofix will not have any Delaware share capital and will not exist as a Delaware entity. Upon the
effectiveness of the domestication, Orthofix Delaware&#146;s authorized share capital will consist of 50,000,000 shares of common stock, par value $0.10 per share. The amount of authorized shares of common stock of Orthofix Delaware will be the same
as the amount of authorized common shares of Orthofix Cura&ccedil;ao prior to the domestication. The Proposed Certificate of Incorporation does not provide for the issuance of preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_65"></A>Common Stock </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the Record Date, we had&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;common shares outstanding. Upon effectiveness of the
domestication, each common share of Orthofix Cura&ccedil;ao will automatically convert by operation of law into one share of common stock of Orthofix Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix Delaware&#146;s common stock will carry the following rights: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Voting. </I>Except as otherwise required by law, the holders of Orthofix Delaware common stock will possess all voting power for the election of Orthofix&#146;s directors and all other matters requiring shareholder
action and will at all times vote together as one class on all matters submitted to a vote of the shareholders. Holders of Orthofix Delaware common stock are entitled to one vote per share on matters to be voted on by shareholders. There will be no
cumulative voting rights with respect to the election of directors or any other matters. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Dividends and distributions.</I> The holders of Orthofix Delaware common stock will have the right to receive dividends and distributions, whether payable in cash or otherwise, as may be declared from time to time by
its board of directors, from legally available funds. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Liquidation, dissolution or winding up. </I>In the event of the liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> of Orthofix Delaware, holders of its common stock will be entitled to
participate in the distribution of any assets of the Company remaining after payment of all creditors and the liquidation preferences of any preferred stock that may be outstanding at the time. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Restrictions on transfer. </I>Neither the Proposed Certificate of Incorporation nor the Proposed Bylaws contain any restrictions on the transfer of its common stock. However, in the case of any transfer of shares,
there may be restrictions imposed by applicable securities laws or by the terms of restricted share award grants. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Redemption, conversion or preemptive rights</I>. Holders of Orthofix Delaware common stock will have no preemptive or other subscription rights and there will be no sinking fund or redemption provisions applicable to
Orthofix Delaware common stock. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_66"></A>Dividends </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not paid dividends to holders of Orthofix Cura&ccedil;ao common shares in the past and have no present intention to pay dividends to holders of our
Orthofix Delaware common stock in the foreseeable future. We currently intend to retain all of our consolidated earnings to finance the continued growth of our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that we decide to pay a dividend to holders of our common stock following the domestication with dividends received from our subsidiaries, we
may, based on prevailing rates of taxation, be required to pay additional withholding and income tax on such amounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The payment of cash dividends in
the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of the domestication. The payment of any cash dividends subsequent to the domestication will be within
the discretion of the Board at such time. Further, if we incur any indebtedness, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_67"></A>Certain Anti-Takeover Provisions of Delaware Law and the Proposed Organizational Documents
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Both the Existing Organizational Documents and Proposed Organizational Documents contain anti-takeover provisions that may have the effect
of delaying or preventing a change in control or changes in our management. The Proposed Organizational Documents, which will be effective following the effectiveness of the domestication, include the following anti-takeover provisions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability of our shareholders to act without a meeting of the shareholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">rules regarding how shareholders may present proposals or nominate directors for election at shareholder meetings; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability of our directors, and not shareholders, to fill vacancies on the Board. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a comparison of how
these provisions may differ from your current rights, please see &#147;<I>Comparison of Corporate Governance and Shareholder Rights</I>&#148; beginning on page 29. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These provisions may frustrate or prevent any attempts by our shareholders to replace or remove our current management by making it more difficult for
shareholders to replace members of our Board, which is responsible for appointing the members of our management, and may discourage, delay or prevent a transaction involving a change in control of the Company that is in the best interest of our
minority shareholders. Even in the absence of a takeover attempt, the existence of these provisions may adversely affect the prevailing market price of our common stock if shareholders view them as discouraging future takeover attempts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, following the domestication, we will be subject to provisions of Delaware law, including Section&nbsp;203 of the DGCL. Section&nbsp;203 of the
DGCL prohibits a Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for three years following the date that such person becomes an interested stockholder, unless certain exceptions
apply. With certain exceptions, an &#147;interested stockholder&#148; is a person or group who or which owns 15% or more of the corporation&#146;s outstanding voting stock (including any rights to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
acquire stock pursuant to an option, warrant, agreement, arrangement or understanding, or upon the exercise of conversion or exchange rights, and stock with respect to which the person has voting
rights only), or is an affiliate or associate of the corporation and was the owner of 15% or more of such voting stock at any time within the previous three years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of Section&nbsp;203 of the DGCL, the term &#147;business combination&#148; is defined broadly to include (i)&nbsp;mergers with or caused by the
interested stockholder, (ii)&nbsp;sales or other dispositions to the interested stockholder (except proportionately with the corporation&#146;s other stockholders) of assets of the corporation or a subsidiary equal to 10% or more of the aggregate
market value of the corporation&#146;s consolidated assets or its outstanding stock, (iii)&nbsp;the issuance or transfer by the corporation or a subsidiary of stock of the corporation or such subsidiary to the interested stockholder, or
(iv)&nbsp;receipt by the interested stockholder (except proportionately as a stockholder), directly or indirectly, of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation or a subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The three-year moratorium imposed on business combinations by Section&nbsp;203 does not apply under the following situations: (i)&nbsp;prior to the date on
which such stockholder becomes an interested stockholder, the board of directors approved the business combination or the transaction which resulted in the person becoming an interested stockholder, (ii)&nbsp;the interested stockholder owns 85% of
the corporation&#146;s voting stock upon consummation of the transaction which made him or her an interested stockholder, or (iii)&nbsp;on or after the date such person becomes an interested stockholder, the business combination is approved by the
board of directors and is also approved at a stockholder meeting by <FONT STYLE="white-space:nowrap">66-2/3%</FONT> of the voting stock not owned by the interested stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 of the DGCL only applies to Delaware corporations which have a class of voting stock that is listed on a national securities exchange or held
of record by more than 2,000 stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_68"></A>Listing of Securities </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix Cura&ccedil;ao&#146;s common shares are listed on Nasdaq under the symbol &#147;OFIX.&#148; Orthofix Delaware&#146;s common stock will continue to be
listed on Nasdaq under the symbol &#147;OFIX.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_69"></A>Transfer Agent </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent for Orthofix Cura&ccedil;ao common shares is Computershare Trust Company, N.A., which is located at PO Box 505000, Louisville, KY
40233-5000. Computershare will continue as the transfer agent for shares of Orthofix Delaware common stock following the domestication. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_70"></A></FONT>COMPARISON OF CORPORATE GOVERNANCE AND SHAREHOLDER RIGHTS</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currently, your rights as a shareholder of Orthofix Cura&ccedil;ao arise under the laws of Cura&ccedil;ao, as well as our
Existing Articles of Association. Upon effectiveness of the domestication, your rights as a shareholder of Orthofix Delaware will arise under Delaware law and our Proposed Organizational Documents, including our Proposed Certificate of Incorporation
and Proposed Bylaws. Delaware law and the Proposed Organizational Documents contain provisions that differ in certain respects from Cura&ccedil;ao law and our Existing Articles of Association and, therefore, some of your rights as a shareholder will
change. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Below is a summary chart outlining important similarities and differences in the corporate governance and shareholder rights associated with each
of Cura&ccedil;ao and Delaware corporate law, as well as the Existing Articles of Association and the Proposed Organizational Documents. You also should review the Proposed Certificate of Incorporation and Proposed Bylaws that are attached hereto as
Annex A and Annex B, respectively, as well as the corporate laws of Cura&ccedil;ao and Delaware corporate law, to understand how these laws apply to Orthofix shareholders before and after the domestication. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cura&ccedil;ao</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Delaware</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Authorized Shares</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">50,000,000 common shares, par value $0.10 per share.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">50,000,000 shares of common stock, par value $0.10 per share.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Shareholder Approval of Amendments to the Governing Documents</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approval of an amendment to the Existing Articles of Association requires the affirmative vote of shareholders in person or represented by proxy and entitled to vote representing an absolute majority of the common shares issued and
outstanding.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approval of an amendment to the Proposed Certificate of Incorporation requires the affirmative vote of a majority of the shares of common
stock issued and outstanding.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approval of an amendment to the Proposed Bylaws
requires the affirmative vote of a majority of the shares of common stock present in person or represented by proxy and entitled to vote.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Board also has the authority to amend the Proposed Bylaws without shareholder approval.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Shareholder Approval of Routine Matters</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approval of routine corporate matters that are put to a shareholder vote require the affirmative vote of the majority of shares present in person or represented by proxy and entitled to vote.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approval of routine corporate matters that are put to a shareholder vote require the affirmative vote of the majority of shares present in person or represented by proxy and entitled to vote.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Shareholder Approval of Business Combinations</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approval of a merger or any sale or disposition of all or substantially all of the assets of a company requires the affirmative vote of shareholders in person or represented by proxy and entitled to vote representing an absolute
majority of the common shares issued and outstanding. Where a company will be the surviving entity in a merger, the board of directors may resolve to merge the Company without a shareholder vote, subject to certain limitations, unless one or more
shareholders representing at least 10% of the shares of common stock issued and outstanding timely request that the board of directors call a general meeting of shareholders.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mergers, consolidations or a sale of all or substantially all of the assets of a corporation generally requires the affirmative vote of a
majority of all shares of common stock issued and outstanding.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mergers in which a
corporation is the surviving corporation and less than 20% of its stock is issued in the merger generally do not require approval of that corporation&#146;s stockholders.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Mergers in which one corporation owns 90% or more of a second corporation generally may be completed without the vote of the second corporation&#146;s board of
directors or shareholders.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Appraisal Rights</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Generally a shareholder of a publicly traded company does not have appraisal rights in connection with a merger.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Delaware law provides that under certain circumstances, minority shareholders that dissent from a merger are entitled to be paid the fair market value of their shares, as ultimately determined by the Delaware Court of Chancery.
Generally a shareholder of a publicly traded company does not have appraisal rights in connection with a merger if the consideration received in the merger is publicly traded stock.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Action by Written Consent of Shareholders</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Existing Articles of Association do not provide for action by written consent of the shareholders.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Proposed Certificate of Incorporation prohibits the ability of shareholders to act by written consent in lieu of a meeting.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Special Meetings of Shareholders</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under the Existing Articles of Association, special meetings of shareholders may be called upon the direction of the Chairman, the Vice Chairman or by resolution of the Board. In addition, Cura&ccedil;ao law provides that
shareholders representing at least 10% of the shares of common stock issued and outstanding may request that the Board convene a special meeting to deliberate on a specific subject, provided such shareholders have a reasonable interest therein. If
the Board fails to act upon a valid request within 14 days, the applicants are permitted to proceed towards convening the meeting.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Delaware law provides that special meetings of shareholders may be called by the board of directors or by such person(s) as may be authorized by the company&#146;s certificate of incorporation or bylaws. The Proposed Bylaws permit
special meetings of the shareholders to be called by (i)&nbsp;the Board, pursuant to a resolution approved by a majority of the Board, and (ii)&nbsp;the Secretary of the Company, upon a request of shareholders holding at least 25% of the shares of
common stock issued and outstanding, so long as any such request is submitted in accordance with and in the form required by the Proposed Bylaws.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Exclusive Jurisdiction</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Existing Articles of Association do not include an exclusive jurisdiction provision, however, Cura&ccedil;ao law generally provides that the Cura&ccedil;ao Court of First Instance (<I>Rechter in Eerste Aanleg</I>) shall be the
sole and exclusive forum for actions, suits or proceedings brought against the Company or any director, officer or other employee for breach of fiduciary duty.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Proposed Bylaws provide that, unless Orthofix otherwise consents in writing, the Court of Chancery of the State of Delaware (or, where the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, the
Superior Court of the State of Delaware, or, if the Superior Court of the State of Delaware lacks subject matter jurisdiction, the U.S. District Court for the District of Delaware) shall generally be the sole and exclusive forum for actions, suits
or proceedings brought against the Company or any director, officer or other employee for breach of fiduciary duty, including, amongst others, with respect to any derivative claim, claim of breach of fiduciary duty, claim related to any provision of
the DGCL or the Proposed Organizational Documents.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Annual General Meeting / Annual Meeting</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Existing Articles of Association provide that the annual general meeting must be held in Cura&ccedil;ao.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Proposed Bylaws provide that the annual meeting may be held at any location, in or outside of the State of Delaware, as the Board shall determine. The annual meeting may also be held remotely, at the discretion of the
Board.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Existing Articles of Association provide that the annual general meeting must be held within nine months after the end of the preceding fiscal year.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The timing of the annual meeting is not addressed in the Proposed Organizational Documents. The Company will adhere to the laws of the State of Delaware and the rules and regulations promulgated by the SEC and Nasdaq with respect to
the timing of the annual meeting.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Existing Articles of Association provide that at the annual general meeting, among other things, (i)&nbsp;the Board shall report on the business of the Company, (ii)&nbsp;the annual accounts, including the balance sheet and the
profit and loss statement, will be submitted to the shareholders for approval and (iii)&nbsp;the appointment of the accountants will be ratified.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Proposed Bylaws provide for certain procedures related to the annual meeting, including with respect to the Chief Executive Officer&#146;s right to preside at such meeting. The substance of the annual meeting is not otherwise
addressed in the Proposed Organizational Documents. The Company will adhere to the laws of the State of Delaware and the rules and regulations promulgated by the SEC and Nasdaq with respect to the procedures related to the annual
meeting.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Advance Notice for Shareholder Proposals</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Advance notice requirements for shareholder proposals are not addressed in the Existing Articles of Association.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Proposed Bylaws provide that, to be timely, a shareholder&#146;s notice relating to an annual meeting proposal or nomination must be received by the Secretary of the Company not later than the close of business on the 90th day
and not earlier than the close of business on the 120th day before the date of the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the immediately preceding year&#146;s annual meeting (provided, however, that if the date of the
annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the shareholder must be so delivered, or mailed and received, not earlier than the close of business on the 120th day before such annual meeting
and not later than the close of business on the later of the 90th day before such annual meeting or the 10th business day following the day on which public announcement of the date of such meeting is first made by the Company).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Election of Directors</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Directors are elected by a plurality of the votes cast on the shares held by the holders present in person or represented by proxy and entitled to vote.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Directors are elected by a plurality of the votes cast on the shares held by the holders present in person or represented by proxy and entitled to vote.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Board Vacancies</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">In the event that one or more directors resigns or is incapable of continuing to act as a director, the remaining directors may appoint one or more persons to fill the vacancy or vacancies. However, if at any time the number of
directors is reduced to less than two, the remaining director shall call a general meeting of the shareholders for the purpose of filling the vacancies.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Any vacancies on the Board may be filled by a majority of the directors then in office, even if less than a quorum, or by a sole remaining director.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Removal of Directors</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Directors may be removed or suspended at any time, with or without cause, by a majority of shares present in person or represented by proxy and entitled to vote.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Directors may be removed at any time, with or without cause, by a majority of the shares present in person or represented by proxy and entitled to vote.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Fiduciary Duties of Directors</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Directors are charged with a fiduciary duty of care to protect the interests of the Company and its business. This fiduciary duty is owed to the Company and not to the shareholders. Directors bear responsibility for the general
course and affairs of the Company and in addition have an obligation to properly perform the specific duties falling within his or her responsibilities (<I>werkkring</I>).</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, the directors are charged with a fiduciary duty of care (to act in an informed and deliberate manner) to protect the interests of the Company and a fiduciary duty of loyalty (in good faith, not out of
self-interest) to act in a manner the director reasonably believes to be in the best interests of the company and its shareholders. Such duties are generally owed to the company, but may be owed directly to shareholders in certain circumstances.
Shareholders may have standing to pursue direct claims for breach of fiduciary duty in these circumstances.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Limited Liability of Directors</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Existing Articles of Association do not include specific limits on director liability.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Under Cura&ccedil;ao law directors can be personally liable (i)&nbsp;for a breach of
their fiduciary duty, (ii)&nbsp;based on tort to third parties (external liability) and (iii)&nbsp;towards the bankrupt estate in the event of bankruptcy.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">As permitted (but not required) by Delaware law, the Proposed Certificate of Incorporation eliminates the personal liability of directors for monetary damages for a breach of fiduciary duty, except with regard to breaches of duty of
loyalty, acts or omissions not in good faith, unlawful repurchases or dividends, or improper personal benefit.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Indemnification of Directors</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Existing Articles of Association impose an obligation for the Company to indemnify directors and pay related expenses under certain
circumstances.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Company is also generally permitted to indemnify its directors
and officers acting in good faith in any action the person is made a party to by reason of the fact that the person is or was a director or officer of the Company.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Proposed Bylaws impose an obligation for the Company to indemnify directors and pay related expenses under certain circumstances.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Company is also generally permitted to indemnify its directors and officers acting
in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Company.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Shareholder Derivative Lawsuits</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Shareholders generally do not have the right to bring a derivative suit, including with respect to improper management of the Company.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A shareholder may bring a derivative suit on behalf of the Company, including with respect to fiduciary duty claims, subject to procedural requirements. Creditors may also have standing to pursue derivative claims for breach of
fiduciary duty in certain circumstances.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Dissolution</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Any resolution providing for the dissolution, liquidation or winding up of the Company shall be valid only if duly adopted at a general meeting of shareholders by the holders of at least a majority of the common shares at the time
outstanding.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, a corporation may voluntarily dissolve (i)&nbsp;if a majority of the board of directors adopts a resolution to that effect and the holders of a majority of the outstanding shares entitled to vote thereon vote for
such dissolution or (ii)&nbsp;if all stockholders entitled to vote thereon consent in writing to such dissolution.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Inspection of Books and Records</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Cura&ccedil;ao law does not grant any specific rights to shareholders pursuant to which they may inspect books and records of the Company.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Under Delaware law, any shareholder may inspect the Company&#146;s books and records for a proper purpose during the usual hours for business, subject to compliance with statutory prerequisites.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_71"></A>MATERIAL TAX CONSIDERATIONS</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_72"></A>Material U.S. Federal Income Tax Considerations </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a discussion of material U.S. federal income tax considerations for beneficial owners of Orthofix Cura&ccedil;ao shares relating to the
domestication and the ownership and disposition of Orthofix Delaware shares acquired pursuant to the domestication. This discussion applies only to Company shares held as capital assets for U.S. federal income tax purposes, and does not describe all
of the U.S. federal income tax consequences that may be relevant to beneficial owners of such shares in light of their particular circumstances, including alternative minimum tax and Medicare contribution tax consequences, or beneficial owners who
are subject to special rules, such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">financial institutions or financial service entities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">governments or agencies or instrumentalities thereof; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">insurance companies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">dealers or traders subject to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> method of tax accounting with respect to the Orthofix shares; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">persons holding the Orthofix shares as part of a &#147;straddle,&#148; hedge, integrated transaction or similar transaction, or persons deemed to sell the securities under constructive sale provisions of the Internal
Revenue Code of 1986, as amended (the &#147;Code&#148;); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">persons who received Orthofix Cura&ccedil;ao shares as compensation for services; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">U.S. shareholders (as defined below) whose functional currency is not the U.S. dollar; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">partnerships or other pass-through entities for U.S. federal income tax purposes or investors in such entities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">holders who are controlled foreign corporations or passive foreign investment companies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regulated investment companies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">real estate investment trusts; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">U.S. shareholders (as defined below) owning or considered as owning 10% or more of the total combined voting power of all classes of stock entitled to vote of, or 10% or more of the total value of all classes of shares
of Orthofix; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">U.S. shareholders (as defined below) that hold their Orthofix shares through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> broker or other <FONT STYLE="white-space:nowrap">non-U.S.</FONT> intermediary;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">persons who are, or may become, subject to the expatriation provisions of the Code; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> entities. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a partnership for U.S. federal income
tax purposes, the U.S. federal income tax treatment of your partners will generally depend on the status of the partners and your activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
discussion is based on the Code, and administrative pronouncements, judicial decisions and final, temporary and proposed U.S. Treasury Regulations all as of the date hereof, changes to any of which subsequent to the date of this prospectus may
affect the tax consequences described herein (possibly with retroactive effect). This discussion </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
does not take into account proposed changes in such tax laws and does not address any aspect of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxation, or any U.S. federal
taxes other than income taxes (such as estate or gift tax consequences). Each of the foregoing is subject to change, possibly with retroactive effect. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>YOU SHOULD CONSULT YOUR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF U.S. FEDERAL TAX LAWS TO YOUR PARTICULAR SITUATION, AS WELL AS ANY TAX CONSEQUENCES
ARISING UNDER THE LAWS OF ANY STATE, LOCAL OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> JURISDICTION. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_73">
</A>U.S. Shareholders </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This section applies to you if you are a &#147;U.S. shareholder.&#148; A U.S. shareholder is a beneficial owner of
Orthofix shares that is, for U.S. federal income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an individual who is a citizen or resident of the United States; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a corporation organized under the laws of the United States, any state thereof or the District of Columbia; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a trust, if (i)&nbsp;a court within the United States is able to exercise primary supervision over the administration of such trust and one or more &#147;United States persons&#148; (within the meaning of the Code) have
the authority to control all substantial decisions of the trust, or (ii)&nbsp;the trust has validly elected to be treated as a United States person for U.S. federal income tax purposes. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. SHAREHOLDERS SHOULD CONSULT THEIR TAX ADVISORS REGARDING THE APPLICATION OF U.S. FEDERAL TAX LAWS TO THEIR PARTICULAR SITUATION, AS WELL AS ANY TAX
CONSEQUENCES ARISING UNDER THE LAWS OF ANY STATE, LOCAL, <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> JURISDICTION. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consequences of the
Domestication&#151;F Reorganization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The discussion under this heading &#147;<I>Consequences of the Domestication&#151;F Reorganization</I>&#148;
constitutes the opinion of Hogan Lovells US LLP, counsel to Orthofix (&#147;Hogan Lovells&#148;), as to the material U.S. federal income tax consequences of the domestication to U.S. shareholders of Orthofix. In the opinion of Hogan Lovells,
although no authority directly addressing the tax consequences of the domestication exists, the domestication should qualify as a &#147;reorganization&#148; within the meaning of section 368(a)(1)(F) of the Code (an &#147;F Reorganization&#148;).
Pursuant to the domestication, Orthofix will change its jurisdiction of organization from Cura&ccedil;ao to Delaware. Except as provided below under the caption headings &#147;<I>&#151;Effects of Section</I><I></I><I>&nbsp;367</I>&#148; and
<I>&#147;&#151;Passive Foreign Investment Company Considerations,</I>&#148; because the domestication should qualify as an F Reorganization, U.S. shareholders generally should not recognize taxable gain or loss on the domestication for U.S. federal
income tax purposes and the domestication should be treated for U.S. federal income tax purposes as if Orthofix Cura&ccedil;ao (i)&nbsp;transferred all of its assets and liabilities to Orthofix Delaware in exchange for all of the outstanding shares
of Orthofix Delaware; and (ii)&nbsp;then distributed the common stock of Orthofix Delaware to the shareholders of Orthofix Cura&ccedil;ao in liquidation of Orthofix Cura&ccedil;ao. The taxable year of Orthofix Cura&ccedil;ao will be deemed to end on
the date of the domestication. Assuming the domestication qualifies as an F Reorganization: (i)&nbsp;the tax basis of a share of Orthofix Delaware received by a U.S. shareholder in the domestication will equal the U.S. shareholder&#146;s adjusted
tax basis in the Orthofix Cura&ccedil;ao share surrendered in exchange therefor, increased by any amount included in the income of such U.S. shareholder as a result of Section&nbsp;367 of the Code (as discussed below) and (ii)&nbsp;the holding
period for a share of Orthofix Delaware received by a U.S. shareholder will include such U.S. shareholder&#146;s holding period for the Orthofix Cura&ccedil;ao share surrendered in exchange therefor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the domestication fails to qualify as an F Reorganization, a U.S. shareholder generally would recognize gain
or loss with respect to their Orthofix Cura&ccedil;ao shares in an amount equal to the difference between the fair market value of Orthofix Delaware shares received in the domestication and the U.S. shareholder&#146;s adjusted tax basis in their
Orthofix Cura&ccedil;ao shares surrendered in the domestication. In such event, such U.S. shareholder&#146;s basis in Orthofix Delaware shares would be equal to their fair market value on the date of the domestication, and such U.S.
shareholder&#146;s holding period for Orthofix Delaware shares would begin on the day following the date of the domestication. U.S. shareholders should consult their tax advisors regarding the potential tax consequences to them if the domestication
were to fail to qualify as an F Reorganization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinion described above is based on customary assumptions and representations from Orthofix. If any
of the assumptions or representations is incorrect, incomplete or inaccurate, the validity of the opinion described above may be affected and the tax consequences of the domestication could differ from those described above. Further, an opinion of
counsel represents counsel&#146;s best legal judgment but is not binding on the IRS or any court, so there can be no certainty that the IRS will not challenge the conclusion reflected above or that a court would not sustain such a challenge.
Orthofix does not intend to obtain a ruling from the IRS regarding the qualification of the domestication as an F Reorganization. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effects of
Section&nbsp;367 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;367 of the Code applies to certain nonrecognition transactions involving foreign corporations, including a domestication
of a foreign corporation in an F Reorganization. Section&nbsp;367 of the Code imposes income tax on certain U.S. persons in connection with transactions that would otherwise be <FONT STYLE="white-space:nowrap">tax-free.</FONT> Section&nbsp;367(b) of
the Code generally will apply to U.S. shareholders that exchange Orthofix Cura&ccedil;ao shares for Orthofix Delaware shares as part of the domestication. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. Shareholders That Own Less Than 10% Percent of Orthofix Cura&ccedil;ao </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. shareholder who, at the time of the domestication, beneficially owns (actually or constructively) Orthofix Cura&ccedil;ao shares with a fair market
value of $50,000 or more but less than 10% of the total combined voting power of all classes of Orthofix Cura&ccedil;ao shares entitled to vote and less than 10% of the total value of all classes of Orthofix Cura&ccedil;ao shares must either
recognize gain with respect to the domestication or, in the alternative, may elect to recognize the &#147;all earnings and profits&#148; amount attributable to such holder as described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless such a U.S. shareholder makes the &#147;all earnings and profits&#148; election as described below, such holder generally must recognize gain (but not
loss) with respect to its Orthofix Cura&ccedil;ao shares exchanged for Orthofix Delaware shares pursuant to the domestication. Any such gain would be equal to the excess of the fair market value of such Orthofix Delaware shares received over the
U.S. shareholder&#146;s adjusted tax basis in the Orthofix Cura&ccedil;ao shares deemed to be surrendered in exchange therefor. Subject to the PFIC rules discussed below, such gain would be capital gain, and should be long-term capital gain if the
U.S. shareholder held the Orthofix Cura&ccedil;ao shares for longer than one year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In lieu of recognizing any gain as described in the preceding
paragraph, a U.S. shareholder may elect to include in income the all earnings and profits amount attributable to their Orthofix Cura&ccedil;ao shares. There are, however, strict conditions for making this election. This election must comply with
applicable Treasury regulations and generally must include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a statement that the domestication is a Section&nbsp;367(b) exchange; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a complete description of the domestication; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a description of any stock, securities or other consideration transferred or received in the domestication; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a statement describing the amounts required to be taken into account for U.S. federal income tax purposes as income or as an adjustment to basis, earnings and profits or other tax attributes; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a statement that the U.S. shareholder is making the election that includes (i)&nbsp;a copy of the information that the U.S. shareholder received from Orthofix establishing and substantiating the U.S. shareholder&#146;s
all earnings and profits amount with respect to the U.S. shareholder&#146;s Orthofix Cura&ccedil;ao shares, and (ii)&nbsp;a representation that the U.S. shareholder has notified Orthofix that the U.S. shareholder is making the election; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">certain other information required to be furnished with the U.S. shareholder&#146;s tax return or otherwise furnished pursuant to the Code or the Treasury Regulations. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The election must be attached by the U.S. shareholder to its timely filed U.S. federal income tax return for the year of the domestication, and the U.S.
shareholder must send notice of making the election to Orthofix no later than the date such tax return is filed. In connection with this election, Orthofix intends to provide each U.S. shareholder eligible to make such an election with information
regarding Orthofix&#146;s earnings and profits upon request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you intend to make such an election or wish to request additional information, please
contact the Company at <U>redomicile@orthofix.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The &#147;all earnings and profits amount&#148; attributable to shares held by a U.S. shareholder
will generally depend on Orthofix&#146;s accumulated earnings and profits from the date that the shares were acquired through the effective date of the domestication. While Orthofix will not be able to determine the amount of any earnings and
profits for the period January&nbsp;1, 2018 through the effective date of the domestication until after completion of the domestication, Orthofix management currently anticipates that it is likely that Orthofix will accumulate positive earnings and
profits in 2018, while earnings and profits for 2017 will be de minimis. Taking this into account, management expects that a positive accumulated &#147;all earnings and profits amount&#148; will be attributable to shares with a holding period
beginning on or after approximately January&nbsp;1, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix management believes that Orthofix had negative earnings and profits during several of
its recent fiscal years prior to 2017.&nbsp;Accordingly, Orthofix management believes that, subject to the calculation of Orthofix&#146;s earnings and profits for fiscal year 2018 through the date of the domestication, Orthofix likely will have
negative accumulated earnings and profits at the time of effectiveness of the domestication for all holding periods that began between January&nbsp;1, 2008 and December&nbsp;31, 2015. On that basis, Orthofix management believes it likely that such
U.S. shareholders would not be required to include in income any &#147;all earnings and profits amount&#148; with respect to such shares as a result of the domestication. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because Orthofix management believes that Orthofix had negative earnings and profits during 2016 but is expected to have positive earnings and profits in
2018, the determination of whether a shareholder who acquired shares during the course of 2016 will have a positive &#147;all earnings and profits amount&#148; with respect to such shares will depend on the specific date during 2016 when the
shareholder acquired the shares, and the resulting pro rata amount of 2016 negative earnings and profits attributable to such shares in relation to the amount of positive earnings and profits attributable to such shares for the period from
January&nbsp;1, 2018 through the date of the domestication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix management believes that Orthofix had significant earnings and profits in years
preceding 2011.&nbsp;Taking into account the positive earnings and profits in those years and the negative earnings and profits in several years since then, management expects that, on balance, a positive accumulated &#147;all earnings and profits
amount&#148; will be attributable to shares with a holding period beginning before January&nbsp;1, 2008. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No assurance can be given that the IRS will
agree with the Company&#146;s calculations of its earnings and profits (or deficits thereof).&nbsp;If the IRS were to make an upward adjustment in Orthofix&#146;s earnings and profits, a U.S. shareholder could have a positive or more positive
&#147;all earnings and profits amount&#148; in respect of the shareholder&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares and thereby may recognize greater taxable income.&nbsp;Subject to the discussion below regarding U.S. shareholders whose Orthofix shares have an aggregate fair market value of less than
$50,000, any U.S. shareholder that has a positive &#147;all earnings and profits amount&#148; attributable to their shares may be subject to U.S. federal taxes with respect to such shares as a result of the domestication. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. SHAREHOLDERS THAT OWN ORTHOFIX CURA&Ccedil;AO SHARES WITH A FAIR MARKET VALUE OF $50,000 OR MORE ARE STRONGLY URGED TO CONSULT A TAX ADVISOR REGARDING
THE CONSEQUENCES OF MAKING AN ALL EARNINGS AND PROFITS ELECTION AND THE APPROPRIATE FILING REQUIREMENTS WITH RESPECT TO SUCH AN ELECTION. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S.
Shareholders That Own Orthofix Cura&ccedil;ao Shares with a Fair Market Value of Less Than $50,000 </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. shareholder who, at the time of the
domestication, owns (or is considered to own) Orthofix Cura&ccedil;ao shares with a fair market value of less than $50,000 should not be required to recognize any gain or loss under Section&nbsp;367(b) of the Code in connection with the
domestication, and generally should not be required to include any part of the all earnings and profits amount in income. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Passive Foreign Investment
Company Considerations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if the domestication qualifies as a reorganization under Section&nbsp;368(a), the domestication may be a taxable event to
a U.S. shareholder of Orthofix shares under the &#147;passive foreign investment company,&#148; or &#147;PFIC,&#148; provisions of the Code to the extent Section&nbsp;1291(f) of the Code is currently effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, a foreign corporation is a PFIC if 75% or more of its gross income for a taxable year is passive income or if 50% or more of the assets (by value)
held by the corporation during a taxable year produce or are held to produce passive income. Passive income generally includes dividends, interest, rents and royalties. If a foreign corporation is classified as a PFIC for any taxable year during
which a U.S. shareholder owns stock in the foreign corporation, the foreign corporation generally remains thereafter classified as a PFIC with respect to that shareholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;1291(f) of the Code generally requires that, to the extent provided in Treasury Regulations, a United States person who disposes of stock of a
PFIC recognize gain notwithstanding any other provision of the Code. No final Treasury Regulations have been promulgated under this statute. Proposed Treasury Regulations were promulgated in 1992 with a retroactive effective date. If finalized in
their current form, these Treasury Regulations would generally require gain recognition by a United States person exchanging Orthofix Cura&ccedil;ao shares for Orthofix Delaware shares if Orthofix Cura&ccedil;ao was classified as a PFIC at any time
during such United States person&#146;s holding period in such Orthofix Cura&ccedil;ao shares and such person had not made a &#147;qualified electing fund&#148; election under Code Section&nbsp;1295 for the first taxable year in which such United
States person owned Orthofix Cura&ccedil;ao shares or in which Orthofix Cura&ccedil;ao was a PFIC, whichever is later. The tax on any such gain so recognized would be imposed at the rate applicable to ordinary income and an interest charge would
apply based on a complex set of computational rules designed to offset the tax deferral to such shareholder on Orthofix Cura&ccedil;ao&#146;s undistributed earnings. However, we are unable to predict at this time whether, in what form, and with what
effective date, final Treasury Regulations under Code Section&nbsp;1291(f) will be adopted or whether the IRS might take the position that gain is required to be recognized under current law notwithstanding the absence of final Treasury Regulations.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix Cura&ccedil;ao believes that it is not and has never been a PFIC. If so, the PFIC rules just described should not apply to the domestication.
However, the determination of whether a foreign corporation is a PFIC is primarily factual, and there is little administrative or judicial authority on which to rely to make a determination. Hence, the IRS might not agree that Orthofix
Cura&ccedil;ao is not and has never been a PFIC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Taxation of Distributions on Orthofix Delaware Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A U.S. shareholder generally will be required to include in gross income the amount of any cash dividend paid on Orthofix Delaware shares. A cash distribution
(or a constructive distribution) on such stock generally will be treated as a dividend for U.S. federal income tax purposes to the extent the distribution is paid out of Orthofix Delaware&#146;s current or accumulated earnings and profits (as
determined under U.S. federal income tax principles). Such dividends paid by Orthofix Delaware may be taxable to a corporate U.S. shareholder at regular rates but will be eligible (subject to applicable requirements and limitations) for the
dividends-received deduction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Distributions in excess of such earnings and profits generally will be applied against and reduce the U.S.
shareholder&#146;s basis in its stock (but not below zero), determined separately for each share, and any excess will be treated as gain from the sale or exchange of such stock as described below under &#147;<I>&#151;Gain or Loss on Sale, Taxable
Exchange or Other Taxable Disposition of Orthofix Delaware Shares</I>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to <FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S.
shareholders, dividends generally will be taxed at the applicable long-term capital gains rate (see &#147;<I>&#151;Gain or Loss on Sale, Taxable Exchange or Other Taxable</I> <I>Disposition</I> <I>of Orthofix Delaware Shares</I>&#148; below),
subject to applicable requirements and limitations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Orthofix Delaware Shares
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon a sale or other taxable disposition of Orthofix Delaware shares, a U.S. shareholder generally will recognize capital gain or loss in an amount
equal to the difference between the amount realized and the U.S. shareholder&#146;s adjusted tax basis in the Orthofix Delaware shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any such capital
gain or loss generally will be long-term capital gain or loss if the U.S. shareholder&#146;s holding period for the Orthofix Delaware shares so disposed of exceeds one year. Long-term capital gains recognized by
<FONT STYLE="white-space:nowrap">non-corporate</FONT> U.S. shareholders may be eligible to be taxed at reduced rates. The deductibility of capital losses is generally subject to limitations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, the amount of gain or loss recognized by a U.S. shareholder is an amount equal to the difference between (i)&nbsp;the sum of the amount of cash and
the fair market value of any property received in such disposition and (ii)&nbsp;the U.S. shareholder&#146;s adjusted tax basis in its shares so disposed of. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_74"></A><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Shareholders </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This section applies to you if you are a <FONT STYLE="white-space:nowrap">&#147;Non-U.S.</FONT> shareholder.&#148; A
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder is a beneficial owner of Orthofix shares that is not a U.S. shareholder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> SHAREHOLDERS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF U.S. FEDERAL TAX LAWS TO THEIR PARTICULAR SITUATION, AS WELL AS ANY TAX CONSEQUENCES ARISING UNDER THE LAWS OF ANY STATE,
LOCAL OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> JURISDICTION. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividends </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any cash distribution (or a constructive distribution) Orthofix Delaware makes to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder of Orthofix
Delaware shares, to the extent paid out of Orthofix Delaware&#146;s current or accumulated earnings and profits (as determined under U.S. federal income tax principles), generally will constitute a dividend for U.S. federal income tax purposes. Any
such dividends paid or deemed paid to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder in respect of Orthofix Delaware shares that is not effectively connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT>
shareholder&#146;s conduct of a trade or business within the United States, as described below, generally will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividend, unless such <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder is eligible for a reduced rate of withholding tax under an applicable income tax treaty and provides proper certification of its eligibility for such reduced rate (usually on an IRS Form <FONT
STYLE="white-space:nowrap">W-8BEN</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> as applicable). In satisfying the foregoing withholding obligation with respect to a distribution, the applicable
withholding agent may withhold up to 30% of either (i)&nbsp;the gross amount of the entire distribution, even if the amount of the distribution is greater than the amount </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
constituting a dividend, as described above, or (ii)&nbsp;the amount of the distribution Orthofix Delaware projects will be a dividend, based upon a reasonable estimate of both its current and
accumulated earnings and profits for the taxable year in which the distribution is made. If U.S. federal income tax is withheld on the amount of a distribution in excess of the amount constituting a dividend, the
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder may obtain a refund of all or a portion of the excess amount withheld by timely filing a claim for refund with the IRS. Any such distribution not constituting a dividend generally will be
treated, for U.S. federal income tax purposes, first as reducing the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder&#146;s adjusted tax basis in such securities (but not below zero), determined separately for each share, and, to the
extent such distribution exceeds the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder&#146;s adjusted tax basis, as gain from the sale or other taxable disposition of such securities, which will be treated as described under
&#147;&#151;<I>Gain on Sale, Taxable Exchange or Other Taxable Disposition of Orthofix Delaware Shares</I>&#148; below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividends (including constructive
dividends) Orthofix Delaware pays to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder that are effectively connected with such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder&#146;s conduct of a trade or business within
the United States generally will not be subject to the foregoing U.S. federal withholding tax, provided such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder complies with certain certification and disclosure requirements (usually by
providing an IRS Form <FONT STYLE="white-space:nowrap">W-8ECI).</FONT> Instead, unless an applicable income tax treaty provides otherwise, such dividends generally will be subject to U.S. federal income tax, net of certain deductions, at the same
regular U.S. federal income tax rates applicable to a comparable U.S. shareholder. In addition, if the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder is a corporation, such holder&#146;s effectively connected earnings and profits
(subject to adjustments) may be subject to a U.S. federal &#147;branch profits tax&#148; at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on Sale, Taxable Exchange or Other Taxable Disposition of Orthofix Delaware Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder generally will not be subject to U.S. federal income tax in respect of gain recognized on a
sale, exchange or other disposition of Orthofix Delaware shares unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the gain is effectively connected with the conduct of a trade or business by the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder within the United States; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder is an individual who is present in the United States for 183 days or more in the taxable year of disposition and certain other conditions are met; or
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Orthofix Delaware is or has been a &#147;United States real property holding corporation&#148; (&#147;USRPHC&#148;) for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on
the date of disposition or the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder&#146;s holding period for such securities disposed of, and, generally, in the case where Orthofix Delaware shares are regularly traded on an established
securities market, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder has owned, actually or constructively, more than 5% of such shares, as applicable, at any time during the shorter of the five-year period ending on the date of
disposition or the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder&#146;s holding period for the security disposed of. It is not anticipated that Orthofix Delaware will be a USRPHC, although no assurances can be given in this regard.
There can be no assurance that Orthofix Delaware shares will be treated as regularly traded on an established securities market for this purpose. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless an applicable tax treaty provides otherwise, any gain described in the first or third bullet points above generally will be subject to U.S. federal
income tax, net of certain deductions, at the same regular U.S. federal income tax rates applicable to a comparable U.S. shareholder and, in addition, a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder described in the first bullet point
that is a foreign corporation will be subject to U.S. federal &#147;branch profits tax&#148; at a 30% rate (or a lower applicable tax treaty rate) on such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder&#146;s effectively connected
earnings and profits (subject to adjustments). Any gain of a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder described in the second bullet point above (which may be offset by U.S. source capital losses during the taxable year of the
disposition) generally will be subject to a flat 30% U.S. federal income tax rate (or a lower applicable tax treaty rate). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="rom571963_74a"></A>Information Reporting and Backup Withholding
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividend payments with respect to and proceeds from the sale, exchange or redemption of Orthofix Delaware shares may be subject to
information reporting to the IRS and possible U.S. backup withholding. Backup withholding will not apply, however, to a U.S. shareholder who furnishes a correct taxpayer identification number and makes other required certifications, or who is
otherwise exempt from backup withholding and establishes such exempt status. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> shareholder generally
will eliminate the requirement for information reporting (other than with respect to dividends) and backup withholding by providing certification of its <FONT STYLE="white-space:nowrap">non-U.S.</FONT> status on a duly-executed applicable IRS Form <FONT
STYLE="white-space:nowrap">W-8</FONT> or by otherwise establishing an exemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Amounts withheld as backup
withholding may be credited against a shareholder&#146;s U.S. federal income tax liability, and a shareholder generally may obtain a refund of any excess amounts withheld under the backup withholding rules by timely filing the appropriate claim for
refund with the IRS and furnishing any required information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="rom571963_74b"></A>Foreign Account Tax Compliance Act
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sections 1471 through 1474 of the Code and the Treasury Regulations and administrative guidance promulgated thereunder (commonly referred
as the &#147;<I>Foreign Account Tax Compliance Act</I>&#148; or &#147;<I>FATCA</I>&#148;) generally impose withholding at a rate of 30% in certain circumstances on dividends in respect of, and, after December&nbsp;31, 2018, gross proceeds from the
sale or other disposition of, securities (including Orthofix shares) which are held by or through certain foreign financial institutions (including investment funds), as a beneficial owner or as an intermediary, unless any such institution
(i)&nbsp;enters into, and complies with, an agreement with the IRS to report, on an annual basis, information with respect to interests in, and accounts maintained by, the institution that are owned by certain U.S. persons and by certain <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> entities that are wholly or partially owned by U.S. persons and to withhold on certain payments, or (ii)&nbsp;if required under an intergovernmental agreement between the United States and an applicable
foreign country, reports such information to its local tax authority, which will exchange such information with the U.S. authorities. An intergovernmental agreement between the United States and an applicable foreign country may modify these
requirements. Accordingly, the entity through which Orthofix shares are held will affect the determination of whether such withholding is required. Similarly, dividends in respect of, and, after December&nbsp;31, 2018, gross proceeds from the sale
or other disposition of, Orthofix shares held by an investor that is a <FONT STYLE="white-space:nowrap">non-financial</FONT> <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entity (as a beneficial owner or as an intermediary) that does not qualify
under certain exceptions will generally be subject to withholding at a rate of 30%, unless such entity either (i)&nbsp;certifies to the applicable withholding agent that such entity does not have any <I>&#147;substantial United States
owners&#148;</I> or (ii)&nbsp;provides certain information regarding the entity&#146;s <I>&#147;substantial United States owners,&#148;</I> which will in turn be provided to the U.S. Department of Treasury. All shareholders should consult their tax
advisors regarding the possible implications of FATCA on their investment in Orthofix shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_75"></A>MANAGEMENT</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_76"></A>Corporate Governance Highlights </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are committed to effective corporate governance and the regular review of our corporate governance practices to continue building on our success and
long-term shareholder value.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Election </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annual elections for all directors </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Independence </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Eight of our nine director nominees are fully independent under Nasdaq standards </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All four Board committees consist solely of independent directors </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Standing Board Committees </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Audit and Finance Committee (met ten times in 2017) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Compensation Committee (met nine times in 2017) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Compliance and Ethics Committee (met five times in 2017) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Nominating and Governance Committee (met six times in 2017) </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Practices and Policies </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Experienced, diverse Board membership with extensive business expertise in life sciences, finance, international planning and operational matters </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Commitment to Board refreshment, with an average tenure of 3.2 years for the nine directors that are nominated to continue serving after the Annual General Meeting </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Independent directors met in executive session at every regular 2017 Board meeting </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Approximately 95% average attendance by directors at Board and committee meetings in 2017 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Strong Board leadership in the oversight of enterprise risk (including recently initiated enterprise risk management program) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Compliance and Ethics Committee of the Board formed in 2013 to oversee and monitor a comprehensive, Company-wide ethics and compliance program that is led by our Chief Ethics and Compliance Officer </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annual Board and committee self-assessments and, beginning in 2016, individual board member performance reviews </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Structured director education and onboarding program </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Shareholders representing at least 10% of the outstanding common shares may call a special meeting </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">No shareholder rights plan (i.e., no &#147;poison pill&#148;) or blank check preferred stock </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">No supermajority voting requirements to approve mergers or other business combination transactions </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">No related party transactions with any directors or named executive officers </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">No political or PAC contributions by Company </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_77"></A>Executive
Officers </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our current executive officers are listed and described below.&nbsp;Messrs. Mason, Rice, Bianchi and Finegan and Ms.&nbsp;Elting
are referred to collectively throughout this proxy statement/prospectus as our &#147;named executive officers.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer and Director</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Global Extremity Fixation</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Legal and Administrative Officer</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Strategy Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond S. Fujikawa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Spine Fixation</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert A. Goodwin II</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Biologics</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley V. Niemann</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, BioStim</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bradley R. Mason.</B> Mr.&nbsp;Mason has served as a director since the 2013 Annual General Meeting.&nbsp;Mr.&nbsp;Mason
rejoined Orthofix in March 2013 as our President and Chief Executive Officer after previously serving as Group President, North America from June 2008 through October 2009, and as a Strategic Advisor from November 2009 through October 2010. Prior to
being appointed as Group President, North America, he had served as a Vice President of the Company since December 2003, when the Company acquired Breg, Inc. Prior to its acquisition by Orthofix, Mr.&nbsp;Mason had served as President and Chairman
of Breg, a company he principally founded in 1989 with five other shareholders.&nbsp;Mr.&nbsp;Mason has over 30 years of experience in the medical device industry, some of which were spent with dj Orthopedics (formally DonJoy) where he became an
owner and executive in its early development stage and held the position of Executive Vice President.&nbsp;Following his retirement from Orthofix in 2010, he served in a variety of part-time consulting and advisory roles, including as a consultant
to Orthofix since October 2012, which consulting relationship terminated as of March&nbsp;13, 2013 when he rejoined Orthofix. Mr.&nbsp;Mason is the named inventor on 38 issued patents in the orthopedic product arena. He graduated Summa Cum Laude
with an Associate of Arts and Associate of Science degree from MiraCosta College. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Douglas C. Rice.</B> Mr.&nbsp;Rice became the Company&#146;s Chief
Financial Officer in April 2015.&nbsp;He joined Orthofix as Chief Accounting Officer in September 2014 and was appointed to the position of Interim Chief Financial Officer later that month. Mr.&nbsp;Rice joined the Company from Vision Source, an
international optometric network provider, where he had served since 2012 as Chief Financial Officer. Mr.&nbsp;Rice served as the Vice President Finance, Treasurer of McAfee, a security technology company, from 2007 to 2012, when it was acquired by
Intel. From 2000 to 2007, he served as the Senior Vice President, Corporate Controller of Concentra, Inc., a national healthcare service provider. Mr.&nbsp;Rice&#146;s over 25 years of finance experience also included finance leadership positions
with la Madeleine, Allied Marketing Group as well as PricewaterhouseCoopers (formerly Coopers&nbsp;&amp; Lybrand). He is a certified public accountant, and holds an MBA and BBA, with honors, from Southern Methodist University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Davide Bianchi. </B>Mr.&nbsp;Bianchi joined Orthofix as President, International Extremity Fixation in July 2013 and was named as the Company&#146;s
President, Global Extremity Fixation in December 2013. From February 2009 through June 2013, Mr.&nbsp;Bianchi served as President of the Heart Valve Global Business Unit at Sorin Group. Earlier in his career, he spent 10 years with Edwards
Lifesciences, where he served as the European Marketing Manager; the Business Director, Emerging Markets; the Managing Director, Germany; the Vice President, Sales; and, most recently, the Vice President, Marketing, EMEA. Mr.&nbsp;Bianchi received
his Master in Business Management from ISTUD Milano. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kimberley A. Elting.</B> Ms.&nbsp;Elting joined Orthofix as Chief Legal Officer in September 2016 and was
named Chief Legal and Administrative Officer in 2017. Before joining the Company, she had served since 2013 as General Counsel and Vice President Corporate Affairs at TriVascular Technologies, Inc. In this role, she led the legal, compliance, human
resources (HR) and government affairs functions. Between 2007 and 2012, she served in various roles of increasing responsibility with St. Jude Medical, including General Counsel and Vice President of HR and Health Policy for the Neuromodulation
Division. She also previously was a partner at the Jones Day law firm where she counseled clients in the health care sector on mergers and acquisitions and regulatory matters. A graduate of Ithaca College, Ms.&nbsp;Elting earned her Law Degree from
the University of Denver and an LL.M. in Health Law from Loyola University Chicago. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Michael M. Finegan.</B> Mr.&nbsp;Finegan joined Orthofix in
June&nbsp;2006 as Vice President of Corporate Development, and became the President, Biologics in March&nbsp;2009.&nbsp;In October&nbsp;2011, he was promoted to Senior Vice President, Business Development, and President, Biologics, and in June 2013,
to his current position as Chief Strategy Officer.&nbsp;Prior to joining Orthofix, Mr.&nbsp;Finegan spent 16 years as an executive with Boston Scientific in a number of different operating and strategic roles, most recently as Vice President of
Corporate Sales. Earlier in his career, Mr.&nbsp;Finegan held sales and marketing roles with Marion Laboratories and spent three years in banking with First Union Corporation (Wachovia). Mr.&nbsp;Finegan earned a Bachelor of Arts in Economics from
Wake Forest University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Raymond S. Fujikawa.</B> Mr.&nbsp;Fujikawa joined the Orthofix team in August 2013 as Senior Vice President of Commercial
Strategy. With more than 33 years of experience in medical device sales, Mr.&nbsp;Fujikawa was directly responsible for establishing sales forces at Mitek, Surgiquip and Li Medical Technologies while serving as their Vice President of Sales.
Additionally, he was Vice President of Sales at Breg, Inc. where he was one of the creators of their business solution program. Mr.&nbsp;Fujikawa is the author of the sales training program &#147;Student of the Game&#148; which is used by companies
to enhance their sales results. He frequently lectures on this program at major university business schools. Mr.&nbsp;Fujikawa began his career as a medical device salesman, which led him to increasing responsibilities in successive management
roles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Robert A. Goodwin II.</B> Mr.&nbsp;Goodwin was appointed President of the Biologics strategic business unit in July 2013. Mr.&nbsp;Goodwin
joined Orthofix in 2006 as Director of Business Development before being promoted to Vice President of Finance in 2008, Vice President of Business Development in 2009 and the role of Vice President of Marketing for Biologics in 2012. He has more
than 23 years of medical device experience, including escalating levels of responsibility in functional areas of finance, sales, new product development, I/T, business development and marketing. Prior to joining Orthofix, Mr.&nbsp;Goodwin was with
U.S. Endoscopy, Aspect Medical Systems, and CR Bard. Mr.&nbsp;Goodwin holds a Bachelor&#146;s Degree in Accounting and Finance from the University of Maine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bradley V. Niemann.</B> Mr.&nbsp;Niemann was appointed President of the BioStim strategic business unit in June 2013. He joined Orthofix in March 2012 as
Senior Vice President of Commercial Operations for Orthofix&#146;s Global Spine Business. Mr.&nbsp;Niemann has more than 15 years of experience in the medical devices industry, with a particularly strong track record in expanding the utilization of
bone growth stimulation technology. From 2004-2012, Mr.&nbsp;Niemann worked in a variety of management roles at DJO Global, Inc. before joining Orthofix. Mr.&nbsp;Niemann holds a Bachelor of Science in Management from DePaul University.<B> </B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_78"></A>The Board and Committees of the Board </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Board </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Existing Articles of Association provides
that the Board shall consist of not less than six and no more than fifteen directors, the exact number to be determined from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time</FONT></FONT> by resolution of the Board. The
Board is currently comprised of nine seats. Directors are elected at each Annual General Meeting by a plurality of the votes cast, in person or by proxy by the shareholders.&nbsp;Directors are elected to serve until the following year&#146;s annual
general meeting or until a successor is elected and qualified.&nbsp;Because we are required by Cura&ccedil;ao law to hold the Annual General Meeting in Cura&ccedil;ao, we do not have a policy regarding director attendance at the Annual General
Meeting of Shareholders, and no directors were present at our 2017 Annual General Meeting of Shareholders. However, in the event that the domestication to Delaware is consummated, such that our annual meeting may be held in the U.S., we except that
some or all directors will attend annual meetings in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board meets at least four times per year in person at regularly scheduled meetings, but will meet more often
in person if necessary.&nbsp;In addition, the Board typically holds several additional meetings each year by telephone conference as events require.&nbsp;The Board met six times during 2017, four of which were
<FONT STYLE="white-space:nowrap">in-person</FONT> meetings.&nbsp;The Board has four standing committees:&nbsp;the Audit and Finance Committee, the Compensation Committee, the Compliance and Ethics Committee and the Nominating and Governance
Committee. During 2017 every director attended more than 75% of the aggregate of all meetings of the Board and the Committees on which he or she served held during the period for which he or she was a director or Committee member, as applicable.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Of the nine persons the Board has nominated for election as a director at the Annual General Meeting, the Board has determined that each of
Mr.&nbsp;Faulstick, Mr.&nbsp;Hinrichs, Mr.&nbsp;Lukianov, Ms.&nbsp;Marks, Mr.&nbsp;Matricaria, Mr.&nbsp;Paolucci, Ms.&nbsp;Sainz and Mr.&nbsp;Sicard are independent under the current Nasdaq listing standards. Mr.&nbsp;Mason is not considered
independent, as he also serves as the Company&#146;s President and Chief Executive Officer. A list of our director nominees and background information for each of them is presented in the section &#147;<I>Proposal 2:</I><I></I><I>&nbsp;Election of
Directors</I>,&#148; beginning on page 81. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Leadership Structure </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Matricaria, who is an independent director, serves as the Chairman of the Board.&nbsp;Mr.&nbsp;Mason, who is also a director, serves as the
Company&#146;s President and Chief Executive Officer.&nbsp;The Board believes that the separation of these two critical roles best serves the Company&#146;s shareholders at this time because it allows our President and Chief Executive Officer to
focus on providing leadership over our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations while our independent Chairman focuses on leadership of the Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Audit and Finance Committee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Audit and Finance
Committee is a separately-designated standing audit committee established in accordance with Section&nbsp;3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;).&nbsp;The committee oversees the Company&#146;s
financial reporting process on behalf of the Board. The committee is responsible for the selection, compensation, and oversight of the Company&#146;s independent registered public accounting firm. The committee reviews matters relating to the
Company&#146;s internal controls, as well as other matters warranting committee attention.&nbsp;The committee also meets privately, outside the presence of Orthofix management, with our independent registered public accounting firm.&nbsp;The Audit
and Finance Committee&#146;s report for 2017 is printed below at page 102. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted a written charter for the Audit and Finance Committee, a
copy of which is available for review on our website at <U>www.orthofix.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit and Finance Committee met ten times during 2017 (four of which
were <FONT STYLE="white-space:nowrap">in-person</FONT> meetings).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Faulstick, Mr.&nbsp;Hinrichs and Mr.&nbsp;Matricaria currently serve as members
of the Audit and Finance Committee, with Mr.&nbsp;Hinrichs serving as Chair. Under the current rules of Nasdaq and pursuant to Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> of Schedule 14A under the Exchange Act, all of the committee members
are independent.&nbsp;The Board has determined that Mr.&nbsp;Hinrichs is an &#147;audit committee financial expert&#148; as that term is defined in Item&nbsp;407(d) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Compensation Committee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee is
responsible for establishing compensation policies and determining, approving and overseeing the total compensation packages for our executive officers, including all elements of compensation. The committee administers our 2012 Long-Term Incentive
Plan (the &#147;2012 LTIP&#148;), the primary equity incentive plan under which we make equity-related awards, together with its predecessor, the 2004 Long-Term Incentive Plan </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(under which some grants made prior to 2013 remain outstanding) (the &#147;2004 LTIP&#148;). In addition, the committee administers our Amended and Restated Stock Purchase Plan (the
&#147;SPP&#148;), an equity plan under which most of our employees and directors are eligible to purchase common shares of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation
Committee met nine times during 2017 (four of which were <FONT STYLE="white-space:nowrap">in-person</FONT> meetings).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted a written
charter for the Compensation Committee, a copy of which is available for review on our website at <U>www.orthofix.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the beginning of 2017,
Mr.&nbsp;Paolucci, together with Drs. Guy Jordan and Anthony Martin, served as the members of the Compensation Committee, with Dr.&nbsp;Jordan serving as Chair. Drs. Jordan and Martin each retired from the Board as of last year&#146;s annual
meeting. To fill the committee seats vacated by Drs. Jordan and Martin, and as part of the Board&#146;s normal committee rotation process, Ms.&nbsp;Sainz and Mr.&nbsp;Lukianov replaced Drs. Jordan and Martin on the committee as of the date of last
year&#146;s annual meeting (at which time Mr.&nbsp;Paolucci became Chair). All of these members (i)&nbsp;are <FONT STYLE="white-space:nowrap">non-employee,</FONT> <FONT STYLE="white-space:nowrap">non-affiliated,</FONT> outside directors who have
been determined by the Board to be independent under the current rules of Nasdaq and (ii)&nbsp;satisfy the qualification standards of Section&nbsp;162(m) of the Code, and Section&nbsp;16 of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No interlocking relationship, as defined in the Exchange Act, currently exists, nor existed during 2017, between the Board or Compensation Committee and the
board of directors or compensation committee of any other entity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Compliance and Ethics Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compliance and Ethics Committee assists the Board in overseeing the Company&#146;s Corporate Compliance and Ethics Program and the Company&#146;s global
compliance with various international and domestic laws and regulations, including those related to the U.S. Food and Drug Administration and requirements of the U.S. Foreign Corrupt Practices Act and other applicable global anti-corruption laws.
The committee also assists the Board in overseeing the Company&#146;s compliance with the Company&#146;s own Corporate Code of Conduct, policies and procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compliance and Ethics Committee met five times in 2017 (four of which were <FONT STYLE="white-space:nowrap">in-person</FONT> meetings). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted a written charter for the Compliance and Ethics Committee, a copy of which is available for review on our website at
<U>www.orthofix.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the beginning of 2017, Ms.&nbsp;Sainz, Ms.&nbsp;Marks and Dr.&nbsp;Jordan served as members of the Compliance and Ethics
Committee, with Ms.&nbsp;Sainz serving as Chair.&nbsp;To fill the committee seat vacated by Dr.&nbsp;Jordan, in connection with his retirement from the Board and as part of the Board&#146;s normal committee rotation process, Mr.&nbsp;Paolucci
replaced Dr.&nbsp;Jordan on the committee as of the date of last year&#146;s annual meeting. All of these members have been determined by the Board to be independent under the current rules of the Nasdaq Global Select Market and the SEC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Nominating and Governance Committee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating
and Governance Committee assists the Board in identifying qualified individuals to become Board members, recommends to the Board nominees for election at each Annual General Meeting of Shareholders, develops and recommends to the Board the
Company&#146;s corporate governance principles and guidelines, and evaluates potential candidates for executive positions as appropriate. In connection with this role, the committee periodically reviews the composition of the Board in light of the
characteristics of independence, skills, experience and availability of service, with an emphasis on the particular areas of skill and experience needed by the Board at any given time. The committee periodically reviews with the Chairman of the
Board and the President and Chief Executive Officer succession planning, and makes recommendations to the Board in connection with succession planning. The committee also oversees the Board&#146;s annual evaluation process, which includes the
completion of questionnaires covering the Board, each committee and individual director performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Governance Committee met six
times in 2017 (five of which were <FONT STYLE="white-space:nowrap">in-person</FONT> meetings).</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board has adopted a written charter for the Nominating and Governance Committee, a copy of which is available
for review on our website at <U>www.orthofix.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the beginning of 2017, Mr.&nbsp;Faulstick, Mr.&nbsp;Hinrichs and Dr.&nbsp;Martin served as
members of the Nominating and Governance Committee, with Mr.&nbsp;Faulstick serving as Chair.&nbsp;To fill the seat vacated by Dr.&nbsp;Martin, in connection with his retirement from the Board and as part of the Board&#146;s normal committee
rotation process, Mr.&nbsp;Lukianov replaced Dr.&nbsp;Martin on the committee as of the date of last year&#146;s annual meeting. All of these members have been determined by the Board to be independent under the current rules of Nasdaq and the SEC.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Code of Conduct </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Corporate Code of
Conduct is the Company&#146;s code of ethics applicable to all directors, officers and employees worldwide.&nbsp;The goals of our Corporate Code of Conduct, as well as our general corporate compliance and ethics program (which we have branded the
<I>Integrity Advantage</I><I>&#153;</I> Program), are to deter wrongdoing and to promote (i)&nbsp;honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships,
(ii)&nbsp;the full, fair, accurate, timely, and understandable disclosure in reports and documents that we file with, or submit to, the SEC and in other public communications made by us, (iii)&nbsp;compliance with applicable governmental laws, rules
and regulations, (iv)&nbsp;the prompt internal reporting of violations of the Corporate Code of Conduct, and (v)&nbsp;accountability for adherence to the Corporate Code of Conduct.&nbsp;Our Corporate Code of Conduct applies to all areas of
professional conduct, including&nbsp;customer relationships, conflicts of interest,&nbsp;financial reporting, use of company assets, insider trading, intellectual property, confidential information and workplace conduct.&nbsp;Under the Corporate
Code of Conduct, employees, directors and executive officers&nbsp;are responsible for promptly reporting potential violations of any&nbsp;law, regulation or the Corporate Code of Conduct to appropriate personnel or a hotline we have established.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our&nbsp;Corporate Code of&nbsp;Conduct is&nbsp;available for review on our website at<U>&nbsp;www.orthofix.com</U>&nbsp;under the Corporate
Governance&nbsp;caption&nbsp;in the Investors section. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board&#146;s Role in Risk Oversight </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board plays an important role in overseeing various risks that we may face from time to time. While the full Board has primary responsibility for risk
oversight, it utilizes its committees, as appropriate, to monitor and address the risks that may be within the scope of a particular committee&#146;s expertise or charter. For example, the Audit and Finance Committee oversees our financial
statements and the Compliance and Ethics Committee assists in the Board&#146;s oversight of compliance with certain legal and regulatory requirements. The Board believes the composition of its committees, and the distribution of the particular
expertise of each committee&#146;s members, makes this an appropriate structure to more effectively monitor these risks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An important feature of the
Board&#146;s risk oversight function is to receive updates from its committees and management, as appropriate. In that regard, the Board regularly receives updates from the President and Chief Executive Officer, Chief Financial Officer, Chief Legal
and Administrative Officer, and Chief Ethics and Compliance Officer, including in connection with material litigation and legal compliance matters. The Board also receives updates at quarterly <FONT STYLE="white-space:nowrap">in-person</FONT> Board
meetings on committee activities from each committee Chair. In addition, the president or other senior executive of each Company division or business unit periodically reviews and assesses the most significant risks associated with his or her
division or unit.&nbsp;These assessments are then aggregated by our management team and presented to the Board.&nbsp;The Board regularly discusses with management these risk assessments and includes risk management and risk mitigation as part of
its&nbsp;oversight of the enterprise risk management program and its ongoing strategic planning process. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Shareholder Communication with the Board
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To facilitate the ability of shareholders to communicate with the Board, we have established an electronic mailing address and a physical mailing
address to which communications may be sent: <U>boardofdirectors@orthofix.com</U>, or c/o Orthofix Holdings Inc., Mr.&nbsp;Ronald&nbsp;A. Matricaria, Chairman of the Board of Directors of Orthofix International N.V., 3451 Plano Parkway, Lewisville,
TX 75056. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Matricaria reviews all correspondence addressed to the Board and presents to the Board a summary of all
such correspondence and forwards to the Board or individual directors, as the case may be, copies of all correspondence that, in the opinion of Mr.&nbsp;Matricaria, deals with the functions of the Board or committees thereof or that he otherwise
determines requires their attention.&nbsp;Examples of communications that would be logged, but not automatically forwarded, include solicitations for products and services or items of a personal nature not relevant to us or our
shareholders.&nbsp;Directors may at any time review the log of all correspondence received by Orthofix that is addressed to members of the Board and request copies of any such correspondence. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nomination of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As provided in its charter, the
Nominating and Governance Committee identifies and recommends to the Board nominees for election or <FONT STYLE="white-space:nowrap">re-election</FONT> to the Board and will consider nominations submitted by shareholders.&nbsp;The Nominating and
Governance Committee Charter is available for review on our website at <U>www.orthofix.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Governance Committee seeks to create a
Board that is strong in its collective diversity of skills and experience with respect to finance, research and development, commercialization, sales, distribution, leadership, technologies and industry knowledge.&nbsp;The Nominating and Governance
Committee reviews with the Board, on an annual basis, the current composition of the Board in light of the characteristics of independence, skills, experience and availability of service to Orthofix of its members and of anticipated needs.&nbsp;If
necessary, we will retain a third party to assist us in identifying or evaluating any potential nominees for director.&nbsp;When the Nominating and Governance Committee reviews a potential new candidate, it looks specifically at the candidate&#146;s
qualifications in light of the needs of the Board at that time given the then current mix of director attributes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As provided for in our Corporate
Governance Guidelines, in nominating director candidates, the Nominating and Governance Committee strives to nominate directors that exhibit high standards of ethics, integrity, commitment and accountability.&nbsp;In addition, our Corporate
Governance Guidelines state that all nominations should attempt to ensure that the Board shall encompass a range of talent, skills and expertise sufficient to provide sound guidance with respect to our operations and activities.&nbsp;Other than as
set forth in the Corporate Governance Guidelines with respect to the Board&#146;s objective in seeking directors with a range of talent, skills and expertise, the Board and the Nominating and Governance Committee do not have a formal policy with
respect to the diversity of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under our Corporate Governance Guidelines, directors must inform the Chairman of the Board and the Chair of the
Nominating and Governance Committee in advance of accepting an invitation to serve on another company&#146;s board of directors.&nbsp;In addition, no director may sit on the board of directors of, or beneficially own a significant financial interest
in, any business that is a material competitor of Orthofix.&nbsp;The Nominating and Governance Committee reviews any applicable facts and circumstances relating to any such potential conflict of interest and determines in its reasonable discretion
whether a conflict exists. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To recommend a nominee, a shareholder shall send notice to the Board c/o Orthofix Holdings Inc., Mr.&nbsp;Luke Faulstick,
Chair of the Nominating and Governance Committee of Orthofix International N.V., 3451 Plano Parkway, Lewisville, TX 75056.&nbsp;This notice should include the candidate&#146;s brief biographical description, a statement of the qualifications of the
candidate, taking into account the qualification requirements set forth above and the candidate&#146;s signed consent to be named in the proxy statement and to serve as a director if elected.&nbsp;The notice must be given not later than 180 days
before the first anniversary of the last Annual General Meeting of Shareholders.&nbsp;Once we receive the recommendation, the Nominating and Governance Committee will determine whether to contact the candidate to request that he or she provide us
with additional information about the candidate&#146;s independence, qualifications and other information that would assist the Nominating and Governance Committee in evaluating the candidate, as well as certain information that must be disclosed
about the candidate in our proxy statement, if nominated.&nbsp;Candidates must respond to our inquiries within the time frame provided in order to be considered for nomination by the Nominating and Governance Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Nominating and Governance Committee has not received any nominations for director from shareholders for the
2018 Annual General Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_79"></A>Section&nbsp;16(a) Beneficial Ownership Reporting Compliance
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Exchange Act requires our officers and directors, and holders of more than 10% of our common shares
(collectively, the &#147;Reporting Persons&#148;) to file with the SEC initial reports of ownership and reports of changes in ownership of our common shares.&nbsp;Such persons are required by regulations of the SEC to furnish us with copies of all
such filings.&nbsp;Based on our review of these reports and related representations by the Reporting Persons, we believe that all Section&nbsp;16(a) reports were filed timely in 2017, except that due to an internal administrative error at the
Company, the Form 4 relating to the Company&#146;s annual equity grant to directors and executive officers on July&nbsp;3, 2017 was filed two business days late for each of the directors and executive officers serving at such time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_80"></A>Compensation Discussion and Analysis </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We focus our compensation program for
our named executive officers and other executives on financial, strategic and operational goals established by the Board of Directors to create value for our shareholders. Our guiding compensation principle is to pay for performance. Our
compensation program is designed to motivate, measure and reward the successful achievement of our strategic and operating goals without promoting excessive or unnecessary risk taking. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2017, our primary business strategy was to accelerate our organic topline growth rate while maintaining Adjusted EBITDA margins. We believe that this
strategy proved effective and resulted in us exceeding our growth expectations for the year. We are currently focused on continuing our organic growth momentum, expanding margins and actively pursuing value-accretive inorganic opportunities to
further accelerate growth. We believe that we remain well-positioned to execute on both organic and inorganic strategic opportunities focused on accelerating shareholder value creation. Notable highlights and accomplishments in 2017 include the
following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Net sales were $433.8&nbsp;million, an increase of 5.9% on a reported basis and 5.5% on a constant currency basis; as net sales increased for each of our SBUs. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Net income from continuing operations was $7.3&nbsp;million, an increase of 108.5% from the prior year. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Net margin, an internal metric that we define as gross profit less sales and marketing expense, was $142.4&nbsp;million, an increase of 1.3% from the prior year.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We manage our business by our four SBUs: BioStim, Extremity Fixation, Spine Fixation and Biologics, which accounted for 43%, 24%, 19%, and
14%, respectively, of our total net sales in 2017. The chart below presents net sales, which includes product sales and marketing service fees, by SBU for each of the years ended December&nbsp;31, 2017, 2016, and 2015. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g571963g0420113918880.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Over the three-year period ending December&nbsp;31, 2017, Orthofix has delivered total shareholder return of 82%, with an
annual compound shareholder return of 22% during that same period. A $100 investment in Orthofix&#146;s common stock at the beginning of 2015 would have grown to $182 at the end of 2017, more than doubling the return of the S&amp;P&nbsp;500 over the
same period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consistent with shareholder interests and market best practices, our executive compensation program includes the following sound governance
features: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#00833e"><I>What we do: </I></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT COLOR="#00833e">&#10003;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top">Align pay and performance </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT COLOR="#00833e">&#10003;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top">Emphasize variable and performance-based compensation, with cash-based and equity-based performance targets approved by the Compensation Committee based on budgeted levels reviewed and approved in advance by the Board
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT COLOR="#00833e">&#10003;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top">Discourage unnecessary and inappropriate risk taking, including obtaining an annual independent risk assessment analysis </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT COLOR="#00833e">&#10003;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top">Regularly monitor our share utilization from equity compensation awards and the potential dilutive impact </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT COLOR="#00833e">&#10003;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top">Maintain robust stock ownership guidelines for our executive officers and directors (including 5x salary for CEO) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT COLOR="#00833e">&#10003;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top">Maintain an incentive compensation clawback policy </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT COLOR="#00833e">&#10003;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top">Provide for &#147;double-trigger&#148; change in control vesting on all new equity grants since 2016, and no &#147;single-trigger&#148; cash or similar payment rights upon a change in control </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT COLOR="#00833e">&#10003;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top">Retain an independent compensation consultant who conducts an annual benchmarking of our compensation against industry peer group </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B><FONT COLOR="#00833e">&#10003;</FONT><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top">Include caps on annual incentive plan payments and shares earned under PSUs </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><FONT
 COLOR="#eb0029"><I>What we don&#146;t do: </I></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#eb0029"><B>X</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT COLOR="#eb0029"><B></B></FONT>Pay dividends or dividend equivalents on unearned performance stock units </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#eb0029"><B>X</B></FONT></TD>
<TD ALIGN="left" VALIGN="top">Maintain employment agreements with executive officers (unless required by law) </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#eb0029"><B>X</B></FONT></TD>
<TD ALIGN="left" VALIGN="top">Pay excise tax <FONT STYLE="white-space:nowrap">gross-ups</FONT> for change in control payments </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#eb0029"><B>X</B></FONT></TD>
<TD ALIGN="left" VALIGN="top">Reprice stock options </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#eb0029"><B>X</B></FONT></TD>
<TD ALIGN="left" VALIGN="top">Pay cash severance under our current agreements and policies (including to CEO) in excess of 1.5x salary and bonus (2.0x in the case of a change in control) </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT COLOR="#eb0029"><B>X</B></FONT></TD>
<TD ALIGN="left" VALIGN="top">Permit hedging or pledging of our securities by directors or executive officers </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Guiding
Principles and Philosophy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee (referred to throughout this Compensation Discussion and Analysis as the &#147;Committee&#148;)
is comprised solely of independent directors. The Committee recommends to the Board for determination by the Board, the President and Chief Executive Officer&#146;s compensation, and discharges the responsibilities of the Board relating to all
compensation of the Company&#146;s other executive officers (including equity-based compensation for both executive officers and other key employees).&nbsp;The Committee guides itself in large part by our executive compensation philosophy.&nbsp;The
compensation program for executive officers reflects the Committee&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;pay-for-performance&#148;</FONT></FONT> outlook, which seeks to align compensation with the goals of
growing our business and increasing shareholder value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee is guided by a set of overall compensation guiding principles. In September 2017,
the Committee adopted the Orthofix Executive Compensation Guiding Principles (the &#147;Executive Compensation Guiding Principles&#148;), which update the Company&#146;s prior Executive Compensation Guiding Principles and Compensation Philosophy for
Senior Executives with a combined set of guidelines. These guiding principles are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each compensation element should be competitive within the medical device industry but also tailored to Orthofix&#146;s business needs, supporting the Company&#146;s business strategy and hiring objectives of
attracting, retaining and motivating top talent. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Variable compensation should provide significant leverage (upside and downside) so that payouts are commensurate with performance and replicate the shareholder-experience. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Compensation Committee will have responsibility for all compensation decisions related to the executive officers, who are Section&nbsp;16 reporting persons (referred to collectively as the Section&nbsp;16 executive
officers). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Management will have responsibility for compensation decisions related to all executives of the Company who are not Section&nbsp;16 executive officers, subject to limits established by the Compensation Committee (i.e.,
long-term incentive awards and change in control agreement participation). </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s executive compensation program should be
easily understood by employees. Management is responsible for effectively communicating the design and administration of the program to employees. Consistent with these principles, the Committee&#146;s compensation philosophy is to fairly compensate
executive officers with an emphasis on providing incentives that balance our short- and long-term objectives.&nbsp;As described in more detail below, achievement of short-term objectives is rewarded through base salary and annual cash incentive
awards, while grants of performance share units, and time-based vesting stock options and restricted stock, encourage executive officers to focus on our long-term goals.&nbsp;These core components remain the basis for our executive compensation
philosophy as we seek to achieve profitable growth. The Compensation Committee retains full discretion to set compensation (including salary and bonus amounts) and make long-term incentive awards that differ from the Executive Compensation Guiding
Principles, especially when special retention, recruitment or other factors suggest that such changes are believed to be in the best interests of the Company and its stockholders. The Executive Compensation Guiding Principles are reviewed and
updated from time to time by the Compensation Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In implementing this overall
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;pay-for-performance&#148;</FONT></FONT> compensation philosophy for the Company&#146;s executive officers, the Committee places considerable emphasis on variable elements of pay
within the executive compensation program. These elements consist of the Company&#146;s annual incentive plan, which is intended to reward executive officers for achieving specific operating and financial objectives during the fiscal year, as well
as a long-term incentive plan that consists of stock options, balanced with both performance-based and time-based vesting stock awards The Committee seeks to provide rewards through the annual incentive plan by measuring performance based on key <FONT
STYLE="white-space:nowrap">pre-established</FONT> measures reflecting positive financial performance by the Company and its business units. The Committee also seeks to provide strong linkage between executives and shareholders with grants of equity,
as the value of these awards appreciates in accordance with the market value of the Company&#146;s common stock. In addition to variable compensation programs, executives also receive health and welfare benefits (including our 401(k) plan) that are
generally consistent with those provided by our peer group and with the level of health and welfare benefits provided to all Company employees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Governance of Executive Compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described
further below, executive compensation for our executive officers is reviewed and established annually by the Committee, which consists solely of independent directors. The Committee&#146;s compensation decisions are intended to reflect its ongoing
commitment to strong compensation governance, which the Committee believes is reflected in the following elements of our executive compensation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Pay At Risk Based on Performance &#151; </I></B>As our programs are designed using a &#147;pay-for-performance&#148; philosophy, actual pay realized (earned) by our executives is predominantly at risk through our
performance-based annual incentive program and through our long-term incentive grants that consist of both stock options (which will only provide value to executives if our stock price appreciates) and both time-based and performance-based vesting
stock awards. For example, 50% of the total annual equity awards made through our long-term incentive grants only vest based on certain total shareholder return (&#147;TSR&#148;) criteria being met. In structuring this mix of compensatory elements,
the Committee seeks to deliver pay in a way that reinforces focus on balancing short- and long-term financial performance objectives, while supporting performance with policies that focus on prudent risk taking and the balance between risk and
reward. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Stock Ownership Guidelines Align Our Executive Officers and Directors with Shareholders </I></B>&#151; The Committee believes that a significant portion of each executive&#146;s and director&#146;s compensation
should be tied to the Company&#146;s financial performance and share price. We seek to award stock options and stock awards pursuant to our long-term incentive plan so that over a period of time, a significant portion of actual compensation is
provided in the form of share-based compensation. In this regard, we have adopted stock ownership guidelines that apply to all of our executive officers and directors. The guidelines provide that the President and Chief Executive Officer should have
an ownership in the Company&#146;s common stock equal to five times his or her annual base salary, while all other executive officers (including executive officers who are not &#147;named executive officers&#148; in the proxy statement) should have
ownership equal to two times his or her annual base salary. The guidelines provide that each director should have ownership equal to three times his or her annual director fee compensation. Full credit is given under the guidelines for common stock
owned, while 50% credit is provided for (i)&nbsp;unvested time-based vesting restricted stock and (ii)&nbsp;the unrealized gain on vested and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">in-the-money</FONT></FONT> stock options.
No credit is given for unvested stock options, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-the-money</FONT></FONT></FONT> stock options or unvested performance vesting restricted stock or
units. The guidelines include a 5 year <FONT STYLE="white-space:nowrap">phase-in</FONT> period from the date of appointment or election, as applicable, and progress towards meeting and maintaining these amounts is measured annually as of February
28. Subject to <FONT STYLE="white-space:nowrap">phase-in</FONT> periods for recent appointments, all executive officers and directors are in compliance with the policy at the present time. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Clawback Policy Promotes Long-Term Performance</I></B> &#151; In 2012, we adopted a clawback policy that applies to each of our executive officers, and applies to both cash-based and equity-based compensation.
This policy is more fully described below on page 63. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>No Repricing of Stock Options</I></B> &#151; Stock options are never issued with below-market exercise prices, and the repricing of stock options without shareholder approval is expressly prohibited under the
terms of our long-term incentive plans. The Committee believes that the issuance of discount stock options and authorization of post-grant date repricings are each not performance-based pay practices, and therefore inconsistent with the
Committee&#146;s commitment to &#147;pay-for-performance&#148;. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Independent Report Supports Committee&#146;s Risk Assessment</I></B> &#151; The Committee annually assesses the relationship between the Company&#146;s compensation policies and practices for all employees and
risk, including whether such policies and practices encourage imprudent risk taking, and/or would be reasonably likely to have a material adverse effect on the Company. At the Committee&#146;s request, Willis Towers Watson delivered a report in
2017, assessing potential risk that may be present in the design or administration of the Company&#146;s compensation program. Consistent with Willis Towers Watson&#146;s findings, the Committee believes that the Company&#146;s employee compensation
programs (executive and broad-based) provide multiple and effective safeguards to protect against undue risk. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>No Hedging Policy</I></B> &#151; Our corporate governance guidelines prohibit all executive officers and directors from engaging in any hedging or monetization transactions involving the Company&#146;s securities,
including through the use of financial instruments such as prepaid variable forwards, equity swaps, collars and exchange funds. No executive officers or directors currently are parties to a hedge with respect to any shares of Common Stock of the
Company. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>No Pledging Policy</I></B> &#151; Our corporate governance guidelines prohibit all executive officers and directors from pledging the Company&#146;s securities as collateral for a loan. Acquiring Company shares on
margin, or holding Company shares in a margin account, is also prohibited. No executive officers or directors currently are parties to a pledge of any shares of Common Stock of the Company. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Double-Trigger Change in Control Vesting </I></B>&#151; Since July 2016, equity grants are made using forms of award agreement featuring &#147;double trigger&#148; vesting, whereby awards will only accelerate
vesting following an involuntary termination of employment if such involuntary termination occurs within 24 months of a change in control (or if such involuntary termination otherwise results from death or disability). In addition we do not provide
for any &#147;single-trigger&#148; cash or similar payment rights upon a change in control. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Use of Independently Prepared Competitive Assessments</I></B> &#151; The practice of the Compensation Committee is to engage the Company&#146;s compensation consultant to prepare an independent executive
compensation competitive assessment to measure our program against peer companies and other survey data. The Committee takes these results into consideration in approving our executive compensation program. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Process </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee is responsible
for establishing and evaluating compensation policies and determining, approving and evaluating executive compensation, including the total compensation packages for our Section&nbsp;16 executive officers. The Committee is also responsible for
administering the Company&#146;s equity incentive plans and other executive compensation policies and programs. The Committee specifically considers and approves the compensation for the executive officers and recommends for approval of the Board
the compensation for the Chief Executive Officer.&nbsp;(The Chief Executive Officer is prohibited from being present during Committee or Board voting or deliberations with respect to his own compensation arrangements.) The Committee also is
responsible for making recommendations to the Board regarding the compensation of directors.&nbsp;The Committee relies on the President and Chief Executive Officer to make recommendations on certain aspects of compensation as discussed
below.&nbsp;The Committee acts under a written charter adopted by the Board.&nbsp;The Committee reviews its charter annually and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
recommends any changes to the Board. The charter is available on our website at <U>www.orthofix.com</U>.&nbsp;As of the beginning of 2017, Mr.&nbsp;Paolucci, together with Drs. Jordan and Martin,
served as the members of the Compensation Committee, with Dr.&nbsp;Jordan serving as Chair. Drs. Jordan and Martin each retired from the Board as of last year&#146;s annual meeting. To fill the committee seats vacated by Drs. Jordan and Martin, and
as part of the Board&#146;s normal committee rotation process, Ms.&nbsp;Sainz and Mr.&nbsp;Lukianov replaced Drs. Jordan and Martin on the committee as of the date of last year&#146;s annual meeting (at which time Mr.&nbsp;Paolucci became Chair).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2017, each member of the Board who served on the Committee was an independent, <FONT STYLE="white-space:nowrap">non-employee,</FONT> <FONT
STYLE="white-space:nowrap">non-affiliated,</FONT> outside director while he or she served on the Committee.&nbsp;The Committee has furnished its report below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Role of Executive Officers </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the
Committee&#146;s request, from time to time certain of our senior management present compensation-related initiatives to the Committee.&nbsp;For instance, while the Committee approves all elements of compensation for executive officers, the
Committee requests on an annual basis that senior management aid the Committee in fulfilling its duties by facilitating the gathering of information relating to potential targets and goals under our annual incentive program as well as possible
equity incentive grants.&nbsp;The Committee then reviews this information in connection with it setting annual incentive targets and goals, or making equity grants.&nbsp;Under the Executive Compensation Guiding Principles, management is responsible
for compensation decisions related to all executives who are <FONT STYLE="white-space:nowrap">non-Section</FONT> 16 officers, subject to limits established by the Compensation Committee (e.g., long-term incentive awards and change in control
agreement participation). In this context, the President and Chief Executive Officer has general oversight for the <FONT STYLE="white-space:nowrap">non-executive</FONT> officer employee compensation process within the Company, and provides input to
the Committee in such capacity.&nbsp;The President and Chief Executive Officer also provides the Committee with additional input, perspective, and recommendations in connection with the Committee&#146;s salary determinations for executive
officers.&nbsp;The President and Chief Executive Officer, Chief Financial Officer, Chief Legal and Administrative Officer, and Vice President of Human Resources frequently attend meetings of the Committee in these respective capacities.&nbsp;These
individuals are excluded from any Committee or Board deliberations or votes regarding their own compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Consultant </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee has the authority under its charter to retain, at the Company&#146;s expense, outside compensation consultants to assist in evaluating
compensation.&nbsp;The Committee also has the authority to terminate those engagements.&nbsp;In accordance with this authority and to aid the Committee in fulfilling its duties, the Committee engaged Mercer LLC (&#147;Mercer&#148;), as its outside
compensation consultant in September 2017. Prior to the engagement of Mercer, Willis Towers Watson served as the Committee&#146;s compensation consultant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In its role as compensation consultant, Mercer, at the Committee&#146;s request, periodically conducts reviews and recommends updates to our executive officer
and director compensation programs and long-term incentive practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with their engagement, Mercer reported to the Committee regarding its
independence based on the six factors outlined in SEC regulations issued under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. The Committee considered these factors and concluded that Mercer is independent and that its
engagement by the Committee raised no conflicts of interest. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Peer Group Benchmarking </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Decisions related to executive compensation program design and pay levels are informed, in part, by the practices and pay levels of comparable peer
organizations. During 2017, the Committee engaged Mercer to conduct an executive compensation analysis that provided market competitive levels of total compensation.&nbsp;This assessment, which was completed and presented in December 2017, compared
Orthofix executive officer compensation levels in comparison with market data to determine whether compensation levels for our executive officers remain consistent with market practice and our compensation philosophy.&nbsp;In conducting the
assessment, Mercer made comparisons to our peer group and survey data including companies in the life sciences/medical devices industries and technology companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In conducting the 2017 benchmarking, Mercer utilized a selection of 19 peer companies. This selection of peer
companies, or &#147;peer group,&#148; reflects revisions to the Company&#146;s 2016 peer group, which revisions were approved by the Committee in November 2017. The revisions to the peer group for 2017 consisted of the addition of Cardiovascular
Systems, Inc., CryoLife Inc., Halyard Health, Inc., LivaNova PLC and Nevro Corp., and the deletion of Exactech, Inc., Globus Medical, Inc. and The Spectranetics Corporation. The members of the peer group were selected for inclusion principally
because of their overall similarity to Orthofix in terms of annual revenue, industry <FONT STYLE="white-space:nowrap">sector/sub-sector,</FONT> medical technology product lines and international penetration. The revised peer group consists of the
following medical technology and device manufacturers and distributors, some of which we compete against for executive talent. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">ABIOMED, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">K2M Group Holdings, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Angiodynamics, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">LivaNova PLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cardiovascular Systems, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Merit Medical Systems, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CONMED Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Nevro Corp.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CryoLife, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Natus Medical Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Haemonetics Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NuVasive, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Halyard Health, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NxStage Medical, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">ICU Medical Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">RTI Surgical Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Integer Holdings Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Wright Medical Group N.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Integra LifeSciences Holdings Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mercer&#146;s 2017 assessment of compensation levels for the Company&#146;s executive officers found that, on average, target
total direct compensation (base salary, target cash bonus and target long-term incentive compensation) for the group as a whole was near the market median based on data for our peer group and survey data (as described above). Specifically, Mercer
reported that each of base salary and target bonus were 4% above the market median, on average, and target long-term incentive compensation was 3% above the market median, on average. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Role of Shareholder <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Say-on-Pay</FONT></FONT> Votes and Shareholder Engagement
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company provides its shareholders with the opportunity to cast an annual advisory, <FONT STYLE="white-space:nowrap">non-binding</FONT> vote on
executive compensation (a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay</FONT></FONT> proposal&#148;), and subsequently evaluates these results. At the 2017 annual meeting, the Company&#146;s <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> proposal was supported by 92% of the votes cast, which we believe supports the Company&#146;s
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;pay-for-performance&#148;</FONT></FONT> approach to executive compensation. The Committee evaluated the results of the vote in the fall of 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee believes that the voting results over the course of the last several years (which has included 90% or greater approval votes at five of the
Company&#146;s last six annual general meetings) affirm shareholders&#146; overall support of the Company&#146;s approach to executive compensation, including continuing efforts by the Committee during that time to evolve the Company&#146;s
compensation programs towards policies viewed by institutional and other shareholders as aligning executive compensation with the interests of shareholders and good corporate governance. In addition to responding to the input of shareholders, the
Committee also has considered many other factors in evaluating and setting the Company&#146;s executive compensation programs, including the Committee&#146;s assessment of the interaction of our compensation programs with our corporate business
objectives, periodic analysis of our programs by our compensation consultant, and annual review of data versus a comparator group of peer companies, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
each of which is evaluated in the context of the Committee members&#146; fiduciary duty to act as the directors determine to be in shareholders&#146; best interests. Each of these factors
informed the Compensation Committee&#146;s decisions regarding named executive officers&#146; compensation for 2017. The Committee will continue to consider feedback from shareholders, including the outcome of the Company&#146;s <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> votes, when making future compensation decisions for its named executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Elements of Executive Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation program for executive officers and other key employees consists of three primary elements: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">annual salary; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">performance-based incentives in the form of annual cash bonuses; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">long-term equity-based incentives under our long-term incentive plan. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee reviews annually what
portion of an executive officer&#146;s compensation should be in the form of salary, potential annual performance-based cash bonuses and long-term equity-based incentive compensation.&nbsp;The Committee believes an appropriate mix of these elements,
commensurate with our compensation philosophy, will assist the Committee in meeting its compensation objectives.&nbsp;See below for more information on the Committee&#146;s guidelines for each element of executive compensation.&nbsp;As part of its
decision making process, the Committee reviews information setting forth all components of the compensation and benefits received by our named executive officers.&nbsp;This information includes a specific review of dollar amounts for salary, bonus
and long-term equity-based incentive compensation.&nbsp;In addition, as further described below, we sometimes grant <FONT STYLE="white-space:nowrap">one-time</FONT> bonuses and stock awards in connection with new hires and promotions, or for
retention or special recognition purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The charts below show the annual total target compensation (full-year base salary, target annual cash
incentive compensation and long-term equity incentive compensation received) for our President and Chief Executive Officer and our other named executive officers for 2017. These charts illustrate that a significant portion of our named executive
officer total target compensation was performance-based (53% for our President and Chief Executive Officer). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g571963g0420113919223.jpg" ALT="LOGO">



<IMG SRC="g571963g0420113919551.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>*</I></TD>
<TD ALIGN="left" VALIGN="top"><I>All other compensation value not displayed as it represents less than 1% of total direct compensation. </I></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Annual Salary </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee makes annual
determinations with respect to the salaries of executive officers.&nbsp;In making these decisions, the Committee considers each executive officer&#146;s performance, experience, contribution to the Company&#146;s success, the market compensation
levels for comparable positions within and outside our peer group, performance goals and objectives and other relevant information, including recommendations of the President and Chief Executive Officer. Under the Executive Compensation Guiding
Principles, we target a base salary range between the 25th and 75th percentile of peer group and/or market data. The Committee also makes annual recommendations to the Board for the salary of the President and Chief Executive Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The range of increase for 2018 was determined based on the individual executive officer&#146;s positioning within the peer group study, as well as individual
performance and contribution to Company performance. The annual base salary amounts for our currently employed named executive officers are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017&nbsp;Annual</B><br><B>Base Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018&nbsp;Annual</B><br><B>Base Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B><br><B>Increase</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">710,800</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">740,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">390,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">420,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael&nbsp;M.&nbsp;Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Strategy Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">412,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">418,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Legal and Administrative Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">382,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">410,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Global Extremity Fixation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CHF</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;364,984</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CHF</TD>
<TD VALIGN="top" ALIGN="right">&nbsp;379,911</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Bianchi is paid in Swiss Francs (CHF). Based on the average exchange rate to U.S. Dollars applicable during the 2017 fiscal year (1.0159), the amounts shown in the table above would be $370,780 and $385,944,
respectively. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Performance-Based Incentives &#150; Annual Incentive Program </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee believes that a significant portion of the compensation for each executive officer should be in the form of annual performance-based cash
bonuses. These bonuses are provided through our annual incentive program, which seeks to tie an executive officer&#146;s total cash compensation to our immediate, <FONT STYLE="white-space:nowrap">one-year</FONT> financial performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee is responsible for approving the annual bonus plan design every year. At the outset of each year the Committee establishes target
performance goals and a range of performance around the target performance goals for which a bonus would be paid as described below. The plan design, metrics, and metric incentive zones should support the annual corporate goals and objectives for
the year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For 2017, performance goals for Messrs. Mason, Rice and Finegan and Ms.&nbsp;Elting were based on Company-wide net sales and adjusted EBITDA
performance, each weighted at 50%. (Adjusted EBITDA consists of EBITDA (defined as GAAP-derived income from continuing operations less net interest expense, income tax expense, depreciation and amortization) net of credits or charges that were
considered by the Committee at the time bonus targets were set to be outside of the normal ongoing operations of the Company.) For Mr.&nbsp;Bianchi, these two metrics were each weighted at 25%, while sales and adjusted EBITDA for
Mr.&nbsp;Bianchi&#146;s Extremity Fixation strategic business unit were each weighted at 25%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee set the performance goals with the intent
that it will be challenging for a participant to receive 100% of his or her incentive opportunity target award. However, an executive officer can earn up to 150%&nbsp;of his or her targeted bonus based upon actual performance measured against the
range of established performance goals. No payouts are made for performance below the 50% achievement threshold on any specific goal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposed goals
and related matrix were reviewed and approved by the Committee in March 2017, and performance was then subsequently assessed by the Committee in February 2018. Each of the Committee members at the time of the applicable action participated in and
approved these respective determinations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below describes the target goals and actual achievement for the categories described above in 2017.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="14" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Weighted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>Achievement</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighting</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Achievement Level (in millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>% of Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:91.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Category of 2017 Goals (1)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Other<BR>NEOs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Mr.<BR>Bianchi</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold<BR>50%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target<BR>100%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum<BR>150%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Achievement<BR>% of Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Other<BR>NEOs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Mr.<BR>Bianchi</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company-wide Net Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">403.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">411.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">423.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">429.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company-wide Adjusted EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">85.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">89.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">90.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Extremity Fixation SBU Net Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">97.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">101.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">98.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Extremity Fixation SBU Adjusted EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>100.0</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>129.5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>126.7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Committee approval of targets in March 2017 provided that targeted amounts would be adjusted to eliminate the effect of subsequent currency fluctuations. The targeted amounts shown in the table reflect the original
targets as adjusted to reflect such <FONT STYLE="white-space:nowrap">pre-approved</FONT> constant currency adjustments. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Aggregate Payouts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To calculate the bonus amount payable, the aggregate weighted achievement percentage for each named executive officer was multiplied by the target amount of
bonus for which that participant was eligible. These results are described in the tables below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Company-<BR>wide Net</B><br><B>Sales&nbsp;Percent</B><br><B>Achievement</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>SBU Net<BR>Sales</B><br><B>Percent<BR>Achievement</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Company-wide</FONT></B><br><B>Adjusted&nbsp;EBITDA<BR>Percent</B><br><B>Achievement</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>SBU Adjusted</B><br><B>EBITDA</B><br><B>Percent&nbsp;Achievement</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted&nbsp;Percent</B><br><B>Achievement</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017 Base<BR>Salary</B><br><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target&nbsp;Bonus</B><br><B>Percentage</B><br><B>of Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted</B><br><B>Percent</B><br><B>Achievement</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total Annual</B><br><B>Incentive&nbsp;Plan</B><br><B>Bonus</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">710,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">920,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">390,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">303,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">412,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">320,124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">382,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">129.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">296,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi <SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CHF</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;364,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CHF</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;277,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Bianchi is paid in Swiss Francs (CHF). Based on the average exchange rate to U.S. Dollars applicable during the 2017 fiscal year (1.0159), the amounts shown in the table would be $370,787 and $281,873,
respectively. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payouts to the named executive officers under the annual incentive program are reflected in column (g)&nbsp;of the
&#147;Summary Compensation Table.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Bonus Payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time,</FONT></FONT> the Committee uses its discretion to grant bonuses for
performance or for other circumstances, such as in the cases of new hires and promotions.&nbsp;(See column (d)&nbsp;of the &#147;Summary Compensation Table.&#148;)&nbsp;The Committee has not granted any bonuses of this nature to named executive
officers since 2014. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Long-Term Equity-Based Incentives </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Overview and Long-Term Incentive Plan &#150; 2012 LTIP </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the Executive Compensation Guiding Principles, the creation of sustainable shareholder value by means of equity incentive awards is a very
important element of the total compensation provided to executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our primary equity compensation plan is the 2012 LTIP, which our shareholders
approved in June 2012.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some current and former executive officers continue to hold outstanding awards under our 2004 LTIP, although we no longer grant
awards under this plan.&nbsp;The Committee administers each of these plans and only the Committee makes long-term incentive plan grants to named executive officers. In addition, the Committee has in rare instances made inducement grants (in
accordance with applicable Nasdaq rules) to newly hired executives outside of shareholder approved plans, as it did in 2013 in connection with the hiring of Mr.&nbsp;Mason. These inducement grants have been made on terms that are substantially the
same as grants made under the 2012 LTIP or 2004 LTIP. The Company has not made any such <FONT STYLE="white-space:nowrap">non-shareholder</FONT> approved plan inducement grants since 2013; however, the Company has entered into a merger agreement to
acquire Spinal Kinetics, Inc., a privately held developer and manufacturer of artificial cervical and lumbar discs, and expects to make equity awards to employees of Spinal Kinetics at or shortly following closing in reliance on the Nasdaq
inducement grant exception. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the present time, the Committee grants three types of equity incentive awards to executive officers:
(i)&nbsp;time-based vesting stock options, (ii)&nbsp;time-based vesting restricted stock, and (iii)&nbsp;performance-based vesting stock units. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Stock Options</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Restricted Stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Performance Stock Units</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Value&nbsp;Weighting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">25%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">25%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">50%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Performance Conditions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">N/A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">N/A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">TSR relative to the S&amp;P Healthcare Select Index</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Term</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ten years</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Four years</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Three-year performance period with additional <FONT STYLE="white-space:nowrap">one-year</FONT> holding period</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vesting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Vest in four equal installments on the first, second, third, and fourth anniversaries of the grant date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Vest in four equal installments on the first, second, third, and fourth anniversaries of the grant date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Cliff vest after three years upon certification of results. Subject to additional <FONT STYLE="white-space:nowrap">one-year</FONT> holding period</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Payout</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Upon exercise, participant acquires common shares at the previously defined exercise price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Participant acquires unrestricted shares of common stock upon vesting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment made in unrestricted shares of common stock at the end of the holding period</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8194;&#8202;Payouts at 50% of
target for relative TSR performance at the 25th percentile</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8194;&#8202;Maximum performance capped at 200% of target for relative TSR performance at or above the
75th percentile; overall payouts (i.e., including both performance results and stock price appreciation) capped at 500% of target</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8194;&#8202;Vesting may not exceed 100% if actual TSR is negative during the performance
period</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the Executive Compensation Guiding Principles, equity incentive awards currently follow the following
principles: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annual long-term incentive awards are delivered in a mix of the types of equity awards described in the preceding paragraph. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annual long-term incentive awards are made to all Section&nbsp;16 executive officers. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annual long-term incentive award values are competitively positioned based on market data for comparable positions and individual performance. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Time-Based Vesting Grants </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the
Company&#146;s operative agreements with executive officers, the unvested portion of any time-based grant is forfeited if an employee voluntarily ceases employment prior to vesting.&nbsp;In the event that an employee is terminated by the Company
without cause any remaining unvested portion of the grant is forfeited.&nbsp;In the event an employee dies, suffers a long-term disability, or retires within certain age and service tenure parameters, the full grant vests.&nbsp;In all of the
foregoing circumstances, vested stock options are subject to a limited post-employment exercise period, which ranges from 3 to 18 months depending on the circumstance.&nbsp;In the case of stock options held by employees who remain continuously
employed, the options expire and are no longer exercisable 10 years from the grant date.&nbsp;Should a change in control occur while a grantee remains employed, unvested portions of the grant will accelerate only if the employee separates from
employment in specific circumstances within 24 months of the change in control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Performance-Based Vesting Grants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In recent years, the Committee has actively worked with its compensation consultant to implement performance-based vesting equity grants. The Committee first
made such a grant in 2013 at the time Mr.&nbsp;Mason joined the Company. Rather than receiving a time-based grant, Mr.&nbsp;Mason agreed that his initial inducement grant of stock options would be subject to a vesting criteria based on sustained
performance of the Company&#146;s common stock. Specifically, 50% of this grant vested upon the Company&#146;s common stock having a sustained average closing price of $45 or greater, while 50% of this grant vests upon the common stock having a
sustained average closing price of $50 or greater. This award ultimately did not fully vest until approximately five years after the grant date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2016 and 2017 Performance Stock Unit Grants </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For 2016 and 2017, the Committee granted 50% of executive officer(s) total annual equity award value in the form of performance stock units (&#147;PSUs&#148;)
that vest based on the total shareholder return (&#147;TSR&#148;) of the Company&#146;s common stock relative to other companies in the S&amp;P Healthcare Select Index during a three-year performance period following the date of grant, with the
change in share price during the performance period measured using the average closing price during the 20 days preceding each of the beginning and the end of the performance period. Achieved vesting percentages will be as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:113.55pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Company&#146;s TSR Percentile Rank</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vesting&nbsp;Percentage</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Below 25th Percentile</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">25th Percentile</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">50%&nbsp;(threshold)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">50th Percentile</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">100% (target)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">75th Percentile or Above</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">200%&nbsp;(maximum)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that the Company&#146;s TSR percentile rank for the performance period falls between any of the amounts set forth
above (to the extent greater than the threshold and lower than the maximum), the vesting percentage will be determined by linear interpolation between such amounts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The PSU award agreement provides that the vesting percentage may not exceed 100% if the Company&#146;s absolute TSR during the performance period is negative.
In addition, the vesting percentage is capped such that the PSU award will never trigger the issuance of shares with a vesting date fair market value of more than five times the fair market value of the target award on the date of grant. Following
the end of the three-year performance period, the shares that vest are subject to a <FONT STYLE="white-space:nowrap">one-year</FONT> holding period requirement. Generally, if an executive voluntarily ceases employment prior to the end of the
three-year performance period, the entire award is forfeited. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2015 Performance Grants </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For 2015, the Committee made grants to executive officers under a form of performance-based vesting restricted stock and performance share unit agreement
covering a three-year performance period. The performance criteria for these awards used two equally-weighted metrics, Adjusted EBITDA and return on invested capital (&#147;ROIC&#148;). Under these grants, recipients received performance-based
vesting restricted stock in an amount equal to 100% of the target performance criteria and performance stock units that provide for additional shares to be issued if performance criteria is achieved between 100% and 150% of targets for the 2018
fiscal year. The aggregate award potential is illustrated in the table below: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:23.05pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Metric</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighting</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B><br><B>(50% vesting)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B><br><B>(100% vesting)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum<BR>Achievement</B><br><B>(150% vesting)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">50%</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$74.6M&nbsp;for&nbsp;2018&nbsp;FY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$78.5M&nbsp;for&nbsp;2016,&nbsp;2017<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">or 2018 FY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$86.4M&nbsp;for&nbsp;2018&nbsp;FY</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ROIC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">50%</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">11.6% for 2018 FY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">12.2% for 2016, 2017<BR>or 2018 FY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">13.4% for 2018 FY</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Results between points will be linearly interpolated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2017, the Committee determined that the vesting criteria for the Adjusted EBITDA 100% vesting performance target had been achieved based on the
Company&#146;s financial results for the fiscal year ended December&nbsp;31, 2016. The performance-based vesting restricted stock related to the ROIC metric and the performance stock units remain unvested, while both metrics remain eligible for
maximum vesting based on 2018 performance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Award Approval Process </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee currently reviews and approves dollar values for executive officer equity incentive grants at its March meeting, with the grant effective date
being the first business day of April, and the number of shares/units underlying each award (and the exercise price for stock options) based on the closing price of the Company&#146;s common stock on such effective date.&nbsp;In prior years, the
Committee reviewed and approved annual grants in June, with grant dates occurring on or around July 1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, the Committee&#146;s approval of annual
equity incentive grants occurs at a time when the Company&#146;s insider trading window for executives is open. However, in the event that grants are approved when such window is closed, the Committee does not seek to affect the value of grants by
timing them in relation to the release or <FONT STYLE="white-space:nowrap">non-release</FONT> of material public information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Purchase Plan
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our SPP, as amended, provides for the issuance of shares of our common stock to eligible employees and directors of the Company and its
subsidiaries that elect to participate in the plan and acquire shares of our common stock through payroll deductions (including executive officers).&nbsp;During each purchase period, eligible individuals may designate between 1% and 25% (or any
other percentage as determined by the Compensation Committee) of their cash compensation to be deducted from that compensation for the purchase of common stock under the plan.&nbsp;Under the plan, the purchase price for shares is equal to the lower
of: (i)&nbsp;85% of the fair market value per share on the first day of the plan year, or (ii)&nbsp;85% of the fair market value of such shares on the last day of the plan year. The plan year begins on January&nbsp;1 and ends on December&nbsp;31.
Elections must be made prior to the beginning of each plan year, except in the case of newly appointed directors, who may elect to contribute within 30 days after becoming a director. As amended, up to a total of 1,850,000 shares may be issued under
the SPP. As of the Record Date, 221,955 shares remain available to be issued under the SPP. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Perquisites and Other Personal Benefits
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our executive officers are entitled to or may otherwise be the beneficiaries of certain limited perquisites including reimbursement for tax
preparation expenses, estate planning expenses and an annual physical exam up to a maximum aggregate amount of $5,000 per executive officer per year.&nbsp;In addition, our executive officers and directors are entitled to reimbursement of expenses
relating to their spouse&#146;s travel in connection with no more than one Board meeting per year.&nbsp;We do not consider any of these significant or out of the ordinary course for similarly situated companies. Under our Executive Compensation
Guiding Principles, the payment of any perquisite will generally require the approval of the Compensation Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Other Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive officers participate in our health and welfare benefits (including our 401(k) plan) on the same basis as other similarly situated employees.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Recoupment (Clawback) Policy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December
2012, we adopted a compensation recoupment, or &#147;clawback&#148; policy, which applies to all of our executive officers. Under this policy, if we are required to prepare an accounting restatement due to material noncompliance by Orthofix, as a
result of misconduct, with any financial reporting requirement under the securities laws, each executive officer is required to reimburse Orthofix for (i)&nbsp;any bonus or other incentive-based or equity-based compensation received by such
executive officer during the <FONT STYLE="white-space:nowrap">12-month</FONT> period following the first public issuance or filing with the Securities and Exchange Commission (whichever first occurs) of the financial document embodying such
financial reporting requirement, and (ii)&nbsp;any profits realized from the sale of our securities of during that <FONT STYLE="white-space:nowrap">12-month</FONT> period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Accounting and Tax Effects </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The impact of accounting
treatment is considered in developing and implementing our compensation programs, including the accounting treatment as it applies to amounts awarded or paid to our executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The impact of federal tax laws on our compensation programs is also considered, including the deductibility of compensation paid to the named executive
officers, as limited by Section&nbsp;162(m) of the Code. Our compensation program historically has been designed with the intention that compensation paid in various forms may be eligible to qualify for deductibility under Section&nbsp;162(m) of the
Code, but there have been and may be other exceptions for administrative or other reasons. However, the Tax Cuts and Jobs Act of 2017 recently eliminated the exception under Section&nbsp;162(m) for performance-based compensation and expanded the
number of employees who may be covered by these deductibility limitations, which may have an effect on how we design future compensation programs and may affect the financial statement impact of executive compensation payments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I>R<A NAME="tx571963_81"></A>eport of the Compensation Committee </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis with the members of management of the Company and, based on such
review and discussions, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be included in the Company&#146;s proxy statement. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Compensation Committee</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Paolucci, Committee<I> </I>Chair</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis V. Lukianov</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Sainz</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_82"></A>Summary Compensation Table </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the compensation earned by or paid to our named executive officers for each of the last three fiscal years during which the
officer was a named executive officer. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:109.20pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name and Principal Position (a)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B><br><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B><br><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus</B><br><B>($)</B><br><B>(d)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock</B><br><B>Awards</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B><br><B>(e)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Awards</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B><br><B>(f)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT></B><br><B>Incentive
Plan</B><br><B>Compensation</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B><br><B>(g)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other</B><br><B>Compensation</B><br><B>($)</B><br><B>(h)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B><br><B>(i)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason &#150; President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">2017<BR>2016<BR>2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">740,000<BR>705,576<BR>689,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<BR>&#151;&nbsp;&nbsp;<BR>&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">2,354,789<BR>2,583,953<BR>1,659,312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">705,975<BR>762,136<BR>473,680</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">920,486<BR>763,000<BR>710,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP><BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD VALIGN="bottom" ALIGN="right">13,708<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP><BR>19,180<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP><BR>26,825<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">4,705,758<BR>4,833,845<BR>3,559,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice &#150; Chief Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">2017<BR>2016<BR>2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">390,000<BR>350,519<BR>337,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<BR>&#151;&nbsp;&nbsp;<BR>&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">588,684<BR>560,551<BR>795,153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">176,501<BR>165,335<BR>226,407</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">303,030<BR>225,630<BR>172,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP><BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD VALIGN="bottom" ALIGN="right">11,859<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP><BR>17,178<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP><BR>22,520<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">1,470,074<BR>1,319,213<BR>1,553,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting &#150; Chief Legal and Administrative Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">382,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">546,657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">163,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">296,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,861<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,400,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan &#150; Chief Strategy Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">2017<BR>2016<BR>2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">412,000<BR>401,972<BR>403,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<BR>&#151;&nbsp;&nbsp;<BR>&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">504,630<BR>516,100<BR>402,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">151,279<BR>152,224<BR>114,872</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">320,124<BR>259,311<BR>206,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP><BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD VALIGN="bottom" ALIGN="right">11,902<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP><BR>19,036<SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP><BR>24,382<SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">1,399,935<BR>1,348,643<BR>1,151,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi &#150; President, Global Extremity Fixation<SUP
STYLE="font-size:85%; vertical-align:top">(14)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">2017<BR>2016<BR>2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">370,780<BR>357,487<BR>359,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<BR>&#151;&nbsp;&nbsp;<BR>&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">462,549<BR>474,093<BR>402,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">138,675<BR>139,828<BR>114,872</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">281,867<BR>249,025<BR>147,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP><BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD VALIGN="bottom" ALIGN="right">69,314<SUP STYLE="font-size:85%; vertical-align:top">(15)</SUP><BR>71,056<SUP STYLE="font-size:85%; vertical-align:top">(16)</SUP><BR>73,581<SUP STYLE="font-size:85%; vertical-align:top">(17)</SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;<BR><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR><BR></TD>
<TD VALIGN="bottom" ALIGN="right">1,323,185<BR>1,291,489<BR>1,097,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR>&nbsp;<BR>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts include salary deferred and further described in &#147;&#151;<I>Deferred Compensation</I>.&#148; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown do not reflect compensation actually received.&nbsp;Instead, the amounts shown are the aggregate grant date fair value of equity awards, as computed in accordance with Financial Accounting Standards Board
Accounting Standards Codification Topic 718 (formerly known as Statement of Financial Accounting Standards No.&nbsp;123(R)), or ASC 718. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown reflect cash bonuses paid in 2018, 2017 and 2016 for performance in 2017, 2016 and 2015, respectively, pursuant to our annual incentive program.&nbsp;Our annual incentive program with respect to the 2017
fiscal year , including the Committee&#146;s criteria for determining the amounts awarded with respect to the 2018 fiscal year, are described above under &#147;<I>&#151;Compensation Discussion and Analysis&#151;Elements of Executive
Compensation&#151;Cash Performance-Based Incentives&#151;Annual Incentive Program</I>.&#148; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $10,600 for 401k matching and $2,772 and $336 for insurance premiums paid by, or on behalf of, the Company with respect to group term and term life insurance, respectively. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $5,400&nbsp;for car allowance, $10,600 for 401k matching and $2,772 and $408 for insurance premiums paid by, or on behalf of, the Company with respect to group term and term life insurance, respectively.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $10,800&nbsp;for car allowance, $10,600 for 401k matching and $5,017 and $408 for insurance premiums paid by, or on behalf of, the Company with respect to group term and term life insurance, respectively.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $10,600 for 401k matching and $931 and $328 for insurance premiums paid by, or on behalf of, the Company with respect to group term and term life insurance, respectively. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $5,400&nbsp;for car allowance, $10,600 for 401k matching and $826 and $352 for insurance premiums paid by, or on behalf of, the Company with respect to group term and term life insurance, respectively.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $10,800&nbsp;for car allowance, $10,600 for 401k matching and $788 and $332 for insurance premiums paid by, or on behalf of, the Company with respect to group term and term life insurance, respectively.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $9,625 for 401k matching and $915 and $321 for insurance premiums paid by, or on behalf of, the Company with respect to group term and term life insurance, respectively. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $10,600 for 401k matching and $966 and $336 for insurance premiums paid by, or on behalf of, the Company with respect to group term and term life insurance, respectively. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects $5,400 for car allowance, $10,600 for 401k matching, $1,663 in disability benefits, and $968 and $405 for insurance premiums paid by, or on behalf of, the
Company with respect to group term and term life insurance, respectively. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $10,800 for car allowance, $10,600 for 401k matching, $1,663 in disability benefits, and $968 and $351 for insurance premiums paid by, or on behalf of, the Company with respect to group term and term life
insurance, respectively. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(14)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Bianchi is compensated in Swiss Francs. Amounts shown in table reflect compensation amounts as converted to U.S. Dollars using the average exchange rate in effect during the 2017 calendar year of 1.0159.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(15)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $24,381 for car and travel allowance and $44,933 for retirement matching. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(15)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $24,261 for car and travel allowance and $46,795 for retirement matching. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(16)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects $27,330 for car and travel allowance and $46,251 for retirement matching. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_83"></A>Grants of Plan-Based Awards </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding plan-based awards that were granted to our named executive officers during the fiscal year ended
December&nbsp;31, 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated Future Payouts</B><br><B>Under <FONT STYLE="white-space:nowrap">Non-Equity</FONT> Incentive</B><br><B>Plan Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated Future Payouts</B><br><B>Under Equity Incentive</B><br><B>Plan Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B><br><B>(#)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B><br><B>(#)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum</B><br><B>(#)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All</B><br><B>Other</B><br><B>Stock</B><br><B>Awards</B><br><B>(#)<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All</B><br><B>Other</B><br><B>Option</B><br><B>Awards</B><br><B>(#)<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity</B><br><B>Exercise</B><br><B>or Base</B><br><B>Price of</B><br><B>Option</B><br><B>Awards</B><br><B>($/Sh)<SUP
STYLE="font-size:85%; vertical-align:top">(6)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant</B><br><B>Date</B><br><B>Fair</B><br><B>Value</B><br><B>of Stock</B><br><B>and</B><br><B>Option</B><br><B>Awards</B><br><B>($)<SUP
STYLE="font-size:85%; vertical-align:top">(7)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">710,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,066,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,369</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,654,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">699,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">705,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">413,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">176,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">229,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">343,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">A. Elting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384,155</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">162,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">163,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">247,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">354,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">222,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bianchi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">07/03/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown represent the threshold, target and maximum amounts that could have been earned for fiscal year 2017 by each Named Executive Officer under our annual performance-based incentive compensation program. The
actual amounts earned by each Named Executive Officer are included in the fiscal year 2017 <FONT STYLE="white-space:nowrap">&#147;Non-Equity</FONT> Incentive Plan Compensation&#148; column of the Summary Compensation Table above and discussed under
&#147;&#151;<I>Compensation Discussion and Analysis&#151;Elements of Executive Compensation&#151;Cash Performance-Based Incentives-Annual Incentive Program</I>&#148; above. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown represent the minimum and maximum threshold amounts in shares earned based on performance if the minimum or maximum performance goals are achieved over the three-year performance period beginning on
July&nbsp;3, 2017. No shares will be issued for performance below the minimum target level. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown represent the target amount in shares earned if the target performance goal is achieved with respect to the three-year performance period beginning on July&nbsp;3, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown include awards of time-based restricted stock granted in 2017 under the 2012 LTIP. Such shares will vest ratably over four years (subject to certain acceleration provisions, as discussed under
&#147;&#151;<I>Potential Payments upon Termination or Change in Control</I>&#148; below). </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown include awards of stock options granted in 2017 under the 2012 LTIP. Such options will vest ratably over four years (subject to certain acceleration provisions, as discussed under &#147;Potential Payments
upon Termination or Change in Control&#148; below). </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The exercise price of the stock options is equal to the closing price of the common stock on the grant date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown reflect the grant date fair value of equity awards, as computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (formerly known as Statement of Financial
Accounting Standards No. 123(R)), or ASC 718. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_84"></A>Outstanding Equity Awards at Fiscal <FONT
STYLE="white-space:nowrap">Year-End</FONT> </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information about the number of outstanding equity awards held by
our named executive officers at December&nbsp;31, 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities</B><br><B>Underlying</B><br><B>Unexercised</B><br><B>Options (#)</B><br><B>Exercisable<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Securities</B><br><B>Underlying</B><br><B>Unexercised</B><br><B>Options (#)</B><br><B>Unexercisable<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Exercise</B><br><B>Price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Expiration</B><br><B>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of&nbsp;Shares</B><br><B>or&nbsp;Units&nbsp;of</B><br><B>Stock that</B><br><B>have not</B><br><B>Vested&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market</B><br><B>Value</B><br><B>of Shares</B><br><B>or&nbsp;Units&nbsp;of</B><br><B>Stock that</B><br><B>have not</B><br><B>Vested ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of&nbsp;Shares</B><br><B>or&nbsp;Units&nbsp;of</B><br><B>Stock that</B><br><B>have not</B><br><B>Vested (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market</B><br><B>Value</B><br><B>of Shares</B><br><B>or Units of</B><br><B>Stock that</B><br><B>have not</B><br><B>Vested ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/13/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/13/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,650<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/30/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,050<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/30/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,643<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/01/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,990<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/03/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,950<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,350<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">456,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,280<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">726,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,184<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">830,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,700<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">913,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,700<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">913,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,300<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,985,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,369<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,661,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,500<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(14)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/04/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,874<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(15)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/24/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,637<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/30/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,335<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/01/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,248<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/03/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(16)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,500<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(17)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,874<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(18)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">266,608</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,212<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,880<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,796<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">207,641</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,425<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">242,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,425<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">242,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,875<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">430,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,592<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,500<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(19)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/26/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,301<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/03/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,200<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(20)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">229,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,525<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">192,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,050<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">385,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/30/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/25/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/25/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/26/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,775<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/30/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,074<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/30/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,516<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/01/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,355<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/03/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">925<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,024<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,652<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,254<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">177,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,050<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">221,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,050<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">221,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,250<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">396,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,508<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355,988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/22/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/26/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,775<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/30/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,074<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/30/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,741<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/01/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,409<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/03/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">925<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,024<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,436<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,983<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">163,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,050<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">221,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,050<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">221,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,660<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">364,302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,965<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">326,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All options listed in this column were exercisable as of December&nbsp;31, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All options listed in this column were not exercisable as of December&nbsp;31, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All of these remaining unvested options are subject to vesting on June&nbsp;30, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-half</FONT> of these remaining unvested options are subject to vesting on each of June&nbsp;30, 2018 and 2019. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-third</FONT> of these remaining unvested options are subject to vesting on each of July&nbsp;1, 2018, 2019 and 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-fourth</FONT> of these remaining unvested options are subject to vesting on each of July&nbsp;3, 2018, 2019, 2020 and 2021. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All of these remaining unvested shares of restricted stock are subject to vesting on June&nbsp;30, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-half</FONT> of these remaining unvested shares of restricted stock are subject to vesting on each of June&nbsp;30, 2018 and 2019. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-third</FONT> of these remaining unvested shares of restricted stock are subject to vesting on each of July&nbsp;1, 2018, 2019 and 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-fourth</FONT> of these remaining unvested shares of restricted stock are subject to vesting on each of July&nbsp;3, 2018, 2019, 2020 and 2021. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">These remaining unvested shares of performance-based restricted stock and performance-based stock units are subject to vesting upon meeting certain EBITDA or ROIC based performance targets in the year ended
December&nbsp;31, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">These remaining unvested market-based performance stock units are subject to vesting upon meeting certain total shareholder return targets in relation to specified index companies over a three-year performance period
beginning on July&nbsp;1, 2016. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>These remaining unvested market-based performance stock units are subject to vesting upon meeting certain total shareholder return targets in relation to specified
index companies over a three-year performance period beginning on July&nbsp;3, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(14)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>All of these remaining options are subject to vesting on September&nbsp;4, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(15)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-half</FONT> of these remaining unvested options are subject to vesting on each of April&nbsp;24, 2018 and 2019. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(16)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All of these remaining unvested shares of restricted stock are subject to vesting on September&nbsp;4, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(17)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">All of these remaining unvested shares of restricted stock are subject to vesting on October&nbsp;3, 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(18)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-half</FONT> of these remaining unvested shares of restricted stock are subject to vesting on each of April&nbsp;24, 2018 and 2019. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(19)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-third</FONT> of these remaining unvested options are subject to vesting on each of September&nbsp;26, 2018, 2019 and 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(20)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">One-third</FONT> of these remaining unvested shares of restricted stock are subject to vesting on each of September&nbsp;26, 2018, 2019 and 2020. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a summary of our standard option agreements, see &#147;<I>&#151;Compensation Discussion and Analysis&#151;Elements of Executive
Compensation&#151;Long-Term Equity-Based Incentives</I>&#148; beginning on page 49. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_85"></A>Option
Exercises and Stock Vested </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information about the number of shares issued upon option exercises, and the value
realized on exercise, by our named executive officers during fiscal 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards or Units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>(a)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of Shares</B><br><B>Acquired&nbsp;on</B><br><B>Exercise (#)</B><br><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value</B><br><B>Realized</B><br><B>on&nbsp;Exercise</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B><br><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of Shares</B><br><B>Acquired</B><br><B>on&nbsp;Vesting</B><br><B>(#)</B><br><B>(d)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value</B><br><B>Realized on</B><br><B>Vesting</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B><br><B>(e)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,752</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,320,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">454,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">766,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">649,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Value realized on exercise calculated based on the difference between the closing price of our common stock on the date of exercise and the option exercise price, multiplied by the number of shares exercised.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Value determined by multiplying the number of vested shares by the closing price of our common stock on the vesting date. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_86"></A>Deferred Compensation </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information about the amount of compensation deferred by our named executive officers at December&nbsp;31, 2017.&nbsp;For any
named executive officer not listed on the following table, no information was applicable. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>(a)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Executive</B><br><B>Contributions</B><br><B>in 2017 ($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B><br><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Executive</B><br><B>Distributions</B><br><B>in 2017 ($)</B><br><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate</B><br><B>Earnings</B><br><B>in&nbsp;2017&nbsp;($)</B><br><B>(d)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate</B><br><B>Balance at</B><br><B>December&nbsp;31,</B><br><B>2017 ($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B><br><B>(f)</B></TD>

<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents the dollar amount of salary set forth on the Summary Compensation Table, which the executive has deferred in accordance with the Deferred Compensation Plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts in the Aggregate Balance at December&nbsp;31, 2017 column, other than earnings on deferred compensation and amounts described in footnote 1 above, have all been previously disclosed in Summary Compensation
Tables in our prior proxy statements (to the extent the officer was a named executive officer in prior proxy statements). </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
 COLOR="#004a97"><B><I>Potential <A NAME="tx571963_87"></A>Payments upon Termination or Change in Control </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Potential Payments to Named
Executive Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Termination </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under
their change in control and severance agreements, each of Messrs.&nbsp;Mason, Rice, Finegan and Bianchi and Ms.&nbsp;Elting is generally entitled to receive the following severance payments and benefits upon termination of the executive&#146;s
employment (i)&nbsp;for death or disability, (ii)&nbsp;by the Company without &#147;cause&#148; (as defined in the agreement) or (iii)&nbsp;by the executive for &#147;good reason&#148; (as defined in the agreement):</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Any unpaid base salary, accrued vacation or prior years&#146; bonus payable or owing through the date of termination; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The&nbsp;pro rata&nbsp;amount of any incentive compensation for the year of termination of employment (based on the number of business days the executive is actually employed by the Company and its subsidiaries during
the year in which termination of employment occurs) based on the achievement of the Company&#146;s performance goals for such year; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">An amount equivalent to 1.5x in the case of Messrs. Mason and Finegan, and 1.0x in the case of Messrs. Rice and Bianchi and Ms.&nbsp;Elting, times the sum of: (i)&nbsp;the executive&#146;s annual base salary,
(ii)&nbsp;the executive&#146;s current year&#146;s target bonus; provided that during the <FONT STYLE="white-space:nowrap">24-month</FONT> period following any change in control and (iii) $12,500 for use towards outplacement services,
the&nbsp;foregoing multiples increase by 0.5 (to 2.0x in the case of Messrs. Mason and Finegan, and 1.5x in the case of Messrs. Rice and Bianchi and Ms.&nbsp;Elting); and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If the executive elects COBRA in a timely manner, the executive will be reimbursed for the Executive&#146;s monthly premium payments for COBRA coverage for a period of up to 18 or 12 months, depending on the executive.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See &#147;<I>&#151;Deferred Compensation</I>&#148; beginning on page 69 for a discussion of payments pursuant to the Deferred Compensation
Plan upon termination of employment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change in control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described above, our change in control and severance agreements provide for a &#147;double-trigger&#148; so that a change in control (as that term is
defined in the agreement) alone does not grant the executive officer any specific right to terminate his employment agreement or receive severance benefits, but as noted above, it increases severance amounts payable following a termination during
the <FONT STYLE="white-space:nowrap">24-month</FONT> period following any change in control.&nbsp;Under the change in control and severance agreement and the Company&#146;s form of time-based equity award agreement, all time-based equity awards
granted in or after 2016 contain &#147;double trigger&#148; vesting provisions whereby awards will vest if, within 24 months of a change in control, the executive is terminated by the Company without &#147;cause&#148; or resigns for &#147;good
reason.&#148; For unvested awards made in 2015 and earlier, the Executive would receive &#147;single-trigger&#148; vesting upon a change in control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See<I> </I>&#147;<I>&#151;Deferred Compensation</I>&#148; beginning on page 69 for a discussion of payments pursuant to the Deferred Compensation Plan upon a
change in control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Change in Control and Severance Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under our current Executive Compensation Guiding Principles, the Compensation Committee provides executive officers with competitive change in control
severance benefits that target market practices. All new change in control agreements must be approved by the Compensation Committee. The Compensation Committee approves all change in control and severance arrangements for executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consistent with the foregoing, in 2016, the Company discontinued its prior practice of entering into employment agreements with
<FONT STYLE="white-space:nowrap">US-based</FONT> executive officers. Instead, the Compensation Committee approved a new form of change in control and severance agreement, which is offered to executive officers. Pursuant to the change in control and
severance agreement, executive officers are eligible to receive the following severance payments and benefits upon termination of their employment (i)&nbsp;for death or disability, (ii)&nbsp;by the Company without &#147;cause&#148; (as defined in
the agreement) or (iii)&nbsp;by the executive for &#147;good reason&#148; (as defined in the agreement): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Any unpaid base salary, accrued vacation or prior years&#146; bonus payable or owing through the date of termination; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The pro rata amount of any incentive compensation for the year of termination of employment (based on the number of business days the executive is actually employed by the Company and its subsidiaries during the year in
which termination of employment occurs) based on the achievement of the Company&#146;s performance goals for such year; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">An amount equivalent to 1.5x or 1.0x, depending on the executive, times the sum of: (i)&nbsp;the executive&#146;s annual base salary and (ii)&nbsp;the executive&#146;s current year&#146;s target bonus; provided that
during the <FONT STYLE="white-space:nowrap">24-month</FONT> period following any change in control, the foregoing multiples increase by 0.5 (to 2.0x or 1.5x, depending on the executive); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">$12,500 for use towards outplacement services (18,750 during the <FONT STYLE="white-space:nowrap">24-month</FONT> period following any change in control); and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If the executive elects COBRA in a timely manner, the executive will be reimbursed for the executive&#146;s monthly premium payments for COBRA coverage for a period of up to 18 or 12 months, depending on the executive.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The right to receive cash payments following a change in control remains subject to a &#147;double trigger&#148; provision, such that
payments by the Company are only owed if the executive separates from employment in specific circumstances in connection with or following a change in control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The agreement contains <FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants
effective so long as the executive is an employee and for a period of 12 or 18 months, depending on the executive, after employment is terminated. The agreement also contains provisions that define certain vesting and exercise rights in connection
with time-based equity incentive grants (such as by defining the terms &#147;cause,&#148; &#147;good reason&#148; and &#147;qualified retirement&#148; for purposes of all prior and subsequent time-based equity grants). The agreement does not
guarantee any minimum levels of cash or equity-based compensation levels during an executive&#146;s employment with the Company. The term of the agreement continues in effect until the earlier of (i)&nbsp;the parties&#146; satisfaction of their
respective obligations or (ii)&nbsp;the execution of a written agreement between the Company and the executive terminating the agreement. The agreement amends and supersedes the applicable executive&#146;s prior employment agreement with the
Company, which prior employment agreements became terminated, null and void upon execution of the new change in control and severance agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section&nbsp;280G </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These agreements reflect that the named executive officer is not entitled to a tax <FONT STYLE="white-space:nowrap">gross-up</FONT> if the named executive
officer incurs an excise tax due to the application of Section&nbsp;280G of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Instead, payments and benefits payable to the named executive
officer will be reduced to the extent doing so would result in the executive retaining a larger <FONT STYLE="white-space:nowrap">after-tax</FONT> amount, taking into account the income, excise and other taxes imposed on the payments and benefits.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain Other Provisions </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The agreements
described above contain confidentiality, <FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants effective so long as the executive officers are employees of Orthofix or any of
its subsidiaries and for a period of one year after employment is terminated.&nbsp;The agreements also contain confidentiality and assignment of inventions provisions that last indefinitely. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix&#146;s obligation to pay or provide any severance benefits under each agreement (other than any benefits as a result of death) is conditioned upon
the executive officer signing a release of claims in favor of the Company and its affiliates by a specified date following separation from employment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Estimated Payments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table reflects the
estimated payments and benefits that would be provided to each of Messrs.&nbsp;Mason, Rice, Finegan and Bianchi and Ms.&nbsp;Elting upon his or her termination or upon a change in control pursuant to the terms of his or her respective change in
control and severance agreement and related equity award agreements.&nbsp;For purposes of this table, we assume that the triggering event took place on December&nbsp;29, 2017, and the price per share of our common stock was $54.70, the closing
market price as of that date.&nbsp;For any triggering event that presupposes a change in control, we assume a change in control has so occurred. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Triggering Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Lump Sum</B><br><B>Severance</B><br><B>Payment&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value of</B><br><B>Stock-</B><br><B>Based</B><br><B>Rights ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;of</B><br><B>Welfare</B><br><B>Benefits</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees and</B><br><B>Expenses&nbsp;of</B><br><B><FONT STYLE="white-space:nowrap">Out-placement</FONT></B><br><B>Firm ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death or disability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,132,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,560,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,735,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Termination&nbsp;for&nbsp;cause&nbsp;or</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">voluntary&nbsp;termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for good reason or without cause</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,132,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,175,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death, disability, good reason or without cause during a change in control period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,843,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,780,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,673,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death or disability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">623,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,223,729</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,874,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Termination&nbsp;for&nbsp;cause&nbsp;or</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">voluntary&nbsp;termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for good reason or without cause</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">623,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">651,044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death, disability, good reason or without cause during a change in control period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">935,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,056,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,025,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death or disability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">611,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,108,846</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,734,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Triggering Event</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Lump Sum</B><br><B>Severance</B><br><B>Payment&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value of</B><br><B>Stock-</B><br><B>Based</B><br><B>Rights ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;of</B><br><B>Welfare</B><br><B>Benefits</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees and</B><br><B>Expenses&nbsp;of</B><br><B><FONT STYLE="white-space:nowrap">Out-placement</FONT></B><br><B>Firm ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Termination&nbsp;for&nbsp;cause&nbsp;or</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">voluntary&nbsp;termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for good reason or without cause</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">611,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625,316</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death, disability, good reason or without cause during a change in control period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">916,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,432,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,369,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death or disability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">988,801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,614,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,641,324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Termination&nbsp;for&nbsp;cause&nbsp;or</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">voluntary&nbsp;termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for good reason or without cause</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">988,801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,026,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death, disability, good reason or without cause during a change in control period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,318,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,356,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,718,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death or disability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">593,248</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,510,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,119,609</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Termination&nbsp;for&nbsp;cause&nbsp;or</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">voluntary&nbsp;termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for good reason or without cause</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">593,248</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">609,379</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination for death, disability, good reason or without cause during a change in control period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">889,872</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,226,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,139,211</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*<I></I></TD>
<TD ALIGN="left" VALIGN="top"><I>Assumes Swiss Francs are converted to U.S. Dollars using the average exchange rate in effect during the 2017 calendar year of 1.0159.</I> </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I>Pay <A NAME="tx571963_88"></A>Ratio Disclosure </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Presented below is the ratio of annual total compensation of our President and Chief Executive Officer, Bradley R. Mason, to the annual total compensation of
our median employee (excluding Mr.&nbsp;Mason). The ratio presented below is a reasonable estimate calculated in a manner consistent with Item 402(u) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We selected the median employee based on full-time, part-time, temporary and seasonal workers employed by the Company or any of its consolidated subsidiaries
as of December&nbsp;31, 2017. In identifying our median employee, we calculated the annual total compensation of each employee as of December&nbsp;31, 2017. Annual total compensation for these purposes included overtime pay, any applicable bonus,
commissions or other cash compensation, equity compensation, benefits, and any other compensation. We did not apply any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cost-of-living</FONT></FONT> adjustments as part of the
calculation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2017 annual total compensation as determined under Item 402 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> for our CEO was
$4,705,758. The 2017 annual total compensation as determined under Item 402 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> for our median employee was $63,664. The ratio of our CEO&#146;s annual total compensation to our median
employee&#146;s total compensation for fiscal year 2017 was 74 to 1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I>Director Co<A NAME="tx571963_89"></A>mpensation </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are elected each year at the Annual General Meeting, which is usually held in June.&nbsp;Other director appointments occur from time to time as
determined by the Board, for instance, in the event of vacancies on the Board resulting from a director&#146;s death, resignation or retirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Employee
directors, such as Mr.&nbsp;Mason, are not provided any additional compensation for their service as a director.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Program and Guiding Principles </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We compensate our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in accordance with the Company&#146;s Director Compensation Guiding
Principles. Our compensation program for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors is designed to appropriately compensate outside directors for their diverse expertise and time commitment required to serve as a director of
a complex and highly regulated global company. The Compensation Committee is responsible for overseeing our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program. The Compensation Committee&#146;s goal for such oversight
is to maintain a program that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">attracts and retains directors with the skills needed to guide the Company in achieving its goals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">is competitive with the compensation program provided to directors at other similarly situated medical device companies; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">directly aligns the interests of the Company&#146;s directors with the interests of its shareholders </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless
determined otherwise by the Board of Directors, our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program each year will consist of an annual cash retainer and equity awards, as well as customary and usual expense
reimbursement in attending company meetings or attending director training. The targeted competitive position for the total annual compensation package (consisting of annual cash retainer plus annual long-term incentive award) will be targeted to
the 50th to 75th percentile range of the Company&#146;s peer group. Each year, the Compensation Committee will review the competitiveness of <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation relative to the same peer group
used to review executive officer compensation levels. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Retainers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each <FONT STYLE="white-space:nowrap">non-employee</FONT> director receives the same base cash retainer amount, but additional cash retainer amounts are paid
to the Chairman of the Board and the chairperson of each Board committee. <FONT STYLE="white-space:nowrap">Non-employee</FONT> directors (other than the Chairman) are paid an aggregate annual cash retainer of $60,000 for service as a director and
member of any committees of the Board on which such director sits.&nbsp;In addition, a <FONT STYLE="white-space:nowrap">non-employee</FONT> director receives an additional annual cash retainer of $10,000 if he or she also serves as the Chair of the
Compensation, Compliance or Nominating and Governance Committee, and $15,000 if he or she serves as the Chair of the Audit and Finance Committee.&nbsp;The Chairman is paid an aggregate annual retainer of $150,000 for service in this role. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Long-Term Incentive Compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We provide <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors long-term incentive compensation under our 2012 LTIP to closely align directors with shareholder interests. We pay <FONT STYLE="white-space:nowrap">non-employee</FONT> directors long-term
incentive compensation in two forms: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a fixed number of stock options awarded to each new director (vesting over four years); and </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an annual fixed value long-term incentive delivered in time-vesting restricted stock (with <FONT STYLE="white-space:nowrap">one-year</FONT> vesting), the value of which is the same for each Director, except the Chairman
of the Board will receive a larger value award commensurate with the role and contribution he or she makes within the Company. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under our
current practice, we provide each director a grant of 30,000 four-year vesting stock options at the time such director joins the Board. In addition, the Chairman received 8,000 shares of <FONT STYLE="white-space:nowrap">one-year</FONT> vesting
restricted stock at the time he joined the Board in March 2014. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In recent years, the annual long-term incentive grant has been made in shares of <FONT
STYLE="white-space:nowrap">one-year</FONT> vesting restricted stock. Since 2017, this grant has been made in the form of <FONT STYLE="white-space:nowrap">one-year</FONT> vesting restricted stock units with deferred delivery (deferred stock units or
DSUs), whereby shares underlying vested awards are not delivered until after the applicable director ceases service as a director. (As a result of the foregoing, directors will not be able to sell vested awards while they continue service as a
director.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2016, the Committee recommended to the Board that these annual grants be made on a fixed value basis rather than the previous approach of a
fixed share basis. For 2017, the annual grant consisted of an amount of DSUs equal in value to $165,000 ($300,000 shares in the case of the Chairman), consistent with 2016 grants, which amounts were approved after the Committee&#146;s review of the
assessment of our compensation consultant and review of our previous director compensation philosophy described below.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are eligible to
participate in our health and welfare programs on substantially the same terms as full-time employees. In addition, directors are each offered the opportunity to enter into a director indemnification agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the 2017 compensation of <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:26.10pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees</B><br><B>Earned&nbsp;or</B><br><B>Paid in</B><br><B>Cash ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Restricted</B><br><B>Stock</B><br><B>Awards</B><br><B>(Number</B><br><B>of
Shares</B><br><B>Granted)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date</B><br><B>Fair
Value</B><br><B>of&nbsp;Restricted</B><br><B>Stock</B><br><B>Awards</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option</B><br><B>Awards<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date</B><br><B>Fair Value</B><br><B>of Option</B><br><B>Awards</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other</B><br><B>Compensation</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald A. Matricaria</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,508<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,019<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450,019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luke Faulstick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,992<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James F. Hinrichs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,992<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guy J. Jordan, PhD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis V. Lukianov</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,992<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lilly Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,992<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anthony F. Martin, PhD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Paolucci</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,992<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">229,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Sainz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164,992<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The following table shows the number of shares subject to outstanding and unexercised option awards and the number of shares subject to outstanding shares of restricted stock or deferred stock units granted to each of
the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors serving during 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown reflect the grant date fair value of equity awards, as computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (formerly known as Statement of Financial
Accounting Standards No.&nbsp;123(R)), or ASC 718. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents annual grant of 6,508 <FONT STYLE="white-space:nowrap">one-year</FONT> vesting deferred stock units on July&nbsp;3, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents annual grant of 3,579 <FONT STYLE="white-space:nowrap">one-year</FONT> vesting deferred stock units on July&nbsp;3, 2017. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table shows the number of shares subject to outstanding and unexercised option awards and the
number of shares subject to outstanding shares of unvested restricted stock held by each of the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors serving during 2017 as of December&nbsp;31, 2017. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:28.85pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Director</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of Shares</B><br><B>Subject to</B><br><B>Outstanding</B><br><B>Stock&nbsp;Options</B><br><B>as of 12/31/17</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of Shares</B><br><B>Subject&nbsp;to</B><br><B>Outstanding<BR>Unvested</B><br><B>Restricted</B><br><B>Stock&nbsp;Awards</B><br><B>as of
12/31/17</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald A. Matricaria</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luke Faulstick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James F. Hinrichs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guy J. Jordan, PhD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis V. Lukianov</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lilly Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Anthony F. Martin, PhD</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Paolucci</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Sainz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_90"></A>Equity Compensation Plan Information </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our primary equity compensation plan in prior years had been the 2004 LTIP until 2012, when our shareholders approved the 2012 LTIP, which is now our primary
equity compensation plan.&nbsp;Some current and former executive officers continue to hold outstanding awards under our previous 2004 LTIP, although we no longer grant awards under this plan.&nbsp;All named executive officers are also eligible at
their discretion to acquire shares of common stock pursuant to our SPP.&nbsp;Each of these has been approved by our shareholders.&nbsp;We have also made inducement grants of stock options to new employees in reliance on the Nasdaq exception to
shareholder approval for such grants.&nbsp;For more information on our equity compensation plans, see &#147;<I>&#151;Compensation Discussion and Analysis&#151;Elements of Executive Compensation&#151;Long-Term Equity-Based Incentives</I>&#148;
beginning on page 59. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides aggregate information regarding the shares of our common stock that may be issued upon the exercise of
options and rights under all of our equity compensation plans as of December&nbsp;31,&nbsp;2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:49.10pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of&nbsp;Securities</B><br><B>to&nbsp;Be&nbsp;Issued</B><br><B>upon&nbsp;Exercise</B><br><B>of&nbsp;Outstanding</B><br><B>Options&nbsp;
and</B><br><B>Rights (#)</B><br><B>(a)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-</B><br><B>Average</B><br><B>Exercise</B><br><B>Price of</B><br><B>Outstanding</B><br><B>Options&nbsp;and</B><br><B>Rights ($)</B><br><B>(b)<SUP
STYLE="font-size:85%; vertical-align:top">(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of&nbsp;Securities</B><br><B>Remaining</B><br><B>Available&nbsp;for</B><br><B>Future
Issuance</B><br><B>Under&nbsp;Equity</B><br><B>Compensation</B><br><B>Plans&nbsp;(Excluding</B><br><B>Securities</B><br><B>Reflected in</B><br><B>Column&nbsp;(a))&nbsp;(#)</B><br><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Approved by Security Holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,152,118<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">886,730<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Not Approved by Security Holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">38.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,302,118<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">886,730<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Column does not include time-based vesting restricted stock or performance-based vesting restricted stock that was unvested as of December&nbsp;31, 2017, as such stock is deemed issued and outstanding at the time of
grant, notwithstanding that such shares remain subject to a risk of forfeiture until vesting. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Column reflects 936,822 shares issuable upon the exercise of stock options, 27,982 shares issuable pursuant to outstanding deferred stock units, and 187,314 shares issuable pursuant to outstanding performance share
units, in each case, as of December&nbsp;31, 2017. Shares issuable pursuant to outstanding performance share units are shown in the table based on the assumption that all applicable performance targets will be achieved at target levels, though
ultimate achievement could be below or above target. All awards were granted pursuant to either the 2004 LTIP or the 2012 LTIP. There currently are no more grants being made under the 2004 LTIP. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If all performance share units outstanding as of December&nbsp;31, 2017 were instead assumed to be achieved at maximum levels, a further 430,815 shares would be issuable in addition to the amount shown in the column.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The weighted-average exercise price in column only relates to the exercise price of stock options because the deferred stock units and performance share units have no exercise price. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Included are 345,555 registered shares available for issuance pursuant to the SPP and 541,175 shares remaining available for future award grants under the 2012 LTIP (which assumes that outstanding performance share
units are achieved at target levels), in each case, as of December&nbsp;31, 2017. If all performance share units outstanding as of December&nbsp;31, 2017 instead were assumed to be achieved at maximum levels, the number of securities remaining
available for future award grants under the 2012 LTIP as of December&nbsp;31, 2017 would be 110,360 shares, and the aggregate amount in column (c)&nbsp;would be 455,915 shares. Of the 345,555 shares that were available for issuance pursuant to the
SPP as of such date, 123,600 of these shares were issued in January 2018 pursuant to plan contributions made during the 2017 fiscal year. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reflects shares issuable pursuant to an inducement grant stock option granted in 2013 to Mr.&nbsp;Mason in reliance on the Nasdaq exception to shareholder approval for equity grants to new hires. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B>CERTAIN RELATIONSHIPS <A NAME="tx571963_91"></A>AND RELATED TRANSACTIONS</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I>Compensation Committee Interloc<A NAME="tx571963_92"></A>ks and Insider Participation
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee, comprised entirely of independent, <FONT STYLE="white-space:nowrap">non-management</FONT> directors, is
responsible for establishing and administering the Company&#146;s policies involving the compensation of its executive officers. No employee of the Company serves on the Compensation Committee. The Committee members have no interlocking
relationships as defined by the SEC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_93"></A>Approval of Related Person Transactions </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our policy, which is set forth in our Corporate Code of Conduct and Audit and Finance Committee charter, is that the Audit and Finance Committee will review
and approve all related person transactions that meet the minimum threshold for disclosure under the relevant SEC rules (generally, transactions involving amounts exceeding $120,000 in which a related person has a direct or indirect material
interest). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_94"></A>Transactions with Related Persons </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tyson Fujikawa, the son of Raymond Fujikawa, our President, Spine Fixation, has been employed by the Company since 2007 and is currently the Vice President of
International Sales Spine Fixation. For 2017, Tyson Fujikawa&#146;s total cash compensation was approximately $376,000 which includes base salary, bonus and sales commissions.&nbsp;In addition, during 2017, he participated in the
Company&#146;s&nbsp;general welfare plans and was granted 2,386 restricted stock awards, which vest in four equal annual installments.&nbsp;These arrangements have been approved by our Audit and Finance Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_95"></A></FONT>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_96"></A>Who are the principal owners of Orthofix common shares?
</I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table shows each person, or group of affiliated persons, who beneficially owned, directly or indirectly, at least 5% of our
common shares. Our information is based on reports filed with the SEC by each of the firms or individuals listed in the table below. You may obtain these reports from the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Percent of Class&nbsp;figures for the common shares are based on 19,269,367 shares of our common stock outstanding as of the Record Date. Except as
otherwise indicated, each shareholder has sole voting and dispositive power with respect to the shares indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:134.80pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name and Address of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;and</B><br><B>Nature of</B><br><B>Beneficial</B><br><B>Ownership</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent&nbsp;of</B><br><B>Class</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">55 East 52nd Street</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New York, NY 10055</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,464,012<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Vanguard Group, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">100 Vanguard Blvd.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Malvern, PA 19355</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,649,893<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Information obtained from a Schedule 13G/A filed with the SEC by BlackRock, Inc. (&#147;BlackRock&#148;) on January&nbsp;19, 2018. The Schedule 13G/A discloses that
BlackRock has sole voting power over 2,417,965 shares and sole dispositive power over 2,464,012 shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Information obtained from a Schedule 13G/A filed with the SEC by The Vanguard Group, Inc. (&#147;Vanguard&#148;) on February&nbsp;8, 2018. The Schedule 13G/A
discloses that Vanguard has sole power to vote or direct the vote of 22,745 shares, shared power to direct the vote of 7,396 shares, sole power to dispose of or to direct the disposition of 1,621,618 shares, and shared power to dispose or to direct
the disposition of 28,275 shares. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I>Commo<A NAME="tx571963_97"></A>n shares owned by Orthofix&#146;s directors
and executive officers </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the beneficial ownership of our common shares, including stock options currently
exercisable and exercisable within 60 days of the Record Date, by each director, each director nominee, each current and former executive officer listed in the Summary Compensation Table, and all current directors, director nominees and executive
officers as a group.&nbsp;The percent of class figure is based on 19,269,367 shares of our common stock outstanding as of the Record Date.&nbsp;All directors and executive officers as a group beneficially owned 1,292,109 shares of Orthofix common
stock as of such date.&nbsp;Unless otherwise indicated, the beneficial owners exercise sole voting and/or investment power over their shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:134.80pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name and Address of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;and</B><br><B>Nature of</B><br><B>Beneficial</B><br><B>Ownership</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent&nbsp;of</B><br><B>Class</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">489,074<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">165,190<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald A. Matricaria</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,613<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,317<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,469<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James F. Hinrichs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,297<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,154<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luke Faulstick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,229<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Sainz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,267<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lilly Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,029<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Paolucci</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,529<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis V. Lukianov</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,566<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Sicard</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All directors and executive officers as a group (16 persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,405,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*<I></I></TD>
<TD ALIGN="left" VALIGN="top"><I>Represents less than 1%.</I> </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 266,192 shares owned directly and 222,882 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the
Record Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 60,367 shares owned directly and 104,823 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 91,613 shares owned directly and 30,000 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 77,752 shares owned directly and 33,565 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 66,572 shares owned directly and 24,897 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 26,297 shares owned directly and 30,000 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 7,729 shares owned directly and 22,500 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>All of such shares are owned directly. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 14,029 shares owned directly and 15,000 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 26,654 shares owned directly and 5,500 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 8,529 shares owned directly and 15,000 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Reflects 4,066 shares owned directly and 7,500 shares issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of the Record
Date. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B>PROPOSAL 2:<FONT COLOR="#ffffff">&nbsp;EL<A NAME="*98"></A>ECTION OF DIR<A NAME="tx571963_98"></A>ECTORS</FONT> </B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Existing Articles of Association provides that the Board shall consist of not less than six and no more than fifteen
directors, the exact number to be determined from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time</FONT></FONT> by resolution of the Board. The Board is currently comprised of nine seats, all of which seats will be up
for election at the Annual General Meeting. We have nominated Mr.&nbsp;Faulstick, Mr.&nbsp;Hinrichs, Mr.&nbsp;Lukianov, Ms.&nbsp;Marks, Mr.&nbsp;Mason, Mr.&nbsp;Matricaria, Mr.&nbsp;Paolucci, Ms.&nbsp;Sainz and Mr.&nbsp;Sicard to stand for election
at the Annual General Meeting for these nine seats. Each seat will be elected for a one year term expiring at the 2019 Annual General Meeting of Shareholders and/or until their successors have been elected. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Director<BR>Since</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Independent</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Audit and<BR>Finance<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compliance<BR>and Ethics<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nominating<BR>and<BR>Governance<BR>Committee</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luke Faulstick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:pmingliu"><FONT STYLE="font-family:Times New Roman">&#10003;</FONT> </FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><I>Chair</I></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Hinrichs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:pmingliu"><FONT STYLE="font-family:Times New Roman">&#10003;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><I>Chair</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:pmingliu"><FONT STYLE="font-family:Times New Roman">&#10003;</FONT> </FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis V. Lukianov</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:pmingliu"><FONT STYLE="font-family:Times New Roman">&#10003;</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:pmingliu"><FONT STYLE="font-family:Times New Roman">&#10003;</FONT> </FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:pmingliu"><FONT STYLE="font-family:Times New Roman">&#10003;</FONT> </FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lilly Marks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:pmingliu"><FONT STYLE="font-family:Times New Roman">&#10003;</FONT> </FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald Matricaria (<I>Chairman</I>)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003; </TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Paolucci</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><I>Chair</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:pmingliu"><FONT STYLE="font-family:Times New Roman">&#10003;</FONT> </FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Sainz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:pmingliu"><FONT STYLE="font-family:Times New Roman">&#10003;</FONT> </FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><I>Chair</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Sicard</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We know of no reason why any nominee may be unable to serve as a director.&nbsp;If any nominee is unable to serve, your proxy
may vote for another nominee proposed by the Board, or the Board may reduce the number of directors to be elected.&nbsp;If any director resigns, dies or is otherwise unable to serve out his term, the Board may fill the vacancy until the next Annual
General Meeting of Shareholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I>Current Directors (and Director<A NAME="tx571963_99"></A>s Standing for Election at the
Annual General Meeting) </I></B></FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left"><B>Luke&nbsp;Faulstick</B></TD>
<TD ALIGN="left" VALIGN="top"><I>Director (Nominated to Stand for <FONT STYLE="white-space:nowrap">Re-Election</FONT> as Director at the Annual General Meeting)</I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Faulstick, 55, joined the Board in September 2014. He has over 25 years of experience as a manufacturing executive and is a recognized expert on Lean Manufacturing and work culture. Since 2012,
Mr.&nbsp;Faulstick has been <FONT STYLE="white-space:nowrap">co-owner,</FONT> President and Chief Executive Officer of PPI Inc., a company operating several manufacturing-focused businesses. Prior to forming PPI, he was the Executive Vice President
and Chief Operating Officer of DJO Global. He previously held senior operating management roles at Tyco Healthcare, Graphic Controls, Mitsubishi Consumer Electronics and Eastman Kodak. Under his leadership, DJO Global&#146;s operations teams and
manufacturing plants won numerous awards including the Shingo Prize for Operational Excellence, Industry Week&#146;s Best Plants, and the Association of Manufacturing Excellence Operational Excellence Award. Mr.&nbsp;Faulstick received a Bachelor of
Science Degree in Engineering from Michigan State University and a Master of Science Degree in Engineering from Rochester Institute of Technology. He previously served on the boards of Alphatec Spine and Microdental, as well as Chairman of the Board
of the Association of Manufacturing Excellence. Currently he is a member of the Rady Children&#146;s Hospital Foundation Board of Trustees and a Certified Board of Director through the UCLA Anderson School of Business. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Board believes that Mr.&nbsp;Faulstick&#146;s extensive experience as a manufacturing executive, operational knowledge and industry expertise, as well as his previous and current board memberships, brings unique and
valuable insight to the Board. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left"><B>James&nbsp;F.&nbsp;Hinrichs</B></TD>
<TD ALIGN="left" VALIGN="top"><I>Director (Nominated to Stand for <FONT STYLE="white-space:nowrap">Re-Election</FONT> as Director at the Annual General Meeting)</I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Hinrichs, 50, was appointed to the Board in April 2014. From April 2015 to October 2017, he served as Executive Vice President and Chief Financial Officer of Alere Inc, a publicly traded diagnostic company,
prior to its sale to Abbott Labs. From December 2010 through March 2015, he served as Chief Financial Officer of CareFusion Corporation, a publicly traded medical technology company, prior to its sale to Becton Dickinson. He previously served as
CareFusion&#146;s Senior Vice President, Global Customer Support, from January 2010 to December 2010, and as its Senior Vice President, Controller, from January 2009 to January 2010. Prior to joining CareFusion when it was spun off from Cardinal
Health, Inc., he worked since 2004 at Cardinal Health in various positions including Executive Vice President and Corporate Controller of Cardinal Health, and as Executive Vice President and Chief Financial Officer of its Healthcare Supply Chain
Services segment. He joined Cardinal Health following over a decade of finance and marketing roles at Merck&nbsp;&amp; Co. He holds undergraduate and graduate degrees in business from Carnegie Mellon University. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Board believes that Mr.&nbsp;Hinrichs&#146; financial and accounting experience gained through the foregoing roles, including in particular his experience as a public company chief financial officer, provide
important expertise to the Board and will, in particular, enable him to provide service and leadership as the Chair of the Company&#146;s Audit and Finance Committee effective as of the Annual General Meeting. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left"><B>Alexis&nbsp;V.&nbsp;Lukianov</B></TD>
<TD ALIGN="left" VALIGN="top"><I>Director (Nominated to Stand for <FONT STYLE="white-space:nowrap">Re-Election</FONT> as <FONT STYLE="white-space:nowrap">Re-Director</FONT> at the Annual General Meeting)</I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Lukianov, 62, became a director in December 2016, bringing to the Board his more than 30 years of experience in the orthopedic industry. From July 1999 to March 2015, he served as Chief Executive Officer and a
director of NuVasive, Inc., a publicly-traded medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders, including serving as Chairman of the Board between 2004 and
2015.&nbsp;From April&nbsp;1996 to April&nbsp;1997, Mr.&nbsp;Lukianov was a founder of and served as Chairman of the Board and Chief Executive Officer of BackCare Group, Inc., a spine physician practice management company.&nbsp;From
January&nbsp;1990 to October&nbsp;1995, Mr.&nbsp;Lukianov held a variety of senior executive positions, including President, with Medtronic Sofamor Danek, Inc., a developer and manufacturer of medical devices to treat disorders of the cranium and
spine and a subsidiary of Medtronic, Inc., a publicly-traded medical technology company. Between 1987 and 1990, he was the director of a business unit at Smith&nbsp;&amp; Nephew Orthopaedics that brought limb lengthening technology to the United
States from Russia.&nbsp;From 2007 until its acquisition in 2015 by Royal Philips, he served on the Board of Directors of Volcano Corporation, a Nasdaq-listed medical technology company. He has previously served on the boards and the executive
committees of BIOCOM, a regional life sciences trade association, the Medical Device Manufacturers Association (MDMA), a national trade association, and the California Health Institute (CHI). Mr.&nbsp;Lukianov also serves on a number of private and <FONT
STYLE="white-space:nowrap">non-profit</FONT> boards. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Board believes that Mr.&nbsp;Lukianov&#146;s experience leading medical device and orthopedic companies brings valuable industry experience to the Board. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left"><B>Lilly&nbsp;Marks</B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><I>Director (Nominated to Stand for <FONT STYLE="white-space:nowrap">Re-Election</FONT> as Director at the Annual General Meeting)</I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Ms.&nbsp;Marks, 70, was appointed to the Board in June 2015. She currently serves as the Vice President for Health Affairs for the University of Colorado and has led the University of Colorado Anschutz Medical Campus.
Ms.&nbsp;Marks has also served as a member of the Board of Directors of the University of Colorado Health System, Children&#146;s Hospital Colorado, and the Advisory Board for Clinical Research of the National Institutes of Health. She is currently
a member of the Board of Directors of the Federal Reserve Bank of Kansas City, the Fitzsimons Redevelopment Authority, the Association of Academic Health Centers (AAHC), the Global Down Syndrome Foundation and the Rose Community Foundation.
Additionally, she is a member of the Association of American Medical Colleges (AAMC) Advisory Panel on Research and is a trustee of the University of Colorado Foundation. Ms.&nbsp;Marks is a graduate of the University of Colorado. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Board believes that Ms.&nbsp;Marks&#146; extensive experience from her previous and current board memberships, as well as her accomplished academic background, brings unique and valuable insight to the Board.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left"><B>Bradley&nbsp;R.&nbsp;Mason</B></TD>
<TD ALIGN="left" VALIGN="top"><I>Director President and Chief Executive Officer (Nominated to Stand for <FONT STYLE="white-space:nowrap">Re-Election</FONT> as Director at the Annual General Meeting)</I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Mason, 64, has served as a director since the 2013 Annual General Meeting.&nbsp;Mr.&nbsp;Mason rejoined Orthofix in March 2013 as our President and Chief Executive Officer after previously serving as Group
President, North America from June 2008 through October 2009, and as a Strategic Advisor from November 2009 through October 2010. Prior to being appointed as Group President, North America, he had served as a Vice President of the Company since
December 2003, when the Company acquired Breg, Inc. Prior to its acquisition by Orthofix, Mr.&nbsp;Mason had served as President and Chairman of Breg, a company he principally founded in 1989 with five other shareholders.&nbsp;Mr.&nbsp;Mason has
over 30 years of experience in the medical device industry, some of which were spent with dj Orthopedics (formerly DonJoy) where he became an owner and executive in its early development stage and held the position of Executive Vice
President.&nbsp;Since his retirement from Orthofix in 2010, he has served in a variety of part-time consulting and advisory roles, including as a consultant to Orthofix since October 2012 (which consulting relationship has been terminated as of
March&nbsp;13, 2013). Mr.&nbsp;Mason is the named inventor on 38 issued patents in the orthopedic product arena. He graduated Summa Cum Laude with an Associate of Arts and Associate of Science degree from MiraCosta College. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Board believes that Mr.&nbsp;Mason&#146;s leadership skills, operational knowledge and industry expertise, and his perspective as the Company&#146;s President and Chief Executive Officer, brings unique and valuable
insight to the Board. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left"><B>Ronald&nbsp;Matricaria</B></TD>
<TD ALIGN="left" VALIGN="top"><I>Chairman of the Board (Nominated to Stand for <FONT STYLE="white-space:nowrap">Re-Election</FONT> as Director at the Annual General Meeting)</I> </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Matricaria, 75, was appointed to the Board in March 2014. He has more than 35 years of medical device and pharmaceutical experience at St. Jude Medical, Inc. and Eli Lilly and Company, Inc. From April 1993 to
May 1999, he served as President and Chief Executive Officer of St. Jude Medical, Inc. and served as Chairman of the Board of Directors from January 1995 to May 2002. Prior to joining St. Jude Medical, Mr.&nbsp;Matricaria spent 23 years with Eli
Lilly and Company, Inc., where his last position was Executive Vice President of the Pharmaceutical Division of Eli Lilly and Company and President of its North American operations. He also served as President of Eli Lilly International Corporation,
as well as President of its Medical Device Division. He currently serves as a director of Kinaxis Inc. a SaaS based software company traded on the Toronto Stock Exchange. Until recently, he served as Chairman of the Board at Volcano Corporation and
as a member of the Boards of Phoenix Children&#146;s Hospital and Life Technologies Corporation. Additionally, Mr.&nbsp;Matricaria previously has served on the board of a number of other public and private companies including Home Depot Inc.,
Diametric Medical Inc., Ceridian Inc., Centocor Inc., Haemonetics Inc., Kinetic Concepts, Inc., Hospira Inc., Cyberonics Inc., Vistacare Inc., Advanced Medical Technology Association (AdvaMed), the Pharmaceutical Manufacturers Association
International Section, the American Diabetes Association, the American Foundation for Pharmaceutical Education, the National Foundation for Infectious Diseases, the National Retiree Volunteer Center and the Indiana Repertory Theatre as well as a
trustee on the board of the Massachusetts College of Pharmacy and Allied Health Science. He also chaired the BioMedical Engineering Institute campaign, which raised an operating endowment for the Institute at the University of Minnesota. He remains
a Trustee emeritus of the University of Minnesota Foundation. Mr.&nbsp;Matricaria holds a bachelor&#146;s degree in pharmacy from the Massachusetts College of Pharmacy and was awarded an honorary Doctor of Science degree in pharmacy, as well as an
honorary PharmD degree, in recognition of his contributions to the practice of pharmacy. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Board believes that Mr.&nbsp;Matricaria&#146;s wealth of experience as both an executive and director in the medical device industry brings invaluable experience and leadership qualities to the Board.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left"><B>Michael&nbsp;E.&nbsp;Paolucci</B></TD>
<TD ALIGN="left" VALIGN="top"><I>Director (Nominated to Stand for <FONT STYLE="white-space:nowrap">Re-Election</FONT> as Director at the Annual General Meeting)</I> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Paolucci, 58, was named to the Board and appointed to the Compensation Committee in March 2016. A seasoned Human Resource (HR) executive, Mr.&nbsp;Paolucci has more than 20 years of global experience working
directly with Boards of Directors and <FONT STYLE="white-space:nowrap">C-level</FONT> executives to improve organizational capabilities and HR programs that result in sustained improvements in business performance. He currently serves as Vice
President and Chief Human Resources Officer for Halozyme Therapeutics Inc., a late stage oncology and biopharmaceutical company on the forefront of cancer research. Prior to Halozyme, Mr.&nbsp;Paolucci served as Executive Vice President and Chief
Human Resource Officer for CareFusion. He also served as Executive Vice President of Human Resources at NuVasive, and spent five years at Life Technologies. He was head of Human Resources for the services division of Hewlett Packard and served in
several leadership roles with EDS, which was acquired by Hewlett Packard. Prior to HP/EDS, he was a partner with the HR consulting firm Towers Perrin. Mr.&nbsp;Paolucci is a graduate of Ohio State University. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Board believes that Mr.&nbsp;Paolucci&#146;s extensive experience as a HR executive and relevant knowledge and understanding of public company compensation issues brings unique and valuable insight to the Board.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left"><B>Maria&nbsp;Sainz</B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><I>Director</I><B> </B><I>(Nominated to Stand for <FONT STYLE="white-space:nowrap">Re-Election</FONT> as Director at the Annual General Meeting)</I><B></B> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Ms.&nbsp;Sainz,&nbsp;52, became a director of Orthofix in November 2012, after previously having served on the Board from June 2008 to September 2011. From April 2012 to June 2017, she was the President and Chief
Executive Officer, and a director, of CardioKinetix Inc., a heart failure related medical device company.&nbsp;From April 2008 to October 2011, she was President and Chief Executive Officer of Concentric Medical, Inc., a company developing and
commercializing devices to perform mechanical clot removal post-stroke, which was sold to Stryker Corporate in October 2011. Upon this acquisition, she served as General Manager of the Stryker Neurovascular business unit until April 2012. From 2003
to 2006, she was the President of the Cardiac Surgery division of Guidant Corporation.&nbsp;After Boston Scientific acquired Guidant, Ms.&nbsp;Sainz led the integration process for both the Cardiac Surgery and European Cardiac Rhythm Management
business of Guidant into Boston Scientific.&nbsp;Between 2001 and 2003, Ms.&nbsp;Sainz was the Vice President of Global Marketing &#150; Vascular Intervention of Guidant.&nbsp;Ms.&nbsp;Sainz earned a Bachelor and Masters of Arts from the Universidad
Complutense de Madrid and a Master&#146;s Degree in International Management from American Graduate School of International Management. Ms.&nbsp;Sainz has served as a director of publicly-traded medical device companies The Spectranetics Corporation
and MRI Interventions, Inc. since November 2010 and January 2014, respectively. Ms.&nbsp;Sainz has also been serving on the Board of Directors of Halyard Health, Inc. since February 2015. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Ms.&nbsp;Sainz provides the Board with significant experience in the medical device industry, as well as insight into international markets.&nbsp;The Board also values the perspective she brings from her current
position as a chief executive officer. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left"><B>John&nbsp;Sicard</B></TD>
<TD ALIGN="left" VALIGN="top"><I>Director (Nominated to Stand for Election as Director at the Annual General Meeting)</I> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Sicard, 54, became a director of Orthofix in March 2018. Mr.&nbsp;Sicard joined the Board in March 2018. He currently serves as the President and Chief Executive Officer, and Board Member of Kinaxis, a global
supply chain management software company that delivers cloud-based solutions to some of the world&#146;s largest manufacturing companies, including many in the life science sector. Mr.&nbsp;Sicard joined Kinaxis in 1994 where he has held a number of
senior management roles including Chief Strategy Officer, Chief Operating Officer, Executive Vice President of Marketing Development and Service Operations and Vice President of Customer Services. Mr.&nbsp;Sicard assumed the role of President and
Chief Executive Officer of Kinaxis in January 2016. Prior to Kinaxis, Mr.&nbsp;Sicard held positions at FastMAN Software Systems, and Monenco Agra. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="21%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Board believes that Mr.&nbsp;Sicard&#146;s extensive experience as a strategic supply chain management executive, as well as his current board membership, brings unique and valuable insight to the Board.
</TD></TR></TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" BGCOLOR="#004a97"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>The Board unanimously recommends that you vote
&#147;FOR&#148;</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>the election of each of the foregoing director nominees standing for election at the
Annual General Meeting.</B></FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_100"></A></FONT>PROPOSAL 3: APPROVAL OF FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER&nbsp;31, 2017</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders will be asked to consider, and, if thought fit, approve the consolidated balance sheet and consolidated statement
of operations at and for the fiscal year ended December&nbsp;31, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Article 116 of Book 2 of the CCC, the Board is required to draw up the
Company&#146;s consolidated balance sheet and consolidated statement of operations within eight months after the end of the fiscal year and to submit the same to the Annual General Meeting for approval. Approval of these financial statements does
not constitute an expression of approval of the Company&#146;s financial performance.&nbsp;Rather, the approval by shareholders of these statements is a legally mandated process under Cura&ccedil;ao law.&nbsp;In the event that shareholders do not
approve the financial statements, the Company may be required to call a special meeting of shareholders to <FONT STYLE="white-space:nowrap">re-submit</FONT> the same financial statements for additional approval, which we believe would constitute a
waste of shareholder assets.&nbsp;As such, we urge shareholders to support the proposal to permit the Company to comply with its obligations under Cura&ccedil;ao law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the Company&#146;s consolidated balance sheet and consolidated statement of operations at and for the fiscal year ended December&nbsp;31, 2017 is
included in the 2017 Form <FONT STYLE="white-space:nowrap">10-K,</FONT> a copy of which accompanies this proxy statement/prospectus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" BGCOLOR="#004a97"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>The Board unanimously recommends that you vote &#147;FOR&#148; the
proposal to</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>approve the consolidated balance sheet and consolidated statement of
operations</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>at and for the fiscal year ended December&nbsp;31, 2017.</B></FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_101"></A></FONT>PROPOSAL 4:&nbsp;ADVISORY AND <FONT STYLE="white-space:nowrap">NON-BINDING</FONT> VOTE ON EXECUTIVE COMPENSATION</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As required by section 14A of the Securities Exchange Act of 1934, as amended, we are providing our shareholders an opportunity
to indicate whether they support our named executive officer compensation as described in this proxy statement/prospectus. This advisory and <FONT STYLE="white-space:nowrap">non-binding</FONT> vote, commonly referred to as <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay,&#148;</FONT></FONT> is not intended to address any specific item of compensation, but instead relates to the Compensation Discussion and Analysis, the tabular disclosures
regarding named executive officer compensation, and the narrative disclosure accompanying the tabular presentation. These disclosures allow you to view the trends in our executive compensation program and the application of our compensation
philosophies for the years presented. Because our Board views the advisory vote as a good corporate governance practice, and because a majority of our shareholders have expressed a preference for an annual advisory vote, we hold such votes on an
annual basis. At the 2017 annual meeting, the Company&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> proposal was supported by 92% of the votes cast, which we believe supports the Company&#146;s <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;pay-for-performance&#148;</FONT></FONT> approach to executive compensation. The Committee evaluated these results of the vote in the fall of 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Committee believes that the voting results over the course of the last several years (which has included 90% or greater approval votes at five of the
Company&#146;s last six annual general meetings) affirm shareholders&#146; overall support of the Company&#146;s approach to executive compensation, including continuing efforts by the Committee during that time to evolve the Company&#146;s
compensation programs towards policies viewed by institutional and other shareholders as aligning executive compensation with the interests of shareholders and good corporate governance. In addition to responding to the input of shareholders, the
Committee also has considered many other factors in evaluating and setting the Company&#146;s executive compensation programs, including the Committee&#146;s assessment of the interaction of our compensation programs with our corporate business
objectives, periodic analysis of our programs by our compensation consultant, and annual review of data versus a comparator group of peer companies, each of which is evaluated in the context of the Committee members&#146; fiduciary duty to act as
the directors determine to be in shareholders&#146; best interests. Each of these factors informed the Compensation Committee&#146;s decisions regarding named executive officers&#146; compensation for 2017. The Committee will continue to consider
feedback from shareholders, including the outcome of the Company&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> votes, when making future compensation decisions for its named executive officers.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed in the Compensation Discussion and Analysis section of this proxy statement/prospectus, we believe that our executive compensation program
properly links executive compensation to Company performance and aligns the interests of our executive officers with those of our shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accordingly, the Board unanimously recommends that shareholders vote in favor of the following resolution: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>&#147;RESOLVED, that the shareholders approve the compensation of the Company&#146;s named executive officers as disclosed in this proxy
statement/prospectus pursuant to the rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the compensation tables and the related footnotes and narrative disclosures.&#148; </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although this vote is advisory and is not binding on the Company, the Compensation Committee of the Board will take into account the outcome of the vote when
considering future executive compensation decisions. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" BGCOLOR="#004a97"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>The Board unanimously recommends you</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>for &#147;FOR&#148; the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> proposal.</B></FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_102"></A>PROPOSAL 5: APPROVAL OF THE AMENDED AND RESTATED 2012 LONG-TERM INCENTIVE PLAN</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders will be asked to consider the terms of the Amended and Restated 2012 Plan and vote on the adoption of the Amended
and Restated 2012 Plan at the Annual General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors has adopted the Amended and Restated 2012 Plan, subject to approval from our
shareholders. We are asking our shareholders to approve the Amended and Restated 2012 Plan as we believe that approval of the plan is essential to our continued success. The purpose of the Amended and Restated 2012 Plan is to provide eligible
employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors an incentive to contribute to the success of the Company and to operate and manage our business in a manner that will provide for the Company&#146;s long term growth and
profitability and provide a means of obtaining, rewarding and retaining key personnel. In the judgment of the Board of Directors, awards under the Amended and Restated 2012 Plan will be a valuable incentive and will serve to the ultimate benefit of
our shareholders by aligning more closely the interests of Amended and Restated 2012 Plan participants with those of our shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our
shareholders approve the Amended and Restated 2012 Plan, the number of shares of common stock reserved for issuance under the plan will be increased by 1,550,000 shares. As of April&nbsp;23, 2018, 9,155 shares remained available for future award
grants under the 2012 LTIP (assuming all currently outstanding performance share units ultimately are achieved at target levels). In addition, if all performance share units outstanding as of such date were achieved at maximum levels, a further
604,879 shares would be issuable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our shareholders approve the Amended and Restated 2012 Plan, the new terms of the plan will govern awards made on
and following the date of shareholder approval and the terms of the plan prior to its amendment and restatement will govern awards made prior to the date of shareholder approval. On the Record Date, the closing price of our common stock was
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of certain material differences between
the Amended and Restated 2012 Plan and the 2012 LTIP as it currently exists: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Amended and Restated 2012 Plan retains the individual limits on the maximum number of shares of common stock that may be granted under the plan pursuant to specified awards and the maximum dollar amount that may be
paid as a cash-denominated award over specified periods, but adds a separate, higher limit on the grants that can be made the first year a grantee is employed by the Company. Notwithstanding that changes resulting from the Tax Act (as described
below) have made imposing these limits on future awards irrelevant for their original intended purpose, which was the ability to grant awards that qualified as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code, we have
retained and expanded upon these individual limits because they currently represent good corporate governance procedures and are favored by institutional investors and proxy advisory services. In addition, the Amended and Restated 2012 Plan adds a
separate limit on the maximum total compensation (including cash payments and the aggregate grant date value of awards) that may be granted in a fiscal year to an outside director. These limits are discussed in more detail below under &#147;<I>Share
Limits</I>.&#148; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Amended and Restated 2012 Plan retains the requirement that awards subject to time-based vesting are subject to a time-based vesting schedule of a least one year following the date of grant and that awards subject
to performance-based vesting are subject to a performance-based vesting schedule that vests based on the achievement of performance metrics over a period of not less than one year from the date of grant, but adds an exception providing that up to 5%
of the number of shares of common stock available for issuance under the Amended and Restated 2012 Plan may be granted without such limitations and that awards that that vest due to a grantee&#146;s death, disability or retirement, or in connection
with a corporate transaction are not subject to the <FONT STYLE="white-space:nowrap">one-year</FONT> vesting limitation. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The 2012 LTIP included certain design features that were intended to allow awards that qualified as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code. These awards were intended to be
exempt from the $1&nbsp;million deduction limit that would otherwise apply under Section&nbsp;162(m) for compensation paid to certain executive officers. The Tax Act eliminated the exception from the Section&nbsp;162(m) deduction limit for
&#147;performance-based compensation&#148; and expanded the group of executive officers to which the $1&nbsp;million deduction limit applies. As a result, while the Amended and Restated 2012 Plan continues to allow awards to be granted that are
subject to performance-vesting conditions, the Amended and Restated 2012 Plan eliminates certain of the provisions that had been required for awards to comply with the exception to the deduction limitation for &#147;performance-based
compensation.&#148; However, the Amended and Restated 2012 Plan still retains certain of the features common to &#147;performance-based compensation&#148; under Section&nbsp;162(m) as in effect before the Tax Act, including certain individual award
limits and a list of performance criteria, even though those features are no longer required by tax law after the Tax Act. The Company may <FONT STYLE="white-space:nowrap">re-evaluate</FONT> these features at a later date as guidance is provided by
the Internal Revenue Service regarding the changes made to Section&nbsp;162(m) by the Tax Act. As a result of the changes imposed by the Tax Act, therefore, none of the new awards under the Amended and Restated 2012 Plan will be able to qualify as
&#147;performance-based compensation&#148; under the provisions of Section&nbsp;162(m) of the Code as in effect prior to the Tax Act, and any awards granted under the Amended and Restated 2012 Plan to our chief executive officer, chief financial
officer, and three other most highly compensated executive officers will be subject to the $1&nbsp;million deduction limit of Section&nbsp;162(m) of the Code. The provisions of the 2012 LTIP will continue to apply to any awards granted on or prior
to November&nbsp;2, 2017 that were intended to qualify as &#147;performance-based compensation&#148; or that were intended to be exempt from the limitations imposed by Section&nbsp;162(m) of the Code. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Though the Company does not currently have a practice of paying dividends, the Amended and Restated 2012 Plan provides that any cash dividends declared or paid on shares of restricted stock will not be paid currently,
but will instead be accrued and will be subject to the same vesting conditions and restrictions that apply to the underlying shares of restricted stock. As a result, any dividends paid in respect of shares of restricted stock will not vest and
become payable unless and until the shares of restricted stock to which the dividends apply become vested and nonforfeitable. The 2012 LTIP allowed dividends to be paid on unvested shares of restricted stock. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Assuming a quorum is present at the Annual General Meeting, the approval of the holders of a majority of the votes cast will be required to approve this
proposal. Neither abstentions nor broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will have any effect on the outcome of voting this proposal. </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" BGCOLOR="#004a97"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>The Board unanimously recommends that you</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>vote &#147;FOR&#148; the approval of the Amended and Restated 2012 Plan.</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_103"></A>Description of the Plan </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A description of the material provisions of the Amended and Restated 2012 Plan is set forth below. This summary is qualified in its entirety by the detailed
provisions of the Amended and Restated 2012 Plan, a copy of which is attached as Annex&nbsp;C to this proxy statement/prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Administration.</I></B>&nbsp;The Amended and Restated 2012 Plan is administered by the Compensation Committee of the Board of Directors. The members of
the Compensation Committee meet the requirements of <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> of the Exchange Act and comply with the independence requirements of current Nasdaq listing standards. In addition, to the extent necessary
to satisfy any transition rule or applicable transition guidance pertaining to awards intended to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
satisfy the criteria for performance-based compensation under Section&nbsp;162(m) of the Code, the committee administering such awards will consist of two or more directors who qualify as
&#147;outside directors&#148; within the meaning of Section&nbsp;162(m) and the applicable guidance thereunder. Subject to the terms of the plan, the Compensation Committee may select participants to receive awards, determine the types and amounts
of awards and terms and conditions of awards, and interpret provisions of the plan. Members of the Compensation Committee serve at the pleasure of the Board of Directors. The Board of Directors may also appoint one or more separate committees, each
composed of one or more directors who need not satisfy the independence requirements described above to administer the Amended and Restated 2012 Plan with respect to employees or other service providers who are not officers or directors of the
Company. In addition, to the extent permitted by applicable laws, the Compensation Committee may, by resolution, delegate some or all of its authority with respect to the plan and awards to the President and Chief Executive Officer and/or any other
officer of the Company designated by the Compensation Committee, provided that the officer delegated such authority may not make grants to Company directors, to &#147;executive officers&#148; (as defined in Rule
<FONT STYLE="white-space:nowrap">3b-7</FONT> under the Exchange Act), or to himself or herself. In addition, the Compensation Committee may not delegate its authority to interpret the Amended and Restated 2012 Plan, any award or any award agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Common Stock Reserved for Issuance under the Plan.</I></B>&nbsp;The common stock issued or to be issued under the Amended and Restated 2012 Plan
consists of authorized but unissued shares or, to the extent permitted by applicable law, issued shares that have been reacquired by the Company. The Amended and Restated 2012 Plan provides for a <FONT STYLE="white-space:nowrap">so-called</FONT>
&#147;fungible share pool&#148; pursuant to which awards of options and stock appreciation rights (&#147;SARs&#148;) will be counted against the plan limit as one share for every one share subject to an option or SAR granted under the plan, and
&#147;full value&#148; awards (all awards other than options and SARs) will be counted against the plan limit as 1.84&nbsp;shares for every one share subject to such full value award. If any shares covered by an award under the Amended and Restated
2012 Plan are not purchased or are forfeited, or if an award otherwise terminates without delivery of any common stock, then the number of shares of common stock counted against the aggregate number of shares available under the plan with respect to
the award will again be available for making awards under the Amended and Restated 2012 Plan in accordance with the previously described fungible share pool. The number of shares of common stock available for issuance under the Amended and Restated
2012 Plan will not be increased by (i)&nbsp;any shares tendered or withheld or award surrendered in connection with the purchase of shares of common stock upon exercise of an option SAR, (ii)&nbsp;any shares of common stock that were not issued upon
the net settlement or net exercise of an option or stock-settled SAR, (iii)&nbsp;any shares of common stock deducted from an award payment in connection with the Company&#146;s tax withholding obligations, or (iv)&nbsp;any shares of common stock
purchased by the Company with proceeds from option or SAR exercises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Eligibility.</I></B>&nbsp;Awards may be made under the Amended and Restated
2012 Plan to directors, or employees of or consultants to the Company or any of our affiliates, including any such employee who is an officer or director of us or of any affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Minimum Vesting Provisions</I></B><B>.</B> Except with respect to a maximum of 5% of the shares that may be granted under the Amended and Restated 2012
Plan, no portion of any award that vests on the basis of a grantee&#146;s continued service may be granted with vesting conditions under which vesting occurs earlier than the one year anniversary of the grant date, and no portion of any award that
vests based upon the attainment of performance measures may be granted with a performance period of less than 12 months. (Certain substitute awards that the Company may assume in corporate transactions are not subject to this provision.) The
Compensation Committee may, however, provide for the earlier vesting, exercisability, and/or settlement under any award in the event of a grantee&#146;s death, disability or retirement in connection with a corporate transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment or Termination of the Plan.</I></B>&nbsp;The Board of Directors may terminate or amend the Amended and Restated 2012 Plan at any time and for
any reason. The Amended and Restated 2012 Plan shall terminate in any event 10 years after the date of shareholder approval of the plan (which, if the plan is approved at the annual meeting, shall make such termination date June 18, 2028).
Amendments will be submitted for shareholder approval to the extent required by the Code or other applicable laws, rules or regulations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Options.</I></B>&nbsp;The Amended and Restated 2012 Plan permits the granting of options to purchase shares
of common stock intended to qualify as incentive stock options under the Code and options that do not qualify as incentive stock options. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Exercise Price.</I>&nbsp;The exercise price of each option may not be less than 100% of the fair market value of our common stock on the date of grant. The fair market value is generally determined as the closing
price of the common stock on the date of grant. In the case of certain 10% shareholders who receive incentive stock options, the exercise price may not be less than 110% of the fair market value of the common stock on the date of grant. An exception
to these requirements is made for options that the Company grants in substitution for options held by employees of companies that the Company acquires. In such a case the exercise price is adjusted to preserve the economic value of the
employee&#146;s option from his or her former employer. The term of each option is fixed by the Compensation Committee and may not exceed 10&nbsp;years from the date of grant (or five years from the date of grant in the case of certain 10%
shareholders who receive incentive stock options). The Compensation Committee determines at what time or times each option may be exercised and the period of time, if any, after retirement, death, disability or termination of employment during which
options may be exercised. Options may be made exercisable in installments. In general, an optionee may pay the exercise price of an option by cash, certified check, or, to the extent an award agreement so provides, by tendering shares of common
stock, by means of a broker-assisted cashless exercise or by means of net exercise. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Transfers.</I>&nbsp;Options and SARs granted under the Amended and Restated 2012 Plan may not be sold, transferred, pledged or assigned other than by will or under applicable laws of descent and distribution.
However, the Company may permit limited transfers of <FONT STYLE="white-space:nowrap">non-qualified</FONT> options and SARs for the benefit of immediate family members of grantees to help with estate planning concerns. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Repricing Prohibited.</I>&nbsp;Except in connection with a corporate transaction involving the Company (including, without limitation, any stock dividend, stock split, extraordinary cash dividend, recapitalization,
reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination, or exchange of shares), the Company may not amend the terms of outstanding options or SARs to
reduce the exercise price or SAR price, as applicable, of such outstanding options or SARs, cancel or assume outstanding options or SARs in exchange for or substitution of options or SARs with an exercise price or SAR price, as applicable, that is
less than the exercise price or SAR price, as applicable, of the original options or SARs, or cancel or assume outstanding options or SARs with an exercise price or SAR price, as applicable, above the current fair market value in exchange for cash,
awards, or other securities, in each case, unless such action is subject to and approved by the Company&#146;s shareholders. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other
Awards.</I></B>&nbsp;The Compensation Committee may also award: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">shares of unrestricted stock, which are shares of common stock at no cost or for a purchase price determined by the Compensation Committee which are free from any restrictions under the plan. Unrestricted shares of
common stock may be granted, subject to 5% limit discussed above under &#147;<I>&#151;Minimum Vesting Provisions</I>,&#148; to participants in recognition of past services or other valid consideration, and may be issued in lieu of cash compensation
to be paid to participants; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">shares of restricted stock, which are shares of common stock subject to restrictions. Shares of restricted stock have the right to vote and the right to receive dividends declared or paid with respect to such shares,
except that cash and stock dividends will not be paid currently but instead will be subject to the same vesting conditions and restrictions applicable to the underlying shares of restricted stock; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">stock units, which are common stock units subject to restrictions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">dividend equivalent rights, which are rights entitling the recipient to receive credits for dividends that would be paid if the recipient had held a specified number of shares of common stock. Dividend equivalent rights
granted as a component for another award, such as in connection with stock units, will not be paid currently but instead will be subject to the same vesting conditions and restrictions applicable to the underlying award; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">SARs, which are a right to receive a number of shares or, at the discretion of the Compensation Committee, an amount in cash or a combination of shares and cash, based on the increase in the fair market value of the
shares underlying the right during a stated period specified by the Compensation Committee. The exercise price for an SAR shall not be less than the fair market value of a share of common stock on the grant date of the SAR. The term of each SAR is
fixed by the Compensation Committee and may not exceed 10&nbsp;years from the date of grant. The Compensation Committee determines when the SAR may be exercised and the period of time, if any, after retirement, death, disability or termination of
employment during which the SAR may be exercised; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">performance and annual incentive awards, ultimately payable in common stock or cash, as determined by the Compensation Committee. The Compensation Committee may grant multi-year and annual incentive awards subject to
achievement of specified performance metrics tied to business criteria (described below). The Compensation Committee may specify the amount of the incentive award as a percentage of these performance criteria, a percentage in excess of a threshold
amount or as another amount which need not bear a strictly mathematical relationship to these performance criteria. The Compensation Committee may modify, amend or adjust the terms of each award and the performance criteria. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Effect of Certain Corporate Transactions</I></B><I>.</I>&nbsp;Unless an applicable award agreement provides otherwise, certain change in control
transactions involving us, such as a sale of the Company, will cause grantees of restricted stock, stock units, stock appreciation rights and options to become fully vested, unless the awards are continued or substituted for in connection with the
change in control transaction. For awards based on the satisfaction of performance conditions (&#147;Performance Awards&#148;) that are denominated in shares of common stock or stock units, if less than half of the performance period has lapsed,
such Performance Awards will be converted into restricted stock or stock units assuming target performance has been achieved (or into unrestricted shares of common stock if no further restrictions apply). If more than half the performance period has
lapsed, such Performance Awards will be converted into restricted stock or stock units based on actual performance to date (or into unrestricted shares of common stock if no further restrictions apply). If actual performance is not determinable,
such Performance Awards will be converted into restricted stock or stock units assuming target performance has been achieved, based on the discretion of the Compensation Committee (or into unrestricted shares of common stock if no further
restrictions apply). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adjustments for Stock Dividends and Similar Events.</I></B>&nbsp;The Compensation Committee will make appropriate adjustments
in outstanding awards and the number of shares available for issuance under the Amended and Restated 2012 Plan, including the individual limitations on awards (described below), to reflect stock splits and other similar events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section</I></B><B><I></I></B><B><I>&nbsp;162(m) of the Code.</I></B>&nbsp;Following the passage of the Tax Act, Section&nbsp;162(m) disallows a tax
deduction for any publicly held corporation for individual compensation exceeding $1.0&nbsp;million in any taxable year to any person who has served as chief executive officer, chief financial officer, or as one of its three other most highly
compensated executive officers in any fiscal year beginning after December&nbsp;31, 2016 (our covered employees). Prior to the passage of the Tax Act, Section&nbsp;162(m) disallowed a tax deduction for any publicly held corporation for individual
compensation exceeding $1.0&nbsp;million in any taxable year to its chief executive officer and each of its three other most highly compensated executive officers, other than its chief financial officer, unless such
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation qualified as &#147;performance-based compensation&#148; within the meaning of the Code. The changes under Section&nbsp;162(m) are generally effective for taxable years beginning in
2018, but there is a grandfather rule for compensation paid pursuant to a written, binding contract that was in effect on November&nbsp;2, 2017, which was not modified in any material respect on or after that date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result of the changes imposed by the Tax Act, the Amended and Restated 2012 Plan does not contain all of the provisions providing for grants of
&#147;performance-based compensation&#148; under the legacy Section&nbsp;162(m) provisions that our 2012 LTIP currently contains. However, the Amended and Restated 2012 Plan does permit the Compensation Committee to provide that vesting of any of
the awards that may be granted under the Amended and Restated 2012 Plan may be made subject to the achievement of performance metrics determined by the Compensation Committee, which metrics may include, but are not limited to: (i)&nbsp;net earnings
or net income; (ii)&nbsp;operating earnings; (iii)&nbsp;pretax earnings; (iv)&nbsp;earnings per share; (v)&nbsp;share price, including growth measures and total shareholder return; (vi)&nbsp;earnings before interest and taxes; (vii)&nbsp;earnings
before interest, taxes, depreciation and/or amortization; (viii)&nbsp;earnings before interest, taxes, depreciation and/or amortization as adjusted to exclude any one or more of the following: stock-based compensation expense; income from
discontinued operations; gain on cancellation of debt; debt extinguishment and related costs; restructuring, separation and/or integration charges and costs; reorganization and/or recapitalization charges and costs; impairment charges; gain or loss
related to investments; sales and use tax settlement; and gain on <FONT STYLE="white-space:nowrap">non-monetary</FONT> transactions; (ix)&nbsp;sales or revenue growth, whether in general, by type of product or service, or by type of customer;
(x)&nbsp;gross or operating margins; (xi)&nbsp;return measures, including return on assets, capital, investment, equity, sales or revenue; (xii)&nbsp;cash flow, including: operating cash flow; free cash flow, defined as earnings before interest,
taxes, depreciation and/or amortization (as adjusted to exclude any one or more of the items that may be excluded pursuant to the Performance Measure specified in clause (viii)&nbsp;above) less capital expenditures; levered free cash flow, defined
as free cash flow less interest expense; cash flow return on equity; and cash flow return on investment; (xiii)&nbsp;productivity ratios; (xiv)&nbsp;expense targets; (xv)&nbsp;market share; (xvi)&nbsp;financial ratios as provided in credit
agreements of the Company and its Subsidiaries; (xvii)&nbsp;working capital targets; (xviii)&nbsp;completion of acquisitions of businesses or companies; (xix)&nbsp;completion of divestitures and asset sales; and (xx)&nbsp;any combination of the
foregoing business criteria. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Share Limits.</I></B><I> </I>The maximum number of shares of common stock subject to options or SARs that can be
granted under the Amended and Restated 2012 Plan to any person who is not a <FONT STYLE="white-space:nowrap">non-employee</FONT> director is 400,000 per <FONT STYLE="white-space:nowrap">12-month</FONT> period, provided that in a grantee&#146;s year
of hire the applicable limit is 800,000. The maximum number of shares of common stock that can be granted under the Amended and Restated 2012 Plan to any person who is not a <FONT STYLE="white-space:nowrap">non-employee</FONT> director, other than
pursuant to an option or SAR, is 200,000 per <FONT STYLE="white-space:nowrap">12-month</FONT> period, provided that in a grantee&#146;s year of hire the applicable limit is 400,000. The maximum amount that may be paid as an annual incentive award or
other cash award in any <FONT STYLE="white-space:nowrap">12-month</FONT> period to any one person who is not a <FONT STYLE="white-space:nowrap">non-employee</FONT> director is $3,000,000 and the maximum amount that may be paid as a performance award
or other cash award in respect of a performance period greater than 12 months to any one person who is not a <FONT STYLE="white-space:nowrap">non-employee</FONT> director is $6,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum total compensation (including cash payments and the aggregate grant date fair value of awards that may be granted under the Amended and Restated
2012 Plan) that may be paid to or granted in a <FONT STYLE="white-space:nowrap">12-month</FONT> period to a <FONT STYLE="white-space:nowrap">non-employee</FONT> director for such director&#146;s service on the Board of Directors or a committee of
the Board of Directors is $1,000,000. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_104"></A>Federal Income Tax Consequences </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Incentive Stock Options.</I></B><B></B>&nbsp;The grant of an option will not be a taxable event for the grantee or for the Company. A grantee will not
recognize taxable income upon exercise of an incentive stock option (except that the alternative minimum tax may apply), and any gain realized upon a disposition of our common stock received pursuant to the exercise of an incentive stock option will
be taxed as long-term capital gain if the grantee holds the shares of common stock for at least two years after the date of grant and for one year after the date of exercise (the &#147;holding period requirement&#148;). We will not be entitled to
any business expense deduction with respect to the exercise of an incentive stock option, except as discussed below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the exercise of an option to qualify for the foregoing tax treatment, the grantee generally must be our
employee or an employee of our subsidiary from the date the option is granted through a date within three months before the date of exercise of the option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If all of the foregoing requirements are met except the holding period requirement mentioned above, the grantee will recognize ordinary income upon the
disposition of the common stock in an amount generally equal to the excess of the fair market value of the common stock at the time the option was exercised over the option exercise price (but not in excess of the gain realized on the sale). The
balance of the realized gain, if any, will be capital gain. We will be allowed a business expense deduction to the extent the grantee recognizes ordinary income, subject to the one million dollar limitation imposed by Section&nbsp;162(m), described
above, and to certain reporting requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Options.</I></B>&nbsp;The grant of an option
will not be a taxable event for the grantee or the Company. Upon exercising a <FONT STYLE="white-space:nowrap">non-qualified</FONT> option, a grantee will recognize ordinary income in an amount equal to the difference between the exercise price and
the fair market value of the common stock on the date of exercise. Upon a subsequent sale or exchange of shares acquired pursuant to the exercise of a <FONT STYLE="white-space:nowrap">non-qualified</FONT> option, the grantee will have taxable
capital gain or loss, measured by the difference between the amount realized on the disposition and the tax basis of the shares of common stock (generally, the amount paid for the shares plus the amount treated as ordinary income at the time the
option was exercised). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we comply with applicable reporting requirements, we will be entitled to a business expense deduction in the same amount and
generally at the same time as the grantee recognizes ordinary income, subject to the one million dollar limitation imposed by Section&nbsp;162(m). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A
grantee who has transferred a <FONT STYLE="white-space:nowrap">non-qualified</FONT> option to a family member by gift will realize taxable income at the time the <FONT STYLE="white-space:nowrap">non-qualified</FONT> option is exercised by the family
member. The grantee will be subject to withholding of income and employment taxes at that time. The family member&#146;s tax basis in the shares of common stock will be the fair market value of the shares of common stock on the date the option is
exercised. The transfer of vested <FONT STYLE="white-space:nowrap">non-qualified</FONT> options will be treated as a completed gift for gift and estate tax purposes. Once the gift is completed, neither the transferred options nor the shares acquired
on exercise of the transferred options will be includable in the grantee&#146;s estate for estate tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event a grantee transfers a <FONT
STYLE="white-space:nowrap">non-qualified</FONT> option to his or her <FONT STYLE="white-space:nowrap">ex-spouse</FONT> incident to the grantee&#146;s divorce, neither the grantee nor the <FONT STYLE="white-space:nowrap">ex-spouse</FONT> will
recognize any taxable income at the time of the transfer. In general, a transfer is made &#147;incident to divorce&#148; if the transfer occurs within one year after the marriage ends or if it is related to the end of the marriage (for example, if
the transfer is made pursuant to a divorce order or settlement agreement). Upon the subsequent exercise of such option by the <FONT STYLE="white-space:nowrap">ex-spouse,</FONT> the <FONT STYLE="white-space:nowrap">ex-spouse</FONT> will recognize
taxable income in an amount equal to the difference between the exercise price and the fair market value of the shares of common stock at the time of exercise. Any distribution to the <FONT STYLE="white-space:nowrap">ex-spouse</FONT> as a result of
the exercise of the option will be subject to employment and income tax withholding at this time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock.</I></B>&nbsp;A grantee who is
awarded restricted stock will not recognize any taxable income for federal income tax purposes in the year of the award, provided that the shares of common stock are subject to restrictions (that is, the restricted stock is nontransferable and
subject to a substantial risk of forfeiture). However, the grantee may elect under Section&nbsp;83(b) of the Code to recognize compensation income in the year of the award in an amount equal to the fair market value of the common stock on the date
of the award (less the purchase price, if any), determined without regard to the restrictions. If the grantee does not make such a Section&nbsp;83(b) election, the fair market value of the common stock on the date the restrictions lapse (less the
purchase price, if any) will be treated as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation income to the grantee and will be taxable in the year the restrictions lapse and dividends paid while the common stock is subject to restrictions will be subject to withholding
taxes. If we comply with applicable reporting requirements, and subject to the one million dollar deduction limitation of Section&nbsp;162(m), we will be entitled to a business expense deduction in the same amount and generally at the same time as
the grantee recognizes ordinary income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Units.</I></B>&nbsp;There are no immediate tax consequences of receiving an award of stock units
under the Amended and Restated 2012 Plan. A grantee who is awarded stock units will be required to recognize ordinary income in an amount equal to the fair market value of shares issued to such grantee at the end of the restriction period or, if
later, the payment date. If we comply with applicable reporting requirements, and subject to the one million dollar deduction limitation of Section&nbsp;162(m), we will be entitled to a business expense deduction in the same amount and generally at
the same time as the grantee recognizes ordinary income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividend Equivalent Rights.</I></B>&nbsp;Participants who receive dividend equivalent
rights will be required to recognize ordinary income in an amount distributed to the grantee pursuant to the award. If we comply with applicable reporting requirements, and subject to the one million dollar deduction limitation of
Section&nbsp;162(m), we will be entitled to a business expense deduction in the same amount and generally at the same time as the grantee recognizes ordinary income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Appreciation Rights.</I></B>&nbsp;There are no immediate tax consequences of receiving an award of stock appreciation rights under the Amended and
Restated 2012 Plan. Upon exercising a stock appreciation right, a grantee will recognize ordinary income in an amount equal to the difference between the exercise price and the fair market value of the common stock on the date of exercise. If we
comply with applicable reporting requirements and subject to the one million dollar deduction limitation of Section&nbsp;162(m), we will be entitled to a business expense deduction in the same amount and generally at the same time as the grantee
recognizes ordinary income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance and Annual Incentive Awards.</I></B>&nbsp;The award of a performance or annual incentive award will have no
federal income tax consequences for us or for the grantee. The payment of the award is taxable to a grantee as ordinary income. If we comply with applicable reporting requirements, and subject to the one million dollar deduction limitation of
Section&nbsp;162(m), we will be entitled to a business expense deduction in the same amount and generally at the same time as the grantee recognizes ordinary income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unrestricted Common Stock.</I></B>&nbsp;Participants who are awarded unrestricted common stock will be required to recognize ordinary income in an
amount equal to the fair market value of the shares of common stock on the date of the award, reduced by the amount, if any, paid for such shares. If we comply with applicable reporting requirements and subject to the one million dollar deduction
limitation of Section&nbsp;162(m), we will be entitled to a business expense deduction in the same amount and generally at the same time as the grantee recognizes ordinary income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section</I></B><B><I></I></B><B><I>&nbsp;280G.</I></B>&nbsp;To the extent payments which are contingent on a change in control are determined to exceed
certain Code limitations, they may be subject to a 20% nondeductible excise tax and the Company&#146;s deduction with respect to the associated compensation expense may be disallowed in whole or in part. The Amended and Restated 2012 Plan includes a
Section&nbsp;280G &#147;best after tax&#148; provision, meaning, if any of the payments under the Amended and Restated 2012 Plan or otherwise would constitute parachute payments within the meaning of Section&nbsp;280G of the Code and be subject to
the excise tax imposed under Section&nbsp;4999 of the Code, the payments will be reduced by the amount required to avoid the excise tax if such a reduction would give the grantee a better <FONT STYLE="white-space:nowrap">after-tax</FONT> result than
if the grantee received the payments in full. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A.</I></B>&nbsp;The Company intends for awards granted under
the plan to comply with Section&nbsp;409A of the Code. To the extent a grantee would be subject to the additional 20% excise tax imposed on certain nonqualified deferred compensation plans as a result of a provision of an award under the plan, the
provision will be deemed amended to the minimum extent necessary to avoid application of the 20% excise tax. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_105">
</A>New Plan Benefits </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2018, there were 8&nbsp;executive officers, 877 other employees and <FONT
STYLE="white-space:nowrap">8&nbsp;non-employee</FONT> directors of the Company and its subsidiaries who are eligible to be participants in Amended and Restated 2012 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;2, 2018, the Compensation Committee made the Company&#146;s annual equity grants to employees, which grants were made out of the remaining
capacity that then-existed under the 2012 Plan (498,996 shares). Due to capacity limitations, the Committee was not able to make all contemplated grants, and at Mr.&nbsp;Mason&#146;s request, Mr.&nbsp;Mason&#146;s restricted stock grant was delayed.
Such grant to Mr.&nbsp;Mason was instead made contingent upon the Amended and Restated 2012 Plan being approved by shareholders at the Annual General Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In July 2018, the Committee contemplates making the Company&#146;s annual restricted stock grant to <FONT STYLE="white-space:nowrap">non-executive</FONT>
directors, which grant is also contemplated to be made pursuant to the Amended and Restated 2012 Plan, contingent upon the Amended and Restated 2012 Plan being approved by shareholders at the Annual General Meeting. The number of shares of
restricted stock granted will be based on the value of the Company&#146;s common stock as of the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table shows these grant
amounts, each of which are contingent upon shareholders approving the Amended and Restated 2012 Plan at the Annual General Meeting: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:64.40pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Dollar<BR>Value<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of Restricted<BR>Stock Awards Granted<BR>Contingent Upon<BR>Approval of Amended<BR>and&nbsp;Restated&nbsp;2012&nbsp;Plan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason &#150;President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,054,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas C. Rice &#150; Chief Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kimberley A. Elting &#150; Chief Legal and Administrative Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael M. Finegan &#150; Chief Strategy Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Davide Bianchi &#150; President, Global Extremity Fixation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Executive Officers as a Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All <FONT STYLE="white-space:nowrap">Non-Executive</FONT> Directors as a Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,455,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,458<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">&nbsp;(2)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All <FONT STYLE="white-space:nowrap">Non-Executive</FONT> Officer Employees as a Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Amounts shown is the aggregate grant date fair value of the awards, as computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (formerly known as Statement of
Financial Accounting Standards No. 123(R)), or ASC 718. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Number of shares represents an estimate of the number of shares of restricted stock to be granted, based on the closing price of the Company&#146;s common stock on April&nbsp;16, 2018. The actual number of shares
granted will be based on the price of the Company&#146;s common stock at the time of grant. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">On March&nbsp;15, 2018, the Company, through a wholly owned subsidiary, entered into a definitive merger agreement to acquire Spinal Kinetics Inc., a privately held developer and manufacturer of artificial cervical and
lumbar discs. In connection with the anticipated closing of the transaction, the Company expects to make equity awards to Spinal Kinetics employees at or shortly following the closing. At the present time, the Company expects these grants to be made
as inducement grants in reliance on the Nasdaq exception to shareholder approval for such grants, rather than as grants from the 2012 LTIP. As a result, these grants are not shown in the table. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_106"></A></FONT>PROPOSAL 6: APPROVAL OF AMENDMENT NO.&nbsp;1 TO THE SECOND AMENDED AND RESTATED STOCK PURCHASE PLAN</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s Second Amended and Restated Stock Purchase Plan (the &#147;SPP&#148;) is a shareholder approved equity plan
under which most of our employees and directors are eligible to purchase common stock of the Company. On April&nbsp;23, 2018, the Board adopted Amendment No.&nbsp;1 to the Company&#146;s Second Amended and Restated Stock Purchase Plan, subject to
shareholder approval (the &#147;SPP Amendment&#148;).&nbsp;The SPP Amendment increases the number of shares subject to awards under the plan from 1,850,000 to 2,350,000.&nbsp;The SPP Amendment does not provide for any other changes to the SPP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SPP Amendment will become effective upon approval by the Company&#146;s shareholders.&nbsp;If the SPP Amendment is not approved by the Company&#146;s
shareholders, the SPP will continue in its current form, but the Company may no longer have sufficient shares to continue offering shares under the plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because participation in the SPP is subject to the discretion of each eligible employee or director and the amounts received by participants under the plan
are subject to the fair market value of our common stock on future dates, the benefits or amounts that will be received by any participant or groups of participants if the SPP is approved are not currently determinable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="rom571963_120"></A>Description of the SPP </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a brief summary of the material features of the SPP and its operation.&nbsp;A copy of the SPP Amendment, together with the current text of the
SPP, is attached as Annex D to this proxy statement.&nbsp;The description below is qualified in its entirety by the detailed provisions of the SPP, which are set forth in Annex D to this proxy statement/prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sponsor </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. is the sponsor of
the SPP. (In the event that the domestication to Delaware is consummated, Orthofix Medical Inc. shall become the sponsor of the SPP.) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Purposes and
Eligibility </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of the SPP is to encourage eligible employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors of the
Company to become owners of common stock of the Company, thereby giving them a greater interest in the growth and success of its business.&nbsp;As of March&nbsp;31, 2018, we estimate that approximately 8 directors, 8 executives and 877 employees of
the Company are eligible to purchase shares under the SPP.&nbsp;Currently, there are approximately 380 participants in the SPP. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Number of Shares of
Common Stock Subject to the SPP </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum number of shares of our common stock that may be issued pursuant to the SPP, subject to anti-dilution
provision adjustments, is currently 1,850,000<B></B>&nbsp;shares.&nbsp;If the SPP Amendment is approved by shareholders, the maximum number of shares of our common stock that may be issued pursuant to the SPP, subject to anti-dilution provision
adjustments, will increase to 2,350,000 shares.&nbsp;As of March&nbsp;31, 2018, 1,628,005 shares had been issued pursuant to the SPP and 221,995 shares remained available for issuance.&nbsp;Shares purchasable pursuant to the SPP may be authorized
but previously unissued shares or shares of stock held in treasury or purchased in the open market or in privately negotiated transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participation in the SPP </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All eligible employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors may participate in the SPP on the first day of any plan
year.&nbsp;Eligible employees participate by electing to contribute to the SPP through payroll deductions, which generally may not be more than 25% of an employee&#146;s compensation.&nbsp;Eligible
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors participate by electing to contribute to the SPP through deductions of their director fees and other compensation that are paid in cash.&nbsp;Eligible participants must elect to
participate in the plan prior to the beginning of the plan year.<B></B>&nbsp;Participants may withdraw from the SPP by providing notice to the Company&#146;s Compensation Committee before the last day of the plan year.&nbsp;Upon withdrawal from the
SPP, all payroll deductions under the SPP cease immediately, and a participant will receive a refund of his or her contribution, including all accrued interest.&nbsp;An employee&#146;s participation in the SPP terminates upon his or her termination
of employment, and will generally terminate upon his or her leave of absence from active employment only if such employee does not continue to make contributions to the SPP during such leave of absence.<B></B>&nbsp;A
<FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s participation in the SPP terminates upon his or her ceasing to be a member of the Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participants in <FONT STYLE="white-space:nowrap">Non-US</FONT> Jurisdictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to participants that are subject to the tax laws of a jurisdiction outside of the US, the SPP allows the Compensation Committee to adopt such
modifications and procedures as it deems necessary or desirable to comply with the provisions of the laws of such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions in order to assure the viability of the benefits paid to such
participants.&nbsp;Further, the Compensation Committee may adopt <FONT STYLE="white-space:nowrap">sub-plans</FONT> applicable to separate classes of eligible employees and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors who are
subject to the laws of jurisdictions outside of the U.S. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distribution of Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SPP provides that as soon as practicable following the last day of the plan year (but in any event, no more than two and
<FONT STYLE="white-space:nowrap">one-half</FONT> months thereafter), the Compensation Committee will distribute to each person who was a participant during the plan year a certificate or certificates representing the number of whole shares of
Company common stock determined by dividing (i)&nbsp;the amount of the participant&#146;s contributions for the plan year plus accrued interest, by (ii) 85% of the lower of the fair market value of the Company common stock on the first and last day
of the plan year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the SPP, &#147;fair market value&#148; means, as of any date that requires determination of the fair market value, the closing
price of our common stock as quoted on Nasdaq on such date of determination (with other definitions provided under the plan if our common stock is no longer traded on Nasdaq). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee may, in its discretion, require a participant to pay, prior to the distribution of Company stock, the amount the Compensation
Committee deems necessary to satisfy the Company&#146;s obligation to withhold applicable taxes that the participant incurs as a result of his or her participation in the SPP.&nbsp;The participant may deliver sufficient shares of Company stock, cash
or irrevocably elect for the participating employer to withhold from the shares of stock to be distributed a sufficient number of shares of stock.&nbsp;The SPP permits the Company or its subsidiary to deduct from all cash payments made to a
participant any applicable required taxes to be withheld with respect to such payments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Administration of the SPP </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee oversees and administers the SPP.&nbsp;The Committee has power to determine the amount of benefits payable to participants and
construe and interpret the plan whenever necessary to carry out the SPP&#146;s intention and purpose.&nbsp;The Committee is authorized to administer the plan as necessary to take account of tax, securities law and other regulatory requirements of
foreign jurisdictions. The Committee is also generally able to designate one or more of its members or the Chief Executive Officer or Chief Financial Officer of the Company to carry out the Committee&#146;s responsibilities under such conditions and
limitations as the Committee may determine. The SPP provides indemnity (except in the case of fraud, willful misconduct or failure to act in good faith) to members of the Board, the Committee, the Chief Executive Officer, the Chief Financial Officer
and other officers or employees to whom duties or responsibilities are delegated in connection with the operation, administration or interpretation of the SPP.&nbsp;Any authority or responsibility that may be exercised by the Committee is also
exercisable by the Board.&nbsp;The Board or the Committee is able to extend or terminate the benefits of the SPP to any subsidiary of the Company at any time without the approval of the Company&#146;s shareholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment and Termination of SPP </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may amend or terminate the SPP at any time.&nbsp;Upon the termination of the SPP, each participant will receive a refund of his or her contributions
for the plan year plus accrued interest.&nbsp;However, the Board must obtain shareholder approval to increase the maximum number of shares issuable under the plan (as it is proposing to do now).&nbsp;Also, the Board may not amend or terminate the
SPP if it would decrease the participant&#146;s accrued benefits as of the effective date of such action, unless the Board determines that amendments to the plan are necessary or appropriate to exempt issuances from or conform the SPP to the
requirements of Section&nbsp;409A of the Code, in which case the Board may adopt such amendments to the plan, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect) as it deems appropriate
under the circumstances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain U.S. Federal Income Tax Consequences </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a general summary of certain U.S. federal income tax consequences to U.S. employees with respect to Company common stock issued under the
SPP.&nbsp;This discussion applies to employees and directors who are citizens or residents of the U.S. and U.S. taxpayers. The information set forth below is a summary only and does not purport to be complete.&nbsp;The information is based upon
current federal income tax rules and therefore is subject to change when those rules change.&nbsp;Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#146;s
tax adviser regarding the federal, state, local, foreign and other tax consequences of the SPP.&nbsp;The SPP is not qualified under the provisions of Section&nbsp;401(a) of the Code, and is not subject to any of the provisions of the Employee
Retirement Income Security Act of 1974. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All amounts contributed to the SPP are deducted from each participant&#146;s taxable compensation on an <FONT
STYLE="white-space:nowrap">after-tax</FONT> basis.&nbsp;Participants will recognize taxable income on the interest they earn on their contributions to the SPP in the taxable year in which the interest accrues.&nbsp;When shares of Company common
stock are distributed to participants at the end of the plan year, participants will also recognize taxable income on the difference between the fair market value of the Company common stock on that date and the purchase price participants pay for
the shares.&nbsp;If participants sell shares of Company common stock that they received under the SPP, any gain or loss will be taxed as a capital gain or loss.&nbsp;Subject to the applicable provisions of the Code and applicable regulations, the
participant&#146;s employer will generally be entitled to a federal income tax deduction in an amount equal to the taxable income that each participant recognizes.&nbsp;Each participant&#146;s employer will be entitled to this deduction for the
taxable year that includes the last day of the taxable year for which a participant recognizes taxable income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For U.S. income tax purposes, the gross
amount of dividends paid to participants who hold shares of Company common stock will be treated as gross dividend income to such holders in the year in which such dividend is received to the extent paid or deemed paid out of the Company&#146;s
current or accumulated earnings and profits as calculated for U.S. federal income tax purposes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;409A </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;409A of the Code applies to compensation plans providing deferred compensation to employees and directors, and potentially could apply to the
SPP.&nbsp;Failure to comply with Section&nbsp;409A, with respect to compensation deferred under the SPP, in the absence of an applicable exemption, could result in current income taxation to the recipient for all amounts deferred as well as the
imposition of an additional 20% tax and interest on any underpayment of tax.&nbsp;In general, Section&nbsp;409A should not apply to the SPP (provided there is no deferral of income beyond the date that is two and one half months after the end of the
plan year). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" BGCOLOR="#004a97"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>The Board unanimously recommends that you vote &#147;FOR&#148; the
proposal to approve Amendment</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>No.&nbsp;1 to the Second Amended and Restated Stock Purchase
Plan.</B></FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_107"></A></FONT>PROPOSAL 7: RATIFICATION OF THE SELECTION OF EY AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2018</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are asking you to ratify the Audit and Finance Committee&#146;s selection of Ernst&nbsp;&amp; Young LLP (&#147;EY&#148;) as
our independent registered public accounting firm for 2018. EY has served as the independent registered public accounting firm of Orthofix since 2002.&nbsp;They have unrestricted access to the Audit and Finance Committee to discuss audit findings
and other financial matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not anticipate that representatives of EY will be at the Annual General Meeting.&nbsp;The work performed by EY during
2017 and 2016 and related fee information is described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although shareholder ratification is not required, the appointment of EY is being submitted
for ratification as a matter of good corporate practice with a view towards soliciting shareholders&#146; opinions that the Audit and Finance Committee will take into consideration in future deliberations. If EY&#146;s selection is not ratified at
the Annual General Meeting, the Audit and Finance Committee will reconsider whether to retain EY. Even if the selection is ratified, the Audit and Finance Committee in its discretion may direct the appointment of a different independent registered
public accounting firm at any time during the year if it determines such a change would be in the best interests of the Company and its shareholders. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" BGCOLOR="#004a97"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>The Board unanimously recommends that you vote &#147;FOR&#148;
ratification of</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#FFFFFF"><B>the selection of EY as independent registered public accounting firm for
2018.</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_108"></A>Principal Accountant Fees and Services </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth fees for professional services rendered by EY for the audits of the Company&#146;s financial statements for the fiscal years
ended December&nbsp;31, 2017 and December&nbsp;31, 2016, respectively, and the fees billed for other services rendered by EY during each such fiscal year. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,241,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,357,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">348,846</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,114,129</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">868,271</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,706,426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,291,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_109"></A>Audit Fees </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Audit fees consisted of the aggregate fees, including expenses, billed in connection with the audits of our annual financial statements and internal controls,
quarterly reviews of the financial information included in our quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and statutory audits of our subsidiaries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_110"></A>Audit-Related Fees </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Audit-related fees in 2017 and 2016 consisted of the aggregate fees, including expenses, rendered for professional services, such as accounting consultations
and assurance services in connection with transactions, not reported under &#147;Audit Fees.&#148;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_111"></A>Tax Fees </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tax fees in 2017 and 2016 consisted of the aggregate fees, including expenses, billed for professional services rendered for income tax compliance, tax advice
and tax planning.&nbsp;These fees included fees billed for federal and state income tax review services, assistance with tax audits and other tax consulting services. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_112"></A>All Other Fees </I></B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All other fees consisted of aggregate fees billed for products and services other than the services reported above.&nbsp;For fiscal years 2017 and 2016, this
category included fees related to professional reference materials and publications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#004a97"><B><I><A NAME="tx571963_113"></A><FONT
STYLE="white-space:nowrap">Pre-Approval</FONT> Policies and Procedures </I></B></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit and Finance Committee approves all audits, audit-related
services, tax services and other services provided by EY.&nbsp;Any services provided by EY that are not specifically included within the scope of the audit must be either <FONT STYLE="white-space:nowrap">(i)&nbsp;pre-approved</FONT> by the entire
Audit and Finance Committee in advance of any engagement, or <FONT STYLE="white-space:nowrap">(ii)&nbsp;pre-approved</FONT> by the Chair of the Audit and Finance Committee pursuant to authority delegated to him by the other independent members of
the Audit and Finance Committee, in which case the Audit and Finance Committee is then informed of his decision.&nbsp;Under the Sarbanes-Oxley Act of 2002, these <FONT STYLE="white-space:nowrap">pre-approval</FONT> requirements are waived for <FONT
STYLE="white-space:nowrap">non-audit</FONT> services where (i)&nbsp;the aggregate of all such services is no more than 5% of the total amount paid to the external auditors during the fiscal year in which such services were provided, (ii)&nbsp;such
services were not recognized at the time of the engagement to be <FONT STYLE="white-space:nowrap">non-audit</FONT> services, and (iii)&nbsp;such services are approved by the Audit and Finance Committee prior to the completion of the audit
engagement.&nbsp;In 2017 and 2016, all fees paid to EY for <FONT STYLE="white-space:nowrap">non-audit</FONT> services were <FONT STYLE="white-space:nowrap">pre-approved.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_114"></A></FONT>REPORT OF THE AUDIT AND FINANCE COMMITTEE</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit and Finance Committee oversees the Company&#146;s financial reporting process on behalf of the Board. The committee
is responsible for the selection, compensation, and oversight of the Company&#146;s independent registered public accounting firm. The committee reviews matters relating to the Company&#146;s internal controls, as well as other matters warranting
committee attention.&nbsp;In addition, the committee assists the Board in overseeing the Company&#146;s Corporate Compliance and Ethics Program. The committee operates under a written charter adopted by the Board of Directors, a copy of which is
available for review on our website at <U>www.orthofix.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management is responsible for Orthofix&#146;s internal controls and financial reporting
process.&nbsp;The independent registered public accounting firm is responsible for performing an independent audit of Orthofix&#146;s consolidated financial statements in accordance with auditing standards of the Public Company Accounting Oversight
Board and to issue a report thereon.&nbsp;Additionally, the independent registered public accounting firm is also responsible for auditing the effectiveness of Orthofix&#146;s internal control over financial reporting.&nbsp;The Audit and Finance
Committee&#146;s responsibility is to monitor and oversee these processes.&nbsp;The committee relies without independent verification on the information provided to it and on the representations made by management and the independent registered
public accounting firm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit and Finance Committee held 10 meetings during the 2017 fiscal year.&nbsp;The meetings were designed, among other
things, to facilitate and encourage communication among the committee, management and Orthofix&#146;s independent registered public accounting firm, Ernst&nbsp;&amp; Young LLP.&nbsp;The committee reviewed management&#146;s assessment of the
effectiveness of the design and operation of Orthofix&#146;s disclosure controls over financial reporting.&nbsp;We discussed with Ernst&nbsp;&amp; Young LLP the overall scope and plans for their audit.&nbsp;We met with Ernst&nbsp;&amp; Young LLP,
with and without management present, to discuss the results of their examinations and their evaluations of Orthofix&#146;s internal controls. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit
and Finance Committee has reviewed and discussed the audited consolidated financial statements for the fiscal year ended December&nbsp;31, 2017 with management and Ernst&nbsp;&amp; Young LLP.&nbsp;We also discussed with management and
Ernst&nbsp;&amp; Young LLP management&#146;s report and the independent registered public accounting firm&#146;s report and attestation on Orthofix&#146;s internal control over financial reporting in accordance with Section&nbsp;404 of the
Sarbanes-Oxley Act. We also discussed with Ernst&nbsp;&amp; Young LLP the matters required by the statement on Auditing Standards No.&nbsp;61, as amended (AICPA, Professional Standards, Vol. 1, AU section 380), as adopted by the Public Company
Accounting Oversight Board in Rule 3200T. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Audit and Finance Committee has received the written disclosures and the letter from Ernst&nbsp;&amp; Young
LLP required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent accountant&#146;s communications with the Audit and Finance Committee concerning independence, and has discussed with the independent
accountant their independence from Orthofix.&nbsp;When considering Ernst&nbsp;&amp; Young LLP&#146;s independence, we considered whether their provision of services to Orthofix beyond those rendered in connection with their audit of Orthofix&#146;s
consolidated financial statements was compatible with maintaining their independence.&nbsp;We also reviewed, among other things, the audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services performed by, and the amount of fees paid for
such services to, Ernst&nbsp;&amp; Young LLP.&nbsp;The committee has determined that Ernst&nbsp;&amp; Young LLP is independent of Orthofix and its management.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon the review and discussions referred to above, we recommended to the Board of Directors, and the Board of Directors has approved, that
Orthofix&#146;s audited consolidated financial statements be included in Orthofix&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2017. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">The Audit and Finance Committee</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">James Hinrichs, <I>Committee Chair</I></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Luke Faulstick</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Ronald Matricaria</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_115"></A>EXPERTS</FONT></B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Orthofix International N.V. appearing in Orthofix International N.V.&#146;s Annual
Report (Form <FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended December&nbsp;31, 2017, and the effectiveness of Orthofix International N.V.&#146;s internal control over financial reporting as of December&nbsp;31, 2017, have been
audited by Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by
reference in reliance upon such reports given on the authority of such firm as experts in accounting and auditing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_116"></A></FONT>LEGAL MATTERS</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hogan Lovells US LLP has passed upon certain U.S. federal income tax consequences of the domestication and certain other legal
matters related to this proxy statement/prospectus. Potter Anderson&nbsp;&amp; Corroon LLP has passed upon the validity of the securities of Orthofix offered by the proxy statement/prospectus and certain other legal matters related to this proxy
statement/prospectus. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_117"></A>INFORMATION ABOUT SHAREHOLDER PROPOSALS </B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you wish to submit a proposal to be included in our 2019 proxy statement pursuant to Rule
<FONT STYLE="white-space:nowrap">14a-8</FONT> of the Securities Exchange Act of 1934, as amended, we must receive your written proposal on or before December&nbsp;29, 2018.&nbsp;Please address your proposals to:&nbsp;Chairman of the Board, Orthofix
International N.V., 7 Abraham de Veerstraat, Cura&ccedil;ao. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Rule <FONT STYLE="white-space:nowrap">14a-4(c)(1)</FONT> under the Securities
Exchange Act of 1934, as amended, our proxy holders may use discretionary authority to vote with respect to shareholder proposals presented in person at the 2019 Annual General Meeting of Shareholders if the shareholder making the proposal has not
notified Orthofix by March&nbsp;21, 2019 of its intent to present a proposal at the 2018 Annual General Meeting of Shareholders. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><A NAME="tx571963_118"></A>MULTIPLE SHAREHOLDERS SHARING ONE ADDRESS</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC has adopted rules that permit companies and intermediaries, such as brokers, to satisfy the delivery requirements for
proxy statements and annual reports with respect to two or more shareholders sharing the same address by delivering a single annual report or proxy statement, as applicable, addressed to those shareholders. This process, which is commonly referred
to as &#147;householding,&#148; potentially provides extra convenience for shareholders and cost savings for companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix and some brokers may be
householding proxy materials by delivering proxy materials to multiple shareholders who request a copy and share an address, unless contrary instructions have been received from the affected shareholders. Once you have received notice from your
broker or Orthofix that they or we will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your consent. If at any time you no longer wish to participate in householding and
would prefer to receive a separate proxy statement and annual report, please notify your broker if your shares are held in a brokerage account or, if you are a shareholder of record of Orthofix, notify Orthofix by sending a written or oral request
to Investor Relations, Attention: Mr.&nbsp;Mark Quick, 3451 Plano Parkway, Lewisville, Texas 75056, Tel. (214) <FONT STYLE="white-space:nowrap">937-2924.</FONT> Shareholders of Orthofix who share a single address, but receive multiple copies of
Orthofix&#146;s proxy statement, may request that in the future they receive a single copy by notifying Orthofix at the telephone and address set forth in the preceding sentence. In addition, Orthofix will promptly deliver, upon written or oral
request made to the address or telephone number above, a separate copy of the proxy statement to a shareholder at a shared address to which a single copy of the documents was delivered pursuant to a prior request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="99%"></TD></TR>


<TR BGCOLOR="#004a97" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff"><A NAME="tx571963_119"></A></FONT>WHERE YOU CAN FIND MORE INFORMATION AND INCORPORATION BY REFERENCE</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix files annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and
copy any reports, statements or other information filed at the SEC&#146;s public reference room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-800-SEC-0330</FONT></FONT></FONT> for further information on the public reference room. Orthofix&#146;s SEC filings are also available to the public from commercial document retrieval services and at the web site
maintained by the SEC at <U>www.sec.gov</U>. You also may obtain free copies of the documents filed with the SEC by Orthofix by going to Orthofix&#146;s website at <U>www.orthofix.com</U>. Orthofix&#146;s website address is provided as an inactive
textual reference only. The information provided on Orthofix&#146;s website is not part of this proxy statement/prospectus, and is not incorporated by reference into this proxy statement/prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix has filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> of which this proxy statement/prospectus forms a
part. The registration statement registers the shares of Orthofix Delaware common stock to be issued to its shareholders in the domestication. The registration statement, including the exhibits and schedules thereto, contains additional information
about shares of Orthofix Delaware common stock. The rules and regulations of the SEC allow Orthofix to omit certain information included in the registration statement from this proxy statement/prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC allows Orthofix to &#147;incorporate by reference&#148; into this proxy statement/prospectus the information it files with the SEC, which means
Orthofix can disclose important information to you by referring you to those documents. Information incorporated by reference is deemed to be part of this proxy statement/prospectus. Later information filed with the SEC will update and supersede
this information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement/prospectus incorporates by reference the Orthofix documents listed below (other than any portions of the documents
not deemed to be filed), all of which have been previously filed by Orthofix with the SEC: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2017; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The Company&#146;s Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on March&nbsp;13 and March&nbsp;15, 2018; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The description of the Company&#146;s common shares contained in the Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">F-1</FONT> filed with the SEC on March&nbsp;6, 1992. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix also incorporates by reference into this proxy statement/prospectus additional documents that it may file with the SEC under Sections 13(a), 13(c),
14, or 15(d) of the Exchange Act after the date of this proxy statement/prospectus and prior to the date of the Orthofix Annual General Meeting; provided, however that it is not incorporating any information furnished under either Item 2.02 or Item
7.01 of any Current Report on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a copy of these filings, at no cost, by contacting
Investor Relations, Attention: Mr.&nbsp;Mark Quick, 3451 Plano Parkway, Lewisville, Texas 75056, Tel. (214) <FONT STYLE="white-space:nowrap">937-2924,</FONT> or by visiting Orthofix&#146;s website, <U>www.orthofix.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, a copy of the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2017
accompanies this proxy statement/prospectus. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="annxa"></A>Annex <A NAME="rom571963_125"></A>A </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ORTHOFIX MEDICAL INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE I: NAME</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of the corporation is Orthofix Medical Inc. (the &#147;<B>Corporation</B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE II: AGENT FOR SERVICE OF PROCESS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The address of the Corporation&#146;s registered office in the State of Delaware is 251 Little Falls Drive, Wilmington, New Castle County, DE
19808. The registered agent at such address is Corporation Service Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE III: PURPOSE </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the Delaware General
Corporation Law (the &#147;<B>DGCL</B>&#148;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE IV: AUTHORIZED STOCK </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1. <U>Total Authorized Stock</U></B>. The total number of shares of stock that the Corporation has authority to issue is 50,000,000 shares
of common stock, $0.10 par value per share (the &#147;<B>Common Stock</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. <U>Common Stock</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>2.1 Relative Rights</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Common Stock shall be subject to all of the rights, privileges, preferences, and priorities set forth in this Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>2.2 Dividends</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends
may be paid on the Common Stock out of any assets legally available for the payment of dividends thereon, but only when and as declared by the Board of Directors of the Corporation (the &#147;<B>Board</B>&#148;). Any dividends on the Common Stock
will not be cumulative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>2.3 Dissolution, Liquidation, Winding Up</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any dissolution, liquidation, or winding up of the Corporation, whether voluntary or involuntary, the holders of the Common
Stock shall be entitled to participate in the distribution of any assets of the Corporation remaining after the Corporation shall have paid, or provided for payment of, all debts and liabilities of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>2.4 Voting Rights</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each
holder of shares of the Common Stock shall be entitled to notice of and to attend all special and annual meetings of stockholders. Except as may otherwise be required by law, each holder of Common Stock shall be
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
entitled to one vote per share of Common Stock held of record by such holder on all matters on which stockholders are entitled to vote generally. Each holder of shares of the Common Stock may
exercise its vote either in person or by proxy, in accordance with the DGCL, this Certificate of Incorporation and the Bylaws of the Corporation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE V: AMENDMENT OF BYLAWS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance and not in limitation of the powers conferred by the DGCL, the Board is expressly authorized and empowered to adopt, alter,
amend, repeal and rescind the Bylaws of the Corporation and any provision or provisions thereof. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE VI: BOARD OF DIRECTORS
</U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1. <U>Director Powers</U></B>. The business and affairs of the Corporation shall be managed by or under the direction of the
Board. In addition to the powers and authority expressly conferred upon them by statute or by this Certificate of Incorporation or the Bylaws of the Corporation, the directors are hereby empowered to exercise all such powers and do all such acts and
things as may be exercised or done by the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. <U>Number of Directors</U></B>. The powers of the incorporator are to
terminate upon the filing of this Certificate of Incorporation with the Secretary of State of the State of Delaware. Effective at the time of such filing, the number of directors comprising the entire Board shall be nine (9). Thereafter, the number
of directors comprising the entire Board shall be fixed by or in the manner provided in the Bylaws of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The names and
addresses of the persons who shall serve as directors of the Corporation upon the filing of this Certificate of Incorporation are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bradley R. Mason</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> c/o&nbsp;Orthofix&nbsp;Medical&nbsp;Inc.,&nbsp;3451&nbsp;Plano&nbsp;Parkway,&nbsp;Lewisville,&nbsp;Texas&nbsp;75056<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald A. Matricaria</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> c/o Orthofix Medical Inc., 3451 Plano Parkway, Lewisville, Texas 75056<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Luke Faulstick</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> c/o Orthofix Medical Inc., 3451 Plano Parkway, Lewisville, Texas 75056<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Hinrichs</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> c/o Orthofix Medical Inc., 3451 Plano Parkway, Lewisville, Texas 75056<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis V. Lukianov</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> c/o Orthofix Medical Inc., 3451 Plano Parkway, Lewisville, Texas 75056<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lilly Marks</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> c/o&nbsp;Orthofix&nbsp;Medical&nbsp;Inc.,&nbsp;3451&nbsp;Plano&nbsp;Parkway,&nbsp;Lewisville,&nbsp;Texas&nbsp;75056<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Paolucci</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> c/o Orthofix Medical Inc., 3451 Plano Parkway, Lewisville, Texas 75056<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Sainz</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ALIGN="right"> c/o Orthofix Medical Inc., 3451 Plano Parkway, Lewisville, Texas 75056<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> &nbsp;<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Sicard</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">c/o Orthofix Medical Inc., 3451 Plano Parkway, Lewisville, Texas 75056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing directors shall hold office until the next annual meeting of stockholders and until their
successors shall have been duly elected and qualified, or until their earlier resignations or removal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3. <U>No Cumulative
Voting</U></B>. No person entitled to vote at an election for directors may cumulate votes to which such person is entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.
<U>Term and Removal</U></B>. Each director shall hold office until such director&#146;s successor is elected and qualified, or until such director&#146;s earlier death, resignation or removal. Any director may resign at any time upon notice to the
Corporation given in writing or by any electronic transmission permitted in the Corporation&#146;s Bylaws. Any director or the entire Board may be removed, with or without cause, by the holders of capital stock having a majority in voting power of
the shares entitled to vote in the election of directors. No decrease in the authorized number of directors constituting the Board shall shorten the term of any incumbent director. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5. <U>Board Vacancies and Newly Created Directorships</U></B>. Any vacancy occurring in
the Board for any reason, and any newly created directorship resulting from any increase in the authorized number of directors, shall, unless (a)&nbsp;the Board determines by resolution that any such vacancies or newly created directorships shall be
filled by the stockholders or (b)&nbsp;as otherwise provided by law, be filled only by the affirmative vote of a majority of the directors then in office, although less than a quorum, or by a sole remaining director, and not by the stockholders.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6. <U>Vote by Ballot</U></B>. Election of directors need not be by written ballot unless the Bylaws of the Corporation shall so
provide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7. <U>Officers</U></B>. Except as otherwise expressly provided in the Bylaws or as delegated by resolution of the Board, the
Board shall have the exclusive power and authority to appoint and remove officers of the Corporation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE VII: DIRECTOR
LIABILITY </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1. <U>Limitation of Liability</U></B>. No director of the Corporation shall be liable to the Corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL, as amended from time to time. Without limiting the effect of the
preceding sentence, if the DGCL is hereafter amended to authorize the further elimination or limitation of the liability of a director, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent
permitted by the DGCL, as so amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. <U>Change in Rights</U></B>. Neither any amendment nor repeal of this Article VII, nor the
adoption of any provision of this Certificate of Incorporation inconsistent with this Article VII, shall eliminate, reduce or otherwise adversely affect any limitation on the personal liability of a director of the Corporation existing at the time
of such amendment, repeal or adoption of such an inconsistent provision. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE VIII: MATTERS RELATING TO STOCKHOLDERS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1. <U>No Action by Written Consent of Stockholders</U></B>. No action shall be taken by the stockholders of the Corporation except at a
duly called annual or special meeting of stockholders and no action shall be taken by the stockholders by written consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.
<U>Annual Meeting of Stockholders</U></B>. The annual meeting of stockholders shall be held on such date, at such time, and at such place, if any, within or without the State of Delaware, as shall be fixed by the Board and stated in the
Corporation&#146;s notice of the meeting. In lieu of holding an annual meeting of stockholders at a designated place, the Board may, in its sole discretion, determine that any annual meeting of stockholders may be held solely by means of remote
communication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3. <U>Special Meeting of Stockholders</U></B>. Special meetings of the stockholders of the Corporation may be called
only (a)&nbsp;by or at the direction of the Board, pursuant to a resolution approved by a majority of the entire Board or (b)&nbsp;by such other person or persons as may be authorized by the Bylaws of the Corporation. The business permitted to be
conducted at a special meeting of stockholders shall be limited to matters properly brought before the meeting by or at the direction of the Board. Special meetings shall be held on such date, at such time, and at such place, if any, within or
without the State of Delaware as shall be fixed by the Board and stated in the Corporation&#146;s notice of the meeting. In lieu of holding a special meeting of stockholders at a designated place, the Board may, in its sole discretion, determine
that any special meeting of stockholders may be held solely by means of remote communication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4. <U>Advance Notice of Stockholder
Nominations and Business Transacted at Special Meetings</U></B>. Advance notice of stockholder nominations for the election of directors of the Corporation and of business to be brought </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by stockholders before any meeting of stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation. Business transacted at special meetings of
stockholders shall be confined to the purpose or purposes stated in the notice of meeting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE IX: CREDITOR AND STOCKHOLDER
COMPROMISES </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever a compromise or arrangement is proposed between the Corporation and its creditors or any class of them
and/or between the Corporation and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may, on the application in a summary way of the Corporation or of any creditor or stockholder thereof or on
the application of any receiver or receivers appointed for the Corporation under the provisions of &#167; 291 of the DGCL or on the application of trustees in dissolution or of any receiver or receivers appointed for the Corporation under &#167; 279
of the DGCL order a meeting of the creditors or class of creditors, and/or of the stockholders or class of stockholders of the Corporation, as the case may be, to be summoned in such manner as the said court directs. If a majority in number
representing three-fourths in value of the creditors or class of creditors, and/or of the stockholders or class of stockholders of the Corporation, as the case may be, agree to any compromise or arrangement and to any reorganization of the
Corporation as a consequence of such compromise or arrangement, the said compromise or arrangement and the said reorganization shall, if sanctioned by the court to which the said application has been made, be binding on all the creditors or class of
creditors, and/or on all the stockholders or class of stockholders, of the Corporation, as the case may be, and also on the Corporation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE X: AMENDMENT OF CERTIFICATE OF INCORPORATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation reserves the right to amend or repeal any provision contained in this Certificate of Incorporation in the manner prescribed by
the laws of the State of Delaware and all rights conferred upon stockholders are granted subject to this reservation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE XI:
EFFECTIVE DATE AND TIME </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The effective date and time of this Certificate of Incorporation shall be at
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[a.m./p.m.] on the [&#9679;] day of [Month], 2018. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE XII: INCORPORATOR </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;is the sole incorporator and [his/her]
mailing address is Potter Anderson&nbsp;&amp; Corroon LLP, 1313 North Market Street, P.O. Box 951, Wilmington, DE 19899-0951.] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">[Incorporator]</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DATED: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="annxb"></A>Annex <A NAME="rom571963_126"></A>B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ORTHOFIX MEDICAL INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">----</FONT></FONT></FONT></FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>B Y L A W S </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">----</FONT></FONT></FONT></FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFICES
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1. <U>Offices</U>.</B> The registered office of the Corporation shall be in the State of Delaware. The Corporation
may have offices at such other places both within and without the State of Delaware as the Board of Directors may from time to time determine or as may be necessary or convenient to the business of the Corporation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEETINGS OF
STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1. <U>Annual Meeting</U>.</B> The annual meeting of the stockholders of the Corporation shall be held on
such date, at such time, and at such place (if any) within or without the State of Delaware as shall be designated from time to time by the Board of Directors and stated in the Corporation&#146;s notice of the meeting. In lieu of holding an annual
meeting of stockholders at a designated place, the Board of Directors may, in its sole discretion, determine that any annual meeting of stockholders may be held solely by means of remote communication. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2. <U>Special Meetings</U>.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Special meetings of the stockholders of the Corporation may be called only (i)&nbsp;by or at the direction of the Board of Directors,
pursuant to a resolution approved by a majority of the entire Board of Directors, or (ii)&nbsp;by the Secretary of the Corporation, following his or her receipt at the principal executive offices of the Corporation of one or more written demands to
call a special meeting of the stockholders submitted by or on behalf of the record holder or holders of at least 25% percent of the voting power of the issued and outstanding shares of the Corporation (the &#147;<I>Requisite Percentage</I>&#148;);
<I>provided</I>, <I>however</I>, that such stockholder demand or demands have been submitted in accordance with and in the form required by this Section&nbsp;2. Special meetings of the stockholders of the Corporation (including those called by the
Secretary following receipt of a written demand or demands from stockholders holding the Requisite Percentage in accordance with clause (ii)&nbsp;of the first sentence of this Section&nbsp;2(a)) shall be held on such date, at such time, and at such
place (if any) within or without the State of Delaware as shall be designated by the Board of Directors and stated in the Corporation&#146;s notice of the meeting. In the case of a special meeting called by the Secretary following receipt of a
written demand or demands from stockholders holding the Requisite Percentage in accordance with clause (ii)&nbsp;of the first sentence of this Section&nbsp;2(a), the date of such special meeting, as fixed by the Board of Directors in accordance with
this Section&nbsp;2(a), shall not be fewer than thirty (30)&nbsp;nor more than ninety (90)&nbsp;days after the date a demand or demands by stockholders holding the Requisite Percentage have been received by the Secretary of the Corporation at the
principal executive offices of the Corporation in accordance with this Section&nbsp;2. In lieu of holding a special meeting of stockholders at a designated place, the Board of Directors may, in its sole discretion, determine that any special meeting
of stockholders may be held solely by means of remote communication. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) To be in proper form, a demand submitted by any stockholder or stockholders pursuant to
clause (ii)&nbsp;of the first sentence of Section&nbsp;2(a) (a &#147;<I>Special Meeting Demand</I>&#148;) shall be in writing and shall set forth: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) as to each Demanding Person (as defined below), (A)&nbsp;the name and address of such Demanding Person (including, if
applicable, the name and address that appear on the Corporation&#146;s books and records) and (B)&nbsp;the class or series and number of shares of capital stock of the Corporation that are, directly or indirectly, owned of record or beneficially
owned (within the meaning of Rule 13d-3 under the Exchange Act) by such Demanding Person (<I>provided</I> that for purposes of this Section&nbsp;2 such Demanding Person shall in all events be deemed to beneficially own any shares of any class or
series and number of shares of capital stock of the Corporation as to which such Demanding Person has a right to acquire beneficial ownership at any time in the future); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) As to each Demanding Person, any Disclosable Interests (as defined in Paragraph (A)(3)(b) of Section&nbsp;13 of this
Article II, except that for purposes of this Section&nbsp;2, the term &#147;Demanding Person&#148; shall be substituted for the term &#147;Proposing Person&#148; in all places it appears in Paragraph (A)(3)(b) of Section&nbsp;13 of this Article II
and the disclosure required by clause (vi)&nbsp;of Paragraph (A)(3)(b) of Section&nbsp;13 of this Article II shall be made with respect to the business proposed to be conducted at the special meeting); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The purpose or purposes for which the meeting is to be called; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) As to each purpose for which the meeting is to be called, (A)&nbsp;a reasonably brief description of such purpose,
(B)&nbsp;a reasonably brief description of the specific proposal to be made or business to be conducted at the special meeting in connection with such purpose, (C)&nbsp;the text of any proposal or business to be considered at the special meeting in
connection with such purpose (including the text of any resolutions proposed for consideration and if such business includes a proposal to amend the Bylaws of the Corporation, the language of the proposed amendment), (D)&nbsp;the reasons for calling
a special meeting of stockholders for such purpose, and (E)&nbsp;a reasonably brief description of any material interest of each Demanding Person in any proposal or business to be considered at the special meeting in connection with such purpose;
and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) If a purpose for which the special meeting is to be called is the election of one or more directors to the Board
of Directors, the name of each person the Demanding Persons propose to nominate at the special meeting for election to the Board of Directors (each, a &#147;<I>nominee</I>&#148;), and as to each such nominee, (A)&nbsp;the name, age, business and
residence address, and principal occupation or employment of the nominee, (B)&nbsp;all other information relating to the nominee that would be required to be disclosed about such nominee if proxies were being solicited for the election of the
nominee as a director in an election contest (whether or not such proxies are or will be solicited), or that is otherwise required, in each case pursuant to and in accordance with Regulation 14A under the Exchange Act, (C)&nbsp;such nominee&#146;s
written consent to being named in the proxy statement, if any, as a nominee and to serving as a director if elected, and (D)&nbsp;all information with respect to such nominee that would be required to be set forth in a stockholder&#146;s Special
Meeting Demand pursuant to this subsection (b)&nbsp;if such nominee were a Demanding Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Corporation may require any proposed nominee to furnish
such other information as it may reasonably require to determine (i)&nbsp;the eligibility of such proposed nominee to serve as a director of the Corporation, and (ii)&nbsp;whether such nominee qualifies as an &#147;independent director&#148; or
&#147;audit committee financial expert&#148; under applicable law, securities exchange rule or regulation, or any publicly disclosed corporate governance guideline or committee charter of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In the case of a special meeting called by the Secretary following receipt of Special Meeting Demand(s) from stockholders holding the
Requisite Percentage in accordance with clause (ii)&nbsp;of the first sentence of Section&nbsp;2(a), each Demanding Person shall further update and supplement his or her Special Meeting Demand so that the information provided or required to be
provided in such Special Meeting Demand pursuant to subsection (b)&nbsp;of this Section&nbsp;2 shall be true and correct both as of the record date for the determination of stockholders entitled to notice of the special meeting and as of the date
that is ten (10)&nbsp;business days before the special meeting or any adjournment or postponement thereof, and such updated and supplemental information shall be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation (i)&nbsp;in the case of information that is required to be updated and supplemented to
be true and correct as of the record date for the determination of stockholders entitled to notice of the special meeting, not later than the later of five (5)&nbsp;business days after such record date or five (5)&nbsp;business days after the public
announcement of such record date, and (ii)&nbsp;in the case of information that is required to be updated and supplemented to be true and correct as of ten (10)&nbsp;business days before the special meeting or any adjournment or postponement
thereof, not later than eight (8)&nbsp;business days before the special meeting or any adjournment or postponement thereof (or if not practicable to provide such updated and supplemental information not later than eight (8)&nbsp;business days before
any adjournment or postponement, on the first practicable date before any such adjournment or postponement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Secretary shall not
accept, and shall consider ineffective, a Special Meeting Demand from a stockholder (i)&nbsp;that does not comply with this Section&nbsp;2, (ii)&nbsp;that relates to an item of business to be transacted at the proposed special meeting that is not a
proper subject for stockholder action under applicable law, or (iii)&nbsp;if the business proposed to be conducted at the special meeting as set forth in such Special Meeting Notice is identical to or substantially similar to an item of business
that will be submitted for stockholder approval or consideration at any meeting of stockholders to be held on or before the ninetieth (90th)&nbsp;day after the Secretary receives such Special Meeting Demand. In addition to the requirements of this
Section&nbsp;2, each Demanding Person shall comply with all requirements of applicable law, including all requirements of the Exchange Act, with respect to any Special Meeting Demand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Nothing in this Section&nbsp;2 shall be deemed or construed to give any stockholder a right to fix the date, time, or place of, or to fix
any record date for, any special meeting of the stockholders of the Corporation. Except as expressly provided in, and in accordance with, this Section&nbsp;2, stockholders shall not be permitted (i)&nbsp;to call or cause any officer of the
Corporation to call a special meeting of stockholders or (ii)&nbsp;to propose business to be brought before a special meeting of the stockholders, other than the nomination of persons for election to the Board of Directors at a special meeting of
stockholders at which directors are to be elected pursuant to the Corporation&#146;s notice of meeting, which nominations may be made only in accordance with, and subject to, this Section&nbsp;2 or Section&nbsp;13(B) of this Article II. Anything in
Section&nbsp;13(B) of this Article II to the contrary notwithstanding, in the case of a special meeting called by the Secretary following receipt of Special Meeting Demand(s) from stockholders holding the Requisite Percentage in accordance with
clause (ii)&nbsp;of the first sentence of Section&nbsp;2(a), if a purpose of such special meeting is to elect directors to the Board of Directors of the Corporation and a Demanding Person has included in his or her Special Meeting Demand the names
of each person the Demanding Person proposes to nominate at the special meeting for election to the Board of Directors, together with all other information required by subsection (b)&nbsp;of this Section&nbsp;2, and so long as the Demanding Person
has otherwise complied with this Section&nbsp;2, then the Demanding Person&#146;s Special Meeting Demand shall be deemed to be, and shall substitute for, the notice contemplated by Paragraph (B)&nbsp;of Section&nbsp;13 of this Article II and such
Demanding Person shall be deemed to have given timely notice of such nominations in the proper form for purposes of Paragraph (B)&nbsp;of Section&nbsp;13 of this Article II and otherwise to have complied with the notice procedures set forth in
Paragraph (B)(2) of Section&nbsp;13 of this Article II, so long as such Demanding Person provides any updates or supplements to such Special Meeting Demand at such times and in the forms required by subsection (c)&nbsp;of this Section&nbsp;2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Anything in this Section&nbsp;2 to the contrary notwithstanding, in the case of a special meeting called by the Secretary following
receipt of Special Meeting Demand(s) from stockholders holding the Requisite Percentage in accordance with clause (ii)&nbsp;of the first sentence of Section&nbsp;2(a), the Board of Directors may submit its own proposal or proposals for consideration
at such special meeting, and at the direction of the Board of Directors, such proposal or proposals shall be included in the notice for the special meeting as a purpose or purposes for which the meeting is called. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) A stockholder may revoke a Special Meeting Demand by written revocation delivered to, or mailed and received by, the Secretary at the
principal executive office of the Corporation at any time before the special meeting. If any such revocation(s) are delivered to or received by the Secretary after the Secretary&#146;s receipt of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Special Meeting Demands from the holders of the Requisite Percentage, and as a result of such revocation(s), there no longer are unrevoked demands from stockholders holding the Requisite
Percentage, the Board of Directors shall have the discretion to determine whether or not to proceed with the special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) For
purposes of this Section&nbsp;2, (i)&nbsp;&#147;<I>Demanding Person</I>&#148; shall mean (A)&nbsp;each stockholder making a demand pursuant to the first sentence of subsection (a)&nbsp;of this Section 2, (B)&nbsp;the beneficial owner or beneficial
owners, if different, on whose behalf such notice is given, and (C)&nbsp;any affiliates or associates (each within the meaning of Rule 12b-2 under the Exchange Act) of such stockholder or beneficial owner, (ii)&nbsp;&#147;<I>Exchange Act</I>&#148;
shall have the meaning provided in Section&nbsp;13 of this Article II, and (iii)&nbsp;&#147;<I>publicly announce</I>&#148; shall mean making a public announcement (as defined in Section&nbsp;13 of this Article II). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3. <U>Notice of Meetings</U>.</B> (a)&nbsp;The Corporation shall give notice of any annual or special meeting of stockholders.
Notices of meetings of the stockholders shall state the place, if any, date, and hour of the meeting, the record date for determining stockholders entitled to vote at the meeting, if such record date is different from the record date for determining
stockholders entitled to notice of the meeting, and the means of remote communication, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting. In the case of a special meeting, the notice shall
state the purpose or purposes for which the meeting is called. No business other than that specified in the notice thereof shall be transacted at any special meeting. Unless otherwise provided by applicable law or the Certificate of Incorporation,
notice shall be given to each stockholder entitled to receive notice of such meeting not fewer than ten (10)&nbsp;days or more than sixty (60)&nbsp;days before the date of the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Notice to stockholders may be given by personal delivery, mail, or, with the consent of the stockholder entitled to receive notice, by
facsimile or other means of electronic transmission. If mailed, such notice shall be delivered by postage prepaid envelope directed to each stockholder at such stockholder&#146;s address as it appears in the records of the Corporation and shall be
deemed given when deposited in the United States mail. Notice given by electronic transmission pursuant to this subsection shall be deemed given: (i)&nbsp;if by facsimile telecommunication, when directed to a facsimile telecommunication number at
which the stockholder has consented to receive notice, (ii)&nbsp;if by electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice, (iii)&nbsp;if by posting on an electronic network together
with separate notice to the stockholder of such specific posting, upon the later of (A)&nbsp;such posting and (B)&nbsp;the giving of such separate notice, and (iv)&nbsp;if by any other form of electronic transmission, when directed to the
stockholder. An affidavit of the secretary or an assistant secretary or of the transfer agent or other agent of the Corporation that the notice has been given by personal delivery, by mail, or by a form of electronic transmission shall, in the
absence of fraud, be prima facie evidence of the facts stated therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Notice of any meeting of stockholders need not be given to any
stockholder if waived by such stockholder either in a writing signed by such stockholder or by electronic transmission, whether such waiver is given before or after such meeting is held. If such a waiver is given by electronic transmission, the
electronic transmission must either set forth or be submitted with information from which it can be determined that the electronic transmission was authorized by the stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4. <U>Quorum and Adjournment</U>.</B> Except as otherwise required by law, by the Certificate of Incorporation of the
Corporation, or by these Bylaws, the presence, in person or represented by proxy, of the holders of a majority of the aggregate voting power of the stock issued and outstanding, entitled to vote thereat, shall constitute a quorum for the transaction
of business at all meetings of the stockholders. If such majority shall not be present or represented at any meeting of the stockholders, a majority of the stockholders present, although less than a quorum, or the presiding officer of such meeting
shall have the power to adjourn the meeting to another time and place. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5. <U>Adjourned Meetings</U>.</B> When a meeting
is adjourned to another time and place, if any, unless otherwise provided by these Bylaws, notice need not be given of the adjourned meeting if the date, time, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
place, if any, thereof and the means of remote communication, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such adjourned meeting, are
announced at the meeting at which the adjournment is taken. At the adjourned meeting, the stockholders may transact any business that might have been transacted at the original meeting. If an adjournment is for more than thirty (30)&nbsp;days or, if
after an adjournment, a new record date is fixed for determining the stockholders entitled to vote at the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder entitled to vote at the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6. <U>Vote Required</U>.</B> Except as otherwise provided by law, the Certificate of Incorporation, or these Bylaws: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Directors shall be elected by a plurality in voting power of the shares present in person or represented by proxy at a meeting of the
stockholders and entitled to vote in the election of directors; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Whenever any corporate action other than the election of
directors is to be taken, it shall be authorized by a majority in voting power of the shares present in person or represented by proxy at a meeting of stockholders and entitled to vote on the subject matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7. <U>Manner of Voting; Proxies</U>.</B> (a)&nbsp;At each meeting of stockholders, each stockholder having the right to vote
shall be entitled to vote in person or by proxy. Each stockholder shall be entitled to vote each share of stock having voting power and registered in such stockholder&#146;s name on the books of the Corporation on the record date fixed for
determination of stockholders entitled to vote at such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Each person entitled to vote at a meeting of stockholders or to
express consent or dissent to corporate action in writing without a meeting may authorize another person or persons to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the
proxy provides for a longer period. A proxy shall be irrevocable if it states that it is irrevocable and if, and only so long as, it is coupled with an interest sufficient in law to support an irrevocable power. Proxies need not be filed with the
Secretary of the Corporation until the meeting is called to order, but shall be filed before being voted. Without limiting the manner in which a stockholder may authorize another person or persons to act for such stockholder as proxy, the following
shall constitute valid means by which a stockholder may grant such authority: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) A stockholder may execute a writing
authorizing another person or persons to act for such stockholder as proxy. Execution may be accomplished by the stockholder or the stockholder&#146;s authorized officer, director, employee, or agent signing such writing or causing such
person&#146;s signature to be affixed to such writing by any reasonable means including, but not limited to, by facsimile signature; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) A stockholder may authorize another person or persons to act for such stockholder as proxy by transmitting or authorizing
the transmission of a telegram, cablegram, or other means of electronic transmission to the person or persons who will be the holder of the proxy or to a proxy solicitation firm, proxy support service organization, or like agent duly authorized by
the person who will be the holder of the proxy to receive such transmission; <I>provided</I>, <I>however</I>, that any such telegram, cablegram, or other means of electronic transmission must either set forth or be submitted with information from
which it can be determined that the telegram, cablegram, or other electronic transmission was authorized by the stockholder. If it is determined that any such telegram, cablegram, or other electronic transmission is valid, the inspectors or, if
there are no inspectors, such other persons making that determination, shall specify the information upon which they relied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any copy, facsimile
telecommunication, or other reliable reproduction of a writing or electronic transmission authorizing a person or persons to act as proxy for a stockholder may be substituted or used in lieu of the original writing or electronic transmission for any
and all purposes for which the original writing or electronic transmission could be used; <I>provided</I>, <I>however</I>, that such copy, facsimile telecommunication, or other reproduction shall be a complete reproduction of the entire original
writing or electronic transmission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8. <U>Remote Communication</U>.</B> For the purposes of these Bylaws, if
authorized by the Board of Directors in its sole discretion, and subject to such guidelines and procedures as the Board of Directors may adopt, stockholders and proxyholders may, by means of remote communication: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) participate in a meeting of stockholders; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) be deemed present in person and vote at a meeting of stockholders whether such meeting is to be held at a designated place or solely by
means of remote communication, <I>provided</I> that (i)&nbsp;the Corporation shall implement reasonable measures to verify that each person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder or
proxyholder, (ii)&nbsp;the Corporation shall implement reasonable measures to provide such stockholders and proxyholders a reasonable opportunity to participate in the meeting and to vote on matters submitted to the stockholders, including an
opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings, and (iii)&nbsp;if any stockholder or proxyholder votes or takes other action at the meeting by means of remote communication, a record of
such vote or other action shall be maintained by the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9. <U>No Stockholder Action Without a Meeting</U>.</B>
Stockholder action by written consent in lieu of a meeting is prohibited by the Certificate of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.
<U>Presiding Officer and Secretary</U>.</B> (a)&nbsp;The Chief Executive Officer shall preside at meetings of the stockholders. In the absence of the Chief Executive Officer, the President shall preside at meetings of the stockholders. In the
absence of each of the Chief Executive Officer and the President, any director or officer designated by the Board of Directors shall preside at meetings of the stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The Secretary of the Corporation shall act as secretary of all meetings of the stockholders, but, in the absence of the Secretary, the
Assistant Secretary designated in accordance with Section&nbsp;11(b) of Article IV of these Bylaws shall act as secretary of meetings of the stockholders. In the absence of the Secretary and any designated Assistant Secretary, the presiding officer
of the meeting may appoint any person to act as secretary of the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11. <U>Conduct of Meetings</U>.</B> At each
meeting of stockholders, the presiding officer of the meeting shall fix and announce the date and time of the opening and the closing of the polls for each matter upon which the stockholders will vote at the meeting and shall determine the order of
business and all other matters of procedure. The Board of Directors may adopt by resolution such rules, regulations, and procedures for the conduct of the meeting of stockholders as it shall deem appropriate. Except to the extent inconsistent with
any such rules and regulations adopted by the Board of Directors, the presiding officer of the meeting shall have the right and authority to convene and to adjourn the meeting and to establish rules, regulations, and procedures, which need not be in
writing, for the conduct of the meeting and to maintain order and safety. Without limiting the foregoing, he or she may: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) restrict
attendance at any time to bona fide stockholders of record and their proxies and other persons in attendance at the invitation of the presiding officer or Board of Directors; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) place restrictions on entry to the meeting after the time fixed for the commencement thereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) restrict dissemination of solicitation materials and use of audio or visual recording devices at the meeting; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) adjourn the meeting without a vote of the stockholders, whether or not there is a quorum present; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) make rules governing speeches and debate, including time limits and access to microphones. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The presiding officer of the meeting shall act in his or her absolute discretion, and his or her rulings shall not be subject to appeal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;12. <U>Inspectors of Election</U>.</B> The Corporation may, and shall if
required by law, in advance of any meeting of stockholders, appoint one or more inspectors of election, who may be employees of the Corporation, to act at the meeting or any adjournment thereof and to make a written report thereof. The Corporation
may designate one or more persons as alternate inspectors to replace any inspector who fails to act. If no inspector so appointed or designated is able to act at a meeting of stockholders, the person presiding at the meeting shall appoint one or
more inspectors to act at the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath to execute faithfully the duties of inspector with strict impartiality and according to the best of his or
her ability. The inspector or inspectors so appointed or designated shall (a)&nbsp;ascertain the number of shares of capital stock of the Corporation outstanding and the voting power of each such share, (b)&nbsp;determine the shares of capital stock
of the Corporation represented at the meeting and the validity of proxies and ballots, (c)&nbsp;count all votes and ballots, (d)&nbsp;determine and retain for a reasonable period a record of the disposition of any challenges made to any
determination by the inspectors, and (e)&nbsp;certify their determination of the number of shares of capital stock of the Corporation represented at the meeting and such inspectors&#146; count of all votes and ballots. Such certification and report
shall specify such other information as may be required by law. In determining the validity and counting of proxies and ballots cast at any meeting of stockholders of the Corporation, the inspectors may consider such information as is permitted by
applicable law. No person who is a candidate for an office at an election may serve as an inspector at such election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;13.
<U>Notice of Stockholder Business and Nominations</U>.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <U>Annual Meetings of Stockholders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Nominations of persons for election to the Board of Directors and the proposal of business to be considered by the stockholders may be
made at an annual meeting of stockholders only (a)&nbsp;pursuant to the Corporation&#146;s notice of meeting (or any supplement thereto), (b)&nbsp;by or at the direction of the Board of Directors, or (c)&nbsp;by any stockholder of the Corporation
(i)&nbsp;who was a stockholder of record of the Corporation (and, with respect to any beneficial owner, if different, on whose behalf such business is proposed or such nomination or nominations are made, only if such beneficial owner was the
beneficial owner of shares of the Corporation) both at the time the notice provided for in Paragraphs (A)(2) and (A)(3) of this Section&nbsp;13 is delivered to the Secretary of the Corporation and on the record date for the determination of
stockholders entitled to vote at the meeting, (ii)&nbsp;who is entitled to vote at the meeting upon such election of directors or upon such business, as the case may be, and (iii)&nbsp;who complies with the notice procedures set forth in Paragraphs
(A)(2) and (A)(3) of this Section&nbsp;13. Except for proposals properly made in accordance with Rule 14a-8 under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (as so amended and inclusive of such rules
and regulations, the &#147;<I>Exchange Act</I>&#148;), and included in the notice of meeting given by or at the direction of the Board of Directors, the foregoing clause (c)&nbsp;shall be the exclusive means for a stockholder to propose business to
be brought before an annual meeting of stockholders. In addition, for business (other than the nomination of persons for election to the Board of Directors) to be properly brought before an annual meeting by a stockholder, such business must be a
proper matter for stockholder action pursuant to the Certificate of Incorporation, these Bylaws, and applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) For nominations
or other business to be properly brought before an annual meeting of stockholders by a stockholder pursuant to clause (c)&nbsp;of Paragraph (A)(1) of this Section&nbsp;13, the stockholder (a)&nbsp;must have given timely notice thereof in writing and
in proper form to the Secretary at the principal executive offices of the Corporation, and (b)&nbsp;must provide any updates or supplements to such notice at such times and in the forms required by this Section&nbsp;13. To be timely, a
stockholder&#146;s notice relating to an annual meeting shall be delivered to, or mailed to and received by, the Secretary at the principal executive offices of the Corporation not later than the close of business on the ninetieth (90th)&nbsp;day
and not earlier than the close of business on the one hundred twentieth (120th)&nbsp;day before the date of the one-year anniversary of the immediately preceding year&#146;s annual meeting (<I>provided</I>, <I>however</I>, that if the date of the
annual meeting is more than thirty (30)&nbsp;days before or more than sixty (60)&nbsp;days after such anniversary date, notice by the stockholder must be so delivered, or mailed and received, not earlier than the close of business on the one hundred
twentieth (120th)&nbsp;day before such annual </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
meeting and not later than the close of business on the later of the ninetieth (90th)&nbsp;day before such annual meeting or the tenth (10th)&nbsp;day following the day on which public
announcement (as defined below) of the date of such meeting is first made by the Corporation). In no event shall the public announcement of an adjournment or postponement of an annual meeting of stockholders commence a new time period (or extend any
time period) for the giving of a stockholder&#146;s notice as described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) To be in proper form for purposes of this
Section&nbsp;13, a stockholder&#146;s notice to the Secretary (whether pursuant to this Paragraph (A)&nbsp;or Paragraph (B)&nbsp;of this Section&nbsp;13) must set forth: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) as to each Proposing Person (as defined below), (i)&nbsp;the name and address of such Proposing Person (including, if
applicable, the name and address that appear on the Corporation&#146;s books and records) and (ii)&nbsp;the class or series and number of shares of capital stock of the Corporation that are, directly or indirectly, owned of record or beneficially
owned (within the meaning of Rule 13d-3 under the Exchange Act) by such Proposing Person (<I>provided</I> that for purposes of this Section&nbsp;13, such Proposing Person shall in all events be deemed to beneficially own any shares of any class or
series and number of shares of capital stock of the Corporation as to which such Proposing Person has a right to acquire beneficial ownership at any time in the future); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) as to each Proposing Person, (i)&nbsp;any derivative, swap, or other transaction or series of transactions engaged in,
directly or indirectly, by such Proposing Person, the purpose or effect of which is to give such Proposing Person economic risk similar to ownership of shares of any class or series of capital stock of the Corporation, including due to the fact that
the value of such derivative, swap, or other transactions are determined by reference to the price, value, or volatility of any shares of any class or series of capital stock of the Corporation, or which derivative, swap, or other transactions
provide, directly or indirectly, the opportunity to profit from any increase in the price or value of shares of any class or series of capital stock of the Corporation (&#147;<I>Synthetic Equity Interests</I>&#148;), which Synthetic Equity Interests
shall be disclosed without regard to whether (x)&nbsp;the derivative, swap, or other transactions convey any voting rights in such shares to such Proposing Person, (y)&nbsp;the derivative, swap, or other transactions are required to be, or are
capable of being, settled through delivery of such shares, or (z)&nbsp;such Proposing Person may have entered into other transactions that hedge or mitigate the economic effect of such derivative, swap, or other transactions, (ii)&nbsp;any proxy
(other than a revocable proxy or consent given in response to a solicitation made pursuant to, and in accordance with, Section&nbsp;14(a) of the Exchange Act by way of a solicitation statement filed on Schedule 14A), agreement, arrangement,
understanding, or relationship pursuant to which such Proposing Person has or shares a right to vote any shares of any class or series of capital stock of the Corporation (including the number of shares and class or series of capital stock of the
Corporation that are subject to such proxy, agreement, arrangement, understanding, or relationship), (iii)&nbsp;any agreement, arrangement, understanding, or relationship, including any repurchase or similar so-called &#147;stock borrowing&#148;
agreement or arrangement, engaged in, directly or indirectly, by such Proposing Person, the purpose or effect of which is to mitigate loss to, reduce the economic risk (of ownership or otherwise) of shares of any class or series of capital stock of
the Corporation by, manage the risk of share price changes for, or increase or decrease the voting power of, such Proposing Person with respect to the shares of any class or series of capital stock of the Corporation, or that provides, directly or
indirectly, the opportunity to profit from any decrease in the price or value of the shares of any class or series of capital stock of the Corporation (&#147;<I>Short Interests</I>&#148;), (iv)&nbsp;any rights to dividends on the shares of any class
or series of capital stock of the Corporation owned beneficially by such Proposing Person that are separated or separable from the underlying shares of the Corporation, (v)&nbsp;any performance related fees (other than an asset based fee) to which
such Proposing Person is entitled based on any increase or decrease in the price or value of shares of any class or series of the capital stock of the Corporation, or any Synthetic Equity Interests or Short Interests, if any, and (vi)&nbsp;any other
information relating to such Proposing Person that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies or consents by such Proposing Person in support of the
nominations or business proposed to be brought before the meeting pursuant to Regulation 14A under the Exchange Act (the disclosures to be made pursuant to the foregoing clauses (i)&nbsp;through (vi)&nbsp;are referred to as &#147;<I>Disclosable
Interests</I>&#148;); <I>provided</I>, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
<I>however</I>, that Disclosable Interests shall not include any such disclosures with respect to the ordinary course business activities of any broker, dealer, commercial bank, trust company, or
other nominee who is a Proposing Person solely as a result of being the stockholder directed to prepare and submit the notice required by these Bylaws on behalf of a beneficial owner; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) if such notice pertains to the nomination by the stockholder of a person or persons for election to the Board of Directors
(each, a &#147;<I>nominee</I>&#148;), as to each nominee, (i)&nbsp;the name, age, business and residence address, and principal occupation or employment of the nominee, (ii)&nbsp;all other information relating to the nominee that would be required
to be disclosed about such nominee if proxies were being solicited for the election of the nominee as a director in an election contest (whether or not such proxies are or will be solicited), or that is otherwise required, in each case pursuant to
and in accordance with Regulation 14A under the Exchange Act, (iii)&nbsp;such nominee&#146;s written consent to being named in the proxy statement, if any, as a nominee and to serving as a director if elected, and (iv)&nbsp;all information with
respect to such nominee that would be required to be set forth in a stockholder&#146;s notice pursuant to this Section&nbsp;13 if such nominee were a Proposing Person; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) if the notice relates to any business (other than the nomination of persons for election to the Board of Directors) that
the stockholder proposes to bring before the meeting, (i)&nbsp;a reasonably brief description of the business desired to be brought before the meeting, (ii)&nbsp;the text of the proposal or business (including the text of any resolutions proposed
for consideration and if such business includes a proposal to amend the Bylaws of the Corporation, the language of the proposed amendment), (iii)&nbsp;the reasons for conducting such business at the meeting, and (iv)&nbsp;any material interest in
such business of each Proposing Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) a representation that the stockholder giving the notice is a holder of record
of stock of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to propose such business or nomination; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) a representation whether any Proposing Person intends or is part of a group that intends (i)&nbsp;to deliver a proxy
statement and/or form of proxy to holders of at least the percentage of the Corporation&#146;s outstanding capital stock required to approve or adopt the proposal or elect the nominee and/or (ii)&nbsp;otherwise to solicit proxies from stockholders
in support of such proposal or nomination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Corporation may require any proposed nominee to furnish such other information as it may reasonably
require to determine (i)&nbsp;the eligibility of such proposed nominee to serve as a director of the Corporation, and (ii)&nbsp;whether such nominee qualifies as an &#147;independent director&#148; or &#147;audit committee financial expert&#148;
under applicable law, securities exchange rule or regulation, or any publicly disclosed corporate governance guideline or committee charter of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) Notwithstanding anything in the second sentence of paragraph (A)(2) of this Section&nbsp;13 to the contrary, if the number of directors to
be elected to the Board of Directors of the Corporation at an annual meeting is increased and there is no public announcement by the Corporation naming all of the Board of Directors&#146; nominees for director or specifying the size of the increased
Board of Directors at least one hundred (100)&nbsp;days before the first anniversary of the preceding year&#146;s annual meeting, a stockholder&#146;s notice required by this Section&nbsp;13 shall also be considered timely, but only with respect to
nominees for any new positions created by such increase, if it shall be delivered to, or mailed to and received by, the Secretary at the principal executive offices of the Corporation not later than the close of business on the tenth (10th)&nbsp;day
following the day on which such public announcement is first made by the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) Only such persons who are nominated in
accordance with the procedures set forth in Paragraph (A)&nbsp;of this Section&nbsp;13 (including those persons nominated by or at the direction of the Board of Directors) shall be eligible to be elected at an annual meeting of stockholders of the
Corporation to serve as directors. Only such business shall be conducted at an annual meeting of stockholders as shall have been brought before the meeting in accordance with the procedures set forth in Paragraph (A)&nbsp;of this Section&nbsp;13.
Except as otherwise provided by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
law, the chairman of an annual meeting of stockholders shall have the power and duty (a)&nbsp;if the facts warrant, to determine that a nomination or any business proposed to be brought before
the annual meeting was not made or was not proposed, as the case may be, in accordance with the procedures set forth in Paragraph (A)&nbsp;of this Section&nbsp;13, and (b)&nbsp;if any proposed nomination or business was not made or was not proposed
in compliance with Paragraph (A)&nbsp;of this Section&nbsp;13, to declare that such nomination shall be disregarded or that such proposed business shall not be transacted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <U>Special Meetings of Stockholders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the
Corporation&#146;s notice of meeting pursuant to Section&nbsp;2 of these Bylaws. Nominations of persons for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected pursuant to the
Corporation&#146;s notice of meeting only (a)&nbsp;by or at the direction of the Board of Directors or (b)&nbsp;if a purpose for such meeting as stated in the Corporation&#146;s notice for such meeting is the election of one or more directors, by
any stockholder of the Corporation (i)&nbsp;who was a stockholder of record of the Corporation (and, with respect to any beneficial owner, if different, on whose behalf such nomination or nominations are made, only if such beneficial owner was the
beneficial owner of shares of the Corporation) both at the time the notice provided for in Paragraph (B)(2) of this Section&nbsp;13 is delivered to the Secretary of the Corporation and on the record date for the determination of stockholders
entitled to vote at the special meeting, (ii)&nbsp;who is entitled to vote at the meeting and upon such election, and (iii)&nbsp;who complies with the notice procedures set forth in Paragraph (B)(2) of this Section&nbsp;13; <I>provided</I>,
<I>however</I>, that a stockholder may nominate persons for election at a special meeting only to such position(s) as specified in the Corporation&#146;s notice of the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) If a special meeting has been called in accordance with Section&nbsp;2 of this Article II for the purpose of electing one or more
directors to the Board of Directors, then for nominations of persons for election to the Board of Directors to be properly brought before such special meeting by a stockholder pursuant to clause (b)&nbsp;of Paragraph (B)(1) of this Section&nbsp;13,
the stockholder (a)&nbsp;must have given timely notice thereof in writing and in the proper form to the Secretary of the Corporation at the principal executive offices of the Corporation, and (b)&nbsp;must provide any updates or supplements to such
notice at such times and in the forms required by this Section&nbsp;13. To be timely, a stockholder&#146;s notice relating to a special meeting shall be delivered to, or mailed to and received by, the Secretary at the principal executive offices of
the Corporation not earlier than the close of business on the one hundred twentieth (120th)&nbsp;day before such special meeting and not later than the close of business on the later of the ninetieth (90th)&nbsp;day before such special meeting or
the tenth (10th)&nbsp;day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. In no event shall the public announcement
of an adjournment or postponement of a special meeting commence a new time period (or extend any time period) for the giving of a stockholder&#146;s notice as described above. To be in proper form for purposes of this Paragraph (B)&nbsp;of this
Section&nbsp;13, such notice shall set forth the information required by clauses (a), (b), (c), (e), and (f)&nbsp;of Paragraph (A)(3) of this Section&nbsp;13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) Only such persons who are nominated in accordance with the procedures set forth in Paragraph (B)&nbsp;of this Section&nbsp;13 (including
those persons nominated by or at the direction of the Board of Directors) shall be eligible to be elected at a special meeting of stockholders of the Corporation to serve as directors. Except as otherwise provided by law, the chairman of a special
meeting of stockholders shall have the power and duty (a)&nbsp;if the facts warrant, to determine that a nomination proposed to be made at the special meeting was not made in accordance with the procedures set forth in Paragraph (B)&nbsp;of this
Section&nbsp;13, and (b)&nbsp;if any proposed nomination was not made in compliance with Paragraph (B)&nbsp;of this Section&nbsp;13, to declare that such nomination shall be disregarded. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <U>General</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) A stockholder providing notice of nominations of persons for election to the Board of Directors at an annual or special meeting of
stockholders or notice of business proposed to be brought before an annual meeting of stockholders shall further update and supplement such notice so that the information provided or required to be provided in such notice pursuant to Paragraph
(A)(3)(a) through Paragraph (A)(3)(f) of this Section&nbsp;13 shall be true and correct both as of the record date for the determination of stockholders entitled to notice of the meeting and as of the date that is ten (10)&nbsp;business days before
the meeting or any adjournment or postponement thereof, and such updated and supplemental information shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation (a)&nbsp;in the case of
information that is required to be updated and supplemented to be true and correct as of the record date for the determination of stockholders entitled to notice of the meeting, not later than the later of five (5)&nbsp;business days after such
record date or five (5)&nbsp;business days after the public announcement of such record date, and (b)&nbsp;in the case of information that is required to be updated and supplemented to be true and correct as of ten (10)&nbsp;business days before the
meeting or any adjournment or postponement thereof, not later than eight (8)&nbsp;business days before the meeting or any adjournment or postponement thereof (or if not practicable to provide such updated and supplemental information not later than
eight (8)&nbsp;business days before any adjournment or postponement, on the first practicable date before any such adjournment or postponement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) Notwithstanding the foregoing provisions of this Section&nbsp;13, unless otherwise required by law, if the stockholder (or a qualified
representative of the stockholder) does not appear at the annual or special meeting of stockholders of the Corporation to present a nomination or proposed business, such nomination shall be disregarded and such proposed business shall not be
transacted, notwithstanding that proxies in respect of such vote may have been received by the Corporation. For purposes of this Section&nbsp;13, to be considered a qualified representative of the stockholder, a person must be authorized by a
writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting of stockholders and such person must produce such writing or electronic transmission, or a reliable
reproduction of the writing or electronic transmission, at the meeting of stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) For purposes of this Section&nbsp;13,
(a)&nbsp;&#147;<I>public announcement</I>&#148; shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press, or comparable national news service or in a document publicly filed by the Corporation with the
Securities and Exchange Commission pursuant to Section&nbsp;13, 14, or 15(d) of the Exchange Act, and (b)&nbsp;&#147;<I>Proposing Person</I>&#148; shall mean (i)&nbsp;the stockholder giving the notice required by Paragraph (A)&nbsp;or Paragraph
(B)&nbsp;of this Section&nbsp;13, (ii)&nbsp;the beneficial owner or beneficial owners, if different, on whose behalf such notice is given, and (iii)&nbsp;any affiliates or associates (each within the meaning of Rule 12b-2 under the Exchange Act for
purposes of these Bylaws) of such stockholder or beneficial owner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) Paragraph (A)&nbsp;of this Section&nbsp;13 is expressly intended
to apply to any business proposed to be brought before an annual meeting of stockholders other than any proposal made pursuant to Rule 14a-8 under the Exchange Act. Nothing in this Section&nbsp;13 shall be deemed to (a)&nbsp;affect any rights of
stockholders to request inclusion of proposals in the Corporation&#146;s proxy statement pursuant to Rule 14a-8 (or any successor thereto) promulgated under the Exchange Act, (b)&nbsp;confer upon any stockholder a right to have a nominee or any
proposed business included in the Corporation&#146;s proxy statement, or (c)&nbsp;affect any rights of the holders of any class or series of preferred stock of the Corporation to nominate and elect directors pursuant to and to the extent provided in
any applicable provisions of the Certificate of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;14. <U>Record Dates</U>.</B> <B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) In order that the Corporation may determine the stockholders entitled to notice of any meeting of stockholders or any adjournment thereof,
the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which record date shall not be more than sixty (60)&nbsp;or fewer than ten (10)&nbsp;days before the date of such meeting. If the Board of Directors so fixes a record date for determining the
stockholders entitled to notice of any meeting of stockholders, such date shall also be the record date for determining the stockholders entitled to vote at such meeting, unless the Board of Directors determines, at the time it fixes the record date
for determining the stockholders entitled to notice of such meeting, that a later date on or before the date of the meeting shall be the record date for determining the stockholders entitled to vote at such meeting. If no record date is fixed by the
Board of Directors, the record date for determining stockholders entitled to notice of and to vote at any meeting of stockholders or any adjournment thereof shall be at the close of business on the day next preceding the day on which notice is
given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any
adjournment of such meeting; <I>provided</I>, <I>however</I>, that the Board of Directors may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the record date for
stockholders entitled to receive notice of such adjourned meeting the same or an earlier date as that fixed for determining the stockholders entitled to vote at such adjourned meeting in accordance with the foregoing provisions of this subsection
(a)&nbsp;of this Section&nbsp;14. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) In order that the Corporation may determine the stockholders entitled to receive payment of any
dividend or other distribution, or allotment of any rights, or the stockholders entitled to exercise any rights in respect of any change, conversion, or exchange of capital stock, or for the purpose of any other lawful action, except as may
otherwise be provided in these Bylaws, the Board of Directors may fix a record date. Such record date shall not precede the date upon which the resolution fixing such record date is adopted, and shall not be more than sixty (60)&nbsp;days prior to
such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be the close of business on the day on which the Board of Directors adopts the resolution relating thereto. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1. <U>Number</U>.</B> The number of directors that shall constitute the whole Board of Directors initially shall be
nine (9), and thereafter shall be no fewer than six (6)&nbsp;and no greater than fifteen (15), the exact number of directors to be determined from time to time by resolution adopted by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2. <U>Powers</U>.</B> Subject to any limitations set forth in the Certificate of Incorporation and to any provision of the
General Corporation Law of the State of Delaware relating to powers or rights conferred upon or reserved to the stockholders or the holders of any class or series of the Corporation&#146;s issued and outstanding stock, the business and affairs of
the corporation shall be managed, and all corporate powers shall be exercised, by or under the direction of the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3. <U>Resignations and Removal</U>.</B> (a)&nbsp;Any director may resign at any time by giving notice in writing or by
electronic transmission to the Board of Directors or the Secretary; <I>provided</I>, <I>however</I>, that if such notice is given by electronic transmission, such electronic transmission must either set forth or be submitted with information from
which it can be determined that the electronic transmission was authorized by the director. Such resignation shall take effect at the date of receipt of such notice or at any later time specified therein. Acceptance of such resignation shall not be
necessary to make it effective unless the resignation specifies that it will not be effective unless accepted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Except as otherwise
may be provided in the Certificate of Incorporation, any director or the entire Board of Directors may be removed, with or without cause, by the holders of capital stock having a majority in voting power of the shares entitled to vote in the
election of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4. <U>Annual Meetings</U>.</B> The Board of Directors shall meet each year
as soon as practicable following the annual meeting of stockholders, at the place where such meeting of stockholders has been held, or at such other place as shall be fixed by the Board of Directors (or if not previously fixed by the Board of
Directors, by the person presiding over the meeting of the stockholders), for the purpose of election of officers and consideration of such other business as the Board of Directors considers relevant to the management of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5. <U>Regular Meetings</U>.</B> Regular meetings of the Board of Directors shall be held on such dates and at such times and
places, within or without the State of Delaware, as shall from time to time be determined by the Board of Directors, such determination to constitute the only notice of such regular meetings to which any director shall be entitled. In the absence of
any such determination, such meetings shall be held, upon notice to each director in accordance with Section&nbsp;7 of this Article III, at such times and places, within or without the State of Delaware, as shall be designated by the Chairman of the
Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6. <U>Special Meetings</U>.</B> Special meetings of the Board of Directors shall be held at the call of the
Chairman of the Board at such times and places, within or without the State of Delaware, as he or she shall designate, upon notice to each director in accordance with Section&nbsp;7 of this Article III. Special meetings shall be called by the Chief
Executive Officer, President or Secretary on like notice at the written request of any two directors then in office. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.
<U>Notice</U>.</B> Notice of any regular (if required) or special meeting of the Board of Directors may be given by personal delivery, mail, telegram, courier service (including, without limitation, Federal Express), facsimile transmission (directed
to the facsimile transmission number at which the director has consented to receive notice), electronic mail (directed to the electronic mail address at which the director has consented to receive notice), or other form of electronic transmission
pursuant to which the director has consented to receive notice. If notice is given by personal delivery, by facsimile transmission, by telegram, by electronic mail, or by other form of electronic transmission pursuant to which the director has
consented to receive notice, then such notice shall be given on not less than twenty-four (24)&nbsp;hours&#146; notice to each director. If written notice is delivered by mail, then it shall be given on not less than four (4)&nbsp;calendar
days&#146; notice to each director. If written notice is delivered by courier service, then it shall be given on not less than two (2)&nbsp;calendar days&#146; notice to each director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8. <U>Waiver of Notice</U>.</B> Notice of any meeting of the Board of Directors, or any committee thereof, need not be given
to any member if waived by him or her in writing or by electronic transmission, whether before or after such meeting is held, or if he or she shall sign the minutes of such meeting or attend the meeting, except that if such director attends a
meeting for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened, then such director shall not be deemed to have waived notice of such meeting. If
waiver of notice is given by electronic transmission, such electronic transmission must either set forth or be submitted with information from which it can be determined that the electronic transmission was authorized by the director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9. <U>Quorum and Powers of a Majority</U>.</B> At all meetings of the Board of Directors and of each committee thereof, a
majority of the total number of directors constituting the whole Board of Directors or such committee shall be necessary and sufficient to constitute a quorum for the transaction of business. The act of a majority of the members present at any
meeting of the Board of Directors or a committee thereof at which a quorum is present shall be the act of the Board of Directors or such committee, unless by express provision of applicable law, the Certificate of Incorporation, or these Bylaws, a
different vote is required, in which case such express provision shall govern and control. In the absence of a quorum, a majority of the members present at any meeting may, without notice other than announcement at the meeting, adjourn such meeting
from time to time until a quorum is present. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10. <U>Manner of Acting</U>.</B> (a)&nbsp;Members of the Board of Directors,
or any committee thereof, may participate in any meeting of the Board of Directors or such committee by means of conference telephone or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other communications equipment by means of which all persons participating therein can hear each other, and participation in a meeting by such means shall constitute presence in person at such
meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Any action required or permitted to be taken at any meeting of the Board of Directors or any committee thereof may be taken
without a meeting if all members of the Board of Directors or such committee, as the case may be, consent thereto in writing or by electronic transmission, and the writing or writings or electronic transmission or transmissions are filed with the
minutes of proceedings of the Board of Directors or such committee; <I>provided</I>, <I>however</I>, that such electronic transmission or transmissions must either set forth or be submitted with information from which it can be determined that the
electronic transmission or transmissions were authorized by the director. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11. <U>Organization</U>.</B> Meetings of the Board of Directors shall be presided over by the Chairman of the Board, if any,
or in his or her absence by a presiding person chosen at the meeting. The Secretary shall act as secretary of the meeting, but in his or her absence the presiding person at the meeting may appoint any person to act as secretary of the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;12. <U>Committees</U>.</B> The Board of Directors may designate one or more committees, each committee to consist of one or
more directors, which to the extent provided in said resolution or resolutions shall have and may exercise the powers and authority of the Board of Directors in the management of the business and affairs of the Corporation (including the power and
authority to designate other committees of the Board of Directors); <I>provided</I>, <I>however</I>, that no such committee shall have the power or authority in reference to the following matters: (a)&nbsp;approving or adopting, or recommending to
the stockholders, any action or matter expressly required by the General Corporation Law of the State of Delaware to be submitted to stockholders for approval (other than recommending the election or removal of directors) or (b)&nbsp;adopting,
amending, or repealing any Bylaw of the Corporation. The Board of Directors may designate one or more directors as alternate members of any committee to replace any absent or disqualified member of the committee. In the absence or disqualification
of a member of a committee, the member or members present at any meeting of such committee and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board of Directors
to act at the meeting in place of such absent or disqualified director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;13. <U>Committee Procedure</U>.</B>
(a)&nbsp;Except as otherwise determined by the Board of Directors or provided by these Bylaws, each committee shall adopt its own rules governing the time, place, and method of holding its meetings and the conduct of its proceedings and shall meet
as provided by such rules or by resolution of the Board of Directors. Unless otherwise provided by these Bylaws or any such rules or resolutions, notice of the time and place of each meeting of a committee shall be given to each member of such
committee as provided in Section&nbsp;7 of this Article III with respect to notices of meetings of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Each
committee shall keep regular minutes of its proceedings and report the same to the Board of Directors when required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Any member of
any committee may be removed from such committee either with or without cause, at any time, by the Board of Directors at any meeting thereof. Any vacancy in any committee may be filled by the Board of Directors in the manner prescribed by the
Certificate of Incorporation or these Bylaws for the original appointment of the members of such committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;14.
<U>Vacancies and Newly-Created Directorships</U>.</B> Unless otherwise provided in the Certificate of Incorporation or in these Bylaws, vacancies and newly-created directorships resulting from any increase in the authorized number of directors may
be filled only by a majority of the directors then in office (and not by stockholders), although less than a quorum, or by a sole remaining director, and directors so chosen shall serve for a term expiring at the annual meeting of stockholders at
which the term of office to which they have been elected expires and until such directors&#146; successors have been duly elected and qualified. Unless otherwise </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provided in the Certificate of Incorporation or these Bylaws, when one or more directors shall resign from the Board, effective at a future date, a majority of directors then in office, including
those who have resigned, shall have the power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;15. <U>Director Compensation</U>.</B> (a)&nbsp;The Board of Directors, by a resolution or resolutions, may fix, and from time
to time change, the compensation of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Each director shall be entitled to reimbursement from the Corporation for his or her
reasonable expenses incurred with respect to duties as a member of the Board of Directors or any committee thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Nothing contained
in these Bylaws shall be construed to preclude any director from serving the Corporation in any other capacity and from receiving compensation from the Corporation for service rendered to it in such other capacity. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFICERS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1. <U>Number</U>.</B> The officers of the Corporation shall include a President and a Secretary. The Board of
Directors also shall elect a Chairman of the Board. The Board of Directors also may elect a Chief Executive Officer, a Chief Financial Officer, one or more Vice Presidents (who may have such additional descriptive designations as the Board of
Directors may determine), one or more Assistant Secretaries, one or more Treasurers, one or more Assistant Treasurers, and such other officers as the Board of Directors may from time to time deem appropriate or necessary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2. <U>Election of Officers, Term, and Qualifications</U>.</B> The officers of the Corporation shall be elected from time to
time by the Board of Directors and shall hold office at the pleasure of the Board of Directors. A vacancy in any office because of death, resignation, removal, disqualification, or any other cause shall be filled in the manner prescribed in this
Section&nbsp;2 for the regular election to such office. Except for the Chairman of the Board, none of the officers of the Corporation needs to be a director of the Corporation. Any two or more offices may be held by the same person to the extent
permitted by the General Corporation Law of the State of Delaware and other applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3. <U>Divisional or
Departmental Vice Presidents</U>.</B> The Board of Directors may delegate to the President the power to appoint one or more employees of the Corporation as divisional or departmental vice presidents and fix the duties of such appointees. However, no
such divisional or departmental vice president shall be considered to be an officer of the Corporation, the officers of the Corporation being limited to those officers elected by the Board of Directors in accordance with this Article IV. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4. <U>Removal</U>.</B> Any officer may be removed, either with or without cause, by the Board of Directors at any meeting
thereof, or to the extent delegated to the Chairman of the Board, by the Chairman of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.
<U>Resignations</U>.</B> Any officer of the Corporation may resign at any time by giving notice in writing or by electronic transmission to the Board of Directors or to the Chairman of the Board; <I>provided</I>, <I>however</I>, that if such notice
is given by electronic transmission, such electronic transmission must either set forth or be submitted with information from which it can be determined that the electronic transmission was authorized by the officer. Such resignation shall take
effect at the date of the receipt of such notice or at any later time specified therein and, unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective unless the resignation specifies that it
will not be effective unless accepted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6. <U>Compensation of Officers</U>.</B> The salaries and other compensation
of all officers of the Corporation shall be fixed by or in the manner directed by the Board of Directors from time to time, and no officer shall be prevented from receiving such salary by reason of the fact that he or she also is a director of the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7. <U>The Chairman of the Board</U>.</B> The Chairman of the Board shall have the powers and duties
customarily and usually associated with the office of the Chairman of the Board, as well as such additional powers and duties as may be from time to time assigned to him or her by the Board of Directors. The Chairman of the Board shall preside at
meetings of the stockholders and of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8. <U>The Chief Executive Officer</U>.</B> The Chief
Executive Officer shall have responsibility for implementation of the policies of the Corporation, as determined by the Board of Directors, for the general management and administration of the business affairs of the Corporation, and for the
supervision of other officers, together with any other powers and duties as may be prescribed by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9. <U>The President</U>.</B> The President shall have, subject to the supervision, direction, and control of the Board of
Directors and the Chief Executive Officer, the general powers and duties of supervision, direction, and management of the affairs and business of the Corporation customarily and usually associated with the position of President, including, without
limitation, all powers necessary to direct and control the organizational and reporting relationships within the Corporation. The President shall have such additional powers and duties as may be from time to time assigned to him or her by the Board
of Directors or the Chief Executive Officer. In the absence or disability of the President, his or her duties shall be performed by the Chief Executive Officer or such persons as the Board of Directors or the Chief Executive Officer may designate.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10. <U>The Vice Presidents</U>.</B> Each Vice President shall have such powers and perform such duties as may from time
to time be assigned to him or her by the Board of Directors, the Chairman of the Board, the Chief Executive Officer, or the President. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11. <U>The Secretary and Assistant Secretaries</U>.</B> (a)&nbsp;The Secretary shall attend meetings of the Board of Directors
and meetings of the stockholders and record all votes and minutes of all such proceedings in a book or books kept for such purpose. The Secretary shall have all such further powers and duties as are customarily and usually associated with the
position of Secretary or as may from time to time be assigned to him or her by the Board of Directors, the Chairman of the Board, the Chief Executive Officer, or the President. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Each Assistant Secretary shall have such powers and perform such duties as may from time to time be assigned to him or her by the Board of
Directors, the Chairman of the Board, the Chief Executive Officer, the President, or the Secretary. In the case of absence or disability of the Secretary, the Assistant Secretary designated by the Chief Executive Officer or the President (or, in the
absence of such designation, by the Secretary) shall perform the duties and exercise the powers of the Secretary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;12.
<U>The Chief Financial Officer</U>.</B> The Chief Financial Officer shall have all such powers and duties as are customarily and usually associated with the position of Chief Financial Officer or as may from time to time be assigned to him or her by
the Board of Directors, the Chairman of the Board, the Chief Executive Officer, or the President. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;13. <U>The Treasurer
and Assistant Treasurers</U>.</B> (a)&nbsp;The Treasurer shall have custody of the Corporation&#146;s funds and securities, shall be responsible for maintaining the Corporation&#146;s accounting records and statements, shall keep full and accurate
accounts of receipts and disbursements in books belonging to the Corporation, and shall deposit or cause to be deposited moneys or other valuable effects in the name and to the credit of the Corporation in such depositories as may be designated by
the Board of Directors. The Treasurer also shall maintain adequate records of all assets, liabilities, and transactions of the Corporation and shall assure that adequate audits thereof are currently and regularly made. The Treasurer shall have all
such further powers and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
duties as are customarily and usually associated with the position of Treasurer or as may from time to time be assigned to him or her by the Board of Directors, the Chairman of the Board, the
Chief Executive Officer, the President, or the Chief Financial Officer. In the absence of a designation of a Chief Financial Officer by the Board of Directors, the Treasurer shall be the Chief Financial Officer of the Corporation unless the Board of
Directors designates another person to be Treasurer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Each Assistant Treasurer shall have such powers and perform such duties as may
from time to time be assigned to him or her by the Board of Directors, the Chief Executive Officer, the Chief Financial Officer, the President, or the Treasurer. In the case of absence or disability of the Treasurer, the Assistant Treasurer
designated by the Chief Executive Officer or the President (or, in the absence of such designation, by the Treasurer) shall perform the duties and exercise the powers of the Treasurer. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1. <U>Certificates</U>.</B> The shares of capital stock of the Corporation shall be represented by certificates,
unless the Certificate of Incorporation otherwise provides or unless the Board of Directors provides by resolution or resolutions that some or all of the shares of any class or classes, or series thereof, of the Corporation&#146;s capital stock
shall be uncertificated. Every holder of capital stock of the Corporation represented by certificates shall be entitled to a certificate representing such shares. Certificates for shares of stock of the Corporation shall be issued under the seal of
the Corporation, or a facsimile thereof, and shall be numbered and shall be entered in the books of the Corporation as they are issued. Each certificate shall bear a serial number, shall exhibit the holder&#146;s name and the number of shares
evidenced thereby, and shall be signed by the Chairman of the Board or the Chief Executive Officer, or the President or any Vice President, and by the Secretary or an Assistant Secretary, or the Chief Financial Officer, or the Treasurer or an
Assistant Treasurer. Any or all of the signatures on the certificate may be a facsimile. If any officer, transfer agent, or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such
officer, transfer agent, or registrar before such certificate is issued, the certificate may be issued by the Corporation with the same effect as if such person or entity were such officer, transfer agent, or registrar at the date of issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2. <U>Transfers</U>.</B> Transfers of stock of the Corporation shall be made on the books of the Corporation only upon
surrender to the Corporation (or a transfer agent designed to transfer shares of stock of the Corporation) of a certificate (if any) for the shares duly endorsed or accompanied by proper evidence of succession, assignment, or authority to transfer;
<I>provided</I>, <I>however</I>, that such succession, assignment, or transfer is not prohibited by the Certificate of Incorporation, these Bylaws, applicable law, or contract. Thereupon, the Corporation shall issue a new certificate (if requested)
to the person entitled thereto, cancel the old certificate (if any), and record the transaction upon its books. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.
<U>Lost, Stolen, or Destroyed Certificates</U>.</B> Any person claiming a certificate of stock to be lost, stolen, or destroyed shall make an affidavit or an affirmation of that fact, and shall give the Corporation a bond of indemnity in
satisfactory form and with one or more satisfactory sureties, whereupon a new certificate (if requested) may be issued of the same tenor and for the same number of shares as the one alleged to be lost, stolen, or destroyed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4. <U>Registered Stockholders</U>.</B> The names and addresses of the holders of record of the shares of each class and series
of the Corporation&#146;s capital stock, together with the number of shares of each class and series held by each record holder and the date of issue of such shares, shall be entered on the books of the Corporation. Except as otherwise required by
the General Corporation Law of the State of Delaware or other applicable law, the Corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares of capital stock of the Corporation as the
person entitled to exercise the rights of a stockholder, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including, without limitation, the right to vote in person or by proxy at any meeting of the stockholders of the Corporation. The Corporation shall not be bound to recognize any equitable or
other claim to or interest in any such shares on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise expressly required by the General Corporation Law of the State of Delaware or other
applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5. <U>Fractional Shares</U>.</B> The Corporation may, but shall not be required to, issue fractional
shares of its capital stock if necessary or appropriate to effect authorized transactions. If the Corporation does not issue fractional shares, it shall (a)&nbsp;arrange for the disposition of fractional interests on behalf of those that otherwise
would be entitled thereto, (b)&nbsp;pay in cash the fair value of fractions of a share as of the time when those who otherwise would be entitled to receive such fractions are determined, or (c)&nbsp;issue scrip or warrants in registered form (either
represented by a certificate or uncertificated) or in bearer form (represented by a certificate), which scrip or warrants shall entitle the holder to receive a full share upon surrender of such scrip or warrants aggregating a full share. Fractional
shares shall, but scrip or warrants for fractional shares shall not (unless otherwise expressly provided therein), entitle the holder to exercise voting rights, to receive dividends thereon, to participate in the distribution of any assets in the
event of liquidation, and otherwise to exercise rights as a holder of capital stock of the class or series to which such fractional shares belong. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6. <U>Additional Powers of the Board</U>.</B> (a)&nbsp;In addition to, and without limiting, those powers set forth in
Section&nbsp;2 of Article III, the Board of Directors shall have power and authority to make all such rules and regulations as it shall deem expedient concerning the issue, transfer, and registration of certificates for shares of stock of the
Corporation, including the use of uncertificated shares of stock, subject to the provisions of the General Corporation Law of the State of Delaware, other applicable law, the Certificate of Incorporation, and these Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The Board of Directors may appoint and remove transfer agents and registrars of transfers, and may require all stock certificates to bear
the signature of any such transfer agent and/or any such registrar of transfers. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEMNIFICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1. <U>Indemnification</U>.</B> (a)&nbsp;Subject to Section&nbsp;3 of this Article VI, the Corporation shall indemnify, to the
full extent that it shall have power under applicable law to do so and in a manner permitted by such law, any person who is made or threatened to be made a party to or is otherwise involved (as a witness or otherwise) in any threatened, pending, or
completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative (hereinafter, a &#147;<I>Proceeding</I>&#148;), by reason of the fact that such person is or was a director or officer of the Corporation, or while
serving as a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise, including service
with respect to an employee benefit plan (collectively, &#147;<I>Another Enterprise</I>&#148;), against expenses (including attorneys&#146; fees), judgments, fines (including ERISA excise taxes or penalties) and amounts paid in settlement actually
and reasonably incurred by him or her in connection with such Proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any
criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The Corporation may indemnify, to
the full extent that it shall have power under applicable law to do so and in a manner permitted by such law, any person who is made or threatened to be made a party to or is otherwise involved (as a witness or otherwise) in any threatened, pending,
or completed Proceeding, by reason of the fact that such person is or was an employee or agent of the Corporation, or while not serving as a director or officer of the Corporation, is or was serving at the request of the Corporation as a director,
officer, employee, or agent of Another Enterprise, against expenses (including attorneys&#146; fees), judgments, fines (including ERISA </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
excise taxes or penalties) and amounts paid in settlement actually and reasonably incurred by him or her in connection with such Proceeding if he or she acted in good faith and in a manner he or
she reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) To the extent that a present or former director or officer of the Corporation has been successful on the merits or otherwise in defense of
any threatened, pending, or completed Proceeding referred to in Section&nbsp;145(a) or (b)&nbsp;of the General Corporation Law of the State of Delaware, or in defense of any claim, issue, or matter therein, he or she shall be indemnified against
expenses (including attorneys&#146; fees) actually and reasonably incurred by him or her in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The termination of
any Proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendre or its equivalent, shall not, of itself, create a presumption that the person seeking indemnification did not act in good faith and in a manner he or she
reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his or her conduct was unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2. <U>Advancement of Expenses</U>.</B> (a)&nbsp;Subject to Section&nbsp;3 of this Article VI, with respect to any person who
is made or threatened to be made a party to or is otherwise involved (as a witness or otherwise) in any threatened, pending, or completed Proceeding, by reason of the fact that such person is or was a director or officer of the Corporation or while
serving as a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee, or agent of Another Enterprise, the Corporation shall pay the expenses (including attorneys&#146; fees)
incurred by such person in defending any such Proceeding in advance of its final disposition (hereinafter an &#147;<I>advancement of expenses</I>&#148;); <I>provided</I>, <I>however</I>, that any advancement of expenses shall be made only upon
receipt of an undertaking (hereinafter an &#147;<I>undertaking</I>&#148;) by such person to repay all amounts advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal that such person is
not entitled to be indemnified for such expenses under this Article VI or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) With respect to any person who is made or
threatened to be made a party to or is otherwise involved (as a witness or otherwise) in any threatened, pending, or completed Proceeding, by reason of the fact that such person is or was an employee or agent of the Corporation, or while not serving
as a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee, or agent of Another Enterprise, the Corporation may, in its discretion and upon such terms and conditions, if any, as
the Corporation deems appropriate, pay the expenses (including attorneys&#146; fees) incurred by such person in defending any such Proceeding in advance of its final disposition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3. <U>Actions Initiated Against The Corporation</U>.</B> Anything in Section&nbsp;1(a) or Section&nbsp;2(a) of this Article VI
to the contrary notwithstanding, except as provided in Section&nbsp;5(b) of this Article VI, with respect to a Proceeding initiated against the Corporation by a person who is or was a director or officer of the Corporation (whether initiated by such
person in or by reason of such capacity or in or by reason of any other capacity, including as a director, officer, employee, or agent of Another Enterprise), the Corporation shall not be required to indemnify or to advance expenses (including
attorneys&#146; fees) to such person in connection with prosecuting such Proceeding (or part thereof) or in defending any counterclaim, cross-claim, affirmative defense, or like claim of the Corporation in such Proceeding (or part thereof) unless
such Proceeding was authorized by the Board of Directors of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4. <U>Contract Rights</U>.</B> The rights to
indemnification and advancement of expenses conferred upon any current or former director or officer of the Corporation pursuant to this Article VI (whether by reason of the fact that such person is or was a director or officer of the Corporation,
or while serving as a director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer, employee, or agent of Another Enterprise) shall be contract rights, shall vest when such person becomes a
director or officer of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Corporation, and shall continue as vested contract rights even if such person ceases to be a director or officer of the Corporation. Any amendment, repeal, or modification of, or adoption of any
provision inconsistent with, this Article VI (or any provision hereof) shall not adversely affect any right to indemnification or advancement of expenses granted to any person pursuant hereto with respect to any act or omission of such person
occurring prior to the time of such amendment, repeal, modification, or adoption (regardless of whether the Proceeding relating to such acts or omissions, or any proceeding relating to such person&#146;s rights to indemnification or to advancement
of expenses, is commenced before or after the time of such amendment, repeal, modification, or adoption), and any such amendment, repeal, modification, or adoption that would adversely affect such person&#146;s rights to indemnification or
advancement of expenses hereunder shall be ineffective as to such person, except with respect to any threatened, pending, or completed Proceeding that relates to or arises from (and only to the extent such Proceeding relates to or arises from) any
act or omission of such person occurring after the effective time of such amendment, repeal, modification, or adoption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5. <U>Claims</U>.</B> (a)&nbsp;If (i)&nbsp;a claim under Section&nbsp;1(a) of this Article VI with respect to any right to
indemnification is not paid in full by the Corporation within sixty (60)&nbsp;days after a written demand has been received by the Corporation or (ii)&nbsp;a claim under Section&nbsp;2(a) of this Article VI with respect to any right to the
advancement of expenses is not paid in full by the Corporation within twenty (20)&nbsp;days after a written demand has been received by the Corporation, then the person seeking to enforce a right to indemnification or to an advancement of expenses,
as the case may be, may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) If
successful in whole or in part in any suit brought pursuant to Section&nbsp;5(a) of this Article VI, or in a suit brought by the Corporation to recover an advancement of expenses (whether pursuant to the terms of an undertaking or otherwise), the
person seeking to enforce a right to indemnification or an advancement of expenses hereunder or the person from whom the Corporation sought to recover an advancement of expenses, as the case may be, shall be entitled to be paid by the Corporation
the reasonable expenses (including attorneys&#146; fees) of prosecuting or defending such suit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) In any suit brought by a person
seeking to enforce a right to indemnification hereunder (but not a suit brought by a person seeking to enforce a right to an advancement of expenses hereunder), it shall be a defense that the person seeking to enforce a right to indemnification has
not met any applicable standard for indemnification under applicable law. With respect to any suit brought by a person seeking to enforce a right to indemnification or right to advancement of expenses hereunder or any suit brought by the Corporation
to recover an advancement of expenses (whether pursuant to the terms of an undertaking or otherwise), neither (i)&nbsp;the failure of the Corporation to have made a determination prior to commencement of such suit that indemnification of such person
is proper in the circumstances because such person has met the applicable standards of conduct under applicable law, nor (ii)&nbsp;an actual determination by the Corporation that such person has not met such applicable standards of conduct, shall
create a presumption that such person has not met the applicable standards of conduct or, in a case brought by such person seeking to enforce a right to indemnification, be a defense to such suit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) In any suit brought by a person seeking to enforce a right to indemnification or to an advancement of expenses hereunder, or by the
Corporation to recover an advancement of expenses (whether pursuant to the terms of an undertaking or otherwise), the burden shall be on the Corporation to prove that the person seeking to enforce a right to indemnification or to an advancement of
expenses or the person from whom the Corporation seeks to recover an advancement of expenses is not entitled to be indemnified, or to such an advancement of expenses, under this Article VI or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6. <U>Determination of Entitlement to Indemnification</U>.</B> Any indemnification required or permitted under this Article VI
(unless ordered by a court) shall be made by the Corporation only as authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or agent is proper in the circumstances because he or
she has met all applicable standards of conduct set forth in this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Article VI and Section&nbsp;145 of the General Corporation Law of the State of Delaware. Such determination shall be made, with respect to a person who is a director or officer of the Corporation
at the time of such determination, (a)&nbsp;by a majority vote of the directors who are not parties to such Proceeding, even though less than a quorum, (b)&nbsp;by a committee of such directors designated by majority vote of such directors, even
though less than a quorum, (c)&nbsp;if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or (d)&nbsp;by the stockholders. Such determination shall be made, with respect to any person who
is not a director or officer of the Corporation at the time of such determination, in the manner determined by the Board of Directors (including in such manner as may be set forth in any general or specific action of the Board of Directors
applicable to indemnification claims by such person) or in the manner set forth in any agreement to which such person and the Corporation are parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7. <U>Non-Exclusive Rights</U>.</B> The indemnification and advancement of expenses provided in this Article VI shall not be
deemed exclusive of any other rights to which any person may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors, or otherwise, both as to action in such person&#146;s official capacity and as to action in another
capacity while holding such office, and shall continue as to a person who has ceased to be such director, officer, employee, or agent and shall inure to the benefit of the heirs, executors, and administrators of such person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8. <U>Insurance</U>.</B> The Corporation may purchase and maintain insurance on behalf of any person who is or was a director,
officer, employee, or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee, or agent of Another Enterprise against any liability asserted against such person and incurred by such person in
any such capacity, or arising out of such person&#146;s status as such, whether or not the Corporation would have the power to indemnify such person against such liability under the provisions of this Article VI or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9. <U>Severability</U>.</B> If any provision or provisions of this Article VI shall be held to be invalid, illegal, or
unenforceable for any reason whatsoever: (a)&nbsp;the validity, legality, and enforceability of the remaining provisions of this Article VI (including, without limitation, each portion of any paragraph or clause containing any such provision held to
be invalid, illegal, or unenforceable, that is not itself held to be invalid, illegal, or unenforceable) shall not in any way be affected or impaired thereby and (b)&nbsp;to the fullest extent possible, the provisions of this Article VI (including,
without limitation, each such portion of any paragraph or clause containing any such provision held to be invalid, illegal, or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal, or
unenforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10. <U>Miscellaneous</U>.</B> For purposes of this Article VI: (a)&nbsp;references to serving at the
request of the Corporation as a director or officer of Another Enterprise shall include any service as a director or officer of the Corporation that imposes duties on, or involves services by, such director or officer with respect to an employee
benefit plan, (b)&nbsp;references to serving at the request of the Corporation as an employee or agent of Another Enterprise shall include any service as an employee or agent of the Corporation that imposes duties on, or involves services by, such
employee or agent with respect to an employee benefit plan, (c)&nbsp;a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be
deemed to have acted in a manner not opposed to the best interests of the Corporation, and (d)&nbsp;references to a director of Another Enterprise shall include, in the case of any entity that is not managed by a board of directors, such other
position, such as manager or trustee or member of the governing body of such entity, that entails responsibility for the management and direction of such entity&#146;s affairs, including, without limitation, general partner of any partnership
(general or limited) and manager or managing member of any limited liability company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1. <U>Books and Records</U>.</B> (a)&nbsp;Any books or records maintained by the Corporation in the regular course of its
business, including its stock ledger, books of account, and minute books, may be kept on, or by means of, or be in the form of, any information storage device or method; <I>provided</I>, <I>however</I>, that the books and records so kept can be
converted into clearly legible paper form within a reasonable time. The Corporation shall so convert any books or records so kept upon the request of any person entitled to inspect such records pursuant to the Certificate of Incorporation, these
Bylaws, or the provisions of the General Corporation Law of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) It shall be the duty of the Secretary or other
officer of the Corporation who shall have charge of the stock ledger to prepare and make, at least ten (10)&nbsp;days before every meeting of the stockholders, a complete list of the stockholders entitled to vote thereat, arranged in alphabetical
order, and showing the address of each stockholder and the number of shares registered in the stockholder&#146;s name; <I>provided</I>, <I>however</I>, if the record date for determining the stockholders entitled to vote at the meeting is fewer than
ten (10)&nbsp;days before the meeting date, the list shall reflect the stockholders entitled to vote as of the tenth day before the meeting date. Nothing contained in this subsection (b)&nbsp;shall require the Corporation to include electronic mail
addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of at least ten (10)&nbsp;days prior to the meeting: (i)&nbsp;on a
reasonably accessible electronic network, <I>provided</I> that the information required to gain access to such list is provided with the notice of the meeting, or (ii)&nbsp;during ordinary business hours, at the principal place of business of the
Corporation. If the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation. If the meeting is to be
held at a place, then the list shall be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present. If the meeting is to be held solely by means of remote
communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible network, and the information required to access such list shall be provided with the notice of the
meeting. The stock ledger shall be the only evidence of the identity of the stockholders entitled to examine such list. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Except to the
extent otherwise required by law, or by the Certificate of Incorporation, or by these Bylaws, the Board of Directors shall determine from time to time whether and, if allowed, when and under what conditions and regulations the stock ledger, books,
records, and accounts of the Corporation, or any of them, shall be open to inspection by the stockholders and the stockholders&#146; rights, if any, in respect thereof. Except as otherwise provided by law, the stock ledger shall be the only evidence
of the identity of the stockholders entitled to examine the stock ledger, the books, records, or accounts of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2. <U>Voting Shares in Other Business Entities</U>.</B> The Chief Executive Officer, the President, any Vice President, or any
other officer or officers of the Corporation designated by the Board of Directors, the Chief Executive Officer or the President may vote, and otherwise exercise on behalf of the Corporation any and all rights and powers incident to the ownership of,
any and all shares of stock or other equity interest held by the Corporation in any other corporation or other business entity. The authority herein granted may be exercised either by any such officer in person or by any other person authorized to
do so by proxy or power of attorney duly executed by any such officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3. <U>Execution of Corporate Instruments</U>.</B>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Board of Directors may in its discretion determine the method and designate the signatory officer or officers, or other person or
persons, to execute, sign, or endorse any corporate instrument or document, or to sign the corporate name without limitation, except where otherwise provided by law, and such execution or signature shall be binding upon the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Unless otherwise specifically determined by the Board of Directors or otherwise required
by law, formal contracts of the Corporation, promissory notes, deeds of trust, mortgages, and other evidences of indebtedness of the Corporation, and other corporate instruments or documents requiring the corporate seal, shall be executed, signed,
or endorsed by the Chairman of the Board, the Chief Executive Officer, the President, any Vice President, the Secretary, the Chief Financial Officer, the Treasurer, or any Assistant Secretary or Assistant Treasurer. All other instruments and
documents requiring a corporate signature but not requiring the corporate seal may be executed as aforesaid or in such other manner and by such other person or persons as may be determined from time to time by the Board of Directors or the
President. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) All checks and drafts drawn on banks or other depositaries on funds to the credit of the Corporation or in special
accounts of the Corporation shall be executed, signed, or endorsed by the Chief Financial Officer, the Treasurer, any Assistant Treasurer, or in such other manner and by such other person or persons as may be determined from time to time by the
Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Unless otherwise specifically determined by the Board of Directors or otherwise required by law, the execution,
signing, or endorsement of any corporate instrument or document may be effected manually, by facsimile, or (to the extent permitted by applicable law and subject to such policies and procedures as the Corporation may have in effect from time to
time) by electronic signature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4. <U>Fiscal Year</U>.</B> The fiscal year of the Corporation shall be such fiscal year as
the Board of Directors from time to time by resolution shall determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5. <U>Gender/Number</U>.</B> As used in these
Bylaws, the masculine, feminine, or neuter gender, and the singular and plural number, shall each include the other whenever the context so indicates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6. <U>Section Titles</U>.</B> The titles of the sections and subsections have been inserted as a matter of reference only and
shall not control or affect the meaning or construction of any of the terms and provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7. <U>Electronic
Transmission</U>.</B> For purposes of these Bylaws, &#147;electronic transmission&#148; means any form of communication, not directly involving the physical transmission of paper, that creates a record that may be retained, retrieved, and reviewed
by a recipient thereof, and that may be directly reproduced in paper form by such a recipient through an automated process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8. <U>Amendment</U>.</B> These Bylaws, or any of them, may be altered, amended, or repealed, and new Bylaws may be made,
(a)&nbsp;at any annual or regular meeting of the Board of Directors or at any special meeting of the Board of Directors if notice of the proposed alteration, amendment, or repeal be contained in written notice of such special meeting or (b)&nbsp;at
any annual meeting of the stockholders (subject to Section&nbsp;13 of Article II of these Bylaws) or at any special meeting of the stockholders of the Corporation if noticed of the proposed alteration, amendment, or repeal is contained in the
Corporation&#146;s notice of such special meeting of stockholders (and subject to Section&nbsp;2 of Article II of these Bylaws). Anything herein to the contrary notwithstanding, any alteration, amendment, or repeal of these Bylaws, or the making of
any new Bylaw, by the stockholders shall require the affirmative vote of the holders of not less than a majority of the voting power represented by the issued and outstanding shares of the Corporation entitled to vote thereon. Any Bylaws altered,
amended, or made by the stockholders may be altered, amended, or repealed by either the Board of Directors or the stockholders, in the manner set forth in this Section&nbsp;8, except a Bylaw amendment adopted by the stockholders that specifies the
votes that shall be necessary for the election of directors shall not be amended or repealed by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9. <U>Certificate of Incorporation</U>.</B> Anything herein to the contrary notwithstanding, if any provision contained in
these Bylaws is inconsistent with or conflicts with a provision of the Certificate of Incorporation, such provision of these Bylaws shall be superseded by the inconsistent provision in the Certificate of Incorporation to the extent necessary to give
effect to such provision in the Certificate of Incorporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10. <U>Forum</U>.</B> Unless the Corporation consents in writing to the
selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if and only if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, the Superior Court of the State of Delaware, or, if and only if
both the Court of Chancery of the State of Delaware and the Superior Court of the State of Delaware lack subject matter jurisdiction, the United States District Court for the District of Delaware) and any state (or, if applicable, federal) appellate
court therefrom shall, to the fullest extent permitted by law, be the sole and exclusive forum for (a)&nbsp;any derivative action, suit, or proceeding brought on behalf of the Corporation, (b)&nbsp;any action, suit, or proceeding asserting a claim
of breach of fiduciary duty owed by any director, officer, or other employee of the Corporation to the Corporation or the Corporation&#146;s stockholders, (c)&nbsp;any action, suit, or proceeding asserting a claim against the Corporation or any
director, officer, or other employee of the Corporation arising pursuant to, or seeking to enforce any right, obligation, or remedy under, any provision of the DGCL or the Certificate of Incorporation or the Corporation&#146;s Bylaws (in each case,
as may be amended from time to time), (d)&nbsp;any action, suit, or proceeding as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware, or (e)&nbsp;any action, suit, or proceeding asserting a claim governed by the
internal affairs doctrine, in all cases subject to the court&#146;s having personal jurisdiction over the indispensable parties named as defendants (including personal jurisdiction by reason of any such indispensable party&#146;s consent to personal
jurisdiction in the State of Delaware or such court). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">END OF BYLAWS </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom571963_127"></A>ORTHOFIX INTERNATIONAL N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED 2012 LONG-TERM INCENTIVE PLAN </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><B>TABLE OF CONTENTS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>1.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>PURPOSE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>2.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>DEFINITIONS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>ADMINISTRATION OF THE PLAN</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-10</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">3.1&#8195;&#8194;&#8201;Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">3.2&#8195;&#8194;&#8201;Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">3.3&#8195;&#8194;&#8201;Terms of Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">3.4&#8195;&#8194;&#8201;Forfeiture; Recoupment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">3.5&#8195;&#8194;&#8201;No Repricing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">3.6&#8195;&#8194;&#8201;Deferral Arrangement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">3.7&#8195;&#8194;&#8201;No Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">3.8&#8195;&#8194;&#8201;Stock Issuance; Book-Entry</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>STOCK SUBJECT TO THE PLAN</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-14</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">4.1&#8195;&#8194;&#8201;Number of Shares of Stock Available for Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">4.2&#8195;&#8194;&#8201;Adjustments in Authorized Shares of Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">4.3&#8195;&#8194;&#8201;Share Usage</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>EFFECTIVE DATE, DURATION AND AMENDMENTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-15</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">5.1&#8195;&#8194;&#8201;Effective Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">5.2&#8195;&#8194;&#8201;Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">5.3&#8195;&#8194;&#8201;Amendment, Suspension and Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>AWARD ELIGIBILITY AND LIMITATIONS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-16</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">6.1&#8195;&#8194;&#8201;Eligible Grantees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">6.2&#8195;&#8194;&#8201;Limitation on Shares of Stock Subject to Awards and Cash
Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">6.3&#8195;&#8194;&#8201;Stand-Alone, Additional, Tandem and Substitute Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">6.4&#8195;&#8194;&#8201;Minimum Vesting Requirements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>AWARD AGREEMENT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-17</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>8.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>TERMS AND CONDITIONS OF OPTIONS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-18</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.1&#8195;&#8194;&#8201;Option Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.2&#8195;&#8194;&#8201;Vesting and Exercisability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.3&#8195;&#8194;&#8201;Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.4&#8195;&#8194;&#8201;Termination of Service</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.5&#8195;&#8194;&#8201;Limitations on Exercise of Option</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.6&#8195;&#8194;&#8201;Method of Exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.7&#8195;&#8194;&#8201;Rights of Holders of Options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.8&#8195;&#8194;&#8201;Delivery of Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.9&#8195;&#8194;&#8201;Transferability of Options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.10&#8195;&#8201;Family Transfers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.11&#8195;&#8201;Limitations on Incentive Stock Options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">8.12&#8195;&#8201;Notice of Disqualifying Disposition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>9.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">9.1&#8195;&#8194;&#8201;Right to Payment and SAR Exercise Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">9.2&#8195;&#8194;&#8201;Other Terms</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">9.3&#8195;&#8194;&#8201;Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">9.4&#8195;&#8194;&#8201;Rights of Holders of SARs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">9.5&#8195;&#8194;&#8201;Transferability of SARs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">9.6&#8195;&#8194;&#8201;Family Transfers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>10.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>TERMS AND CONDITIONS OF RESTRICTED STOCK AND STOCK UNITS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-22</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">10.1&#8195;&#8201;Grant of Restricted Stock or Stock Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">10.2&#8195;&#8201;Restrictions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">10.3&#8195;&#8201;Restricted Stock Certificates; Book-Entry Registration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">10.4&#8195;&#8201;Rights of Holders of Restricted Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">10.5&#8195;&#8201;Rights of Holders of Stock Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">10.6&#8195;&#8201;Termination of Service</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">10.7&#8195;&#8201;Purchase of Restricted Stock and Shares of Stock Subject to Stock
Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">10.8&#8195;&#8201;Delivery of Shares of Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>11.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>TERMS AND CONDITIONS OF UNRESTRICTED STOCK AWARDS AND OTHER EQUITY- BASED AWARDS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-23</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>12.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>FORM OF PAYMENT FOR OPTIONS AND RESTRICTED STOCK</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-24</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">12.1&#8195;&#8201;General Rule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">12.2&#8195;&#8201;Surrender of Shares of Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">12.3&#8195;&#8201;Cashless Exercise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">12.4&#8195;&#8201;Other Forms of Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>13.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>TERMS AND CONDITIONS OF DIVIDEND EQUIVALENT RIGHTS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-25</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">13.1&#8195;&#8201;Dividend Equivalent Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">13.2&#8195;&#8201;Termination of Service</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>14.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>TERMS AND CONDITIONS OF PERFORMANCE AWARDS AND ANNUAL INCENTIVE AWARDS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-25</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">14.1&#8195;&#8201;Grant of Performance Awards and Annual Incentive Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">14.2&#8195;&#8201;Value of Performance Awards and Annual Incentive Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">14.3&#8195;&#8201;Earning of Performance Awards and Annual Incentive Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">14.4&#8195;&#8201;Form and Timing of Payment of Performance Awards and Annual Incentive
Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">14.5&#8195;&#8201;Performance Conditions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>15.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>PARACHUTE LIMITATIONS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-27</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>16.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>REQUIREMENTS OF LAW</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-27</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">16.1&#8195;&#8201;General</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">16.2&#8195;&#8201;Rule 16b-3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>17.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>EFFECT OF CHANGES IN CAPITALIZATION</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-28</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">17.1&#8195;&#8201;Changes in Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">17.2&#8195;&#8201;Reorganization in Which the Company Is the Surviving Entity Which Does not
Constitute a Corporate Transaction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">17.3&#8195;&#8201;Corporate Transaction in which Awards are not Assumed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">17.4&#8195;&#8201;Corporate Transaction in which Awards are Assumed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">17.5&#8195;&#8201;Adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">17.6&#8195;&#8201;No Limitations on Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>18.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>GENERAL PROVISIONS</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>C-31</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.1&#8195;&#8201;Disclaimer of Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-31</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.2&#8195;&#8201;Nonexclusivity of the Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-32</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.3&#8195;&#8201;Withholding Taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-32</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.4&#8195;&#8201;Captions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-33</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.5&#8195;&#8201;Other Provisions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-33</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.6&#8195;&#8201;Number and Gender</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-33</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.7&#8195;&#8201;Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-33</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.8&#8195;&#8201;Governing Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-33</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.9&#8195;&#8201;Foreign Jurisdictions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-33</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.10&#8194;&#8201;Section 409A of the Code</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B></B>C-34</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">18.11&#8194;&#8201;Non-Payment of Dividends or Dividend Equivalent Rights on Unvested
Awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">C-34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ORTHOFIX INTERNATIONAL N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED 2012 LONG-TERM INCENTIVE PLAN </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>PURPOSE </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan is intended to (a)&nbsp;provide eligible persons with an incentive to
contribute to the success of the Company and to operate and manage the Company&#146;s business in a manner that will provide for the Company&#146;s long-term growth and profitability, and (b)&nbsp;provide a means of obtaining, rewarding and
retaining key personnel. To this end, the Plan provides for the grant of options, stock appreciation rights, restricted stock, stock units (including deferred stock units), unrestricted stock, dividend equivalent rights, other equity-based awards
and cash bonus awards. Any of these Awards may, but need not, be made as performance incentives to reward the holders of such Awards for the achievement of annual or long-term performance goals in accordance with the terms of the Plan. Options
granted under the Plan may be <FONT STYLE="white-space:nowrap">Non-qualified</FONT> Stock Options or Incentive Stock Options, as provided herein. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>DEFINITIONS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of interpreting the Plan and related documents (including
Award Agreements), the following definitions shall apply, unless the context clearly indicates otherwise: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.1</B>
<B>&#147;Affiliate&#148;</B> means any company or other trade or business that controls, is controlled by or is under common control with the Company within the meaning of Rule&nbsp;405 of Regulation&nbsp;C under the Securities Act, including any
Subsidiary. For purposes of grants of Options or Stock Appreciation Rights, an entity may not be considered an Affiliate unless the Company holds a &#147;controlling interest&#148; in such entity within the meaning of Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.414(c)-2(b)(2)(i),</FONT> <I>provided,</I> that (a)&nbsp;except as specified in clause&nbsp;(b) below, an interest of &#147;at least 50&nbsp;percent&#148; shall be used instead of an interest of &#147;at
least 80&nbsp;percent&#148; in each case where &#147;at least 80&nbsp;percent&#148; appears in Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.414(c)-2(b)(2)(i)</FONT> and (b)&nbsp;where the grant of Options or Stock Appreciation
Rights is based upon a legitimate business criterion, an interest of &#147;at least 20&nbsp;percent&#148; shall be used instead of an interest of &#147;at least 80&nbsp;percent&#148; in each case where &#147;at least 80&nbsp;percent&#148; appears in
Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.414(c)-2(b)(2)(i).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.2</B> <B>&#147;Annual Incentive
Award&#148;</B> means an Award, denominated in cash, made subject to the attainment of performance goals (as provided in <B>Section</B><B></B><B>&nbsp;14</B>) over a Performance Period of up to one (1)&nbsp;year, which shall be the Company&#146;s
fiscal year, unless otherwise specified by the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.3</B> <B>&#147;Applicable Laws&#148;</B> means the legal requirements
relating to the Plan and the Awards under (a)&nbsp;applicable provisions of the Code, the Securities Act, the Exchange Act, any rules or regulations thereunder, and any other laws, rules, regulations, and government orders of any jurisdiction
applicable to the Company or its Affiliates, (b)&nbsp;applicable provisions of the corporate, securities, tax, and other laws, rules, regulations, and government orders of any jurisdiction applicable to Awards granted to residents thereof, and
(c)&nbsp;the rules of any Stock Exchange or Securities Market on which the Stock is listed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.4</B> <B>&#147;Award&#148;</B> means a
grant under the Plan of an Option, a Stock Appreciation Right, Restricted Stock, a Stock Unit, Unrestricted Stock, a Dividend Equivalent Right, a Performance Award, an Other Equity-Based Award, an Annual Incentive Award or cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.5</B> <B>&#147;Award Agreement&#148;</B> means the agreement, in such paper, electronic or other form as determined by the Committee,
between the Company and a Grantee that evidences and sets out the terms and conditions of an Award. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.6</B> <B>&#147;Benefit Arrangement&#148; </B>shall have the meaning set forth in<B>
Section</B><B></B><B>&nbsp;15</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.7</B> <B>&#147;Board&#148;</B> means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.8</B> <B>&#147;Cause&#148;</B> shall have the meaning set forth in the applicable agreement between the Grantee and the Company or an
Affiliate, and in the absence of such agreement, means, as determined by the Committee, (i)&nbsp;gross negligence or willful misconduct in connection with the performance of duties; (ii)&nbsp;conviction of a criminal offense (other than minor
traffic offenses); or (iii)&nbsp;material breach of any term of any employment, consulting or other services, confidentiality, intellectual property or <FONT STYLE="white-space:nowrap">non-competition</FONT> agreements, if any, between the Service
Provider and the Company or an Affiliate. Any determination by the Committee regarding whether an event constituting Cause shall have occurred shall be finding, binding and conclusive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.9</B> <B>&#147;Code&#148;</B> means the Internal Revenue Code of 1986, as amended, as now in effect or as hereafter amended, and any
successor thereto. References in the Plan to any Code Section shall be deemed to include, as applicable, regulations and guidance promulgated under such Code Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.10</B> <B>&#147;Committee&#148;</B> means a committee of, and designated from time to time by resolution of, the Board, which shall be
constituted as provided in <B>Section</B><B></B><B>&nbsp;3.1</B> (or, if no Committee has been so designated, the entire Board itself). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.11</B> <B>&#147;Company&#148;</B> means Orthofix International N.V. and any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.12</B> &#147;<B>Corporate Transaction</B>&#148; means, subject to <B>Section</B><B></B><B>&nbsp;18.10</B>, (a) a &#147;Person&#148; or
&#147;group&#148; (within the meaning of Sections 13(d) and 14(d)(2) of the Exchange Act) becomes the &#147;beneficial owner&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) of more than fifty percent
(50%) of the total voting power of all classes of stock of the Company; (b)&nbsp;individuals who on the Effective Date constitute the Board (together with any new Directors whose election by such Board or whose nomination by such Board for election
by the shareholders of the Company was approved by a vote of at least a majority of the members of such Board then in office who either were members of such Board on the Effective Date or whose election or nomination for election was previously so
approved) cease for any reason to constitute a majority of the members of such Board then in office; (c)&nbsp;the Company consummates a transaction with, or merger with or into, any Person, or any Person consummates a transaction with, or merger
with or into, the Company, other than any such transaction in which the holders of securities that represented one hundred percent (100%) of the voting stock of the Company immediately prior to such transaction (or other securities into which such
securities are converted as part of such merger or consolidation transaction) own directly or indirectly at least a majority of the voting power of the surviving Person in such merger or consolidation transaction immediately after such transaction;
(d)&nbsp;there is consummated any direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one transaction or a series of related transactions, of all or substantially all of the
assets of the Company and its Subsidiaries, taken as a whole, to any &#147;Person&#148; or &#147;group&#148; (within the meaning of Sections 13(d) and 14(d)(2) of the Exchange Act); or (e)&nbsp;the shareholders of the Company adopt a plan or
proposal for the liquidation, winding up or dissolution of the Company. The Board shall have full and final authority, in its sole discretion, to determine conclusively whether a Corporate Transaction has occurred pursuant to the above definition,
the date of the occurrence of such Corporate Transaction, and any incidental matters relating thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.13</B>
<B>&#147;Disability&#148;</B> means the Grantee is unable to engage in any substantial gainful activity by reason of a medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be
expected to last for a continuous period of not less than 12&nbsp;months. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.14</B> <B>&#147;Dividend Equivalent Right&#148;</B> means a right, granted to a Grantee
pursuant to <B>Section</B><B></B><B>&nbsp;13</B>, to receive cash, Stock, other Awards or other property equal in value to dividends or other periodic payments paid or made with respect to a specified number of shares of Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.15</B> <B>&#147;Effective Date&#148;</B> means June&nbsp;18, 2018, the date of the approval of the Plan, as amended and restated, by the
Company&#146;s shareholders, the Plan, as amended and restated, having been approved by the Board on April&nbsp;23, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.16</B>
<B>&#147;Exchange Act&#148;</B> means the Securities Exchange Act of 1934, as amended, as now in effect or as hereafter amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.17</B> <B>&#147;</B><B>Fair Market Value</B><B>&#148;</B> means the fair market value of a share of Stock for purposes of the Plan, which
shall be determined as follows, subject to <B>Section</B><B></B><B>&nbsp;18.3</B>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) If on the Grant Date or other determination date
the shares of Stock are listed on an established national or regional stock exchange (a &#147;<B>Stock Exchange</B>&#148;), or are publicly traded on an established securities market (a &#147;<B>Securities Market</B>&#148;), the Fair Market Value of
a share of Stock shall be the closing price of the Stock as reported on such Stock Exchange or Securities Market (provided that if there is more than one such Stock Exchange or Securities Market, the Committee shall designate the appropriate Stock
Exchange or Securities Market for purposes of the Fair Market Value determination) on the Grant Date or other determination date. If there is no such reported closing price on such date, the Fair Market Value of a share of Stock shall be, as
determined by the Committee, the mean between (i)&nbsp;the highest bid price and the lowest asked price of the Stock as reported on such Stock Exchange or such Securities Market on such date or (ii)&nbsp;the high and low sale prices of the Stock as
reported on such Stock Exchange or such Securities Market on such date, or if no sale of Stock shall have been so reported for such date, on the immediately preceding day on which any sale of Stock shall have been reported on such Stock Exchange or
Securities Market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) If on such Grant Date or other determination date the shares of Stock are not listed on a Stock Exchange or
publicly traded on a Securities Market, the Fair Market Value of a share of Stock shall be the value of the Stock as determined by the Committee by the reasonable application of a reasonable valuation method, in a manner consistent with Code
Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.18</B> <B>&#147;Family Member&#148;</B> means, with respect to any Grantee as of any date of determination,
(a)&nbsp;a person who is a spouse, former spouse, child, stepchild, grandchild, parent, stepparent, grandparent, niece, nephew, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mother-in-law,</FONT></FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">father-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">son-in-law,</FONT></FONT>
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">daughter-in-law,</FONT></FONT> brother, sister, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">brother-in-law,</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">sister-in-law,</FONT></FONT> including adoptive relationships, of such Grantee, (b)&nbsp;any person sharing such Grantee&#146;s household (other than a tenant or employee), (c)&nbsp;a trust in which any one or more of the
persons specified in clauses&nbsp;(a) and (b)&nbsp;above (and such Grantee) own more than fifty percent (50%) of the beneficial interest, (d)&nbsp;a foundation in which any one or more of the persons specified in clauses&nbsp;(a) and (b)&nbsp;above
(and such Grantee) control the management of assets, and (e)&nbsp;any other entity in which one or more of the persons specified in clauses&nbsp;(a) and (b)&nbsp;above (and such Grantee) own more than fifty percent (50%) of the voting interests.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.19</B> <B>&#147;</B><B>Grant Date</B><B>&#148;</B> means, as determined by the Committee, the later to occur of (a)&nbsp;the date as
of which the Company completes the corporate action constituting the Award, or (b)&nbsp;such date subsequent to the date specified in clause&nbsp;(a) as may be specified by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.20</B> <B>&#147;Grantee&#148;</B> means a person who receives or holds an Award under the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.21</B> <B>&#147;Incentive Stock Option&#148;</B> means an &#147;incentive stock option&#148;
within the meaning of Code Section&nbsp;422. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.22</B> <B><FONT STYLE="white-space:nowrap">&#147;Non-qualified</FONT> Stock
Option&#148;</B> means an Option that is not an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.23</B> <B>&#147;Option&#148;</B> means an option to purchase
one or more shares of Stock at a specified Option Price pursuant to <B>Section</B><B></B><B>&nbsp;8</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.24</B> <B>&#147;Option
Price&#148;</B> means the exercise price for each share of Stock subject to an Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.25</B> <B>&#147;Original Effective
Date</B>&#148; means April&nbsp;13, 2012. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.26</B> <B>&#147;Other Agreement&#148;</B> shall have the meaning set forth in<B>
Section</B><B></B><B>&nbsp;15</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.27</B> <B>&#147;Other Equity-Based Award&#148;</B> means an Award representing a right or other
interest that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Stock, other than an Option, a Stock Appreciation Right, Restricted Stock, a Stock Unit, Unrestricted Stock, a Dividend
Equivalent Right, a Performance Award or an Annual Incentive Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.28</B> <B>&#147;Outside Director&#148;</B> means a member of the
Board who is not an officer or employee of the Company or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.29</B> <B>&#147;Parachute Payment&#148;</B> shall have the
meaning set forth in <B>Section</B><B></B><B>&nbsp;15</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.30</B> <B>&#147;Performance Award&#148;</B> means an Award made subject
to the attainment of performance goals (as provided in <B>Section</B><B></B><B>&nbsp;14</B>) over a Performance Period of up to ten (10)&nbsp;years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.31</B> <B>&#147;</B><B>Performance Measures</B><B>&#148;</B> means objective performance criteria on which performance goals under
Performance Awards are based, such as: (a)&nbsp;net earnings or net income; (b)&nbsp;operating earnings; (c)&nbsp;pretax earnings; (d)&nbsp;earnings per share; (e)&nbsp;share price, including growth measures and total shareholder return;
(f)&nbsp;earnings before interest and taxes; (g)&nbsp;earnings before interest, taxes, depreciation and/or amortization; (h)&nbsp;earnings before interest, taxes, depreciation and/or amortization as adjusted to exclude any one or more of the
following: stock-based compensation expense; income from discontinued operations; gain on cancellation of debt; debt extinguishment and related costs; restructuring, separation and/or integration charges and costs; reorganization and/or
recapitalization charges and costs; impairment charges; gain or loss related to investments; sales and use tax settlement; and gain on <FONT STYLE="white-space:nowrap">non-monetary</FONT> transactions; (i)&nbsp;sales or revenue growth, whether in
general, by type of product or service, or by type of customer; (j)&nbsp;gross or operating margins; (k)&nbsp;return measures, including return on assets, capital, investment, equity, sales or revenue; (l)&nbsp;cash flow, including: operating cash
flow; free cash flow, defined as earnings before interest, taxes, depreciation and/or amortization (as adjusted to exclude any one or more of the items that may be excluded pursuant to the Performance Measure specified in clause (h)&nbsp;above) less
capital expenditures; levered free cash flow, defined as free cash flow less interest expense; cash flow return on equity; and cash flow return on investment; (m)&nbsp;productivity ratios; (n)&nbsp;expense targets; (o)&nbsp;market share;
(p)&nbsp;financial ratios as provided in credit agreements of the Company and its Subsidiaries; (q)&nbsp;working capital targets; (r)&nbsp;completion of acquisitions of businesses or companies; (s)&nbsp;completion of divestitures and asset sales;
and (t)&nbsp;any combination of the foregoing business criteria. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.32</B> <B>&#147;Performance Period&#148;</B> means the period of
time during which the performance goals under Performance Awards and Annual Incentive Awards must be met in order to determine the degree of payout and/or vesting with respect to any such Performance Awards or Annual Incentive Awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.33</B> <B>&#147;Plan&#148;</B> means this Orthofix International N.V. Amended and Restated
2012 Long-Term Incentive Plan, as it may be further amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.34</B> <B>&#147;Prior Plan&#148;</B> means the
Orthofix International N.V. Amended and Restated 2004 Long-Term Incentive Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.35</B> <B>&#147;Purchase Price&#148;</B> means the
purchase price, if any, for each share of Stock subject to an Award of Restricted Stock, Stock Units or Unrestricted Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.36</B>
<B>&#147;Restricted Stock&#148; </B>means shares of Stock awarded to a Grantee pursuant to<B> Section</B><B></B><B>&nbsp;10</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.37</B> <B>&#147;SAR Exercise Price&#148; </B>means the per share exercise price of a SAR granted to a Grantee pursuant to<B>
Section</B><B></B><B>&nbsp;9</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.38</B> <B>&#147;Securities Act&#148;</B> means the Securities Act of 1933, as amended, as now in
effect or as hereafter amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.39</B> <B>&#147;Service&#148;</B> means service of a Grantee as a Service Provider to the Company or
any Affiliate. Unless otherwise provided in the applicable Award Agreement, a Grantee&#146;s change in position or duties with the Company or any Affiliate shall not result in interrupted or terminated Service, so long as the Grantee continues to be
a Service Provider to the Company or any Affiliate. If a Service Provider&#146;s employment or other Service relationship is with an Affiliate and the applicable entity ceases to be an Affiliate, a termination of Service shall be deemed to have
occurred when such entity ceases to be an Affiliate unless the Service Provider transfers his or her employment or other Service relationship to the Company or any other Affiliate. Any determination by the Committee whether a termination of Service
shall have occurred for purposes of the Plan shall be final, binding and conclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.40</B> <B>&#147;Service Provider&#148;</B>
means, as of any date of determination, (a)&nbsp;an employee, officer, or director of the Company or an Affiliate, or (b)&nbsp;a consultant (who is a natural person) or adviser (who is a natural person) of the Company or any Affiliate who provides
bona fide services to the Company or any Affiliate and whose services are not in connection with the Company&#146;s sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market for the
Company&#146;s stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.41</B> <B>&#147;Share Limit&#148;</B> shall have the meaning set forth in
<B>Section</B><B></B><B>&nbsp;4.1(a)</B>.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.42</B> <B>&#147;Stock&#148;</B> means the common stock, par value $0.01 per share,
of the Company, or any security for which the shares of Stock may be exchanged or into which the shares of Stock may be converted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.43</B> <B>&#147;Stock Appreciation Right&#148; </B>or<B> &#147;SAR&#148; </B>means a right granted to a Grantee pursuant to<B>
Section</B><B></B><B>&nbsp;9</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.44</B> <B>&#147;Stock Unit&#148; </B>means a bookkeeping entry representing the equivalent of one
share of Stock awarded to a Grantee pursuant to<B> Section</B><B></B><B>&nbsp;10</B> that may be settled, subject to the terms and conditions of the applicable Award Agreement, in shares of Stock, cash or a combination thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.45</B> <B>&#147;Subsidiary&#148;</B> means any corporation (other than the Company) or
<FONT STYLE="white-space:nowrap">non-corporate</FONT> entity with respect to which the Company and Subsidiaries collectively own, directly or indirectly, fifty percent (50%) or more of the total combined voting power of all classes of stock,
membership interests or other ownership interests of any class or kind ordinarily having the power to vote for the directors, managers or other voting members of the governing body of such corporation or
<FONT STYLE="white-space:nowrap">non-corporate</FONT> entity. In addition, any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other entity may be designated by the Committee as a Subsidiary, <I>provided</I> that (a)&nbsp;such entity could be considered as a subsidiary according to generally accepted accounting
principles in the United States of America and (b)&nbsp;in the case of an Award of Options or Stock Appreciation Rights, such Award would be considered to be granted in respect of &#147;service recipient stock&#148; under Code Section&nbsp;409A.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.46</B> <B>&#147;Substitute Award&#148;</B> means an Award granted upon assumption of, or in substitution for, outstanding awards
previously granted under a compensatory plan by a business entity acquired or to be acquired by the Company or an Affiliate or with which the Company or an Affiliate has combined or will combine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.47</B> <B>&#147;Ten Percent Shareholder&#148;</B> means a natural person who owns more than ten percent (10%) of the total combined
voting power of all classes of outstanding voting securities of the Company, the Company&#146;s parent (if any) or any of the Company&#146;s Subsidiaries. In determining stock ownership, the attribution rules of Code Section&nbsp;424(d) shall be
applied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.48</B> <B>&#147;Unrestricted Stock&#148; </B>shall have the meaning set forth in<B> Section</B><B></B><B>&nbsp;11</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context otherwise requires, all references in the Plan to &#147;including&#148; shall mean &#147;including without
limitation.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>ADMINISTRATION OF THE PLAN </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.1</B> <B>Committee.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The Committee shall administer the Plan and shall have such powers and authorities related to the administration of the Plan as are
consistent with the Company&#146;s articles of incorporation and bylaws and Applicable Laws. Without limiting the generality of the foregoing, the Committee shall have full power and authority to take all actions and to make all determinations
required or provided for under the Plan, any Award or any Award Agreement, and shall have full power and authority to take all such other actions and make all such other determinations not inconsistent with the specific terms and provisions of the
Plan which the Committee deems to be necessary or appropriate to the administration of the Plan, any Award or any Award Agreement. All such actions and determinations shall be made by (i)&nbsp;the affirmative vote of a majority of the members of the
Committee present at a meeting at which a quorum is present, or (ii)&nbsp;the unanimous consent of the members of the Committee executed in writing or evidenced by electronic transmission in accordance with the Company&#146;s articles of
incorporation and bylaws and Applicable Laws. Unless otherwise expressly determined by the Board, the interpretation and construction by the Committee of any provision of the Plan, any Award or any Award Agreement shall be final, binding and
conclusive whether or not expressly provided for in any provision of the Plan, such Award or such Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) In the event that
the Plan, any Award or any Award Agreement provides for any action to be taken by or any determination to be made by the Board, such action may be taken or such determination may be made by the Committee or another committee constituted in
accordance with this <B>Section</B><B></B><B>&nbsp;3.1</B> if the Board has delegated the power and authority to do so to the Committee or such other committee pursuant to this <B>Section</B><B></B><B>&nbsp;3.1</B>. Unless otherwise expressly
determined by the Board, any such action or determination by the Committee or other committee shall be final, binding and conclusive whether or not expressly provided for in any provision of the Plan, such Award or such Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Except as provided in <B>Section</B><B></B><B>&nbsp;3.2</B> and except as the Board may otherwise determine, the Committee shall consist
of two or more Outside Directors of the Company who: (a)&nbsp;meet such requirements as may be established from time to time by the Securities and Exchange Commission </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for plans intended to qualify for exemption under <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> (or its successor) under the Exchange Act, and (b)&nbsp;comply with the independence
requirements of the Stock Exchange or Securities Market on which the Stock is listed or publicly traded; <I>provided,</I> that any action taken by the Committee shall be valid and effective whether or not members of the Committee at the time of such
action are later determined not to have satisfied the requirements for membership set forth in this <B>Section</B><B></B><B>&nbsp;3.1</B> or otherwise provided in any charter of the Committee; <I>provided, further </I>that, notwithstanding anything
in the Plan to the contrary, to the extent necessary to satisfy any transition rule or applicable transition guidance pertaining to Awards intended to satisfy the criteria for performance-based compensation under Code Section&nbsp;162(m), the
Committee administering such Awards shall consist of two or more Outside Directors who qualify as &#147;outside directors&#148; within the meaning of Code Section&nbsp;162(m) and the applicable guidance thereunder. Without limiting the generality of
the foregoing, the Committee may be the Compensation Committee of the Board or a subcommittee thereof if the Compensation Committee of the Board or such subcommittee satisfies the foregoing requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The Board may also appoint one or more committees of the Board, each composed of one or more directors of the Company who need not be
Outside Directors, who may administer the Plan with respect to employees or other Service Providers who are not &#147;executive officers&#148; as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;3b-7</FONT> under the Exchange Act or directors
of the Company, may grant Awards under the Plan to such employees or other Service Providers, and may determine all terms of such Awards, subject to the requirements of <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> under the Exchange Act
and any Stock Exchange or Securities Market on which the Stock is listed or publicly traded. Any reference to &#147;Committee&#148; in the Plan, any Award or any Award Agreement shall be deemed, as applicable, to refer to any committee appointed by
the Board pursuant to this <B>Section</B><B></B><B>&nbsp;3.1</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) To the extent permitted by Applicable Laws, the Committee may, by
resolution, delegate some or all of its authority with respect to the Plan and Awards to the Chief Executive Officer of the Company and/or any other officer of the Company designated by the Committee, provided that the Committee may not delegate its
authority hereunder (i)&nbsp;to make Awards to directors of the Company, (ii)&nbsp;to make Awards to employees who are (A) &#147;executive officers&#148; as defined in <FONT STYLE="white-space:nowrap">Rule&nbsp;3b-7</FONT> under the Exchange Act, or
(B)&nbsp;officers of the Company who are delegated authority by the Committee pursuant to this <B>Section</B><B></B><B>&nbsp;3.1</B>, or (iii)&nbsp;to interpret the Plan, any Award or any Award Agreement. Any delegation hereunder will be subject to
the restrictions and limits that the Committee specifies at the time of such delegation or thereafter. Nothing in the Plan will be construed as obligating the Committee to delegate authority to any officer of the Company, and the Committee may at
any time rescind the authority delegated to an officer of the Company appointed hereunder and delegate authority to one or more other officers of the Company. At all times, an officer of the Company delegated authority pursuant to this
<B>Section</B><B></B><B>&nbsp;3.1</B> will serve in such capacity at the pleasure of the Committee. Any action undertaken by any such officer of the Company in accordance with the Committee&#146;s delegation of authority will have the same force and
effect as if undertaken directly by the Committee, and any reference to the &#147;Committee&#148; in the Plan, any Award or any Award Agreement shall be deemed, to the extent consistent with the terms and limitations of such delegation, to refer to
each officer delegated authority by the Committee pursuant to this <B>Section</B><B></B><B>&nbsp;3.1</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.2</B> <B>Board.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board from time to time may exercise any or all of the powers and authorities related to the administration and implementation of the
Plan, as set forth in <B>Section</B><B></B><B>&nbsp;3.1</B> and other applicable provisions of the Plan, as the Board shall determine, consistent with the Company&#146;s articles of incorporation and bylaws and Applicable Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.3</B> <B>Terms of Awards.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the other terms and conditions of the Plan, the Committee shall have full and final authority to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) designate Grantees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)
determine the type or types of Awards to be made to a Grantee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) determine the value or number of shares of Stock to be subject to an
Award; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) establish the terms and conditions of each Award (including the Option Price of any Option, the SAR Exercise Price of any SAR,
and the Purchase Price of shares of Restricted Stock or vested Stock Units, the nature and duration of any restriction or condition (or provision for lapse thereof) relating to the vesting, exercise, transfer, or forfeiture of an Award or the shares
of Stock subject thereto, the treatment of an Award in the event of a Corporate Transaction (subject to applicable agreements), and any terms or conditions that may be necessary to qualify Options as Incentive Stock Options); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) prescribe the form of each Award Agreement evidencing an Award; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) amend, modify, reprice (except as such practice is prohibited by <B>Section</B><B></B><B>&nbsp;3.5</B> herein), or supplement the terms of
any outstanding Award, which authority shall include the authority, in order to effectuate the purposes of the Plan but without amending the Plan, to make Awards or to modify outstanding Awards made to eligible natural persons who are foreign
nationals or are natural persons who are employed outside the United States to reflect differences in local law, tax policy, or custom, <I>provided</I> that, notwithstanding the foregoing, no amendment, modification or supplement of the terms of any
outstanding Award shall, without the consent of the Grantee thereof, materially impair the Grantee&#146;s rights under such Award; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) make Substitute Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.4 Forfeiture; Recoupment.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The Committee may reserve the right in an Award Agreement to cause a forfeiture of the gain realized by a Grantee with respect to an Award
thereunder on account of actions taken by, or failed to be taken by, such Grantee in violation or breach of, or in conflict with, any (i)&nbsp;employment agreement, <FONT STYLE="white-space:nowrap">(ii)&nbsp;non-competition</FONT> agreement,
(iii)&nbsp;agreement prohibiting solicitation of Employees or clients of the Company or an Affiliate, (iv)&nbsp;confidentiality obligation with respect to the Company or an Affiliate, (v)&nbsp;Company or Affiliate policy or procedure,
(vi)&nbsp;other agreement, or (vii)&nbsp;other obligation of such Grantee to the Company or an Affiliate, as and to the extent specified in such Award Agreement. If the Grantee of an outstanding Award is an employee of the Company or an Affiliate
and such Grantee&#146;s Service is terminated for Cause, the Committee may annul such Grantee&#146;s outstanding Award as of the date of the Grantee&#146;s termination of Service for Cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Any Award granted pursuant to the Plan, to the extent provided in any Award Agreement relating thereto, shall be subject to mandatory
repayment by the Grantee of such Award to the Company to the extent that such Grantee is or in the future becomes subject to (i)&nbsp;any Company or Affiliate &#147;clawback&#148; or recoupment policy or (ii)&nbsp;any Applicable Laws, in each case
that require the repayment by such Grantee to the Company or Affiliate of compensation paid to such Grantee by the Company or an Affiliate in the event that such Grantee fails to comply with, or violates, the terms or requirements of such policy.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If the Company is required to prepare an accounting restatement due to the material
noncompliance by the Company, as a result of misconduct, with any financial reporting requirement under the federal securities laws, any Grantee of an Award under such Award Agreement who knowingly engaged in such misconduct, was grossly negligent
in engaging in such misconduct, knowingly failed to prevent such misconduct or was grossly negligent in failing to prevent such misconduct, shall reimburse the Company the amount of any payment in settlement of such Award earned or accrued during
the period of twelve (12)&nbsp;months following the first public issuance or filing with the United States Securities and Exchange Commission (whichever first occurred) of the financial document that contained information affected by such material
noncompliance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding any other provision of the Plan or any provision of any Award Agreement, if the Company is required to
prepare an accounting restatement, then Grantees shall forfeit any cash or Stock received in connection with an Award (or an amount equal to the Fair Market Value of such Stock on the date of delivery thereof to the Grantee if the Grantee no longer
holds the shares of Stock) if pursuant to the terms of the Award Agreement for such Award, the amount of the Award earned or the vesting in the Award was expressly based on the achievement of <FONT STYLE="white-space:nowrap">pre-established</FONT>
performance goals set forth in the Award Agreement (including earnings, gains, or other performance goals) that are later determined, as a result of the accounting restatement, not to have been achieved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.5</B> <B>No Repricing.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in the Plan to the contrary, except in connection with a Corporate Transaction involving the Company (including,
without limitation, any stock dividend, stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT>
combination, or exchange of shares), the Company may not (a)&nbsp;amend the terms of outstanding Options or SARs to reduce the Option Price or SAR Price, as applicable, of such outstanding Options or SARs; (b)&nbsp;cancel or assume outstanding
Options or SARs in exchange for or substitution of Options or SARs with an Option Price or SAR Price, as applicable, that is less than the Option Price or SAR Price, as applicable, of the original Options or SARs; or (c)&nbsp;cancel or assume
outstanding Options or SARs with an Option Price or SAR Price, as applicable, above the current Fair Market Value in exchange for cash, Awards, or other securities, in each case, unless such action (i)&nbsp;is subject to and approved by the
Company&#146;s shareholders, or (ii)&nbsp;is an appropriate adjustment pursuant <B>Section</B><B></B><B>&nbsp;17</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.6</B>
<B>Deferral Arrangement.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Committee may permit or require the deferral of any payment pursuant to any Award into a deferred
compensation arrangement, subject to such rules and procedures as it may establish, which may include provisions for the payment or crediting of interest or Dividend Equivalent Rights and, in connection therewith, provisions for converting such
credits into deferred Stock equivalents and for restricting deferrals to comply with hardship distribution rules affecting <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plans subject to Code Section&nbsp;401(k)(2)(B)(IV),<B>
</B><I>provided</I> that no Dividend Equivalent Rights may be granted in connection with, or related to, an Award of Options or SARs. Any such deferrals shall be made in a manner that complies with Code Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.7</B> <B>No Liability.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No member of the Board or the Committee shall be liable for any action or determination made in good faith with respect to the Plan, any
Award, or any Award Agreement. Notwithstanding any provision of the Plan to the contrary, neither the Company, an Affiliate, the Board, the Committee, nor any person acting on behalf of the Company, an Affiliate, the Board, or the Committee will be
liable to any Grantee or to the estate or beneficiary of any Grantee or to any other holder of an Award under the Plan by reason </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of any acceleration of income, or any additional tax (including any interest and penalties), asserted by reason of the failure of an Award to satisfy the requirements of Code Section&nbsp;422 or
Code Section&nbsp;409A or by reason of Code Section&nbsp;4999, or otherwise asserted with respect to the Award; <I>provided</I>, that this <B>Section</B><B></B><B>&nbsp;3.7</B> shall not affect any of the rights or obligations set forth in an
applicable agreement between the Grantee and the Company or an Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.8</B> <B>Stock Issuance; Book-Entry.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any provision of the Plan to the contrary, the ownership of the shares of Stock issued under the Plan may be evidenced in such
a manner as the Committee, in its discretion, deems appropriate, including by book-entry or direct registration or by the issuance of one or more stock certificates. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>STOCK SUBJECT TO THE PLAN </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.1</B> <B>Number of Shares of Stock Available for
Awards.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Subject to adjustment pursuant to <B>Section</B><B></B><B>&nbsp;17</B>, the maximum number of shares of Stock reserved
for issuance under the Plan shall be equal to the sum of (i)<U></U>&nbsp;Four Million Seven Hundred Fifty Thousand (4,750,000) shares, plus (ii)<U></U>&nbsp;the number of shares of Stock available for awards under the Prior Plan as of the Original
Effective Date, plus (iii)<U></U>&nbsp;the number of shares of Stock subject to awards outstanding under the Prior Plan as of the Original Effective Date which thereafter (A)<U></U>&nbsp;terminate by expiration, forfeiture, cancellation, or
otherwise without the issuance of such shares, (B)<U></U>&nbsp;are settled in cash in lieu of such shares or (C)<U></U>&nbsp;are exchanged with the Committee&#146;s permission, before the issuance of such shares, for compensatory awards not
involving shares (the &#147;<B>Share Limit</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Any of the shares of Stock reserved and available for issuance under the Plan
may be used for any type of Award under the Plan, and any or all of the shares of Stock reserved for issuance under the Plan shall be available for issuance pursuant to Incentive Stock Options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Shares of Stock to be issued under the Plan shall be authorized but unissued shares, or, to the extent permitted by Applicable Laws,
shares of treasury stock and issued shares that have been reacquired by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.2</B> <B>Adjustments in Authorized Shares of
Stock.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with mergers, reorganizations, separations, or other transactions involving the Company or a Subsidiary to which
Code Section&nbsp;424(a) applies, the Committee shall have the right to cause the Company to assume awards previously granted under a compensatory plan by another business entity that is a party to such transaction and to grant Substitute Awards
under the Plan therefor. The Share Limit shall not be increased by the number of shares of Stock subject to any such assumed awards and Substitute Awards. Shares available for issuance under a shareholder-approved plan of a business entity that is a
party to such transaction (as appropriately adjusted to reflect such transaction) may be used for Awards under the Plan and shall not reduce the number of shares of Stock otherwise available for issuance under the Plan, subject to applicable rules
of any Stock Exchange or Securities Market on which the Stock is listed or publicly traded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.3</B> <B>Share Usage.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Shares of Stock subject to an Award shall be counted against the Share Limit as used as of the Grant Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Any shares of Stock that are subject to Awards of Options and SARs shall be counted against
the Share Limit set forth in <B>Section</B><B></B><B>&nbsp;4.1(a)</B> as one (1)<U></U>&nbsp;share of Stock for every one (1)<U></U>&nbsp;share of Stock subject to such Award. Any shares of Stock that are subject to Awards other than Options or SARs
shall be counted against the Share Limit set forth in <B>Section</B><B><U></U></B><B>&nbsp;4.1(a)</B> as 1.84 shares for every one (1)<U></U>&nbsp;share of Stock subject to such Award. With respect to SARs, the number of shares of Stock subject to
an award of SARs shall be counted against the Share Limit under the Plan regardless of the number of shares of Stock actually issued to settle such SARs upon exercise. With respect to Performance Awards and Annual Incentive Awards, a number of
shares of Stock at least equal to the target number of shares issuable under such Award, and with giving effect to the share counting rules set forth in this section, shall be counted against the Share Limit as of the Grant Date, but such number
shall be adjusted to equal the actual number of shares issued, with giving effect to the share counting rules set forth in this section, upon settlement of the Performance Awards and Annual Incentive Awards, to the extent different from such number
of shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Any shares of Stock related to Awards under the Plan or awards outstanding under Prior Plan as of the Original Effective
Date which thereafter terminate by expiration, forfeiture, cancellation, or otherwise without the issuance of such shares or is settled in cash in lieu of shares shall be available again for grant under the Plan in an amount determined in accordance
with the methodology set forth in <B>Section</B><B><U></U></B><B>&nbsp;4.3(b)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The number of shares of Stock available for
issuance under the Plan shall not be increased by the number of shares of Stock (i)&nbsp;tendered or withheld or subject to an Award surrendered in connection with the purchase of shares of Stock upon exercise of an Option or Stock Appreciation
Right, (ii)<U></U>&nbsp;that were not issued upon the net settlement or net exercise of an Option or Stock-settled SAR granted under the Plan, (iii)<U></U>&nbsp;deducted or delivered from payment of an Award in connection with the Company&#146;s tax
withholding obligations as provided in <B>Section</B><B><U></U></B><B>&nbsp;18.3</B> or (iv)<U></U>&nbsp;purchased by the Company with proceeds from Option or Stock Appreciation Right exercises. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>EFFECTIVE DATE, DURATION AND AMENDMENTS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.1</B> <B>Effective Date.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan became effective on the Original Effective Date. The Plan, as amended and restated, shall be effective as of the Effective Date. The
Plan as in effect prior to its amendment and restatement shall apply to all awards granted on and after the Original Effective Date and prior to the Effective Date. Following the Original Effective Date, no awards shall be made under the Prior Plan.
Notwithstanding the foregoing, shares of Stock reserved under the Prior Plans to settle awards which are made under the Prior Plans prior to the Effective Date may be issued and delivered following the Effective Date to settle such awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision of the Plan or any Award, each Award made under the Plan prior to November&nbsp;2, 2017 that was intended
to qualify as &#147;performance-based compensation&#148; within the meaning of Section&nbsp;162(m)(4)(C) of the Code prior to its repeal (&#147;<B>162(m) Awards</B>&#148;) and each Award which was otherwise not subject to the deduction limitation of
Section&nbsp;162(m) of the Code shall be subject to any additional limitations as the Committee determines necessary for such 162(m) Award to qualify as &#147;performance-based compensation&#148; as described in Section&nbsp;162(m)(4)(C) of the Code
prior to its repeal (or to be so exempt) pursuant to the transition relief rules in the Tax Cuts and Jobs Act of 2017, and to the extent any of the provisions of the Plan or any Award (or any amendments hereto pursuant to this amendment and
restatement of the Plan) would cause any 162(m) Awards to fail to so qualify or other Awards to be so exempt, any such provisions shall not apply to such Awards to the extent necessary to ensure the continued qualification or exemption of such
Awards. To the extent permitted by Applicable Law, the Plan and any such Awards shall be deemed amended to the extent necessary to conform to such requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.2 Term. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan shall terminate automatically on the first to occur of (a)&nbsp;the day before the tenth (10th)&nbsp;anniversary of the Effective
Date, (b)&nbsp;the date determined in accordance with <B>Section</B><B></B><B>&nbsp;5.3</B>, and (c)&nbsp;the date determined in accordance with <B>Section</B><B></B><B>&nbsp;17.3</B>. Upon such termination of the Plan, all outstanding Awards shall
continue to have full force and effect in accordance with the provisions of the terminated Plan and the applicable Award Agreement (or other documents evidencing such Awards). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.3 Amendment, Suspension and Termination. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may, at any time and from time to time, amend, suspend or terminate the Plan, <I>provided</I>,<I> </I>that with respect to Awards
theretofore granted under the Plan, no amendment, suspension, or termination of the Plan shall, without the consent of the Grantee, materially impair the Grantee&#146;s rights under any such Award. The effectiveness of any amendment to the Plan
shall be contingent on approval of such amendment by the Company&#146;s shareholders to the extent provided by the Board or required by Applicable Laws (including the rules of any Stock Exchange or Securities Market on which the Stock is then listed
or publicly traded), <I>provided</I> that no amendment shall be made to the <FONT STYLE="white-space:nowrap">no-repricing</FONT> provisions of <B>Section</B><B></B><B>&nbsp;3.5</B>, the Option Price provisions of
<B>Section</B><B></B><B>&nbsp;8.1</B>, or the SAR Exercise Price provisions of <B>Section</B><B></B><B>&nbsp;9.1</B> without the approval of the Company&#146;s shareholders. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>AWARD ELIGIBILITY AND LIMITATIONS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.1 Eligible Grantees. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to this <B>Section</B><B></B><B>&nbsp;6</B>, Awards may be made under the Plan to any Service Provider, as the Committee shall
determine and designate from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.2 Limitation on Shares of Stock Subject to Awards and Cash Awards. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During any time when the Company has a class of equity securities registered under Section&nbsp;12 of the Exchange Act: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The maximum number of shares of Stock subject to Options or SARs that may be granted under the Plan to a Grantee other than an Outside
Director is 400,000 shares per fiscal year; <I>provided, however</I>, the maximum number of shares of Stock subject to Options or SARs that can be granted under the Plan to a Grantee other than an Outside Director in the fiscal year that the person
is first employed by the Company or its Affiliates is 800,000 shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The maximum number of shares of Stock that may be granted under
the Plan, other than pursuant to Options or SARs, to a Grantee other than an Outside Director is 200,000 shares per fiscal year; <I>provided, however</I>, the maximum number of shares of Stock subject to Awards other than Options or SARs that can be
granted under the Plan to a Grantee other than an Outside Director in the fiscal year that the person is first employed by the Company or its Affiliates is 400,000 shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) The maximum amount that may be paid as a cash-denominated Annual Incentive Award (whether or not cash-settled) in respect of a Performance
Period of 12 months or less to a Grantee other than an Outside Director shall be $3,000,000, and the maximum amount that may be paid as a cash- denominated Performance Award (whether or not cash-settled) in respect of a Performance Period greater
than 12 months to a Grantee other than an Outside Director shall be $6,000,000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The maximum total compensation (including cash payments and the aggregate Grant Date fair
value of Awards (computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or its successors)) that may be granted under the Plan) that may be paid to or granted in a fiscal year to an Outside
Director for his or her service as a member of the Board or a committee of the Board is $1,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preceding limitations in this
<B>Section</B><B></B><B>&nbsp;6.2</B> are subject to adjustment as provided in <B>Section</B><B></B><B>&nbsp;17</B>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.3 Stand-Alone,
Additional, Tandem and Substitute Awards. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Section</B><B></B><B>&nbsp;3.5</B>, Awards granted under the Plan may, in the
discretion of the Committee, be granted either alone or in addition to, in tandem with, or in substitution or exchange for, (a)&nbsp;any other Award, (b)&nbsp;any award granted under another plan of the Company, any Affiliate, or any business entity
to be acquired by the Company or any Affiliate, or (c)&nbsp;any other right of a Grantee to receive payment from the Company or any Affiliate. Such additional, tandem and substitute or exchange Awards may be granted at any time. Subject to
<B>Section</B><B></B><B>&nbsp;3.5,</B> if an Award is granted in substitution or exchange for another Award, or for an award granted under another plan of the Company, any Affiliate, or any business entity acquired by the Company or any Affiliate,
the Committee shall require the surrender of such other Award or award under such other plan in consideration for the grant of such substitute or exchange Award. In addition, Awards may be granted in lieu of cash compensation, including in lieu of
cash payments under other plans of the Company or any Affiliate. Notwithstanding <B>Section</B><B></B><B>&nbsp;8.1</B> and <B>Section</B><B></B><B>&nbsp;9.1</B>, but subject to <B>Section</B><B></B><B>&nbsp;3.5</B>, the Option Price of an Option or
the grant price of an SAR that is a Substitute Award may be less than one hundred percent (100%) of the Fair Market Value of a share of Stock on the original Grant Date; <I>provided</I> that, the Option Price or grant price is determined in
accordance with the principles of Code Section&nbsp;424 for any Incentive Stock Option and consistent with Code Section&nbsp;409A for any other Option or SAR. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.4 Minimum Vesting Requirements. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except with respect to a maximum of five percent (5%) of the Share Limit, (a)&nbsp;no portion of any Award (other than Substitute Awards) that
vests on the basis of the Grantee&#146;s continued Service shall be granted with vesting conditions under which vesting occurs earlier than the one (1)&nbsp;year anniversary of the Grant Date, and (b)&nbsp;no portion of any Award (other than
Substitute Awards) that vests upon the attainment of Performance Measures shall be granted with a Performance Period of less than twelve (12)&nbsp;months. Notwithstanding the preceding, the Committee may provide for the earlier vesting,
exercisability, and/or settlement under any such Award (i)&nbsp;in the event of the Grantee&#146;s death, Disability or retirement, or (ii)&nbsp;in connection with a Corporate Transaction. The foregoing five percent (5%) limit shall be subject to
adjustment consistent with the share usage rules of <B>Section</B><B></B><B>&nbsp;4.3</B> and the adjustment provisions of <B>Section</B><B></B><B>&nbsp;17</B>. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>AWARD AGREEMENT </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Award granted pursuant to the Plan shall be evidenced by an
Award Agreement, which shall be in such form or forms as the Committee shall from time to time determine. Award Agreements employed under the Plan from time to time or at the same time need not contain similar provisions but shall be consistent with
the terms of the Plan. Each Award Agreement evidencing an Award of Options shall specify whether such Options are intended to be <FONT STYLE="white-space:nowrap">Non-qualified</FONT> Stock Options or Incentive Stock Options, and in the absence of
such specification, such Options shall be deemed to constitute Non- qualified Stock Options. In the event of any inconsistency between the Plan and an Award Agreement, the provisions of the Plan shall control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>TERMS AND CONDITIONS OF OPTIONS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.1 Option Price. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Option Price of each Option shall be fixed by the Committee and stated in the Award Agreement evidencing such Option. Except in the case
of Substitute Awards, the Option Price of each Option shall be at least the Fair Market Value of a share of Stock on the Grant Date; <I>provided,</I> that in the event that a Grantee is a Ten Percent Shareholder, the Option Price of an Option
granted to such Grantee that is intended to be an Incentive Stock Option shall be not less than one hundred ten percent (110%) of the Fair Market Value of a share of Stock on the Grant Date. In no case shall the Option Price of any Option be less
than the par value of a share of Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.2 Vesting and Exercisability. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Sections 6.4, 8.3 </B>and <B>17.3</B>, each Option granted under the Plan shall become exercisable at such times and under such
conditions as shall be determined by the Committee and stated in the Award Agreement; <I>provided, </I>that no Option relying on the five percent (5%) exception set forth in <B>Section</B><B></B><B>&nbsp;6.4</B> shall be granted to Grantees who are
entitled to overtime under Applicable Laws that will vest or be exercisable within a six (6)-month period starting on the Grant Date. For purposes of this <B>Section</B><B></B><B>&nbsp;8.2</B>, fractional numbers of shares of Stock subject to an
Option shall be rounded down to the next nearest whole number. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.3 Term. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Option granted under the Plan shall terminate, and all rights to purchase shares of Stock thereunder shall cease, on the day before the
tenth (10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) anniversary of the Grant Date of such Option, or under such circumstances and on such date prior thereto as is set forth in the Plan or as may be fixed by the Committee and stated in
the Award Agreement relating to such Option; <I>provided,</I> that in the event that the Grantee is a Ten Percent Shareholder, an Option granted to such Grantee that is intended to be an Incentive Stock Option shall not be exercisable after the day
before the fifth (5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) anniversary of the Grant Date of such Option; and <I>provided, further</I>, that, to the extent deemed necessary or appropriate by the Committee to reflect differences in
local law, tax policy or custom with respect to any Option granted to a Grantee who is a foreign national or is a natural person who is employed outside the United States, such Option may terminate, and all rights to purchase shares of Stock
thereunder may cease, upon the expiration of a period longer than ten (10)&nbsp;years from the Grant Date of such Option as the Committee shall determine. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.4 Termination of Service. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Award Agreement with respect to the grant of an Option shall set forth the extent to which the Grantee thereof, if at all, shall have the
right to exercise such Option following termination of such Grantee&#146;s Service. Such provisions shall be determined in the sole discretion of the Committee, need not be uniform among all Options issued pursuant to the Plan, and may reflect
distinctions based on the reasons for termination of Service. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.5 Limitations on Exercise of Option. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision of the Plan, in no event may any Option be exercised, in whole or in part, prior to the date on which the
Plan is approved by the shareholders of the Company as provided herein or after the occurrence of an event referred to in <B>Section</B><B></B><B>&nbsp;17</B> which results in the termination of such Option. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.6 Method of Exercise. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms of <B>Sections</B><B></B><B>&nbsp;12</B> and <B>18.3</B>, an Option that is exercisable may be exercised by the
Grantee&#146;s delivery to the Company or its designee or agent of notice of exercise on any business day, at the Company&#146;s principal office or the office of such designee or agent, on the form specified by the Company and in accordance with
any additional procedures specified by the Committee. Such notice shall specify the number of shares of Stock with respect to which such Option is being exercised and shall be accompanied by payment in full of the Option Price of the shares of Stock
for which such Option is being exercised, plus the amount (if any) of federal and/or other taxes which the Company may, in its judgment, be required to withhold with respect to the exercise of such Option. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.7 Rights of Holders of Options. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Grantee or other person holding or exercising an Option shall have none of the rights of a shareholder of the Company (for example, the
right to receive cash or dividend payments or distributions attributable to the shares of Stock subject to such Option, to direct the voting of the shares of Stock subject to such Option, or to receive notice of any meeting of the Company&#146;s
shareholders) until the shares of Stock subject thereto are fully paid and issued to such Grantee or other person. Except as provided in <B>Section</B><B></B><B>&nbsp;17</B>, no adjustment shall be made for dividends, distributions or other rights
with respect to any shares of Stock subject to an Option for which the record date is prior to the date of issuance of such shares of Stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.8 Delivery of Stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Promptly after the exercise of an Option by a Grantee and the payment in full of the Option Price with respect thereto, such Grantee shall be
entitled to receive such evidence of such Grantee&#146;s ownership of the shares of Stock subject to such Option as shall be consistent with <B>Section</B><B></B><B>&nbsp;3.8</B>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.9 Transferability of Options. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in <B>Section</B><B></B><B>&nbsp;8.10</B>, during the lifetime of a Grantee of an Option, only such Grantee (or, in the
event of such Grantee&#146;s legal incapacity or incompetency, such Grantee&#146;s guardian or legal representative) may exercise such Option. Except as provided in <B>Section</B><B></B><B>&nbsp;8.10</B>, no Option shall be assignable or
transferable by the Grantee to whom it is granted, other than by will or the laws of descent and distribution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.10 Family Transfers.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If authorized in the applicable Award Agreement and by the Committee, in its sole discretion, a Grantee may transfer, not for value,
all or part of an Option which is not an Incentive Stock Option to any Family Member. For the purpose of this <B>Section</B><B></B><B>&nbsp;8.10</B>, a transfer &#147;not for value&#148; is a transfer which is (a)&nbsp;a gift, (b)&nbsp;a transfer
under a domestic relations order in settlement of marital property rights, or (c)&nbsp;unless Applicable Laws do not permit such transfer, a transfer to an entity in which more than fifty percent (50%) of the voting interests are owned by Family
Members (and/or the Grantee) in exchange for an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interest in such entity. Following a transfer under this <B>Section</B><B></B><B>&nbsp;8.10</B>, any such Option shall continue to be subject to the same terms and conditions as were applicable
immediately prior to such transfer, and the shares of Stock acquired pursuant to such Option shall be subject to the same restrictions with respect to transfers of shares as would have applied to the Grantee thereof. Subsequent transfers of
transferred Options shall be prohibited except to Family Members of the original Grantee in accordance with this <B>Section</B><B></B><B>&nbsp;8.10</B> or by will or the laws of descent and distribution. The provisions of
<B>Section</B><B></B><B>&nbsp;8.4</B> relating to termination of Service shall continue to be applied with respect to the original Grantee of the Option, following which such Option shall be exercisable by the transferee only to the extent, and for
the periods specified, in <B>Section</B><B></B><B>&nbsp;8.4</B>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.11 Limitations on Incentive Stock Options. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Option shall constitute an Incentive Stock Option only (a)&nbsp;if the Grantee of such Option is an employee of the Company or any
corporate Subsidiary, (b)&nbsp;to the extent specifically provided in the related Award Agreement and (c)&nbsp;to the extent that the aggregate Fair Market Value (determined at the time such Option is granted) of the shares of Stock with respect to
which all Incentive Stock Options held by such Grantee become exercisable for the first time during any calendar year (under the Plan and all other plans of the Company and its Affiliates) does not exceed one hundred thousand dollars ($100,000).
Except to the extent provided in the regulations under Code Section&nbsp;422, this limitation shall be applied by taking Options into account in the order in which they were granted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.12 Notice of Disqualifying Disposition. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Grantee shall make any disposition of shares of Stock issued pursuant to the exercise of an Incentive Stock Option under the
circumstances provided in Code Section&nbsp;421(b) (relating to certain disqualifying dispositions), such Grantee shall notify the Company of such disposition immediately but in no event later than ten (10)&nbsp;days thereafter. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.1 Right to Payment and
SAR Exercise Price. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A SAR shall confer on the Grantee to whom it is granted a right to receive, upon exercise thereof, the excess of
(a)&nbsp;the Fair Market Value of one share of Stock on the date of exercise over (b)&nbsp;the SAR Exercise Price as determined by the Committee. The Award Agreement for a SAR shall specify the SAR Exercise Price, which shall be no less than the
Fair Market Value of a share of Stock on the Grant Date of such SAR. SARs may be granted in tandem with all or part of an Option granted under the Plan or at any subsequent time during the term of such Option, in combination with all or part of any
other Award or without regard to any Option or other Award; <I>provided,</I> that a SAR that is granted subsequent to the Grant Date of a related Option must have a SAR Exercise Price that is no less than the Fair Market Value of one share of Stock
on the Grant Date of such SAR. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.2 Other Terms. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Sections 6.4</B>, <B>9.3 </B>and <B>17.3</B>, the Committee shall determine, on the Grant Date or thereafter, the time or times
at which and the circumstances under which a SAR may be exercised in whole or in part (including based on achievement of performance goals and/or future Service requirements), the time or times at which SARs shall cease to be or become exercisable
following termination of Service or upon other conditions, the method of exercise, method of settlement, form of consideration payable in settlement, method by or forms in which shares of Stock shall be delivered or deemed to be delivered to
Grantees, whether or not a SAR shall be granted in tandem or in combination </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with any other Award, and any and all other terms and conditions of any SAR; <I>provided</I>, that no SARs relying on the five percent (5%) exception set forth in
<B>Section</B><B></B><B>&nbsp;6.4 </B>shall be granted to Grantees who are entitled to overtime under Applicable Laws that will vest or be exercisable within a six (6)-month period starting on the Grant Date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.3 Term. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each SAR
granted under the Plan shall terminate, and all rights thereunder shall cease, on the day before the tenth (10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) anniversary of the Grant Date of such SAR, or under such circumstances and on such
date prior thereto as is set forth in the Plan or as may be fixed by the Committee and stated in the Award Agreement relating to such SAR. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.4 Rights of Holders of SARs. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Grantee or other person holding or exercising a SAR shall have none of the rights of a shareholder of the Company (for example, the right to
receive cash or dividend payments or distributions attributable to the shares of Stock underlying such SAR, to direct the voting of the shares of Stock underlying such SAR, or to receive notice of any meeting of the Company&#146;s shareholders)
until the shares of Stock underlying such SAR, if any, are issued to such Grantee or other person. Except as provided in <B>Section</B><B></B><B>&nbsp;17</B>, no adjustment shall be made for dividends, distributions or other rights with respect to
any shares of Stock underlying a SAR for which the record date is prior to the date of issuance of such shares of Stock, if any. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.5
Transferability of SARs. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in <B>Section</B><B></B><B>&nbsp;9.6</B>, during the lifetime of a Grantee of a SAR, only
the Grantee (or, in the event of such Grantee&#146;s legal incapacity or incompetency, such Grantee&#146;s guardian or legal representative) may exercise such SAR. Except as provided in <B>Section</B><B></B><B>&nbsp;9.6</B>, no SAR shall be
assignable or transferable by the Grantee to whom it is granted, other than by will or the laws of descent and distribution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.6
Family Transfers. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If authorized in the applicable Award Agreement and by the Committee, in its sole discretion, a Grantee may
transfer, not for value, all or part of a SAR to any Family Member. For the purpose of this <B>Section</B><B></B><B>&nbsp;9.6</B>, a transfer &#147;not for value&#148; is a transfer which is (a)&nbsp;a gift, (b)&nbsp;a transfer under a domestic
relations order in settlement of marital property rights or (c)&nbsp;unless Applicable Laws do not permit such transfers, a transfer to an entity in which more than fifty percent (50%) of the voting interests are owned by Family Members (and/or the
Grantee) in exchange for an interest in such entity. Following a transfer under this <B>Section</B><B></B><B>&nbsp;9.6</B>, any such SAR shall continue to be subject to the same terms and conditions as were in effect immediately prior to such
transfer, and shares of Stock acquired pursuant to a SAR shall be subject to the same restrictions on transfers of shares as would have applied to the Grantee or such SAR. Subsequent transfers of transferred SARs shall be prohibited except to Family
Members of the original Grantee in accordance with this <B>Section</B><B></B><B>&nbsp;9.6</B> or by will or the laws of descent and distribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>TERMS AND CONDITIONS OF RESTRICTED STOCK AND STOCK UNITS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.1 Grant of
Restricted Stock or Stock Units. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards of Restricted Stock or Stock Units may be made for consideration or for no consideration
(other than the par value of the shares of Stock, which shall be deemed paid by past or future Services by the Grantee to the Company or an Affiliate). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.2 Restrictions. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Sections 6.4 and 17.3</B>, at the time a grant of Restricted Stock or Stock Units is made, the Committee may, in its sole
discretion, (a)&nbsp;establish a period of time (a &#147;<B>restricted period</B>&#148;) applicable to such Restricted Stock or Stock Units and (b)&nbsp;prescribe restrictions in addition to or other than the expiration of the restricted period,
including the satisfaction of corporate or individual performance goals, which may be applicable to all or any portion of such Restricted Stock or Stock Units as provided in <B>Section</B><B></B><B>&nbsp;14</B>. Awards of Restricted Stock or Stock
Units may not be sold, transferred, assigned, pledged or otherwise encumbered or disposed of during the restricted period or prior to the satisfaction of any other restrictions prescribed by the Committee with respect to such Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.3 Restricted Stock Certificates; Book-Entry Registration. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Section</B><B></B><B>&nbsp;3.8</B> and the immediately following sentence, the Company may issue, in the name of each Grantee to
whom Restricted Stock has been granted, stock certificates representing the total number of shares of Restricted Stock granted to the Grantee, as soon as reasonably practicable after the Grant Date of such Restricted Stock. The Committee may provide
in an Award Agreement that either (a)&nbsp;the Secretary of the Company shall hold such certificates for such Grantee&#146;s benefit until such time as such shares of Restricted Stock are forfeited to the Company or the restrictions applicable
thereto lapse and such Grantee shall deliver a stock power to the Company with respect to each certificate, or (b)&nbsp;such certificates shall be delivered to such Grantee, <I>provided,</I> that such certificates shall bear legends that comply with
applicable securities laws and regulations and make appropriate reference to the restrictions imposed on such Award of Restricted Stock under the Plan and such Award Agreement. Pursuant to <B>Section</B><B></B><B>&nbsp;3.8</B>, to the extent
Restricted Stock is represented by a book-entry, such book entry shall be notated to evidence the restrictions imposed on such Award of Restricted Stock under the Plan and the applicable Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.4 Rights of Holders of Restricted Stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Restricted Stock shall have the right to vote such shares of Restricted Stock and the right to receive any dividends declared or
paid with respect to such shares of Restricted Stock. Notwithstanding the foregoing, cash dividends declared or paid on shares of Restricted Stock (i)&nbsp;shall not be paid currently but instead shall be accrued, (ii)&nbsp;shall be subject to the
same vesting conditions and restrictions applicable to such underlying shares of Restricted Stock, and (iii)&nbsp;shall not vest or become payable unless and until the shares of Restricted Stock to which the dividends apply become vested and
nonforfeitable. All stock distributions, if any, received by a Grantee with respect to Restricted Stock as a result of any stock split, stock dividend, combination of stock, or other similar transaction shall be subject to the same vesting
conditions and restrictions applicable to such underlying shares of Restricted Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.5 Rights of Holders of Stock Units. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>10.5.1 Voting and Dividend Rights. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of Stock Units shall have no rights as shareholders of the Company (for example, the right to receive cash or dividend payments or
distributions attributable to the shares of Stock subject to such Stock Units, to direct the voting of the shares of Stock subject to such Stock Units, or to receive notice of any meeting of the Company&#146;s shareholders). Subject to the
restrictions on Dividend Equivalent Rights set forth in <B>Section</B><B></B><B>&nbsp;13</B>, the Committee may provide in an Award Agreement evidencing a grant of Stock Units that the holder of such Stock Units shall be entitled to receive Dividend
Equivalent Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>10.5.2 Creditor&#146;s Rights. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A holder of Stock Units shall have no rights other than those of a general unsecured creditor of the Company. Stock Units represent an
unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.6
Termination of Service. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Committee provides otherwise in an Award Agreement or in writing after such Award Agreement is
issued, but prior to termination of Grantee&#146;s Service, upon the termination of such Grantee&#146;s Service, any Restricted Stock or Stock Units held by such Grantee that have not vested, or with respect to which all applicable restrictions and
conditions have not lapsed, shall immediately be deemed forfeited. Upon forfeiture of such Restricted Stock or Stock Units, the Grantee thereof shall have no further rights with respect thereto, including any right to vote such Restricted Stock or
any right to receive dividends or Dividend Equivalent Rights, as applicable, with respect to such Restricted Stock or Stock Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.7 Purchase of Restricted Stock and Shares of Stock Subject to Stock Units. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Grantee shall be required, to the extent required by Applicable Laws, to purchase the Restricted Stock or shares of Stock subject to
vested Stock Units from the Company at a Purchase Price equal to the greater of (a)&nbsp;the aggregate par value of the shares of Stock represented by such Restricted Stock or Stock Units or (b)&nbsp;the Purchase Price, if any, specified in the
Award Agreement relating to such Restricted Stock or Stock Units. The Purchase Price shall be payable in a form provided in <B>Section</B><B></B><B>&nbsp;12</B> or, in the sole discretion of the Committee, in consideration for past or future
Services rendered to the Company or an Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.8 Delivery of Shares of Stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the expiration or termination of any restricted period and the satisfaction of any other conditions prescribed by the Committee, the
restrictions applicable to Restricted Stock or Stock Units settled in shares of Stock shall lapse, and, unless otherwise provided in the applicable Award Agreement, a book-entry or direct registration or a stock certificate evidencing ownership of
such shares of Stock shall, consistent with <B>Section</B><B></B><B>&nbsp;3.8</B>, be issued, free of all such restrictions, to the Grantee thereof or such Grantee&#146;s beneficiary or estate, as the case may be. Neither the Grantee, nor the
Grantee&#146;s beneficiary or estate, shall have any further rights with regard to a Stock Unit once the shares of Stock represented by the Stock Unit have been delivered in accordance with this <B>Section</B><B></B><B>&nbsp;10.8</B>. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>TERMS AND CONDITIONS OF UNRESTRICTED STOCK AWARDS AND OTHER EQUITY- BASED AWARDS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) In
each case subject to the five percent (5%) limit set forth in <B>Section</B><B></B><B>&nbsp;6.4</B>, the Committee may, in its sole discretion, grant (or sell at the par value of a share of Stock or at such other higher purchase price determined by
the Committee) an Award to any Grantee pursuant to which such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Grantee may receive shares of Stock free of any restrictions (&#147;<B>Unrestricted Stock</B>&#148;) under the Plan. Awards of Unrestricted Stock may be granted or sold to any Grantee as provided
in the immediately preceding sentence in respect of past or future Service and other valid consideration, or in lieu of, or in addition to, any cash compensation due to such Grantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The Committee may, in its sole discretion, grant Awards in the form of Other Equity-Based Awards, as deemed by the Committee to be
consistent with the purposes of the Plan. Subject to <B>Section</B><B></B><B>&nbsp;6.4</B>, Awards granted pursuant to this <B>Section</B><B></B><B>&nbsp;11(b)</B> may be granted with vesting, value and/or payment contingent upon the achievement of
one or more performance goals. The Committee shall determine the terms and conditions of Other Equity-Based Awards at the Grant Date or thereafter. Unless the Committee otherwise provides in an Award Agreement or in writing after such Award
Agreement is issued, upon the termination of a Grantee&#146;s Service, any Other Equity-Based Awards held by such Grantee that have not vested, or with respect to which all applicable restrictions and conditions have not lapsed, shall immediately be
deemed forfeited. Upon forfeiture of any Other Equity-Based Award, the Grantee thereof shall have no further rights with respect to such Other Equity-Based Award. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>FORM OF PAYMENT FOR OPTIONS AND RESTRICTED STOCK </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.1 General Rule. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment of the Option Price for the shares of Stock purchased pursuant to the exercise of an Option or the Purchase Price for Restricted Stock
or vested Stock Units shall be made in cash or in cash equivalents acceptable to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.2 Surrender of Shares of Stock.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that the applicable Award Agreement so provides, payment of the Option Price for shares of Stock purchased pursuant to
the exercise of an Option or the Purchase Price for Restricted Stock or vested Stock Units may be made all or in part through the tender or attestation to the Company of shares of Stock, which shall be valued, for purposes of determining the extent
to which such Option Price or Purchase Price has been paid thereby, at their Fair Market Value on the date of such tender or attestation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.3 Cashless Exercise. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to an Option only (and not with respect to Restricted Stock or Stock Units), to the extent permitted by Applicable Laws and to
the extent the Award Agreement so provides, payment of the Option Price for shares of Stock purchased pursuant to the exercise of an Option may be made all or in part by delivery (on a form acceptable to the Committee) of an irrevocable direction to
a licensed securities broker acceptable to the Company to sell shares of Stock and to deliver all or part of the proceeds of such sale to the Company in payment of such Option Price and any withholding taxes described in
<B>Section</B><B></B><B>&nbsp;18.3</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.4 Other Forms of Payment. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent the Award Agreement so provides and/or unless otherwise specified in an Award Agreement, payment of the Option Price for shares
of Stock purchased pursuant to exercise of an Option or the Purchase Price for Restricted Stock or vested Stock Units may be made in any other form that is consistent with Applicable Laws, including (a)&nbsp;Service to the Company or an Affiliate
and (b)&nbsp;net exercise, net settlement or share withholding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>TERMS AND CONDITIONS OF DIVIDEND EQUIVALENT RIGHTS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.1 Dividend Equivalent Rights.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Dividend Equivalent Right is an Award entitling the recipient thereof to receive credits based on cash distributions that would
have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other Award to which such Dividend Equivalent Right relates) if such shares of Stock had been issued to and held by the recipient of such Dividend Equivalent Right
as of the record date (with or without being subject to forfeiture or a repayment obligation). A Dividend Equivalent Right may be granted hereunder to any Grantee, <I>provided</I> that no Dividend Equivalent Rights may be granted in connection with,
or related to, an Award of Options or SARs. Subject to this <B>Section</B><B></B><B>&nbsp;13</B>, the terms and conditions of Dividend Equivalent Rights shall be specified in the Award Agreement therefor. Dividend equivalents credited to the holder
of a Dividend Equivalent Right may be paid currently (with or without being subject to forfeiture or a repayment obligation) or may be deemed to be reinvested in additional shares of Stock or Awards, which may thereafter accrue additional Dividend
Equivalent Rights. Any such reinvestment in additional shares of Stock shall be at the Fair Market Value thereof on the date of such reinvestment. Dividend Equivalent Rights may be settled in cash or shares of Stock or a combination thereof, in a
single installment or in multiple installments, all as determined in the sole discretion of the Committee. Notwithstanding the foregoing, a Dividend Equivalent Right granted as a component of another Award (i)&nbsp;shall not be paid currently but
instead shall be accrued, (ii)&nbsp;shall be subject to the same vesting conditions and restrictions applicable to the Award to which the Dividend Equivalent Rights correspond, and (iii)&nbsp;shall not vest or become payable unless and until the
Award to which the Dividend Equivalent Rights correspond becomes vested and settled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.2 Termination of Service. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Committee otherwise provides in an Award Agreement or in writing after such Award Agreement is issued, a Grantee&#146;s rights in
all Dividend Equivalent Rights shall automatically terminate upon the Grantee&#146;s termination of Service for any reason. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>TERMS AND CONDITIONS OF PERFORMANCE AWARDS AND ANNUAL INCENTIVE AWARDS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.1 Grant of
Performance Awards and Annual Incentive Awards. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms and provisions of the Plan, the Committee, at any time and from
time to time, may grant Performance Awards and/or Annual Incentive Awards to a Grantee in such amounts and upon such terms as the Committee shall determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.2 Value of Performance Awards and Annual Incentive Awards. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Performance Award and Annual Incentive Award shall have an initial cash value or an actual or target number of shares of Stock that is
established by the Committee at the time of grant. The Committee shall set performance goals in its discretion which, depending on the extent to which they are achieved, shall determine the value and/or the number shares of Stock subject to
Performance Awards and Annual Incentive Awards that will be paid out to the Grantee thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.3 Earning of Performance Awards and
Annual Incentive Awards. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms of the Plan, after the applicable Performance Period has ended, the Grantee of
Performance Awards or Annual Incentive Awards shall be entitled to receive a payout of the value and/or the number shares of Stock subject to Performance Awards and Annual Incentive Awards earned by the Grantee over such Performance Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.4 Form and Timing of Payment of Performance Awards and Annual Incentive Awards.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment of earned Performance Awards and Annual Incentive Awards shall be made, as determined by the Committee, in the form, at the time, and
in the manner described in the applicable Award Agreement. Subject to the terms of the Plan, the Committee, in its sole discretion, (a)&nbsp;may pay earned Performance Awards in the form of cash, shares of Stock, other Awards, other property or a
combination thereof and (b)&nbsp;shall pay the value of the earned Performance Awards and Annual Incentive Awards at the close of the applicable Performance Period, or as soon as reasonably practicable after the Committee has determined that the
performance goal or goals have been achieved; <I>provided</I> that, unless specifically provided in the Award Agreement for such Awards, such payment shall occur no later than the fifteenth
(15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)&nbsp;day of the third (3<SUP STYLE="font-size:85%; vertical-align:top">rd</SUP>) month following the end of the calendar year in which such Performance Period ends. Any shares of Stock paid
out under such Awards may be granted subject to any restrictions deemed appropriate by the Committee. The determination of the Committee with respect to the form of payout of such Awards shall be set forth in the Award Agreement for the Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.5 Performance Conditions.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The right of a Grantee to exercise or receive a grant or settlement of any Performance Award or Annual Incentive Award, and the timing
thereof, may be subject to the achievement of such Performance Measures as may be specified by the Committee. The Committee may use such business criteria and other measures of performance as it may deem appropriate in establishing any performance
conditions. Performance under any of the Performance Measures (i)&nbsp;may be used to measure the performance of (A)&nbsp;the Company, its Subsidiaries and other Affiliates as a whole, (B)&nbsp;the Company, any Subsidiary, and/or any other Affiliate
or any combination thereof, or (C)&nbsp;any one or more business units or operating segments of the Company, any Subsidiary, and/or any other Affiliate, in each case as the Committee, in its sole discretion, deems appropriate and (ii)&nbsp;may be
compared to the performance of one or more other companies, or one or more published or special indices designated or approved by the Committee for such comparison, as the Committee, in its sole discretion, deems appropriate. In addition, the
Committee, in its sole discretion, may select Performance Measure specified in <B>Section</B><B></B><B>&nbsp;2.31(e)</B> for comparison to performance under one or more stock market indices designated or approved by the Committee. The Committee also
shall have the authority to provide for accelerated vesting of any Performance Award or Annual Incentive Award based on the achievement of performance goals pursuant to the Performance Measures specified in this <B>Section</B><B></B><B>&nbsp;14</B>.
For the avoidance of doubt, nothing herein is intended to prevent the Committee from granting Awards subject to subjective performance conditions (including individual performance conditions); <I>provided,</I> that such Awards shall not be
considered Performance Awards under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>14.5.1 Evaluation of Performance. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Committee may provide in any Performance Award or Annual Incentive Award that any evaluation of performance may include or exclude any of
the following events that occur during a Performance Period: (a)&nbsp;asset write-downs; (b)&nbsp;litigation or claims, judgments or settlements; (c)&nbsp;the effect of changes in tax laws, accounting principles, or other laws or provisions
affecting reported results; (d)&nbsp;any reorganization or restructuring events or programs; (e)&nbsp;extraordinary, <FONT STYLE="white-space:nowrap">non-core,</FONT> <FONT STYLE="white-space:nowrap">non-operating,</FONT> or <FONT
STYLE="white-space:nowrap">non-recurring</FONT> items and items that are either of an unusual nature or of a type that indicates infrequency of occurrence as a separate component of income from continuing operations; (f)&nbsp;acquisitions or
divestitures; (g)&nbsp;foreign exchange gains and losses; (h)&nbsp;impact of shares of Stock purchased through share repurchase programs; (i)&nbsp;tax valuation allowance reversals; (j)&nbsp;impairment expense; and (k)&nbsp;environmental expense.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>PARACHUTE LIMITATIONS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Grantee is a &#147;disqualified individual,&#148;
as defined in Code Section&nbsp;280G(c), then, notwithstanding any other provision of the Plan or of any other agreement, contract, or understanding heretofore or hereafter entered into by such Grantee with the Company or an Affiliate, except an
agreement, contract, or understanding that expressly addresses Code Section&nbsp;280G or Code Section&nbsp;4999 (an &#147;<B>Other Agreement</B>&#148;), and notwithstanding any formal or informal plan or other arrangement for the direct or indirect
provision of compensation to the Grantee (including groups or classes of Grantees or beneficiaries of which the Grantee is a member), whether or not such compensation is deferred, is in cash, or is in the form of a benefit to or for the Grantee (a
&#147;<B>Benefit Arrangement</B>&#148;), any right of the Grantee to any exercise, vesting, payment or benefit under the Plan shall be reduced or eliminated: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(a) to the extent that such right to exercise, vesting, payment, or benefit, taking into account all other rights, payments, or benefits to or
for the Grantee under the Plan, all Other Agreements, and all Benefit Arrangements, would cause any exercise, vesting, payment, or benefit to the Grantee under the Plan to be considered a &#147;parachute payment&#148; within the meaning of Code
Section<U></U>&nbsp;280G(b)(2) as then in effect (a &#147;<B>Parachute Payment</B>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(b) if, as a result of receiving such
Parachute Payment, the aggregate <FONT STYLE="white-space:nowrap">after-tax</FONT> amounts received by the Grantee from the Company under the Plan, all Other Agreements, and all Benefit Arrangements would be less than the maximum <FONT
STYLE="white-space:nowrap">after-tax</FONT> amount that could be received by the Grantee without causing any such payment or benefit to be considered a Parachute Payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as required by Code Section&nbsp;409A or to the extent that Code Section&nbsp;409A permits discretion, the Committee shall have the
right, in the Committee&#146;s sole discretion, to designate those rights, payments, or benefits under the Plan, all Other Agreements, and all Benefit Arrangements that should be reduced or eliminated so as to avoid having such rights, payments, or
benefits be considered a Parachute Payment; <I>provided, however,</I> to the extent any payment or benefit constitutes deferred compensation under Code Section&nbsp;409A, in order to comply with Code Section&nbsp;409A, the Company shall instead
accomplish such reduction by first reducing or eliminating any cash payments (with the payments to be made furthest in the future being reduced first), then by reducing or eliminating any accelerated vesting of Options or SARs, then by reducing or
eliminating any accelerated vesting of Restricted Stock or Stock Units, then by reducing or eliminating any other remaining Parachute Payments. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>REQUIREMENTS OF LAW </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>16.1 General.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall not be required to offer, sell or issue any shares of Stock under any Award, whether pursuant to the exercise of an Option
or SAR or otherwise, if the offer, sale or issuance of such shares of Stock would constitute a violation by the Grantee, the Company or an Affiliate, or any other person of any provision of the Company&#146;s articles of incorporation or bylaws or
of Applicable Laws, including any federal or state securities laws or regulations. If at any time the Company shall determine, in its discretion, that the listing, registration or qualification of any shares of Stock subject to an Award upon any
Stock Exchange or Securities Market or under any governmental regulatory body is necessary or desirable as a condition of, or in connection with, the offering, issuance, sale or purchase of shares of Stock in connection with any Award, no shares of
Stock may be offered, issued or sold to the Grantee or any other person under such Award, whether pursuant to the exercise of an Option or SAR or otherwise, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unless such listing, registration or qualification shall have been effected or obtained free of any conditions not acceptable to the Company, and any delay caused thereby shall in no way affect
the date of termination of such Award. Without limiting the generality of the foregoing, upon the exercise of any Option or any SAR that may be settled in shares of Stock or the delivery of any shares of Stock underlying an Award, unless a
registration statement under the Securities Act is in effect with respect to the shares of Stock subject to such Award, the Company shall not be required to offer, sell or issue such shares of Stock unless the Committee shall have received evidence
satisfactory to it that the Grantee or any other person exercising such Option or SAR or accepting delivery of such shares may acquire such shares of Stock pursuant to an exemption from registration under the Securities Act. Any determination by the
Committee in connection with the foregoing shall be final, binding, and conclusive. The Company may register, but shall in no event be obligated to register, any shares of Stock or other securities issuable pursuant to the Plan pursuant to the
Securities Act. The Company shall not be obligated to take any affirmative action in order to cause the exercise of an Option or a SAR or the issuance of shares of Stock or other securities issuable pursuant to the Plan or any Award to comply with
any Applicable Laws. As to any jurisdiction that expressly imposes the requirement that an Option or SAR that may be settled in shares of Stock shall not be exercisable until the shares of Stock subject to such Option or SAR are registered under the
securities laws thereof or are exempt from such registration, the exercise of such Option or SAR under circumstances in which the laws of such jurisdiction apply shall be deemed conditioned upon the effectiveness of such registration or the
availability of such an exemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>16.2 <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3.</FONT></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During any time when the Company has a class of equity security registered under Section&nbsp;12 of the Exchange Act, it is the intention of
the Company that Awards pursuant to the Plan and the exercise of Options and SARs granted hereunder that would otherwise be subject to Section&nbsp;16(b) of the Exchange Act shall qualify for the exemption provided by
<FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> under the Exchange Act. To the extent that any provision of the Plan or action by the Committee does not comply with the requirements of such
<FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3,</FONT> such provision or action shall be deemed inoperative with respect to such Awards to the extent permitted by Applicable Laws and deemed advisable by the Committee, and shall not affect the
validity of the Plan. In the event that such <FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> is revised or replaced, the Board may exercise its discretion to modify the Plan in any respect necessary or advisable in its judgment to satisfy
the requirements of, or to permit the Company to avail itself of the benefits of, the revised exemption or its replacement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>EFFECT OF CHANGES IN CAPITALIZATION </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.1 Changes in Stock.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the number of outstanding shares of Stock is increased or decreased or the shares of Stock are changed into or exchanged for a different
number of shares or kind of capital stock or other securities of the Company on account of any recapitalization, reclassification, stock split, reverse stock split, <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination of stock, exchange of
stock, stock dividend or other distribution payable in capital stock, or other increase or decrease in such shares of Stock effected without receipt of consideration by the Company occurring after the Effective Date, the number and kinds of shares
of stock for which grants of Options and other Awards may be made under the Plan, including the Share Limit set forth in <B>Section</B><B></B><B>&nbsp;4.1(a)</B>, the individual share limits set forth in <B>Section</B><B></B><B>&nbsp;6.2,</B> and
the five percent (5%) limit set forth in <B>Section</B><B></B><B>&nbsp;6.4 </B>shall be adjusted proportionately and accordingly by the Committee. In addition, the number and kind of shares of stock for which Awards are outstanding shall be adjusted
proportionately and accordingly by the Committee so that the proportionate interest of the Grantee therein immediately following such event shall, to the extent practicable, be the same as immediately before such event. Any such adjustment in
outstanding Options or SARs shall not change the aggregate Option Price or SAR </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Exercise Price payable with respect to shares that are subject to the unexercised portion of such outstanding Options or SARs, as applicable, but shall include a corresponding proportionate
adjustment in the per share Option Price or SAR Exercise Price, as the case may be. The conversion of any convertible securities of the Company shall not be treated as an increase in shares effected without receipt of consideration. Notwithstanding
the foregoing, in the event of any distribution to the Company&#146;s shareholders of securities of any other entity or other assets (including an extraordinary dividend, but excluding a <FONT STYLE="white-space:nowrap">non-extraordinary</FONT>
dividend, declared and paid by the Company) without receipt of consideration by the Company, the Committee shall, in such manner as it deems appropriate, adjust (a)&nbsp;the number and kind of shares of stock subject to outstanding Awards and/or
(b)&nbsp;the aggregate and per share Option Price of outstanding Options and the aggregate and per share SAR Exercise Price of outstanding SARs as required to reflect such distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.2</B> <B>Reorganization in Which the Company Is the Surviving Entity Which Does not Constitute a Corporate Transaction.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Section</B><B></B><B>&nbsp;17.3</B>, if the Company shall be the surviving entity in any reorganization, merger, or
consolidation of the Company with one or more other entities which does not constitute a Corporate Transaction, any Award theretofore granted pursuant to the Plan shall pertain to and apply to the securities to which a holder of the number of shares
of Stock subject to such Award would have been entitled immediately following such reorganization, merger, or consolidation, with a corresponding proportionate adjustment of the per share Option Price or SAR Exercise Price, if applicable, so that
the aggregate Option Price or SAR Exercise Price thereafter shall be the same as the aggregate Option Price or SAR Exercise Price of the shares of Stock remaining subject to the Option or SAR as in effect immediately prior to such reorganization,
merger, or consolidation. Subject to any contrary language in an Award Agreement, any restrictions applicable to such Award shall apply as well to any replacement shares received by the Grantee as a result of such reorganization, merger, or
consolidation. In the event of any reorganization, merger, or consolidation of the Company referred to in this <B>Section</B><B></B><B>&nbsp;17.2</B>, Performance Awards and Annual Incentive Awards shall be adjusted (including any adjustment to
performance goals applicable to such Awards deemed appropriate by the Committee) so as to apply to the securities that a holder of the number of shares of Stock subject to the Performance Awards or Annual Incentive Awards would have been entitled to
receive immediately following such reorganization, merger, or consolidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.3</B> <B>Corporate Transaction in which Awards are not
Assumed.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in the applicable Award Agreement or with respect to Performance Awards and Annual Incentive
Awards, in another agreement with the Grantee, or as otherwise set forth in writing, upon the occurrence of a Corporate Transaction in which outstanding Awards are not being assumed, continued, or substituted for, the following provisions shall
apply to such Award, to the extent not assumed, continued, or substituted for: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) All Grantees of shares of Restricted Stock, Stock
Units, and Dividend Equivalent Rights shall become vested in their Awards as of immediately prior to the occurrence of a Corporate Transaction and any shares of Stock or cash that become vested pursuant to the operation of this
<B>Section</B><B><U></U></B><B>&nbsp;17.3(a)</B> shall be delivered, immediately prior to the occurrence of such Corporate Transaction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) All Grantees of Options and SARs shall become immediately vested in their Awards as of immediately prior to the occurrence of a Corporate
Transaction; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Either or both of the following two actions may be taken: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) At least fifteen (15)&nbsp;days prior to the scheduled consummation of such a Corporate Transaction, notice shall be given to all Grantees
of vested Options and SARs outstanding hereunder (including Options and SARs that become vested pursuant to the operation of <B>Section</B><B></B>&nbsp;<B>17.3(b))</B> that such Options and SARs shall remain exercisable for a period of fifteen
(15)&nbsp;days and shall thereafter be terminated. With respect to the Company&#146;s establishment of an exercise window, (A)&nbsp;any exercise of an Option or SAR during the fifteen <FONT STYLE="white-space:nowrap">(15)-day</FONT> period referred
to above shall be conditioned upon the consummation of the applicable Corporate Transaction and shall be effective only immediately before the consummation thereof, and (B) upon consummation of any Corporate Transaction, the Plan and all outstanding
but unexercised Options and SARs shall terminate. The Committee shall send notice of an event that shall result in such a termination to all natural persons and entities who hold Options and SARs not later than the time at which the Company gives
notice thereof to its shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">and/or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Committee may elect, in its sole discretion, to cancel any outstanding Awards of Options, SARs, Restricted Stock, Stock Units,
and/or Dividend Equivalent Rights and pay or deliver, or cause to be paid or delivered, to the holder thereof an amount in cash or securities having a value (as determined by the Committee acting in good faith), in the case of Restricted Stock or
Stock Units, equal to the formula or fixed price per share paid to holders of shares of Stock pursuant to such Corporate Transaction and, in the case of Options or SARs, equal to the product of the number of shares of Stock subject such Options or
SARs multiplied by the amount, if any, by which (A)&nbsp;the formula or fixed price per share paid to holders of shares of Stock pursuant to such transaction exceeds (B)&nbsp;the Option Price or SAR Exercise Price applicable to such Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) For Performance Awards and Annual Incentive Awards denominated in Stock or Stock Units, if less than half of the Performance Period has
lapsed, such Performance Awards and Annual Incentive Awards shall be converted into Restricted Stock or Stock Units assuming target performance has been achieved (or into Unrestricted Stock if no further restrictions apply). If more than half the
Performance Period has lapsed, such Performance Awards and Annual Incentive Awards shall be converted into Restricted Stock or Stock Units based on actual performance to date (or into Unrestricted Stock if no further restrictions apply). If actual
performance is not determinable, such Performance Awards and Annual Incentive Awards shall be converted into Restricted Stock or Stock Units assuming target performance has been achieved, based on the discretion of the Committee (or into
Unrestricted Stock if no further restrictions apply). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Other-Equity Based Awards shall be governed by the terms of the applicable
Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.4 Corporate Transaction in which Awards are Assumed.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in the applicable Award Agreement, in another agreement with the Grantee, or as otherwise set forth in writing,
upon the occurrence of a Corporate Transaction in which outstanding Awards are being assumed, continued, or substituted for, the following provisions shall apply to such Award, to the extent assumed, continued, or substituted for: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The Plan and the Awards theretofore granted under the Plan shall continue in the manner and under the terms so provided in the event of any
Corporate Transaction to the extent that provision is made in writing in connection with such Corporate Transaction for the assumption or continuation of such Awards, or for the substitution for such Awards of new common stock options, stock
appreciation rights, restricted stock, common stock units, dividend equivalent rights and other equity-based awards relating to the stock of a successor entity, or a parent or subsidiary thereof, with appropriate adjustments as to the number of
shares (disregarding any consideration that is not common stock) and option and stock appreciation rights exercise prices. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) In the event an Award is assumed, continued or substituted upon the consummation of any
Corporate Transaction and the employment of such Grantee with the Company or an Affiliate is terminated without Cause within one year following the consummation of such Corporate Transaction, such Award shall be fully vested and may be exercised in
full, to the extent applicable, beginning on the date of such termination and for the <FONT STYLE="white-space:nowrap">one-year</FONT> period immediately following such termination or for such longer period as the Committee shall determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.5 Adjustments</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjustments under this <B>Section</B><B></B><B>&nbsp;17</B> related to shares of Stock or securities of the Company shall be made by the
Committee, whose determination in that respect shall be final, binding and conclusive. No fractional shares or other securities shall be issued pursuant to any such adjustment, and any fractions resulting from any such adjustment shall be eliminated
in each case by rounding downward to the nearest whole share. The Committee may provide in the applicable Award Agreements at the time of grant, or any time thereafter with the consent of the Grantee, for different provisions to apply to an Award in
place of those provided in <B>Sections</B><B></B><B>&nbsp;17.1, 17.2, 17.3</B> and <B>17.4</B>. This <B>Section</B><B></B><B>&nbsp;17</B> shall not limit the Company&#146;s ability to provide for alternative treatment of Awards outstanding under the
Plan in the event of change in control events that are not Corporate Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.6 No Limitations on Company.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The making of Awards pursuant to the Plan shall not affect or limit in any way the right or power of the Company to make adjustments,
reclassifications, reorganizations, or changes of its capital or business structure or to merge, consolidate, dissolve, or liquidate, or to sell or transfer all or any part of its business or assets (including all or any part of the business or
assets of any Subsidiary or other Affiliate) or to engage in any other transaction or activity. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>18.<U></U></B></TD>
<TD ALIGN="left" VALIGN="top"><B><U></U>GENERAL PROVISIONS </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.1 Disclaimer of Rights.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No provision in the Plan or in any Award or Award Agreement shall be construed to confer upon any individual the right to remain in the employ
or Service of the Company or an Affiliate, or to interfere in any way with any contractual or other right or authority of the Company or an Affiliate either to increase or decrease the compensation or other payments to any natural person or entity
at any time, or to terminate any employment or other relationship between any natural person or entity and the Company or an Affiliate. In addition, notwithstanding anything contained in the Plan to the contrary, unless otherwise stated in the
applicable Award Agreement, no Award granted under the Plan shall be affected by any change of duties or position of the Grantee thereof, so long as such Grantee continues to provide Service. The obligation of the Company to pay any benefits
pursuant to the Plan shall be interpreted as a contractual obligation to pay only those amounts provided herein, in the manner and under the conditions prescribed herein. The Plan and Awards shall in no way be interpreted to require the Company to
transfer any amounts to a third party trustee or otherwise hold any amounts in trust or escrow for payment to any Grantee or beneficiary under the terms of the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.2 Nonexclusivity of the Plan.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither the adoption of the Plan nor the submission of the Plan to the shareholders of the Company for approval shall be construed as creating
any limitations upon the right and authority of the Board or the Committee to adopt such other incentive compensation arrangements (which arrangements may be applicable either generally to a class or classes of individuals or specifically to a
particular individual or particular individuals) as the Board or the Committee, in its discretion, determines desirable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.3
Withholding Taxes.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The Company or an Affiliate, as the case may be, shall have the right to deduct from payments of any kind
otherwise due to a Grantee any federal, state, or local taxes of any kind required by Applicable Laws to be withheld with respect to the vesting of or other lapse of restrictions applicable to an Award or upon the issuance of any shares of Stock
upon the exercise of an Option or pursuant to any other Award. At the time of such vesting, lapse, or exercise, the Grantee shall pay in cash to the Company or an Affiliate, as the case may be, any amount that the Company or such Affiliate may
reasonably determine to be necessary to satisfy such withholding obligation; <I>provided, however,</I> that if there is a same day sale of shares of Stock subject to an Award, the Grantee shall pay such withholding obligation on the day on which the
<FONT STYLE="white-space:nowrap">same-day</FONT> sale is completed. Subject to the prior approval of the Company or an Affiliate, which may be withheld by the Company or such Affiliate, as the case may be, in its sole discretion, the Grantee may
elect to satisfy such withholding obligation, in whole or in part, (a)&nbsp;by causing the Company or such Affiliate to withhold shares of Stock otherwise issuable to the Grantee or (b)&nbsp;by delivering to the Company or such Affiliate shares of
Stock already owned by the Grantee. The shares of Stock so withheld or delivered shall have an aggregate Fair Market Value equal to such withholding obligation. The Fair Market Value of the shares of Stock used to satisfy such withholding obligation
shall be determined by the Company or such Affiliate as of the date on which the amount of tax to be withheld is to be determined. A Grantee who has made an election pursuant to this <B>Section</B><B></B><B>&nbsp;18.3</B> may satisfy such
Grantee&#146;s withholding obligation only with shares of Stock that are not subject to any repurchase, forfeiture, unfulfilled vesting, or other similar requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The maximum number of shares of Stock that may be withheld from any Award to satisfy any federal, state, or local tax withholding
requirements upon the exercise, vesting, or lapse of restrictions applicable to any Award or payment of shares of Stock pursuant to such Award, as applicable, may not exceed such number of shares of Stock having a Fair Market Value equal to the
minimum statutory amount required by the Company or the applicable Affiliate to be withheld and paid to any such federal, state, or local taxing authority with respect to such exercise, vesting, lapse of restrictions, or payment of shares of Stock;
<I>provided, however</I>, for so long as Accounting Standards Update <FONT STYLE="white-space:nowrap">2016-09</FONT> or a similar rule remains in effect, the Board or the Committee has full discretion to choose, or to allow a Grantee to elect, to
withhold a number of shares of Stock having an aggregate Fair Market Value that is greater than the applicable minimum required statutory withholding obligation (but such withholding may in no event be in excess of the maximum required statutory
withholding amount(s) in such Grantee&#146;s relevant tax jurisdiction). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding <B>Section</B><B></B><B>&nbsp;2.17</B> or
this <B>Section</B><B></B><B>&nbsp;18.3</B>, for purposes of determining taxable income and the amount of the related tax withholding obligation pursuant to this <B>Section</B><B></B><B>&nbsp;18.3</B>, the Fair Market Value will be determined by the
Committee in good faith using any reasonable method as it deems appropriate, to be applied consistently with respect to Grantees; <I>provided, further</I>, that the Committee shall determine the Fair Market Value of shares of Stock for tax
withholding obligations due in connection with sales, by or on behalf of a Grantee, of such shares of Stock subject to an Award to pay the Option Price, SAR Exercise Price, and/or any tax withholding obligation on the same date on which such shares
may first be sold pursuant to the terms of the applicable Award Agreement (including broker-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assisted cashless exercises of Options and Stock Appreciation Rights and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sell-to-cover</FONT></FONT> transactions) in any manner
consistent with applicable provisions of the Code, including but not limited to using the sale price of such shares on such date (or if sales of such shares are effectuated at more than one sale price, the weighted average sale price of such shares
on such date) as the Fair Market Value of such shares, so long as such Grantee has provided the Company, or its designee or agent, with advance written notice of such sale. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.4 Captions.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The use
of captions in the Plan or any Award Agreement is for the convenience of reference only and shall not affect the meaning of any provision of the Plan or such Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.5 Other Provisions.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Award granted under the Plan may contain such other terms and conditions not inconsistent with the Plan as may be determined by the
Committee, in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.6 Number and Gender.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to words used in the Plan, the singular form shall include the plural form, and the masculine gender shall include the feminine
gender, as the context requires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.7 Severability.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law in any
jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.8 Governing Law</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
validity and construction of the Plan and the instruments evidencing the Awards hereunder shall be governed by, and construed and interpreted in accordance with, the laws of the State of Delaware, other than any conflicts or choice of law rule or
principle that might otherwise refer construction or interpretation of the Plan and the instruments evidencing the Awards granted hereunder to the substantive laws of any other jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.9 Foreign Jurisdictions.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent the Committee determines that the terms set by the Committee imposed by the Plan preclude the achievement of the purposes of the
Plan in jurisdictions outside the United States, the Committee will have the authority and discretion to modify those terms and provide for such additional terms and conditions as the Committee determines to be necessary, appropriate, or desirable
to accommodate differences in local law, policy, or custom or to facilitate administration of the Plan. The Committee may adopt or approve <FONT STYLE="white-space:nowrap">sub-plans,</FONT> appendices, or supplements to, or amendments, restatements,
or alternative versions of the Plan as in effect for any other purposes. The special terms and any <FONT STYLE="white-space:nowrap">sub-plans,</FONT> appendices, supplements, amendments, restatements, or alternative versions, however, shall not
include any provisions that are inconsistent with the terms of the Plan as in effect, unless the Plan could have been amended to eliminate such inconsistency without further approval by the Company&#146;s shareholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.10 Section&nbsp;409A of the Code.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan is intended to comply with Code Section&nbsp;409A to the extent subject thereto, and, accordingly, to the maximum extent permitted,
the Plan will be interpreted and administered to be in compliance with Code Section&nbsp;409A. Any payments described in the Plan that are due within the &#147;short-term deferral period&#148; within the meaning of Code Section&nbsp;409A will not be
treated as deferred compensation unless Applicable Laws require otherwise. Notwithstanding any provision of the Plan to the contrary, to the extent required to avoid accelerated taxation and tax penalties under Code Section&nbsp;409A, amounts that
would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six (6)-month period immediately following the Grantee&#146;s &#147;separation from service&#148; within the meaning of Code Section&nbsp;409A
will instead be paid on the first payroll date after the six (6)-month anniversary of the Grantee&#146;s Separation from Service (or the Grantee&#146;s death, if earlier). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, notwithstanding anything in the Plan to the contrary, in the case of an Award that is characterized as deferred compensation
under Code Section&nbsp;409A, and pursuant to which settlement and delivery of the cash or shares of Stock subject to the Award is triggered based on a Corporate Transaction, in no event will a Corporate Transaction be deemed to have occurred for
purposes of such settlement and delivery of cash or shares of Stock if the transaction is not also a &#147;change in the ownership or effective control of&#148; the Company or &#147;a change in the ownership of a substantial portion of the assets
of&#148; the Company as determined under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT> (without regard to any alternative definition thereunder). If an Award characterized as deferred compensation under Code
Section&nbsp;409A is not settled and delivered on account of the provision of the preceding sentence, the settlement and delivery shall occur on the next succeeding settlement and delivery triggering event that is a permissible triggering event
under Code Section&nbsp;409A. No provision of this paragraph shall in any way affect the determination of a Corporate Transaction for purposes of vesting in an Award that is characterized as deferred compensation under Code Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, neither the Company nor the Committee will have any obligation to take any action to prevent the assessment of
any excise tax or penalty on any Grantee under Code Section&nbsp;409A, and neither the Company or an Affiliate nor the Board or the Committee will have any liability to any Grantee for such tax or penalty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that the Company determines that a Grantee would be subject to the additional twenty percent (20%) tax imposed on certain
nonqualified deferred compensation plans pursuant to Code Section&nbsp;409A as a result of any provision of any Award granted under the Plan, such provision shall be deemed amended to the minimum extent necessary to avoid application of such
additional tax. The nature of any such amendment shall be determined by the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.11 Non-Payment of Dividends or Dividend
Equivalent Rights on Unvested Awards </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, and notwithstanding anything in the Plan or any Award Agreement to
the contrary, no dividends or Dividend Equivalent Rights shall be paid on any unvested Award and any dividends or Dividend Equivalent Rights granted in respect to any Award shall be paid at the time, if at all, that the Award to which it relates
become vested. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To record adoption of the Plan by the Board as of April&nbsp;23, 2018 and approval of the Plan by
the shareholders on June&nbsp;18, 2018 the Company has caused its authorized officer to execute the Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">ORTHOFIX INTERNATIONAL N.V.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to the </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Orthofix International N.V. 2018 Omnibus Incentive Plan </I></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I><A NAME="rom571963_128"></A>(Proposed Amendment) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 1 TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ORTHOFIX INTERNATIONAL N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECOND AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Orthofix International N.V. (the &#147;Company&#148;) has established and maintains the Second Amended and Restated Stock
Purchase Plan (the &#147;Plan&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company&#146;s Board of Directors desires to amend the Plan, subject to the
approval of the Company&#146;s shareholders, to increase the number of shares of common stock of the Company reserved and available for issuance pursuant to the Plan from 1,850,000 to 2,350,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, by virtue and in exercise of the power reserved to the Company&#146;s Board of Directors by Section&nbsp;9 of the Plan,
the Plan be and hereby is amended, subject to approval by the Company&#146;s shareholders, in the following particulars, to be effective as of the date the Company&#146;s shareholders approve the Amendment: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">By substituting the phrase &#147;2,350,000 shares&#148; for the phrase &#147;1,850,000 shares&#148; in Section&nbsp;3(a) of the Plan. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>(Current Text of Second Amended and Restated Stock Purchase Plan) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ORTHOFIX INTERNATIONAL N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECOND AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK PURCHASE PLAN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Orthofix International N.V. Amended and Restated Stock Purchase Plan is hereby amended, restated and renamed the &#147;Orthofix International N.V. Second Amended and Restated Stock Purchase Plan,&#148; and adopted by the Company, effective as of the
Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"><U>Purpose</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the Plan is to encourage eligible employees and directors to
become owners of common stock of Orthofix International N.V., thereby giving them a greater interest in the growth and success of its business. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"><U>Definitions</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following definitions are used throughout the Plan: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) &#147;<U>Board of Directors</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) &#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) &#147;<U>Committee</U>&#148; means the Compensation Committee of the Board of Directors. If, at any time, there is no acting Compensation
Committee of the Board of Directors, the term &#147;Committee&#148; shall mean the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Company</U>&#148;
means Orthofix International N.V., or any successor to substantially all of its business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) &#147;<U>Director</U>&#148; means a member
of the Board of Directors who is not also an employee of the Company or of a Subsidiary and is not an Employee for purposes of this Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) &#147;<U>Effective Date</U>&#148; means the date determined in accordance with Section 11. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) &#147;<U>Employee</U>&#148; means a full-time or part-time employee of the Company or of a Subsidiary that has been designated as a
participating employer under the Plan. Notwithstanding the foregoing, unless otherwise prohibited by the laws of the local jurisdiction, &#147;Employee&#148; shall not mean a temporary employee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h) &#147;Fair Market Value&#148; means, as of any date that requires the determination of the
Fair Market Value of Orthofix Stock under this Plan, the value of a share of Orthofix Stock on such date of determination, calculated as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) If shares of Orthofix Stock are then listed or admitted to trading on a Nasdaq market system or a stock exchange which reports closing
sale prices, the Fair Market Value shall be the closing sale price on such date on such Nasdaq market system or principal stock exchange on which the share is then listed or admitted to trading, or, if no closing sale price is quoted on such day,
then the Fair Market Value shall be the closing sale price of the share on such Nasdaq market system or such exchange on the next preceding day on which a closing sale price is reported; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) If shares of Orthofix Stock are not then listed or admitted to trading on a Nasdaq market system or a stock exchange which reports
closing sale prices, the Fair Market Value shall be the average of the closing bid and asked prices of the share in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on such date, or, if no
closing bid and asked prices are reported on such day, then the Fair Market Value shall be the average of the closing bid and asked prices of the share in the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market on the next preceding day on which closing bid and asked prices are reported; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) If neither (i) nor (ii) is applicable as of such date, then the Fair Market Value shall be determined by the Committee in good faith
using any reasonable method of evaluation, which determination shall be conclusive and binding on all interested parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i)
&#147;<U>Orthofix Stock</U>&#148; means the Common Stock of the Company, $.10 par value. Unless the context indicates otherwise, the terms &#147;share&#148; or &#147;shares&#148; shall refer to a share or shares of Orthofix Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(j) &#147;<U>Participant</U>&#148; means an Employee or Director who elects to participate in the Plan; provided, however, that no employee
shall be allowed to be a Participant at any time if such employee, after exercising his or her rights to purchase shares under the Plan, would beneficially own shares of the Company&#146;s Common Stock (including shares that may be acquired under
any outstanding options) representing five percent or more of the total combined voting power of all classes of stock of the Company. For purposes of the foregoing sentence, (i)&nbsp;an individual shall be considered as beneficially owning the stock
owned, directly or indirectly, by or for his brothers and sisters (whether by the whole or half blood), spouse, ancestors, and lineal descendants, and (ii) stock owned, directly or indirectly, by or for a corporation, partnership, estate, or trust,
shall be considered as being beneficially owned proportionately by or for its shareholders, partners, or beneficiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(k)
&#147;<U>Plan</U>&#148; means the Orthofix International N.V. Second Amended and Restated Stock Purchase Plan, as further amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(l) &#147;<U>Plan Year</U>&#148; means the <FONT STYLE="white-space:nowrap">12-month</FONT> period beginning on January&nbsp;1 and ending on
December 31; provided, that, pursuant to Section 7, the Committee may change the duration, frequency, start and end dates of future Plan Years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(m) &#147;<U>Subsidiary</U>&#148; means (i)&nbsp;a domestic or foreign corporation, limited liability company, partnership or other entity
with respect to which the Company, directly or indirectly, has the power, whether through the ownership of voting securities, by contract or otherwise, to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
elect at least a majority of the members of such entity&#146;s board of directors or analogous governing body or (ii) any other domestic or foreign corporation, limited liability company,
partnership or other entity in which the Company, directly or indirectly, has an equity or similar interest and which the Committee designates as a Subsidiary for purposes of the Plan. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"><U>Shares Subject to the Plan</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The total number of shares of Orthofix Stock reserved
and available for issuance pursuant to the Plan shall not exceed 1,850,000 shares. The shares of Orthofix Stock purchasable pursuant to the Plan may be authorized but previously unissued shares of Orthofix Stock or shares of Orthofix Stock held in
treasury or purchased in the open market or in privately negotiated transactions. The Company shall bear all costs in connection with issuance or transfer of any shares and all commissions, fees and other charges incurred in purchasing shares for
distribution pursuant to the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) A Participant shall have no rights as a shareholder with respect to shares of Orthofix Stock
purchasable pursuant to the Plan until the date the Participant or his nominee becomes the holder of record of such shares. No adjustment shall be made for dividends or other rights for which the record date is prior to such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If the Committee determines that the total number of shares of Orthofix Stock to be purchased pursuant to the Plan on any particular date
exceeds the number of shares then available for issuance under the Plan, the Committee shall make a pro rata allocation of the available shares on a uniform and <FONT STYLE="white-space:nowrap">non-discriminatory</FONT> basis, and the payroll and
other deductions of each Participant, to the extent in excess of the aggregate purchase price payable for the Orthofix Stock <FONT STYLE="white-space:nowrap">pro-rated</FONT> to such individual, shall be refunded pursuant to Section&nbsp;6. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"><U>Eligibility</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Employee and Director (subject to Section&nbsp;5(b) hereof) shall be
eligible to participate in the Plan on the first day of any Plan Year, provided that he or she is actively employed or is a Director of the Company on such day. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"><U>Participation</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) An eligible Employee shall become a Participant for any Plan Year by
electing to contribute to the Plan, through payroll deductions, either a fixed amount or a percentage of his or her compensation for the Plan Year; provided, however, that such fixed amount or percentage shall not be less than 1% nor more than 25%
(or such other percentage as the Committee may determine) of his or her compensation for the Plan Year. For purposes of the Plan, an Employee&#146;s compensation shall mean (i)&nbsp;for <FONT STYLE="white-space:nowrap">non-commissioned</FONT>
employees, his or her regular salary or straight-time wages, overtime, bonuses, and all other forms of compensation, excluding any car allowance or relocation expense reimbursements; and (ii)&nbsp;for commissioned employees, his or her commissions,
guaranteed payments, overtime, bonuses, and all other forms of compensation, excluding any car allowance or relocation expense reimbursements. An Employee&#146;s election to participate in the Plan for any Plan Year shall be made prior to the
beginning of such Plan Year on an authorized form and shall be made in accordance with procedures established by the Committee from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) An eligible Director shall become a Participant for any Plan Year by electing to contribute
to the Plan, through a deduction of his or her annual director or other compensation paid in cash, either a fixed amount or a percentage of such director compensation for the Plan Year. A Director&#146;s election to participate in the Plan for any
Plan Year shall be made prior to the beginning of such Plan Year or, if later, within 30 days after the date on which such individual first becomes an eligible Director, on an authorized form and shall be made in accordance with procedures
established by the Committee from time to time. Notwithstanding the foregoing, a Director&#146;s election to participate in the Plan for the Plan Year in which he or she first becomes eligible to participate may be made within 30 days after the date
on which such individual first becomes eligible to participate; provided, however, such election shall apply only to an amount of his or her annual or other director compensation paid in cash for such Plan Year equal to the total amount of the
Director&#146;s annual or other compensation paid in cash for such Plan Year multiplied by the ratio of the number of days remaining in the Plan Year after such election is made over the total number of days in the Plan Year for which such Director
receives annual director or other compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) A Participant must complete a new election with respect to each Plan Year in order to
participate in the Plan for such Plan Year. During any Plan Year, a Participant may make a <FONT STYLE="white-space:nowrap">one-time</FONT> election to decrease (including to zero) his or her rate of payroll deductions applicable to such Plan Year.
Such <FONT STYLE="white-space:nowrap">one-time</FONT> decrease shall not limit Participant&#146;s ability to withdraw from the Plan pursuant to Section&nbsp;5(e) below. To make such <FONT STYLE="white-space:nowrap">one-time</FONT> decrease, the
Participant may submit a new election authorizing the new rate of payroll deductions at any time but no later than thirty (30) days before the last day of the Plan Year and in accordance with such other procedures as are established by the Committee
from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Participant contributions (i)&nbsp;in the case of Employees, shall be credited or deposited as soon as practicable
following each payday, and (ii)&nbsp;in the case of Directors, shall be credited or deposited as soon as practicable following the Company&#146;s deduction of all or a portion of the Director&#146;s annual or other compensation. The Company shall
maintain bookkeeping accounts of all Participant contributions but shall have no obligation to pay interest or to hold such amounts in a separate interest-bearing account at a bank or other financial institution (except as required by applicable
law). To the extent separate interest-bearing accounts at a bank or other financial institution are required by applicable law, each such account shall be maintained in the name of the Plan for the benefit of Participants, and the balance of each
such account shall remain the property of the Participants until transferred to the Company pursuant to Section&nbsp;6. After the close of each Plan Year, the balance of the account will be used by (or transferred to) the Company to purchase
Orthofix Stock for distribution to Participants and to pay cash in lieu of fractional shares as provided in Section&nbsp;6. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) A
Participant may elect to withdraw from the Plan by providing notice to the Committee before the last day of the Plan Year. Upon withdrawal from the Plan, all payroll and other deductions under the Plan shall immediately cease, and a Participant
shall receive, in lieu of any other benefits under the Plan, the following: (i) a refund of his or her contributions as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
soon as practicable following the date of withdrawal from the Plan, and in any event no later than the date that is two and <FONT STYLE="white-space:nowrap">one-half</FONT> months following the
last day of the Plan Year in which such Participant withdrew from the Plan, and (ii)&nbsp;to the extent a separate interest-bearing account at a bank or other financial institution was required by applicable law, a refund of the interest, if any,
accrued through the date of payment at the rate in effect at the bank or other financial institution holding Participant contributions, which refund of accrued interest, if any, shall be paid immediately following the end of the Plan Year in which
such Participant withdrew from the Plan, and in any event no later than the date that is two and <FONT STYLE="white-space:nowrap">one-half</FONT> months following the last day of such Plan Year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) An Employee&#146;s participation in the Plan shall terminate upon his or her termination of employment. An Employee&#146;s participation
in the Plan shall, unless otherwise required by applicable law, terminate upon his or her leave of absence or absence from active employment for any other reason only if such Employee does not continue to make contributions to the Plan during such
leave in accordance with procedures established by the Committee. An Employee whose participation in the Plan has terminated pursuant to this Section&nbsp;5(f) shall be deemed to have withdrawn from the Plan for purposes of this Section&nbsp;5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) A Director&#146;s participation in the Plan shall terminate if, during any Plan Year, such Director ceases to be a member of the Board of
Directors for any reason. A Director whose participation in the Plan has terminated pursuant to this Section&nbsp;5(g) shall be deemed to have withdrawn from the Plan for purposes of this Section&nbsp;5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h) A Participant who withdraws his or her contributions or otherwise ceases participation before the last day of the Plan Year may again
participate in the Plan for any subsequent Plan Year, provided he or she satisfies the eligibility requirements of Section&nbsp;4 and makes a timely election to contribute for such Plan Year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) If any law, rule, or regulation applicable to an eligible Employee or Director prohibits the use of payroll or other deductions for
purposes of the Plan, or if such deductions impair or hinder the operation of the Plan or affect the composition of the Board of Directors or any committee thereof, an alternative method of payment approved by the Committee may be substituted for
such eligible Employee or Director, as applicable; provided, however, that if any law, rule or regulation relating to a Director participating in the Plan, in the sole discretion of the Board of Directors, would affect the composition of the Board
of Directors or any committee thereof, the Board of Directors may terminate such Director&#146;s participation in the Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"><U>Distribution of Common Stock</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) As soon as practicable following the last day of each
Plan Year, but in any event no later than the date that is two and <FONT STYLE="white-space:nowrap">one-half</FONT> months following the last day of such Plan Year, the Committee shall distribute to each Employee and Director who was a Participant
for the entire Plan Year (or, in the event of the death of an Employee or Director prior to such distribution, to the Employee&#146;s or Director&#146;s beneficiary, as applicable) a certificate or certificates representing the number of whole
shares of Orthofix Stock determined by dividing (i) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the amount of the Participant&#146;s contributions for the Plan Year (plus interest, if any, accrued to the extent required by applicable law on such contributions through the end of the Plan
Year) by (ii) 85% of the Fair Market Value of the Orthofix Stock on the first day of the Plan Year or, if lower, on the last day of the Plan Year. Cash in the amount of any fractional share shall be paid to the Participant by check as soon as
practicable following the last day of each Plan Year, but in any event, no later than the date that is two and <FONT STYLE="white-space:nowrap">one-half</FONT> months following the last day of such Plan Year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The Committee may, in its discretion, require a Participant to pay to the Company or its Subsidiary, as appropriate, prior to the
distribution of the Orthofix Stock, the amount that the Committee deems necessary to satisfy the Company&#146;s obligation to withhold applicable taxes, at the minimum statutory rate, that the Participant incurs as a result of the Participant&#146;s
participation in the Plan. To satisfy the minimum statutory tax withholding requirements, a Participant may (i)&nbsp;deliver to the Company or its Subsidiary, as appropriate, sufficient shares of Orthofix Stock (based upon the Fair Market Value of
the Orthofix Stock at the date of withholding) to satisfy the Company&#146;s tax withholding obligations, (ii)&nbsp;deliver sufficient cash to the Company or its Subsidiary, as appropriate, to satisfy tax withholding obligations, or
(iii)&nbsp;irrevocably elect for the Company or its Subsidiary, as appropriate, to withhold from the shares of Orthofix Stock to be distributed to the Participant the number of shares necessary (based upon the Fair Market Value of the Orthofix Stock
at the date of withholding) to satisfy the Company&#146;s tax withholding obligations. In the event the Committee subsequently determines that the aggregate Fair Market Value (on the date of withholding) of shares of Orthofix Stock withheld as
payment of any tax withholding obligation is insufficient to discharge that tax withholding obligation, then the Participant shall pay to the Company, or its Subsidiary, as appropriate, immediately upon the Committee&#146;s request, the amount of
that deficiency. The Company or its Subsidiary, as appropriate, shall also have the right to deduct from all cash payments made to a Participant (whether or not such payment is made in connection with the Plan) any applicable taxes required to be
withheld with respect to such payments. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"><U>Administration of the Plan</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The Committee shall administer the Plan and shall keep a
written record of its actions and proceedings regarding the Plan and all dates, records and documents relating to its administration of the Plan. The Committee is authorized to interpret the Plan, to make, amend and rescind such rules as it deems
necessary for the proper administration of the Plan, to make all other determinations necessary or advisable for the administration of the Plan and to correct any defect or supply any omission or reconcile any inconsistency in the Plan in the manner
and to the extent that the Committee deems desirable to carry the Plan into effect. The powers and duties of the Committee shall include, without limitation, the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Determining the amount of benefits payable to Participants and authorizing and directing the Company with respect to the payment of
benefits under the Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Determining the duration, frequency, start and end dates of future Plan Years; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Construing and interpreting the Plan in its sole discretion whenever necessary to carry
out its intention and purpose and making and publishing such rules for the regulation of the Plan as are not inconsistent with the terms of the Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Compiling and maintaining all records it determines to be necessary, appropriate or convenient in connection with the administration of
the Plan; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) Administering the Plan as necessary to take account of tax, securities law and other regulatory requirements of
foreign jurisdictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Any action taken or determination made by the Committee shall, except as otherwise provided in Section&nbsp;8
below, be conclusive on all parties. No member of the Committee shall vote on any matter relating specifically to such member. In the event that a majority of the members of the Committee would be specifically affected by any action proposed to be
taken (as opposed to being affected in the same manner as each other Participant in the Plan), such action shall be taken by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) The Committee may designate one or more of its members or the Chief Executive Officer or the Chief Financial Officer to carry out its
responsibilities under such conditions or limitations as it may set, except that the Committee may not delegate its authority with regard to participation in the Plan by eligible Directors or by eligible Employees who are officers for purposes of
Section 16(b) of the Securities Exchange Act of 1934, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) No member of the Board of Directors or the Committee, the Chief
Executive Officer, the Chief Financial Officer, or any other officer or employee of the Company or any of its Subsidiaries to whom any duties or responsibilities are delegated hereunder shall be liable for any action or determination made in
connection with the operation, administration or interpretation of the Plan, and the Company shall indemnify, defend and hold harmless each such person from any liability arising from or in connection with the Plan, except where such liability
results directly from such person&#146;s fraud, willful misconduct or failure to act in good faith. In the performance of its responsibilities with respect to the Plan, the Committee shall be entitled to rely upon information and advice furnished by
the Company&#146;s officers, the Company&#146;s accountants, the Company&#146;s counsel and any other person the Committee deems necessary, and no member of the Committee shall be liable for any action taken or not taken in reliance upon any such
advice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Anything in the Plan to the contrary notwithstanding, any authority or responsibility that, under the terms of the Plan, may
be exercised by the Committee may alternatively be exercised by the Board of Directors. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"><U>Claims Procedure</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) If a Participant does not receive the timely payment of the
benefits which the Participant believes are due under the Plan, the Participant may make a claim for benefits in the manner hereinafter provided. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) All claims for benefits under the Plan shall be made in writing and shall be signed by the
Participant. Claims shall be submitted to the Committee, or to a representative designated by the Committee. If the Participant does not furnish sufficient information with the claim for the Committee to determine the validity of the claim the
Committee shall indicate to the Participant any additional information which is necessary for the Committee to determine the validity of the claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Each claim hereunder shall be acted on and approved or disapproved by the Committee within 90 days following the receipt by the
Committee of the information necessary to process the claim. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) In the event the Committee denies a claim for benefits in whole or in
part, the Committee shall notify the Participant in writing of the denial of the claim and notify the Participant of his or her right to a review of the Committee&#146;s decision. Such notice by the Committee shall also set forth, in a manner
calculated to be understood by the Participant, the specific reason for such denial, the specific provisions of the Plan on which the denial is based and a description of any additional material or information necessary to perfect the claim with an
explanation of the Plan&#146;s appeals procedure as set forth in this Section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) If no action is taken by the Committee on a
Participant&#146;s claim within 90 days after receipt by the Committee, such claim shall be deemed to be denied for purposes of the following appeals procedure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Any Participant whose claim for benefits is denied in whole or in part may appeal for a review of the decision by the full Committee. Such
appeal must be made within three months after the Participant has received actual or constructive notice of the denial as provided above. An appeal must be submitted in writing within such period and must: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) request a review by the full Committee of the claim for benefits under the Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) set forth all of the grounds upon which the Participant&#146;s request for review is based and any facts in support thereof; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) set forth any issues or comments which the Participant deems pertinent to the appeal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) The Committee shall regularly review appeals by Participants. The Committee shall act upon each appeal within 60 days after receipt
thereof unless special circumstances require an extension of the time for processing, in which case a decision shall be rendered by the Committee as soon as possible but not later than 120 days after the appeal is received by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The Committee shall make a full and fair review of each appeal and any written materials submitted by the Participant in connection
therewith. The Committee may require the Participant to submit such additional facts, documents or other evidence as the Committee in its discretion deems necessary or advisable in making its review. The Participant shall be given the opportunity to
review pertinent documents or materials upon submission of a written request to the Committee, provided the Committee finds the requested documents or materials are pertinent to the appeal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) On the basis of its review, the Committee shall make an independent determination of the
Participant&#146;s eligibility for benefits under the Plan. The decision of the Committee on any claim for benefits shall be final and conclusive upon all parties thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) In the event the Committee denies an appeal in whole or in part, the Committee shall give written notice of the decision to the
Participant, which notice shall set forth, in a manner calculated to be understood by the Participant, the specific reasons for such denial and which shall make specific reference to the pertinent provisions of the Plan on which the Committee&#146;s
decision is based. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"><U>Amendment and Termination</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The Plan may be amended or terminated by the Board of
Directors at any time, provided that no such action shall have the effect of decreasing a Participant&#146;s accrued benefits as of the effective date of such action. Upon termination of the Plan, each Participant shall receive a refund of his or
her contributions for the Plan Year (plus interest, if any, accrued to the extent required by applicable law through the date of termination). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Without shareholder consent and without regard to whether any Participant rights may be considered to have been &#147;decreased,&#148; the
Committee shall be entitled to establish the exchange ratio applicable to payroll and other deductions, in a currency other than United States Dollars, permit payroll and other deductions in excess of the amount designated by a Participant in order
to adjust for delays or mistakes in the Company&#146;s processing of properly completed payroll and other deduction elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts
applied toward the purchase of shares of Orthofix Stock for each Participant properly correspond with amounts deducted from the Participant&#146;s compensation, and establish such other limitations or procedures as the Committee determines in its
sole discretion advisable which are consistent with the Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"><U>Beneficiary Designation</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Participant may file a written designation of a beneficiary
who is to receive any Orthofix Stock or cash under the Plan in the event of such Participant&#146;s death prior to delivery to such Participant of such Orthofix Stock or cash. If a Participant is married and the designated beneficiary is not the
spouse, spousal consent shall be required for such designation to be effective to the extent required by applicable law. Such beneficiary designation may be changed by the Participant at any time by written notice to the Committee. All beneficiary
designations shall be made in such form and manner as the Committee may prescribe from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"><U>Effective Date</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan, as amended and restated herein, shall become effective on the
first day of the Plan Year following the date it is approved by the Board of Directors. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"><U>Participants in <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Jurisdictions</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) To
the extent that Participants are domiciled or resident outside of the U.S. or are domiciled or resident in the U.S. but are subject to the tax laws of a jurisdiction outside of the U.S., the Committee shall have the authority and discretion to adopt
such modifications and procedures as it shall deem necessary or desirable to comply with the provisions of the laws of such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions in order to assure the viability of the benefits paid to such
Participants. The authority granted under the previous sentence shall include the discretion for the Committee to adopt, on behalf of the Company, one or more sub-plans applicable to separate classes of eligible Employees and Directors who are
subject to the laws of jurisdictions outside of the U.S. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any other provision of the Plan to the contrary, to the
extent the Company is required to comply with the EU Prospectus Directive in any jurisdiction with respect to awards made to eligible Employees or Directors in such jurisdiction, the Committee may suspend the right of all eligible Employees and
Directors in such jurisdiction to participate in the Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"><U>Miscellaneous</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Nothing in the Plan shall confer upon a Participant the right to
continue in the employ or continue to be a Director of the Company or a Subsidiary or shall limit or restrict the right of the Company or a Subsidiary to terminate the employment of a Participant at any time with or without cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) No right or benefit under the Plan shall be subject to anticipation, alienation, sale, assignment, pledge, encumbrance or charge, and any
attempt to anticipate, alienate, sell, assign, pledge, encumber or charge such right or benefit shall be void. No such right or benefit shall in any manner be liable for or subject to the debts, liabilities or torts of a Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Neither the Company nor any Subsidiary shall be under any obligation to issue or deliver certificates for shares of Orthofix Stock
pursuant to the Plan if such issuance or delivery would, in the opinion of the Committee, cause the Company to violate any provision of applicable law. The Company and its subsidiaries will use their best efforts to comply with applicable laws but
will not be liable for any failure to comply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) If any provision in the Plan is held by a court of competent jurisdiction to be
invalid, void, or unenforceable, the remaining provisions shall nevertheless continue in full force and effect without being impaired or invalidated in any way. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) The Plan shall be construed and governed in accordance with the law of the State of New York
and without giving effect to principles of conflicts of laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) All notices or other communications by a Participant to the Committee,
the Company, or any Subsidiary under or in connection with the Plan shall be deemed to have been duly given when received in the form specified by the Committee at the location, or by the person, designated by the Committee for the receipt thereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding anything to the contrary contained in the Plan, notices and other elections under this Plan may be delivered or made
electronically, in the discretion of the Committee. In addition, in the discretion of the Committee, shares otherwise deliverable under the Plan may be delivered or otherwise evidenced through book entry or other electronic format without the need
to deliver an actual share certificate; provided, however, an actual share certificate shall be delivered if requested by the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h) The Board of Directors or the Committee may extend or terminate the benefits of the Plan to any Subsidiary at any time without the
approval of the shareholders of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) The proceeds received by the Company from the sale of Orthofix Stock pursuant to the
Plan shall be used for general corporate purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(j) No shares of Orthofix Stock may be issued under this Plan unless the issuance of
such shares has been registered under the Securities Act of 1933, as amended, and qualified under applicable state &#147;blue sky&#148; laws and any applicable <FONT STYLE="white-space:nowrap">non-U.S.</FONT> securities laws, or the Company has
determined that an exemption from registration and from qualification under such state &#147;blue sky&#148; laws and applicable <FONT STYLE="white-space:nowrap">non-U.S.</FONT> securities laws is available. The Committee may require each Participant
purchasing shares under the Plan to represent to and agree with the Company in writing that such eligible Employee or Director, as applicable, is acquiring the shares for investment purposes and not with a view to the distribution thereof. All
certificates for shares delivered under the Plan shall be subject to such stock-transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations, and other requirements of the Securities and Exchange
Commission, any exchange upon which the shares are then listed, and any applicable securities law, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"><U>Compliance with Code Section 409A</U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan and any options granted hereunder are
intended to meet the short term deferral exemption from Code Section&nbsp;409A and shall be interpreted and construed consistent with this intent. Notwithstanding any provision of the Plan to the contrary, in the event that the Board of Directors
determines that the Plan or any option granted hereunder may be subject to Code Section&nbsp;409A, the Board of Directors may, without the consent of Participants, including the affected Participant, adopt such amendments to the Plan or adopt other
policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Board of Directors determines are necessary or appropriate to (i)&nbsp;exempt the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Plan or any option granted hereunder from Code Section&nbsp;409A or (ii)&nbsp;comply with the requirements of Code Section&nbsp;409A and Department of Treasury regulations and other interpretive
guidance issued thereunder. Notwithstanding the foregoing, the Company shall not be required to assume any increased economic burden in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN THE PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;20. Indemnification of Directors and Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Before Domestication.</I> Book 2 of the Cura&ccedil;ao Civil Code does not limit the extent to which a company&#146;s articles of association may provide
for indemnification of officers and directors. However, such provision may be held by the Cura&ccedil;ao courts to be unenforceable, to the extent it seeks to indemnify or exculpate a fiduciary in respect of their internal liability towards the
Company for mismanagement or for external liability caused by such fiduciaries, actual fraud or willful default, or for the consequences of committing a crime. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Article 11 of Orthofix International N.V.&#146;s articles of association provides, in relevant part, that the company shall promptly indemnify, to the full
extent permitted by law, any person made or threatened to be made a party to a threatened, pending or completed action, claim, litigation, suit or proceeding, by reason of the fact that the person, or his or her testator or intestate, is or was a
director or officer of the company. Orthofix International N.V. shall from time to time pay to or reimburse a director or officer any and all other reasonable direct and indirect costs of any type or nature whatsoever incurred by or on behalf of
such director or officer in connection with any action, in advance of the final disposition or conclusion of any such action, within 10 days after the receipt of the director&#146;s or officer&#146;s written request therefore. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. has generally entered into standard indemnity agreements with its officers and directors, which further outline the company&#146;s
mandatory and permissive indemnity and insurance obligations. These indemnity agreements in some cases limit the director&#146;s or officer&#146;s rights to indemnification in specific circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has the power to purchase and maintain insurance on behalf of any person who is or was a director or officer of the Company, and/or is or was
serving as a director or officer of an affiliate, against any liability asserted against him or her and/or incurred by or on behalf of him or her in any such capacity, or arising out of his or her status as such a director or officer, whether or not
the Company would have the power to indemnify him or her against such liabilities under this Article 11 or under applicable law. The purchase and maintenance of such insurance shall not in any way limit or affect the rights and obligations of the
Company and/or any director or officer under Article 11. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the directors and officers have entered into an indemnification agreement with the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>After Domestication</I>. If the domestication is completed, the following provisions and laws will apply to Orthofix Medical Inc. (as a
Delaware corporation) and its directors and officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;102(b)(7) of the DGCL permits a corporation, in its certificate of incorporation, to
limit or eliminate, subject to certain statutory limitations, the liability of directors to the corporation or its stockholders for monetary damages for breaches of fiduciary duty, except for liability (i)&nbsp;for any breach of the director&#146;s
duty of loyalty to the corporation or its stockholders, (ii)&nbsp;for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii)&nbsp;under Section&nbsp;174 of the DGCL or (iv)&nbsp;for any
transaction from which the director derived an improper personal benefit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(a) of the DGCL empowers a corporation to indemnify any
director, officer, employee or agent, or former director, officer, employee or agent, who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in the right of the corporation) by reason of his service as a director, officer, employee or agent of the corporation, or his service, at the corporation&#146;s request, as a director,
officer, employee or agent of another corporation or enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit
or proceeding provided that such director or officer acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, provided that such
director or officer had no reasonable cause to believe his conduct was unlawful. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;145(b) of the DGCL empowers a corporation to indemnify any person who was or is a party or is
threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that such person is or was a director, officer, employee or agent of
the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another enterprise, against expenses (including attorneys&#146; fees) actually and reasonably incurred in connection with the
defense or settlement of such action or suit provided that such director or officer acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification may be
made in respect of any claim, issue or matter as to which such director or officer shall have been adjudged to be liable to the corporation unless and only to the extent that the Delaware Court of Chancery or the court in which such action or suit
was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such director or officer is fairly and reasonably entitled to indemnity for such expenses which the court
shall deem proper. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;145 of the DGCL further provides that to the extent a director or officer of a corporation has been successful in the
defense of any action, suit or proceeding referred to in Section&nbsp;145(a) or Section&nbsp;145(b) of the DGCL or in the defense of any claim, issue or matter therein, he shall be indemnified against expenses (including attorneys&#146; fees)
actually and reasonably incurred by him in connection therewith, provided that indemnification provided for by Section&nbsp;145 of the DGCL or granted pursuant thereto shall not be deemed exclusive of any other rights to which the indemnified party
may be entitled, and empowers the corporation to purchase and maintain insurance on behalf of a director or officer of the corporation against any liability asserted against him or incurred by him in any such capacity or arising out of his status as
such whether or not the corporation would have the power to indemnify him against such liabilities under Section&nbsp;145 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proposed new
Orthofix Medical Inc. certificate of incorporation provides that no director of Orthofix Medical Inc. shall be liable to Orthofix Medical Inc. or its stockholders for monetary damages for breach of fiduciary duty as a director except to the extent
that such exemption from liability or limitation thereof is not permitted under the DGCL as currently in effect or as the same may hereafter be amended. This provision in the certificate of incorporation does not eliminate the directors&#146;
fiduciary duties, and in appropriate circumstances, equitable remedies such as injunctive or other forms of nonmonetary relief will remain available under Delaware law. In addition, each director will be subject to liability for breach of the
director&#146;s duty of loyalty to Orthofix Medical Inc., for acts or omissions not in good faith or involving intentional misconduct, for knowing violations of law, for actions leading to improper personal benefit to the director, and for payment
of dividends or approval of stock repurchases or redemptions that are unlawful under Delaware law. The provision also does not affect a director&#146;s responsibilities under any other law, such as the federal securities laws or state or federal
environmental laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The new Orthofix Medical Inc. bylaws also provide that Orthofix Medical Inc. shall indemnify and advance expenses to its officers and
directors to the fullest extent permitted by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As permitted by the DGCL, we intend to enter into indemnification agreements with our
directors and executive officers in connection with the domestication. These agreements, among other things, will require us to indemnify each director and officer of Orthofix Medical Inc. to the fullest extent permitted by law and advance expenses
to each indemnitee in connection with any proceeding in which indemnification is available. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;21. Exhibits and Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits listed below are part of this Registration Statement and numbered in accordance with Item 601 of Regulation
<FONT STYLE="white-space:nowrap">S-K.</FONT> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:28.45pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/884624/000094787101500352/ex1-1_070901.txt">Certificate of Incorporation of Orthofix International N.V. (filed as an exhibit to the Company&#146;s Annual Report on Form <FONT
STYLE="white-space:nowrap">20-F</FONT> dated June&nbsp;29, 2001 and incorporated herein by reference) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/884624/000110465912014637/a12-4033_1ex3d2.htm">Articles of Association of Orthofix International N.V. (filed as an exhibit to the Company&#146;s Annual Report on Form 10-K for the fiscal
 year ended December 31, 2011 and incorporated herein by reference) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#annxa">Proposed Certificate of Incorporation of Orthofix Medical Inc. (attached as Annex A to the proxy statement/prospectus that forms a part of this registration statement) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#annxb">Proposed Bylaws of Orthofix Medical Inc. (attached as Annex B to the proxy statement/prospectus that forms a part of this registration statement) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d571963dex41.htm">Form of Common Stock Certificate for Orthofix Medical Inc. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d571963dex51.htm">Opinion of Potter Anderson&nbsp;&amp; Corroon LLP as to the validity of the shares of Orthofix common stock </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;8.1*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d571963dex81.htm">Tax opinion of Hogan Lovells US LLP </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d571963dex101.htm">Form of Indemnification Agreement </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d571963dex51.htm">Consent of Potter Anderson&nbsp;&amp; Corroon LLP (included in Exhibit 5.1) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d571963dex81.htm">Consent of Hogan Lovells US LLP (included in Exhibit 8.1) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.3*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d571963dex233.htm">Consent of Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney (included on signature page to this Registration Statement) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1*</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d571963dex991.htm">Form of Proxy Card </A></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Filed herewith </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;22. Undertakings </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top">The undersigned registrant hereby undertakes: </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp;To file, during any
period in which offers or sales are being made, a post-effective amendment to this registration statement: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">To include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act of 1933; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than 20% change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration Fee&#148; table in the effective registration statement; and </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.
</TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) That, for purposes of determining any liability under the Securities Act of 1933, each filing of the
registrant&#146;s annual report pursuant to Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#146;s annual report pursuant to Section&nbsp;15(d) of the Securities
Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
be the initial bona fide offering thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) That, for the purpose of determining liability under the Securities Act of 1933 to any
purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed
to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a
document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify
any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial
distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities
to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such
purchaser: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) To deliver or cause to be delivered with the prospectus, to each person to whom the prospectus is sent or given, the latest annual report,
to security holders that is incorporated by reference in the prospectus and furnished pursuant to and meeting the requirements of Rule <FONT STYLE="white-space:nowrap">14a-3</FONT> or Rule <FONT STYLE="white-space:nowrap">14c-3</FONT> under the
Securities Exchange Act of 1934; and, where interim financial information required to be presented by Article 3 of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> is not set forth in the prospectus, to deliver, or cause to be delivered to
each person to whom the prospectus is sent or given, the latest quarterly report that is specifically incorporated by reference in the prospectus to provide such interim financial information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) That, prior to any public reoffering of the securities registered hereunder through use of a
prospectus which is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c), the issuer undertakes that such reoffering prospectus will contain the information called for by
the applicable registration form with respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) That every prospectus: (i)&nbsp;that is filed pursuant to the immediately preceding paragraph, or (ii)&nbsp;that purports to meet the
requirements of Section&nbsp;10(a)(3) of the Act and is used in connection with an offering of securities subject to Rule 415, will be filed as a part of an amendment to the registration statement and will not be used until such amendment is
effective, and that, for purposes of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial bona fide offering thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) To respond to requests for information
that is incorporated by reference into the prospectus pursuant to Item 4, 10(b), 11, or 13 of this form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means.
This includes information contained in documents filed subsequent to the effective date of the registration statement through the date of responding to the request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) To supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved
therein, that was not the subject of and included in the registration statement when it became effective.<B> </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(B) Insofar as indemnification for
liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the
securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Act and will be governed by the final adjudication of such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant has caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Lewisville, Texas on April&nbsp;23, 2018.</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="50%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ORTHOFIX INTERNATIONAL N.V.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;BRADLEY R. MASON</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Bradley R. Mason</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>President and Chief Executive Officer, Director</B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each person whose signature appears below constitutes and appoints Bradley R. Mason and Douglas C. Rice, and each of
them, his or her true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and
stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this registration statement and any and all related registration statements necessary to register additional securities, and to file the same,
with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto such attorneys <FONT STYLE="white-space:nowrap">in-fact</FONT> and agents, and each of them, full power and authority to do and perform each
and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each such <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, or any of them or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated
on April&nbsp;23, 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;BRADLEY R. MASON</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Bradley R. Mason</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President and Chief Executive Officer, Director</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Executive Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;23, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;DOUGLAS C. RICE</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Douglas C. Rice</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Financial Officer</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Financial
and Accounting Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;23, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ RONALD A. MATRICARIA</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ronald A. Matricaria</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chairman of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;23, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;LUKE FAULSTICK</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Luke Faulstick</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;23, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;JAMES HINRICHS</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>James Hinrichs</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;23, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;ALEXIS V. LUKIANOV</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Alexis V. Lukianov</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">April&nbsp;23, 2018</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;LILLY MARKS</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Lilly Marks</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">April&nbsp;23, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;MICHAEL E. PAOLUCCI</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Michael E. Paolucci</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">April&nbsp;23, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;MARIA SAINZ</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Maria Sainz</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">April&nbsp;23, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;JOHN SICARD</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>John Sicard</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">April&nbsp;23, 2018</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d571963dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g571963p1.jpg" ALT="LOGO">

 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">THIS CERTIFIES THAT is the owner of CUSIP DATED COUNTERSIGNED AND REGISTERED: COMPUTERSHARE TRUST COMPANY, N.A.
TRANSFER AGENT AND REGISTRAR, FULLY-PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK PAR VALUE OF $0.10 PER SHARE OF Orthofix Medical Inc., a corporation incorporated under the laws of the State of Delaware (herein called the &#147;Company&#148;),
transferable on the books of the Company in person, or by duly authorized attorney, upon surrender of this Certificate properly endorsed. This Certificate and the shares represented hereby, are issued and shall be held subject to all of the
provisions of the laws of the State of Delaware and the Certificate of Incorporation of the Company, as amended, copies of such Certificate of Incorporation and all amendments thereto being on file at the office of the Company in executive offices
in Lewisville, Texas, and at the office of the Transfer Agent of the Company to which reference is hereby made and to all provisions whereof the holder, by acceptance of this Certificate, assents. This Certificate is not valid unless countersigned
by the Transfer Agent and registrered by the Registrar named hereon. Witness the signature of its duly authorized officers. COMMON STOCK PAR VALUE $0.10 COMMON STOCK SEE REVERSE FOR CERTAIN DEFINITIONS Certificate Number Shares . ORTHOFIX MEDICAL
INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE WITH AN AUTHORIZED CAPITAL OF 50,000,000 SHARES OF COMMON STOCK EACH WITH A PAR VALUE OF US $0.10 President Chief Financial Officer By AUTHORIZED SIGNATURE DEL AWAR E IN CO RPORAT ED ORTHOFIX
MEDICAL INC. </FONT></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g571963p2.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">For value received, hereby sell, assign and transfer unto Shares Attorney Dated: 20 Signature: Signature: Notice: The signature to this
assignment must correspond with the name as written upon the face of the certificate, in every particular, without alteration or enlargement, or any change whatever. PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE (PLEASE PRINT
OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE, OF ASSIGNEE) of the capital stock represented by the within Certificate, and do hereby irrevocably constitute and appoint to transfer the said stock on the books of the within-named Company
with full power of substitution in the premises. . AUTHORIZED SHARES THE COMPANY WILL FURNISH TO ANY SHAREHOLDER WITHOUT CHARGE, UPON REQUEST ADDRESSED TO THE SECRETARY OR ANY OF ITS TRANSFER AGENTS, A FULL STATEMENT OF THE RELATIVE RIGHTS AND
LIMITATIONS OF THE COMMON SHARES AUTHORIZED TO BE ISSUED, SO FAR AS THE SAME MAY HAVE BEEN FIXED, AND A STATEMENT OF THE AUTHORITY OF THE BOARD OF DIRECTORS TO DESIGNATE AND FIX THE RELATIVE RIGHTS AND LIMITATIONS OF THE COMMON SHARES. Signature(s)
Guaranteed: Medallion Guarantee Stamp THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (Banks, Stockbrokers, Savings and Loan Associations and Credit Unions) WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION
PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15. The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations: TEN COM - as
tenants in common UNIF GIFT MIN ACT - Custodian (Cust) (Minor) TEN ENT - as tenants by the entireties under Uniform Gifts to Minors Act (State) JT TEN - as joint tenants with right of survivorship UNIF TRF MIN ACT - Custodian (until age and not as
tenants in common (Cust) under Uniform Transfers to Minors Act (Minor) (State) Additional abbreviations may also be used though not in the above list. </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d571963dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>Exhibit 5.1</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g571963g0419085815907.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">1313 North
Market Street</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">P.O. Box 951</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">Wilmington, DE 19899-0951</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">302 984 6000</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.potteranderson.com</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">April 23, 2018 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7 Abraham de Veerstraat </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cura&ccedil;ao </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"><U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT></U> </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have acted as special Delaware counsel to Orthofix International N.V., a limited liability company (<I>naamloze vennootschap</I>) presently
organized under the laws of Cura&ccedil;ao (the &#147;Company&#148;), in connection with the proposed domestication of the Company in the State of Delaware pursuant to Section&nbsp;388 of the General Corporation Law of the State of Delaware (the
&#147;DGCL&#148;). We are attorneys duly qualified to practice law in the State of Delaware. We have been asked by the Company to provide you with our opinion with respect to certain matters of Delaware law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company proposes to change its jurisdiction of organization from Cura&ccedil;ao to the State of Delaware by converting pursuant to
Articles 304 and 305 of Book 2 of the Cura&ccedil;ao Civil Code and domesticating in, and continuing as a corporation incorporated under the laws of, the State of Delaware pursuant to Section&nbsp;388 of the DGCL (the &#147;Domestication&#148;). We
understand that the Domestication is subject, among other things, to approval by the Company&#146;s shareholders. The continuing entity following domestication will be named &#147;Orthofix Medical Inc.&#148; In this opinion, we refer to the Company
following its domestication as the &#147;Domesticated Corporation.&#148; At the effective time of the Domestication, the Company&#146;s currently issued and outstanding shares of common stock, ten United States cents ($0.10) par value per share,
will automatically convert by operation of law and in accordance with the resolutions of the Company&#146;s Board of Directors authorizing the Domestication, on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, into the shares of common stock, ten United States cents ($0.10) par value per share, of the Domesticated Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This opinion is being rendered at the request of the Company in connection with the above-referenced Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-4</FONT> filed by the Company on April 23, 2018 with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), relating to the Domestication
(together with all amendments thereto as of the date hereof, the &#147;Registration Statement&#148;). </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In connection with the opinions set forth herein, we have reviewed the following documents: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1. An unexecuted copy of the certificate of corporate domestication of the Company proposed for filing with the Secretary of State of the
State of Delaware pursuant to Section&nbsp;388 of the DGCL (the &#147;Certificate of Domestication&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2. An unexecuted copy of the
certificate of incorporation of the Domesticated Corporation proposed for filing with the Secretary of State of the State of Delaware in accordance with Sections 103 and 388 of the DGCL (the &#147;Delaware Certificate of Incorporation&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3. An unexecuted copy of the proposed bylaws of the Domesticated Corporation (the &#147;Bylaws&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4. Resolutions of the Board of Directors of the Company, dated April 23, 2018, relating to, among other things, the Registration Statement and
the Domestication; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">5. The Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For purposes of the opinions set forth herein, we have not reviewed any documents other than the documents listed in (1)&nbsp;through (5)
above. In particular, we have not reviewed, and express no opinion on, any document (other than the documents listed in (1)&nbsp;through (5) above) that is referred to or incorporated by reference into the documents reviewed by us. We have assumed
that there exists no provision in any document that we have not reviewed that is inconsistent with the opinions set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In
addition, we have conducted no independent factual investigation of our own but rather have relied solely on the foregoing documents, the statements and information set forth therein, and the additional matters related or assumed therein, all of
which we have assumed to be true, complete, and accurate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and subject to the assumptions, qualifications,
exceptions, and limitations set forth herein, we are of the opinion that, following the filing of the Certificate of Domestication and the Delaware Certificate of Incorporation with the Secretary of State of the State of Delaware and upon the
effective time of such Certificate of Domestication and Delaware Certificate of Incorporation: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1. The Company shall be domesticated in,
and will continue as a corporation incorporated under the laws of, the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2. The validly issued, fully paid, and
nonassessable shares of common stock, ten United States cents ($0.10) par value per share, of the Company that are outstanding immediately prior to the Domestication shall be converted by operation of law and in accordance with the resolutions of
the Company&#146;s Board of Directors authorizing the Domestication into an equivalent number of duly authorized, validly issued, fully paid, and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of common stock, ten United States cents
($0.10) par value per share, of the Domesticated Corporation. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The foregoing opinions are subject to the following assumptions, qualifications, exceptions, and
limitations: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">a. We have assumed that the Company is, and at all times relevant for purposes of rendering this opinion was, duly
organized, validly existing, and in good standing under the laws of Cura&ccedil;ao and has, and at all times relevant for purposes of rendering this opinion had, the full power, authority, and legal right to effect the Domestication. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">a. We have assumed that, at all times relevant for purposes of rendering this opinion, the laws of Cura&ccedil;ao authorize and permit the
Domestication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">b. We have assumed that, prior to the effective time of the Domestication, the shareholders of the Company will have
approved the Domestication in compliance with the applicable laws of Cura&ccedil;ao and the Company&#146;s organizational documents, and that the Domestication will be duly authorized by the Company in compliance with the applicable laws of
Cura&ccedil;ao. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">c. We have assumed that, prior to the effective time of the Domestication, all necessary action was taken, or will be
taken, under the applicable laws of Cura&ccedil;ao to authorize and permit the Company to domesticate in the State of Delaware pursuant to Section&nbsp;388 of the DGCL and that any and all consents, approvals, and authorizations from applicable
Cura&ccedil;ao governmental and regulatory authorities required to authorize and permit the Company to domesticate in the State of Delaware pursuant to Section&nbsp;388 of the DGCL have been, or will be, obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">d. We have assumed that, prior to the effective time of the Domestication, the Registration Statement, as finally amended, will have become
effective under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">e. We have assumed that (i)&nbsp;the current drafts of the Certificate of Domestication and the
Delaware Certificate of Incorporation, in the forms thereof submitted for our review, without alteration or amendment (other than filling in the appropriate date(s) and making such other minor changes as appropriate to reflect the passage of time)
will be duly authorized and executed and thereafter be duly filed with the Secretary of State of the State of Delaware in accordance with Sections 103 and 388 of the DGCL, (ii)&nbsp;no other certificate or document has been, or prior to the filing
of the Certificate of Domestication and the Delaware Certificate of Incorporation will be, filed by or in respect of the Company with the Secretary of State of the State of Delaware, and (iii)&nbsp;the Company will pay all fees or other charges
required to be paid in connection with the filing of the Certificate of Domestication and the Delaware Certificate of Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">f.
With respect to the foregoing documents, we have assumed (i)&nbsp;the genuineness of all signatures on documents examined by us, (ii)&nbsp;the authenticity of all documents submitted to us as originals, (iii)&nbsp;the conformity to authentic
originals of all documents submitted to us as certified, conformed, or other copies, and (iv)&nbsp;that the documents, in the forms submitted to us for review, have not been and will not be altered or amended in any respect, except for, only with
respect to the Certificate of Domestication and the Delaware Certificate of Incorporation, as provided above. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">g. This opinion is limited to the laws of the State of Delaware presently in effect. We have not
considered, and we express no opinion on, the laws of any other jurisdiction, including federal laws of the United States (including, without limitation, federal laws and rules and regulations relating to securities) or the laws of Cura&ccedil;ao.
In addition, we express no opinion as to the antitrust or securities laws of the State of Delaware and the rules and regulations relating to either thereof. We assume no obligation to revise or supplement this opinion if any applicable laws change
after the date of this opinion by legislative action, judicial decision, or otherwise, or if we become aware of any facts that might change the opinions expressed above after the date of this opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We consent to the filing of this opinion with the Securities and Exchange Commission as an exhibit to the Registration Statement and the
reference to Potter Anderson and Corroon LLP under the caption &#147;Legal Matters&#148; in the Registration Statement. In giving the foregoing consent, we do not thereby admit that we come within the category of persons whose consent is required
under Section&nbsp;7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder. This opinion is limited to the specific matters set forth herein and is rendered solely for your
benefit. Except as stated above, this opinion may not be relied upon by any other person or entity, or be furnished or quoted to any person or entity, without our prior written consent. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Potter Anderson&nbsp;&amp; Corroon LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Potter Anderson&nbsp;&amp; Corroon LLP</TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>4
<FILENAME>d571963dex81.htm
<DESCRIPTION>EX-8.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-8.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 8.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">


<IMG SRC="g571963g34e03.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hogan Lovells US LLP</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Columbia Square</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">555 Thirteenth Street, NW</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Washington, DC 20004</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">T +1 202 637 5600</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">F +1 202 637 5910</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">www.hoganlovells.com</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;23, 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix
International N.V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7 Abraham de Veerstraat </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cura&ccedil;ao
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel to
Orthofix International N.V., a Cura&ccedil;ao limited liability company, (&#147;<B>Orthofix</B>&#148;) in connection with its registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> filed on April&nbsp;23, 2018 with the Securities
and Exchange Commission, as amended and supplemented through the date hereof (the &#147;<B>Registration Statement</B>&#148;) under the Securities Act of 1933, as amended (the &#147;<B>Act</B>&#148;) relating to its domestication as a Delaware
corporation in accordance with Section&nbsp;388 of the Delaware General Corporation Law and the corporate law of Cura&ccedil;ao as laid down in Book 2 of the Cura&ccedil;ao Civil Code (the &#147;<B>Domestication</B>&#148;). Through the
Domestication, Orthofix will change is jurisdiction of incorporation from Cura&ccedil;ao to Delaware by deregistering as a limited liability company with the Cura&ccedil;ao Trade Commission and continuing and domesticating as a corporation
incorporated under the laws of the State of Delaware. For purposes of this letter, references to &#147;Orthofix&#148; shall mean Orthofix International N.V. as it currently exists under Cura&ccedil;ao law and will continue as Orthofix International
Inc. under Delaware law from and after the Domestication. The term &#147;Orthofix Cura&ccedil;ao&#148; is used to refer to Orthofix prior to the Domestication and the term &#147;Orthofix Delaware&#148; is used to refer to Orthofix from and after the
Domestication. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bases for Opinion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinions set
forth in this letter are based on relevant current provisions of the Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;), Treasury Regulations thereunder (including proposed and temporary Treasury Regulations), and
interpretations of the foregoing as expressed in court decisions, applicable legislative history, and the administrative rulings and practices of the Internal Revenue Service (the &#147;<B>IRS</B>&#148;), including its practices and policies in
issuing private letter rulings, which are not binding on the IRS except with respect to a taxpayer that receives such a ruling, all as of the date hereof. These provisions and interpretations are subject to change by the IRS, Congress and the courts
(as applicable), which may or may not be retroactive in effect and which might result in material modifications of our opinions. Our opinions do not foreclose the possibility of a contrary determination by the IRS or a court of competent
jurisdiction, or of a contrary position taken by the IRS or the Treasury Department in regulations or rulings issued in the future. In this regard, an opinion of counsel with respect to an issue represents counsel&#146;s professional judgment with
respect to the merits of such issue, if </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 23, 2018 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such issue were to be litigated, but an opinion is not binding on the IRS or the courts, and is not a guarantee that the IRS will not assert a contrary position with respect to such issue or that
a court will not sustain such a position asserted by the IRS. Furthermore, no assurance can be given that future legislative, judicial or administrative changes, on either a prospective or retroactive basis, would not adversely affect the accuracy
of the opinion expressed herein. We undertake no responsibility to advise you of any new developments in the law or in the application or interpretation of the federal income tax laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In rendering the following opinion, we have examined such statutes, regulations, records, agreements, certificates, opinions and other documents as we have
considered necessary or appropriate as a basis for the opinion, including, but not limited to, the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">the Registration Statement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">representations and covenants set forth in a letter to us, dated as of the date hereof, together with all exhibits and attachments thereto (collectively, the &#147;<B>Management Representation Letter</B>&#148;); and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">such other documents as we deemed necessary or appropriate (those documents referred to in clauses (1)&nbsp;through (3), the &#147;<B>Reviewed Documents</B>&#148;). </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of rendering our opinion, although we have knowledge as to certain of the facts set forth in the above-referenced documents, we have not made an
independent investigation or audit of the facts set forth in the Reviewed Documents. We consequently have relied, without independent investigation, upon the representations and statements as to factual matters that are set forth or described in the
Reviewed Documents and the assumptions in the Management Representation Letter. We have assumed that the information presented in such documents or otherwise furnished to us is accurate and complete in all material respects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this regard, we have assumed (and will rely upon) the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">that (A) all of the assumptions, representations and statements set forth in the Reviewed Documents are true, correct, and complete as of the date hereof, (B)&nbsp;any representation or statement made as a belief or
made &#147;to the knowledge of&#148; or similarly qualified is true, correct and complete as of the date hereof, and that such representation or statement will continue to be true, correct and complete, without such qualification, (C)&nbsp;each of
the Reviewed Documents that constitutes an agreement, or each agreement described in a Reviewed Document, is valid and binding in accordance with its terms, and (D)&nbsp;each of the obligations imposed by or described in the Reviewed Documents has
been and will continue to be performed or satisfied in accordance with its terms; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">the genuineness of all signatures, the proper execution of all documents, the authenticity of all documents submitted to us as originals, the conformity to originals of documents submitted to us as copies, and the
authenticity of the originals from which any copies were made; </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 23, 2018 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">that any documents as to which we have reviewed only a form were or will be duly executed without material changes from the form reviewed by us; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Orthofix will comply with its representations and covenants contained in the Management Representation Letter. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any material variation or difference in the facts from those set forth in the Reviewed Documents and upon which we have relied may adversely affect the
conclusion stated herein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon,
subject to, and limited by the assumptions and qualifications set forth herein (including those set forth below), the discussion contained in the Registration Statement under the heading &#147;Consequences of the Domestication&#151;F
Reorganization,&#148; insofar as such discussion constitutes statements of U.S. federal income tax law or legal conclusions, represents, subject to the assumptions, limitations and conditions set forth therein, our opinion as to the material U.S.
federal income tax consequences of the Domestication to the beneficial owners of Orthofix Cura&ccedil;ao shares and the material U.S. federal income tax consequences to them of owning and disposing of Orthofix Delaware shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>* * * * * </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion does not address
any federal, state, local or foreign tax issues other than the specific opinion set forth above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We assume no obligation by reason of this opinion or
otherwise to advise you of any changes in our opinion subsequent to the date hereof. Except as provided in the next paragraph, this opinion may not be distributed, quoted in whole or in part or otherwise reproduced in any document, filed with any
governmental agency without our express written consent, except that it may be provided to the Internal Revenue Service, or relied on by any other person for any other purpose without our prior written consent. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Orthofix International N.V. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 23, 2018 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion letter as Exhibit 8.1 to the Registration Statement and the
reference to Hogan Lovells US LLP under the caption &#147;Legal Matters&#148; in the Registration Statement. In giving this consent, however, we do not admit thereby that we are an &#147;expert&#148; within the meaning of the Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Hogan Lovells US LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HOGAN LOVELLS US LLP </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>d571963dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FORM OF INDEMNIFICATION AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Indemnification Agreement (this &#147;Agreement&#148;) is dated as of the <B>[&nbsp;&nbsp;&nbsp;&nbsp;]</B> day of
<B>[&nbsp;&nbsp;&nbsp;&nbsp;]</B>, 20<B>[&nbsp;&nbsp;&nbsp;&nbsp;]</B>, [and effective as of immediately following the Effective Time (as defined below)], by and between ORTHOFIX MEDICAL INC., a Delaware corporation, (the &#147;Company&#148;) and
<B>[Name]</B> (the &#147;Indemnitee&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors has determined that having the ability to attract and retain
qualified persons to serve as directors and/or officers is in the best interests of the Company&#146;s stockholders and that the Company should act to assure such persons that there will be adequate certainty of protection through insurance and
indemnification against risks of claims and actions against them arising out of their service to and activities on behalf of the Company; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[WHEREAS, the Company completed the change of its jurisdiction of organization from Cura&ccedil;ao to the State of Delaware in accordance with
the conversion procedures of Articles 304 and 305 of Book 2 of the Cura&ccedil;ao Civil Code and the domestication procedures of Section&nbsp;388 of the Delaware General Corporation Law, effective as of the filing of certificate of corporate
domestication and certificate of incorporation with the Secretary of State of the State of Delaware or at such later effective time as specified in such filings (the &#147;Effective Time&#148;); and] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Section&nbsp;145 of the General Corporation Law of the State of Delaware (the &#147;DGCL&#148;), among other things, empowers the
Company to indemnify and advance expenses to its officers and directors and to indemnify and advance expenses to persons who serve, at the request of the Company, as directors, officers, employees, or agents of other corporations or enterprises, and
expressly provides that the indemnification provided by Section&nbsp;145 of the DGCL is not exclusive; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company has
adopted provisions in its Bylaws addressing indemnification and advancement of expenses to its officers and directors, and providing that the Company may enter into indemnification agreements that further specify the rights and obligations of the
Company and such persons with respect to indemnification, advancement of expenses and related matters; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in order to induce
and encourage highly experienced and capable persons such as the Indemnitee to serve or continue to serve as directors and officers of the Company and in other capacities with respect to the Company and its affiliates, and to otherwise promote the
desirable end that such persons will resist what they consider unjustified lawsuits and claims made against them in connection with the good faith performance of their duties to the Company, with the knowledge that certain costs, judgments,
liabilities and expenses incurred by them in their defense of such litigation are to be borne by the Company, the Board of Directors of the Company has determined that the following Agreement is reasonable and prudent to promote and ensure the best
interests of the Company and its stockholders; and </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the Indemnitee&#146;s service as a director or officer of the
Company, or service at the Company&#146;s request as a director, officer, employee, or agent of other enterprises or entities, as of or after the date hereof, and for other good and valuable consideration, the sufficiency of which is hereby
acknowledged, the parties hereto agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. <U>Service by Indemnitee</U>. The Indemnitee will serve and/or
continue to serve as a director or officer of the Company faithfully and to the best of the Indemnitee&#146;s ability so long as the Indemnitee is duly elected or appointed and until such time as the Indemnitee is removed, terminated, or tenders a
resignation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. <U>Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>General</U>. The Company shall indemnify the Indemnitee (i)&nbsp;as provided in this Agreement and (ii)&nbsp;subject to the provisions
of this Agreement, to the full extent permitted by applicable law and in a manner permitted by such law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Proceedings Other Than
Proceedings by or in the Right of the Company</U>. Except as provided in Section&nbsp;4 hereof, the Indemnitee shall be entitled to the rights of indemnification provided in this Section&nbsp;2(b) if, by reason of the Indemnitee&#146;s Corporate
Status (as hereinafter defined), the Indemnitee is or was, or is or was threatened to be made, a party to or is or was otherwise involved in a Proceeding (as hereinafter defined), other than a Proceeding by or in the right of the Company to procure
a judgment in its favor. The Indemnitee shall be indemnified pursuant to and in accordance with this Section&nbsp;2(b) against all Losses actually and reasonably incurred by the Indemnitee or on the Indemnitee&#146;s behalf in connection with such a
Proceeding or any claim, issue, or matter therein, but only if the Indemnitee acted in good faith and in a manner that the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal
action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Proceedings by or in the Right of the
Company</U>.<B> </B>Except as provided in Section&nbsp;4 hereof,<B> </B>the<B> </B>Indemnitee shall be entitled to the rights of indemnification provided in this Section&nbsp;2(c) if, by reason of the Indemnitee&#146;s Corporate Status, the
Indemnitee is or was, or is or was threatened to be made, a party to or is or was otherwise involved in a Proceeding brought by or in the right of the Company to procure a judgment in its favor. The Indemnitee shall be indemnified pursuant to and in
accordance with this Section&nbsp;2(c) against all Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee&#146;s behalf in connection with such a Proceeding or any claim, issue, or matter therein, but only if the Indemnitee
acted in good faith and in a manner that the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company; <U>provided</U>, <U>however</U>, that no indemnification for such Expenses shall be made in respect of any
claim, issue, or matter in such Proceeding as to which the Indemnitee shall have been adjudged liable to the Company unless (and only to the extent that) the Court of Chancery of the State of Delaware or the court in which such Proceeding was
brought shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, the Indemnitee is fairly and reasonably entitled to indemnity for such
expenses that the Court of Chancery or such other court shall deem proper. Anything in this Agreement to the contrary notwithstanding, if the Indemnitee, by reason of the Indemnitee&#146;s Corporate Status, is or was, or is or was threatened to be
made, a party to any Proceeding by or in the right of the Company to procure a judgment in its favor, then the Company shall not indemnify the Indemnitee for any judgment, fines, or amounts paid in settlement to the Company in connection with such
Proceeding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Indemnification for Expenses if Indemnitee is Wholly or Partly Successful</U>. Anything in this Agreement to the
contrary notwithstanding, to the extent that the Indemnitee, by reason of the Indemnitee&#146;s Corporate Status, is or was, or is or was threatened to be made, a party to any Proceeding and is successful, on the merits or otherwise, in defending
such Proceeding (including dismissal without prejudice), the Indemnitee shall be indemnified to the maximum extent permitted by law against all Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee&#146;s behalf in
connection with the defense of such Proceeding. If the Indemnitee is not wholly successful in defending any such Proceeding but is successful, on the merits or otherwise, in defending one or more but less than all claims, issues, or matters in such
Proceeding (including dismissal without prejudice of certain claims), the Company shall indemnify the Indemnitee against all Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee&#146;s behalf in defending each such
successfully resolved claim, issue, or matter. To the extent the Indemnitee has been successful, on the merits or otherwise, in defending any Proceeding, or in defending any claim, issue, or matter therein, the Indemnitee shall be entitled to
indemnification as provided in this Section&nbsp;2(d) regardless of whether the Indemnitee met the standards of conduct set forth in Sections 2(b) and 2(c) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Indemnification for Expenses as a Witness</U>. Anything in this Agreement to the contrary notwithstanding, to the fullest extent
permitted by applicable law, to the extent that the Indemnitee, by reason of the Indemnitee&#146;s Corporate Status, is or was, or is or was threatened to be made, a witness in any Proceeding to which the Indemnitee is not a party, the Indemnitee
shall be indemnified against all Expenses actually and reasonably incurred by the Indemnitee or on the Indemnitee&#146;s<B> </B>behalf in connection therewith. To the extent permitted by applicable law, the Indemnitee shall be entitled to
indemnification for Expenses incurred in connection with being or threatened to be made a witness, as provided in this Section&nbsp;2(e), regardless of whether the Indemnitee met the standards of conduct set forth in Sections 2(b) and 2(c) hereof.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Partial Indemnification</U>. If the Indemnitee is entitled under any provision of this Agreement to indemnification by the Company
for some or a portion of the Losses actually and reasonably incurred by the Indemnitee in a Proceeding, but not for the total amount thereof, the Company shall indemnify the Indemnitee for the portion of such Losses to which the Indemnitee is
entitled. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. <U>Advancement of Expenses</U>. Anything in this Agreement to the contrary
notwithstanding, but subject to Section&nbsp;4 hereof, if, by reason of the Indemnitee&#146;s Corporate Status, the Indemnitee is or was, or is or was threatened to be made, a party to, or is or was otherwise involved in, or is or was, or is or was
threatened to be made, a witness to any Proceeding (including, without limitation, a Proceeding brought by or in the right of the Company to procure a judgment in its favor), then the Company shall advance all Expenses actually and reasonably
incurred by or on behalf of the Indemnitee in connection with any such Proceeding in advance of the final disposition of such Proceeding within ten (10)&nbsp;calendar days after the receipt by the Company of a written request for such advance or
advances from time to time. Such written request shall include or be accompanied by a statement or statements reasonably evidencing the Expenses incurred by or on behalf of the Indemnitee and for which advancement is requested, and shall include or
be preceded or accompanied by an undertaking by or on behalf of the Indemnitee to repay any Expenses advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal that the Indemnitee is not
entitled to be indemnified against such Expenses under this Agreement or otherwise. Such undertaking shall be sufficient for purposes of this Section&nbsp;3 if it is in substantially the form attached hereto as <U>Exhibit A</U>. Any advances and
undertakings to repay pursuant to this Section&nbsp;3 shall be unsecured and interest free. The Indemnitee shall be entitled to advancement of Expenses as provided in this Section&nbsp;3 regardless of any determination by or on behalf of the Company
that the Indemnitee has not met the standards of conduct set forth in Sections 2(b) and 2(c) hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. <U>Proceedings
Against the Company; Certain Securities Laws Claims</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Anything in Section&nbsp;2 or Section&nbsp;3 hereof to the contrary
notwithstanding, except as provided in Section&nbsp;7(d) hereof, with respect to a Proceeding initiated against the Company by the Indemnitee (whether initiated by the Indemnitee in or by reason of such person&#146;s capacity as an officer or
director of the Company or in or by reason of any other capacity, including, without limitation, as a director, officer, employee, or agent of Another Enterprise), the Company shall not be required to indemnify or to advance Expenses to the
Indemnitee in connection with prosecuting such Proceeding (or any part thereof) or in defending any counterclaim, cross-claim, affirmative defense, or like claim of the Company in such Proceeding (or part thereof) unless such Proceeding was
authorized by the Board of Directors of the Company. For purposes of this Section&nbsp;4, a compulsory counterclaim by the Indemnitee against the Company in connection with a Proceeding initiated against the Indemnitee by the Company shall not be
considered a Proceeding (or part thereof) initiated against the Company by the Indemnitee, and the Indemnitee shall have all rights of indemnification and advancement with respect to any such compulsory counterclaim in accordance with and subject to
the terms of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Anything in Section&nbsp;2 (other than Section&nbsp;2(d)) or Section&nbsp;3 hereof to the contrary
notwithstanding, except as provided in Section&nbsp;2(d) hereof with respect to indemnification of Expenses in connection with whole or partial success on the merits or otherwise in defending any Proceeding, the Company shall not be required to
indemnify the Indemnitee in connection with any claim made against Indemnitee for (i)&nbsp;an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of
Section&nbsp;16(b) of the Securities Exchange Act of 1934 or similar provisions of state statutory law or common law, or (ii)&nbsp;any reimbursement of the Company by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by the Indemnitee from the sale of securities of the Company, as required in each case
under the Securities Exchange Act of 1934 (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section&nbsp;304 of the Sarbanes-Oxley Act of 2002 (the &#147;<B>Sarbanes-Oxley Act</B>&#148;), or the
payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of Section&nbsp;306 of the Sarbanes-Oxley Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section 5. <U>Procedure for Determination of Entitlement to Indemnification; Independent Counsel</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) To obtain indemnification under this Agreement, the Indemnitee shall submit to the Company (following the final disposition of the
applicable Proceeding) a written request for indemnification, including therein or therewith, except to the extent previously provided to the Company in connection with a request or requests for advancement pursuant to Section&nbsp;3 hereof, a
statement or statements reasonably evidencing all Losses incurred or paid by or on behalf of the Indemnitee and for which indemnification is requested. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification,
advise the Board of Directors in writing that the Indemnitee has requested indemnification. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Upon written request by the Indemnitee for
indemnification pursuant to the first sentence of Section&nbsp;5(a) hereof, if required by applicable law and to the extent not otherwise provided pursuant to the terms of this Agreement, a determination with respect to the Indemnitee&#146;s
entitlement to indemnification shall be made in the specific case as follows: (i)&nbsp;if a Change in Control (as hereinafter defined) shall have occurred and if so requested in writing by the Indemnitee, by Independent Counsel (as hereinafter
defined) in a written opinion to the Board of Directors; or (ii)&nbsp;if a Change in Control shall not have occurred (or if a Change in Control shall have occurred but the Indemnitee shall not have requested that indemnification be determined by
Independent Counsel as provided in subpart (i)&nbsp;of this Section&nbsp;5(b)), (A) by a majority vote of the Disinterested Directors (as hereinafter defined), even though less than a quorum of the Board of Directors, or (B)&nbsp;by a committee of
Disinterested Directors designated by majority vote of the Disinterested Directors, even though less than a quorum of the Board of Directors, (C)&nbsp;if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by
Independent Counsel in a written opinion to the Board of Directors, or (D)&nbsp;by the Company&#146;s stockholders in accordance with applicable law. Notice in writing of any determination as to the Indemnitee&#146;s entitlement to indemnification
shall be delivered to the Indemnitee promptly after such determination is made, and if such determination of entitlement to indemnification has been made by Independent Counsel in a written opinion to the Board of Directors, then such notice shall
be accompanied by a copy of such written opinion. If it is determined that the Indemnitee is entitled to indemnification, then payment to the Indemnitee of all amounts to which the Indemnitee is determined to be entitled shall be made within ten
(10)&nbsp;calendar days after such determination. If it is determined that the Indemnitee is not entitled to indemnification, then the written notice to the Indemnitee (or, if such determination has been made by Independent Counsel in a written
opinion, the copy of such written opinion delivered to the Indemnitee) shall disclose the basis upon which such determination is based. The Indemnitee shall cooperate with the person, persons, or entity making the determination with respect to the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnitee&#146;s entitlement to indemnification, including providing to such person, persons, or entity upon reasonable advance request any documentation or information that is not privileged or
otherwise protected from disclosure and that is reasonably available to the Indemnitee and reasonably necessary to determine whether and to what extent the Indemnitee is entitled to indemnification. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section&nbsp;5(b) hereof, the
Independent Counsel shall be selected as provided in this Section&nbsp;5(c). If a Change in Control shall not have occurred (or if a Change in Control shall have occurred but the Indemnitee shall not have requested that indemnification be determined
by Independent Counsel as provided in subpart (i)&nbsp;of Section&nbsp;5(b)), then the Independent Counsel shall be selected by the Board of Directors, and the Company shall give written notice to the Indemnitee advising the Indemnitee of the
identity of the Independent Counsel so selected. If a Change in Control shall have occurred and the Indemnitee shall have requested that indemnification be determined by Independent Counsel, then the Independent Counsel shall be selected by the
Indemnitee (unless the Indemnitee shall request that such selection be made by the Board of Directors, in which event the preceding sentence shall apply), and the Indemnitee shall give written notice to the Company advising it of the identity of the
Independent Counsel so selected. In either event, the Indemnitee or the Company, as the case may be, may, within 10 calendar days after such written notice of selection has been given, deliver to the Company or to the Indemnitee, as the case may be,
a written objection to such selection; <U>provided</U>, <U>however</U>, that such objection may be asserted only on the ground that the law firm or person so selected does not meet the requirements of &#147;Independent Counsel&#148; as defined in
Section&nbsp;23 of this Agreement, and the objection shall set forth the basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated,
the law firm or person so selected may not serve as Independent Counsel unless and until such objection is withdrawn or the Court of Chancery of the State of Delaware or another court of competent jurisdiction in the State of Delaware has determined
that such objection is without merit. If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section&nbsp;5(b) hereof and, following the expiration of twenty (20)&nbsp;calendar days after submission
by the Indemnitee of a written request for indemnification pursuant to Section&nbsp;5(a) hereof, Independent Counsel shall not have been selected, or an objection thereto has been made and not withdrawn, then either the Company or the Indemnitee may
petition the Court of Chancery of the State of Delaware or other court of competent jurisdiction in the State of Delaware for resolution of any objection that shall have been made by the Company or the Indemnitee to the other&#146;s selection of
Independent Counsel and/or for appointment as Independent Counsel of a law firm or person selected by such court (or selected by such person as the court shall designate), and the law firm or person with respect to whom all objections are so
resolved or the law firm or person so appointed shall act as Independent Counsel under Section&nbsp;5(b) hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section&nbsp;7(a) of this Agreement, Independent Counsel
shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing). If the determination of entitlement to indemnification is to be made by Independent
Counsel pursuant to Section&nbsp;5(b) hereof, then the Company agrees to pay the reasonable fees and expenses of such Independent Counsel and to fully indemnify and hold harmless such Independent Counsel against any and all Expenses, claims,
liabilities, and damages arising out of or relating to this Agreement or its engagement pursuant hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6. <U>Burden of Proof; Defenses; and Presumptions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In any judicial proceeding or arbitration pursuant to Section&nbsp;7 hereof brought by the Indemnitee to enforce rights to indemnification
or to an advancement of expenses hereunder, or in any action, suit, or proceeding brought by the Company to recover an advancement of expenses (whether pursuant to the terms of an undertaking or otherwise), the burden shall be on the Company to
prove that the Indemnitee is not entitled to be indemnified, or to such an advancement of expenses, as the case may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It shall be a
defense in any judicial proceeding or arbitration pursuant to Section&nbsp;7 hereof to enforce rights to indemnification under Section&nbsp;2(b) or Section&nbsp;2(c) hereof (but not in any judicial proceeding or arbitration pursuant to
Section&nbsp;7 hereof to enforce a right to an advancement of expenses under Section&nbsp;3 hereof) that the Indemnitee has not met the standards of conduct set forth in Section&nbsp;2(b) or Section&nbsp;2(c), as the case may be, but the burden of
proving such defense shall be on the Company. With respect to any judicial proceeding or arbitration pursuant to Section&nbsp;7 hereof brought by the Indemnitee to enforce a right to indemnification hereunder, or any action, suit, or proceeding
brought by the Company to recover an advancement of expenses (whether pursuant to the terms of an undertaking or otherwise), neither (i)&nbsp;the failure of the Company (including by its directors or Independent Counsel) to have made a determination
prior to the commencement of such action, suit, proceeding, or arbitration that indemnification is proper in the circumstances because the Indemnitee has met the applicable standards of conduct, nor (ii)&nbsp;an actual determination by the Company
(including by its directors or Independent Counsel) that the Indemnitee has not met such applicable standards of conduct, shall create a presumption that the Indemnitee has not met the applicable standards of conduct or, in the case of a judicial
proceeding or arbitration pursuant to Section&nbsp;7 hereof brought by the Indemnitee seeking to enforce a right to indemnification, be a defense to such proceeding or arbitration. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The termination of any Proceeding by judgment, order, settlement, conviction, or upon a plea of <I>nolo contendre</I> or its equivalent,
shall not, of itself, adversely affect the right of the Indemnitee to indemnification hereunder or create a presumption that the Indemnitee did not act in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the
best interests of the Company, and, with respect to any criminal Proceeding, that the Indemnitee had reasonable cause to believe that his or her conduct was unlawful. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee&#146;s action is
based on the records or books of account of the Company or Other Enterprise, including financial statements, or on information supplied to Indemnitee by the officers of the Company or Other Enterprise in the course of their duties, or on the advice
of legal counsel for the Company or Other Enterprise or on information or records given or reports made to the Company or Other Enterprise by an independent certified public accountant or by an appraiser or other expert selected by the Company or
Other Enterprise. The provisions of this Section&nbsp;6(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the Indemnitee may be deemed or found to have met the applicable standard of conduct set forth in
this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The knowledge and/or actions, or failure to act, of any other director, officer, agent, or
employee of the Company or of Another Enterprise shall not be imputed to the Indemnitee for purposes of determining the Indemnitee&#146;s right to indemnification under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7. <U>Remedies of Indemnitee</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In the event that (i)&nbsp;a determination is made pursuant to Section&nbsp;5 of this Agreement that the Indemnitee is not entitled to
indemnification under this Agreement, (ii)&nbsp;advancement of Expenses is not timely made pursuant to Section&nbsp;3 of this Agreement, (iii)&nbsp;except when the determination of entitlement to indemnification is to be made by Independent Counsel
pursuant to Section&nbsp;5(b) hereof, no determination of entitlement to indemnification shall have been made pursuant to Section&nbsp;5(b) of this Agreement within sixty (60)&nbsp;calendar days after receipt by the Company of the Indemnitee&#146;s
written request for indemnification, (iv)&nbsp;under circumstances in which the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section&nbsp;5(b) hereof, no determination of entitlement to
indemnification shall have been made pursuant to Section&nbsp;5(b) hereof within eighty (80)&nbsp;calendar days after receipt by the Company of the Indemnitee&#146;s written request for indemnification (unless an objection to the selection of such
Independent Counsel has been made and substantiated and not withdrawn, in which case the applicable time period shall be seventy (70)&nbsp;calendar days after the Court of Chancery of the State of Delaware or another court of competent jurisdiction
in the State of Delaware (or such person appointed by such court to make such determination) has determined or appointed the person to act as Independent Counsel pursuant to Section&nbsp;5(b) hereof), (v) payment of indemnification is not made
pursuant to Section&nbsp;2(d) or Section&nbsp;2(e) of this Agreement within twenty (20)&nbsp;calendar days after receipt by the Company of a written request therefor, or (vi)&nbsp;payment of indemnification pursuant to Section&nbsp;2(b) or
Section&nbsp;2(c) of this Agreement is not made within twenty (20)&nbsp;calendar days after a determination has been made pursuant to Section&nbsp;5(b) that the Indemnitee is entitled to indemnification, then the Indemnitee shall be entitled to seek
an adjudication by the Court of Chancery of the State of Delaware of the Indemnitee&#146;s entitlement to such indemnification or advancement of Expenses. Alternatively, if the foregoing conditions have been satisfied, the Indemnitee, at his or her
option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. The Indemnitee shall commence such proceeding seeking an adjudication or an award
in arbitration within 180 calendar days following the date on which the Indemnitee first has the right to commence such proceeding pursuant to this Section&nbsp;7(a); <U>provided</U>, <U>however</U>, that the foregoing clause shall not apply in
respect of a proceeding brought by the Indemnitee to enforce his or her rights to indemnification under Section&nbsp;2(d) of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that a determination shall have been made pursuant to Section&nbsp;5(b) of this Agreement that the Indemnitee is not entitled
to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;7 shall be conducted in all respects as a <I>de novo</I> trial, or arbitration, on the merits and the Indemnitee shall not be prejudiced by reason of
that adverse determination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If a determination shall have been made pursuant to Section&nbsp;5(b) of this Agreement that
the Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;7, absent (i)&nbsp;a misstatement or misrepresentation by the
Indemnitee (or anyone acting on the Indemnitee&#146;s behalf) of a material fact, or an omission of a material fact necessary to make the Indemnitee&#146;s statement (or statements of persons acting on behalf of the Indemnitee) not materially
misleading, in connection with the request for indemnification or in connection with the provision of information or documentation pursuant to the last sentence of Section&nbsp;5(b), or (ii)&nbsp;a prohibition of such indemnification under
applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) In the event that the Indemnitee, pursuant to this Section&nbsp;7, seeks a judicial adjudication of or an award in
arbitration to enforce the Indemnitee&#146;s rights under, or to recover damages for breach of, this Agreement, then the Indemnitee shall be entitled to recover from the Company, and shall be indemnified by the Company against, any and all Expenses
actually and reasonably incurred by or on behalf of such Indemnitee in such judicial adjudication or arbitration, but only if (and only to the extent) the Indemnitee prevails therein. If it shall be determined in said judicial adjudication or
arbitration that the Indemnitee is entitled to receive part but not all of the indemnification or advancement of Expenses sought, the expenses incurred by the Indemnitee in connection with such judicial adjudication or arbitration shall be
appropriately prorated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8. <U><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT></U>. Except to the extent expressly
provided herein, and only to such extent, the rights of indemnification and to receive advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which the Indemnitee may at any time be entitled under
applicable law, the Company&#146;s Certificate of Incorporation, the Company&#146;s Bylaws, any agreement, a vote of stockholders, a resolution of directors, or otherwise, both as to action in or by reason of the Indemnitee&#146;s Corporate Status
and as to action in or by reason of any other capacity of the Indemnitee while serving as a director or officer of the Company. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and
remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. In the event of any change after the date of this Agreement in any applicable law, statute, or
rule that expands the power of a Delaware corporation to indemnify a member of its board of directors or an officer, employee, agent, or fiduciary, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greatest
benefits afforded by such change. Anything in this Section&nbsp;8 to the contrary notwithstanding, to the extent the time periods specified in Section&nbsp;3 and Section&nbsp;7(a) hereof with respect to the time at which the Indemnitee shall be
entitled to seek an adjudication or an award in arbitration as to the Indemnitee&#146;s entitlement to indemnification or advancement differ from similar time periods specified in the Company&#146;s Certificate of Incorporation or Bylaws, the time
periods set forth in Section&nbsp;3 and Section&nbsp;7(a) hereof shall control and be binding on the Indemnitee and the Company and shall be deemed a waiver of any contrary right specified in the Company&#146;s Certificate of Incorporation or
Bylaws. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9. <U>Insurance; Subrogation; Other Sources of Payment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees,
or agents of the Company or Another Enterprise, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, employee or agent under such
policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of the commencement of such proceeding
to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result
of such proceeding in accordance with the terms of such policies. To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees, or agents of the Company or Another
Enterprise, the provision of directors&#146; and officers&#146; liability insurance as provided in this Section&nbsp;9(a) shall be in addition to the Company&#146;s obligations under Sections 2 and 3 hereof and shall not be deemed to be in
satisfaction of those obligations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event of any payment to or on behalf of the Indemnitee under this Agreement, the Company
shall be subrogated to the extent of such payment to all of the rights of recovery of the Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary
to enable the Company to bring suit to enforce such rights. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Except to the extent required by applicable law, the Company shall not be
liable under this Agreement to make any payment to Indemnitee with respect to amounts otherwise indemnifiable hereunder (or for which advancement is otherwise provided hereunder) if and to the extent that the Indemnitee has otherwise actually
received such payment under any insurance policy, contract, agreement, or otherwise. Nothing hereunder is intended to affect any right of contribution of or against the Company in the event the Company and any other person or persons have <FONT
STYLE="white-space:nowrap">co-equal</FONT> obligations to indemnify or advance expenses to Indemnitee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company&#146;s obligation
to indemnify or advance Expenses hereunder to the Indemnitee, in connection with or by reason of Indemnitee&#146;s service at the request of the Company as a director, officer, employee, agent, or fiduciary of Another Enterprise, shall be reduced by
any amount that the Indemnitee has actually received as indemnification or advancement of Expenses from such Other Enterprise with respect to the Proceeding for which indemnification or advancement of Expenses is sought. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10. <U>Contribution</U>. To the fullest extent permitted by applicable law, if the indemnification provided for in this Agreement
is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, for any and all Losses, in connection with any claim relating to an
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i)&nbsp;the relative
benefits received by the Company, on the one hand, and Indemnitee, on the other hand, as a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii)&nbsp;the relative fault of the Company (and its directors, officers,
employees and agents), on the one hand, and Indemnitee, on the other hand, in connection with such event(s) and/or transaction(s), including any relevant equitable considerations. To the extent the Proceeding or any claim or issue in the Proceeding
involves allegations concerning the misstatement or omission of material facts or other disclosure-based claims, the relative fault of the Company and Indemnitee shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or Indemnitee and the parties&#146; relative intent, knowledge, access to information, and opportunity to
correct or prevent such statement or omission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11. <U>Settlements</U>. Notwithstanding anything in this Agreement or the
Company&#146;s Certificate of Incorporation or the Bylaws to the contrary, the Company shall have no obligation to indemnify the Indemnitee under this Agreement for any amounts paid by or on behalf of the Indemnitee in settlement of any Proceeding,
unless the Company has consented in writing to such settlement, which consent shall not be unreasonably withheld. The Company shall not settle any Proceeding or claim therein in any manner that would impose any fine, penalty, limitation or material
obligation on, or require payment from, the Indemnitee without the Indemnitee&#146;s prior written consent, which consent shall not be unreasonably withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12. <U>Survival of Rights; Binding Effect; Successors and Assigns</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The indemnification and advancement of Expenses and other rights provided by, or granted pursuant to, this Agreement shall continue during
the period that the Indemnitee is a director or officer of the Company and shall continue through and after the Termination Date so long as Indemnitee shall be subject to any possible Proceeding (including any appeal thereto), by reason of
Indemnitee&#146;s Corporate Status, with respect to claims arising from any action taken or omitted (or that are alleged to have been taken or omitted) by the Indemnitee, or from any facts or events that occurred (or that are alleged to have
occurred), on or before the Termination Date, and shall further continue for such period of time following the conclusion of any such Proceeding as may be reasonably necessary for Indemnitee to enforce rights and remedies pursuant to this Agreement
as provided in Section&nbsp;7 of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) This Agreement shall be binding upon the Indemnitee and upon the Company and its
successors and assigns, and shall inure to the benefit of the Indemnitee, the Indemnitee&#146;s heirs, personal representatives, executors, administrators, and assigns and to the benefit of the Company and its successors and assigns. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company further agrees that in the event the Company or any of its successors or assigns (i)&nbsp;consolidates with or merges into any
other corporation or entity and shall not be the continuing or surviving corporation or entity of such consolidation or merger or (ii)&nbsp;transfers or conveys all or substantially all of its properties and assets to any corporation or entity,
then, and in each such case, to the extent necessary, proper provision shall be made so that the successors and assigns of the Company as a result of such transaction assume the obligations of the Company set forth in this Agreement, including,
without limitations, the requirements with respect to directors&#146; and officers&#146; liability insurance set forth in Section&nbsp;9. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13. <U>Severability</U>. If any provision or provisions of this Agreement shall be
held to be invalid, illegal, or unenforceable for any reason whatsoever: (a)&nbsp;the validity, legality, and enforceability of the remaining provisions of this Agreement (including without limitation, each such portion of any Section of this
Agreement containing any such provision held to be invalid, illegal, or unenforceable, that is not itself held to be invalid, illegal, or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest
extent permitted by law; (b)&nbsp;such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c)&nbsp;to the fullest extent
possible, the provisions of this Agreement (including, without limitation, each such portion of any Section of this Agreement containing any such provision held to be invalid, illegal, or unenforceable) shall be construed so as to give effect to the
intent manifested by the provision held to be invalid, illegal, or unenforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;14. <U>Acknowledgement</U>. The Company
expressly acknowledges, confirms, and agrees that it has entered into this Agreement and has assumed the obligations imposed on the Company hereby in order to induce the Indemnitee to serve or continue to serve as a director or officer of the
Company, and the Company acknowledges that the Indemnitee is relying upon this Agreement in serving or continuing to serve in such capacity. In addition, both the Company and Indemnitee acknowledge that in certain instances, federal law or
applicable public policy may prohibit the Company from indemnifying its directors, officers, employees, agents or fiduciaries under this Agreement or otherwise. Indemnitee understands and acknowledges that the Company may be required in the future
to undertake with the Securities and Exchange Commission to submit the question of indemnification to a court in certain circumstances for a determination of the Company&#146;s rights under public policy to indemnify Indemnitee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15. <U>Notice by Indemnitee</U>. The Indemnitee agrees to notify the Company promptly and in writing upon being served with any
summons, citation, subpoena, complaint, petition, indictment, information, or other document relating to the commencement or threatened commencement of any Proceeding or matter that may be subject to indemnification or advancement of Expenses
covered hereunder. The failure of the Indemnitee to so notify the Company shall not relieve the Company of any obligation that it may have to the Indemnitee under this Agreement or otherwise, except to the extent the Company is materially prejudiced
by such failure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16. <U>Notices</U>. All notices, requests, demands and other communications hereunder shall be in writing
and shall be deemed to have been duly given (i)&nbsp;if delivered by hand to the party to whom said notice or other communication shall have been directed, on the date so delivered, or (ii)&nbsp;if mailed by certified or registered mail with postage
prepaid, on the third business day after the date on which it is so mailed. All such notices, requests, demands, and other communications shall be delivered to the Indemnitee or to the Company, as the case may be, at the following addresses: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">If to the Indemnitee, to the address set forth on the signature page hereto </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">If to the Company, to: </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Orthofix Medical Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><B></B>3451 Plano Parkway, Lewisville, Texas 75056 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn: Kimberly A. Elting, Chief Legal and Administrative Officer </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address as may have been furnished to the Indemnitee by the Company or to the Company by the Indemnitee, as the case may be, by like notice.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;17. <U>Counterparts</U>. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be
deemed to be an original but all of which together shall constitute one and the same Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;18. <U>Headings</U>. The
headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19. <U>Entire Agreement; Prior Indemnification Agreements</U>. This Agreement constitutes the entire agreement between the
parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written, and implied, between the parties hereto with respect to the subject matter hereof. This Agreement shall supersede and
replace any prior indemnification agreements entered into by and between the Company and the Indemnitee and any such prior agreements shall be deemed automatically terminated upon execution and delivery of this Agreement by the Company and the
Indemnitee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;20. <U>Modification and Waiver</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) No amendment, modification, supplementation, or repeal of this Agreement or any provision hereof shall be binding unless executed in
writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) No amendment, modification, supplementation, or repeal of this Agreement or of any provision hereof shall limit or restrict any rights
of the Indemnitee under this Agreement in respect of any action taken or omitted by the Indemnitee in or by reason of the Indemnitee&#146;s Corporate Status prior to such amendment, modification, supplementation, or repeal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21. <U>Governing Law; Submission to Jurisdiction; Service of Process</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) This Agreement and the legal relations among the parties with respect to the matters addressed hereby shall be governed by, and construed
and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except with respect
to any arbitration commenced by the Indemnitee pursuant to Section&nbsp;7(a) of this Agreement and except to the extent permitted by Section&nbsp;2(c) hereof with respect to a determination by a court in which an underlying Proceeding was brought
that the Indemnitee is entitled to indemnification of Expenses notwithstanding an adjudication of liability to the Company, the Company and the Indemnitee each hereby irrevocably and unconditionally (i)&nbsp;agrees and consents to the jurisdiction
of the courts of the State of Delaware for all purposes in connection with any action, suit, or proceeding that arises out of or relates to this Agreement and agrees that any such action instituted under this Agreement shall be brought only in the
Court of Chancery of the State of Delaware (or in any other state court of the State of Delaware if the Court of Chancery does not have subject matter jurisdiction over such action), and not in any other state or federal court in the United States
of America or any court or tribunal in any other country; (ii)&nbsp;consents to submit to the exclusive jurisdiction of the courts of the State of Delaware for purposes of any action or proceeding arising out of or in connection with this Agreement;
(iii)&nbsp;waives any objection to the laying of venue of any such action or proceeding in the courts of the State of Delaware; and (iv)&nbsp;waives, and agrees not to plead or to make, any claim that any such action or proceeding brought in the
courts of the State of Delaware has been brought in an improper or otherwise inconvenient forum. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each of the Company and the
Indemnitee hereby consents to service of any summons and complaint and any other process that may be served in any action, suit, or proceeding arising out of or relating to this Agreement in any court of the State of Delaware by mailing by certified
or registered mail, with postage prepaid, copies of such process to such party at its address for receiving notice pursuant to Section&nbsp;16 hereof. Nothing herein shall preclude service of process by any other means permitted by applicable law.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22. <U>Nature of Agreement</U>. This Agreement shall not be deemed an employment contract between the Company and the
Indemnitee, and, if Indemnitee is an officer or employee of the Company, Indemnitee specifically acknowledges that Indemnitee may be discharged as an officer or employee of the Company at any time for any reason, with or without cause, and with or
without severance compensation, except as may be otherwise provided in a separate written contract between the Company and the Indemnitee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;23. <U>Definitions</U>. For purposes of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) &#147;Another Enterprise&#148; and &#147;Other Enterprise&#148; refer to a corporation, partnership, limited liability company, joint
venture, trust, employee benefit plan, or any other form of enterprise, other than the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &#147;Change in Control&#148; means, and shall be deemed to have occurred if, (i)&nbsp;any
&#147;person&#148; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company acting in such
capacity or a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, becomes the &#147;beneficial owner&#148; (as defined in Rule <FONT
STYLE="white-space:nowrap">13d-3</FONT> under the Securities Exchange Act of 1934, as amended), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the
Company&#146;s then outstanding voting stock, (ii)&nbsp;during any period of two (2)&nbsp;consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board of
Directors of the Company and any new director whose election by the Board of Directors or nomination for election by the Company&#146;s stockholders was approved by a vote of at least a majority of the directors then still in office who either were
directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof, (iii)&nbsp;the stockholders of the Company approve a merger or consolidation of
the Company with any other corporation other than a merger or consolidation that would result in the voting stock of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted
into voting stock of the surviving entity) at least fifty percent (50%) of the total voting power represented by the voting stock of the Company or such surviving entity outstanding immediately after such merger or consolidation, or (iv)&nbsp;the
stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company (in one transaction or a series of related transactions) of all or substantially all of the Company&#146;s
assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &#147;Corporate Status&#148; describes (1)&nbsp;the Indemnitee&#146;s status as a present or former director or officer of
the Company (whether before or after the Effective Time), (2) the Indemnitee&#146;s present or former status, at any time while serving as a director or officer of the Company (whether before or after the Effective Time), as a director, officer,
employee, agent, or fiduciary of Another Enterprise to the extent the Indemnitee is or was serving in such capacity with respect to such Other Enterprise at the request of Company, and (3)&nbsp;the Indemnitee&#146;s present or former status as a
director, officer, employee, agent, or fiduciary of Another Enterprise to the extent the Indemnitee served in such capacity with respect to such Other Enterprise while serving as a director or officer of the Company (whether before or after the
Effective Time), continued serving in such capacity with respect to such Other Enterprise after ceasing to be a director or officer of the Company, and is or was serving in such capacity with respect to such Other Enterprise at the request of
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &#147;Disinterested Director&#148; means a director of the Company who is not and was not a party to the Proceeding in
respect of which indemnification is sought by the Indemnitee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) &#147;Expenses&#148; includes, without limitation, reasonable attorneys&#146; fees;
retainers; disbursements of counsel; court costs; filing fees; transcript costs; fees and expenses of experts; fees and expenses of witnesses; fees and expenses of accountants and other consultants (excluding public relations consultants unless
approved in advance by the Company); travel expenses; duplicating and imaging costs; printing and binding costs; telephone charges; facsimile transmission charges; computer legal research costs; postage; delivery service fees; fees and expenses of
third-party vendors; the premium, security for, and other costs associated with any bond (including supersedeas or appeal bonds, injunction bonds, cost bonds, appraisal bonds or their equivalents), in each case incurred in connection with
prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding (including, without limitation, any judicial or arbitration Proceeding brought to enforce the
Indemnitee&#146;s rights under, or to recover damages for breach of, this Agreement), as well as all other &#147;expenses&#148; within the meaning of that term as used in Section&nbsp;145 of the DGCL and all other disbursements or expenses of types
customarily and reasonably incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, actions, suits, or proceedings similar to or of the
same type as the Proceeding with respect to which such disbursements or expenses were incurred; but, notwithstanding anything in the foregoing to the contrary, &#147;Expenses&#148; shall not include amounts of judgments, penalties, or fines actually
levied against the Indemnitee in connection with any Proceeding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) &#147;Independent Counsel&#148; means a law firm, or a person
admitted to practice law in any State of the United States, that is experienced in matters of corporation law and neither presently is, nor in the past three (3)&nbsp;years has been, retained to represent: (i)&nbsp;the Company or the Indemnitee in
any matter material to either such party (other than with respect to serving as Independent Counsel (or similar independent legal counsel position) as to matters concerning the rights of Indemnitee under this Agreement, the rights of other
indemnitees under similar indemnification agreements, or the rights of Indemnitee or other indemnitees to indemnification under the Company&#146;s Certificate of Incorporation or Bylaws), or (ii)&nbsp;any other party to the Proceeding giving rise to
a claim for indemnification hereunder. Notwithstanding the foregoing, the term &#147;Independent Counsel&#148; shall not include any law firm or person who, under the applicable standards of professional conduct then prevailing, would have a
conflict of interest in representing either the Company or the Indemnitee in an action to determine the Indemnitee&#146;s rights under this Agreement. For the avoidance of doubt, the term &#147;Independent Counsel&#148; shall not include any law
firm or person who represented or advised any entity or person in connection with a Change in Control of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)
&#147;Losses&#148; means all Expenses, judgments, penalties, fines, liabilities, and amounts paid in settlement in connection with a Proceeding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &#147;Proceeding&#148; means any threatened, pending, or completed action, suit, arbitration, alternative dispute resolution mechanism,
investigation (including any internal investigation), inquiry, administrative hearing, or any other threatened, pending, or completed proceeding, whether brought by or in the right of the Company or otherwise, and whether civil, criminal,
administrative, or investigative. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &#147;Termination Date&#148; shall mean the date on which the Indemnitee is no longer a
director or officer of the Company; <U>provided</U>, <U>however</U>, that if (1)&nbsp;the Indemnitee continues to serve as a director, officer, employee, agent, or fiduciary of Another Enterprise after the date on which the Indemnitee is no longer a
director or officer of the Company, (2)&nbsp;the Indemnitee is serving in such capacity with respect to such Other Enterprise at the request of the Company, and (3)&nbsp;the Indemnitee served in such capacity with respect to such Other Enterprise
while serving as a director or officer of the Company, then &#147;Termination Date&#148; shall mean such later date which the Indemnitee is no longer serving in such capacity with respect to such Other Enterprise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) References herein to &#147;fines&#148; shall include any excise tax assessed with respect to any employee benefit plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) References herein to a director of Another Enterprise or a director of an Other Enterprise shall include, in the case of any entity that is
not managed by a board of directors, such other position, such as manager or trustee or member of the governing body of such entity, that entails responsibility for the management and direction of such entity&#146;s affairs, including, without
limitation, the general partner of any partnership (general or limited) and the manager or managing member of any limited liability company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) (i) References herein to serving at the request of the Company as a director, officer, employee, agent, or fiduciary of Another Enterprise
shall include any service as a director, officer, employee, or agent of the Company that imposes duties on, or involves services by, such director or officer with respect to an employee benefit plan of the Company or any of its affiliates, other
than solely as a participant or beneficiary of such a plan; and (ii)&nbsp;if the Indemnitee has acted in good faith and in a manner such the Indemnitee reasonably believed to be in the interest of the participants and beneficiaries of an employee
benefit plan, the Indemnitee shall be deemed to have acted in a manner not opposed to the best interests of the Company for purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(<I>Remainder of page intentionally left blank)</I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company and the Indemnitee have executed this Agreement, on the day and year first above
written, [effective as of immediately following the Effective Time]. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ORTHOFIX MEDICAL INC.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">INDEMNITEE</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="81%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>Exhibit A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">UNDERTAKING </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, agree to reimburse the Company for all expenses paid to me or on my behalf by the
Company in connection with my involvement in <B>[name or description of proceeding or proceedings]</B>, in the event, and to the extent, that it shall ultimately be determined that I am not entitled to be indemnified by the Company for such
expenses. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Typed Name
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE></DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </U>) ss: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before me
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
on this day personally appeared
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;</U>, known to me to be the person whose name is subscribed to the foregoing instrument, and who, after being duly sworn, stated that the contents of said instrument is to the best of his/her knowledge and belief true and correct
and who acknowledged that he/she executed the same for the purpose and consideration therein expressed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GIVEN under my hand and official seal at
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, this <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> day of
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 20<U>&nbsp;&nbsp;&nbsp;&nbsp;</U>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notary Public</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">My commission expires: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>6
<FILENAME>d571963dex233.htm
<DESCRIPTION>EX-23.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Consent of Independent Registered Public Accounting Firm </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#147;Experts&#148; in the Registration Statement (Form <FONT STYLE="white-space:nowrap">S-4)</FONT>
and related Proxy Statement/Prospectus of Orthofix International N.V. for the registration of 19,382,784 shares of its common stock and to the incorporation by reference therein of our reports dated February&nbsp;26, 2018, with respect to the
consolidated financial statements of Orthofix International N.V.,&nbsp;and the effectiveness of internal control over financial reporting of Orthofix International N.V., included in its Annual Report (Form
<FONT STYLE="white-space:nowrap">10-K)</FONT> for the year ended December&nbsp;31, 2017, filed with the Securities and Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/
Ernst&nbsp;&amp; Young LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dallas, Texas </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;23,
2018 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>d571963dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>ANNUAL GENERAL MEETING OF ORTHOFIX INTERNATIONAL N.V.</B></P>
<P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"><B>Date:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">June 18, 2018</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"><B>Time:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">11:00 A.M. (Atlantic Standard Time)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"><B>Place:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">7 Abraham de Veerstraat, Cura&#231;ao</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Please make your marks like this: </B>&#9746;<B></B><B> Use dark
black pencil or pen only</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="9"><FONT STYLE="font-size:8pt">The Board recommends a vote <B>FOR</B> proposals 1, 3, 4, 5, 6 and 7 and a vote <B>FOR</B> all of the director nominees in proposal 2.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Directors</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Recommend</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT
STYLE="FONT-FAMILY:'WINGDINGS 3'">&#105;</FONT><B></B><B></B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Against</B></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Abstain</B></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:8pt"><B>1:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">Adoption of the domestication resolution to change the jurisdiction of organization of the Company from Cura&#231;ao to the State of Delaware.</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>2:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Election of the following director nominees</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Withhold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">01 Luke Faulstick</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">02 James F. Hinrichs</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">03 Alexis V. Lukianov</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">04 Lilly Marks</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">05 Bradley R. Mason</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">06 Ronald Matricaria</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">07 Michael E. Paolucci</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">08 Maria Sainz</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">09 John Sicard</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Against</B></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Abstain</B></P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>3:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Approval of the consolidated balance sheet and consolidated
statement of operations at and for the fiscal year ended December 31, 2017.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>4:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Advisory vote on compensation of named executive officers.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>5:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Approval of an amendment and restatement of the 2012 Long-Term Incentive Plan to, among other things, increase the number of authorized shares.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>6:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Approval of an amendment to the Second Amended and Restated Stock Purchase Plan to, among other things, increase the number of shares subject to awards.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>7:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ratification of the selection of Ernst &amp; Young LLP as the Company&#146;s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2018.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>For</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>8:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">To consider and act upon any other matters which may properly come before the meeting or any adjournment or postponement thereof.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt"><B>To attend the meeting and vote your shares in person, please mark this box.</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Authorized Signatures - This section must be completed for your Instructions to be executed.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="5" VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B></B>Please Sign Here</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Please Date Above</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B></B>Please Sign Here</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Please Date Above</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5">Please sign exactly as your name(s) appears on your stock certificate. If held in joint tenancy, all persons should sign. Trustees, administrators, etc., should include title and authority. Corporations should provide
full name of corporation and title of authorized officer signing the proxy.</TD></TR></TABLE>
</DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Annual General Meeting of Orthofix International N.V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>to be held on Monday, June 18, 2018 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>for Holders as of April 24, 2018 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>This proxy is being solicited on behalf of the Board of Directors </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="15"> <P STYLE="margin-top:0pt;margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g571963imx4.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>


<IMG SRC="g571963imx1.jpg" ALT="LOGO">
&nbsp;&nbsp;<U>INTERNET</U></B></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><U>VOTE&nbsp;BY:</U></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>


<IMG SRC="g571963imx2.jpg" ALT="LOGO">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>TELEPHONE</U></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Go To</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>866-240-4561</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>www.proxypush.com/ofix</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&#149; Use any touch-tone telephone.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>&#149; Have your Proxy Card/Voting &nbsp;&nbsp;&nbsp;Instruction Form ready.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&#149; Follow the simple recorded</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;instructions.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&#149; Cast your vote online.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&#149; View Meeting
Documents.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>OR</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>


<IMG SRC="g571963imx3.jpg" ALT="LOGO">
&nbsp;&nbsp;<U>MAIL</U></B></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; text-indent:-3.00em; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&#8195;&#8194;&#8201;&#8201;&nbsp;&nbsp;&nbsp;&#149; Mark, sign
and date your Proxy Card/Voting Instruction Form.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; text-indent:-3.00em; font-size:8pt; font-family:Times New Roman"><B>OR</B>&#8195;&#8201;&#8201;&nbsp;&nbsp;&nbsp;&#149; Detach your Proxy Card/Voting
Instruction Form.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; text-indent:-3.00em; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&#8195;&#8194;&#8201;&#8201;&nbsp;&nbsp;&nbsp;&#149; Return
your Proxy Card/Voting Instruction Form in the</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; text-indent:-3.00em; font-size:8pt; font-family:Times New Roman"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B>&#8195;&#8194;&#8201;&#8201;<FONT STYLE="font-size:4pt">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;
&nbsp; postage-paid envelope provided.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">The undersigned hereby appoints Kimberley A. Elting and J.
Brent Alldredge, and each or either of them, as the true and lawful attorneys of the undersigned, with full power of substitution and revocation, and authorizes them, and each of them, to vote all the shares of common stock of Orthofix International
N.V. which the undersigned is entitled to vote at said meeting and any adjournment or postponement thereof upon the matters specified and upon such other matters as may be properly brought before the meeting or any adjournment or postponement
thereof, conferring authority upon such true and lawful attorneys to vote in their discretion on such other matters as may properly come before the meeting and revoking any proxy heretofore given.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS PROXY WILL BE VOTED AS DIRECTED OR, IF NO DIRECTION IS
GIVEN, SHARES WILL BE VOTED FOR THE PROPOSALS IN ITEMS 1, 3, 4, 5, 6 AND 7 AND FOR THE ELECTION OF EACH OF THE DIRECTOR NOMINEES SPECIFIED IN ITEM 2.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>All votes must be received by 5:00 P.M., Eastern Time, June 17, 2018.</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="5" VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman"><B>PROXY TABULATOR FOR</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman"><B>ORTHOFIX INTERNATIONAL N.V.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman"><B>P.O. BOX 8016</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; font-size:8pt; font-family:Times New Roman"><B>CARY, NC 27512-9903</B></P></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" BGCOLOR="#d8d8d8" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000" BGCOLOR="#d8d8d8">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" BGCOLOR="#d8d8d8" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000" BGCOLOR="#d8d8d8">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#d8d8d8" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000" BGCOLOR="#d8d8d8">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;&nbsp;&nbsp;&nbsp;EVENT&nbsp;#</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;&nbsp;&nbsp;&nbsp;CLIENT#</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> </div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="32%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="32%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="32%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revocable Proxy &#151; Orthofix International N.V.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual General Meeting of Shareholders</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>June 18, 2018
11:00 a.m. (Atlantic Standard Time)</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>This Proxy is Solicited on Behalf of the Board of Directors</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" ROWSPAN="2"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="right">


<IMG SRC="g571963imx5.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned appoints Kimberley A. Elting and J. Brent Alldredge, each with full power of substitution, to act as proxies for
the undersigned, and to vote all shares of common stock of Orthofix International N.V. that the undersigned is entitled to vote at the Annual General Meeting of Shareholders on Monday, June&nbsp;18, 2018 at 11:00 a.m. at the offices of Orthofix
International N.V., 7 Abraham de Veerstraat, Cura&ccedil;ao, and any and all adjournments or postponements thereof, as set forth below.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy is revocable and will be voted as directed. However, if no instructions are specified, the proxy will be voted FOR the proposals in Items 1, 3, 4,
5, 6 and 7 and FOR the election of each of the director nominees specified in Item 2.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>(CONTINUED AND TO BE MARKED, DATED AND SIGNED ON REVERSE SIDE)</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g5719631a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g5719631a.jpg
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MQ  =$  !! ,! 0             # @0%!@ '" $4_\0 %@$! 0$
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L\IIVH[<DN_T[:N!J\<+1P,9DG$TIDL1,P]1A/"*3T2_KL>2%,78.RRRS_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g5719632a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g5719632a.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  0 !L# 1$
M A$! Q$!_\0 %@ ! 0$                 "0 "_\0 'Q   04! 0$  P
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,(]S,_<SK'UKFO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g5719633a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g5719633a.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( !  &P,!$0 "$0$#$0'_Q  7   # 0                  " D"_\0
M'A   04! 0$! 0           @$$!08' P ($2+_Q  7 0$! 0$
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g5719634a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g5719634a.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X3NQ:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM
M<#I-;V1I9GE$871E/C(P,3@M,#0M,C!4,3 Z,C4Z,#(M,#<Z,# \+WAM<#I-
M;V1I9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C Q."TP-"TR
M,%0Q,#HR-3HP,BTP-SHP,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX
M;7 Z365T861A=&%$871E/C(P,3@M,#0M,C!4,3 Z,C4Z,#(M,#<Z,# \+WAM
M<#I-971A9&%T841A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^061O
M8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L
M/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V
M/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH
M96EG:'0^,34R/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%
M05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!
M04)!05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!
M04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#
M=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(
M>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&8O.$%!15%G06U!14%!=T52)B-X03M!04E205%-4D%F
M+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%
M04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!
M0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC6455
M37!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#
M3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT
M+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ
M8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!
M341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C13
M3D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG
M6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E7
M5G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A9
M84AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+
M;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X0356;EAV1T]X5C)+=7A6,DMU
M>%8R)B-X03M+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+)B-X03MU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU)B-X03MX5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X)B-X03M6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6)B-X03LR2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6379,;FPO52]-3W17;6HV8D@V;#-D=454*U92,5HR4%I6
M5W!/)B-X03M1>35"0TIK951B:'A(2DE21#=0.&QE54Y-.'!E6')B4G)!5E=)
M8W)I8VEJ5%1-4&IK8C4Y:#)',F-X;7I(2DQI3#%/2$5-8U)%4$)F)B-X03LK
M8V]V*U5W,'(O=&YJ+VLO2FTS-TPK9RLY,4AA,S%2.7IX:DYM-F@R2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+)B-X03MU>%8R2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+=7A6,DMT9T9I04)5;EE!9%-C5D%F5C,U1R]L:5!+
M;6DO<%A5639A+W%A07EQ=S-G9TY')B-X03M72#)9+V%F,V]/,F,O<G16-&MQ
M2#!H-EA1-EAW;S)F<4PP+TU">FYZ4B]Z;$8O>6U';&8Y<SAF.&XU33-N6F8P
M2#-U:C=7*W%0=65-)B-X03M:<S-53WA6,DMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8W
M6"]Z)B-X03MJ-2M6-3%/.5AZ8G$X3F1/=$@O,T=23TYP<#!/.&Q/-E)N<#1T
M.&IM<C=1,5A#3T-04'$W9G,S4U=F16PX2#!8<"MO5U=O5V]U<DM6)B-X03M:
M-V1M9$9L43%5;4IZ1S%$,TA*5'9M;&Q%9S!89&<R:4U#6'I2+WIL1B]Y;4=L
M9CES.&8X;C5-,VY:9C!(,W5J-U<K<5!U94U:<S-5)B-X03M/>%8R2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+
M=7A6,DMU>%8R2W-V+T%#>#AG6&YN)B-X03M8>DQ(64IY:C V0VMU<%A)+UEI
M<CEK2"MD*VDO9C)Z2#%7;T=+3CEE:FPV4%1(3$]U9S5V82]Z<B]-0WDX;2M8
M669*+VQZ:&(S,7A!)B-X03M):7-8+TAR854T-V5$>4199#968G)1-7%T1G!Z
M;&QX>35F95AB83=5:D9$9VIZ4#)";&XU22\X06MR9$$O=T--578X03%%4UIJ
M-C,K)B-X03LY:S5/:B]U;RLU;D=9<FMV;6HO;DM,+VQ-3DLO-UHT+S50>5IV
M3WDO;U!V9$@R=#E59F,X67I:=6]D:7)S5F1I<G-69&ER<U9D:7)S)B-X03M6
M9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<4PP
M;E-R+U9T4W1T3G-):E!E6&-G:6=I6'%78CE12%5N)B-X03MT:UIZ15):-4)N
M:F=:>452>DPV;6EJ,$0X;79Y,TQ0=W5.4F(W4D=Z6&0V-#)!-RMM;C1+4$4W
M-D$X5W!Y*U@S0C9-8T]M>&9J8W9L)B-X03MV5W19,417=%9U9%4Q1U5Z6'0R
M-6MM:U!I97=(64%B061H;2]H05)!035"-7I*:TTU1U(U;#EC+VMJ+S5+,U%0
M*TU5=B]54DIN3V$S)B-X03LK.6LY4&\O-W%0=5IX;4LU3#5O+S5Y:2\U5$13
M=BLR95 K5#AM8GIS=C9$-S-2.7)F5D@S4$=-,F)Q2%EQ-T9867$W1EA9<3=&
M6%EQ)B-X03LW1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$K;"]Y3B],=3$X<F%&2C5Y.'="8F4Y;F=A5TPQ9'9Q)B-X03MT
M<'@U1C)R,&1X=69"9'4U>E(V-U5(2DQG:GDK.'91-D141$A(:FQZ4#)"-#,K
M86XU:#-8;EAZ23DP0WEA5F$Q:3!Y,F)B:DA89#)()B-X03LX.&A&5#E!-UIS
M.4IP>&EJ6%4X,U9A>E4K3% K:4]41$UY6$1F63,U22\X06MR9$$O=T--578X
M03%%4UIZ5W0O=EI05F%0.$%U;RLU)B-X03MN1UER:W9M:B]N2TPO;$U.2R\W
M6C0O-5!Y6G9/>2]O4'9D2#)T.55F8SA9>EIU;V1I<G-69&ER<U9D:7)S5F1I
M<G-69&ER<U9D:7)S)B-X03M69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I
M<G-697-F:TPK5V%E6G183W5A;D=(,%13-4%"13(T;G51039X:V9Y24=$3C0W
M1'5C)B-X03LQ*W8Q4$)(:$@Q2#=N6CEN85AJ4$=E42LY;3,U*S9T-3(Q67(U
M6#AV-DIQ8RMM2GAK,4LX9W1,:#0U,S):26M:54E:139T-'0O<3<T)B-X03MV
M6CA-8V9826DK;3=L.6]Z>5,Y14%A-C=&-&HO04UQ.3@O9CE3,7%V+U-$8R]W
M1$Y'8E@X>&HO;E(K6610*U=Y9GI:9DEU+S56-S4K)B-X03LO=T-P83%8+T%+
M46)N+VUJ2#AX:B]N4BM96#AT:R]M>2M29E9V-5 R1CE99FQV;VQP9E<X='!D
M>%)Y0U<S;E)O-49*;FM)-4EW1$19)B-X03LQ>FYT6DE(2U-(<&1*16I&14AU
M6FIM335$-3<O04]C:G9,2&U85B].5VUZ-E9P3C=Q14UD:45E5S%T-5IL5G97
M:U!%=$=R04=H-EIU)B-X03M/>F-S67=.:T1D,#-A;4M5<%(T45,X4C%44G18
M,&TT5S(Q5WAU3E!U2%%32D1D4E!#-5%K9TU&:T-M;%9)<C=:=%EZ:DE71&)P
M-7=L)B-X03M%,4E59SAK>&1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7(V9B]W0V-8+SA!)B-X03ML
M06(O05 W87,S+U5.8C5O=3%0-W=F,68P;#9$<W(K-U Y8CE!978U<EA:=7A6
M,DMU>%8R2W5X5CAW+S@U468X<#E99CES<4@O<4IU)B-X03M-,S-:9CDR9C8S
M-D$X+S)R+V5$*W(K:W9(.#),<DA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ-T9867$W1EA9)B-X03MQ-T9867$W1EA9<3E1+TLO.#=0
M.$,V0F-A4BMH=C!J-CDR.3,V+S%N,$MC-#0T*TA(,'!F.3E6<EAV;41Q=$8T
M<W5+-C(W;EEA5%AE)B-X03M$2&AQ.2LY;"]W1#!.8B\S-B\X03 O.$$O6G1M
M3B]*6#E,-U R=58O2R\X05(K,SEJ=CA!;V$S+T%,.68O<"\O04]Z8D@K4W8V
M6#)F)B-X03MT6"M6+W=#:CEV-TAF.417+W=$9G(O.$%4+SA!.6TR4#AL9C!V
M<R]A=CAR+T%.2#=F,E!9+TI(;6(O1DAL87<Q-S9T.50K=DLW9E9U)B-X03MF
M<3A/16I*.79I;&9S,2MZ;7-Z-'5#6FIZ<#)M2$IX=T5U.5!-<6)8;68U;R]N
M4"]!244Q:3$P,SE$+W!(-C%B:30Y6#9Z-DA'<G-N)B-X03M(:C95=&9S5G)8
M33=3-DQX451D9D)W9%AR9D))1EAF;2MF9GI1+TU(+TA7=C(K<B]!1D0Y2&5H
M84IA96@V,W(Q-%-34V,K6$-,+V9T)B-X03M+53=:=61,<"]#:G<S93=P3EAQ
M9D=L>%97>D0X>4A&9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-6)B-X03MD:7)S5F1I<G-69&ER<U9D:7)S5F1I<C='+TI(
M+W=!;&)O2"]!0FEL+W=#;VE43V$Q=CA!97EE<3!F.$%D4CEZ3TUX6$IF3D@O
M3U58)B-X03LO2UEA5B\R>G@O>69K>F5D;"]19F4V4'1B-F\K-31X;7ID43=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W)B-X03M&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<2MR9GEF.$%/9FLK=R],9E),
M4RLQ,U0W4S=I:FM%='909'=2>4M44$E2>5)N1$19)B-X03LQ>FXY6FAM8W!)
M:69K.4QP32M-66]G>4A,=EIL+W=!<D,X9R\Y5$QP6"]39&)F.$%.95DS-69*
M+TYL.&DU2#5N2"]/:CAW*V5V*V-J)B-X03MT8C!B5B].5VUZ-E9F,C)O47@R
M25(U8E=62FQ6=E=K4$5T1U=!3D0P>F-D;7=L1T)S5G4V8G142D=5;SA*0F53
M-7-85G5X5C)+=7A6)B-X03LR2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R)B-X03M+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+)B-X03MU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU)B-X03MX5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+<VXO=T-662]M2B]W0E,U<5 O045J
M>68P>6HX,6DO;D)Y=GE78BMA6&8X)B-X03MQ>"]-5"]Q6$Y2+S92-5 V62]M
M<U@X-$PK4WIF>E,W+T%*5FHK66XO049,;6\O.$%34$HO5$@X,6DO;D)F>5=B
M*V%89CAQ>"]-5"]Q)B-X03M83E(O-E(U4#99+VUS6#@T3"M3>F9Z4S<O;%=0
M-6EF.5,U<5 O4U!*+U1(.#%I+VY"9GE78BMA6&8X<7@O350O04ML>E5F.$%P
M2&LO)B-X03MP:BMA>&9Z9W8U3$XO3DQV*U99+VU*+S%,;6\O.4DX;CE-9GI7
M3"MC1B]*6G8U<&0O=T%Q>"]-5"]Q6$Y2+S92-5 V62]M<U@X-$PK)B-X03M3
M>F9Z4S<O;%=0-6EF.5,U<5 X03!J>68P>"].678U=U@X;&TO;6PS+TMS9GI%
M+S9L>E5F*VME5"MM4#5R1B]/0R]K<S,X,'4O=T-6)B-X03M9+VU*+W="4S5Q
M4"]!16IY9C!X+TY9=C5W6#AL;2]M;#,O2W-F>D4O-FQZ568K:V54*VU0-7)&
M+T]#+VMS,S@P=2\U5FHK66XO575A)B-X03MJ+S!J>68P>"].678U=U@X;&TO
M;6PS+TMS9GI%+W=#<&,Q2"]!2U(U4#99+VUS6#@T3"M3>F9Z4S<O;%=0-6EF
M.5,U<5 O4U!*+U1()B-X03LX,6DO;D)F>5=B*V%89CA!2W-F>D4O-FQZ568K
M:V54*VU0-7)&+T]#+VMS,S@P=2\U5FHK66XO575A:B]!3DDX;CE-9GI73"MC
M1B]*)B-X03M:=C5P9"]Y<D@X>% K<&,Q2"]P2&LO<&HK87AF>F=V-4Q.+TY,
M=CA!;%=0-6EF.$%5=6%J+W="23AN.4UF>E=,*V-&+TI:=C5P9"]Y)B-X03MR
M2#AX4"MP8S%(+W!(:R]P:BMA>&9Z9W8U3$XO3DQV*U99+VU*+S%,;6\O.4DX
M;CE-9GI73"MC1B]*6G8U<&0O>7)(.'A0.$%Q6$Y2)B-X03LO=T-K950K;5 U
M<D8O3T,O:W,S.#!U+S56:BM9;B]5=6%J+S!J>68P>"].678U=U@X;&TO;6PS
M+T%#<D@X>% K<&,Q2"]P2&LO<&HK)B-X03MA>&9Z9W8U3$XO3DQV*U99+VU*
M+S%,;6\O=T134$HO5$@X,6DO;D)F>5=B*V%89CAQ>"]-5"]Q6$Y2+S92-5 V
M62]M<U@X-$PK4WIF)B-X03MZ4S<O04I6:BM9;B]!1DQM;R\X05-02B]42#@Q
M:2]N0F9Y5V(K85AF.'%X+TU4+W%83E(O-E(U4#99+VUS6#@T3"M3>F9Z4S<O
M;%=0)B-X03LU:68Y4S5Q4"]34$HO5$@X,6DO;D)F>5=B*V%89CAQ>"]-5"]!
M2VQZ568X07!(:R]P:BMA>&9Z9W8U3$XO3DQV*U99+VU*+S%,;6\O)B-X03LY
M23AN.4UF>E=,*V-&+TI:=C5P9"]W07%X+TU4+W%83E(O-E(U4#99+VUS6#@T
M3"M3>F9Z4R\O6CPO>&UP1TEM9SII;6%G93X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]X;7 Z
M5&AU;6)N86EL<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS
M.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @(" @
M(" @(#QD8SIF;W)M870^87!P;&EC871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R
M;6%T/@H@(" @(" @(" \9&,Z=&ET;&4^"B @(" @(" @(" @(#QR9&8Z06QT
M/@H@(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B
M/C,\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \
M+V1C.G1I=&QE/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z
M>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @
M(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @(" @(" @("!X;6QN<SIS=$5V
M=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E
M179E;G0C(CX*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#HY
M,#$U,30Y-D)&-#1%.#$Q.#0P.4,U1#DW1#<P,#4P0SPO>&UP34TZ1&]C=6UE
M;G1)1#X*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HY,#$U
M,30Y-D)&-#1%.#$Q.#0P.4,U1#DW1#<P,#4P0SPO>&UP34TZ26YS=&%N8V5)
M1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.F,Q
M.65D8C@U+31D,S4M-&0P,BUB.&%E+3AC83!E-V4W-#DP,#PO>&UP34TZ3W)I
M9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ4F5N9&ET:6]N0VQA
M<W,^9&5F875L=#PO>&UP34TZ4F5N9&ET:6]N0VQA<W,^"B @(" @(" @(#QX
M;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z.$8Q-3$T.39"
M1C0T13@Q,3@T,#E#-40Y-T0W,# U,$,\+W-T4F5F.FEN<W1A;F-E240^"B @
M(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z.$8Q-3$T.39"
M1C0T13@Q,3@T,#E#-40Y-T0W,# U,$,\+W-T4F5F.F1O8W5M96YT240^"B @
M(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^=75I9#IC,3EE
M9&(X-2TT9#,U+31D,#(M8CAA92TX8V$P93=E-S0Y,# \+W-T4F5F.F]R:6=I
M;F%L1&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.G)E;F1I=&EO;D-L
M87-S/F1E9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \
M+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*
M(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z03@R14%#-3%"1C0T
M13@Q,3@T,#E#-40Y-T0W,# U,$,\+W-T179T.FEN<W1A;F-E240^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,3@M,#0M,C!4,3 Z,C$Z-3,M
M,#<Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS
M;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\
M+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS
M879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M:6YS=&%N8V5)1#YX;7 N:6ED.CDP,34Q-#DV0D8T-$4X,3$X-# Y0S5$.3=$
M-S P-3!#/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z=VAE;CXR,#$X+3 T+3(P5#$P.C(U.C R+3 W.C P/"]S=$5V=#IW
M:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!
M9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R
M94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S
M=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N
M<RYA9&]B92YC;VTO<&1F+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R
M/D%D;V)E(%!$1B!L:6)R87)Y(#$P+C Q/"]P9&8Z4')O9'5C97(^"B @(" @
M(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D
M9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!44&<](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @(" @(" @(" @>&UL;G,Z
M<W1$:6T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$:6UE
M;G-I;VYS(R(*(" @(" @(" @(" @>&UL;G,Z<W1&;G0](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]&;VYT(R(*(" @(" @(" @(" @>&UL
M;G,Z>&UP1STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @
M(" @(" @/'AM<%109SI.4&%G97,^,3PO>&UP5%!G.DY086=E<SX*(" @(" @
M(" @/'AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/D9A;'-E/"]X;7!4
M4&<Z2&%S5FES:6)L951R86YS<&%R96YC>3X*(" @(" @(" @/'AM<%109SI(
M87-6:7-I8FQE3W9E<G!R:6YT/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L94]V
M97)P<FEN=#X*(" @(" @(" @/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=$1I;3IW/C8Q,BXP
M,# P,# \+W-T1&EM.G<^"B @(" @(" @(" @(#QS=$1I;3IH/C<Y,BXP,# P
M,# \+W-T1&EM.F@^"B @(" @(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO
M<W1$:6TZ=6YI=#X*(" @(" @(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @
M(" @(" @(#QX;7!44&<Z1F]N=',^"B @(" @(" @(" @(#QR9&8Z0F%G/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1.86UE/E1I;65S3F5W
M4F]M86Y04RU";VQD350\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @(" @
M(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y4:6UE<R!.97<@4F]M86X\+W-T1FYT
M.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C
M93Y";VQD/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.F9O;G14>7!E/D]P96X@5'EP93PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @
M(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/E9E<G-I;VX@-2XR
M,#PO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/G1I;65S8F0N='1F/"]S
M=$9N=#IF;VYT1FEL94YA;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI"86<^"B @(" @(" @(#PO>&UP5%!G.D9O;G1S
M/@H@(" @(" @(" \>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @(" @(#QR
M9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/E!!3E1/3D4@,CDT-2!#
M/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X
M;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @/'AM<%109SI3=V%T8VA'<F]U
M<',^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'AM<$<Z9W)O=7!.86UE/D1E9F%U;'0@4W=A=&-H($=R;W5P/"]X;7!'
M.F=R;W5P3F%M93X*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E
M/C \+WAM<$<Z9W)O=7!4>7!E/@H@(" @(" @(" @(" @(" @(" \>&UP1SI#
M;VQO<F%N=',^"B @(" @(" @(" @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y004Y43TY%(#(Y-#4@0SPO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E-03U0\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z=&EN=#XQ
M,# N,# P,# P/"]X;7!'.G1I;G0^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUO9&4^3$%"/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.DP^,CDN,#$Y-C P/"]X;7!'.DP^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.D$^+38\+WAM<$<Z03X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z0CXM-3,\+WAM<$<Z0CX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X;7!'
M.D-O;&]R86YT<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O=7!S
M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z17AT96YS:7-&
M;VYT4V5N<V4](FAT=' Z+R]W=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E
M;G-E+R(^"B @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93IS;'5G/@H@(" @
M(" @(" @(" \<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#Q%>'1E
M;G-I<T9O;G1396YS93I&;VYT2VEN9#Y/<&5N5'EP92 M(%14/"]%>'1E;G-I
M<T9O;G1396YS93I&;VYT2VEN9#X*(" @(" @(" @(" @(" @(" @/$5X=&5N
M<VES1F]N=%-E;G-E.D9A;6EL>3Y4:6UE<R!.97<@4F]M86X\+T5X=&5N<VES
M1F]N=%-E;G-E.D9A;6EL>3X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES
M1F]N=%-E;G-E.D]U=&QI;F5&:6QE4VEZ93XP/"]%>'1E;G-I<T9O;G1396YS
M93I/=71L:6YE1FEL95-I>F4^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I
M<T9O;G1396YS93I&;W5N9')Y/DUO;F]T>7!E(%1Y<&]G<F%P:'D\+T5X=&5N
M<VES1F]N=%-E;G-E.D9O=6YD<GD^"B @(" @(" @(" @(" @(" @(#Q%>'1E
M;G-I<T9O;G1396YS93I697)S:6]N/C4N,C \+T5X=&5N<VES1F]N=%-E;G-E
M.E9E<G-I;VX^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS
M93I+97)N:6YG0VAE8VMS=6T^,#PO17AT96YS:7-&;VYT4V5N<V4Z2V5R;FEN
M9T-H96-K<W5M/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N
M<V4Z1F]N=%-E;G-E7S$N,E]#:&5C:W-U;3XR-#DQ,S4R.30V/"]%>'1E;G-I
M<T9O;G1396YS93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/@H@(" @(" @(" @
M(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z0VAE8VMS=6T^,C0Y,3,U,CDT
M-CPO17AT96YS:7-&;VYT4V5N<V4Z0VAE8VMS=6T^"B @(" @(" @(" @(" @
M(" @(#Q%>'1E;G-I<T9O;G1396YS93I0;W-T4V-R:7!T3F%M93Y4:6UE<TYE
M=U)O;6%N4%,M0F]L9$U4/"]%>'1E;G-I<T9O;G1396YS93I0;W-T4V-R:7!T
M3F%M93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M<F1F.D)A9SX*(" @(" @(" @/"]%>'1E;G-I<T9O;G1396YS93IS;'5G/@H@
M(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP
M;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W
M(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!_\  $0@ $  ; P$1  (1 0,1 ?_$ !<   ,!
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:W?54W9FU0:HNQ)U1?Y4>^*/P #,G-9G/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g5719635a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g5719635a.jpg
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M Q$!_\0 &    @,                 " D  P7_Q  E$  ! P,$ @(#
M       $ P4& @<3  $($A$B%2$)%"/_Q  : 0 !!0$                &
M  $"!PD#_\0 (A$  @(" @(# 0$          @,!! 41  82(1,Q010C_]H
M# ,!  (1 Q$ /P! ^M*.9C\:1PP_'PV<A+#71Y(7.KY%-=KX))5HL Y<?[)
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'S/U/G/G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g5719636a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g5719636a.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X3W$:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM
M<#I-;V1I9GE$871E/C(P,3@M,#0M,C!4,3 Z,C4Z-#,M,#<Z,# \+WAM<#I-
M;V1I9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C Q."TP-"TR
M,%0Q,#HR-3HT,RTP-SHP,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX
M;7 Z365T861A=&%$871E/C(P,3@M,#0M,C!4,3 Z,C4Z-#,M,#<Z,# \+WAM
M<#I-971A9&%T841A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^061O
M8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L
M/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V
M/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH
M96EG:'0^,34R/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%
M05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!
M04)!05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!
M04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#
M=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(
M>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&8O.$%!15%G06U!14%!=T52)B-X03M!04E205%-4D%F
M+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%
M04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!
M0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC6455
M37!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#
M3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT
M+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ
M8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!
M341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C13
M3D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG
M6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E7
M5G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A9
M84AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+
M;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X0356;EAV1T]X5C)+=7A6,DMU
M>%8R)B-X03M+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+)B-X03MU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU)B-X03MX5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X)B-X03M6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6)B-X03LR2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+<3EL6EAL.612,FQL0DIC,U5Z0DEO26Q,=7I(;T9686LT2E-!
M1FQL)B-X03M'0FMA07-V6"]*+R]!1&I4-6DQ1TY,<GI&9$QP141B:3%J06UU
M4U X<6@Y3E!V2CA2;71Z9'!X1S!28G1-4%I5:G9-,#E,:B]!0VXO)B-X03M!
M0V0X;E=(,2]6;TEN:6I)<F0V<$PV;DDY46]J*T=.:69!2E4U9VY6-3AH;V99
M-T%A5$)J1FM$-'-3,7(X+W9);6EL;U!*+VPV2V52)B-X03M$4DQO>%(R:T%)
M-DUQ;W9Q35!N>'I):#)F:VQV3U@V6$=Y9'!9-&)11B]92&Q(;GHX>F9-=FYA
M4S-/<BMG:TYO>G1B45<X9D)536=!)B-X03MB9&EZ;79%9%1M># K;&II*VPQ
M;7 Q:SAU>'%M2EIK3TLW1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W
M1EA9<3=&6%EQ-T98)B-X03M9<3=&6%EQ-T9867$W1EA9<3=&5U1E42]Y+S$W
M>G!Q;W-T36HT45(P3C5F3T0V54M(=3-I>' X2VIC+TMP>6I586E/25=82C R
M;&QL)B-X03M.1&PS=G$W>4HK5S-L;GE:6D-,5%E"2F5S;T9Z<4UO0FYK4&9F
M.6AF.&QD=FUD.#4O4'%:-51V>3=N;SA';6AI1E)#5B]M;BMB3VUE)B-X03M3
M3$E1>'%T-7)T=W1B5WE**T9&-F5R3E1C2EAO3W)D=D54,'5K3U4Y,%=V5C9U
M3TED.'4U.')E6G9.9FU$>DYQ3&%H<E8T.3%/83A&)B-X03M9,&IJ56UV1TY"
M.$M,.',V1$9H:D%615!/-7,X.&AU4E-J3$=L,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%8R2W5X)B-X03M6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5D]02U!L8E4O3D=V,G5I-F-V-RLU8C1P1%AJ2$=.,VME;EI2+U1+
M.#)5631M4F)S1T4U)B-X03M*0TEF6FYK+WEL<$AL5%%O3D@P>5!J1$5/57-P
M*S-,2V9T4T]F1G9W1S-43UIZ6G!:2F-297!X66\T-#A)-4MF;FYZ8EIE52],
M3C5R)B-X03M6,5)J079',VAR47EZ3G1'9RM:-BLQ5&IG=VY*35)#33)5631M
M4C90:3-7=%HQ2%=T5G5D53%'67HS=#(U:VUK4&EE9T$W2V\R03=$)B-X03M/
M;VA!4D%!-4(U6$IK335'4C5L035*<F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER)B-X03MS5F1I<G-69&ER
M<U9D:7(V:R\U>#(X:DIO,VQB.5 S561.4S%O0C1Y4G5L;TXT=U K36@K32M)
M-"M'84AT2%!X5#12>6HY-S!86C)$)B-X03MG:'A(;DPW;G)7834R3#5W+W=#
M8VYV3DPS1W1A9C5A:&8Y>%EX+U<W<%(P33@Q46=0*W!(=5 X05=Z9#EL-'%I
M6CDW<$\Q<W4T:#A8)B-X03MI1V)2,#=S5F1I<G-69&ER<U9D:7)S5F1I<G-6
M9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6
M5&)Y)B-X03MN;V(V.35M,'92,4I!=G)M3T8R2%956FAZ8B]9<%4U6&UY8T5$
M3'5B<T=0:FU).35F8W1V0D1B=U(R.$-#3T=&5FII:EA92W%I:6=F)B-X03M)
M1$]62G0V,69G5FA6-350+TQF5'1D=3ED,2\V;DYQ=6]Y97 V*W%Y4D5"5D%6
M16E356A!159106%6.3AY4FUY;4EJ1S9(8S0U=S1X)B-X03M)>4E(164Y;#%G
M.6A*6GA0<#=24%IS2W=T8FQ415)8.6MP.%!8=WI(;&0W.#(X2E9R+VMF>6HU
M9VEA4%8Y2W0W;W8Q;4M"6E%F859/)B-X03M-9RMH<W-X-35W*VMS36U'17A5
M:&(U>2].;CAK8GIY:VIA=G!$=F4V05=P3'E&6G)9:S!(<54R6D0P1# Y:C<W
M<E-A-%I05$QA6#-U)B-X03MJ,6UG3U Q4C-J.7IY<DYG-G@R2W5X5C)+=7A6
M,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6
M,DMU)B-X03MX5C9L+W=!-#1A84QV.'E)-V=I;S K,&YU050R3&-94"M:,EE(
M855Q>%8S;#)86F-B>3,S0CE76GHW,$QS5F9"97 V:F0V;&9Z,S$S)B-X03M.
M2E!C5'5895-6>DDU<6$W<S(U>G)94D524650>5I$3U)*6G8K5&8U:5AV;%1Z
M4&)15%1T*V=R*U)98C9":694475E2WIG9&EH-BM+)B-X03LU:38S5$1*0R]W
M0TE/6F].4V-C=T0Y2F98=6,T.4EP6%9R8C-D<DQA,TUA>E<X-DY(3D4T<7))
M-&]Y:V5"0G=G:T=W9VDS>%@K63-L)B-X03M.=DMN;DA59$=&5&)24#9L;3=B
M;&]*0GIJ<64U05!%*S1Z<#E.;3A306LX='$X4&@U1$AP,%DQ;#=J3WA6,DMU
M>%8R2W5X5C)+=7A6)B-X03LR2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6-U0O>FDT<6YZ6G$W8W9I1FA13#1G>DI5+U)43E@R<#E!
M.3=T)B-X03LK>69Q:RML8S!J=D50<4UJ>#9F9%-)94QP1DEY<T]O255K2$1(
M;45&.$4U,7IX<G-69F-0:U!65'$S:W923E)9;'!,:7EG859J=51))B-X03M%
M0WEF.$]$;DLU-&-->5!.-B]$4&EG1#-H4&-Q8DAZ:"]W0353-F%S978V2G%1
M5VAU<E=70FI18B]6-4$S+TTO3C,R5DPP>4AM-E!T)B-X03MA3SA4-S-I1V)2
M,41S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9E=&8X-'HV)B-X03MH2&)F;4)08D]A9EAB0U=/365,
M;SAC=B]!0D9'>EAD<'AV2&9C6&%D;%-R25(S:#E36F]89G):63!L:F5+46-K
M8T986'A"1D--459F)B-X03M!,'-44E-V12]W0G%.:7)5.%%A2$]V0G0T,E5A
M3DQ-55!S4#AJ6FUM+TMV45AA=%%K-F)M=3!D>DMG+S1J;DXV-%9M;"M/:C%'
M:&QE)B-X03M'3$\X>$A,9E!N+T]68SAB6$AL<4%F,VMA6&MJ1#)C=V=F.$%%
M1&TT-TM','9H*VPP=F$O.%!X+U$X17IB=6UD:7)S5F1I<G-69&ER)B-X03MS
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7%F
M95)0351E6%!.*VQA>E5I3S!U1DTY3W!H9C1*4CE-)B-X03MB3FQ7;W@X8T1&
M=C R6&=Y0U0W96IK:FQJ4U=.9SAB9TUJ<6%G<5)514A/5DEE<UA9<2M)9GI!
M,'<V6#4T,3)X;U971RMN.4U(<C9B)B-X03M/6%0O04E2:&Y5-F581FII9DHU
M5%9W-&-S:#5S9GDU>#,Q+RM1=CA!-4MF478K:G(O<4UM>FY.9B]F4RM(,T(V
M8G,O*S5J.&9V3% X)B-X03MW,TYF2U@O3U)7=G@V;BM95#)K3$)O=$IT-#=5
M:T=O.55K>7EF4U!50VXU6C!(6C)0:'@S,W909'%:3TQ*6#@P4$QS>C-7=7A6
M,DMU)B-X03MX5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6
M,DMU>%8R2W5X5C)+=7A6,DMV<'HO;DAZ.'E9=%@P5E!+*V]Z06%R)B-X03MP
M<6-B275D-3=696=&97)21&%N.'1$-#5O=3!.3G=Y-'AY3#!06C)P-#0X2BMO
M9F,Y:7I7=7EF35@O3U,S;&53>#@S46$Y1V@K<39V)B-X03M#<7E/0G-,:3-!
M46<O3U!H5#9C,W9:;5<T8U!C-DAT6$95>%!V95!:<VY64'10.$%+<E-:9$LO
M3'918DM:945Q,G%Y>4ED:7)4:WI%)B-X03M(,TAQ8C5Z1W%N>%I*2'IE<S P
M3TA(1653<"M9=FYM=SAM*U=R:E9,9W$Q,'=-96XR<$\X<S5(=VIB.6QF=$UF
M1#-P9S K035*548Q)B-X03M'8UEO1U)F1C$U9#-.-V1Z6&PQ25IB;31K85=A
M5G1Y>G53>DUF;51N5'A!06]02WEK6D5K.'EO-%=,<U9D:7)S5F1I<G-69&ER
M<U9D)B-X03MI<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7%V6EAT,UDS8TXU6GI08C-6=31K:&UJ2E8P9%1514592E)")B-X03M&
M2&MY:$UX3FIM*V@O25 O041K:G!L,41(6F5B,"MP,UEO=C93:%5T1$HR<DEI
M9W1'9DAI0W9Y>E1A:G,P:F5'-#=N96%F=$]-=' W)B-X03M(-TAP1W)7=FMF
M.$%-1%%:3DQE.'0Y4W,U=4UI=&%Z23!K8FID6%%J:U998CE2-&<U9W=/5$1+
M-F]U9D]-37-A-6=S03!F.$$U>#$X)B-X03MN84)Q8V5Q-GIQ-UAD:F)T>FIT
M<FA9-$EI=S-8,5A,2&M"5'!T6#5B6FU4-U)N359%55A$>#EM-#13-&EB<%!0
M3U@U*V533D%I:VDP)B-X03LK8V$Q<5,Q0U%7<E9H0B]Y-39&2V8V=DDU5F@P
M1U-F4#!H='HV+TA$:V5)*U0U<C@U*V1T93@S-G4R<#9V34=907)B,C96155+
M5G)W)B-X03MJ5W K:VYC.3@S;4A"2$A';W5G,4=O;&QL8VMG>3%O9&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6)B-X03MD
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D)B-X03MI<G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F1I)B-X03MR<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5F1I<G-66E O)B-X03M!37%X+TU4+T%+;'I59CA!<$AK+W!L2#5R1B]/
M1&QF:W,S.#!U+S56:BM9;B]5=6%J+S!J>68P>"].678U=U@X;&TO;6PS+TMS
M9GI%)B-X03LO=T-P8S%(+T%+4C50-EDO;7-8.#1,*U-Z9GI3-R]L5U U:68Y
M4S5Q4"]34$HO5$@X,6DO;D)F>5=B*V%89CA!2W-F>D4O-FQZ568K)B-X03MK
M950K;5 U<D8O3T,O:W,S.#!U+S56:BM9;B]5=6%J+T%.23AN.4UF>E=,*V-&
M+TI:=C5P9"]Y<D@X>% K<&,Q2"]P2&LO<&HK87AF)B-X03MZ9W8U3$XO3DQV
M.$%L5U U:68X055U86HO=T)).&XY369Z5TPK8T8O2EIV-7!D+WER2#AX4"MP
M8S%(+W!(:R]P:BMA>&9Z9W8U3$XO)B-X03M.3'8K5EDO;4HO,4QM;R\Y23AN
M.4UF>E=,*V-&+TI:=C5P9"]Y<D@X>% X07%83E(O=T-K950K;5 U<D8O3T,O
M:W,S.#!U+S56:BM9)B-X03MN+U5U86HO,&IY9C!X+TY9=C5W6#AL;2]M;#,O
M04-R2#AX4"MP8S%(+W!(:R]P:BMA>&9Z9W8U3$XO3DQV*U99+VU*+S%,;6\O
M=T13)B-X03M02B]42#@Q:2]N0F9Y5V(K85AF.'%X+TU4+W%83E(O-E(U4#99
M+VUS6#@T3"M3>F9Z4S<O04I6:BM9;B]!1DQM;R\X05-02B]42#@Q)B-X03MI
M+VY"9GE78BMA6&8X<7@O350O<5A.4B\V4C50-EDO;7-8.#1,*U-Z9GI3-R]L
M5U U:68Y4S5Q4"]34$HO5$@X,6DO;D)F>5=B*V%8)B-X03MF.'%X+TU4+T%+
M;'I59CA!<$AK+W!J*V%X9GIG=C5,3B].3'8K5EDO;4HO,4QM;R\Y23AN.4UF
M>E=,*V-&+TI:=C5P9"]W07%X+TU4)B-X03LO<5A.4B\V4C50-EDO;7-8.#1,
M*U-Z9GI3-R]L5U U:68Y4S5Q4#A!,&IY9C!X+TY9=C5W6#AL;2]M;#,O2W-F
M>D4O-FQZ568K:V54)B-X03LK;5 U<D8O3T,O:W,S.#!U+W=#5EDO;4HO=T)3
M-7%0+T%%:GEF,'@O3EEV-7=8.&QM+VUL,R]+<V9Z12\V;'I59BMK950K;5 U
M<D8O)B-X03M/0R]K<S,X,'4O-59J*UEN+U5U86HO,&IY9C!X+TY9=C5W6#AL
M;2]M;#,O2W-F>D4O=T-P8S%(+T%+4C50-EDO;7-8.#1,*U-Z9GI3)B-X03LW
M+VQ74#5I9CE3-7%0+U-02B]42#@Q:2]N0F9Y5V(K85AF.$%+<V9Z12\V;'I5
M9BMK950K;5 U<D8O3T,O:W,S.#!U+S56:BM9;B]5)B-X03MU86HO04Y).&XY
M369Z5TPK8T8O2EIV-7!D+WER2#AX4"MP8S%(+W!(:R]P:BMA>&9Z9W8U3$XO
M3DQV.$%L5U U:68X055U86HO=T)))B-X03LX;CE-9GI73"MC1B]*6G8U<&8O
M6CPO>&UP1TEM9SII;6%G93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]X;7 Z5&AU;6)N86EL
M<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I
M<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P
M.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF
M;W)M870^87!P;&EC871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @
M(" @(" \9&,Z=&ET;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @
M(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/C,\+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE
M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM
M;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O
M4F5S;W5R8V52968C(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*
M(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#HW0C@V,#1#0T)&
M-#1%.#$Q.#0P.4,U1#DW1#<P,#4P0SPO>&UP34TZ1&]C=6UE;G1)1#X*(" @
M(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HW0C@V,#1#0T)&-#1%
M.#$Q.#0P.4,U1#DW1#<P,#4P0SPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @
M(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.F,Q.65D8C@U+31D
M,S4M-&0P,BUB.&%E+3AC83!E-V4W-#DP,#PO>&UP34TZ3W)I9VEN86Q$;V-U
M;65N=$E$/@H@(" @(" @(" \>&UP34TZ4F5N9&ET:6]N0VQA<W,^9&5F875L
M=#PO>&UP34TZ4F5N9&ET:6]N0VQA<W,^"B @(" @(" @(#QX;7!-33I$97)I
M=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z-T$X-C T0T-"1C0T13@Q,3@T
M,#E#-40Y-T0W,# U,$,\+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @
M(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z-T$X-C T0T-"1C0T13@Q,3@T
M,#E#-40Y-T0W,# U,$,\+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @(" @
M(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^=75I9#IC,3EE9&(X-2TT9#,U
M+31D,#(M8CAA92TX8V$P93=E-S0Y,# \+W-T4F5F.F]R:6=I;F%L1&]C=6UE
M;G1)1#X*(" @(" @(" @(" @/'-T4F5F.G)E;F1I=&EO;D-L87-S/F1E9F%U
M;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \+WAM<$U-.D1E
M<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @
M(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T
M:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#II;G-T86YC94E$/GAM<"YI:60Z03@R14%#-3%"1C0T13@Q,3@T,#E#
M-40Y-T0W,# U,$,\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IW:&5N/C(P,3@M,#0M,C!4,3 Z,C$Z-3,M,#<Z,# \+W-T
M179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G
M96YT/D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+W-T179T.G-O
M9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D
M/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%
M=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)
M1#YX;7 N:6ED.C=".#8P-$-#0D8T-$4X,3$X-# Y0S5$.3=$-S P-3!#/"]S
M=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE
M;CXR,#$X+3 T+3(P5#$P.C(U.C0S+3 W.C P/"]S=$5V=#IW:&5N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU
M<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N
M9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R
M9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U
M=#TB(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC
M;VTO<&1F+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%D;V)E(%!$
M1B!L:6)R87)Y(#$P+C Q/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SIX;7!44&<](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]T+W!G+R(*(" @(" @(" @(" @>&UL;G,Z<W1$:6T](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS(R(*
M(" @(" @(" @(" @>&UL;G,Z<W1&;G0](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]S5'EP92]&;VYT(R(*(" @(" @(" @(" @>&UL;G,Z>&UP1STB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @(" @(" @/'AM
M<%109SI.4&%G97,^,3PO>&UP5%!G.DY086=E<SX*(" @(" @(" @/'AM<%10
M9SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/D9A;'-E/"]X;7!44&<Z2&%S5FES
M:6)L951R86YS<&%R96YC>3X*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE
M3W9E<G!R:6YT/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#X*
M(" @(" @(" @/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(#QS=$1I;3IW/C8Q,BXP,# P,# \+W-T
M1&EM.G<^"B @(" @(" @(" @(#QS=$1I;3IH/C<Y,BXP,# P,# \+W-T1&EM
M.F@^"B @(" @(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$:6TZ=6YI
M=#X*(" @(" @(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @(" @(" @(#QX
M;7!44&<Z1F]N=',^"B @(" @(" @(" @(#QR9&8Z0F%G/@H@(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @/'-T1FYT.F9O;G1.86UE/E1I;65S3F5W4F]M86Y04RU"
M;VQD350\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z9F]N=$9A;6EL>3Y4:6UE<R!.97<@4F]M86X\+W-T1FYT.F9O;G1&86UI
M;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C93Y";VQD/"]S
M=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G14
M>7!E/D]P96X@5'EP93PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @(" @
M(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/E9E<G-I;VX@-2XR,#PO<W1&;G0Z
M=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F-O;7!O
M<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @(" @(" @
M(" \<W1&;G0Z9F]N=$9I;&5.86UE/G1I;65S8F0N='1F/"]S=$9N=#IF;VYT
M1FEL94YA;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" \+W)D9CI"86<^"B @(" @(" @(#PO>&UP5%!G.D9O;G1S/@H@(" @(" @
M(" \>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@
M(" @(" @(" @(" @(" \<F1F.FQI/E!!3E1/3D4@,CDT-2!#/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4&QA
M=&5.86UE<SX*(" @(" @(" @/'AM<%109SI3=V%T8VA'<F]U<',^"B @(" @
M(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$<Z
M9W)O=7!.86UE/D1E9F%U;'0@4W=A=&-H($=R;W5P/"]X;7!'.F=R;W5P3F%M
M93X*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E/C \+WAM<$<Z
M9W)O=7!4>7!E/@H@(" @(" @(" @(" @(" @(" \>&UP1SI#;VQO<F%N=',^
M"B @(" @(" @(" @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y0
M04Y43TY%(#(Y-#4@0SPO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIT>7!E/E-03U0\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z=&EN=#XQ,# N,# P,# P
M/"]X;7!'.G1I;G0^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUO9&4^3$%"/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.DP^,CDN,#$Y-C P/"]X;7!'.DP^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.D$^+38\+WAM<$<Z03X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z0CXM-3,\+WAM<$<Z0CX*(" @(" @(" @
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @
M(#PO<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X;7!'.D-O;&]R86YT
M<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z17AT96YS:7-&;VYT4V5N<V4]
M(FAT=' Z+R]W=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E;G-E+R(^"B @
M(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93IS;'5G/@H@(" @(" @(" @(" \
M<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G13
M96YS93I&;VYT2VEN9#Y/<&5N5'EP92 M(%14/"]%>'1E;G-I<T9O;G1396YS
M93I&;VYT2VEN9#X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E
M;G-E.D9A;6EL>3Y4:6UE<R!.97<@4F]M86X\+T5X=&5N<VES1F]N=%-E;G-E
M.D9A;6EL>3X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E
M.D]U=&QI;F5&:6QE4VEZ93XP/"]%>'1E;G-I<T9O;G1396YS93I/=71L:6YE
M1FEL95-I>F4^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS
M93I&;W5N9')Y/DUO;F]T>7!E(%1Y<&]G<F%P:'D\+T5X=&5N<VES1F]N=%-E
M;G-E.D9O=6YD<GD^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G13
M96YS93I697)S:6]N/C4N,C \+T5X=&5N<VES1F]N=%-E;G-E.E9E<G-I;VX^
M"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I+97)N:6YG
M0VAE8VMS=6T^,#PO17AT96YS:7-&;VYT4V5N<V4Z2V5R;FEN9T-H96-K<W5M
M/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z1F]N=%-E
M;G-E7S$N,E]#:&5C:W-U;3XR-#DQ,S4R.30V/"]%>'1E;G-I<T9O;G1396YS
M93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/@H@(" @(" @(" @(" @(" @(" \
M17AT96YS:7-&;VYT4V5N<V4Z0VAE8VMS=6T^,C0Y,3,U,CDT-CPO17AT96YS
M:7-&;VYT4V5N<V4Z0VAE8VMS=6T^"B @(" @(" @(" @(" @(" @(#Q%>'1E
M;G-I<T9O;G1396YS93I0;W-T4V-R:7!T3F%M93Y4:6UE<TYE=U)O;6%N4%,M
M0F]L9$U4/"]%>'1E;G-I<T9O;G1396YS93I0;W-T4V-R:7!T3F%M93X*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D)A9SX*
M(" @(" @(" @/"]%>'1E;G-I<T9O;G1396YS93IS;'5G/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@ $  ; P$1  (1 0,1 ?_$ !@   (#                  @)  (%_\0
M(1   00" @,! 0          !0(#! 8!!P ($1(3"13_Q  9 0 " P$
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%NY3S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g5719637a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g5719637a.jpg
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M$0'_Q  7   # 0                  !PD$_\0 '1   @(# 0$!
M     P0%!@$"!P ($__$ !@!  ,! 0                 %!@()_\0 'A$
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(F_$W#QPY_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g5719638a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g5719638a.jpg
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M 0$! 0$! ?_  !$( !  &P,!$0 "$0$#$0'_Q  7  $  P
M   )  0%_\0 (A   00" P # 0$         ! (#!08!!P ($PD1%!47_\0
M& $!  ,!                !P " PG_Q  C$0 " @(" @(# 0         !
M @,$!1$ !A(4$S$5%D$A_]H # ,!  (1 Q$ /P !^=*.<Q^*KTY^-M':'1PF
M\"KY(1E:7OLC2U_/K84-(!==:HSK[-S_ -_W,W*20;Z=9I.=:B2O%RO@ @@3
M,P7;VB!AH4D\[/WD]?RS8E:<;SC#C*TTG:5&S=DW?5_#8OXT<>_X R+L3.[O
M%$M4JS2JC=6Z'^PXA<NUR2.N<RV)NO72*1<'7%+VOS65$CJ1C_-EC;1A1$26
M5K(*K$Q9%L(&+*&;)8,;'(>8;,&]?S%(:<4VDD?V;9>\'TIPZUZM-.^:D^C:
M%_:<(*DLJL5*EE!*MKR4D;\6T2-CZ.B1OZ)X=L K,H8.%8@,N_%@#H,-@'1^
MQL Z/^@<K\MRO)R<G%PZ)_(W5>G=,UU' U>XQ=EIFYKQL#9#=*&KI$)V>UW:
M==C52(U#MHJ;E 28R%J,N,>77S/Y%XC8I-LF9Z+K(5E"_5,F_;ND6.SVKKO8
MJR06<74IT3::=9L!=KWFLRY+&K%&ZR2V8F1)U^2I))Z\4,D[0-XQIG3^]5NK
MU:,:5[4<]7*V[M\5%@:+L%&Q16M'C,DTTB-'%6D5VA;XK<<?LRS1UTL)Y2E%
M-2+<O,RTLS'@Q#4I)GR+45&-Y9C8QLTITE$?'LJ4I30(27<#"-J4K*&&VTY5
MG./OB)$ACBCC+O(8XT0R2';R%5"EW/\ 7?7DQ_I)X;RN))9) B1"21W$<8U'
4&'8L$0'>D3?BHV= #F9S3F?/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g571963g0419085815907.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963g0419085815907.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !J -H# 2(  A$! Q$!_\0
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M?V3ZO(D%QY7FR&6,;-K97M@9/K4RM;0VI.HYI5%9&S_PG/A;_H.V/_?T4?\
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ML&BQ6VG17$L$MQ<7)W2;'9"8T"G(RO5B._ID@'5T444 %%%% !1110 4444
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M>3X?_P"?_4O_  $3_P"+K*IT:/+((XD:1ST5%))_ 5K8X>9=C3\GP_\ \_\
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M^$"\/?\ /H__ '^?_&NEHHYF+V4.R.:_X0+P]_SZ/_W^?_&@^ O#Q&/LC_\
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MK;<X^\I/?UK0HH RH=$$:6\4E]<306Y4QQ.L>!MZ<A03^=:@  P  !T I:*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g571963g0420113918240.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963g0420113918240.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  D , # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MJA?7_P!D 6*%YYV^Y$G?GJ3T H OT5SUUI]_J"^;J&IO96@7+P6[[1[YDZ_E
MBLKPZ=/L)+_5(RUGILI$<(D<YFVYS)@^O3Z 4 =M17.S:]=O"US:V %E&I9I
M[B3R\_1<9JMJOBB[LO#UIJBV$J+/CS<H9#;@]"5')'TH ZOM69>^(=(TYMEU
MJ%NDG_/,/N?_ +Y&3^E<.^I:;?KNUC5=7O%D /DPV\D4?Y*!G\:M:?K^CVUR
MYTS0I180QX:X2W&6?T&3V[F@#HSXE$S!;'2]0N@1D.(A&A_%R/Y4Q;[Q-<,?
M+TFRMDSP9[HN3^"K_6LN/QW+=3-%IWAS4+M%.&:-XQCZ\\5<?Q%KBQ^8/#+H
MF,DRW2KCZ\4 6OLGB6:)O,U:SMW)X\BT)P/^!,:<FC:DP_TCQ%>EL?\ +*.)
M /PVFN8/BKQ/KDDUCHVCP6\R</<37&X(#]!U]*W=&L=8TNQ\EXXI9G.^662=
MF+.>I^E %C_A&4*$2ZMK$A(Y;[:ZY_!< ?A534;/0M"MQ+?75Z=Y"(CWDTCN
M?]D;LD_2JM]KOB*/44L+.'3KB\8C=&H<B)/5VSQ]*EL?#^L17LFH75S8W-\^
M=LTD3'RQ_=49P!0!I+X8T:<+.UK+N8!_GFDR/K\U'_"(:'O+_8LL>"3*_/ZT
M_P"S:_MQ_:%IGU^SG_&D%GKK2(7U6%0IRP2 ?,/QZ4 +'X:TJ"(10Q2Q(. J
M7$BC]&ILGARW<@I?:G%CC$=_*,_K5A-/D&L27LMU+(FP)% ?N(>[?4^M2:CI
MT6IPK#.\@B#;F1&(#^Q]O\* *)T&Y2+;#K^J(1T+,DGY[E/\Z06/B&&%O*UN
M*>0\K]IM%P/^^"M;RJ%0*!P!@4M &"FH:Y:RXOM*BFA"9,UG+EL_[C ?S-7+
M#6++4V:."5EF3EX)%*2+^!P<>_2M*N/\=65K<64$S:E/IUY!+YEO):J#,[8/
MR@=2/;IZT =A5*\U&UL(]]Q,J^@[GUP*QYIM<O('AGC32H1N,ETLRNRJK=AT
M (QR>F>E9,/V/[-#=379L](A8F.2Y?\ TBY/)SN/(4]0!R?:@#2AUO4]<+#1
M;46]NK8:ZNU/.,<*O?K^E8OB&_TO2I(;/5-5N+V_E)\NWC?8O/=@O;FMA=6O
M+JVDNH(/[-T2",R-/,N))%'.43^$8!Y/Y5RNGVL=YK+:EIMI -:U&,/$Q.[[
M%;$\2/SR[=A^'8T 2PP7MS%8Z+"+B:"$9^SRDX.2?GF)Y"CLG4UV=AX>BMY5
MN;Q_M=T!@.X^1!Z(O0"F02:7X9M8['SS)<MSMSOFG;NQ'4DG\JS?$,>OZE9P
M)"L]G'-<)&R0$&0(?O,Q_A&!CCU% &CJ>K(]XEA9P&^N#]^-?]6@XY<]O85M
M.ZQ6^^=D50/F). *Q#=II4ATO1]*EGN$4%MHV(,CJSGJ?S-2+H\UX5GUNX6?
M:=PMXP1$GU[M^- &9<ZE=>)9Y+#2(Y8[)#B:[*E _P#LH?3U-17L&GZ1''!*
MS7MUM/DVJ<(@]2!V]2:NRW^HZ];O;Z$ILK;[AOIHR/KY:'&?J>*B'A)[/31:
M:=>O'/*P%S>S'?,5[[>V3^E &/I%Z^D7XBL[$7%[?2;KF5ODPH'\*CH!T%7K
MZ[O=;O3ID&UI@ 9@IS':CU8_Q/Z"K=W:)IIM=&T>V,3WF?.NSDE5'WCNZ[CV
MJK.FO"1])\.6 T^UM\A[VY',IQ_ .I)_O'B@#I--TZTT33Q#  B+R[L>7/<L
M?6N<USQ/>W=P=+\/;/M#?ZRZE'R0KW-%CX4UJ30GBU77))-0DRP8+N2-CWQQ
MNP/PIMM\,].B@MTDU+4I)$8O(WG8$K'^\,8H T]$_LC1=)9A>I(2Q-Q=2G#2
M/W)-6+#Q=HNIO,+2\5TA^_)C"?GWHG\)Z1<Z9)I\UNSPR !R7)8X]^WX5-I_
MAK1],MQ!:6$21@8"MEOYT 9VI>.]$TRW>9I99T0@$PQELD]!]:U?[<T^.VBF
MGN$@$JA@DAPPR.XJ6YTJPO!$+FTAD$3;HU9>%/J*G%E: [A:P@^OEC- &%)X
MVT2.X2(2S-O) =86*\>^*2Y\71"('3]/OKV0MMVQPG'3KFND  &   *6@#E8
M/%6HR6@DD\,:FD^<&(J/7@YJ=M6\02[OL^@;.>#/<*/T%='10!SAM?$U[E9K
MZUL8R>ENA=@/J>E6M/T"RTZX:ZQ)<73_ 'KB=MS_ (9Z?A6S10!GZMI5IK6F
M3Z;?(SVMPNV15<J2,@]1S533_"NBZ=*MQ#9*]P!Q/.QED_[Z8DC\*** -EE5
MT9'565A@J1D$>E>)I>MH?Q0N] T>&WL(;VZ!EN((AYV, [03E0O)XVT44 >M
M:=HEEI.][=&::0YEGE;?)(?=CS^'2M/\*** "BBB@ HX/4"BB@ _"C\*** "
:BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g571963g0420113918568.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963g0420113918568.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #J = # 2(  A$! Q$!_\0
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MH/8F8+.C*A!& 68%@H/<X&<5>KB+K1KZ\U7488EPRWPN5=\@,C6Y08/J&XH
M[;<H4L6&!U.>E9J^(M(>WDG6_B,<9"L03U/3 ZG/;'6LC2_#5U9V-]9EDBCN
M;"& ;&) E"%7;]1SWQ5!?#NKF[T[4FMH%FT^.&$6XEXF"!@6!Q@?>X!]* .G
M.OZ2#;C[?#_I #18;[P)P/ID\<]^*G34[633FOHY"\"JS953D[20<#KU!KC8
M_".IQ07=KMA9-1\MI9!)_P >Y$C.0!CYAAN,=ZUM3TVXM]=CU.VA'V6*!EG!
MPP*X8_(N,ALGMP>] '1P3QW-O%/"VZ.5 Z-Z@C(J2LKPU;36?AG3;><$2I;J
M&!Z@XZ?ATK5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M._\ ^_H_PH_LEO\ H)W_ /W]'^% &E16;_9+?]!._P#^_H_PH_LEO^@G?_\
M?T?X4 :5%9O]DM_T$[__ +^C_"C^R6_Z"=__ -_1_A0!I45F_P!DM_T$[_\
M[^C_  H_LEO^@G?_ /?T?X4 :5%9O]DM_P!!._\ ^_H_PH_LEO\ H)W_ /W]
M'^% &E16;_9+?]!._P#^_H_PH_LEO^@G?_\ ?T?X4 :5%9O]DM_T$[__ +^C
M_"C^R6_Z"=__ -_1_A0!I45F_P!DM_T$[_\ [^C_  H_LEO^@G?_ /?T?X4
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M"O\ X4 :5%9O]MVW_/&\_P# 5_\ "I;?4X;J;RDCN%8C.7@91^9% %VBBB@
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ML-K,5\T,[L%.0I9BV!],XJOK=J\MS9.MW/&&N%7:A&!UYZ=:VZS=5_UFG_\
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M_P %_P#(TVOT;^5?(X7$577@G)[KJSZS$T*2HS:BMGT1Z3]JU;_H&P_^!/\
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MFM_\?_\ P 5I2^(BI\)FUSOBG[MM]3715SOBG[MM]37-F_\ N<_E^:.K*?\
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M/^/Q/QKXBG\:/KL9_NU3T?Y&Q4EO-';W,4TSA(HV#.QZ #J:CJMJ/_(+NO\
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MG6?^?'2/_ 3_ .O0?B3K./\ CQTC_P !/_KU]3[*1T\K/I/S8_[Z_G1YL?\
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MGMKIR ;<*@RK<Y4@@\#^]2C1+[^T;/45TATM;=(8YK/Y-TC*K@N!G!P6&,T
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MC5<#RUP/LR^GUJY;VU]'-NGU#SDQ]SR0OZBN(S+M%%% !1110 4444 %%%%
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MDQ>64\I-C')7:,&GUSQU^9?%;:9,;>U@1?E$Y97N,C.Z,_=('((Z]: .AZ#
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M3_MS2_\ G_@_[[K!U?4[&6]W1W4;+M'(.:NE\1%38@KG?%/W;;ZFMK[=:_\
M/=*PO$<J7"V_DMYFTG.T$XKGS7WL'-1UV_-'3E;Y<7!O3?\ (Y^K6G_\??\
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MMKZ2#49WVVR+(%4^K,#U4#K6,NJZA+J7R:DZ3O=S020G!6*)4R'VGIV.3ZT
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MB@ HHHH **** (I+:"9@TL$<C+T+("10;:W)<F"(EQASL'S?7UJ6B@" 65J
M@%M"-ARN(Q\I]O2IZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
)HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g571963g0420113918880.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963g0420113918880.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #; ;,# 2(  A$! Q$!_\0
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M[_O_ (T?V'I__/*3_O\ O_C0!HT5G?V'I_\ SRD_[_O_ (T'1-/ SY4G_?\
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M8?V@]A]KB^U)'YCQ[N57U-7*Y3^S;P>)KUK>R=;"0,]W%*ZM%=L4PI0$?*W
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M -&BL\:=< @_VK=G!Z83G_QVM"@ HHHH **** "BBB@ HHHH **** "BBB@
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MR'9Q_P"J3_=%.K,3^V=B[?L&,<9WT[_B=?\ 3A_X_7$=9HT5G?\ $Z_Z</\
MQ^C_ (G7_3A_X_0!HT5G?\3K_IP_\?H_XG7_ $X?^/T :-%9W_$Z_P"G#_Q^
MC_B=?].'_C] &C7,:O\ \A.7Z#^5:W_$Z_Z</_'ZQ-0\_P"VO]H\OS<#/EYV
M]/>M:/Q&=38K5TNB_P#(-7_>/\ZYJMG3?[2^QK]E^R>5DX\W=NS^%:5?A(I[
MFY16=_Q.O^G#_P ?H_XG7_3A_P"/US&YHT5G?\3K_IP_\?H_XG7_ $X?^/T
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M)+U9HT5G?VM_U#[_ /[\?_7H_M;_ *A]_P#]^/\ Z]:&9HT5G?VM_P!0^_\
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M3VX>:^E$>VUF65$4G'F;AP5R0/7)J73?$L&HW:P_9Y(8Y87GMY7((EC5MK'
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M\/-%1[B%6$'(9P"/F-=3]OL_^?N#_OX*PENR&6*YC5_^0G+]!_*M_P"WV?\
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M_7=JS:^QH_PX^B_(VCL?2GPXLK27X>Z*\EK"[F#EFC!)^8UU/]G6/_/G;_\
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:%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g571963g0420113919223.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963g0420113919223.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %3 44# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ I&
M941G=@JJ,EB< "EJKJ&G6FJVC6E]"L]LQ!>)_NO@YPP[CU!X/>@"/3-:TK6H
MY)-*U.ROTC.UVM9UE"GT)4G% UK2CJQTH:G9?VD!N-GYZ^=C&<[,[NG/2O.O
M"7AR"V^(GB3Q+H%LEIH:VWV."*W0+%<S+@NR*.-JLI7(X)SCO7!QWUVO[/UK
MJZNS:D->%T)B,N9O-/S9ZDT ?1-S=6]E#YUU<101;E7?*X5<L0 ,GN20![FJ
M^I:UI6BQQR:KJ=G8)(=J-=3K$&/H"Q&:\H^-&FVW]H>#]6:.3[<^IPP%C*Y4
M)G) 0G:.>I R<5ZEJN@Z+K!CEU?3+.^$"G9]KA654!QD@-D \#F@!VF:_HVM
M-(NE:O87[1 &06MRDI3/3.TG&<&I=2U;3=&MUN-4U"TL86;8LEU,L2EL$X!8
M@9P#Q[5RWPWTRRATJ^UFQLH+.'6+MKB&&")8U2!?DB^5>.57?]7-<A\/I&\1
M_&'Q?J.MH);[2Y/LUBD@R+>/>Z_(#T.%'(_O'U- 'J:^(-%?3?[275[!K#!;
M[4+E#%@$ G?G'!('7J:H?\)WX/\ ^AKT/_P8P_\ Q576T+3AKK:XELB:@;=K
M>25% ,B$J?F[G&P8],FO'/@E+K*:'-;6=A:R:5+K4B7DID)D1/*Z"/;C;D*,
M[NYX[T >X1W=M+9K>1W$+VK1^8LZN"A3&=P;IC'.:S[#Q3X>U6Z%KIVO:7>7
M!!816]Y'(Y ZG"DFO+?B[LANO!'AFWQ#X?N;X0W$<;X1@CQJ(R?09/![CVK;
M^-UC:0?#)[N*.."XTV:!K&2-=K0MO5<(1]WCT]!Z4 >FUE7'B?0+34O[-N=<
MTR&^W*GV:2[C67<V-HVDYR<C''.:XKQ3XCUVT^!']MQ[X=6EL(#+(!AHR^T.
MP]#AB?;\*UOACH^F6OPSTE+>VA9+ZT6:Z)0'SW=?G+Y^]UQSV&* .R1TD!*,
MK $@D'/(."/SIU><>(+Z3PGJ/A?P5X</]GQ:K=RLUPB(QMX@_F,L:L"H)+$#
M(( [=QD7?C?78O#_ ([L%U&0:CX;D#6^H>3%OF1B2 Z[=F1@@D*,C'0]0#UZ
MBO%])\4>,+OQ3X;TN7Q"ICUG0Q>3-]ABS"^&.8^/O84?>W+DD[<849T_Q%\5
MR_!:Q\1QZKY.JKJ9M))5MXBLR<\LI4@'I]W% 'O-%>7Q^-M6T#Q?XJT?4[IM
M4M].TK^U+=VB1'7"J6C.P ;<GC(R!U)I/!/B#QIKQT;4Y(+R?2]1CE-Y)(+1
M(K8\[#;A6\P@$;2) Q[T >HT5\^6_P 1/&%MI<&I3ZX;A4\2?V8T3VD(\R'&
M3N*J.?3;MZGKQCJ_%'C;6_#_ ,0Y+#4KQ]+TFY2-=,N&MTDM9&_Y:>:^W>K9
MX!!PO!92#F@#UBFNZ1KN=E49 R3CDG 'YUYA\1?%6OZ+>:FEM?MI\%OIWVFQ
M:U6*>2XES\WFQLCLL8QC?\J@]6)( Q/%^M:IKMK\,;O^T)[(:M=023Q6VW:)
M,H0XW*<X+<!LC@<&@#V1;^S:_>P6[@-ZD8E:W$@\Q4)P&*]0,]ZL5X\_B&[\
M/?%3Q6UPZW\>FZ!]I5Y+:!)Y"HC.&E1%8@G/'3GIP*DLO&VOZ?:^"]8U'4#?
M1>)+@PW%GY,:1V^\_(8BJA_ER =[-D9[\T >NU4U'5=.T>V%SJ=_:V4!8();
MF98U+'MEB!G@UXAX@\<^,--E\<O;^('\K0[NW6U1[2 DB1R"K'9RN/;/ YZY
M]<U*X_M#P)<7,BC_ $C3S(RXX^9,D?K0!IZ?JFGZO;?:=,O[6]M]Q7S;:99%
MR.HRI(S50>*?#QU+^S1KVEF_\SROLOVR/S=_3;MSG/MBO)/!UT_PY^(/B;P=
M@F"\ N](1CP[MPJ#ZY )_P"F9JQX,L18_M!^)[-)&S'I4:F4  LVV#+^F2<G
MZF@#V&SO[/4(WDLKN"Y2.0Q.T,@<*XZJ2.A'<58KP[PI?^)[[X4Z]J6BZE%9
MZG8:E<2 0:?;JMRJHA(95C W$9^8#)/7VZ[PRK^/_AY=7>H:@VJ0:K$0EC<%
M$C@9?X"\2(_WQR?3&,]6 .TTS6;#6?M?V"<R_8[E[6?,;+LE7&Y?F SU'(X]
MZOUY]X-^'LV@ZRNI:F\-W<1P9AF^UW$C02OQ*B!V*^7@*%)&_KDFO0: "BBB
M@ HHHH **** "BBB@ K.US2CK>DSZ?\ VA>6*S#:\UFRK)M[@%E;&?4#/O6C
M10!R'AOX?6_AN_AN4\1>(M02",QPVVH7WFPQ\8!"!1@@9 ] 33T^'ND).JK-
M=C34O/MRZ7N3[,L^<[A\N_&[YMN[;GMCBNLHH Y+Q;X!M?&-S:2W^L:K!':2
MB:WAMFA5$D'\66C+$_4D>U;UQIAN]"FTNXOKI_.@:&2Z^192",%OE4*#SV7'
MM5^B@"*VMXK2UAMH$"0PH(T4=E P!7.ZCX&TV[\0CQ!97-YI.L%=DMW8.JF=
M,8VR(ZLC#IU7/ YX%=/10!C1>'WC@G+:SJ4M]*GEB^D,1DC7.<(GE^4ON=F3
MQG.!C \/_#2+PM8366B^)]>M;>:0RR+_ **Y+D $Y: D< =Z[BB@#F9/ FB7
M7A2'P[J"3W]K"YE6:XE/G^:6+&3>N#ORQY'7)SU-5Y_A]9ZE]BCUW5]5UNUL
MV#Q6M\\7EEQC#/Y<:&0C_;)')SG-==10!#<VEO>6<MI<P1S6TJ&.2)U!5E(P
M01Z5S&E^ XM"@:ST;7]:L--+EUL4DADCCSU5&DC9U!Y/#=22,5UM% '/:KX-
MTS5+73X@]S:3Z;*)K.[@DS-$_P#$=SAMV[^+<&W9YYYJ@WPXTEO#VK:3]LO]
MVL2F:_O=\9GG8G/)*;0.V%48'3UKL** .$M_A;86NIZ9J,>NZT+G3;/[%;-N
MM\+%@C!'E<G#'D^U<;X_\ CPY\+H?#OA^+6-4#ZFEPL8@,[H,'=S$@P.G7UX
MKVVB@#E=%\':3%<:AJ\CWU_<ZO L4\FHC:XAV@"/9M7:,=01N]3FCPYX%M_"
MT M-.UG5_P"ST=Y(K*26-HXF;T.P.0,\*6([D$UU5% 'FQ^"^BMIXLCK6M^2
M+\ZC]^#/GXQN_P!5^G2M_6/ 6GZX9H[V_P!0:SN+B.YN;,/'Y4SIMQG*%E'R
M#.PKG)KJJ* .*UGX9:3K6M:EJ<FH:I;OJ5H+.ZBMY4$;Q@#'WD)!X!X/;T)!
M?<?#?2KG0M"TQ[_40VARK)8W:O&)DV] ?DVD<#^'/RCWSV5% '*1^ =-3Q=>
M^(GN[V>>]M?LD]M,8VA>+ &TC9N_A!SNR>^:AT[X;Z3I]YI<S7FH7D&DEVTZ
MTN9$:*U+'.5PH9L=!O9L"NQHH \^O_A#I&I-K9N-8UG&M2I+>*KP ,4)*@?N
ML@#/^-=1<>'_ #_#<.B1ZK?01QQ+"UQ&(3+(@7;AMT97D>BC\*V:* ,"7PCI
MUSKVDZY>//<ZGI<+Q17$FT%]PP6<*H&1SC  &X\5EV/PZM]/\77/B>+7]8;4
M[I!'<._V;;(@VX7:(< ?*O3!XZ]:[.B@#BM&^&UIH.F2:=8Z[K*VLMX+R5&,
M!\Q^,JW[K[IVC(J]X2\$6?@UKX:?J&H307DIF>WG,7EI(>K($1=OI@<<#CBN
MGHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BC-% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445GZAK-EIJ_P"D
M3 ,1D(.6/X4#2;V-"HY;B&!"\LB(HZEC@"N(U#QC=3Y2S00)_?;EO\!^M<]/
M<SW+[YY7D;U=B:=C6-%O<[ZZ\6Z9;DJCO,1_SS7^IP*R+CQO*<BWM%7T:1L_
MH/\ &N3HIV-51BC<E\6ZK)]V2./_ '$_QS55]?U5R2;V3GTP/Y5FT4%\D5T+
MO]L:E_S^S_\ ?9IZ:YJD?W;V7KGDY_G6?10/E78V(_%&KQD$W(<>C(/Z"M"'
MQM=K_KK:)Q_LDK_C7+T46)=.+Z'>VOC.PEP)TD@/<D;A^G/Z5M6NHVEZ,V]Q
M')ZA6Y'U%>44Y79&#(Q5AT(."*+$.@NAZ_17G-CXIU&S(5W%Q&.TG7\_\<UU
M>F^)["_VHS^3,?X).,_0]Z5C&5*43;HI 0>E+2,PHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "JU[?6VG6KW-W,D4*#+,QQ
M67XD\4V/ARTWS-YEPP_=0*?F8_T'O7B^N>(M0\077FWLOR*?DB7A$^@]?>JC
M%LZ:&&E4U>B/3]6\6RS11_V<0()D#I/U+ ^@[8.0?<5RSN\CEW9F9CDLQR36
M1X9O_-SI,S<2-NM23]V3NOT;^8'J:U2"#@C!%-JQNZ:IOE"BBB@ HHHH ***
M* "L^TU)GTZ6\O8X[=8W=2(Y#)PK%?[H.21T ]*T*QU\/CR9()=3OIH7+,$8
MQJ%8MNW#:@.0>1G(]J!._0D7Q%I;21Q"Y/F2=(S$X9?FV_,,97GCYL5/::K9
MWMU+;P/(TD0RVZ%U7&2,AB &&0>03TJHWAZ-LDWUWO8?._[O+G>K;C\F,_*!
MP,8[9YJKIGA]TGN6U*VM)8I7\P1D1RY?)PQ/E(<C)ZECSU]4*\B>'5M4:^>"
M?3+:%(D265A>EBB,6&<; "1M)(S]":>WBC1XQF2[*8&YE>%P4&<98$949XYQ
MG(]15DZ5&U_=W,D\TBW4(A>!MNP*,XQA=W\3=3W^F*,/A:VM[>2"&[N(TDB,
M9$<4*=2#G"Q@9XQTH#WB[9ZU8W\Y@MY)#( V0T+I@@X(^8#GD''7!!Z&M"L^
M'25AO%N?M=P[!Y'VMLVG>!D<*#@;>.?KFM"@:OU-G2O$EYII",?.@_N,>1]#
M7<:;K%IJD>Z"3YA]Y&X8?A7EU203RVTRS02,DBG(846,YTE+8]=HKFM#\41W
MNVVN\1W!X#?PO_@:Z7K4G+*+B[,****!!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<OXO\7P>'+39'MEOI1^[B/0#^\WM_/\ ,BQXL\30^'-,
M,ORO<R96&,G[Q]3[#O\ _7KPR]O;C4+R6[NI6DFE;+,?\]*N,;ZG7AL/[1\T
MMA;V^N=1NY+J[F:6:0Y9F_SP/:J]%%:GJI6T0 D'(."*[BUO1J^GB]_Y>$(2
MZ&/XNS_\"QS[@^HKAZOZ/J3:7?K,5WPL-DT?]]#U'U[CW I-7,ZL.9:;G545
M)-&(W&QQ)$ZAXY .'4]#4=9G&%%%% !1110 R:)+B"2&5=T<BE&&>H(P:Y%=
M+LH8-?DLM*6&XB9A;M_9Y^93$JD*-HW@L&X&1GG'//8T4A-7.3N+O6&N+@QW
M=['&'E")'IQP%5 RX+(<DG(ST/( STLV5[KDVI7.8(VAPI2*?S(@H]0WDXSC
MJNYCG^[TJ>'4[L+)%<3VJW%M._VC$# >2HW9 WY!(*\\C)QCBFVWBRPNQ#Y4
M<S>;O VM&V"HR1\K'<<<_+G'?%!/S,73H?LFH&:STYHV$MP0(M+D@<(=Y7<[
M860?=PGR]1Z5/9ZCKS+;[A=R/ND4K+;%0_&5+'RU [?W._WCP-5?$2@*\EG=
M9>. K"L0+!I"V/FW;2/E'/ 'KS@/3Q);2:A9V:VUP9+I Z\QC:"">1NSQ@Y(
M!'O0))=S DN-8NK&&.[.H-B17C$%LV9B)%)20F)-H [X4'/4X-=Q1106E8**
M**8PKLO#OB8N4L[YOF/$<I[^Q]_?_)XVBD3**DK,]A!R,BBN4\,^(?/"V5V_
M[T#Y')^\/0^]=74G'*+B[,****"0HHHH **** "BBB@ HHHH **** "BBB@
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MR*"91ZHQZ*TM3TY($6]LRTEA*V%+<M$W78_OZ'^(<^H&;2)3N%%%% PHHHH
MSGM+AO."K$J.#\OF,58Y],87OTSG/.:A;3;EK3R"(2-BIRWH6_V<=QV_QK1F
M9UGM]KD*SE67 P?E)_I5!KB\E$C1_+D;D",IPN2.<C@Y SR>^*6AC)10+8%
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MQTP.O4T#M?9E=)[K?M+W!*EPF8<"0Y.-QV\#IR,5-ITM[)$OGJK+DY=BRO\
M]\E%S]>*:FKQS(OE1MOD#! Q7&5[<$Y_#-6+*Z^UP[BC(P R&&,Y .1STY[\
MTT5&U]&6:***9H7[>>&[M!IU^^V($F"<C)@8_J4/<?B.<@X]W:3V-T]M<)LE
M0\C.01U!!'!!'((Z@U9K1A>'4[5-/O9%CD08M+END??8_P#L$]_X3ST)I$-6
MU1S]%2W-M-:7,EO<1M'-&VUD8<@U%0 5WGPZ\,O?7J:K,A\N-L6X(^\XZO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g571963g0420113919551.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963g0420113919551.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %8 58# 2(  A$! Q$!_\0
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M09)1';>9(5<A1(.N'*["F.ASD^E7F\;7,$\$5S96R?-/'<.MP2D;(6 ^8J
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M0Q/TQ0K$Q<%J.DTJ:73[*!G3?;@*VUB 0.,CCKQ^M0G0W\I5V6^X1E2<MUW
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M>96.\N_^2A:-_P!@J_\ _1MI705S!F6?QUH;J<J=)OB#ZCS;/%=/4G"%%%%
M!1110 4444 %%%% !1110 444'@4 >>_%'4O)TJ&R4X:XDY]U7D_J5KR>NR^
M)-YY_B*. '(@A&1_M,2?Y;:XVMHK0]C"QY:2"D<E48JNX@9 SUI:1P2C!6VL
M1P<9Q5'09MKJ$$S-/) D),>\R95CMXZD=.W%2B;36)<>025\PG:.0>]5X]%,
M<6S[3C$?E@K$%].3Z]/U-"Z&HC"&X8J(]@^7'?([_2IU,5S]B5KG3EE@A2.)
MVN,* J#I@D9]N*=))$EQ/&;-"4C\P,0O[S/!']/RJ.'2/)>+9<$(C!V0(.6
M(Z]JN3VJ3S0RMD-$<C'<>A]LX/X4]1I2:U*_FZ>A)D2".1-N]2HRI/2CS[#S
M-BK#\I,;?*!@;2Q'TQ44NC)))<.)=IE.>5SCG)[U(VF;C_KN-Y< H#U3:?\
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M?!<WD>,=+?\ O3;/^^@5_K7TG"=T*'VJ9*QRXB"A)6)****DP"BBB@ HHHH
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M:0C(P: /F[Q!I#:-JTMMR8C\\+'NAZ?B.A]Q677M/CKPP-2LV\I1YR$O"?\
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M9Y\L$"^2K#,G)6,X(P.@/(_^M6Q5>:X,,@W1GRSGYP><@$]/PI,B2ZF>US/
M$6'?MWR9W1D_Q'';Z5:A:Y,D8:5F$BA\[ -N.H_44?VB59%>(*S,!]_L<8QZ
M]>GL:L0M%(SR(%W$X)!YXZ9H)BM=&34444S4***FM;::\NHK:W0O-*P5%'<F
M@#<\&:$=;UM/,3=:P8>7T8_PK^)_0&OHBPMOL]N ?O'DGWKF/!?AJ+1].BB4
M!MOS.^/ON>I^G8>PKLJRD[L\RM4YY:;!1112,0HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH AN8$N(6C<9!%>0^//"KQROJ%M&?,49F4#[X_O#W'?\_6O
M9*IW]BEY"01AAT--.QI3J.G*Z/F6BNS\8>$9-/FDO;.+$766)1]S_:'M[=OI
MTXRM4[GK0FIQNADH8Q.$ +%3@$XR:RAI]SO5]JJX5%W>83MPI!QQ]*V**=@E
M%/<QGTZ=S"4C6)4!!1).A]<[<\_A3H=.FC,6Z),(P/\ K#UV8)Z=<U80I)]M
M0SN5CER=LARHV@XSU'.:@<75K(S&1G40]"Y)& ,G'Y\^]29\J6HZ/37$<8)5
M6\I0Y!R=ZC"D'\?T%6--MY+6T\N3[VXG&00/R J:UF$]LD@&,\?>STXZ]_K4
MU-(TC%;H***4 D@ 9)X%,HN>*& N[&W Q]GL(%/U9?,/ZO6'6SXL</XJU%5^
M[#+Y ^D8"?\ LM8U)&4=D%%%%!04444 %5WMW>X\SSW"@8V #'\JL44":N5H
MK&*&#REZ$Y8X S3X;98'D96)WG.#VZG^IJ:B@%%(****!AU.!7K?P_\ !C6R
MK>7<>+J0="/]4I[?[Q[_ )>M9W@?P/(TT5_?1?ON&BB8?ZO_ &F_VO0=OKT]
MCM+5+6$(H^IJ)2Z'%B*U_=B2Q1K%&$48 %/HHJ#C"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** *5_IZ7D?3#CH:\B\4^")(9I+C3XL-U:!
M1P?=/\/R]*]JJM=V45W&5=?H::=C2G4E3=T?,9!5BK @@X(/:DKUOQ1X(BNR
MTP!CGQQ,J_>_WQW^O7ZUYCJ6E7FE3^5=1%<_=<<J_P!#6JDF>G2K1J+3<HX
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3 HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g571963g34e03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963g34e03.jpg
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MPRMJEOHILG_+&FVNV<9QJ*7==ZGWP*"CWA.]!(2@J*7:#O 3$X"4%.SOV!,
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MI.F^H5+>ZBM=1(^SP80E7KT>TM9VD(Y57 #S2SFUP4(2*1:-0%1"-BO'"XD
M0.HFV*B#HS;<0'LB4?/B'Z;[_EPW\\MB]R_E\>8QYC'F,>8QYC'F,>8QYC'F
),>8QYC'F,__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g571963imx1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963imx1.jpg
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MY4UFTF5=U:RND#(BKT,J#\L'+Y$S!*)&S*-0 \E4162FJL"!'1@6LO$P;#Q
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H:[C9IX,/WB_"O],JS\;,O;^3"_A!^RC\_"N1G],OQXW2.;WWZU/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g571963imx2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963imx2.jpg
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M P,# P,# P,# P,# P,# P,# P/_P  1"  ; !(# 1$  A$! Q$!_\0 A
M P$                 !P@)!@$! 0$                  0 "$   !0$#
M"04"#P         #! 4&!P(!%0@ $A,4-#46%QAC)3<X"54982(R)%2D9=56
M9B=7*%AI$0 " @ %!0$             $0$A05%AH1(QD<'Q F+_V@ , P$
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AMO:^.[\K U+UQRW\B\_H=_G-X<_Z([)]R_7<H;_6Q__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g571963imx3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963imx3.jpg
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L:M4P*"6P0Q&@, 69D P&+0_%63?"7)RD#GTZ)HGY;U'H/5]V_ ^[L"I?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g571963imx4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963imx4.jpg
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M P,# P,# P,# P,# P,# P,# P/_P  1" 'X  X# 1$  A$! Q$!_\0 @P
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MYA4]AMU#3LNF/&VIE!WC31Z)5=\CLSEM3L'M6;^8Y)&L9S%-W:C>OB;4\?\
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&JNGL?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g571963imx5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963imx5.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !D
M  #_X0,K:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I$
M;V-U;65N=$E$/2)X;7 N9&ED.C T-4,T-3DU-#1$-#$Q13A".#DX03(X,D5%
M,#1!-D$W(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.C T-4,T-3DT-#1$
M-#$Q13A".#DX03(X,D5%,#1!-D$W(B!X;7 Z0W)E871O<E1O;VP](D%D;V)E
M(%!H;W1O<VAO<"!#4S8@5VEN9&]W<R(^(#QX;7!-33I$97)I=F5D1G)O;2!S
M=%)E9CII;G-T86YC94E$/2)U=6ED.C8P,C,Q968P+6$Y-#$M-&,R-"TX8F,S
M+6%D-38Y9C<X8F8W,R(@<W12968Z9&]C=6UE;G1)1#TB=75I9#HT,#(X9C4U
M-BTQ9&0R+3$Q8C(M,&$P,"TU860V93@Y-S P,#,B+SX@/"]R9&8Z1&5S8W)I
M<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0]
M(G(B/S[_[@ .061O8F4 9,     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,#
M 0$! 0$! 0(! 0(" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P/_P  1" 'X  \# 1$  A$! Q$!_\0 ?@
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+CI5(&K63:\D?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g571963p1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963p1.jpg
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __
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M8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO]O1BB/6L_P#%MO[=+_;T8HCUK/\
MQ;;^W2_V]&*(]:S_ ,6V_MTO]O1BB/6L_P#%MO[=+_;T8HCUK/\ Q;;^W2_V
M]&*(]:S_ ,6V_MTO]O1BB/6L_P#%MO[=+_;T8HCUK/\ Q;;^W2_V]&*(]:S_
M ,6V_MTO]O1BB/6L_P#%MO[=+_;T8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO
M]O1BB/6L_P#%MO[=+_;T8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO]O1BB/6L
M_P#%MO[=+_;T8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO]O1BB/6L_P#%MO[=
M+_;T8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO]O1BB/6L_P#%MO[=+_;T8HCU
MK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO]O1BB/6L_P#%MO[=+_;T8HCUK/\ Q;;^
MW2_V]&*(]:S_ ,6V_MTO]O1BB/6L_P#%MO[=+_;T8HCUK/\ Q;;^W2_V]&*(
M]:S_ ,6V_MTO]O1BB/6L_P#%MO[=+_;T8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V
M_MTO]O1BB/6L_P#%MO[=+_;T8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO]O1B
MB/6L_P#%MO[=+_;T8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO]O1BB/6L_P#%
MMO[=+_;T8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO]O1BB/6L_P#%MO[=+_;T
M8HCUK/\ Q;;^W2_V]&*(]:S_ ,6V_MTO]O1BB/6L_P#%MO[=+_;T8HCUK/\
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M$O>K_P#/G7 !(FY2]R@_>7V9>XX!N.P;B'OUH\5RL?\ ]ER/_IR_<H,W#/\
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M!$U='6.HJ02>OVK>0/>'UW:'C$JWZ4)=1Z)42HBJ8I!;XCZG39+LZLNM,89
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MNX] [S"/<8QO9XB/L =')/:JZQ;+*_U20()B'11P!C*C])6X" D#;]\0'Z-
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MB(^3RS;<>8\A%TBR2[,AY!R<K9(YB)D/K)C+8TM7'U.M;H[G&C?L4TY2QES
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M8%CB') D!I5(^Y2>W4:KM[^\E .YNDJ'_NG @;\Q5T2%#\Y@UMPN-RL9S-3
M(.D#)?L[N42"F._3^M)YJ0!^4P:H,AHCJ\&2(['0.JD!@ 0,@J(I&#W@F;O;
MF#Z0+^?3>>J$LJ""Z751,KE,-]S(!V+A[0W1,/:KT_<'?W%U*%'64$VKE+<
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M+Q7D29H^9+5/3<?)P](FTKTD9]CZ,KC%S(51O(-J/'2)Q=O8N14=2DH*RCE
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MZ_ET[Z*BM%>4H#W"*$D.W[)EO'\@>IT]A"A5H@4H&'LE2 (^PRRHE^@ 3.L
M!OH*]CHCO1* ;O'J ]/_ !!3;!UZ (N&QB% ?RZ5[ BS)BL<!%N^06 !_:2*
M;MZ> F16(("/O[?;J>T(KS'7V^V:$6#;KY2H'Z^T03<%3_S[Z41)RE9"8"D\
MQFL;;X ,JT4'Z.PWV*G7V !@U:^W[42CM>)#L10C@FW]6N7RE-_$-E4P\H?]
M8@?2.I0^U18Q4;+"4CI'RE.@$*X H=0_W+@@B0^P^':??Z-&(T5IU5WD+I;B
M@L*A0_[%V(G'Q_8<]5B?D-WAJN.JCDJ]-P4QP24(9!8?^R5V 3[?6%$_]6L
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M0MJ2BHIYY"]R[Q! !';<$]@'<.A0.NL81'_5_-H&)H"46#O1-N'K7BP[C_4
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M\/&XL;\C%L80GY49B.VX[2NRBWB\R1,B9$==M6(MJS=S[HE42NS^)G H^WW
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M40Z+I2B!T^T!V*<Z!3^:@!O:(;IA[PT(?1OJ0%+P(H8"J%1<F3, F!1*034
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MP]-4TJHRL\I9 !% 3*HEZ^F.;<Y/H;JB(&'?V$.(A[ $-*==4]BRB#=TC\0
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MQBF.@)3&';O3,(!X"4-&?X4*<%D4U0 J@"(EZIG#<BJ8B&X'24 0.0WY!VU
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M*DM3V:?5HI7HL)9UU)""BASR@I(CL=94\4L0B)0*<Z#M/;UI$P-\1#]ARAL
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MA<'.F4H^\^XF'H4OLU1(GX:!--=5>!'2Y=P51CVI2"(J)MTBG!/IU2!R0^Q
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M/^RLOKY4?N"EK7BEVU"W(!"L.<:+I7">E:W!_C;$ZAI6%:'>ORRB.5Z4M7F
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MGT4\DY]MQ$?B @_&!??XZ$;:C1&*3B5:/7 4.]PT>'[5&PG+YC=QV]Q3ME%
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MU#;B*"3<#; 783B?J/:(;!:1';(H0KEG&P$9Q:9056.HGZH0[F[02AW+.#"
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MF,7H=NX.'QHD[@$IBK=Q"CU 1Z:R 10:=BI!2HBJBS?=0@/6ZJ8E4*!2%<@
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MFW#DH"[CF,,G9$[0YTI*( %2*;:^\E:YB3D17Z96HC&>4JV:1QE"REM086&
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M!'DL8FY;)'A)((,9T!(D":/0L1H"N/%E"%+Q$K,_"69P'<%NI';V=R=6B[G
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M4*PMBB5N@0?$J1!-X]3F*!CB&_4>XXCJFI*"BPN%O[RT03+YJY"K./+Z@5,
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M01*Y2#=00(3?RO4E-W>8F(E$2"/:/AK)J*U[^Y19#BDJ^1$2*-7:B*J)P*(
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MRK)A5H)S.JT^DKV=:+;SKY&3L+^1O#Y:Q6.2GG;=U!LFQ'X.URID-UC8Y))
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M;E 0<*@9-N0=@5.3P[OJ%^G;;5D #XM4"HU "*/46A.]<SL0764-W@02HHD
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M$4D 61*<O8N!"@4#I#OL"X![? X>(^ Z$O0_3^A-%C032>BNY1.8IQ7.F@L
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MV6JX2'W#D!9U"YNA;E;*E;4Y]Q6Y]M/RSO:V5FOOY.H0*,'%2=1B7S:'7,[
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M))R38-P;I%[FR[DX^!SF,0O: [B8YM_#?5U&XZ)W)N=&33:/&P=P-FCTAG
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MMTZ( GT#I_V1DQ#6#$]J,.U)"NF:[L3'8%[&A!)W(K*D$5UP*)_KBH ^6AL
M_P"F.KMDVJGO2D319MS&%ZW#;<PAY"Q2E  W$=_)$   ]^J!+2A5\3=$G:-6
MBR/G>M*11T<[@2.$E4A*4^P(E,<H*EW! I0'W:&1!9J*5?1*_NQ0W5(R+@/
M/(<)'-O[NS<I]_S:SO/6B.$F69N$! #H+$#;?<Z9R@/40^L(;#JB0*T".B3"
M AX]-:%=%531$:(C1$:(C1$:(C1$:(C1$:(X1OHCA7]AO</74<(LZ3)VKL*;
M98X>\$S 7_K" %TW1'50D)2$8</Z]1LW'V@HY3$P?ZB8J'W_ "@&L[^RH67>
MH=)'C5H1$VST%%43$<)E0;JG$QD3 <2%,KY)=U4]R_GUJ))Z:I5*$UHOL*<A
M'3CO*!B&.9-(!*8-RCL1-0>W8??J&,W[$<Z).=XT0=I*D8)=C@@-E/-465^U
M3$RC<_PB3;<@G)^40T$9$:U",7U2D9 XB'E-F:?MW!HD8?'Q[E 4';01/5U0
M.\I&TD7J *M2*%(#<^Z?8BBG_=U3&40'<J91V( B3Z.W6I1B:E1@DKMY(RB0
ME*X<>F2,19'8XE!XLE\10*!1  :".Y>O];O^[XA&$?:C#4)0,NY%%-5)5RH9
MP&S=$JR@F,8"]4Q#O$")H#T./@0 'Q\-39%V1)TA=MGGJECK'5?$*@LI]H!2
M*)B=1NDD.XF*D8H&)U^(QNT1\0 *1$AAT5#.KU7#J0*HAYKD&(B=)R<JBI0=
MEZE402$H@)4"_5.</'P*/B.H(B-2SK18CHZM1E';=$K0BS@7+<?3)($64(!R
MD3**2NQ3!Y2 I& 1,'0!Z!UT,($OT6.C=$&=O&*I9!1XL*AP\I\Z.8W:*)MO
M*-\6_E-VZG@7P*!A$>HCJ@1D-H1@LQG;N0W,['= Q3E;HJH);E[@.GZQ;=,P
MBKL;[,!^IX]##T;8QH-4:JM2DOO$A2+-68HHF%%Z8B $%PZ1$Q56P&2,D/D=
MX;GV\=^T.F^H82CU/<G<L9'#-PLYC_1"1!!P91R=NN<H"BY#STV:8' _:(J*
M&[P#;M*':'CJ[9 "3U48]$F4/'*)2YO.61:1IW8IIJ)%425<&;E4*0?($#>4
MW,IV% "#NH/]'4:3BE2A-%=$11EG#UWZIDX6$C5L)$U_+,FL")7+L@ N5,3=
MAUB)@'CLD'OU3,@"+%D?MT3LNS<HB'F-U2 /@<2#V&]P@8 [/T".LB0/5;!!
M27Z/;K7?T55-$=&B(T1)WJ1UF;E-(>Q?RQ4;*>(IN$?M$3 'CN"A0_+J@L0^
MBA"8VJA56229RCZ:1D3 "7@"*YGHK+M@V$!*4Q $Y!#J42CMXAKD(:3C4#]B
MST9.1C>8X;L70 J)2JN>XX;@[;II@W*<QO %DE'( </$>A@^C&@W!7N53F.1
MPT8*G$Y55?.26,/Q'2;""@-US#T!7S>P -^T7<?$!V=#()W*KPRC,ASMRB/J
M#@D*"8?$"J@#NX0*/0#))E,<Y0^L!1$.N@:6J)5Y*"C=(@&[44R$.BNF;84N
MP@;+)F'< 'M+UZ=>N^^HY![U>B2L53B)Q<EV<K%[D1$ *19FGL5$2  [%/V"
M)CI^)1./B7KK1 Z:*+7;: &6K0)]#C<*T9YMT*<OKB@W(8OB*_=\0#X@0O7<
M!VU@@D2[-I4+T93:*>P[=N_B'U?<(AMKHD$]63[53RQ_<'_J_P VIM[T<=B/
M+']P?^K_ #:;>]''8CRQ_<'_ *O\VFWO1QV(\L?W!_ZO\VFWO1QV(\L?W!_Z
MO\VFWO1QV(\L?W!_ZO\ -IM[T<=B/+']P?\ J_S:;>]''8CRQ_<'_J_S:;>]
M''8CRQ_<'_J_S:;>]''8CRQ_<'_J_P VFWO1QV(\L?W!_P"K_-IM[T<=BT?)
M2 GH5L#ZG_Q&]#<4Q-L)@(4# 4-N[M$?#<-_#7/8$?-B)EXF0!^M<&22,>9A
M20B5YS+O;J[<,HNN04G5/75['$=&I+VRLRCU**S1E)[9RUIA7':,O8F]:D+U
M^"Z\W?VDJ[%(/31)8](5DW!57/Z2X[C\GC^%CZ>A=G\YDR?9,5LXXCO,Z1W1
M@;A(MM(UGNH01'YM?R+>3D_F$HQ%N(:G\4W8==6J::!1'8G[\_ 3/TED%E8K
M4BGR&PRYFZS&S4M"0C1V>J6P)B6K*,A"FEJQ5K&Y4!\I$KL$F+-=8Z;13L\O
ML]BP[,;?ZCX.-A3A"4>-O@3,1)ZQ82VR:4HCP[A)R #*KOPVB9<)D2D6)R(-
MTJTOVKU"\9O*#CE@0$  $0PUC,$@*H*I2I_@V&["E5$"BH4"] ,( (^T U^7
M_40(Y_.$M?F[W_4DOHW&,>/L-IY,?N"G#7AEWE#F>7$(VQPNM8:@_O,8%SQ8
MF:O1KMZQ=G?+92IJ,1, XCR*.0;UB640DUB;=BJ+,Q%!!,QA#W'T';S;OJ.,
M./S+>#D_)YQ\V<8RB(C"R#<MM,@/>MB5F)UC*X)1\0"^;?JS>XNQZ+E<YCCK
MO*X/YGQ8^7MSG"9G+E,.-F]NM@RVXMXPR9AMLH691FT#(J8]>G+Z2@=0NU-4
M7C_4E8$7?.IPSJ\%&MH[DS4(]:4;/W$@:V27XTSJ9=96,LSZ4B6K@$5$B%19
MD;**.$BF Y '8/V";5^!]/\ F7)S,N+ND1(80'EX^AB >TN26%%\FO".S*!Z
MWXL_9NN4KJMYX]2<;.7%M1)P!71?3].O$ M(R=A1)'6^B27WS#=[<JI)!%1:
M$"12:,GQWR!SN^\OE([E'P7K/&N8O$7.2Q__ $[-VU( "L+@:5="TMI,H[=&
MJ:K?!R\S,MX\V:4A)_[T33WM2O:Z]3\<0?NZ.Z?_ '.8#]'5HD/_ $Z_+H Z
MKZPG'L-[OUA_+KBV]RB.PWN_6'\NFWN10#RFXYU'EKQZROQNO\M8X"FY?JZE
M4L$S4%XQM98]@H^92 KPZ\O'RT8D[!9@0-UFRQ.T1^'?80H!" L77$67?DX\
M3\OY7Y=9AD761JG9>:W'^$P-FAI2YJ!B8A5>O6&MV.+R[7VSBO/5H_*0O:;$
M Z7547CWP,"G7:G54644M5H7)!NXIYJ7RKL=0V0$,M7//.?LLY1<<G\&\M;+
M=+P\QDU=6?)^!,*6K!-6C7,53\=UB"B:4_I]K4,X8,&S=0CALB*2Q"^:"IBF
M\Z49F6M2'R<^.\EC6MXM<9 S&,#6,2\\L.,W992F_>;FM_,(MPW++CYXH-1%
ML:8JD@(I5XY$R(H(=':;LWQ:,4WEW]GV+7ISY+.![I7[LWR=FCD!EJ^S2/'F
M*QWE?([K$UAM&'*KQ6EYVP86J%9KQ\7(8ZM\$RF+5**3Q;1#32EF3?J$?F4V
M*8%5?,(-&_K706!/EQ8IP#D+"64H2[Y LMSPIC;/>.6CJ788SKT/;B<B[W1L
M@7>>FZSCNA4RNQ#N(DL?L6<*TAVT>P81A?(,BL)2*%,5#,D,OH-V&]WZP_EU
MG;W+*.PWN_6'\NFWN1'8;W?K#^73;W(L+A,PH+=/!)0?_8,'L_+IMJ/:HN?:
M< _@:N()]OJU&8&:[["!%2.EQ\\_4-D$0'X_W@'M#J.O*'XWZ#7ZE8_"%N#(
MH>2(B ^?Y@@Z$_U_4EV W<'@)=@^#;IY>VLG5NBU1(TB"HX%L;_P/>=5J'B5
MRJ0XBNWW#8!0:JB(E ?K[^XG6F@?JG59GIU&ZJ2B0E!5P'IU._J1,H"'E/%!
M*(]I$#F$#=/B$P!OTTBQIT16NBDCT$W0;G!L(^;U^U<D<]I%1,/[2AU2E,4/
MHVZ!H/$6[4Z]ZM7 [($GJ@%4<+* @OVCW%.9T )MD"&$0^Q3<E3*7;V"(^W0
M5IT")I?MU""9D!U!447CWS@R8;'567639 (A^Z*Q1/V^PJ>P] UN)'Q=Q'[5
M%M78(=  -@Z!L)0#8.@;!OT#8-<2TX1V'_=_67^71PCI6A'K."]Y"#VA]90Q
MBD2*/M[E3"! Z:R9L64)"S^0Q;[ LN+@_M3;  $]^QG"HE*/^J4=3Q&H4<MV
M!6"_*GT:-4$@#H"ABBNJ/OV%43$+O]!0U=C_ !&J-VK HX<N=C*'44 .GQG$
M2]/9VB8"[!^3IJ@"*H8:)MDFBZ\<X\M%0PI>4N40*8Q"*(+IJD,)B@)2@4Y
M'Q]FMQ($G0GM2)@R*HI'-W"S5-%W%_> ]ZP&,"P(HM5B@FD!S%%8JHG ! #;
ME-T 0TE,AR'=U':B7-F\>JL[;O7"RXL"$9E,BF"8JF5 JX.BG4,!B*%3(F41
MV$04 VLDR(>-'1RK@6:.%@9+,_.] 3N=^:L;M=*J@8K0031(GVD%(14.7<0
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MJMT#"DH ?$4VZ0AV[#X^!@$!U#;#HP32U<JMU#.E$&IV3G=)KYC9/=FF*@J
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M6<G.8H@4ZBBANXQ3'#8Q-P';PZ;=-<LI!U0R>4WKE -DE%4@WV$I#B!!VZ"
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M(F.+OXB=05$!$X^P^^_3;5,!JC+!ZY\HNG+DV.LD4Z;=N9)'99F82BH(E,F
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M'59(O'"9B&<R*+=P E'8$%CD:*D 1 OP>04%=OW1$?;K88%AT")U@I!PA%M
M17.<A2JD,(_4,9)=9(VZ1^XG02;>'LUB<!O+J4ZIY!XU6V]2V3[QVW5;[MU
MZ=>@ * C_JAK+3&FB>Q7>@;K?$V<EW'J"#@014'Z"J#W(G'_ %@UG>10K8-*
MI"NU5;*=JR9RCMOVG 2[AL'U3AN4WC[-];B7"AU<*J#U=L E3,)=_K%$=R&#
MV 8A@$HAMH8@EU*)<15H[*/FD%FJ.X>:@45$!]OQ-_K$W$?V!_-K)!CWA Z2
MN62J/8I\*J B/:NB/F)#X=!$ W(;Z#  AJQ(TZJFOM6FE5%!Q*/A[A!@^.<A
M3= 4!\9)HX3#H(;B9$!*/Y-<S.!'M'W*/7N3B<IV9T&Y!'S9$HH*&*(%[7).
MY9=T&^__ &0FV_I 4/=J:@GL561T)F:B!&PE2!V!&8]NW]W,0I2IO/W>U,IO
M+'<.IQ3 =0>+7I517N@],@F9NF(N&HE(U3 WQN3F "^E.8?\1MN8P]"B'</@
M.@J:Z%%G:F3,@)SG!3U'<LNJH.P"8VX'(8HA\!$0#L[1^J!>OMU"KUHD3;N%
M82JF-Y!"F-% <.ID=^U8ZF_Q"L0![2;]?)$!\=]:]FO51-%F,F9>H)=@F6)=
MZR?S \$4SO\ H4_O\\2B!2COX"/3;?7'(.)=FU9*Z+%(#"([%\1\0Z^(_1KI
M,%7*IY(>XGZ/YM&1RCR0]Q/T?S:,CE'DA[B?H_FT9'*/)#W$_1_-HR.4>2'N
M)^C^;1D<H\D/<3]'\VC(Y1Y(>XGZ/YM&1RCR0]Q/T?S:,CE'DA[B?H_FT9'*
M/)#W$_1_-HR.4>2'N)^C^;1D<J/LK$ F.;F.Q=OP_(=P> "'EAU$0VV[?'?V
M:Y\5OFK<3UF/OJNOE&(Q;AN?#L/W+R#W9==1FFCD5XF[O<],D)$E9O!DI*.Q
M.SA8*'J\9:&\TDWBE(&28,(U1G]YN <IG<&*^\IHY\E3]B\)&U;A:'$Q;BX8
M]27 -\R,I&#$RW F0EM#4&UY!Q\GR#*<B;M;QJ/]EOZF6]S#YDW^7GGAZO%)
M6E",Y(X?D',?9'<HT*LX6KMK5>/G)V4RW?&FO4+'!XF97UQA(8BZ0)@F0O7L
M0D?U*P8B?E$\;D &(']J+ /%F;2FWJ"Z[6.WY)?!/_KP]WADO4IQC\G_ );\
M ^G*F5 <,8Q%(J0B*8$&EPHE\ON$3=@@/3<1Z:_*OJ/_ /F'.J_^<O5[?Q)5
M7T?C*<=8Z?A1^X*<=>&7>4*<@U:BAC)=2\1DS+U[\;XE(=E N$FLD,PIEFD)
MUET5991(@,H^S'9N'9=]SM4E"@ B( /NOZ?0Y>?J:,>#NV;/(?)9[2N@RAY8
MP,DWHL 3NG9\R$#TG*)+ .OF'ZPW/3MKT-.?JFQDY'#_ )IQ(,,>0C<\X\MA
M#&DY(&RWDFS<NAWE:C.(!) ,UZ]*7T]&B+QN669]8UYY@RC*A&'C.3U,CDI%
M@W80,RZ20O6=E#R\RY<N$A<.$CKD12.1(P&V P)*J]V_[*P\?R[WIV1-R6[B
M[U"\@'MX] &TZD?: OE%QC++%:WX'[;FBOXQ2+:+RC7+!,HQZ 1EBJ%0@F<Q
M&RR2,G;+\X7@F!VKANT573FXBK)2;IHJZ]*S4%KY8 3N$==;UYON>GK^/:<F
M=B[<D01X86PY=SH9&,2 YJZZW Q SHSZ"9'O);]Y^Q>Q"+$/NN-Z_P#S SVW
MZ;_W=/7X^7V!+]P]X?I#1$;A[P_2&B(W#WA^D-$1N'O#](:(C</>'Z0T1&X>
M\/TAHB-P]X?I#1$;A[P_2&B(W#WA^D-$1N'O#](:(C</>'Z0T18EQ#R5NH?U
M2GM_H&U$7-]*!(U%@C*=P%3CQ4*<G11,Y'#CL51'_> /0/$#>'MUWS\:W+5;
M*P,J0#E=E(5\<?/<% -RJ%V B9D>[P22* $$O[([^_K95T^%1)U# FX3;^#
M#%<K?NM5CG,#=$^VP%:KJE[Q#]DQ0\"FZ74?WE>]9WPG0(H]0()UP J0I=O_
M (L%#@5(NWM634. DV\0W >@])&M#HAHCRBE;(KMSE,HV(90BO[+@IA,=PFH
M/B!%A*)A']E0 'Q ='JQT18FX*J-"2+9(ZJP%7>KI%#[0R!MS.&YOV2G;D(
M!W#L!R;> Z&DMI2B3R#=)JU8@W['ZBJ(2:!B;>D(^:LSKKEW$2E<'=)!O^[W
M=XZR#4O3I[G62G]R[4=&!0ZIU-^I!W#L @]2@F4.A"[#X!TT 97N5R+)9R(
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M[")E #;L[>[PWU1<!H=0C]JPRC%>.;@<B:J8"FDR4(8@@*B2IO+(NF(=#+H
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M0Z=4K!40.N@=D9Z];AN<P%0=+%350Z[@8RXE$Z?[8$W+\6_=Y"?Q=_\ 0D=
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M  A$_).  7<#'[-@Z=0%MOO0T2Q=@A'D3>N7B"9TE2F?K]XK**H+"5)4RGD
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M@6WP]K*QPA3<8,3%DI*2MY[TM)9 N%IDUEG2SU8K8Q!=+=X+&.!P&)ZNL[Y
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MS?$%%9!%1<.X@^0Z,INB11'N[B[D3\SN3$PB3V;EZZWNB0XZI[%89RXC5V2
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M")AX=?I]![%0MS;(*.14   B28;J+&V B9?>(EZ[^XH?$.N$TJ-5:)0=X@U
M4&8[#MLHZ.'VRH[?]F ; BEMX;?%UZCJ;3*I6>KIO$X&^/??V[^_WB/O'?Q'
M6F:BJ7(,Q%,'+@_D-QW IC% RBHA[&Z73S/I,(]H>_62:[1JKW=4@EIQ*+;_
M -R+Y"JO<DW*':=XY5 HF,;O  \M-%(HG/V@!0 .H]=:A#<:Z*$=JU1FV4,1
MND)C%5<++R$L[!7N*"A"#WM&ZIMNXB)U^TRF^P#W;")AZ<Q,8D^QA^]-$_MV
M)W3@4Q/]W1I&B7:H8AR+O$S**%!-FD'VQ6_V>PGV#O ?A$ 'NUQ2FPI4NHY-
M%E4=-47A48IND?L:*H'>.B"J@@9)9+<$6Q#%2563*(AV"(@01^+W#!NE\3ZJ
M+ _<>01N?S%#'!\00*40,LX.N46RO:0.TIS]IRB/38I2^P-6([>Q:HE244ZD
M $SA(QDMA J(#NV0[@$ .LH<I$U5@ >@[@4@^ ;]=#.(TU1PA(P"@DD#E%1X
M4/*="D'G)ME$C"DL94Y-DS* =,=DRF$P[]1 .NIU?HCKE?E2:U1,=AA:@A<%
M7;OD1C\UH6KQI(JSJK-ZUD 9A*=)!AYB=5,OZ,7!5C>D!0B7>(&[-TMT@#V'
M0=ZH&I*^2E>F><-=QWA'&%A/R*L\?7N&<!?)C,\4UN#W(UMQI><L\-GV5*=+
MKLD_O8>7&$:(A?XN/7\G\1R,$J@^8 >44> 3C F*%]/L_J6_"[TU_>NFY&;Q
M@#FFI5*1Y5(\$0R?:QRY-O)/D#^&5+@KBB*-CMI5)M1?_F,1P&2X ]-9504+
M C=C,TQ/Z<SQ,,F/M_:I7_Q+FNUU'F)??QFYH,)E^WTFKX,S;.8-C\DY)Y,8
MWR6ZQ\&?[2WQ?-P?X7L5/DKEG1GC!N1Q!1=T=MYF5AVL0B^<M57+ER6;:46O
M"-=5.E1Q'RXR'8\J9;QQ?[-'O:IDVOS&-,E9+OO("O6O*<! <6<2/(BD*\:I
M9C"X'B:?DW(K]7[U<NT_-C'J\@)6I7S4IDPU<++Q%"HFO)LCS6(FK+C<ZY8/
MK[)\?)-ERW8Y'>\E$GC3+R]CPRRKP3;NQ"BK6\P*75:QI.DJ =!)&J>O4V*S
M2BC%$1&BU1ZLRVR4JO+",_C3Q9BHK*%>N^5\T4E!HCCO)>6CT#&^ *ACY];I
M3+.(>3N7W5ADXVP98MS!C7I6"448C%2*+E!NT4*J:1?4/MU*@VMN[%(D#5;C
ME>V0&7[A2LWTG)KCA#G2QY*JL;D7.<13(SE]B^W4W&QP@:BRMS3'[D'3V*EW
M%=;-V'HIF*<$?)(KE4!74\0.I=&8-T?[%S?C&4A P7B!&[V+)2[<^4>+9N0Z
MN/I7YB);BA31HF11M(WE;(;]>Q,$E[TI'A(!4S(IF7V]?N@"(!?$W5D-"6_8
MNW&Q<L.>#7)AS0U<X/&T=DBYS'&3\2DR IG9_@"O6NCSS1%L6SB&694ZHQEF
M1KJ,KWSTC7C,4C IYB8'//O4_B"C')$]R&S]R&89#XG7/*<)0T<T8^<8YEI>
M'R'4<1W";QCQ4Y&V>W42\UNPQ$4N7#]\N<I P$U(>C32)-+(J-5%)*-2(3+T
MKJJ& :6K* V%YM%Q;76V9PC>;=$R+8\)YQG>-M#BAY*L;U5<U.^8O+K\+U,C
M/&YE*-*6N!@$J@S9_?P+P:L&FR.7NASB(VO2BK-\+,GNOS>44;[R?-DR8LS+
M-Q4LU(5.(AGO- )X+3_RQ,ON4,8Q\#(FXN*UH+V=X:('TYB=P=R1O7]A@C%^
MI4/3L]W]:ZLX,X]S;1<M6&O9:)/5R*GN,^)+!4H>+N>=,E8RO,FH\4+?+M,W
M#-,W,NL>YMJC]XA%R-::E9 ZBW[>0\YZ<ITHS49D'N4D:4[5H%CPKDW%TOE^
M5P<XR^PN#'Y@'&*DXX<7C)7)"_8\;X5E:OQRLMW2?0TQ?Y-.7QD-J?SII=XW
M[03.+INJY*@55$N373Z:(X.O85"&6Y?D&3*RK;.E@6:PHYPY.I/'D'_SL5["
MR[5##?"8V.4ZXA@.>/?4V?JG%G%@#YTI"F?C-F1*#G8"C ^Y4"E/V=Z^@>6,
MDQN-)G@E>CS-Z88<.CD9A=9&O5C,5JB%VLA@1RG1?Q;&(PMAO;EC]_)IJ,EK
M$@9\1X "N<'F_=K=(,H'J.JY=RC)\I<CYGOV0:5$YDK?'_)[2Q\-Z)98RR6&
MO-ZV:8HJJM$Y',\7IL8^V0$DSY4*#%JVD_E)$J*R:RNS1,3 ,C,LK1FZK5*M
M<>6V2+57+M*L.251KO+5C/\ (62KU>93C:RX :<7(&YUV'Q36X&PK,(6JV?-
MCI2BR3>#?':-)^02D@<%.FHZ'4V^U&C]7[5/GR\7%R5-F"OM%[?;6431,=R,
M5E&UNN1\31+5D91.[M96.L./.3@S5SQWF8!;L'-Q;0<_,P:R*[/N39O$S^HH
MDU*LI(KD>TJ9/#!34<2R'+%QRL6XU9_#FLA8%,[%9L+Z;C];3,3M0F3A38;(
M+3DM]T)40,?@BJI7#.C1_?&%*H 2)T[%JA/<Z^LV$\&&KN++%C7);5B=.[S)
ME9LU'S%R.FQ"*4:1+5K]VWG)U^D,E5>12,S,*I8N09M]MC '>=43-C#6JP=7
M"X'P)C[DA5&'!MQBI[;&%GM],Y1SF<5N2<_R#R75%I*+EL>1%)+:FLS=C.Z_
M8"1I%!A$5EFS<Z/JU"(G5,8^LUC0*DBK_8N=L)+Y*;Y4Q<KR2G[FT>EQIQF<
M(DNIN="8N[&:X9-_&ZE2;8NEFV/%':SY-B"Y+:5TJ! ;%?=S3M :YH:K1(_A
M_8NM/F#3=MA<MU:<@G^79AQ XP;+4?%\#_S 55G=;TE<9YVHK@S*F"/Q+38W
MD$)$63)Q#Y#K,G7G$<K'&(H@P/-G$0?K68IFRECF\4O)O+%7"M9Y O+[D-KQ
MXQQA!N7+N;7=1J4YGIKD ,_6Z&=S-OL&.:PK2:@V=2(2!FRC.$E&3%)MY"BS
M<AH00:U"=CLWT9)<=XGO60+IQ&@\YUK/T+=,898S'@S-+X^9\UMX.[4+&>(K
M3<>/MWLL[2K;7J5<#6*$E:VO(SH-R_>=G*[9N%%%DU$ /2CH2&+*_P"6FZ47
MG%"Y&GYM[E%S5;J:PLI]3F6M<TW:60#'>_BA'-4FO@EJY18@B4OW V15^J#$
M?1B<H[A*3T4F_33W)!Z^X)7"/!J[Y"#SB4Y8V%M;HQ5QF V(D^+HY4LA3G+&
M*E_@*7"R/&,K)Q!NV8!*GMX-]E!F1=$$\MU76@/9M9="?+VQ5D?'7'NKVG);
M1L>]WS"V,)!XHZOO(&Y7'[V-2/O.9&]P6;;9/QM7NQYV0W=I0K5DF#KS4SE[
M")$+0#J274D 3W+YEFD<@GXT4Q;!<IRC6ET^*='/S#<7!QS =1L?F5?)O&=-
MNJP7LIPO4?D'[N7O9; EC]1-P%;%T94"B$<8,$!AJZW1ZMKW+KK&>7(_#]PP
M)93V6Y$Q4K_S615[4IU<YJW&G+7-[%\>G6/&\ZSS1%72^I3)H]"4&/5.4L(0
MWJ0:F(X.Y[[';H=%@BA[?<M/N%BYF7&^9@R;7H/-<%BC.Q<D8SPVLPLDZB6J
MV?CRS;WOCQ=7&(D(UI9L<,,WW;&-U8STD\!)*;CK;7VKD/*(B09(@RIH@VZ'
M5:D3)/,N DOQO&U?/$TTRS7+%SOH]"G6=R,VH][N[&X8#PCQ,G&JJ7E5:"BI
MG(>/;/+UYP5)NQ/$3,BN@4J#DP6A'?\ 2BH$32E%5.K\P)9MA[C#8(&X62?Q
M%E3*LG]]Y9S3F%"FY4Q7:,%3MQQN^R1R#PH1E(2LO 903F(,B2OGDCQ9,151
M444;=T$"[#5/"*A1U0I>[-[QBE'.-DR*FSB\%8:1D6>7F_.^)F('(S'/7(M'
M*5'BQP=89.!LTKCYHWAH'[[M;Z67G(6-AI SITU=J+*7:>TNG:W;W=R]#;L(
MR1>HE%!P@5N51Z1RU62,8BJQA1;BF E AB]OF&, "*9@Z>[;G&^ ?W,N*JM5
M$B"2O>Z3(L!3^E55 R"3E3M,"0!N!DT5A/MNF8VP[_"(^&IN+Z41V5#Q#N.(
M042"D;RR@JDH(>F=&*0 ,<%"@8".#=OUP$>X?K /B#?&18HDK1SZDSW<ZI1!
MTB0R)Q %6YFJ0 D/;N(%."RIQ*<-PZZT8L JR4E=MSODT91(J1?2J))OFY *
MFH99=,"@Z;&^Q34.1,2B(=I#^S8>FL$$#PU4J-%19D=DX2\H!?1JC9T3=,IS
MJ,D2F0$Q5D3;J^E #A[!$@!XB'A!)PYH5NFG5:Z\;"'J6Y5![/[L^BW8*=&Z
MY2^0FBJH3J+90S8I0. ] , "(& HZYP(EI-[5E;1#SB<JW[))'=R@":3DP=A
M7B9C%[DU._8 <IJ$ 1 1#8=AV'H.N&Y;,"\311FT2IRP, "N@L"S;?85";[D
MW\ 53^LF._3]WW#H)!F(JJYT28G<0  ##N'@8!$!\=P$!\0^@=75/:G--RDY
M(5-\ BJ =I'A  RI ]@+E[?MR![^A@^G6"""XT5 [$E<ME&Q@*<.XIR]Z:A1
M[TE2[]#IF\# /N\0]H:T""'1:@J9P\F6HM@^S9K&,S.':9+SF^XN'RP>!D4W
M(D22#P.<AO8&N72+'4CZ!9(Z)]9M49'UI6I2I)%=*BX#S"@$J=!-)-P9NIW;
MF**B9S+==C&W*7H ZXR3$5U;ZD?ZDA;;OB& /A8E>.NP"B "\V<*  ;!U(T3
M$H_#T%0P;="AUV*>UE7*6L7RBKN0:$W&.,+87!P'8%#F1!,Q6)O%-9,$@ 50
MW[=M@W'PS./A!%))]ZNEDBLSQX1X%6+YP$2 H"5-!%PF=+9WV?U0E.("!=^]
M38>W???4A)W$E>Y8RD2:$4475[Q.("JJ<-SJF-T*0I0W$"]=B)AO^?6]2P42
M-HD==#[<.Q)LJJD@UW'?=!4Q2*NA$P]YP*(=I/JEVW'<?"D@&FJ)AMIDU#5/
M;N.=K=ZV)U"=4R>:[ @IG-OL8Q]P';V; ([=-8/\7^RH>GM4XF4 #&Z^T?:'
MO'Z==2O1%;YI?WOUA_+J5[T]Z/-+^]^L/Y=*]Z>]'FE_>_6'\NE>]/>CS2_O
M?K#^72O>GO1YI?WOUA_+I7O3WH\TO[WZP_ETKWI[T>:7][]8?RZ5[T]Z/-+^
M]^L/Y=*]Z>]'FE_>_6'\NE>]/>CS2_O?K#^72O>GO1YI?WOUA_+I7O3WK1\E
MJ%-0+:43""9H1T"ANTI]B_9@/P[_ !" #X> ^ ]-<UB6V_"3L1(=68/4OW+C
MNQ,K4HAW,2S5JU%Y.LLU2?K+U:PW]3OSC8KE/6V43FH2"HR->CHAJM6:G,S%
M>@;(\JTQ)W"*AF;],KC9%BV%(!:@HH4Q/UWP&9CY=B&-@@CT_:QX6P=TKDIR
M)W38F(D(Q)D*:EZT(7R'-;SC*YN^;WO($,!^QSJU*)]F;)+QGR_N0-G:2#9&
M:+R;Q,W1=),8&>D'KD*Q;%&C.2!V#]L9LK&/T%0$H*K)B=5( *3<I%K'QKOZ
MD<?8VR%G\LON"91ZQT9C0@]CT*[T0?R2_HQOVZ^Z3KU)\92KEXXX#*Y[/4!A
MG&0+^6FDB3S?P9#=_:D@1)!(O=^R0I2AX  !TU^5O4;#U#FB/P_.7OYY+Z-Q
MW_Q]D_\ "A]P4X:\.NZHXRN6W&IBH4:!B++8?Q+0Q)$SB#-S'&APOE:-9WYD
MGSMDW%Y#5D'CUJ;S.\CINF8A3G I#>R>E#Q YH'G+][&X_Y;*_$M&49^9\K>
M\F+QC([;E[R[<PS&$I"1$22/2OU!'J*7IF0]*XF-F\Q\]@-:OQA*WY/S^-\U
M<:<X1WV<;SKUH[GC=MPE$2D!$R/KUM>ZHU#0(O'E*JV:0=<VXF:?3J4=_P T
M=3C8J2EU+"A7V->6M_()09&OH1#!^Y.V9OTE?4^G362.0%@.0!^,/V+#Y>S^
M07<:$#>'%721$QW&7EXU).0'(T=CI5E\HR-QAE DB!OQ?Z[CG^A/.%XF/;9K
MH+4+!!*),;='1S11)K86S:QM647*2C3[G:R4%"2J3P'D:@<3O&+9,I#E %1
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MN.P=1 3I^W]GXMP'89P^OTU4251FBX8MI,PG&*1*4RCDI#*K,".2 B[:BGN
MN$""("=,?J=@@;X0W Y!VCXEDE+(U^Y[#0;P!3%B(>A/W=Z;]D<-T''J0 I7
M2Y4_@,8?B'MW'KK,A7>.J GJG,&X&';;<PCV@':.XCX; 'OWU-Y"J<RMT&)?
MMR%5=;;D0'84D/;W. _:4]Q/#W^[67,J]$%1W)HDY C5%5X\6,"12B(^TQA
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M$?#4+$L-/IHH>P:)*9XJ\>J>F(F=-LV1;)K&**+-'O,90R;<A #S"D3(GL!
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M';.&)/6E.(B1TW,4  H%[#_&@N)NP>T3)G*._7IK))C0:%) !8!DEU53!($
M#E  $Z9"[D2*':3S$B% %$ *&P*) (#^T4O4-41 ^%0$A)"-EF)N]@/GQZYQ
M4*AWBJBBHH83'!(4Q.9! QA'M$G<4@CL)=NH4D2^+5'2QX"+DR7W<L+>2;)_
MW@0,4/6 (AWH'V\U!XW0V^R-\92G =Q#<=04K+1'+IO761>$!!Z)V+M,>YNZ
M3$$U&RVP"!R&,(G2$P#L8!$4E"CMW&#IJ@$%Q4)[=4G>3,?&(E^_7((2">_W
M4]8B15X@J8ID_6I(E*<"!V[AL.Q3=0.4"]=6,3+X13JH2M.>2TB^ %RMT&BR
MYTU FE!\MG)F2$?)6=KI=Z3)P"9A^T;BNNF(@'U-P'E$0*=.SL^G>H]$HC9
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M%2%/Y15_+.!@2,H<2'61$P?&;X4Q#X0[OK:4CI\2LF9+0DSHG K)+S?,3,D
M=H;+I&+VG*W1-V%[ #KYJ@D2)T$.[;86WM4 =5]&E%'4,JJ=RZ?=JXK%,==P
MX*8OV::0"("5NB'P_LIE'<1V'?1S(-T"4 =(!(XDS@54?*CDS@*J:9P,5Z8A
MO_"JJCN*Z)3!NIV;)CT* FZB&@T=-4&JV5V= &2;PW:4Q13:J)I@ &55V$J
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MXR0IAJRWK;>N4J_PEAKR-6;8\5KF-WSA]*/?/?*()D6\LBR:R:HE^W\!EF'
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MJ.P!UU"2U%K7VK(YDG;XPI,4TDB)[D1)W%6! HC\0K*$#TR:WM'853B/L#V
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M"@@F8#+=-BKF,+,3?M !]@.8H#X=VP#JEV<Z*DT55#2!A%$Z(+IB #Y1R!Y
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M:&)F<CFF%JS<C+=9QQ$RG<W&)C&3"4@!X1O(.I;5RW9A?G/>9BU:!E+02D2
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M)!)OY?;M52B44P'IMX:UXNH^U#&(Z_8LJ/)#GFW'M#Y>1P( B<R9.:># 3.
MAL;S"&J1RG$P>/@.LF)-0 />IMB:/]BM=9^YXJ*]CKY<\B[W[3%*?F]A4B9B
MCU(8.RM($$NQO 1VTC*34$66ML6UI[%F1Y!\[D!$Z/RW2H*"':._-O!I#G$#
M=Y0543K2BA@[_B\3" ]=M]9,I&A^XJ-'M^Q9'G(;GPN";EQ\NCT8"0J8F;\V
ML'ID$Z(@81*X6JV_=O\ %\/;L([]!T$B* *M!M?L25'D5SI*83M_ER"LJ82B
M9<G-["*QQ$ $@&.Z/6QW$"=-NX1 .@!K1,V<Z?3HHT='^Q95N07/=QVD/\N<
M2I$#9/R^;>#S*^P!*!U*N((DV* ? &_3Q#4W$#2JC1[?L6NFYA\@*)?<(U',
M_"!WBVKYOS+7<)1UXB>3>*<FJ0%MM4#:9Z'=2U6KD$SF'D<JA4W!%%"K%,0Q
MBB.X;[-TB?%HKM!!8Z+Z%"FNXW\\?)2$>J")]U% WZ NY+L8.GB5,0#V;CKD
MTT6-%J61A;%H5P("7FBUJUH6*T;+>F.7MJ%F$I>XA%!2!0G<4! -P,8#;#MK
MLX)?-M=]V __ #!=;+'^6N'LMR^XKR$T^DO;"M#1;8\:T1=MUYF2?KI.3*Q+
M",1)*R%G&-@_6+@NP8)J@<6Q5#"](GVJ.TEE?3_M/+S;>+9-^49G;$1 IXI2
M\(CNDP8D]>A)(B0'^.0(,/+!#BON]W8%TC@J4&Y9LR'<JO&&0B<FL:I44'[]
M$73O(63IH&<Z^J$O(2Z-C=0CG(P4&QE(8A$H6(9.2F([:*[ 7T?U1:'%^G,/
M!S9;LK'N3N"() MPJ!.(BVX6_,MEG,Y$-M,2O*\?<N7K]R4 #"0$0)5!IIV#
M<QKH.U;-PSK\G-YYN=%K%?<3V(H^3FK'<*[8K2A$V['\?CE:0DJ[*-S?B*SQ
M:[U5,Z4<Z;QC0Z\FS5%L^611\E77#ZVN@>G,?DLNX;?-2C;MPE&#PN>:!NC+
MPQ(&L@9'PD/$$N%S\5:\W*N6A#=8K(N>D:@C6HT/:.JTKB34+CGVIR]VR:>T
M/:_E3D,M,-74%8$&B;I[8U9*2M2UD:QRYG"<>9XDHR;@_,T6%-0PM3%*4A]=
M_P!8\CA>F[D,'C#".9C\; $2@3$1BPCL)#.QW':YT>JX;.)/+G"Y>DT)3 /:
M)2J_[G[U]-\W\Q&W#>U!QSD< 0EGF,B8\IT=@6Q/)K'TXWR!9'TV_K+I7+3\
MB\ $;7"*2C,S?S6R:0 #A(AA;B58GRC@/0]_UE@7/4-G.-N-B_<.1$PN@PC&
M.X>2&.^5"X>E.M#[1E<H>*O?("S&;VH["\?$7(._NZ_7TJM0Y4X(EVF05;A5
MX2SU_)-VH=[D%8&+N\4\K->F4JI)6"+AI)U$Q+*&+ M9V.%H OP1:))*%(JJ
MJB5J*7>])>H86N/&%ESC<XNUE0&_9+S"-P=@22"8G^%R_827Z',8/^8-T1E"
M]*UO(!&T-J W?VK@/&BF3Y7Y>:=B81L<61QUD.^\>KI>Y:S$16HN- (WNZ(P
MC&*=,)5_)+RMC<1@O8N14<HQR9&Z")T'"JB?TGEK?%VOU+-J\9>1D8MK*A:$
M:3O? \G!  C$2VRBQGXB7%?&[C<X@9,(N/,,22S@$. />X?LIU3<2(-_R</&
M%<BY5(UU9V&84:S1:_+N;^_Q_,PMCR':FKE1:6;1D#0ZK%0*:"*\HV6>@,@9
MLS76*3=++E_^(.[./@QML1+Q1C"-V.VU%@ \IW)7'.TB/A$B!IPR%N/$M%C*
M4BPZ^$DR?L CM8.'K11=9VR5FKM2M%272&KUB'K^*',4_&=7DJ<ZB(MNU>L8
MR8GGP^MA[-,A)/&957*"Y!522<BT03V6]AP97,7+OX.9$_-7;D\@2B([;D9&
MA,8Z2B-H+ NQ(W'3QTI;HB\*0B!%M&(#T'?J/:RD29KUD<?+_P PPU6CI=Y.
M)<D<7.D$*@J[3=  XYO*ZZ)$(P&QTF2+0YTG#@$T%78=QE4$B@ #XRQD8\?U
M'Q+^5MC;/&7P=^G^); ^+J]0'('0E=VU(GA;_4#(MOUU$EZM<"B8<&88$Z?D
MG'%&.A.CL(>48:A#B9/81$0\L>G7KTU^3N=,3SN;MT^;O?\ 4DOIV &P+(_X
M4/Y0I8UXM=M17F<LB:A+!%WEECEY^*\<"%ID'AV+9-L7(U4,^@A<IB!@7N#$
M%(=(G@JJ_*0>AAU[5Z,...>!RL&?(V?E,S\"$1*1/RE_;=8],>39$C_#&T9=
M%Z#^ID<R7I*0P.5M<+D_F'&_YJY,VXB/YCB;[&X5W9D-V'"/\4[\8FA4J:]5
M7OR-$7CPAJW/Q%,YLN)")4(6>Y.XX=HJL):/>MU8<ELSN*B3$R+]-S7R*E*L
MDL[770].90YDQ2< 54G[#NY%DYO "W(&4>*O N"*^7C=H(ET(BQ?JX7R4E\7
M,.C7X$_^:?T=,&.V#"'2L,[:2-GU%IE<E;S9XB8DGS>ONG\.RD8JF@T<1T(H
MNVDD[1,Q[=D_0;B6+4$H&!4BSI1;L<M<N7#9Q\21'(7[PM1G%M\8R(E,L2Q&
MT2)B_C'8P ZEHQ\QY![+&1!T#4 ]I)]Q6_1"3R)XC4A5C!2=L8WR:R/4L>U/
M[JC\D$7OBMP9L[);XEM7[ Y;S4I48J&5,V5%BZ?NW-D=.$%1.4R1/#WA#)];
M7[EZ4+(PX6YWIB1MG9M)C"1E$;1<)BX<"/E")H05Y&(E;P!\4O-)$8]I&I%:
M$5;MW$]%-$7Q\))\:\P<:YE::7S[F"KUC-\6UG)"><1+"^,'B$Y1<?.T7,#&
M-J_=YB A +.A.%1D8YP]1;@<[4I.WP=[U-*WZLQ/5>-"'Y!AW)XQ,1$2E;D&
MN7&$CNA"4O 8/&0!)8DKOX^/&W@2P+A(SKP%P1+L"-(]Q([6JM+XJY+;P4KC
MX\$P+?*I ,:Y@6<@9:"D4YVK+QSILRFV5IQU.RS%S6[%82Q8MV;MNLS9]5!0
M,JY;';K][UAQ'S^/D&^V/G7[AR;<B1LG&NPPN1!W "6YB#*HW!B)#J\=DSQ\
MF-V<)2M ;9 &M?[I9M&H:LOI[*U?B71<?TVU8\P)(M)[&;/(L[B^0>XZ\T8R
M?OK.9L\F]LB2Z==1=QZ+B.,JDFJ];(HE2(W34*D82C\LMW_5G(9U[C>2Y$3Q
M<DVA=!NN#&R1&(  D8L_]ESJ0Z]CN7^,M8OGX]B4,B(.W= ZRZDZ'V/30+XR
M92K4IR3L5:PAZQK#7')&1(O+4/4V#"0?JTRJ&0>,[A8[<D@Y:Q=$K$=3[!(R
M+)%PT1D'2J*12)^2[0 WVSBLJSZ5PI\S;M^9A8V/.R;GA&^X2/+%O4W#*48P
M+$@!W+Q*].$[N7D2QH1(E-B'%(Z^)]!U)#/V:KHKEG2FMXF7V9\!1%CM$5CA
M2L8CN5,+#6NU!)UFKL49&G6.)HSN!+*)T=5NP60F%GRK. CY9NB*'F'574UZ
MSZ-Y0\?8_(/4!C8NYN^_:N>"#3N$B<97-U) GP,#,Q)%& 7D.5L6;^[)QGF+
M6R$XU+,*$!OA('BZ K1\KR=/82/%;(%WCDSXPMLA<'%>834PC!5V I$K9X!.
MR5Q%NTL%FM4W U&3MR\0$:T0\N2C(-H8B*"92+#Y#@<;+C:YCB<$RCR6/&#R
MB-TYRC$F,P\8QB;@ANW$^"4R'+D+K9 C?GB7;C?+W-Q;0  LU'^$EGZ@+GBZ
MU&PQ%DFX::<NU96O.%*T4JCXA48_\.L @X<L2CY+-B5O%$325;1OG-TT!*HT
M.1VV4],7VWC<S&O8-J]BMY<P)$=IE(&3FI\509,2?B&TC<NC<A.V96YTE$M[
MJC]G[%Z@N)B2B_&3#23UF" #C*C;M5$G9 15^[Y JI (_54>(B4"E^S. >3O
MVE^$ V_*OJZ0_P!2YDX__=7?O'7Z.OIW"/\ E]F/06H_M4[ W52#9NON4O@B
MY**Q/H BH""Y"A](G /=KUUW-5Y<JIUOA,FZ9* 4?K&*'JT-_880*7S2]1Z;
MD#5]BBQD3;F#^Y.C)!_N2G*L0.O0!;N .<G4? !(.CGJA=:N% KG\1F66QK\
M6MD:/I#W&[.V@M(-I-"BR%BCK<]KA&YEEXH6;BR0[9V8XI>?YB0 !P)N4<';
MKU5!Z=%JK?CWA6%H&+<;,L71[*F8?MT#D;&\"W5E'#.HW.MS4E.UR=8N4Y=2
M2<NXJ5EG+A,CI1=$3+F[R"78 @:1[E22[O50U8."O$BQQ%)A%\9.ZVACF'LM
M:ITA1[[E7&ECAZI<I]Q:K73W-QHMOK=JFZ;8+&Z4?.(F0?.H_P!483D2*;8=
M:8=@02DI\/A_$2^&W."UJ?2W&&%J8EC4N*UZ_%'I(4-&/)'?A@D&"*34D2C'
MIE2( ;'*.QP,"@ ?6'!+-1"[OU7/;7@?Q+:U*^4IW0/OJ*R>TI4==I.V9+RE
M;;S+PV-[&UM^.X%KDNUY"E\CP%=HUK9)R,6QC)5FT:/0%8B?FF,8>3:.S[U-
MTNJW2E\.^/%-78N8J#F9$(6YU7)\5^-<KY>R9]UWZ@(3R-0LD..1<E6H8Q]%
M$M#THE; FBY\\/4$5\M+LP3%F;[U29+:9O!.%[')YGF):K1+F2Y%4>.QSF]9
MNL^9HY/IT/!3E6C(VR,&;TC19XQJ]D=QI9!!-&2%@H1 S@4D&Y4MB+=%'(]R
MI<N.F#\HMHN*O="1M;*+Q=?<'QK1TK84DV>*,JQ-;K^0J8F6.>L#&B[1"U*.
M0<*&,9R0C0HI*IF$YC218:!EIR.JV^\XPQWD.(BJQ::.A.0-;L5!M$ R?.'+
M<L=8,66&(M6/IA)5*11>G<UFR5]F\1*J)TCJ(%!4JA!,4R(8:J D* ZGP?X_
MT*Z(7ZET2?@)YO=YO(J:+#..>FE;+<;)8)*V6&7/CI')2>,'1)JR2[IXY9*1
M96"ZS@XF2'?;4\+]4,BEM#X5<6L0WB*O5#Q\C2;5!*V22JD<%HO#BFX_D+J1
MVE:W>+,9VJVSF-\;NIUG(+(N%:[&1R@MW*R)3%254(8&%0'3>2*J9+!CZC6F
MRT*WV6K-K79L825@EZ#.",DL[K$C:ZR^IMD>M&QG:<:NO*UF379J KYI2D4$
MQ"D/L8+NJ^BA)]RUQY@'#\O0\EXY4H$.-,S3<9Z\9*JDN\EBM+;:+$_C96QS
MKY!)^640=2TE#M5%"-7+= !1#L(!1, RCU"HD0D4AQRQ!(XIG<'3- 8KXILM
MDF+A.U6,?S:;>5M\]D57+LK;'4D:5+:_Q*YR<L,YZTCL'*+\"G3.0I"%+H,0
MW3O3<27ZLI#IF-Z+4YW(=HK$-#M)W)-H;7G(#QX#M9_:;@UJU=HS"9?&=N%/
M(=H5>J1S, 0131%)F01+WB<YI(MHX= 3HMJ.D=$1,+=Z@8PB(G:./4I"(>Y$
MX[^WV)==6,MR&JO;B1RN5(SY O</4'[(4S)IE 3*C\1FO?VDWW$.FA.T:* ]
M4I<'475,H4L4=( \M+L'?M(40 I0 I#%*'3<>HB(ZD2]*NJ=$$(^4$I2D:==
M@V$[D1WZ;  >7VCH2!VJ"A2UVBY(0C,[PA"(B!U/3H 43KG+\?VCA1P ^5]4
M!V#IK.X=BKK"DVCF1_/=KI^:(;E(HJ59^H7KN( (J*(I#]   _LAH9$A@H G
M%9^X%KY#1JH@#@"F RY#-T2(;#L(=Q?5+G4-U$>T-R] '60*UJG>FYM&F66!
M0QA<. ZE.) 210 ?K"D03&*B @/4PB8P^_V:T9T8:*O1.'GLF1#BB4)"0 .Q
M%,@@*)%@ZB=0QO@2(D40'N/U$>A2B.LN>NBRWU)K(10ZIG;Q3U+M0HE$^X@F
M@01^)) !V, &_:,/Q&\/ -M5VH**[NQ+#($1*"BQ3#W% Q&I1#U#@@CT,(#_
M .'0$P?$H8 Z>&X]-7=V(RM\Y8Q% ,)2G6 H*^4':3L( @D@0! 3 @B _"&_
M4=S#U$=04+H[)-V*JG!NW* N#AN!U-_(03\#.7(AMLB0.NV^YS?"'7PT[!T;
MJG@%FT>W(R8%!0$Q$RCE4OQKKF,)U%SE$ [U#G$1[A\/8 =-8+FI42,HKNUP
M( "JJ<0ZF-W#U#J81-]7;_-JM1T=.QS-HX.P@@LX'83G3, "&WB05.HI@/@/
M;\0^\-99PA*:U%EW:A$B]PE,.Q$4RAVAUWV*4  1'Z1W'WCK0T[UH,G(6C9B
M "X BBW: ]@?'L/L I#=!#^D<-OHU'*CE)UGCMV8J*0'*0=P*DD.P&\/KCL'
MP_\ 5+] : "J,Z6H))QFRJJIC*F#^I(/;OUW$  !#S  ?VAV*/LWU#51+&DD
M=ZJ=$4C(B7<P*%[5" 7P JP&#Q$?=J&+!P5IF"6*I(@005V4*<# 5-3M% %/
M]/MW()C>W?4<J+"1%0R92I%*P[#]IDCII*$/TV[B'#83;[[==]]'[46(&C,'
M78#,P+ 7N!P*>Z0&V^OY?=V  ^SIXZNZ6G1"[+(=$WE=JB9) 3F^$I2)II$'
M?;N$^XF+X>SIJ/V(E)4R=I11$"$(  "0 7T_?TW$![ ,IMN.VPZR2>QT2!S)
MBT4*EY)E>TW<8Y]B 8O_ +@I0$H@&_01UL#M1OJ2!P@21[ED%CBH =PIJ&W$
M/Z(@.XI@'LVW+^36@65#=5A0=N6>Z"P&.0H]HHG\2[^T@CW= W]NX:A#J+,+
M-H] 1:B0%P#<R70G<(!X"G^P)O>&Y?R:KD:Z(FU)9=H<Q0$>T#?$@<-R (>\
M.@@8/>&PZ$@]*K3)R%-I)$ ![477@43B "IN&X%$^P K[@Z 8/;OJ R"RY"9
MA!1FN( )TU$]RCL(E$-_$ [=MP'?V^(:W\0JJG$5F<BU.T?I^453H1=( ^Q.
M':)5"AV[IG*<H#N7IOUUFH-%*C1-92*MU#-77;ZD@"<BA2B"3M$-NQR@(AV"
M!@^N&X]AM_8(:I+U5U65190R9$Q$#=@F%$3[F\HY@ IMNH"*:A1$#%WV$/#8
M0 0@55?3@IMV@!5"D%11'?<P$\/.2WZK-^[H)BAN4>A@*/35!(]BCLDXIJ%4
M*X:J^0[1#M(KU,50@#W @N4-A42WWV'Q+N(AMN(:CNA;JG ZS-X"7G)ECGB@
MB4Y3#NW46 !W%)4 *0R9]]P$![@_:*&@)'L4(3>YC3)K"?<S9SV=52@!RJDZ
M@0%2[]BZ8 /0=P$ \!#6M_3HJ&"<$WS@6H)NVHK@W  5.AW+)G0W#M5$A@]2
MW.F/3?XNGB(ZSU4:B0*H1C[[5LNF=0F_P^:+=^WVV^$?B2553#P'H8/>&J)2
M""A65L@Y.FJT*]*H!OM$!70(H*:Q ZD!5N=L/:L3IUWZ^_5W5=JJDA) (_+T
M$C3H(A]9R'4!'H( 02AO^4=5PZSU7!WR_53HUKE:)RQQ45/F'<W$G N!/L4B
MF7G0&$H 4-P(( (;B'AI$ OJZW,U'L"Z?R?D,,<-Z\TC89Y>+E=;0E3J/2JN
M$6P>6":/$RUA>K/YV7<C%5ZNP%:@7LC(R*_F @V;B5-)=PHB@K#/N^U0#M42
MES[>VCZ"A9[CED"%L<KF6 Q%Z>8OE,1J[D\Y0GN1"7ZJ6=JH"%NIS*-C'3-4
M@,V<F23:J-SM2"'=K1)-#0H0-76.R<A_N-&_'E\7J0DS6\Y5G M5BFUVIC9I
M=[5;JU 7*%F7%N74;L:-6QA+,W.L9^DH[!UW-$$'+HZ"2L\P@-J@'9V)W6RO
MD&.Q??<AN\ W.,LN.I2QMI:B6VZ4\AIV!J\,A//[Q1[D4[J,G:C(L%S#'*&3
M9N'"B*B:J+8Y#E+K?1S]B-6A59[/%VCL,47*<KAF1?2]UM.-ZJQQM$Y*J!)-
M!IE:?A:Y2YI]-JMRQRR*DC8V?JFY%#*HI*'. '!,0-@RJ\4$:LZV_&V14KRI
M=89_0Y7%MTQW9&=6N]8EY*)E_N][*UN%N$(\C9^H/7<'-1LQ7; U<)F.=NY1
M.8R;AND8H=_)$DBI=1F4MMDF[A)5N$LI)N$P*Y3:G(@_[#$#M. -VH)@B)B@
M ]QQ$W3;?69%B[,C=5:8DL(&(=!DFD8? #]S@0_9#RSIKM$A#V )E-O?[M @
MA^J']BS1S%BBOW+1*GF+=Z:CDADSK?:E[=P517(<@@;80["EUF9/:FBL4310
M,)14DD#%$Q>Q0KL>I1[>I54UN[;;WZHD_8A*O17334*8)02J)B50"J%:]!*.
MY1$HHI' /R[:A=M*($I> 4BYE"RZ!DU2D6 /*:E /. #[[BMN ;B/LVTB0:,
MJ31DD!4IOA3EVHCN B  S4$2@/7X2J=/'Q]FM,W1!K35+72B:K5JX4EB@8H&
M;F A6I1$$S")!Z@K^P(!X!X:Q&DF90NF\!;&\7;UQON >6*WEC] "U23*&WM
MV'6ZI'5+T4&YF;GRXQ=51,Q'!3JIE+]4?+5^-XKYG:)1+U -NG36=QW *DK$
M O#[@!$$ _I'574#W;E(5!/J'3J8=OIU:+*PG(B0!%X[,?\ ]V)P;)C] (H]
MIE0^@1,.K[$!7"/.!5/[\X!)M6QRD#YB^#! PI"W1$?X;9R 0 3E*<QNHB(]
MH[[>.L7!VK4>OL7>(HKJ=7"P%*8>J#8!3 ?])P;=<X?Z/8 ZT_8LNRU7(28(
M8^MP-FB:I2UBS'41\H5!.4M4L!NX"$52755$X%+]F/FF*(@7J.X=C!/^=M$_
M[Z'\P77R_P#MICMA(?85Y'J?$V%:0@_N,\DRL+X8R-CSHOTFRRLS*%59K+/$
M4FSUM"IO1.B@+0QC)@V2%F#5 B[KU'[)RKN/\K/YO;+'C$GZJAC0EM7;^]N+
M1;XW&W,RC&!.X2^L=A72V)24]?(?)1U03IP=-QQ1ZS#7!>KR*,I#+42DV*"J
M5L30@WDU6;9")3[B!D(]..,4&J:LL=ULZ2.8VO3>=CFRX?B<;+\>5E7Y&WO!
M$Q.8E*+$1E&1@)1.]W(B(,"O,XEH0NWO+!%B,')&C @&CCXC]3NMQXL0?X6R
M QY097JT[4*B[N+VIX\H+*-L%.C1+>$W=BL,BA5(R#4>R>+Z_%.T2 _A'3QA
M(2BC=)\02#OKI>L<X96$/27#W(WLB-D7+UT[9R>RT8C<9 "Y(BHF!*,7VKFX
MW;9NC/R(M9NR,8@$BLG<T'P@=E"64$5"@K<=,EY"P?#R 2\ZGDM#-55K[U.6
MK9<CXR@4U3XZ>4]^'J(RT%<QRX#,1@-5I=KZ5R1LDHJ@=)3V/.Y"UZLX>QS&
M3:VXT<46+DQMEY5YP;F\4E 1(\$G$"""2'!74O\ S&'>E9M/OA*+=DH]"_>#
MIJ"&[E]@J;#<5LMX^M5HR/@9[(VS)V,ZE"9'D(S'X,TG\7"QTK<X)Y62LAL#
M1H^,P206/Z=VJ4%&Z"($322*D'Q;+N^JN&S+6'QO(Q&+:R;D[376:4VA(G<(
MF0.E0=2:DN?:['Y7E6I3OV#YY@(S(&FVM*T/;]6B^?'*K*\.I:;>[D(MIB[%
ML-'6#$+%NC7WT=+R%?NM;0A(V'@*;"2JTE;KC!UR9;J%[EUD$"]P/$FI!9MQ
M^C^CN$E9PXVX&.3RAF,B7B&V,H3>1N7)!H1)B:L"?X3(N5Z]R6:<FZ9Q\&,Q
MMLU:5%'J&[]5GKG')M%\4\6<6!=2D5R'*YM/($J3=S.0\;&WEPV2=,L?V$$H
M26B7]B&ELVB,<2-*YFT)] &J/E)'7.;&9ZJN7/5V3ZOV0EZ::WANT9$VP2]V
M'B! \QR26@8%RY 78^6%W"M<7*N>TKH%0!3X3T?;[WHHICF\W+<7LRMIRIS%
M07QU&UUGE2MOX!O03RIWV0XR0I=RLL?:[-%>AE7Q;3)QSD[N/0?>3'1[M15+
MX>_R]^=BSZQP\K&N1O0RYR-B>[>'\K;*U$QB7$=L9T)#SE !>/$97>/O6H Q
M\H#<&KK0E_;M9G8 J-[LP:S->H$[4Q284^V5"+FDF45,O)9H6]U^&8X^O+R:
MDG< L-AGR2]/(*LNJU<M'O>HV*FHV5[S>9XNY>QLG+QLYSG6KY ,P!(VI$W(
M,!+PQ(G2#@Q82<$,NC,"5N%R($=T0X&C@,:]33LZIZME9FIC@'F&&BXQXL\_
MYE<3/(E%M( F=%)*@9"5!M][2$D[:R,;'-A,D+LJZKP[?X7*AP2#MX,&_9A^
MHV).Z1MCQE\$D=3.WJ  Q)T#,^FJ[5HMPM\D>$WX?=+O7J[P, A@W#("4A!#
M%&.P$B9BG3(/X0A_A3,0QB&(7P 0$0$/ =?E'G6_/<TC3YN]_P!22^GX%<&R
M^OE0_E"EC7BUVU#6>W$ UQNNM9:K(7.)"Z8J3- Q;MVQ>'D%\J4M"%E0<,@%
MP#:N32C>17)]15!H<A_@,;7N7H*WGW?4D8<9E6\++^2SCYLXQE'8,'(-R#2H
M]ZV)V8G6,IB4?$ OFGZMWN(L>BI7.<P+W)\?^9\4/(M3G;F;DN5PHV;NZ'BV
MXUXV\F<=)0M2C+PDJ9=>FKZ6C1%XXHJ.6J--YOV&73BW(*<FZ)8UW,9(1,P\
M0C&TWR!*_?KPS&.LDO JQD>DY.L8[,ZY$"'4*4A>Y4G[#R##*S. L0>.WBKL
M:@@&6S&8 DQ$G)#,6>G<ODEXR_+\R(8GSH >UYU/<MS=5V37HY<:QRL[3LDY
M:7;WS[VA'AGY:EC^FST=%U!.WP?K)R6M#/+]AL3!U'(CYJ)6 -WAF;=('.WC
M?G+%GE?S:\8W^.PSY6V0V^9=N F9A)@(FR 8S=B9;H[B65A;(QA;9KUR+^P1
MT!&OB>G<R68YO>'29NIHO657K5;H$03$^&LB+QKV-5KCO*:"SA?)&0XQY7(B
M!>R]EL<=.R;2>9M2NV$7)).UDNPB1D,<I@<N. OW!*[+(RKIR,FRP/F"R0UJ
MW(2D8B$#",K<B8RE$@'5^>QEV(7!:DT;6T0C)Z1)UD:.:DEQ4>Y=,3;)6KVU
MLTM+*4:R=5FO1RZZPR4<I(J@\%N*[A=8'3Z13.BS$?-6%PJ<HH)IIF(9;RO5
MX0CE<?.6#M^4NP% 1X*.P TUK&CU)Z/S;Y8V4//_ ,8:&I=J OVM^SW2/FSB
M-@SD)0+!GE]D!YQ_M<A)+,<C93J#N-6K5H>TJ.E)=FZNU*=*-IF6L,=#K[B_
MC'99AWYJJCD%BIB?7BN!]9<YZ;Y&WP5FQ'D<:-+5JZ#O@)D BW/2,9$ ;9 Q
M#!F7E;V!CY^(<Z1\FYUE0@MVQU<"KNY)*^?,7PRJ,RQQ97[9\P.&2J#B<MT7
M6(*#H%H-8:JYE9M-G9D98JEG1;,1D[3Z=B J+O4CN713( 9MYZI?HMWU]D8L
MLK+P_3A&;MB9S-R&V1$7CI"K1<TVT%:L%XJWB8DHVX'-C'=1F)8=X)HYI[2O
MI3)8:P_Q5H(0],15D[+E>E-Y6W94N%DCIZ_W>N5I".BX%)&6K#(8F%J\8Z;M
M0;,6*:K%4B:"A_,5(4Y/F'YSS/K#.WY9\O'Q+OX=BU$QM6Y3),G$BYE)R\I%
MW,@&!7E;^/C\3A 62YNCXB02>X-0#Z_>HLI2+:,;O[8+Y*I5RDPCVU6NW23=
M\Z@U(5J8CEK#RQ">L;2BTN]> W0BG2;A!5\\%L0QTU$UC>7Y*$KUZ.%.'G9]
M^0C:@/CC)]1(LVUG,@Q #ZAAX[!EY,93M2:U!S(RJ".P]O8.GNJN"8PE%O,%
M<,64UI%8E@36A_E##,TPB)NQV^KNKTV-<KQ!3$A'5Z9C2529Q,FD>-B(9P0B
M+NOJB595PF/G?0[\LWB;UGF^2E+*N^1Y&1$F,(3%MXVV>0.^-ZDYR!)%P%A'
M3Q\;@OQ-O:TA,F#5(?5Z:-5N[5;IEF3%[!MLBD@[ T<-EE,39*2G9=2PV6*R
MA47L12H1.=>0YK(6Q.,NE4*^AP/&2QE52/DP<I()!W=3@+1L9,N,G<M[)0%^
MSM#0-JX/,D ^W;Y.DSNC3:6<TX,@2N1%^(+O&,WU>--Q/>*MVN%Z'^(6Q.-^
M($"J%$B&+<=E*B0K4B;81C)4#($28K+,$@2[/+[41 H=FWCT#\[>L6_U%F#0
M_-W7_P#,*UK75?2^&_[&TU1Y<:_6NA1UZR%Y:2IJK*M5306_K44U-MMA.0IC
M!L AN!A 1 0W\0'?5<A'5J31/N*1)1RCO\( FX4[>OP@'8H*A/$?#;;4D75<
M)<_3<$74*1X8P)=B1?-;H&Z)E*00W2*AMN8!\-M8CJJ='2$@ONXH =H<=_VB
M.$@VZ^P%ENNN21#%0&J<G1WA6S5(R30P"BHN8/.5#JJ(%(.QT%/$"^&N.+.K
MJF@"+F #*,V?<'L\[O -A]AA9AO^C7)W E93HD+M%FY.#-B'G*)(ICZ@W<)2
M#WF$2E9%$H=P%]NN)JL5LZIO$7NX=OI>NWUC.?U"4I0']&N6@6"Z<F!'A3JK
M"NW("""BGP-CF$#F#RR=ICK@'0RGM+KC)!Z+938*2PB(*/%AV$=_+1;);^(;
M#NFIM^4-AUR ]RRZ5MX])=5))0[A4#G*&RKA8Q=A,'=N0IB$$ +OXAKC,E6H
MZHNBR%9?9HW$ACGV 4$C?#W#V_$8#&'8/IU14+*P AVB'I5UV_0 !,Q@7;]/
M  25W$@;AX$,4-/:JSU2F0,X(9-H[:HNDFZ*9-V_8(]Q@\PX^G="'8?O-^RH
M/AH X=&3446_<!$G:S(X; "#DQA(&X_[I[N)B]? A@#6]!VJLG9R5PDT127;
M-7I%SF<"( "2@@41(E]FN4Z>XB&X;'#6/BJ*([)I,*!=M@?QX@'4/M#-P_,(
M.FFY=;B&["J*Z)V:G5(V760?LW0J@1L0ITR@ILH'<?N%!8G;\/O3U@EZ,RFG
ML2$Z1S#NM&LU#= !0AB=YNGL\YL3M#W;F$=6--#175*XYF07 J_="QS)I&4[
M4SMC%$Q0$J0";UB8 '?U\-NFI*;AE#JL@E9-^\P19W#HP[G44!JJDF8?'L(H
MY,0ZO](=PUD/HA5&@F57(4D>L0!-W*;^C1 Q"B)E-C$7-V@ ![@#KH0R.E:W
MK7!U'2Q&[- XB"7G*F65.4O0A$T$TR )0('UN_;?1AHE D_8NZ!- RZODG'8
M&S<1;)&-T#=<Q3&<*@'C\2FP:NB.LK@[4JP,V@IF*W+Y9$&Q?-4-VANHL8B0
M"/QJ".YAV^D=9KJJ%C*=8@""!"I'Z?WA<I5E";CM]@V QDBG#?H8XFV\>W?5
M-5EDI72(V+Y!1,=0 !9\X6/YBRS@P;_:JF$.XB)?A .A2AT  U.]5(0,)@W2
M#N >H*F P([!XF(("45P#^C\._01#51DXJE*U:E;)[E6< 5=T<0#S3"8/LB'
M-[@((CV^!=]@Z: U<H/L6%)L90@K'.":)1V,J;?J;;ZI '85#_0&CU0_:EZY
MTVB!$VY3)K+$[CJFV\T$1Z%VZCV"MMOM["[;ZG7N1-J#95;ZHAVEZG5./:0@
M>\YAZ;_0'76GZJ-T3D<21R8)MS][I4@&.X$H_9IF 1 "%-]43AL._CMK.I<Z
M*CL2!NW<.E! NZ@]P"90P[ 7N$/K&'H&XCT]HCJDNJ2 EJC@L;WH(=JBX[E6
M<"'U!$ W31]X%WZB/B/Y-1G49(V[5R\,=4QS%3*/>LNH/PE /K;"/0Q@ / -
M;) #+71*3/A*7TK$IDB?M+"'VRYA';<1 -R@._3;KK+4=9(ZI0W44CB"+DQC
M>< ]C(1 =]_^T5W P)@/LV\?;J%CHHG41!\CY@@<R!@'N1$HE53,4NX"W.4
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M@.M"78G17))((_U:"2>_UC$(4IQZ;!N8  PC](COJDNLNN$^<G6=X![_ /\
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MVKOYIY452I4'Y<K8B8IJ=PY)Y, J ]2 8P)XJ.J.P#M]?2JGA[UC.\^:B81
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MI'509I%Z%!)150YMNP@'6,4#&-U#8 )X>.HB1*';) 9)!,B@"':HX43*)C^
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MOOYAB]H;^SW:R:GN1-HE5<K= ,H=0P=-Q$QC#T[NO@&_Y@U7 '>B<MP8M@*
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M5%9E0LAP\E1[Q;&<+6BO<?6$^-EKE/S!_3UF,-:2SD_89]64<L#.FS"249G
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MT]]E,1KQ=PJBX21D4NX3%9=?)O0YGS+.*(<;RM[<(V@)2WQ#>,&#0+2C\,P
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M#K]9JFNTC'6#Y=F684TO6H)@?E'C99U,S0+NDVSU[C"QJ/8?S(^MF,?RF[%
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M">T>HCTT#.>Q.K*Q-$B906<]W88 %)'P,M[A$P?42W\1\1]FBRLRRIUF*9C
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MRKAN]*XX?[ZAOX 8PC]':0P[_F$-)N8J.4F5$?,-^4VD2=JUT=6D$1.4/>8
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M=V?%VCN @.PA^?80'7(P1@$Y.P[V[13Q^R,F/Y4S[;?F*;6(:E$V;:Y&1DY
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M3A':)W_+B \6%IX-LG\$B1.1! ZD:$KQUR1@+<"!4.]"YE74:AF3U;EHF1X
MYE"PJ3#"$B>2F)6[DU>18NU1?-J5?HU&-8HE>,895G'SI4DW)FHF[4R*$$3.
M4U )G$\VW^I.''&VRN2XR^VYP&WVR2:&0)BY#]6.A7;BYX6\VOS$/<#&2]4/
M'AT9]@'![PY"IG=8AQNN<A#=Q"'4IT,8Y2F[$]RE,(@'PE_(&ORGZBCL]0YT
M14#,O?\ 4DOI?'L<&RVGE0_E"F+7AUVU%>9S21*&L:)H['(KW\5XX *O(LS/
MVJC8V1JH60G1;$^(5Z>P%671/X)+,2G'H77M/HP8QYX#+SKG'6/E,S\>$MDA
M+Y2_MM;NS(EMQY#^*-TQZKT']3)9L?2<CQ_%6N9ROS#CO\K<@;D3'\QQ?,O[
M1_%AV]V9"7\$[$9=%*FO5E[\C1%X\I 81%/GDA$,;8F9+DS4F\N9_--W\0[E
M'MSSNW4<5YHSCHCTA56PH)N1=OTR 4RA55RHE$JG[%M1R!/T[*\;9M_EEPQ8
M,0!;QCXB=SU<AH]C!ZKY3D2$/FIRK^/%A_XKC*.J0V0N[=[CAEO59F0EF%FK
MEC8D!1J\DJ2F\6?PTT]LAVDA#QCB#17!BJX;GCSBT2!XV.@9!)MY+D1/!NQY
M69\[%$3"=N73S"&E$0I*0DS@'<'.V3@F7CXQ$KI _P >1<=E!H2= W7M^R4:
M<[*ZXBRC=T$12E&,+,&A6#R0>U.'J\C6; DO,6YDJLZJ5@D;[E1SD)I!/6#
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MD6@<XQCM:0B?!M)Z>P/%UW,7B,O'R[>3>M@X7XAVF<OP@2[UZ]FK]2"N*OF
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MCZEIV2XB9C+E)O$8^2K\#9X^"OT,QES@I)Q$=>8U.<*@X2@B2#)FLS=JK-7
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M+V',-'@I>^X1NDLK+9ZQ94X:/M%OI%SE$GCI]E/&E:].J^EV=D!,59=-N1=
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MX+_&F@OOOW%\LX^T#DV  '?WDVUPLJF_7,HEY0\QMV!N8Z!P$H &XB181#8
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MPQC($P1,*B79^#(7M\LYA$QB '@(]1U^5_4;_P"H,Y]?G+W_ %)+Z/Q@;C[
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MK[=M9C4LJ4A24.F<#E'J'OZ@(>T#!OU*/M#6I ,HG!P0"-2G2(8I%C@HH41
M1((E'L+TZ[=1$!]VL"IJJFPIC 8I@,("!@$!]H" ]!UR'11.QP$[0RJ9>U18
M"G6V#J*:9MC*D)^Z<W40UQJIHW'WC^G7*RB=T1,J@/=VBN8IFZ*AN@J$#M.=
M,1]Y2] $?'7#W*II'</$1W =A =P$I@Z" [ZY0Q43BR4["J&.(^40"[&$N_E
MK*?"0Q/IV$1'7&=54C63424,0W78 ,!@'X3%'8 ,4>FX".MQ9E%F9;BJ4=Q
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M1+%QRLG78<CKM$AC) H'A>-A:R+]WU+ZDA<MRVV_*^9\N,(BX#&>RV=]MR1
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MOVDS><3?V@(=IR@'M]@ZG6BJ1[![@_1JNHE382B8R1P#L6*9,1\-AZ"4V_\
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M!]FD(@8O@8YP_8+[NOB/L#3V(KDW.[CO4^H</*, !VE(D8.WM#V;%$=]&16
MU'S3IF$ 32'[0_L*3Q*/A^T'AI[-4^Y7@YV5)VAVH)[D*G[/+-\)]_Z1@$1W
MU&HBQBW,*XI!L(=3 <?J^4  /F"/M^ =_I'5[^J+,5P1-0A4R[-R")=A_P"U
M WPG4-[A$/#W:5*+$9N?SS(AM\ [B<0^ J?B!S?T=AT19R+D%4B!>C<2G0\>
MINX-A4,;WB8.GNT1)DF^ZIBJ !2I"(K"/3M* [#^<1\-5T2KS0<%73  *4I
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MV\%2CN81V#Q.'70(D9"B<P$* B8P@4H!X]?$?R &^JB7.1W1 $U.X$CE37$
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MBR9V>1?@U4W5"-]24WE>8S^(N\Z!#G?+Q[-Z-;5DR$H2@0")W ^ZYLW;C;B
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M#N74#[,@?"4>H*'$/A*(CT[=QW'4/8BO7_O"95R]3[@1< VZ' ! AP^@Y?\
M-H.Q%A02 QA,IN"1 $QS!]'@4!]YAZ?DT)19US X2%8 V.D($4( [@"8CNF8
M/Z(>'Y=-$6)!$IC;J")4R%$RIOW0 =@*'](X:%%G7,#E(5B  "C\(D =Q!(W
M0IM_'I[=-$2=!(#B)S]$TOC4$!W'M#;8H;=-S".B+*Y'SR%<AX@/E*%\0+MN
M)!WW\# /Z=$U5K;[+N7,'5,0 A?WU# ( &_4  H#OH45KHNY_,*&Y5?C*/MW
MV^,FWO(;H/NT"%*TB@5,J!M^]R7O-UV FP;I%$-O$XEZ_1HZ)$@EW+=H[@4F
MYU-_$"$'XMP#Z0VU46=W]KV+E^JJ40V$1$2F(.W;U\1,&VH$655,"M11*.YD
M#)G.&_CYHCTVZ;=N^VG5%C43_N9$@$14 R:QR^P"J@8A0\?$-P'5%).J-$Y)
MI@0Q3@(""+7RM_8!BF'?_P"5UCKW.A6NCU,8?I_G_P"G7(IT[T:BB-$1HB-$
M1HB-$1HB-$1HB-$1HBJ [;_2 A^K1%L0E X)G$P 4[8Q!'?8OQ]FWZ-QUCJM
M T3<FD'ICHB.QSJG[ #VBW* #M[^[8=:ZIJ55L4!;"D(B N3F(0=^@"F'=OX
M^ CTU.KJ+&V 4C&5$.B!3&'WF$1$I2^/3<=4HL3A, 5 2;F34#S$_P#1,.X@
M'7Q 1VT1+#%*)?2 (BHB0%0'?<#'$-U$P#V=!Z?3J/UZ(D38H"IN;<"I@)S&
MZ@( 'U0#Z3&V#6BBRN1\\H+E 0$3 18OL*< V*(#T^L'Z]0!D5&VR)3NA\2_
M9I /@8Y@V$?;T*7?0]B*QPF7HL3ZBVYPZ]2FWV,0?9T-^K5194#"V3\\Q0$Q
MQ[";^TI?KC]'3H'OU$6)=(@""A!$4E0$4_>!O 4S>/4HZH^U%E0$$$O/$ \P
MPF32 ?#8-Q4,/]';IJ:HL:Z9=@52#[,X>'L(8.IB?D#V?1JHJMR^40[@_3M^
M!$!_:5']H/H3#KJ=R(6*54OGI@&X_"H0O@50=Q[@'IT/U'\NB*C9, $ZJH?9
MI !A ?VC?]F0/RC^K1%D./JB"?IYJ7Q' OBHF(^(![TP#]&FB+ W2!14"_L=
M1,8?V2!XB(>S<.FJB5>81SWH#L7VMOH$H;>6/T&#]>HB0@F(G @!N(F O;[>
M[VEVWW\=5$L%0J1BMAV,D!1*KL.W<<VVY@#]XGLU$259+RE?+'ZO02F#]HAO
M WY1#51*0,+5(G:/:LJ)5! !ZE3 ?A+]'?XZFJ+&X(4P$62  (IOW%#_ +-7
M;XRCUZ .VX:#L17(E!$IES;=Q3]J0#MU.(=#_D* Z=R*H[.4A]JZ1>[QW%1/
MKOO_ $R>W1%B;I=ZNQAV(!1.<WN3*.XC^?;;\^CHK%U144.;P*;;M#W% /A+
M^0 _7JHL.BB-$1HB-$1HB-$4=9=6,GC6[;))*F5J=Q2 JATTPW_!=E.7M,LB
MX1WW2 ![R&)L(B8!#X1[W&A\ZS_SH?SQ77S"V//L\L_<5X],4VU>KVRD3"BY
MHB%,BY@9U5@5)=^P@;+'GAI"29L7AY&N'(S3<&<(^E(DS4713%9$P!VD_9_*
MX,,WCKD=HN946G '3=!B X:568O5B6/;\>LW)0G&,C+RJ#W+=<8TVV2E/R]C
M2)1AULB<<96$R9CA&QOW&0KB0T';VE=R/2GD52X"18))6V.BVCTQ?4R"K1DU
M%LW.9$RAR^+Y?-P[.9@\G=>/%\E;G8O;&M1W2@]J8,R#X)$Q+;7)>0<!=^Q:
ME=A=B03?LM.( HP+$-4%Z'W+H:3)!Y58R>8\93ML9KR-E:P\[B>U-7;*WP%O
MGH\TLS2%Q(O3,Y/'"BA5#PLX_<QCI=^V%D#0%A Q/61D9_#G\CYBU9E&%HRA
M?@VV<(EM '%PT$XQ$A7<[+EN6[>3'YG%D6E)C ZQ)[^SL)]B=[?E+(5<DY;"
MM&L$O1,/4J278Y_S'5W:4%;K-:HY!R@_Q+BVQ(I*.H4(?S4T94[8Z3=!1!W]
ML@Q:)@:<=PV!>Q(<_GVXW^7O1?$Q;GBA&V2XO7H_Q;M8/VQH92*W>R98T)8=
MB6VV)#?,4)(U [!TIKUHM;I'RKJY:Z=DBTVNV9-?V!S6XZ8JC]S2V,BK .WC
M=W.KR:[XUQ2+DQRZ%A]UG$"M$0$YW"?Q>7V.1_5W)X_.QL+"Q\2&+"9%V(DV
MX -M V?A-K_$?X3U7;Q.%GD8UR_<,P6!BP[]=?%V=.UTW5AAFOB&9U0L4V*Y
MY25@W4B3+N"+NLU1CK=0+-'L&J,CC:G.G,TA2+S6A6? L;U0N5"D\\"N6Q#I
MD[]V?#>N+8Y#D[5G$A<#6,BT/%"[$D[;TP!YEN3!@0U6H670$[^!D2L;I2E'
MXHGX6(U Z$:.*CV+>7%!AK],P$W#W)& Q;:Z6&286[2P.F\6-32;RZ]M:VGT
M"DD_9/XU1AZ 4W1$&RTJP2C4W"7>D9/P]CEKO$8L\6=CS.;A=-F5NCFX\=DH
M.SQ:6X,YVR,R-5J>)">4)0EMQ91WNSM&NX'OZ5ZT463,\QLC>_YTK43(-<=<
M><31M-Q<?+D'8:M:+'F>Y6B-07O$H^296&%A'5:+>WKDD0#UZQ08K(D<"!5E
M#AYG'QLO".-PN9.!Y7D\SS;\;,X2A;QH1/X8C0D3V ;F!,G(+A8N0L>7/*L1
M)QK4!&)+O*1-2>PAR6>@ '50&>0F*WB>BUX)&9,>YV68S++GE)R(G&*D6KO6
M*Z\B+)6DVT@\C+"#&0?HIJE;NVJCD4DDVQ5#F<>UPQ\;-YO)RI"/DV+<<>#
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M:29A\MCEEDIM'TF=&$D$+Y6,]\2:M4+E%K=Z1&5MC86WR["->F.F" 2"P=P
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M<68WE3V.7MQ+9%1?XMJ\9<',1,Q]=I$?#6GTRZS7RSI'2 $$DQ*^>*?2/3W
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MCK!9&CR>84IE%M75=SI*P;6$G;#$'I\I&2[58*Q+_=*S=J:5[80%&9R$^W4
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M(0H>XI"@0H>\=B@&M+"KHB-$1HB-$1HBCC+SY)CC>YN'"H(-2U:W"[4,GYQ
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M(%)N"1.B8#TW 0ZG,'[Q] B4=AG229RCL8AO+7'^@'Q)J&_T2@(:=>Y$F75
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M,VS;E:,8W(S;S(3EXI2B1(F+RN_A^*<I"-(@T7!OOXN2)X\I2D10@G:6H7#
M$4K13!=\@-;0>-2Y#91HE%J546KV48/ ^$ZB_LML/:(B]GK\U,W[()!M5?BK
M(U8.738J;)Y)-T8QZ)P;$(=%77A^.XF[A7)GTWAW[V7=$K4LF_,0M[)6]T1:
MMD1D0" 7.TF09Z$+DR,B-^(AG78AB9"W&+D]/$:@'KU#=%H4/;>+SZ*7=/:T
MS<KT"'CHR771KTFRDHN,K$NS4CGU7C3N;ZSR%>9!]2AD9)K/R4(S2K;('*)$
M4RE61[F7Q_K&%^$,:[MAD2DP,XD&4@=VXM VX-/9$PC,F[(1+DUXK=S"$0"
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M*S<N6,JU;'X@OP^PSU3C4YNY8KL(N582V5^V8].D\FWJ\6V;.H,&"+1Z9:5
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M  CD!6PY3R=1>._'?D-,P4;D2@R=*AH*OKWV?QN$_!I1LX^&-,U;H2!BJ*'
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MV1$I&Y92ZP%?92CXJ12)%?NERD*4H  4*2#&FA766JLHT1&B+0,H@N;'=R%
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M&:U:,N.K/*T3A(UB,_QTL_L]FM=WKZF$:'8D(VUV1=%ZYM-\DT*F]?&43?\
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MT]M=DD5(VHUJUD!VJU#N/*F H2"KH")@5L4,R5-.9<(XYSLVH47?_P 0HO\
M'E^C,L4*1J%TG:-:8:U0,7-UQ:0925;D8^2>0\C6K5)14HS4\UD\82"R*Y!
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MMU!2O;5:O,;A&8NHL_ER]V;&F)HVY.$).[,,/XTG+"[K-09R7ED+V-FZ@1C
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M]44\SO,V;B)C#]DE_5E_-?K"U*SZAS+=R)C=&3=!!U#$!M2*>T^TZKZ5PO\
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M2NY1C$BU"+RFU-TI.T(W-D).9D$$^!EP6,;+Y*4[DS&-J4B=Y+ /4@#4D5H
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M>[<1W$3;CUW\1$1\?SZC2=D2\P)J)).E3!Y9"BDH ?64.GT(0H= W.4>H^P
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MY.NW2ML<P61REBYG3K<WK^5X&X2$U9;6P@;88M<QE:ZU65IHZDX:38R$G#S
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MG2-=.](T0?F@Q?MV3Y9!R\0352D8L7.BWNT [%*3S@1AUI1L&URC7#-N();
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M"]1DUSNG"R2J9UQ42]DR,*/I/A\;A\N0^4ECB_= 8&[>%;@F7>6Z3"W':8@
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M7$WN^%$G: #^4Q]<4?B0ZIMUSHN034>Z#\R*D96"M2YL;QO!?)>/']U\DOW
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MO ^;&;G8H;WD.U\?\:X^X:M\ZRE&I\/./JW(-GUHKMK<3C:!(8LE(H/C)>H
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M^Q?*"5P[<<<XN+)3F+>1,/BV9N?R\<>Y6Q#$X'F.-"V5LA'Y>8Z&RQ#%*4Y
MWJW9FS8K4C2<9/6J,6:PUKCY--J:4DEQ2!O.JV]::U[UUW1>'DWE#D51GG\
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M:\?S_!WD'<N6D3CNQ2O*;*TJ2;4K>:[U7\^8ZO+U>!6D9T8/E1/7]E!R$I2
M8BN:H1!%&)31RCDL<<C^+4;>GTZ+ZK<W<1L<D0/!2XU_!UBN,)B'E/CNX$A&
M&/G,Y9L4U&9PQE&GU^=D:&<[:7:Q5&OT[5E9MN1-1>,19"LHF)&JFU/3M6(E
MGKJ%ROPFPWD*I9>XH/8S V;,/9$H.%<JU_YC64<D(2[2L\@<J2L+76D,\2N,
ME-2<9R&LD]F5H_M,-8XT'*,+7C+-3+L@=EC]!JK(AC5QT4:\[<5Y_O\ R2RC
M8J'QYO*]OJ60.(\IA3)M6Q3?\EVBRT:G63'EFR):Z'GM]ENO8QXRQ%64//1T
MO48F!<6&S^F5<K$?$D4RI0ZJQ($=5TK\OC"&6\5\ALIV&^8XM--K\IB?),%&
MS$RP(T8/962^91SJRA'1;%4JR@&6?8RR%!329=@W82C=0.IA*% )-%)$$#Z=
M H+G^/5]LF8)R)F^/F79KD[/<^)RZ3_)N1CY5QAN:X%3%L>KO* \R0:7&M.\
M;ON,[D**?&W;ZW\4"+S[O ?_ (UU&JQ5>FH9OM4K)<2YUO\ (O7XM,<'JMLH
M/N$(,GF%ONMJWGG>:_P>WG7$>I'+.DVAKLYN+,JA>Y8H'D +\6XAKDC\";AY
MC]'4-U;AZ_(M;L_XPX]WO&^67OS-^.URP])S,%8:A<J)Q5/3^-U-N*?X3<22
M9JSC-I5T+"SL\4=$".0:N0=)+*((F)D@FO3^I7=T)IM^U6_+FP!R$Q_G#$$Y
MDN RY6+_ %K$F5(;EM9Y+!2U!J>6<CS+F#!J]R!G6?S==FW*.;D+PV<SE3FJ
M["@$9%BNFY-$HN0C-6&O>I(AJ:=$P\C*4[R3RX^8#6Z#AK,5WY-IR?"9MQ>S
M/6$)IU1< 7!/'-4G7MD=V]*61A,--X,4C3%D7<)MPM<*!8TOWB</0Z$U]ZH+
M .:53M'\/EZ:VQ3E3+G&_*&3Z):>6G-N?Y=T&%A;3DBZ7F$D\NYM6X:7&UXK
M:RDA+Y PY0(*=%2+@6#=TWC?ON/D08B#519#/53=T!Z!OVII@>,'+J/J.,*7
M7ZAEFNXZYCJ7OCMFB%G;>9[<>+'%6L\EKEEW \O<I%:P2KR.M9.(5JLN-U :
MNW3^/DG\ T67/Z$QB;J=%7B[T<?:5$N6N.&?D3R%A3P'F>^WB)O7+AUA['=K
MQ=:<FXCL:<QS>S#?\8QU.R=CC*N/\J<)<DRM-DX-PRR&HNI .*PJR3,4?NM1
ML?)I+WHX[>SZ=ZD]U@N_DR7EV>Y9\6^06>\.6.?YN#A.AT**L-^<4?+]XY+6
MZTP-Q0BH::CG%9<9$Q<_A&])O2OI6->1BW0>KBO4[KI?8CT#%C1*J-PTY$H4
M:[Y3S!0[M=>:%-S_ /+$<4C)WX@F)N91BJ+C_A=7^3$_CV4:3"4:I77+B/NS
M2Y.FJ1$; 1L]%T1R0J6T8Z_3HLF0T'PL?V_T*6^ V'\H8IY66(ZF&\DM:A,T
MW.*>2,IYGQI8<897KEG>95A)^F5.Z94K^29_"7.8UI%:06AK;'P3:7KT.S*5
M5VD#U9H:Q^*B2((^G]87V]UV%E&B(T1:/E!$ZV/[64@B4 K5G,HJ!1,9%/\
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M^)B76,7+G@W8VI$^5&Y4 /4"ON'>OI=G;AH7F';0Y%GSG4*P_P <X]HDI@6
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MC""1IN(##1!!C4T=03.\X>7&2F.'Z'5'=QHEKO.8^-E<S-+5RP8$:JT2&N/
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MP)'YF%/_  RJO5YQ[<$=X$PBZ32,@1QB/'"I$#&*842GI\,8$Q,03%-V!TW
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MO'*SQXCB?'A7#HS)M&M5P&+DO)581T>[?1;%H=( %))!94J:/EE[AV#7Y/\
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M+**5JBX7C59=)G$K+O4$%1*4%UR[Z,8MKHH)2)<?1UK6(*_Q)H')&M8UQKR
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MC5JC$7B8_$^/P+7IUDA(1QXX;_6 G)@6SERS2%Y6(,7,FU/W]R3IFFH4IS%
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M17JV^.].Q?\ +\&[D9TFW3O2G$3G;)@YG=,C,2A6)V,2!T);D^:S)1'F71&
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M4YN47([,P=-V*BSDRSDB (+('.CK[EB71V=?."PX\Y'N\&&9XPIW,V.YO?P
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M=.S)XEQNW.N\15;.#&;0\BB9-1NHJJ*8HF 2 (F,<Y0 QC&$=]?D_P!8G_\
M23,%/^[NZ=\@OK'"UXRQ)R7M1_:NB->N+RZ-$1HBY7XOYMME_LW,E._RD4E
MX'Y;7S%-5<-(]&))&8VJN(L/7=,)M9$YOO1\TDKC)*JNU  YD1(00V3#?C+F
M#]ZT0S-U"X\J_P Y+CI: AI M5MK.M7B&C;SCJ687O"EOD++C)?(&.Z18+[:
MZ52LCSUOQ&%0C,GQEF=1=E:,9%2ND=G(3US)TQ21EVK9@69/&5OFCXEC,:\B
MW5,:9.C+GB+)7(S"'WA&U6H6229R6 ,'6[,MKSG7JY8+3$P=MQ9'L*DX9L1=
MNFWWE+E3;'*FFH*H4R<*"!<=BV^2^9Q2S7;.]1@<+Y4OYN/43?SWUU5;)ALU
MU-*8OH WZ>6<82>9$9Y9K]1M4:U50KE@=100\U(F0214*B[:.%L LFPTJ*IF
MY!?,%@H:3;U[#$Y873UC!LIA"_,*K6+5CBRS.0N'_)+DEC:B/7TQ/Q\U#'95
M3$\99W[IBT=']+)Q;02"E(.%$.0R[%!'J?I4*"\3_-6D86N+Q>:V\1>LGW"Y
M4^+Q?58BS8HP?$%I[#A?Q*SIE&?LUXRS<JA1V#9ID3.RR+!$72CYTI)-FJ"
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MT"70CD"+.C$3$"U5HQJ_\*:Y7YQ&&H6,8(/,49&97A!GF27ON-+U=\"XRN5
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MP#CB6-5,G<G(-C575#Q[/)XXB<H33B0I?XF#*<A2:379UFA/SS6&591DDL9
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MU*$\@<9D#=.KD&-2(B([PPJ[:+R%JY,\%D& &\9$&'N*]1W&8I2<<L!E(&Q
MPUC/L 5/.$"?@R%$H"J)$A5$ _:[2[^.P:_+/J(F7/YQE\1R[W_4DOI/&/\
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M>BU2KPJ<#.-6:A2**JE XJ>5P?2_%<?CW<B]"-B]+;.Y<MO#RQ+9(C=.4Y@
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MG7YR]_U)+Z/QO_Q]C_DQ_E"G'7AEWE$^;"JFH"P(WPF-C_B[&@_BLZSI J9
MR54A4@/,9+MG&]S3 88"]_887_:<#$$Q1]L]$F(]01,\ \E'Y3,_  B7_P G
M?:ZT@1_ES_F-''E.""Q'S[]4!<EZ0D+?+#A)_F/&_P";)G%A^98CV'A*,O\
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M3L"*\,O(L)X1:UJ!703.LLNW(?S?/8F!REJR+8N2RLEQ"Y";$VXD3 C$2 )
M:8$H5N3!H 6X<65[')+1-B)<N 7.C??V437>*\A6XRY2D;$A5I*\V&R5^BXV
M5>S[QN&+D9"N2D!D"PQCJ=N-CA8&R1D O7()S&&3509$2>G$"]BA^QQ^5+,N
M8^-<F<B&/"$KM[;$?C-,3M1+0$I1D1=F).\GC[-78>+?: COE*G4"A';3H%Z
MAN'P'+QAPH59_(2#L,68_P#5+RSM)])J":*?&25?/$B F\<G(/:=<!W6,F)S
M%(81+K\K^LR_J?.\,8CYN[\(8:AV'0=@Z:57TC@Q+\KL;ZR\L/\ :NA!,;W_
M *@UZRO+D,J=YO?^H/Y-51'>;W_J#^31%Y]XZSV.Q<DLVHXXLG*2>Y35GYH[
M>M5AL,GG%_@6N\3(EOBMUFFONRBHI@!CC!ICN1GSN6S@0FTK:NS]*4JXL=<0
M7,!0:;6^U:YC?&C['./N($MRZF.=+W#^4N(3W(>5I*)O7+NU7]7G+)!C=NS;
M7YGC.6D,CT>:C\:HOV]-ARH1]<)+H.S*MS2OIU#P(6+[6=^[1;[BN*YV_>_'
M#!V7GN;"MN3M+XZ<B,Z9*=RLDD\PS*\;*T8F>,.3]FA'A6M%MG(-U5L:I.(I
MDHV1?2$S;E$TQ JXCMI:59/""XU!7/N,[#R*B+;PHMES<<ELEY+=8SX,1\GB
MBW?\UF/;DP=+?<##+EKQUDRI/[)Q\N\$4LA(/<IU_*D'&2H$8.DOO1%):*.G
M@ NJP8BC5[/I[$TPLGG<<+74V;Y/FV?D>EQSK1_EYC2E.10&=9Q"T9B+,&L:
M59 :@XR"?):< 6=)D;N8%H0LNP C1>CK1!ZNHP?PLSUT74,?0L^Q)H/-Z\[R
M@4S9+?,LY#8WL85ZYY+F(.(XU3%5SE',8FD8HLTX3$:>-DK%'Q4G69%[')M
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MN,NML 6'10_AF,YC*IXGM#NL9\0R<C!<+\;O[);*UE*'G%Z_2_F<<N6JE7R
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MD0CK9BI1TVE).NSC<DQ W$C=D=N,N1U/(J.J]/LVROJ6SM@5%P@[53,F8X&
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M "'*6[7EX>!B6;&.TI0/EP$R91W/"1N$1 )(WQ8;JLN"["0A#'=YRE*<O:2
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M6=Q3OS4D!51<H(5]U2FPNGY]\T?$=:M#FJY,QMEC&RE)L&.JEFUQ<;#@E-3
MMMRP[@R4J"MD'&9ED[-<5#P]LA926=U!C86,%'S#<[Q4BB;Q-K21TU3:>B?9
M[YH&'X:!>WJ8QIG&#PG),<Z+8OSF]A*<YI6<I/CO4[W=;Q7Z4S:WIU>89U.U
MC&4^[JZ]@B89A9$HQ4S5;M.W%<".NB"'UJ9N/'*R%SS>+'CUWC'+^%[9$8UQ
MUFJ'A\L,J<S<W3#^3'UDBZ;>(8U(NUS0BU"R]2>M7T1+&83$8J5/SFX H&VC
M)Z#5)4':NLWCP#=R#-104^GF*G.8RSD2@  )SF^(4RAT .GY-1FJ5CJL35LX
M<AVE$2)"( H<QNU(3% 1 3;?6$@#].VA30I0L\,V 6S-01#H"KD?ZTYB   4
M@C]1(H= U&=0E(2&>+CY)#+*@<1,9,#"<#&$=Q.8-Q#??Q$=:#=50LBKL[$H
ML&9]WXB55XX ?[NT)L()D  V\]<=_A)]7KN;IMO&!]BAJ>Y)D3J) IV**;KB
M)G!^XPG7-X"*IM]S[@;8 \ #H'30]RHJE95CD34*BMY2@[(JN3;F,W3+L84&
MQ!,'F.CB8!'P(F'CU^'495)A5[ [6YC@8XB"BAE#JKK=Q0*855C !C 8"@':
M %( ;   &M =J)0U<NE2=S(IG!B%.DW645$C)NH8!*L<J@;@IY)>@@3IOT[@
M'6>M5%B$O9W"J[</W)BG*8WFG39$!7;S"(MR& 5^[;XA5$X#].J$+K&@\3!8
M.X%' - \P46Z8*]FVW80QNB")3'  V,8O3?0A2I++,"DFH"CA4R;$BW4?/74
M677)UV("#?RRF)V[AOYG:7Z=*+2M+ZU?M;INDVR!CAW BU @]H#W&.LJJNH!
M_+#KU#8/=HI0)(\D#&46VFMDA#L[#&:;'32W*450Z;B(!N._OUH"O>HFX'PG
M H%EV*I"AVIIF*0"D_:,4#$>"!=]_ "AKD9NA1D[N#+@*27DL'*B20@JLW<"
M18YE0W,F(BF<VQ2B!?KB&P:X7ZU53/WBF AO*,@ HA\*JCEN4HE AB]H*.T@
M 2  "/:'0-M]NFN?7L*E.B=RN7)F*:1';61*N(;MU!,BL1NB&R91*454P YM
MQ$#)D =@UP'5:]B:A4*@4Q3%>QI"B;;R3J%9IB;H8^R(J-" .W7N(&_MURAR
M.U0I:TDCHHN%TW;>2*!!)V("HHZ.NMN0.X6A5T5%"I]P]0(/7?7'(5[$ 32H
M[ W8D1M(1VP@9,%UTX]N!QVW$"]SAJH81-L/P;F^C7+'3M0IV:&G3.$EE%VR
MQ2[G,JF*XO 03+W&( K+(ME 'W[IAU\!UQR8%@G1-YY)NJY,9:773<F,97R-
MT6;D#&$=P*FDGYI_*\ ,0PB'O'6X@MI1"$H043,90Q0DW!U0 IS=S\_G%.(!
ML8ZJB::P&'Q 1'69$BB!V2QZ/EJ>E0C!(BD4" F;TJ:(F*0"*&,0%5! YS";
MKV]0TAVNH5B2.\W-Y;9 @&[1-W.#AW=H[E$?*;&*(E]FDNVJ)>Y5D4VK=,P-
MBF<"JX7 '#A4QQ,(%3[P,@F!MRI[B([COK(U3HD97,D4PF*HF4Y@V$P*."F$
M.G0Q@ !$.FM-'JJ-:J(<P\>L5Y\BJ\&6J0TLSBER+]U3)J.M=UI-JK+B?CU8
MJR)P5NH4M6K9%1]AAS>GD6B+XK601*4C@BA2% ,L#)BCD$MHMPJ%0K6/*G6*
M'1Z?!5.DTF&CZ]4JM6V[2-A*W!Q39-I'1<-')I(HLVK1ND4I0#81V[C")A$1
MY PT363E;@R].41\QB\111 [I0$"'%+O3*/:8WH%3B8PG$/8(ZQ(DEGHAIHD
M1EDU@ A91V4P;;(JNC& .T!["B@^*<P 7?8 #8-!11SH@2O"?5.W<% .GF%,
M@<?RJ)]Y!W^@FMT1E3U()@(N6ZR(>U0H X1#\IT!.<NW](A?S:,.B:Z+,0Y%
M2]Z9RJ$_>*8!#\@B ]!^C1BHM-RBD"N/+B4INQ?\*6T6JFVY4W(TFT$24.':
MH D()]_JG_T3>&NQQW_>VGT\V'\\5U<LO8F3J(2^XKQU8_FD(&9J5A43,Z:1
M;]NE.P<?V1;64A7J*C&>:-#0!FR*CB1@5G)5%69F[MLFJ8YP$I3)&_;.?8&3
MQ\\6R8QN2B#"1&[;*+2B3N[) %I/$GVNOCMN[*S/?*H+4T-:$/WZ*;<=XS<'
MC>1&!RSJE4?0RM&OF)W4!&PU"C@OE-R"P:4I[7K):CN[E88JXUR?;"5?TZ*4
MK)KMC)E5/V+CZSRW,PC<XOU#.T9V[OFV,A]UQ[=R!$Q*,&A$QE&1%280$M*A
M>2Q+<K?G6)-MV"43VD$-4Z.#H-2VJF.N.8;DE%2EQBJ2>E9PC;/%Q=U@V#UV
M-14):3C#ADQHW?52(!A,OYTRL;*5Z)(G'QZBR3Y5=,O;W>!R8Y7I&X,:[?&1
MZ;E;E*S(UD-M19)$BXB/%&<CND'B 5RB,.2><08Y;@$!F(/\;="]"-!K1:5D
M2TL+I9UJRREV5@X\8JOSVH-,21:TK)*9ZRU"+'BG<YD!)G%KMRU%O)+J!"HJ
M^I<N44$13;^I>K.2^0XS"/%<>,R]9V^HLNT+OG':V-9EXA&SN/Q@#QD,Q=RT
M8Q.<B\)7#C1_[.W)AVR(U);M.GV5==Q8;^61C&;Q1=I<</%L:.1:7$K0\W^/
M&Q%C)>C=2Y%Z)]ZV,7%(<A:VJ"AEA5:@K%F! '"R0FW^?\U^JO.0Y:S;MYDX
MPQKQ<"V/%T:X  +GA+,S/XF!JO8L/@?,PY72-TY 2@=S;3W=GOZ4T7$-PQ"O
MQVR,%8PE)QV&<KX^=3$BA8G[R>D:YD:'7:QC*_XPRA/%+**R==B?(75;JK>:
MT!!R4AB-_,;/5?H/&\U:]68!R>>_SO&9#0$!&,9V9@G9=M1HTJAP"Y9ZL8KU
MR];N\=G&)!%R$=7)!THVG;W54I,XG&F3(NO<A))&39XEEJ&ID.<;P3I23M%.
ML<#)3]?F::T(>(=K2ZL[=2KQZ!6QD7P(.BR0$6,DH!O"QO\ +\3>N>E<4Q'-
MV[WE0W4$X2VR%PAP(^"I_A>)@XHN8V+5R9RY"7D7([I-T(<;.S6G:Q=0V:S2
M%THF6L\J,TL;+0^&&.$<)8ZA9B L\="0<A?*A'WZUH,+M$5J:LDH"UB6[IU4
MP.CRKA4GG)J(IG#S$,/%X[D<+TU&9RIW,R67E7I"4=\A;F8P/ERE&(! \#-L
M H798-R4\>Y?E&,+=N(A #^$.'UUU/BUW'N4#24$I4Z/CZH(,F]>=.TW^3+$
MG%0UFK+Y5Y:&K1M6H^7J[Y1T$18XVDPZ*[QO']B;H'GFF643W.I[=AWAF<AE
M<D?':!%F#[9,(/O(D/BC*9H95&T!@:#QS1BT361CN,B34]*'1@V@JZFLDHA$
M?+US[*OH:NS+9GR3PR?[CF&CQ&.=HDJ]I!)([:L%8MQDE!-Y@ =P8R8["L8!
M*D77@S8\W]3<'R9W+=R?&7WE%B=8_P!MV [0*]-2O*8T/-]/W "TC?@Y?NE_
M4W[5ZJ>,YC&XY8#,9,J1C8:QD(I$5%<J8C2X41("QE%C*=OO$YA'WCK\H^I!
MM]19T7)_SEZII_ZDE]&XT-Q]D4I:C]P4WZ\,NZHRR^2>/2%2UNY1%"E?Q1CX
M2V2<?)1T>1@7(-7-,PHNEF[D@/+5# XBFQ.S=9R]33 2B8#![-Z0.!'G >2P
M[V?B?*Y?X-J)G,S^4O>7<V@Q.VQ<VWYE_#"W*1! 8^C?J-'EI>EI#A.2Q^(Y
M#Y_CVR;\Q;MBV.0Q?.L[C&0WY5GS,6U%GG=O0@#$R$A)NO65[RC1%X[)"2+(
MK\[VKN/@VWW;RBID?)MHIBNSDW:8WO.BT8M)2B:[9]-2CR5>D3:%;K ^!UY)
M6BA%"I%+^QK%GRAZ>E"5TREQ=T@R+@?AX[T((C$#5QM9]U'7RO)'@RJ%A>!T
M_O7._1:523F;E>N,>)%>Y6<S#5E"LW*)E'<+53)/WUVL44FS5(Q!\D$:ND_4
M;-53IIF>&8I&7]<J7OYYMF4!RAD.'C F1!I*XX%N)ZD5! =B1'<6V@^-M">P
MW; >X#HU68Z=[=O12A0&IHOB).H4Y2S*B_K]@=LDH\L UE8IZ,E$L\IMKJRM
M3EK2D<7,:R2E.89==-6TFE5"J*E\PRA"^N\K,S]=6)YHB8"[ 4W,QC(V=FWQ
M^9N\\7&_#VOMHO(V0V !;)>I^XSW=-M8MUW+7GT;4Q^73R,/2G=S/--LVX52
MR(T8G>GQ@C!LW462/EJZN>-; :4DGSI/SBR2IY 4$D?+ K/R@'R NY/_ .)_
M&PSC9V'"OFT:>:9'=X;C$T T:CO_ !.K9C;N<->,-P/GP!UVD=/87H>YNB^C
MG!R?QZQD*/"4YUE%_%O..]:DZQ# C Q=ZA8]['PD8=XG*G=E82=A?$6.9N6+
M @*.">40!*GKY=Z_L<K<CD7\WR(W?S#;,@GRRQF6(U '7=5F.I7F>#GB6[L=
M@F3Y98-X@:.QZ]S+2.-T3RM8YWQ9+9/:<DW7&9&?S^MQXBD9S'K>[5UZUM2B
M3\^=7<>1L):](1AGA&IVKE4I69CF;%]&"NNSZFRO1USTW=APPP1ZF,,891V3
MV3\'_P"S@N!(2;=05^+Q,MXD>3.=;^9^8C@O/8-P>G]H]A&O;THZY,^8K/4"
M>QUE%=P_O"TPVS;'P-.BV32%+'5^P1T'D$SA"SO6JQXY[&24$LL<A(PJ3HS@
M$50'RCF /<_TOM<GB\AB0 M#&.),W#)]\H_AMM&H:3!Y."''0+Q'(W;-S(D=
MI-W?+K0,#KTJ.Q/',]A7BY6Q.A%N+JIF5OA; KJU(7LT>$:QDFL&BBWB<>MK
M2S;L%F;T43K.@?K#"JB#PK8Y7(K@+T/.<N%SSD>4.&EFY6WRWW[7)>X8G=0T
MBWB'A>C+AYH#YJU"WO\ F96;6[=\(+!F)H!^UTCY%QMD=9 Q#)4<+/\ Q1!U
M:X^CQKYL=S:TY0B-@+:764![);MR,^S4\M*#5.)'\)JQPID6,3RVXZX_1M[&
M_+<ZUG[!Q9@#=D*#:3'RQ;-/PA:%L^+\3<YB""4Y 3A?MFR#YS,.M0^Y^F[<
M^E&7.=K4HP2Y7\*B@R:N*^U>3\-!HNRPE?F#1D=*66&:J+O'&T'%I*)GD1(N
MHV(U H',M#$$H^Y<?+,.-Y=R4B(W"(2F1NE$';"1IJ:[:._07%XB<=D@;9B0
MP< :'4@?N7J8XHE61XS88;)=[=TCB_'X.UGIG#IV)S1+X#CW.A*H?[4IA3,<
M.P2CN4.SM#7Y0]8#_P#2?-<@@Y=W3_:'T_I7U;A)"7'62*?A1_:IU$K9#M7<
M&\Q8VP%5<;K+"?W(D^(2G'M^JD4!#7KE=!HO,$J\5'2P_9I@W((_UCH!45-]
M)4"&#M'_ $S!M[0T8+.JQJD;I !GKE143= *L?8IA#V$:MP #[[^':?Z=/8B
MX%+P5[LCV:S.,WY+EL26GE&QYD2_'Y[ 8_C*TZS36U:O*TULTN[>&"]MZ!"V
MNDQ<TI#J*!ZV79D4.Y3;&<-EL; ]2M[J-U9EEX&<:9S#:')?+%VK#[%MLY&9
MRL^0H7%DK9ZS<'>'<1)3,Y+5;&1)ZL.Y.IH).KU<K7<%F,6Y=M(]W:U6Y5U/
M)$=2,6.E4E+0=@3Y0>%]8H?)5[R-993OM@ <FYNRO7\;.X.MIUVNV7D)3Z%5
M<E-D[-'1[.?EXATOCQF_8I.E#'9JJ*I H=(2@6[/<IN+,N>X[Y2>-H=**CJ3
ME*W5K[SQ_ XNR/,RV*L$7RSV^ J]HNU@KL[3[%?JE87N&K^Q87]]$'EH<BJ:
MS$C546I7S1!V2&#5!5\PZKO_ #MA&%SG@O+/'J7!W6*]ES&-LQ+)3-?-'N)R
M"B+=7G57<2$.G(LUV2LG&M70F0!8ITS*$#N 0$0UR"L6).BR"QW+D7+N+>+V
M1H*^WVR<A6-0I_)#!<%\N!G;*WD&J5EJ:SQN1,EPC*-I%F6:G%QF=U>[!)0Q
MXH_FIF<QIFYD!,"Q1P1$FI6GEV:54(5WA7QEQ?FYL:S\H*LRRI4I#CG<I+&M
M2IW'_!-0@6/%J3R1G*J>3CFB1\.A5V$Q6KE+2%@=.EW"YXYN5TDJV;I)IDQ$
M1.I6G<?UJ4\L?+QJ>6&&46,=F:WM:WF[)^3LJWZFV;$V(<W8RE%,MUC']>67
MC:QD6NS<1#VVE,Z&BO6[*DM]X,RR3M-9)V@=,A-^4LB1#=P5\U\LC%;FO1YX
M;*UA966KY1IN3:%9,@56AYA2KK^F<7:%Q*<5ZXU[(\2M%Y-@+KBZAH.)-5\5
MO(A-*>L:.FZJ*6S9T +K3G[/VJ9L </X; ]U87Z+MUAO=B3P](8EE74U T>F
MP<NE,9>L.9I"R1U6I5;KT/7RMINPGC8Z*8(HQ["';-TBF44(98]V1=R2ZQ(O
M3O6B7?@'PYL,+R<FN1E4IN1+3R1M=FF;/E3)]/HH6VB1EVJ\!B:FT/&UQ5C%
M7-,B*##1L<UK8D=$<'E3F<=QG3@1%L^KZ=JT#*C+@RN<4L]6>[U/&N/+I=K5
MQMJO-/&V9\HY$D<E<>+/B')%GP5(UU#-,_9V<%%Q>?:[F:\Y*H3IM.T)LU&M
M,K8=S*EE"-Q,P#.VNA=:) ]K+I*O_*?QY$4.Q8C)E&X*XL<XGLF&J#'0N+L(
MU6>IE1L<C!KLGUMR!%TR/N>9K#3(>!2BH=Y*G2*DR565>%>OE!=A?+':IN)\
M7537GSB=C^T9#O/).2SA:,1V>+M?'C,KVQL(>GKU&@DXC1>7R&=R2%O9K,'M
M<L=-RU.)3*KE4AF9$D7+8R9TA$UV,'Z4UJH21X1]'2'DAP@J?*K(-6S$AE ]
M?[\*SN)DF[?'F-\O-E:%>93\4_C#&,CD*"GX[%^35T7OE%LK%JY.\CQ0(JBH
M+9NH2F,9AR_[%!+:&[T07R_L>4[$%MP^?(60UH6\VGB'<WEAFB51N^9N^'U5
MX_U"FLDVT:V68*-K:SX]1IY<RY/,34D'/IQ( )=N8P=PH9/[0_VK#CGA57L,
MY)P/9#<EK$OC' UIRJQXY8(LD=CUC7J^ZSK V:&<4=:YIM65VR*O6(Z9=(U9
M)50KQG&HF05!Z)3."TP[794R<=Y4H9;X-4#-;3E"I;K).F3Y0-\#?B%.-9PA
M3X\LO'53[QQC;:B28C)J+E'+:Q-VK]TTEVKZ/=':@V51.V54(;.V+M6JR)$-
MW+DN_P#"G)V(&U"R9BIW?LIYHK.77EJ4NF%:SQ:PM*8UI\OBF>QS*PV/\$V^
MOP.%KY6K:1\3\1,IN9;RYWBZ<JR? :/08",.Q;$@:'18N./RTK<UPX+_ "!F
MB[TC/UTK4W'VP&J.-,K0@-)'E9GSDR6JY.CY2L(T;+0V%EG)6&MC K-M"NU&
M@*1@M_+07#)@1JAG5FI_0M/E_EV\;:K+4'B^ARGE*=D6_8SY%H2.*:]6<70\
MID/'^6<KTW-%TDJ#B^.ADH3#]&H&0L;-30S2&(UCRMTW34WJ5SJJ:NR.G\2U
MN)#LNB[-Q!P'FOD5><JTG/437GV3LB0[W-%#KU0PG<K3-9#X[MJ=4K0RIUYN
M%9F<D8M=(P$/!0MS:QAEBII F=$8QZ\4<K9,6T6-Q 8IXO'RWJ2ZHN(JW%7F
M2963!F2\_9*Q]=K1CO'F4(L$N2-VMMVR54+'C6YQ3NI6>HK.+2DFU$HLY5DI
M$LW*3H#@X37T(QD*?$J)#Z=RCBR_+[I7H)C!].Y@Y)QE:>0?&>Q8HS<PBJ_A
M9S;\]XJKLY:_77^OUP]/CH/&DG297/KV(%U7X\D>UAYAFP%N55!FZ3& TZIN
M.K4"ZCY'X0KMV+Q8@XSD'*8+O>.<MELF!)2/94Z:F+3D"O80R747]*<56X-U
MV%O@'>.YV8D7[%N*#L&[,YDUT2E\Q.:T.JD:/1<BY ^7T,W>.)&/DHJY7&M4
M#/N3.5/)?DG9[+1H17*LO=YEY=[GAF>QQ">CDGS/*^886GR8L6,8VKL/ U5!
M 7)UTDTEFQ7>6)^I=ZYYX^H<@G^&WY\@V/'MKPID&9O==FH.(K<ZE9X:W8XN
MN(;S4)V-L;%TT.A,4O(#U$KIL9%^S7!!PB<3%,0T,3J-%D4Z:KES*?RW\(6C
M&.#L;WS)5D80&&N.-7XE8ZGW1J0V=O)IED' %PQI>U$+)$O8"5R/'Y!P'!>E
MA%F;B+E_6.&:S19-4I-:VQ:JV)5?O=3MPJQC4<9U&WV:N9=B,RER1;%5G]JJ
M%$QECG'$4ZQ^=U1G57I5(Q9%,(6.;Q$Y%/OO)=PZD)!:7.Y\Q4A$TVZ4,.S1
M26M%JB7R]J''<=,"8+KN0KQ"V/C'?XW*&#\XLF]>_B-3[BRN<Y9Y!5N@+'\.
M2U;N-?LTC69V(72!K*P#U1%4OF=BI,MVJ;BY-*KDZ,^6]A=U3<TUG&%[897Q
M=%,^2] @< QT1B3'HL,B7^-M<=8\4Y#Y.UB@SF7U8ZA35O<H0Q'?FNJ\LJU7
M?#)FCVQ2Z$ :A;W'7JD&%^$N>LX9?L&7>4MRS;66T#%<0F6/RY-L''AWDZ0L
M?&?+F1\OOA%OQV:N\?P5/DGUL9,QE3.1L,P](Y>^1'(D:-PAC(:J&3!AWK95
M?EFT"+N=HB;%R@L*G(/*=%IAJ);(['&$*AD.9B...=L5YR895R+ UJM,(SDI
M?:YD*$K;67L,\V#L8R*J!$6ZDHX55-'MJF\-I3Z?4IMMWRV*Q;Z+A^JI9'L)
M9C#N<L]YTBI2Z8XQQDJDV6R<C+=?KA=$;9B>WQ:]-D7%6?Y!<_AF0 I7L,=$
MIRF5!5PFK"!T6=Y]S*$^+A/E\<*[^K'1_.RG6RU-8FT\9#Q%RM6/&CT+#$<B
M\JYXLC)Z6JQ<+$IV*OW?D&K!O/(;MHYF8K5IY:+LQDS3<]%9&4AI35=GY.X5
MT3)AN4R#^Y7%D'*FR8(L-N/'-H(Z52<X"0IK>#:P)GS$Y'#:<"EH^N]6*QB^
M<IY0D^$ ,5D29NY<G'^41CLTQ)O?XU7)>,4L_)BPQB<3C?$C.YOE>5&/,SXY
MNXY5RB6L'R+EV1JD9FQ^-<=2#Q(&J;-LDZ(\$@*E;?J6MY[/H%T9>."E"N=8
MRW6YJ_W.,1R]Q!Q=PZDEX]M!&=PM.Q4_R0_B;I'E58JH#:I-?);H'*:P*-2E
M;) 1(-S]UVDZ*"1>G:ZBYC\KS%[6\6EX2XO76#K=;LOWF8PTCCC$S%Z^E,Y-
M;?\ Q!K4SGA"JDR_(8T5FK]*2S*%,]2=,GBJ*0/E&#5NS(9BQU5W]NJEOCYP
M_E\,94ALHV?DCD;.$S3,!_\ +50(BZUZB5Z)@\:-K17+,P>2#BIP46ZL^0E3
MUALWD9AP=)*1(F0P-D#%,)VU0R<,S!W2B0X/4&;B;+!S%JMAHRS\SF'-*636
M0@RM5+4R6@E%\=F#TAA6I,BA!E254 ?7]JQ]E 'M$#=FJ;B*]S+G"O\ RFL<
MUZ@S.*5<SV]7&:.-F6)L<L(/%F#JG,5BH1]JI=CC'=XN]5HL?9\N7&#C*(RA
MF4I+J)"5BJZ6<(NI!RH]TVE7>7=JJ7\B?+FI5[SY;LW5[)<A2(_*-UQWD;*U
M7:XRQ#:).PVS'$75ZZS=4G*MLJ$S><7L+E6J3%1M@:L'"@.F[8ZC,6#IRY<*
MS0U4$B RT&=^5C69JH*8AG\Z98EN/U3C,\(8,Q&A T!LTP[-9^HN2L=R4N%P
M3A!M&0&>,JSEV?;5!C*G\F.3>$]69\=NV42:T03J_5=).>,#U')HY8IV3;G2
MK:?">$<!J+,J_4)QHK1<,Y0G<CN14;V"*?H$DLB,[,^A)%7M 63%;SV0HNRD
M5#8 %>J/TZ+JTK5HW$57*J(G'X@0(<RI4P\0*8"")U3!X;;E#Z="25FJ1NI%
M903)HAV$W[>[8/,,7]T #HD0=OJE\?;OK41%N]: "N;L5C@"C@!3((;]O:(*
MG+MX]1*1$FW[1Q /RZA8::K)99'LHG'-3D8%(98W:FF!1W*910W8F0%-BG4,
M)A^(W0  !$-!'=KHJ ^NB:V+180$@;*")Q5<N#_"4RJFPJ*JJ#T#O'P]P  ;
M=-4[= A9.#D4614D$A%1XX**GF#\((-M^PRQ"&\#G-\"9A#??<VWPZP 3[%G
M2B:0.;?L*4I2DV @%#;;?J.W7<1$>OOWZZYF "U%*$6!GHK>H4%O'-C"5T<N
MY5W*@!U:(]0["%[OM#!L;?X0_:VR2WPJDMIJL[A^8Q 00 C5F@3M31+VIID2
M(4>JG;L7X0#<?9H(C4K+-7JFM!-Y*' J/>1J8-R$3 2JNBCM]HH<.TR#40'<
M  0,;Q$0#IJG9$/U1QH4^K.&$0T\A($A,B/F*G  *U*KT#<"?]J8HCT\0[A\
M!$=8$3(OT4;JF0[B0>&[Q,+8AMA YRE.[.4?#M3/NDU*(> #W&V]A=;VQ&JM
M';HE?DLV+,5G@%.Y<$#L5=G%4Y$=]_,V4$P%45_9 I0$0\ UDASX=%371-Q5
MU#% K=GL3]]79JF("(]2EV.L/3VBF&M[0.M5*)>U3=[*.E/1 DW HE*HFX4!
M1<P_9) 8IT>\/:;8/#QT+:5JJ0.FJ:5E@ 3'<&A#&,8=Q$OD")Q'<0[P54$#
M#OX &^FR/>HY25HX(Y5(DP(X7[S&#S8Z004; 5/<RNX2!DB&*78?J=PB/LU9
M#:*K6T*]X[>O%=G!X],I !)%-RW.W?%2(  4".UP%J*@]1'L)V[COTTVQ(ZK
M(+42,YV:!@*J[=%5   $)'ND4#"&X% AD3&*7ZW3<P!]&JQ9AHB=7"RR*:2(
M19F1B[JJOT%O***A@ "&.DT\QQL1,=MCIB ==QUG:"7=T!24YWPI=ZTBT<-3
M%$H^0"+0XA^YYSGU"*I@+[-DS?EWZ:  H 7[U.]7H%C"MC>C]<#M<QR$:JI+
MJ('2+V>>;R'HE9B7O*!0%$0  W$-9DYE5F5>K*BBSLQ.QS&-"H ([K$$'"9!
M#IWG:H)BLD8!]H'-_I![--$:%%G8JJ$[G2$XW%- OF@CV).2F.4>TB2*YS/'
M0&,<0W 2G[0#P#6)"H#51)A?E,?M<FE@4.8>T3=Z2*ICCT%)T0K9(WF&-\)>
MX#CM]76Q%M&6B&2Y%L959-,D>Z,94Q4^]9R7;81ZB<#.S#L7Q'<NLEFJ:*#M
M61T4BRYQ")9^602D2[E4CF[2%[>H^G,(#N&_CL.^@ B-2A"2^1N/_P!JF9@#
MKMYJ/38!'VM_HUI^\J#5.#U--!)LU&+43[2>>KZ=9, \Q<>X-BIN4S")"% !
M#M]NN.%3N>JI[TWBH@3Q/(- \-SF<]@#O]4#G]0AU#V?GUNO10:IU0,X*P57
M;ODERN# B0%4TU0\LFRAQ%1N9(X 81 / =]8(#Z+1"0G6<&*)73(BY.NXHF(
MY+](^0J0B@?D*!QUH1'0K"L23;GW%HN=!0OBFD<2]@B&P =JN D+M[NP/RZ.
M>NBJO!1TB.YR$<D ?KM]TER_2*)S>6H(?T3!_HZ4]A400&KDQE4A[5B_UBB0
M&0=%'Q JH?"?<-_!0H@;V;ZI<>Q5:ID,'WX NJ9 .[4-4K25LNW(9-VBN-3L
M/E+=J1R$!4IP "'*(;','3?J'8P-HSK)_P"-#^:*ZN7$?+7"/]W+[BO(M2PH
MII6!-8C-D(QO%E>HHOEG8P,U*-6_J*XR4=QSY,P5:2LR0E[FZR;413=>C!NT
M3?CK]F9DLR.%<CCD^89!R&W1!(WD BDQ$T</\.YR8KX]&$"8&0T'5^RC]SJ>
ML!)2YLKWN<R2G/1-S&GT)"WP[5LXCGR>/GL-'$10H)XE9E(ERS7WA:8A#H>>
M>KH&6,=90ZQ3"3U/U;+''!8N/QFR7'^9<,"2[S$B^\EQY1_%-PTNGH-I7DN/
M!A</FOO(#]H']T=NFT:=I6[<.VD2OS)<EN:U[0RRX5S Y@$ZI]Q_>Y[&5M)L
MS0.0FE!9OH9*)(4RRSD(M4&B9"%^\SBEV%+U_6=R5KT)9&+Y1XS=CQD+@/PE
MCNM&;2=V )K_ &5S<83/E#"XXO"-PC;_ &F-)-T/7]RC#Y?$K18&A _D'EW8
M6\.1%*AKPV=QD6^B)EU)-I(D+&02HJII,%2+D!1]]XE.=9P0PIB!2EUW_P!2
M+7)Y%X6K,;$L'\O,K1$B)Q(,=\CVCH-O0AZJ<=\M&=F5PS$]X<,\2PT]K]J[
MBY@Q_*V:ROD9]@5GR$985<8BQBOR3C7DS0%G4]37-G?E0B\".!2D1,_;0:TL
M598RB*9T@.8IA9"CW>@^CK_H^UPMNUZB^0_.1DWAB2VW*7!;'BR69X&0CMH:
MZC<Y7F^2'(7\F<L0WX8WDP,Q2H,C2/2@?3^52AR]G:4:0AZ[;G.78IHSPCDB
M1LD5.EKDODFQPK+%4\G+-G;Z,>K-8ZT,$ETU3 _\UF@X3 Y2BW41,'BO1V/R
M9@,O!%@R_,;8C(.+429#:P(!,2=&J=#4+/-&Q&<(2-QQ9ZUF==>_MZ+Y>XV:
M4A/Y;<,M;SY%3:*\M+[_  M9G.<:$_*:FP+9ROD86S%W&E^[01<'*6.,C)F7
M([%EW(BY#7USDYY__P"*1C@BSYL>+M'(+#S/BE2UNJ')&M/AW59>*N^1'AS.
M\;G_ '%&=GVQ=^_L_K6V.XE5[P[=QMK<6#M81#Q5,ZA:TX6DX=M:;&VQ:SQ@
MTAEG%,>PTC?W$\G:3RJ2-A,F*)FOVR*(:\=&\+?KHW,+87N !]P F8P-_P U
MQO<6O+\G;^&&+^$E<$GEQLHR>GVASL;_ ,3[WKHH@LZ93U>*5R&B2.OC!:&"
M$.+9T$A8\4&J]7D:M+3I)HI6QHR*AGD8U;*R39%8WEG&015:(]P^R8MRT,NZ
M>*E*7&S$]]1MA?\ ,D)B+5<R$B=I(KX")%EX^_ @#S&%QA3^[M=Z4T9F4FSD
MDRA?E]9\E_0-'R,=R4Q 16.NK&8D6KA\UJ]I;/&SQFHZ%RTL'WB=3UHO%?5D
M-_6F+NW[?%V+1O\ ZC<= SE'=QF0Q@0"!NBS$!B&T8-V=5Y"S%_3LXU_QX?=
M)>I+C,)S<<L"&43(BH.&L9B=)(3BFF8:9#=Q$S*J*J&(41Z"8YC"'B(CUU^5
M_40'^H,YG(^;O:Z_XDM5](XS_P".L?\ *C]P4WZ\,N\H5Y KU9OC-=6Y0LM8
M(+\;XE3/&0CH64@:56RQ24:X^*N!TQ!I$V)1J[<DW^T;(*$V'NV'W7]/X<I<
M]31CPU^SCYWR6>=]V.Z'EC!R3>BS'Q7+(G;@>DY1/1?,?U@N\#9]#SN>I<7(
MS.)_-.)!M6)[+GFGEL(8\]SCP6<@VKMT/XK4)QJ[*:M>E+Z<C1%X\UYMY-N^
M=D6_-76BD%R=IT<F#:M5F*<H-@N^>GZ+I]8"HLW[URX.Y4'SE$GK@AS[$(IN
M8 _81QQC#T]=QW)EQ=T^*4Y"MO&!:+D "E 8BA<A?*KX!AE@R#2OQ/OW7*:T
M[ DD,"-"J.1,AN9%G!OZY7V=7K;VPKV"LMFEYR%ZFMP3TLI'(A*P+^-K0OGK
M)^X.Q;(F;;)!Y8J%)O*F>3Y'&XB ,X7;GFS$1&1\JUXI!C26Z3 Q&XUK5BNI
MCQ-NW/,TC&@CVDT?ZG^KVK<XNKRUCQ1@?#YF,]6+;EF$R5?KAD*=AZ1:*G5<
M&P5N=3T:[?6N#D*<\<#:5SQZ[^*,5%[(^5%'*D1<Q/,\-?S+&+SW(<]=VW</
M"G;M6H1,XSNY$H") B1, 0.[;*HC^("6T[L+9N8]C&MDQG-Y2)9HQ!+.7ZT)
M!U:++K6+0IL34#\;5FKZ6P#>L8IT&<<#$SQ[=+7>P&"9LF5(1H_L;EU"NSV!
M1):*CY87@Q9&!2(N ;CVZ]2OSY(W_P#4TR(^H+.0+T2\=L;<0T;,FB'\+B1@
MPDY)&Y=R%V$;IPH1?"G Q/:9&IF _;H]0.Y<9R<M,\4KPV:9U9'HTI4K95'=
M6N]&@#RV-<TT-DX.K%SU0J\HX79Q=DJQ&;4[V-,"BK5<6P U:.&Q'(>[VL7#
M]:\>#PFW)A>A*5VW>EMNV+M'$I"IC(D[),Q /B(++I2M7\#)A:NS-N=L^$@>
M&0UUZ]">HT9UUYD?YKM%LV(F<9(9.>/%+Q"V>(L4:AB5HY>@BPC7L:Y;3T8_
ML$JT@V<_).VQVIEVJJ3EF"Q@(4"B37J/&_I#RUCEYS^5M[+,XF)E=(C*KC:0
M 2P?=6A;M=>7O<[<OV#8%R1)!!:(IVU)^JBY9Q'C53.<R2WR\"ZG.-E11IUL
MO>3+&Q=/YW,5Y@%XNP-*-BQBJ]<>D@8>4[VE@?E.Y,FS!^CZDIG2#</:.=Y>
M/IW&&'9N>7ZGO;[=NS;E';CVY/ RO%JR(\5H4KL.VA*\7BXEV]=C>)EY%MI$
MR J?[(]O5G #UJ%TEEB#_P":ED]:7V;:TN]DNYY/$]D)#2\A5(RN3C7LG,=S
M$?(7./28G=S\<V>,)68=GCX[SO);M4D3+;>J<5E?Z3N1EBVY9'%&R(Y,-T=\
MI@^&[2'PB)(E&(W2H92)9=C*E+E;4A< %\G\/L(&L#5P268DM[ERY?KM.,,?
M8(S0P@IZH35+R9D2DY;_ !LXKF.(HN2*M*U$%V;A:K'E+C9HN^1M6DBR"[=P
ME][3 ORF4$G]V'W#B^/M7L_E>#-R-VSD8UF[C"#W#Y4XRI%P(1-N4H,")&$-
MK#JNEE3G:Q\?*((G"9C(/3<&]]0]>I=:UD2G1\'9[(WKTF=>MKJ1DW7WZT>_
M9Q)JK8F2<E43*.'S<A(UDO&R1#)MI-!JJ1)R)4E0(<RH][CN3R+^!"Y?C&&5
M;\$HAB=\)",J ]HUB3HY!-%T+]JW8D8#_ (,J4+&HU[BO2%Q/.M_RS8;0:"B
M8A,8X_ G<")$FX+1LD=50",WL@B81,&Q4DEE$D]MBG,4-]?FGUA7U-F2EURK
MOWCM /U@'N7T[@X@<;9V_!Y46^U=!(HIMRBL<W<KL8RKE<P"8 #Q#<VR:"0
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MAOJ%Q0GW*I6^>*K 0CQRT=,BE*DA]VH$4=@F4=R*F2."YCF4WW$R)"F#?<
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MNLH03%$N^Q_*6#L.;Z2EW^G442<YC%2,<7+A^F;ZP)*F!N ^/:H03F4V'V]
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MT-L]?B0T/:$ZL7B9P0,V="@DY-V-1<*^HCRK=P!Z8JQQ*9LD<P" %W(9 X@
MD$GADCM&BH%**JJ9&CWN635C%7*PHJ^68I4O6F$2$5 P%!!<JX[E4(H7N XE
M, !N(Z@)(I7]RA#%+EW#AF3SG*!'B*6XK^40QR.6Y@$'23AKL8Q1%,.XIB=P
M%4*41V#0!Z!$L,R+Y /(AP1>/4[1!,XBNW*4Y=_+/VF%1L!BCL E$4Q ?J[^
M&7JTOB0538T63.F+)XGY9VZIT"D7#N35 O:=N**P 4IS^28HA]53?P#6CVA:
M^%+%_.]0S-YOF&W6:_W@YA4,F=(RR9!< 4QS]JB ;"H!A#<=S 'A@"I/19=9
MSE35$$'*/:<2]XHK%*!A#?;S4A*(E4*&VP'3,(?3J^Q 6KU2.-.^9(E],IYR
M1#.$1;+#W* DBNJF4A%3 )%BB4H? IU]QM63$UU5)!"5+GCI,[5/8&ZI7.ZS
M9PD8$P[FKH.I.JK?X@W WQ$W#8#:!P.Y2JN6:/V0=Q"F7;#\78HH!S;%Z;MW
MG<)3AU^JH(_Z0>&HX/M5961LAT>$14$Q"NU/.:KE*/EB8B1A!5LIW;;F,(@(
M![>@Z2';V(2Z5/%6JK8X&0,@<RK<A3('W3$QG"8#]FH81*(;^PVVL@%U&/1*
MA9HG$1(^1ZB.Q52'2-[?>4Q/T&TWGL5?N29!L\3DG"J"I>\C1HGW(N$A$!!9
MVIM_6[" E.&J=K>]'"?SJNS)G,OYR!BIG4%=,Q#I&["";N51$YB@([>)=O?M
MKC:M-%$D;$EDVC8HE3/V-FY15#TAB"8$B .YQ( [[^_KJT=*>]6*K2)7; HN
M6I *=PN*9U&_:7RVXI@84TBCOW"ML([;]=1H^]4,ERAD5Q IY Z9S#N<I!6,
MWW]Q#J>6!=_<.X!K*GL211)-$P$]&LL<P")3+*AV' 1\2E0 ?, ?]+6@R):1
M=Z)0\Y))%$2]A?,.#<Y2^])8QCK_ *=_=J4Z)18!1:**&$CE1RIT[41.":AN
MG4"K*CVJ=OT  CI7W(L::CLIQ(V:BV..W<*93F7V]O>JKOL'3KX!I1*+(MZ<
MX;R)R$7Z?&W'S%1_^&* BB [>W<!U0_14/T5HE*F7S(Y)-8/$7 _;KEZ?M(G
MV!N.X]/A'\NK7^)/:J$,],43NS$].8=Q]=MV"/4=T@V\_N^DFE-(ZI3HJA]U
M"8P)]5-@ A70G(V[O=N38X@/L[]@U/$GB6(PRX*% A3E+M\ (=OD 41V#M!,
M!1.4?IWU7AUU0,LAP:[!Z_RB.!$/A9]O>/4-_.#8S<IMO=UU"_\ #HG<%>8%
M>T0C#I GL/<"0B#L0_:%03@54!'W$Z:>U2CK$F#E4!%V@FJ0!^)=R((&+MO_
M -L!0.80#V;&_)JTZ*ZZ*XOW:7N\E8JB@#NGZKN3;B/@/:9, ,IU#IW@ ?1J
M-)1CU5RJ\@ ?WI$KA(QMRE,0#H]0V#RU$=^P=O8 Z>'HK3WJ@MD *"KCS8XP
M["4HF*X%3Z2(C]LF&W[PZ>RJB5><N!2E8F37(01$#G4(NX_,DL!!3*8/84!_
M+J)[4B$!.H)5&"GFF,'5(RA#&$?$>Q4JA-_T!JT3VK,!6K<Q04>KIFZF,W((
MB9,0'H"BJ F*4!#QVW, :,>B59)P<+G?/ 1>M2$.@T.4I5C$,< \](W<9<@"
MIV 0H;B/71NU/<KEDI-1%;RC)F^Q4+W$%F8@"8A@*)U-A$HB([: LJ"RRM?5
M(-&H@<[TYFR @)%DTVQ#>44/V#D45, ^SX0U2TC6B4)33()O'3]@JY5(78CY
M,I3.40( G304 I2=^Q0[4!_1K<6B#U-$=M%<#5$H;JOD ^A,JBQO_9*4G_M:
M$DH"Y8!8&BC)%%0")+.#E=.BF!0Y44^X7"A^[9+[0=RF =NX-"#UH$9)Y*1$
MJ"!% *DDH[:@5!'X15$%BB)2II_:.#!L ]=P#V[:L8]7Z*C7O54FKY\/U5&[
M?ZW:GT7$.O\ 7+@(D;@(#]4@[]>I@'IH2!IJA;WH3)'1:SL%3%54.=N*3-H
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MIU29!P*Y#C'-RMVBI@\A=5/RBBV(7M;F*BGL=03B(J;#V)AWAL([: ;3XJE
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M6S23AR]2=Q$U.&B&2J[--,I2'\1QT8>L,J7+YMT>3;-L6[5LW8B-R[$D7)W
M(7"8W8L!ME".^33)JO(W+4,"T<:U$F]('=(@%QUB!X@ ==7-'HF6]UNP5,&%
MLNC*2G,T66S3=NM)IIM#TAE!OV+$E2JLY,UN$FY*L2\G<H*.;RPIJ*M6S$J@
M#Z7N["AY'C<O'S!/!P1&UP-J(MQ /F>97?<C&<HB0C"1,0?%*35*\=D@PE&[
MD$G)E6H9AT);J?<R<[3DZYT[@EF3)E<FHMC8'/)7'L(\E92$KUF._.CC^ZFD
M&2Q9F&F6\JK]T2[19JHH0BK9<3I(J=B8%-Q8W$X.5^H6'QV7&7RD>-NRC&,I
M0(\<&K$@@."XT(J0N]:NSAP]V1J99$ 33LEVN-67J#P.H"V#\-+ !2@KBK'J
MNQ&Z+0@>;48A3X6K<B:#8-Q_JR%*0G@   ;:_,/.,.;S(AV&5=ZO_'+KU7T?
M"<X=HR^+RH_<%*^O%KM*.LJ$NBE.4+C^+B9FR_B.BF(PFTV2L>,(2\UP]L="
M20<M&OJXZJ%>N&P]_>5RDF*8&4 I1]B]*RX6/,@\_=NV>-^6RGE;,A/S/EKW
MD1> E+;._P"7"=&,)2$B(N1Z9Z^CZFGZ;E'TA8Q\GF_G<%K=\0-OR!G8QRY-
M<E".^WB>=<M'=N%V$# 2F(Q,BZ]=7N:-$7C\JDQ-VFL<UHR3MU?A$V')6HM(
M5U>GLQ7TH)BR?\A'0;2M<CU%G#QR0#$$RRKHHQX+E$FQ2@/Z\SQCX63P-^S:
ME<F>,NRD( 2,B88PTD?N;Q,OE)C^#E6/^/"IT<F?[JI#'R[FJ3,DRC[)4IQ6
MJF4DV<E%3[^4/)KH,6+]K^'IE2MPRSM<)!P!S%>$*F"9%BCON !R?+6L^R+D
M[5^W;R#MG"<0 (EW>)D6IV'5C[>ANG8N,)1D85B07KW'KW.GZP.WF>73:(GW
M^/FEH+,T^+3O"46G*R#R'&/G9%@Q@HA4Y(:2GH9^_?2#IZYBT'1HI==43JJ)
M$\WIX-O']/V/.LV\B=DPD?+\R6T2W1!?J!( 1 !;< -#3LWKTLJZ^08"3C6E
M&[FT^[V+:(-ZY6=MK/=X:VYI;N9J%QHC99ZO0\[Q@FE!C:I4$K(2[II5JSW"
MZQ7F^K;&DHT?1,V"R3<R!4O,#I7XVX6S:XZ5K!A./G;+<C#-#RE+8;?BB('0
M[9!R0X+LM1?=YN0]R428[I5MFC DT);HXT6SR.2IE[3)6+:PZU:A*^RB(M"L
M5YJSK1I&)^X0:QC5NV9Q LY%.!8,"Q0J/"KF/+'.0R9B 4 X,7B;5O,W$BY<
MN2D\YDRVG<Y)<N#-]Y H(,00=;>RB+0E'X0 PC3V#]@UK1:G)9,,\AFROX+]
M#*VQQ5!L=I9,V$3^(PJR:(09&L\DD_4D&,^5LE*@HDW:+3C"-5D#G0<()>7V
M[/#0&00+^Z-D2,(;C(0WN9#:30CX1J(RD(AP:R683:B6 E+XBU21HY^_ZUOD
M]DE15+\.7.CUG)<15H]C:3!>85M/M)5_!1,M,QD8[DP8%ESR<?'2KF.59>8J
MS!\\9E^T(NNFIXF/%QCD_,X-^[BW+LMA-N1B8[R :.S%M^[4QC+0@!=F%^<H
M^3>C&8#?$'!%2_:XT[*CM*C23K$O8DSTR/F<DXTK=\C8>YO8O+%8@(]A;R5F
M6F7C*NX/9IM+6]R72#KF*ZBVTL^9D8M"^<F<#'.4_F[=_'M2CF9-G$S,BS,V
MQ*S*4IVR8Q!N9!\/E3:DC")>2ZXL;9"S$RA9N1=IEG8D@1_M=P)39"Y%>4ZN
MI4N!#'3*"^Y\?I6 U3<N&3:YN']51BCR56EWZDH]9P1H!BS0(V(1@@=)HHX
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M-6,LFEYIPZ_-RR+4XPQO'GY$S;MQ),0),3N+&7ABSN*.P8Z+IXD(7'\UHVX
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M2N&)]CJ'.=PBFDGL4YS"D)_A*;;<-TP 3#L4OB(ZL0X*+*DBJ8Y5W)N]<O\
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M(EWW[ )YW=[NXRG?W!U]@!J;8K6T)29([T!5==[$X (^>LH(('';P\M<X+I
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M0+YZ@ #=%/;H<A53[F11(<! 0*&WO$=")$L*!0 I,61<N'#Q)N!H]DKZ9;=
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M5;H^0N8RR"RC9 C@QMCE\QP0.UT   ?"7J50.@]H]VWB-#&HU4*7*I*"<SA
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M.N[=GE$55V[=1<H^:BX1-KJV>#X3(R1'A,Z=J_ PB;>1-Y"9B9SWB>V8$8,
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MY[F#*[EQCNLQF8SC9A$ R>48P,2+AE&7X<HBW.(% D\RT;>S&#0?Q,"#,O0
M$EZ,PI5RIZAN,E!I:KJ3SG*(6B_31$'BE'@7'H(6N2LG$E:SX7B^PLJUDI2<
MCY62E2IM8]ZY%J5SYH/%E/@+X2[ZLY;D2+'! 8^% $>9,;I2 +QV6B#$1I'X
M@' ^$+L6\.Q8 N9Q,[I#; 6 )U>74]*?6EUPKV4\,UF/L&.I7)&2>)Y?2BBU
MN]JG[$]QI84YR6R'>J-(6B(&/M]/BJG&P"*19GHUESNDF[@QOZDO5P<[B.>R
M)6.2^6Q?5D9&+VK<8QO1V1MVY[9$PG*9))B:P >(ZKFOV\C"A&[9$Y\60#6N
MTN\@XJ&T?0_8H]4S78G!I<BM"KK8]FWAB3C*ZK1MHO4FV<,:90&,W8:S'M92
M5'&S265B)08@D:X&162,X,JH).[R'Y%Q]HQO'*N#9 &0,!M@"#.X8QD2(BX1
MOCNW  -%NG6N9]TDV+=O<3HP-:L XUU[N]2ZGC>WVN#K^0N6DGD-N20<_B;#
M^%%+'*T&IHUJQ1E3F)J[VFF0ZS60AWD-86!XM"*?.D%';U<'CLI0[B+>)ARN
M-CWI\?Z-CCF0@V1DFV+ES<)2 A"Y)P1*!W&40=H!C'M'9CCW;EH7^4MW"2?!
M;W,-O4MTK3H3]\)Y/XV5J#IEFR)B^?"<QQ#-:XK/TB?:1,9;ZY#(3C&3%M*/
MW+MG&76DGGXJ$C"N_/6,V;J&!>/432,MKSO%>JKN5E6^*YZR(YUS<(2!/ESD
M0V[0RMS(,Y "DBS2!++HY&':(GDX<B;( $HLT@-?80#[T[U&V4#.TW6JAFN2
MI4I>XZOR\*ME>W1-@F7MBB%:A*7+#5FL5GDIRCUIO.5^[)R%ED_)K#QHK5VK
M,BP+J($,;@Y#"Y?TY:N9O!2NPX4W1(V 8!I;HPO0A';<F8F#6H_B"7FF3,"5
MSV<FSF&%O.V^>01N8FC':27 H=:?#VFBBZ)J\K$5?(J=^E6$C%8P-2\3594M
MLKTA%R>28Y?\$,HF!F6$.S&E'FGT9** F^;+, ;O&/JBH'<E4)YR]R$)Y6):
MXZW*%W(WW[@V2$HVIM/=*.X[A$2B"8D%Q/:XBRZAM;9RG?+Q@1$$%P95T+:4
M/V+T6\4I '?&'!RZ;1^U8N<<4@K=*48J0\BU$8J1$S&0B3/I((YVS.EY2B8+
MJ@!^FXAMM^;?5MH6?4V;;!C(C*NN8EX_$*@L'!]B^C<'(GCK).GEAOM4^$ 0
M*7\G\^O7CJO,)M26% 5FA"][@JZH() .WV*QS+)*JCL/EHIBH8HC[1+L&X]-
M<A#UZ,B%VPI(*.3;KNDC)N3*B ;B5 W>=)(OBDD"7< %#Q =QW'<=0%RW1-%
M>4XR ?9F$K$Q2_:@(@=V7IT2Z@)&XAXG_;]G3<1'P^U%8=4K-T*":8&%RF51
ML@F(%^)  16Z?]FD1(R9A,(= ]X[!HSAU5E!D*Q%0,8BCM<O9YQMDTDQ*<JB
M1""<P>2B14H#N(AN(;CH[$ :(O+3R@S5-\D).S_,@@)"4CL.\6/F"<3N(?&J
M19NRMUE<<Q6?Z$PYB91;MRIJB@EF"^2$77P< *BBE8KPM]B)/'::G7D?$_8?
MV_M7( WAZD$E?63YA^9LA3%@K'R]>,$PM&\G>6;249V*\Q13*AQ:XO-@^ZLR
M\A)Y5'<(B?7@A4A:4DJ8AW]D>IF2W!L._),[H@#4_<LQ ^(Z#[5V%Q]B^/./
M*#!\9^.,G3@@^+!8'!<A3*_-L):0QP]CJLPE&,'D1-FH9U&W.4B9)K*.E'8$
M7DE7AES")U#B$B#$$QK%8EN?<>JFR2:KQA6R!DU/5N'J*O>N4P&.;SBI*N51
M$  44O- "@'3?8I??KEA(3KT ^@1^Q>8WFO,-1Y:?-0M<PL8DSC2A?)TQW0G
M+M!G+@V4F.2$/ELIF#7L3D&Z\E;2&57324 # W*<G:;;;@D')/6C+F&@'M4J
M\=V:4?\ (>XW46'E44K[SW1@<5MG0@9L)9KF!F>TV3+$L"X*."I-*SC&8M,F
MLX6/_4QPG6$!$=02\&TZ?O63_B$]G[%]>N<^9G/%GA1R;S+2P3C9G$&"[B[Q
MWLBGY$;:$H3\+X\,5$P>2*4;8I%@;L'8HE3[1V#J')*D768C=(!<0YQO$UPE
MX?<<?EQ\.TRVSFEG;&S;%>$4"&(Z>TIS+1!W&=.:^7'R!G:T14:E-RTI8'<D
MZ[QE[&X(W1%905>WB(,:#XE1XB9G0?1ESQ\Q?'N#^%/";Y>G!]L9U.X'B,XT
MFP9.9O$B.[#DW&/#VE7#E3E0DHU4!4LG9,Q9)IT<1P00,55[,@3;M$ U#0")
MU6HDRD9=6^]=E<2.87( JW-.D\VFE :YEXEU?'W(.1-C2OO:W6B8:S'AN1R]
M#T]RSDI:6%_8\4V*K3U7=R0+E3E08(NA(F90X!R0D=IB= L2B*&.A4S?*VIZ
M]>X"\9B6YEZFU9=I"N?LE.7J()24CD+DM/2N;;F^DE!,=1PY/)WXR ^<8Y@2
M1(03"!0T VAQJ0I/XBR@SY/(J#PY8XZ3,)#X3Y)\L<)L$0/\<2VJ6:;E)1,<
MDHJ!/6-DHR41*D AW"7=,X <HE+J$A&)!'T=69\55](Z?=Z7D,MA=T:Y5*W&
MJUEDJ;/OZ=8H:RM(.W5\Y&\_6Y5S#.WB+.8BG"A4WC%<Q7#50W8H4A]M5XFH
MJ%E;FU=+*^O3D&Y5"^>DF"2Q1.F)4$$Q*JS6,!50[%%#B4Q# 8N^P_2(TV.I
MU5B2C51\9%<5D/)2(@U=@4%43K.3@H9)<#"4Z:X)ID # /:</8 ]!OBB'2J'
ML6OYB)8U1LY%TMW.&B:X)E72;_;JF*1;L%-<QR%)N'0_=L(#XZL9Q_B?1/:L
MRF_D++N2'].F53U":Z9B'3,F7N.13H IK%'J'4!\!#IL.LT/A&I2FBPL7\A'
MI=CA955)8PK'46'SA;F6V$$71E0.!DDR[$*KMT[=C;>.AA'HC!9G2OKW29%6
M[8/N\OG NBF":R3E8IB) 'E&*4W8B<QC%'<#=Q=PT  %#4HKS23)$IRO&  N
M4@F1%!=4B;T2AL4$2G!806,80[B;[EW';<.N@C,Z&B56,$F"::9R)+)/P*8R
MJP*D,BY54,910BQ?) 3H"J<0 0'N(&VWAL-\9]B55Q'D>[=@@+9XF#+L6<IG
M61$PN3B(-"I&!$OF)%* G[@#8=R^!MPU@PF ]$8K*Y.R; H\106W*43.$5%R
ME3==/$H$0W3=;@':;]H?A,&P[@ D:)58F#EJ9$RP,!,LNJHHN5==?N14$0#T
MYR%%+L,V(4I #?P#?KOOK<@="45[A\*QB,R,VA"F[%EQ!(R@^0F8HE3$RAS[
MBX5*(?D*.@B-2563D1S)J]4?, H]=FZ/E &_O%(@!^O6&B[*,%0S)^J'>LH0
M@#[7+HA!Z=!Z'-YG3;W:FZ(+=%H$ *T6[1$-G#P#'#V-DCK=!\ \PWE$_7JN
M36.BM>FBRHOV[0W<U1<'/TW465*4@]>H&22 HF*/N$PAJ;7U4-=4H3DQ7W(=
M$$#F,/VK(J:2O7KU)L;O#K[RCJ&(BC#HA2(=+"0Y% 5 _4HJF,BL   =3IK"
M!QV]Y=P'V:F\"B.H#SUR,Q'Q?K\-.Y+G9MW/6^8&KXRQC0("1N.6LP70R(KH
M4O%>/XHBL]<9XZ>QUQ33(QCF^[E\X:M2'6*E)PJ 9::+Y<94S1R@SY,YKQU,
MV&8Q+E3&&#6>>(KY:'%;($#7^9.4:%.RB\#4D\R\QIB+<4#%3BWS+(R"D/CT
MWK8\5 *:PN>Y,IL>(]50PTK].Q= XGX(2M2DLI_PDC<9\5<69CXM1%=:/\?5
M-.8YT8HY&6E.04N^0[7RCMDC;U,DNJQ&R2:+,[QP][I-KYP'!,!.LTH5-U:U
MK[EO5KQ[QMPLSPKRFSIGW*-P/#8.HW#6.RM-Y%MD[4<KP>:[%68**O%WJ6/B
MDI3^Z7^S+H+*VPB*"#%!V98RR2"9%DM42IH HPKU2^6SA"4Q!3JM3KN:9^6%
M>V6#\1P\*?/&0IVC7OD]247I*O$1$$XLLGFAY/5:9,9<[E"9+#JD6#N0.W4
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M8<67DZO8[[,G;1M<H.4+$F7(;:2K\@,\_MS<UQ=Q\@P3!:16:N5U%6O:=%-
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MW(/B1YO+1\I-<@E5-S<5Z"Q,^]8YCUCD'"L7K1N6[=L?BF$=OCN3\1AN=XQ
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M"C.:KV/8*::<@:[$2DT,JEC^2D\^4&_SR-=FETFTS&04?8TW#M@=PX=/8X'
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M[3N%C[ /O\I$$@V^C<=783J5DAU>$HY !*B4&Y1Z;-TRHF$/9L8 [Q_3OJ&
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MU<)I.13UGQ2JY<)04#:**I>\6U%7F_%(Y!LJ>4*VXYUQV((DN<N9;S*Z!*S
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MQ=A%)+M $"[ .PI'+N8Q=]C=X^T '5):G1-551P9R068E!-RJ IN"%$QBIH
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M:XV8KS94;-CO(F.F%^JCNJ6E%-E-,Z^SR7;G=55=1Y$R%9MG$(^2%ND;N,5
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M"1N*5T1DF7J(4O(C!CB6O6*4K$19/[N<_P 2<03UDA&H+"*BZT=Y @9,P=N
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M$OO,Q3$4<@50IA%-4O<4F_03]QO$P;/+&UA\7[$8)7)/5'P$:I)-2N4NU3U
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M;V"7PPVR#':1(@NX)74R#$786[8!MD/0/7J_?]RD">C'-I^7_FJ*C%&"R_\
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MW5L)$V[8#=4TEE]EUVH^]-4.P2 /3V:O\/>B9'8'0:E$ $ZS*36=(GVV\QB
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M:<#<W,1316CZ*++T?F'AJ/<3\PSC7K=@[CD)S*6)IV5415;HJ)N953O(4XB
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M_5TYA1-W(S^7LBQK&0CF[B7LC=)G+1$)3WB<Z692CX..F6JA(KN..Z/<3VS
MX8XUT<CS4_.S;4Y[7 %BP6)$14&4QM,-UR4"-U-5XXWHQM^78@7D!O!J9?N!
M[!W*8JY6J%QZ4@5<B,JHOEPIK%+V2O&H$];F= 2;P\U6JM1)^8Q3*RV)EI9A
M>Y=%T]^](4ZL;4I1)NX0*<PD#U[,R.6]63,..%P<)NC 2-V,#<J)3N0C=:XV
MR/AVS:=V)(/5=J-NSASC*[(&_(5B02U"0#7:Y.H/2FJYY4/9"J662RRZ71E[
MY38BR1K,H0K=0TU;)&&OCZ74I456JBSB20UDKSIVT5F&K@6Y2)D29J-RB?7M
MD(XMR&/8X: \K%R/+D2)-MM1E;83E.1D#"0B=A#EWD"5TK\CN'FTE*78SDD$
M$AZ?<O4!Q0CV<9Q=P8!%7+ILGC:AE*X6>OI Q#DC),I59!S(-F3U=X)U3"N=
M1!$Q7 F$Q"[;:_*?K"Y*YZHS20(GYJ[0,!4C0"C=C$T7U'A([>/M%W>V/VJ?
MEQ2*U.*Q>]+;?8!ZF-T\H$S (;',<0[1#VCKURNZFJ\ST25L"K,H(O3]ZBIQ
M/ZS;M*LLH!1%);P*18GU2;CL<H!L.^X:I8U"@HKG2(/%TT^X2"SV< J3ZQ%S
M )6Y/8!B".YSE'H;8N@+#VIJ5?ZH$BJ XV373()P*0?@7 NP%,W,/4X'4V#M
M\2B/4-NHS;V:*NK"-E4B^<EL#I0 .Z(8^R3E0W4Y!';8BB?U4S>P"@ ]/"N-
M#I]R,R$SIO5E $H"DU+Y2J"Q0$P.5R_$10FXE$"(&VZ"(#WCL(Z,P[RIJ5A=
M&4:(E0[C&;.#E;IK&$3*L@/W"J*F^YED 0(;8W4Q!  $!#XM!4OU0T2M=(@$
M!RBH"2C=,>PX#NFH@4.[R%@_;1$H;E'Q(/4-0$Z=J,L3,"NF0$624(H;99R0
M=P.DHN<5"*$5#Q+W_P!6<.G3;Q 0U2X+C1%C9CYA%6[O907"ZYDU0^$'293B
MD40 -NQP0B0"8H>T.X!T-*C^I/:D(E.5F@FH)#.&S@CEFX4'<KI/U0IJIJ"7
M8!5.D;M4#H AL?Z T#XCV,B4Q+@AB+L +Y8QJHH))>TK3Q;@)?89$OV9O9N3
M<.@ZDA_%VJA.^L*JFB(T1&B*O^6_NT1:HX6*Y<R+X-E$VR)8MBF0![CO3=YC
M 3Q*)$O,!0P^ >(_5US!P!'WGV+&NB>CG<-5&:+9PIZU1SYCEP0PD%,%D%D%
M'([;!W>6/8D0=P[0W'H ZXV$@2=!HJ62IW(NB)M&S<Y#F;.$#G.NFFN#=)<P
MHJJJ"I\1UUP6$0#?XS!W#TU(P <G0J,/<LZKAN1L+$&#5<ZR1TR%#SD3F.83
M ==59)3X"E,;N,?81$>@==M1I:@H0R&3F/3:%=.VVZZA0]6L5PH43*D'L,DF
M0Q%3$3(<!*0@ (]?:81U#&;[0BQH^@._.LY;O$DUB%7;-062.*2R0%2465[D
MNP[E1(4]@'X4P#IN;<=")MJI57OA8O4UF;(SM(P%^-T)4C U4((*))HB&P&=
M H4N_79,O4>H@ HB<2#+16JR)GB$FC=0JCPA#D(!$B()'4%8X;BD4!6 RBYE
M $!W\1ZB/CJG=NJJY:B3D0:>N0=.U''<X(HB5(J:(D:J)E,=#L,*X@9=1,5
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M<HC]82E]NN1G!B/:$JZVS\^^_M]_Y!]NN);5-$1HB-$1HB:Y=T5%L5OXG?J
MS$H#\0(*; Z,4H?$)_)$2E#]\Q=;@*OT"A2/M4(S?(H@1-TX,X$Q@+WHL&J
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M\A)-G=$OHG760:GI]L^V;BZ(HN["DVINH#-1DFL\36*U.?95))4X'(44R'.
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M1RZ[UU+1R0>4D0!W]4S<?!QLB%WU1D8]R<#<-G#M^.7G0 GYET2;;(?"(R
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MY9%-("EWZG*(#ON&M2:18:_>BRN2IO#-41$IT@$78G3$-]D0[43)G+]43+*
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M[A]_^;15@CN'W_YM$8([A]_^;1&"023OR6QDBN 07<$4[%1#N%NBF!?4.P(
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MG[?N1(ED%'*#YL8B1GR"JI@2 #%0?M!.1WVDWWV4$%!Z]134,(> [C06(/\
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M1J'1%XZY5I%1SSF\ZC+&>:GV_*2HS"D8I6(\IX6<3MV?@:,W<M-/A8S'8V:
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M(E( BT(8YU!$QC;*+*["JJ<>A"E*0/R 0A0  'P#?KJ5.BB2)%4<J.Q6 R"
M.!+Z;;M.L)4&_P 3DP#N!1WW[ VZ_6]VM$B(#:MJFJ4/  S10@=.[RB%*'0.
MX54BD*'N 1Z:D=71*!\1_*/^?6%I81W]8L([; W0+_KBJX,/YA+UUH_"&[5
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MV*%^!=!3J!A #AW)G#;8Q3!L;;80'4=BB3MEC)*KI.0*41=F*5P4.Q%<?)0
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M<;<0*77-&(B&/Q?<%DU*6F0*5N@T,8R#15057:BHE!V^*791PN[.4 %([I0
M 0_K#=^W3PU'J2/B^[V(E+CS5R-VZ)3-6ZCA$NXE[5E$TC>H."*0[>F)LE]8
M0[NNX![=9#!R=5%D7433;.46J93F*@N!Q[A*@F<R1@$5U_B4.J)AW$ [CC[1
M#0:@RT5[UF23(D4JSE4HJ)D*!E5/A(D %#<B!!^IX>/4YO>/AK+O0:(066!
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M!%V2%NS-B6Z5-+[WD#D*X4BS*$*U[5"B?MYXM3L6_4F=$_EMBW*Y&W!@92+
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MA*.W36GVR:5._H5-4T"99D<LPPW.U>&+ZM-4#)$\PP['(_3[1]$\ P["KMV
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MNE(JHQ[XR":?F)'!+8W)&=T_J9@0L1B\.,O[0\A'6+D%BSZ[1N#Z&JYL<_\
ML=]M?F(?8)+U7\9B GQRP&0#F.!<,XR #FV$Q@"F0NQC"'03"'B(=!'7Y2]2
M?_S#G?\ [Y>_ZDE])XS_ ./L?\J/W!3?KPR[RA?D A67.-%TK=/RM8A!NV)U
M#2\,T5?/RR:.5Z4M7X\&Z)3G%I-SZ;9DY/MLDV<'..P%$=>Z>@+G)V_4L9\1
MCVLK-^2SAY=R0C'8<')%V;FFZW:,[D!_%.$8BI7S+]7K7!W_ $1.WZBS,C!X
MO\TXDF]9@9W!=CRN%+'M[0"=E_(%JS<.D;=R<C0%31KTM?34:(O'+/EA2)\\
MVT.>V,!8\I:*694DG[%6 ^\W=WS@S,JR!NQ30;1JR:J(KFD#%;E,(@8Y=@,;
M]DXLKT9^G9W=DA+B[VU@=S>7CZUUU;;72B^37H@6\F9U\\-[I7/I[%%F.(5U
M(OK;CV&</(M_>ZO-(1S9JM$1*L=;J4=2R5]0LW-INBU5HM(0PLWD@F1$K%%X
MH5$Y3*&[_+<Q?MV(6N2G$3-B]$L7(,9^"5(_$6D\8EW(!D*+QUF7F2-HD;9C
M[J_53[ZJ6*P2:-@'$&6,;.$XO*F&TLM-FDPX:OK6>8Q#,V)K]\0*[G)EEI=?
MMT#66N06P!'G8.&$FUE5U 0!! 15]=S9XY]49G \H-_%\B+,MH:(%^(82'E1
MG*$Y>67D) Q,8U<T\C:E<CAV[]@M>LREXM'B=0>C#<&BU03T"F<M]Q^OB:P<
MM(FMP;-O0:0_;3N/(4RA(0F>9Y=A7XF/DU3S#MNA6+T^F&\Q&L(,"1<5&H.V
MO=YR9M>%GQG)V>5CZ+G=O3N9=\2C<D0_RL?%)BSO"(,)&?BE+;+0KNP%J[:/
M(VX0B(1I$/69HY#T<U#, *,FGC-ARQY&M;,C:$LN44<^J1-^RUDVUQ=:DXZU
M(OG:;R+:/:\I(3;**J=5&=2=.F;L&"KA(BI2J 5!!JMV?5W.6.+PS'?'&.#(
MVK%BWNC(?PF6]H[I2$2-PW,2*.21P<=CW<[+$8UWUE*4?K^A8E?4VW<9,5S^
M(<6UN.<8/M/IV][7H-?@L>TOS[0_KS"7<V.,QNW>13-K!S3QVT$LHMW-^Q\0
MIC&*J!0'X[A^J.7Q^9R,V]++CO,!<)NS!B"1M-PN3(-H"_AH&"]JR>+PK^%;
MA P,_$8L!XFU I]??K5?&>]2LIQ^OQ<\7>)ME=G M$%BK*56=(1BE<S/2DUD
M44WSQJ1]'S4#8ZY7JXZ=LG9HUF15['('\M)11<AONN!9AZDX@\%@RMW(BS*_
M8N5WV)_%M!8B0E*0C(;I,)'4 +T^!R<:[*<H!]S'H\6[*5;NU4OY>GT>,)6U
M6QX,'*9EL\^C)4*QO8B!FIVCXX>22\C"2[*)L-ACZ:]G,BR(E<0+]IY,_ QR
M2IMRG<)&UX/A\27JPRSN5-T<'CVVOVP2(7+D6>+PB9M: (N1/@G(@-X2N:Y.
M> ]BR(',F7!9S&/0]0-U#$LXUZJ&\BXL;1[7C-@F"4=P\LM:LDN+[.1,[/UM
M:6OTY.PT5>)S[S?R=[H-GEJZRJDS%-"O'H+2OW<;RA.58Z&O-\-S,[]_EO4%
MR,9V8X]J-F)$9 6H@FW%HB$XB1G"4F#P=BS.N"X(Q\G$D*O(R/;)P"-2"S$
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MK<B ]J&PE5<[;=_38R;4>G<(CT,?P+OT'?5TJ=4"4 0I"E(0"E(4H%*4/
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MG_*$E8=E3,<1<[&6*MT*PPTF]FI4BI6_(:NTYKQ97?,&S$HI(Y R_)3M2ER
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MZ5\ABZ19"X[CIK),T$!\Y+'_ -.\)#C.0V699ECSLFZ7,[A(<V7 :,;=(CQ
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M/+CQ.'FW\F4[F(#&<K1'BN&9$A*47>,XQ/E;0]L;/&*!<'(;I7K-L"(W&AZ
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M#2A6:]$F BK;?R2F6;]!\@HAYJ7O!N)C "B>W[ B A^R.FOM5[BLQ%4'!13
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MB*8EES*D$2*%,/%!GD30NK/H!V+J[-N5JM@_$F3<S7QV>*@<54.TWN15:$,
M=E;B73]DR1.U.+EP\E9%-!HV0,9,'#I=-,H=QR@.B=H,@S-U_IHL@.648\(J
M'+8XX?\ &FE/F1*I.QF%Z')6Z&="B_?M+O9X1O;;P>0'M;F"5>6V=>KNSJ&,
M?U*A]PU(@"(<5961>1[%TT ")C=K!*65V$!=>:(]=NH"N[2%,@?0D80]^VM=
M-665:8B9"F,]6>LTS#V^4@=4&P"/42]P'="MX^P"E]P:H?HQ6@'U5Z;DY@\M
MJY;)H@40*+]L1 @!X;)-B&;K&+])@* ZC=H+]RA5Y& &-YJJ3!\K[%1[DRD'
MV>4BFDLFGM[!#XOI'3=T#@*,=4H%N8>OHAZ[#N606*.X  =0'M#KJ/W_ &*^
MW15%$1 1%@IW!X%]<;8?8/U5AW_0&C]_V**H-]C;_=B&_P"R=18JINO^FF<X
M;_ET?O568"NR[[%9-R!X[><IT$/<4K<A1_3J4[R5.[JL!C)#N"T@8^P["FB8
MB0  ==MF_<X_]K5KV*K(D8A-P:LU#B.P"<Q/)*;\JRX@L?Z>@[_3H>\J K+Y
M;E4-U52MR#U$B =QAWV$0,X5ZE$1]I2%'_/J.!HA6(BK9(3$;%,LH([* WW6
M4$>O598QNSQ]IS=-5CU3N5X$<K?UIP;D_P!VB<16,'N.N  4@#[0(&X>_4H.
M]!W(!1LW^P1+W&#<0;H%$YMQ\3*#U*F)AZB8X@(C[]*FJ:*GDJ+_ /BA J0[
M!Z5,^X& ?\2J %\S;VE* %'V[Z.VFJ4"5          %     "AX%  Z  :*
M.JZ*(T1&B(T1&B(T16G(FJDL@LFDN@X15;.6ZZ9%F[ELX3,BX;.4%2G1<-G"
M)Q(HF<IB'((E, @(AIKJJOGX_P"$$KB*:"Y\&<E1?'ITA..+4IQ]O=0_BKP\
MF+*Z*X!],0&,#2,/:N/5BE2NUBKR6/9:(:G\XYW$6[$Q@-Q&W_9^I:W/25?O
M7(5>C<N\68K&],>X$Y5<7Z'5.3UHY)9@MW$"2'G_ (>Y DOCB8EL@T.U)V-(
MW*+%]"LU@DDWP-D*@;[L*@":*QQ %@SXHG1J^W^E;.V57!+=:)Z;_,L<(0-Q
M%IRN^7U:,H..4<>7&U.S5-Y'XCO,?\.I*7BVTLQMS#+S&$M4KGVJ0/KC$%%L
MA'/%5"E$I^T$CZ%PE]->M%-G<=/;5;I?^?3&#BN5AL79#^5L@YIR6-V_#"5N
MO,W&L="9B9F0;S%W_C0SKSHK[&B-'GGKX81!B=<KAP;S %,3G6,WZZ/3JILT
M?=]2UZZ<^:[?;9F>E8QY;U.TX_N?'B+J6(6'!K >7N3O(C%?)&1)+-;3D)&R
M5*HV;$DW4H=!TW/"MI S(//1 RYD0 YU(9DD@=G178U2/KHLE2QGRMRED&CY
MCIN"W&),JP7&Z+XPV7EESMMY9R[7RA _9SUFL;;@3@:YO,<#<[;96YWZCBRV
M&!.@*YD#ME$-TM )2KI3Z?2B$Q 9Z.]/WKM/"G#''&*K@PR_=+#:^0O(=C%'
MA6&<LP?<KF5I$*LB5!Q5L&X]KD;#XQX]THZ)02^[ZI%L5UT"E(\=/!#O'4;8
M&M2LF1(84"Z^UR+"-$1HB-$1HB-$1HB/?](" ^'4!\0Z]! =%7204%4 _N@D
M$F^_I5#""0;]1%NH "* B/[(@)/H#1WU5HF-.VT][..*?^):P>UH-_5.Z>:?
MA5+,@V!--87*T F^-*E0*DJ0_F"D!0*8IMP 0$6AHA?W)]\M=+^I4\\G^Y7.
M/>4NW@FN(";;W=X&'Z0T=^Y"RL45;*@5-V04C%'=/U(>7VF$!^)%P4W8 ^S<
MI@'5#C1"^BR>6Y)U16*L3;?L< ([ '78JZ>RGP_2!QU''55E8J<#AVNV2A=O
M Q"^H*7Z042^V( [_N@(?KT :H*C_6L13HAT0D#)=1#L7,"@?D['/:OL ^XW
M35(/4*K/L[,&P>C<D'H'<"R6P>WI_>2#^@-3P]X18#(;FW&-;B;P%0BQ$A_-
MLD0X[?EU7[RH%0$A  $6*G<(C\(/C;#U\?B6#QT?O^Q;8>]'IQ\?1#N [_%(
MJF+UWZ;?%T -'Z/]BQ[$G/'E 15308,E?$5RB(B8?_>D.BDFMX=1-N/N$-7=
MTJ0JW56G<*)@*;ERU41$.T18-DU1[/ 06:J'7.)-]]^P#  #X:,#H[]ZGWJP
MA$5"@+%=\Z(41 43F5%J)O'80[V@H>[H(@'@(:M06D "A%**I@'X14C48U0.
MH/ 5'<H]=A\]FEW%_(J8"_EU/>Z+(L1<J8%=/4'B!@W$B?D-5C /[HG\XJ_3
MPV,F8?$- W0,5?N6!(S4IQ!B1P*P]?*D$%1(/[&Y5GRB:H%  \$E%"_1JE_X
MM.[^A0=RR"FZ*8=T_NLHCN)V8&?MS]/^U1$I$DQ]O]5_K:./;]B),9!H7^L4
M(]$3"81:+_$8=O$\4('9G,7V!V"(#J@GI3V_OU6@%4JAP,!&Z14O#878N(/;
M<=PV*@*R1Q'V[)DW\-].\_950AF9*O(=J ;U*\B<@B'1DLU%';;KVJB/K%-_
M;N(=/9K+CHWV_P!2E5D30;)? #:1$!\2G*;L-M[1[#$(;?Z0ZZ$G6CJ]4M*J
M)2^6BR7*!=P*4P(H)EV]A=S;% ?> #K+=I4*/+<+?UBH(IB/]4V$1.<!Z=IW
M!B@8H#_0* _3HX1E>8[=J0J8B1$  032#J<WL^ A0,J<>G40 1'2IKU5+^Y8
MQ*LZW*H4S=L(#N0_PN5_H4 H_8(B'[/4QO;MJT%1JI1F2@YTTB"8YR)I)AU,
M80*0H?E\/HZ?DU/9JI7JDY2G<'(JJ0Q$43 =!(_P'4/^RX5)U$HE#ZA1V$-^
MX0WVV::*Z+.HH1(AE%#=I"?6$?IVV#;Q$P[] \1'0=R,>JQHD.)S.52B54X
M1,@]3(-P-W%3-[.]0WQ'\=S;![-4MH-%'6L7\I3T&YD4*4Q%:Q;4A%1,JJ1
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M,X.@J3Z5R=ZW>_57Y2.7*$[?'6[<ATO3#SVR,6J =Q$?$Q.T,"#XR=F<>$^
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MX#VJ;0CSGW[)VH![0%-?J'7<-_/VZ^[PT:/>JRPG<+E^N[:I;=1^QV_UOM'
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MM$;5T)R=_&M]G#/:+(P,QCUG6ZY646+J3)&L!<OD3J)BKY"+=3B$?3D<OYO
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M@,5W205;^#I/_>M/[13_ +K4^8M]ZE$?@Z3_ -ZT_M%/^ZT^8M]Z41^#I/\
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M ,Q(_P# :>='L*>5'M*/^6:]?^JUG_S$C_P&GG1["GE1[2C_ )9KU_ZK6?\
MS$C_ ,!IYT>PIY4>TH_Y9KU_ZK6?_,2/_ :>='L*>5'M*/\ EFO7_JM9_P#,
M2/\ P&GG1["GE1[2C_EFO7_JM9_\Q(_\!IYT>PIY4>TH_P"6:]?^JUG_ ,Q(
M_P# :>='L*>5'M*/^6:]?^JUG_S$C_P&GG1["GE1[2C_ )9KU_ZK6?\ S$C_
M ,!IYT>PIY4>TH_Y9KU_ZK6?_,2/_ :>='L*>5'M*/\ EFO7_JM9_P#,2/\
MP&GG1["GE1[2KT^--Z(<I_O*JJ=H[^6JM(*)'_HJ$%A\1!]H=-//CV%/*CVE
M.BV ,CN$7#=63J)D'!6Y13$T@/E@U0,W1%,YF0J;E2.(?$)NO7QT\Z/85H0
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M\%V(Z%38'=RDRO'C(2C@[H)*IHJJ)N$S^2=Z4I_6$73='. QQA,HL5P;KO\
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M6GS%OO2B/P=)_P"]:?VBG_=:?,6^]*(_!TG_ +UI_:*?]UI\Q;[THC\'2?\
MO6G]HI_W6GS%OO2B1S- EY: GX9O+H1+F8B)6,;R::)G@L%Y"'DXU%\+-3R4
MW@,UWY5?),8I5/+V$0WW#GM9<;5Z%TQ<1F"W:Q!;WLN&];\VT;;L\2/K#+Y)
M)?*+N</Z0D%R&C5@6/\ _&J\E07Q52>6NU0(+%$ULDVZIUH4%D#C_=A*)41
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L ,4^=[O/^S]^B*+I3\6_=LC_ /A1_P# O/K_ ,$NW_PZGUOZ.HK3N^U?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g571963p2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g571963p2.jpg
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __
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M P& P& P& P& P& P& P& P*9!?U9&-93R%=+.X'/ 6$L>ZQM *C;D)*!9H
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M.'NWW59)Q>]K@>ULG:US8Z7M5B94E1'!7]ZB9/J,C2A87H)R[NQ(P[V,(]@
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MU\[7T3[)O;FQM;>'%U\C9G=POF<.(G"-%SE,\B(PR_J8^C.<<YZUCZ<JUO\
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M>M?IWK73O6O3OH].]]&M>G^'>]^C ^X# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M8G&(LP(Q&HC.._\ Q;]!Y=5JVJC"D\,L--6+):[?0"ZWTS!'2:L8;.-E"*N
M10P()."9::6FQUA494/*9D-CR5WT(D2W191IH#.F?XL#+N>M&PNHH/=3NGG
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M764T*[WJIZ<8NQUQ9PV=REE1#L6!)"G*319(Y.B4(FM_;$*.7./<GZ.+RG1
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MFA=V+3DEO*KGL7E'.8'&V7UY8Q"*4V-><:6^/CU(6XJOI [+3(!$;3<*RL)
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MW&%P@KNL7QJB&X+.**-B,I(UHPDBZ^U@=G0]4>'X_BN2O:HXXWE(I$*%<A;
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M%PE9DYB,(DUD[4UY24=JBR&UKO180A<7"01V)5X8X/A2<2I<VJ=KQJ2RR^T
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MF,*+J_Q7!8/#U#.ELR>R9^N8I([5%Q^@L&?"8XA<#Z[L'C9/K%LNN;71$J7
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M=H7FR31O-WV)QSLE[<D42(2HVAYH$FH]#2MS88_*!&(9BKJO1@M#4== %?L
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MK5=T(E%>JYJS3)2FC;0[H6625='8_+[49Q+FU^/0K"H1%WTQ6)60:80X:;U
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M*K61 .5DDE,9KTL4;&Z;& \T(K+L8V9<O>+4I=)=#YM1<IF#ZU*6)LL^-O\
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M#8D?E2$UT3-YZ=T4EC) :$L0%!H=ZZ#!ZV+ES>:]@,C9V>/2&#P]]8(\(D;
MQO,:971G8QIVI6Q$"9VQ<B/1-@B&1>>C!LD -A2GF%:Z"QB#LER\SU6%:R33
MEJ15Y!G_ $\@V6[Z>HFP.FG4L08Z#8'+OS>?WX&P1!IUT&];70UI-?\ [L3U
M"W+FXUI7#Q$4T =Z_A+I T8$A:.%.,58EL22EMYFC4!::-J4!K.0!$:'0B=
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MR-L*M]0:1:0O2EG;CW9%IM"[ ;M)'$U.-8GT@ _K]$=0>NRTM/T'H[8SK$<
M1&)EMS*SEQB/ :8WZ8ZU@96T+<P[]6+F3I946DVDS7_V,YJ4G\@$O^:J#2O_
M *,P8=BY1-DI6FXTC+;XY4M9," I1I44A9('%FI&4JT8RG:4EID+402!1HZ-
MMP^OH.A=9 FWT])!75+<K-PA@,!@,!@5Y67_ '$]?^8=I?[QI1A96'A# 8#
MK^R_]&T'^OE5_P"]"'X6%@80P*$+XL\;R4[HE(HVKDY#R602O"GAC&G$-.ED
M)DM1)DYI*,LU E;I2<8Y)2DXBBTR\T:@K0#1C'LMR[OZL'''M%!NJ+JC6U49
M!#CRPP.-A3CC!;6B8P,W==-^DP4@6-M3(O@@T+N:8HGI[(H 0BY95+Q\HQ$P
MN,82U%793 \,AL;=VSW291IW9C/?ETJ/;G3M$8S' DZ4.:AS'LX0Q"<3QJ=[
M[86Q[%R[XU0U)PX;0;%:FKR/GL*T3DS*6F(L:)6VN8UTL=#7-(K)1!4E.1[I
M/7Q28HT+MC%#PM-$+8U1PABY58BX84.VW/$KP;HV-MDD!+1^Y+"V :&N'Q94
MWP)TK%"L9VMN:$J].%'!WM6A*1[5B;2N\". F"?U30EU35+&E7'6AIPXN[M,
M*?KJ2N<@=4[X^KWF)LR]4].R=@210*YU./2#&X''Q9 G;3^UV/2EO3E)S=#)
M+  )+EE9U2-/6<>VJ;$K&"S8YH:E["WBD\9:7H)# ZG-ZER8-EKDIQ9[$N5M
M*0XU$9H:89Z0DW8.T*+$$1,QV*;_ *CG&3<8>HJ.LVDY')[#369*7$X #'^3
M2!+=8N0):1^>Q%[7N,?%9@M*QH1C[ PL  "UOJ!%H:I6F5QYH<E 4UETW6.F
MXEC,C($6X1'1I_=\]NDC0H9QEC;Q!-;U+9,7<@TL72$TMT5Z'T]X-ZXN6'2\
M6N.",]K5)J.J\M2S'(5+>I]S60:@M8U28<T:5YYYB01JYR:)@:-U2*3]F'I7
M$P:DH8#AB'L:I\7J9.,W':-H536Q4=5+6V+3=FJ6U) XT6WF=+!(XKV.D7J[
M:8M)J-S%W0Z("'1(4KLL+T'051^C!JE)V>G:J8(>Z5^SUY$$,)?%)RQ\BY;$
MWC9GM8HTD <K>41Q)A3JJ&6@3@[11HP>BTY0-;ZI8-!%SVHIKC#QRT!^*%1E
M4G$R<@U)("%,%CBI.ZHCY8FGAC<K3J&\TD;8*<)"WG2;0=$:=0][T#1^]F;&
MJ7O<N.U#/ $Q3G3E;+"DLFE,R+)-AK%V Y3.9"1+9L^JB H@E+7"82M(2YN@
MSM&=_<""E!_:'%@&$7+/R>H:LFLGC\UEU>0Z2RV*"2"CLC>H^VN+PT^KW(#T
MVA2KE*<P_0&MZ*"M2!%O84JT.E!6@':T/!<LJ57D"(CL:B!,,BY45ABJ/+HC
M'"V)M QQA9$52=;%E3"UA3:1-*B.+$A1J$9  "2F%A$7L.PZW@N>U44SXH47
M,&.7LQ<&98BHG+BUNTB?X<SL#8^+5[1+"9RG,-&M:'-L4D*)85MP4ISTIR=2
ML,&H,+$>+M,%RQ\'X9\9($PP5B:Z=A+IX=,X&6,/4G86R12%*F ZR%][8QV<
MDIIPU07N7NRDK8=  D&Z*@I@DE'C+V75*3?U7>.'7=1^!=4_]N-#\P.I>X-'
MMD*V25-*)BE+4)-M!W<I#)VAM3$.18 A"O G*[?1FRP;"35/BRG]7>A_6[ _
M>#]<>N8L:>HC[G[H,G?&Q2H?764F*B#NY]82K4H?5SF T?6,*<5IZD&PGG&#
M$+E\>^.U#2-N1-#Y3U<.3:VLT?CC>C41!D[%%'8JU/3%'8\F"!&#9+"SL4D<
M4)",.])@HEZDCJ=D>: 0N5E,4:C\73JD<<96QC2+%QSFJ2M2,A"G.7J"R23E
M0R4X"R^V&4G+!O>M?X( Z_1K6$9O 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# KRLO\ N)Z_
M\P[2_P!XTHPLK#PA@,!@5_9?^C:#_7RJ_P#>A#\+"P,(8&+>V=%(6=T8G+OG
MJ]X0*VQ=ZN<W-E7]T6D#3G]S=V56WN[8I[(S?4/2GDGE"Z! &$6M;T'XX2;C
MCR'B=>U*6P)KR>G#7*WD*\6RWZN.S;$<E='][Y((./Y9S<=R<JAR6,:)J?(B
M(I(@D:4X@1:<U<G/,2C" Z1E%_P8JS*JY_)V&\)?1!]E]W?..=35/$*;D]BZ
MBZ@YZ4H+(1S&RZU52"S[%<ZVN&OI.ZMK@:8XR=81(F,0T9JTU8G0*4HO'O\
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MK];'+ '=R7(7 ;T3OJ=KMH2';& "O120TC  MYI[544I8'M!ZM4LI#R-8[0
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MEIEO8!/WI0O3=CHXO9YA!:3["*\K+_N)Z_\ ,.TO]XTHPLK#PA@,!@5_9?\
MHV@_U\JO_>A#\+"P,(8&->'5*Q-+D]+@.!J)I0JG%66TM#J_N9B=&2,\X#>Q
ML2)R>G=8(L&]%IDB<]0</H 6 0MZUL-9&KFOQX>V]I<FA^L)P(D$VD%<QY.F
MH2_QNLBF\1(F"F7QR/L?AAIZ?%\0+@#QIW[HG. UC0& 5"*'L 1&M,_B89Q1
MR[XZH7">LKO9*2/2&KJF:+SL&*RB/RV+3&)U.^*'I(WS-WA\B8&R3D(.]1]2
M6>5I()4D'HK1Y1>U"?M2:93*P+UKBLI+'H;)U<K4RR5,,CE#'&X56EF6:]JX
MY$E\<:Y$^'-E;1"6JV]L:W*7-I SE("0".6%@!L0M[UH1$RC:+E7Q]<%L_:T
MEEM)KS5<_K>K;$8-M[\5(XA/[?!&!5I&'F.G-);VG73$R8MY*07=]E;4FF$"
M&$Y.I 4-,LM5G(>K;G>98P5^LF:US@KDH99<7(:GMF!)6%^2I65>ICJYRGT(
MC#:&1D-TB0J1MX3A+0IE(#ME=EOK8)B8ZKMPB('V# DQ\@2J9O$$ZJ)$%JI4
MF/DK,4?&4QVPZ)42 DQ:$QE(-V+6@C4Z+"+IUT;P4\K[9M>QE-"EK]-(VUHK
M(DS-#8"L4NR32282F1(ESBPL4=4@,&0Z.#N@;%!R<!0A=J62(0>G6L%2&6?6
MI+6-\-L.#%,I;F>R&/!DL8 -8'E,(L"EH&X"<-) N:<9H-#3['VH-BUK8==.
ML+4L@=.82F<G9F43&+)WA@0ENCZU'2!I*<F5M.V0$EQ=D(U853:A-$J*T$XX
M "Q;,#T;^%KI(B8[TI@MV2,8[5K\+DNABVQ49.Y8R=DH@C:_)(NNEI2SOG<A
M,*61+BD0U/:=GI2/L^GK:WK1:ED)=;E90(J%J9G.8W&T-B.XV&%NCLY$)69^
M="XL^S;NR9Y%OU42 R+1I<L+-..+)- 1U0"$,8 B%2F)+VRJ#"B4[NUGFG+#
MF\DHE>D-,-7IDNUZA"4 !HA&+"$.MG#*UK8PE:Z^]:#Z<(J=DY(T-))B97['
M;,(<IB6ND#5MB(?$O>A/$4ERB!R-C*,,$!*>_,\O2&(#D(#!*PG!_P#H^KO0
MMEJ>U:35)(Z^JG="R/[*\+8^MVVOR-J=4+@J9''6A;VWNZ=(><:VK=:#O?9'
M: 9Z-^C",(?95=)4+LYJI]"DS:P.1C,^N!\J8B4+*[DEF&G-3LK,7A(;7(HH
MH0A$'" :$(=[V'HUO"U+ $7A4:J1R&)I;"C*E^B*D*26HD[@ \N*J#(NQ35.
M7)EY6A-S!WR*25"N3B5G$A4$*0[*V/>A:T*ERD=X4W$F-WDLCM* M+$PH8ZZ
M/3FIE3+M*U-DN7-K9%G)>(I88),WR)>\)2D1XM:*4B4%]F(76UTBI2%NL*$.
MBEL0)).SA<WI2_I&9H7*P-;T[FQ=S7,[\)K97/N;JX)VY>VG!$<22,D0 =H
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M_P!P*;*P;61.>J(3EA;!J!'$GK#=*@&M?6^](S?+QJ<^9+I<9(I,$*VQ#+%
MQIDS C;FY>?9<_M!0@:#4C62N:B#7FQ%A>CR#"U1>@ -"9H[8S!$U2CD+\M>
MM(V^0%_>YD[2E96;'%HE%$@XE"&1F]VH)4MO5'#53XTMK/W5XGJ!JN9R6*G_
M *"E*E2F2EEEITQ6R1B<Y2FM?+TJ"K)!7DDC+DYIW.N7*DG%L/*9HJ@.7>"%
M"R^@&=(M4-S,F4!32".3)0L7A+$#I5E@"7U2=B+V-4LK9_"A+/WFRQ,=Q3^N
MHA<LW8[)L2.Q4EL(?$\_9HA'( ;+ZVGA84LB@;R\PZ)-Z15HS;HD 81WA,0G
M4#,,&(RI"EOENUBH<EKR1,'TMS7S1/+U!SA&8,^IC0#DG*)Y>&8] [L"E*M0
MNC9RM>T.N\!-T6%N0&""9U#P'C7/X_A_T2N+<%8Q'N,MO<9E-@R1TCELZ7?]
MIC:VD1<(T9%HQ&6Q/%FAXT_;.;6[<33+=IG%4N+[P8:41W9'I.E3C5UM):EX
M<QZJK6*M(J:.[V>U[NT^/M.V-B9C"5O(:?LUF64;*) VD:>YLE3RAE %A(7&
M=5I0B[$>U1A9)Y8G*XI5C5Y;%7-4H2R4F>SXPM'.F:TB& SW>TQ!L]JY"DWB
M=86DH&<)FI6Z1U&F@QRC0]:]UR-!"'2H0U BZY8K^RZI(VOC:_52F9B+4FLP
M5<K0D1=LF1C:S<3'/B,6SE/B9BV:2W*(@ZF.IA6PB*$Y=(! $E$,@0US=_CM
MMF@>7%6CF\3F5361^]DJL&#6Q"7?8Z_K]!"VLNTXA2D#4O$6K\QE<F-C<&V,
MT:WE&;ULWU@8N5B/WU.[%)R:I3AKX1QP%'ME"22R[ ?H7XP([9E!*5P-8E,B
M3MLF+FK=71#VF5*9HU0I/+F] L&8)X5O2C241!J\9!XR]#5UM%8UY>T*@\S]
MXX?8<H*8=O*\TB(35CBUII6"*NEJ([Q<(K$'JQ&Z0/#(:LM0QT7C<SQKEP4[
MIHDL18VYJ/1#5*^Z7HE\I"LX%4\8LU8IBE=LK%&F,M5#HR2L.8F,,F)"0O-1
MEDDFKW!,Z-NCU!99?2:U;," .U9VL),W-K!]U;$[KLGQ4.[SW':?2OW+CG3I
M;N&!8].'8?\ T73J7:V^]E_@=;?<_P#J^#H[U49GIO>^[68<D[;;MW7HB$?/
M[EI8*-[;-:[3_K'J<+6X:UU__I_6F]C_ .KDX'IW'IKM5HW5AFZ3:7G*-I/=
M9CWK:(<X3/Y3?V__ -+K1$-*,8.U_P ,03>^[_G(=81TIHW.RA)=J+).5!*-
M:1J0[B3"3WLI&XR52Z$[V7Z2-/*!T;TVQ!]*?37HP'PU!V!Y@1:PPIBRA6F>
M-0%"G3F*O<R.!V:M+AJMC/<.QU_)@VIEIQ3YV6O@ $3W37\W&+ YJ8O8!H%8
M4]H')1G%.@$IFH='CNYF*VZ/)FXW03/0?ZI7MJ]5H(_0?MRV6/X"<K"O2..3
M@2DTT%C&EIQK3SRTONHQ"T4C,F*)[)0]MO\ E!Z3Q,@YD[3?PQ!/[WO^< #@
M:$R[G W0!*DDSTNL1V@GJO4FU)4,.@I29[;VZ;V\!$P,Y)[LD_[?GS%#24B-
M$K/0. TX$:A$4I4GN $IK3?YO6NYT5.S.8V%9=LL7*F;>V20NR2HT(V]&]M\
M<41)&H4;*UH9P[!LE\2'-A:$M24%>VC1F;(2&",$33*_JRLI1<X7LB#6H] T
MFB48EC:YN->LB,*V/63$@-T1D*1 N"2L)$VS*%2 TY&L*)/[UVA!@.Z@3#&)
MBEV'QN<F*%!A-D'$$&*UQQ";W383=)DJB3,[JC1Z-'_*&Z;XZB5M6C!?"-"M
MVI%_+%%X0(CDY+-)&?8YR@L"EL--*W$V$K1R=)*G5W<4NQ@^$7IUC2M,T;'K
MX1 4FE0/Y8T>!TIHQ/B@(@J+..5C(1M9*PS</CY/?U22/R!M<5NPE^A-MV?'
M)"Y;+!\ C;;H@'\D>;@<#8O8(T9I)5HG$JAI%A)2WW-CH]E*CX:V,B19W<7\
MD9M%+$BE\[/?P3!*]I!?S<L&$>E5&YR<<M&FL<Y(2>>Z&(R-1-A/TA)5O$>6
MMJ?1AOPU.FEI;5R'0A_"/TY;.'_*$%8'TN.3@*DHT=CFF)P+4QYJ7W38@:.2
M%2]>]*$/;!_E :51520R]IKX8 IN]Z_ES!8'QNC<Y3'- U]D&N9*+3'IT(W$
MV%'IYV@22,EYV(Q/\-O]?JG- =OLO^J^K- +^"H-PO18&$5Y67_<3U_YAVE_
MO&E&%E8>$,!@,"O[+_T;0?Z^57_O0A^%A8&$,#%/KZR1=E=I))7ALCT=8&U:
M\/K\]KTK6SLS0VIS%;BZ.KDN-(1M[>@2$C-..-& LHL.Q"WK6M[P/S7D/+N]
MG=\2)ZV;Z71,J[FO(>'Z93*T$QD!IX6V)+Y6DGR=8PRAA2*1%[:CT2AL"#TG
M:V+2H'4$7AO3'GV6OGD9:%]5K)>/;-7Q]/&)+DLQLJ%V-FL?F:U2SR-7 +*G
MZF2->F27-)2IH EK_24MO-UH_8U.S=J>@OLQDB(F)MJLMYTWJC@O*BR=0V!"
M9: +Y>(X^VK(S)D#+)G?C>^3F+1_3G9!<_<!HT\F=8D ]<43&1FIBC#22A#$
M7HX9=,7$=>M-E>.O+9;>%R673+S" U_-*:JRJG^UH<XN(UDEA=GSB5VTQ.\9
M,, 22@>X.K9*_;WF-/R?6B7UI=0*- *WUB2B3C46W8PRA[S.XXP2B+0YR&]!
M?9GZR]0A1125.S2+U2G"I6^MI&TLJZ.1KH*%KLO62M)W@7P2NN+6]8*:,2+S
M(JS9)Q-H$@KZP96ZQHJ9;8%$4#'WY%-%%=W+!*+G"9H,;7=2,U1'9M8*,1R9
M*%<XA3)E98TH' G2 PWHFK3F;\X:YB5#5%R.[!P4UU8KH_!<@-:5OE3PUMT4
MJRV;&DJ,C3%(--XGIL-JM4B%H)JC1:G6R32RA=<9!-,W7>KMX\Q2.LDO30IP
MJ^9DS!.XMT<=8,B701\7JI%-7[C8S5OZEFK?.@P8;<Y@Y(-IJ_K'C-2@)-%T
M: %,)<70MFA>6AEZVO,:\25JZQ)OAM;HI.Y.+Y(HZK>2INAO&]:)FL*&S,RU
M>0<A89-1JPQ*ZDJ34RTD\.]A)WU0C).-0UYK?S1X9*FF!BE-1V ROS_$*_DT
MU*C04<NCD&4VF":J80W>\*<:(A[)5(82>8N4%A*"@V> (@B$4LTE+HEEW7S/
MZX8H4NE+U5=BM3REC#)82>#JG. J9*YUN_4\MNY/*VXAFE;L!6-OB3:<0O3%
M=<+<X:!I2<4D-+6"&B7FGWF9QYCB\LD,+IR92$IN3RXN%N<@?X;&H_,W>! K
M%RE:(P\I\=WF.I$D=LXA4G4JT8 J#4"HD6BOY 9XC!L94W+B,V[*[=@S-")<
MT3"JD3LZDQA[4QA.^3=H:Y1+H8!UBZ4E].3K6EUD4-/*2.!9QK49I02$2H"C
M2E.G).-=6N#9YJ-(3A.[IJY99HO=VY-%WTDUV9&D+:JA;R[0>)O$P(+#+$"D
M]HCMJRQ3 E?P@'$3!G7D=F8G2B/&71/>YU#YB;S.7V.%3*D'&-1B3)J ;QO<
M=F,6E&HE+;]MVZJAC+:_E&N;2M<VTQ]K-!L1S>E--2A<3-G _D=AT)P65=G.
MZ*TW,9['G2%2X4?J.1P!EL&:DH69W;SU$Y@CQ9"=CB;"AE":5KWE/%&<9HSS
M$6DP#M@*!HX0][ 2,;5=(_,GVS20]N2T9*5J&%Q>U)=:Z!-,:R<GIDCU?T]4
MUXHWN+.+5.%,7?TRJ%6:$M0F&J)5Z<"RP% &F'I7LL8KN9>9K5X57S;<K@[D
MUL5/WLX4PR-S(\LKNYS;O3Y!8S"GLPQ<J9FN)[DKW/4@5 ')000U)NE0H.T2
M$0]$T]:CP8JL>7DEMWD@T4XP5V7&8TP0ZZ%ML.DC=&UT?FNP:KGD.@6H=%MQ
M][.:%[0(Z5@7'.NMJPB (*,1*564J 0)QJ+==?\ F"57.)DC@ZV,RV$OCI8)
M,&;DLL/BZ$_N:Z+7=*6F9+TX'\PPF)O!%"/)"1>E[XB5*#2 $'FC"K"D$XS$
M6A;7YG%1+8B;:3E +(C]+I@P5O6VFY;A)[.DEMDT%&.0D*B9C.U2YQD(EDBC
M\S:6-$HTG[LLE+DE;B!F;4%&B+HFZ[T@:/,$A!#L&,3*&39GE[W-Y7$85&TK
M2T*7"1K('-C(W:#&B WREZ+7R"E(Z'4@DW9#"5MFZRA$$\01$Z)I8]E\QF&/
M[K7\<;*ALA5*;/:H/-(<RDO-7F$GUA8%<VG:C'-WA\U/-,;&>3$*<>Q*6@X_
MUB6ITF" !A"C2@ T_P E?C\S]H6[;WEAIB8KV!BKR\+'MR.+'>(M-EU]&JCA
M]+6(G=E$<>)"V$" [PVU33 IC!@.6*4I>T(E"(P*T9='\UE(/,'A6I(YQ];"
MY4XH6.;)(W()4U;BR- RH)=RFL3BK #R8VOEYTRDJI3-X&(QP[@B'HE&<$\(
M-&B[F FF:M^AN&3 8%1W_8KE3]$75;3,T)W]WJ^IK%L1K8E9B@E(\N,*B#Q)
M$34J.2%FJRDS@I;0E#$4$1@0CWL.M[Z-86(N8AI-??.R<U_/(]#J<K>&W,H>
M&[BV[$H4DX TK'DN^I7<Z5W9&-XT4JCQ,BW#*D&KC@%II"5R6J= 4')TV]J0
M&HQB8N?-2\E\U%T6Q*PYA5<,BDH9F%3?Z&)*' V2)W18OIV2\18H0UR**FEM
M3NVR=.^\C71$\,YHDBQ$Y,@$8ME&C.V671X_CM?H5'95>SW3$ADJDJ'L5DI%
MSN<S$RRN)=%F(#*T&D[$%XB6[%>WWO2].G4[(4%.VBMZ,*'V6]!$$9CI;0%R
MY^W_ !^ 4C+GZ*0-89:G$&0\O7DVO*KM.R2XI'T15/F-D54,+-.4;X-(D#9*
M@:]^UL9(2TH!:1%@[0>HWHBY_.EWT3RPO2[;@6Q+W%AT=AL;1TJ=*5\=;76T
MV4"VR>/4"NQ_1(;DCTU9H;LEK<)KZO;59#0O2N*8LA4$?55!"74F(B+0:\?,
M0F=/6?RQJ\%91IY=ZYBK"FXP#-D3@B#;]N"K"*V+-H',^A(;N/IHBS6 UO@S
MD.E!PXRB=U>P:V@%TB,+B)_F\";S'IJ3841;E]2,[G6NCI@Z6S(8T\NZ^70*
MO(U0_"^T%-B-46"W*!RMKC,BY6F:?$9 PK4\=:Q+DH%)Y8TAI=$5Y_\ ?_HG
M3MSR?U'#J@+S@L/B\NN7DTG9 5-7K6MD\AB3PH5H'.5OK\8XPUFD<J.@S' F
M%4N&Y)4*@K1QJ0L6PZ4@%A-/JF)[(=;5SN<[8"^R2HE=.P*!PBA*SOF0NG(Q
M\?(DH>TL]735&^102AJ,!X;$5@Y0!>RR)X6)'HQND8#D)C9H:0S9HTUV]J[J
MUM6])1R=M:II ?3XJ\K6&UC/"U\?8YD5,7AJN%1;*6-MNU+A*E3*D51TRMBQ
M*E/=1@< JA=F2EV#7228C3?>VDELJ9H1'':5R 3F!F94^E2\3.POTH<]$[-+
M)UW-@B[8\/[F;VAH?Y-*F.,Z.D75ZNM[T9=R&2L3@C;UQ#B044YHFU>D(<-&
MM+AW=W2FK6[2IJ="T;HWJ5*9.8+L%!)1X=E&!$#0BQZ"'=Z_8NIVGKII[/L^
MV[3UBCZG9=P]:]KUNVZO9^J]]YZWZ.[_ ,I_@>G Y#?&4OK]=X:P=EVW:==P
M2![/NVTFE'7Z3M=3L-KR.OT_X/;%]/1UP](<_7#1U]E^M6[M-&=CL'?DW7T;
MZQ]4=EL/:];1GK;^:]7]/>/Y/_#^#@<0/;,;LK1;NV&;/[#L- 7I1[.[UM6%
M-V6@F[[3O&V\_0.CIZ^R#.CIZ@N@.&GYBV#1FGIIV6(L)P1Z<4>P;*&@&Z -
MT+MNC98VPH2G0OT;(#LS_ UO>!]&^LA>A[&\M0-%!.$9L;@D#HL*<I*>H$/>
MSM: $@A:2,>]_P"" X&]]&AAZ0Y[>F?0]E[=FW1@3!%"!M<ET/1H%Q;6(K8>
MUZ=&!<S0)]A_3H\6B_\ #WK6!\ ],Y@BPENS88(X1(2@@7I1B-$I.5)TX2]!
M-WL8E"A">6#6NGKC)&'73L M:#B%]9!@"8!Y:A@&$L8!A<$@@" :@-="AA%H
M[>A!,;"!J0[UZ-D $9KX&M[P GYC $0QO+4$  &F#&)Q1A" !"5.N.&(6SM:
M" E$K*.%O?H"4: >_@BUO8<A/3, 0@"=FP(P#,+& 2]+H0#"59#>:6(.S=;"
M,I>I+(%K?I"<8$&_A"UK8 O3,,0  =FP8S!E%@ %>E$(9ARI0A)  .C=[$,U
M<E-)#K7I$:6,&OA!WK00&T;49ZVJZQ;+3IAS+<!K^63PB*QQ8E4/LKU&8D\R
M].PL)8!'=NZ/Z%E-"DUH(^O_ (6M;"'>%B+FFK<6Y8/D?]Q%5N2.AY*DME%2
M*B&M=(29R7R=@47;/6F ,RQZ;9&N/22:LTSQ(D914L3'MHUBCKDEM'6$'82U
MX*TE_F@UTU,$@=HQ74L>.QKFUI9#'1[=HHP1*9RNM6FZ7,B#()&!Z<D@7)]!
M2#B8 L/7<.Z*2%!"-02%2-.-$L\Z^93748;1.LIKF=)&_;V_5^C7M:^%.A+K
M;D2C<<D$EA9"3WG3.+4Q)A2,!!$D<BD;&/16U!IY",]$H5#1*.,OF.%DR.7Q
MJ;5T)IDK38$VKR-PAH?8^Z/3V\1BQE$'2$:>$TB5I'%U,3-BY:I;VM&O6$IT
MPC.IK9:@H@NA/JQ\Q.MK8=JN+C->V*5%+1-I]K131RW#B$#+);PK!\M6$L+D
MSIY2J?SA%,T?.2N"E.G-3IUII&BQ'$B-.)).$PLM9RQ8F2WY77\B:MMD=9[3
M;:/9W_:E*6<JL%-QI?>5<J7O'K!8@3MD335V0A0H!EZ/4*782CK:"G!HP)*Z
M-;I1YH4635;)K.A=,3Q]:4D$D#[#W!\?((Q,LCFK1Q+9.9)$-7FI)*\O#*B-
MJ=ZZIKIM&:F Y)32 :&#91QAK1UJ?QUI?5-\KS;.M^T*\7LK8R,M:QB1/3D[
MG*@)UB9SC5LS^NG=N5;]9+VHYK0)8:$_U@$XD)YA@]]D4#6M82<:BU217S-Z
MRFJG;+'*XG:R4K5,+4QQH/<H.V-#_%)W6EDVVR2LF:NTF0Q A".&5.[C#_.S
M"5BCL.Y'*DQABHDNBNU+Z2\P^KKYG\-A$/@EHIDLU*9D:&4.\?2E,S;*'>C(
M]R&]WW<Y$X+2"B4D!DJ<H2Y.:H2FN>ME%;&0(I48)PF(N6SZ:L**T:G,!"JT
M7*O^VR4*A<T1]X6DIYJ\2->]-C:J<2EBI*U/SRZ.NQ(B! 2C&:I $OHZX<,W
M+F175"D)!E)H)41*$_6SS"B(Q#2TAP5;0X*A'# 6AT29I2PJ51FQ;UOKI##1
M>DL0][%SYI"QL]<Q!2\+F B,,)[J2UE.HT)Z%&7W**L"!$T(0$A-"0WM3#'Q
MD[)3$A*3IRC]FZ!K9PQC)UE*1/3, 0@"=FP(P#,+& 2]+H0#"59#>:6(.S=;
M",I>I+(%K?I"<8$&_A"UK8 O3,,0  =FP8S!E%@ %>E$(9ARI0A)  .C=[$,
MU<E-)#K7I$:6,&OA!WK0<0OK&, 1@>6H0!@+, ,+BC$ 99R-0X$C"+1V]" :
M@2&GAWKT")+&/7P0[WH GUD $8AO#4 )99IQ@A."0(0%$(T[B<:/>SM:"62W
MJRCQ"WZ DF@'OX(M;V'(;TS%B, 8[-@!%". :$:]*$18TYZ5*H"9H1NM@$0I
M6DECUOHV$PX =]&Q!UL&GIG$/1>G9LV,1@"@@TO2[&(TQ<:V +T'1O3LP;D2
M-/K7Z=G@$7_A:WK \Q[RB4I32V=Y8Q.2I/H+2(]64J2F+5B56<UB-(2JB3U2
M<_NAAG4*&$9I11G4%KJ[WH*WX^6R"\J:@=I>J1,*N4-1_KAE[;O1+5(F5S71
MV3($*WJ@]8M2:0M"D"15U0=Z2Z+-ZH>OU=%F*FDAK+_N)Z_\P[2_WC2C!*P\
M(8# 8%?V7_HV@_U\JO\ WH0_"PL#"&!YEB-&XHU;>X)$R] O3'HUR%804J1K
M$:HH1"E(K3'A&2H3*"1B 86,.PC#O>MZWK>!&F6 0.-,K)'(["8BP1Z,K=N4
M;866-LS4RQ]QV)6+:]D:T*(A"TK=B<#][-(++,Z3S/3\,72+2!8V-KB8WFN#
M>A7&M*X+FUFK$B=48VN04RI$%P;QGEC$C7!1KCB=&E["9HHX8>GJC%K85V*C
MJ4$_.<I%3]6BD[V)W$\R,5?Q/;\[B?R%"9^$YN^VGU@O$]IE1I:O9I@^\@,&
M$SK:%O6RW*?DLC,F=ES^G:6PA]<T3>VN3T2@2E.S@W-)JXYJ;USB H*Q6B;#
MG-2-.48,19(E!NP:ULP?21D\!@?C2_<L(4NN.SJU8.'E831Q>Y*]Q+W@6(4[
M?J0O:/E+2]!OWBR2MJU6_H$S@X6&"4A&>C4@6(X^8:G&L3[*<0'2IJ[8N8<D
M'*5R_CW"SZ+A5=O52\AJMB[0RN4KE13"['R7D/9W$RR7NC:^:H@PM%BQV)5H
MQ.ZH:YU C+CR:2D*!)];+*-4BJO\FP=E7"@HVQG>!0CB)$7^N:W<ZBT:="6Q
M&W2QQD5V*96X(]UQ"&Z ;CRI>Q22KF<:T8W9*8><>F,ULLQ(5VI(B^V>J U3
MRY?)S=M%H6:H:8CK-.I"9%)O9\9<'.0HRT=AT]8E[)*QCLW%"8GW2RV.PXOH
M<I9U9>RC%"Y,;\!<J,*3"<>DL!:'+*OZVO"6P*-<4*SE*NLD%Q-T=DFB&B(.
MC)(8O6J>WWLMR/>X GW$8G/5$K<4NW0@PQJ5*QFG=\4;.5@3"(Z7:Q)%<;)/
M^+M>78VT?3(U2GD#4E62AML**&NL0C<2'?+11<ED[,['14@@](SPUV4C;7-+
MWIB2DG"V2L6(P=H<*J:\E9U[S(<[E*;(6R\,82WJYK)V*%IV.</3,4SP@JQF
M*X?>>.7*RLD(DKM%Y8W,],DD.C48B"6KTX%IS#0!3EC4C37;*--?F),$%4IG
M>#<1F9E<9I6Q\VFC)&1"C,V+FZ3BW+N3"1ID("ZX;%4@85"YDW&B'HHE8G$X
M.(1=8*P)S6$NF^](IYRFF]9S)6QN/&.B6LF,L]PM$F1!>!H&Z9O#$S<9KS@J
M*&SI]@$:942'0N0#VXO"5R3@+-=6!:L+4%:+.."2(N.EKF%?T?1\;ZOO>(4>
MR(3YM:YZ.31*-18@@*A;$)!9[LK=RUSA"$QRTI7*XX>N1NZ=,:2)2Y;5HEBH
MLT*I2*ZU+/1.]7&P*JY&RZR.-A),JK>N8S:(HI 7)R?WVQR)+1H+ 8&*.213
M$(=(B;(8TZI1'@')BA')U 2QIC ",[ HDQ4Q34:!7G6-"-[K'J\X_P!/RE-(
MT*F72!]C5H32Q4UQKW--6E>*ZBI^1R^K0'6)<"6)*$"=PCI9A2 *=*C <;HU
M4OVVFIB9[97+'.5LP=W%V1K^(L";:_G;K6JJ<#(?G%8]R2,V?R'>.)*53((X
M942)GDDD94<82/BY.K6;3@C8@)NWWHH!HB:?/K^)1>*<U)Y"XW&)(EX31QDC
M9-<5))6F+U0\.:Z:HX_R @]E6.P0.,Q\-11=MV^,LGK;29\1@4$)]J79.:7H
M1P-EFO\ $T^; K.43:O8YTUQ?AM05AI4[-/+CE[Y%W/3K44[-J^M(?;AB!F?
M@4J<=++;3KYP:TF 5HB_5[EK1VSA&FGHTY:\9E^M+#%X*Z1)N*2P:.(&!\31
M>0#CIL<9R48%+4B8SHX8M;"TG<MN$;*94!:4>P[$D[B1HK8=$E]4QU9P$3BI
M:Y&YEQJ/EN3<X.[NWN &9N N0NK^4,A^<T:L*;1Z9P>R3! 5G $$Q2$6]&"%
MK>\(Q#%65;Q?K^[5?0B.]H[+'X?J**,+1UWQP0*&I>\C]7H$_6=ES6K-3'*=
M_P L:G-&6(6P"WK9;ETL]55?'FXYH8*W@3&TJ$[RD/:V>'QYL;CTLB(0II F
M.1(FXA,8G?4S8F+6 $'850$Y03-"T6'6A<L&"B*<!8@;9\-H>9893.VL2*4'
M,B(]>U(&I^ETG3"9 G%#3,CB<_3MU4J5B0!*M88KWVYAF@%Z +GL6SA# 8'$
M8 & &68 )A9@1 & 8=" , M;"( PBUL(@B#OHWK?HWK @$;J6JH:EVBA]9U]
M%$6WHB2;21N&1QB2[D24D:=*_;3M;:E*V])B#! +5=';@ +>M"UK>]86Y9,=
M?P(P2L9D(B(QKU;FX+A#C;,(2U>]JVI>\K58A(M[4JW=<Q(3U1@^L-0<C(&9
ML0BB]A(E@P , (LP(1EC"( P##H0!@%K81!$$6MZ$$6M]&];]&]8&'11N/-H
MVTQN865 8SLNHVT&(FM"E&U1[6T8M,+:(@@L2%ET)N3[[J5U2.D@OX/P ] =
M<?BL8B:42&+1QAC2(0$8!(X^SM[,E$!O0IFM  2=N3IB=@0MB,E.3KHZ"B"@
M%AZ !#K0=*R&0]Q6#<'"*1M<O,5G.!BY8Q-:I88O4Q\Z)J%HU)Z49PE:B+*#
M&P9FQ=<;>,2?>]DBV#8<T41BC8K X-L8CS>O++4$EK43*VI%8"5:%D;%10%)
M"8LX):EMC3<G,#H70,AO3%[Z0D%:"'QMB$39RV$IHB\=:BHJWJ6F+EMK(VH2
MXVU+0I0+&QA F3%!9V]6!"1HTE/V99FB0:%K?4#T!'G2HZH?%+.L>ZQKQX5Q
MYT<7Q@5.D+C;@I8WIX=MOSL\,YZMM.-;'1T?-[6J%!&P&GJ]]L,0C/A86Y34
MIL;2'!8[$-Z$ET<4Z)(X.120@MP7I6P2P;:F6+ %Z4*D[>-P4;( ,0@E;/,V
M'6NN+I(]V!'EL1BCDO$ZN,8CR]T&-O,&Y+65M5+QF-)+JF:C!+#TPU AMB=]
M7%I][%TD@6'A!T:-,T(,9X;UYV'=O<*%]VVEVBVG]UF/L-HMQS4/VD[+N/9]
MUW$0Z:NSZ.IZNUW;H['X&%N7:=7T"4]X[Q"(@H[UM?M5VT:9C>\[=!,PG/:C
MKHA=MMQ%'6_9_6Z>VVA3]?I[$OJDN7=[C0K1XE6H?%N\C5:7#4>[[3VXENI/
MJ;:5B.[IV@E6IEKUOVF]]?UG_.NGM_Y3 ZT\!@J02026%1),)O\ 5^D D\<9
MR1(M-(GH;5I)LM&':;U8.2N.T_4ZO8[<%.P=';F]8MRZ0UQ7H20)@P.&!3EI
M2D)9 8NQZ)+1$1U1$"$8"M(>H%*3$U9K6 O6NH%N-&FUKL1;!LERT3>X?=3[
M-Y"%37:P$+)EEELJ5LK^)T<@6F'&O5?H(2ID2^U692E>ZSE-3LJ0YQ.;M*EG
MK0I4C/!O2%M))-14/"_'<QG,T@+'QBIID4J3%*!T=EJ"%+U7O*KVAE"Z:M9X
MYZH+]WT-HDZ>TX5B?:]<>C*.-++4Z#LPOI\9;!\=HW)%C1(#+4K^-MSRP2*'
M)HZL,A<:8UG;-M>Q61R0:%.T)ST &^-7/+I<4UJ4RA07H)IHR3S@F;5*#,^2
M^2J\@!!)2<B#0XE.02F3D$%1EE+))3HXZKB"0@HH"+0"R4L27GM98=:T$#<<
M8F#K1(Q V2WPVNJ^/*.(/@L-.(4$JTZ@DV,,AA1Z=>SMD>7$'%C0[ :2M8&5
M&A-"+6PF(TA)(M;+* $(MW&0*#'&FGG0N)FGGGJE1YQD=9QFG*EKTWR18I-,
M$CV,P]7(FE*O-'O>Q&+4Q1XM[-+ +0"H%!B#23R(7$R3DYZ12G.*CC.6:0I0
M/#E(4*@DP"/0RCT3^\K%Q0P[T(M8J..#O1AHQ"+<OJ&"0=K,0&MD-BC<:UB;
M1MAB&.M"0QN&S-2]A:!H!IT98D8FIC=52)-LO8=D)%)I(.J68,.R(ZCI6FVY
MIDK WU+62%BF9R=3,&5' XLF:96H2*!*TI\E;B6H"-].3*Q;-+$J :(!F]BU
MO6_3A;EZD]150D5H7!+6%>)E[6RJHVV+D\+C9*MNCJX+@!:P(5);:$Y(RK .
MRK1J4L02#-*3="#OM!](N1)4=4(#UJI#6->(E+E&2H4XJ$D+C:8]?#2$*9K(
MB2TXEM 8JC)+:B)3@0#V)*$@D!>B^H$.M"Y><-+TZ!G)CH*GK0,?3C"80QA@
MD6"SD& 7;<P#);--6D18P.0MJ-;"#6]'[[3_  O3@N4A;X)"&DI&0U0V*MA+
M>>W*D!+?'FA&4A4LZ0UO:%",M,C+ F/:T!XR$PP:"(@D8@ V$.]ZPB,NM*U2
M_/<H?I! 8Q(EDTW%#I0GD+0C?6AX<(04X)HL]JF-V*6-'O T(G(:<"\)(58D
MQ9!0S!%IR EEN4AW7T"$WB:10B(":A!. )LW&F;;>("F-ZAJ@ D6T7=MA/B
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MID0U!9(JUEQ10U9"<:H;G -DDD'2E<P&+S %S0:D29*S)2WL80%B.VW*2R@
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MG3^Q%8TD1B+<\)'5_=- ATAGP5XVUM,5J6]F/B<76JRERD)*,[180 ,$8:4
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M;OM\5O2ES>%C$^%/J<X^NE26)3!J7,FT$L@;>LKDHXIH5A$ET>X+#.CM# B
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M)?7,W;-/4-GD:>XA*F?:I:ATZ1Z1-RAI>&_:UN4)'!)I8WJS"^T(-+-!UND
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M)4G7-()+ F4*"32ZI7<?"Y<V1-)'H98K@A="'MU=%$FG#7X@N*I&[NCN[FM
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M6&(W4@A<:60,1:EX<AO)@#U'5!L25,E*WK>R>N(DS:W<(8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&'
M,D,?),&4:^,Y1I0Q%F%F.:(!A9@!;", P"/T( P"UO6];UTZW@</>6.?2!D]
MJH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH
M/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C
M\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\!
M[RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![R
MQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQS
MZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0
M,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,G
MM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5
M!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\
M?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@
M/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>
M6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.
M?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2
M!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D
M]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]J
MH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/
MC\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\
M![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@/>6.?2!D]JH/C\![
MRQSZ0,GM5!\?@/>6.?2!D]JH/C\![RQSZ0,GM5!\?@95.I3JR0*4AY*I.;K>
MRSTYH#B3-!%L M@-+$( ]:$'>M]&_P!.L#NP& P& P*R64K3;BL5N#A4M9+U
MZ]2>L7+ED#BJI8M6*31'*5:M2>U#.4*5!P]C&8,6Q#%O>][WO>"Y>;P(H_[&
MJI^[R(_,^%N3P(H_[&JI^[R(_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/
MS/@N3P(H_P"QJJ?N[B'S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:JG[O(C\SX+D\
M"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:
MJG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[R(
M_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N[B'S/@N3P(H_P"QJJ?N\B/S/@N3
MP(H_[&JI^[R(_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"Q
MJJ?N\B/S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/
MS/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[N(?,^"Y/ BC_L:JG[NXA\SX+D\
M"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:
MJG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[R(
M_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N[B'S/@N3
MP(H_[&JI^[R(_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"Q
MJJ?N\B/S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/
MS/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:JG[O(C\SX+D\
M"*/^QJJ?N[B'S/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:
MJG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[R(
M_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N\B/S/@N3
MP(H_[&JI^[N(?,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"Q
MJJ?N\B/S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/
MS/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:JG[O(C\SX+D\
M"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N[B'S/@N3P(H_[&JI^[R(_,^"Y/ BC_L:
MJG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N\B/S/@N3P(H_[&JI^[R(
M_,^"Y/ BC_L:JG[O(C\SX+D\"*/^QJJ?N\B/S/@N3P(H_P"QJJ?N\B/S/@N7
MWP)I#HZ/!NJNC?Z=>'D1Z-]'Z/\ ^D?P=."Y6"RL;)&VQ*R1UG:V!F0Z,"B:
M&5O2-38C"<<8H-"E0(22$J?1J@T8Q: #76&+8M^G>]X1E,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M4RXU[9JMP7*D5^RUK1J5BE0D;"(35RDAN3''#,(0$J%L04+5!20H6BPC.,&:
M+0>D0MBWO>%OR>/PVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,
MOJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4
MO[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X
M+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CP
MVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\
MQ<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^
MH=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_
ML7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@O
MR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:
MUOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%
MS+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZA
MU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q
M>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(
M\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6
M_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,
MOJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4
MO[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X
M+\CPVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CP
MVM;\Q<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\
MQ<R^H=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^
MH=2_L7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_
ML7@OR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@O
MR/#:UOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:
MUOS%S+ZAU+^Q>"_(\-K6_,7,OJ'4O[%X+\CPVM;\Q<R^H=2_L7@OR/#:UOS%
MS+ZAU+^Q>"_(\-K6Z-__ /14RZ?1Z?<.I?1^G_\ POH]."_):\<;G5I943>]
M2%9*W-,$W2I_7H6IM5N AJ#32QG(6-&WM9&R21A*UHHD&MA!K>^D6][V1F\!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@8&
M3RF,PEA<I3,9 RQ6-,Q(5#M()$YHF9F;2!G%IRS%KDX')T:8)J@X!8.N/77,
M&$.ND0M:V$?A]JUE81+:?!+"A4Q+>$KXM:_=J3LST->DB[BVL\F4)2F]8>::
M7''=X2)5^]!_F:E444=U!F #L5,)]@,!@,!@,!@,#7QVNV2LKPTL3C2LN1ND
MB6N"&+H5E@4.@72<YL3FK5@6!N76PF<',PAN*VI,+**$:21\(P(=:WT%IV@N
M69&+PM1=#3DQT&4M4 ;03NAQ+Q$-IJ%.XGA1AMC:C9+>>YI@'BZO04-05H71
MLP'2*CQ9'Q-LG\N5E?6ZD?Q3P5'B>)MD_ERLKZW4C^*>"H\7G5VQ/D"52N7<
M>["1(42<Y6L6*YI1B9*D2IBQ'*%*E0=:P"2$Y!(-C&,>]!"'6][WK6L%0XI;
M:GBXO9J+C[8*PH.P!$8EFM&*"];,)*4EZV,FUAAUL:<\!FO3Z0#"+7HWK>"H
M\7%#;LY<R-JFV@)^X)0J5J,2E#-Z*5D:6-JU0W.*79R>US"]*4#@D-(/!T]8
MHXL8!:T(.]:%0[@6K8)AQR8OCS8@U"<)0E! )G1HCB GZ'L@1Q6K5V,H)VBQ
M=38M:ZW5WT?HW@J'0XV_.&A$>XNU SUK;TN@B4KW&<44B1)PC, 4 1ZI3:Y1
M!6AFF!#K8A:Z1"UK].\%0]OB;9/Y<K*^MU(_BI@J/$\3;)_+E97UNI'\5,%1
MXGB;9/Y<K*^MU(?BI@J/$\3;)_+E97UNI'\4\%1XGB;9/Y<K*^MU(_BG@J/%
MTEVI81PSRR>/%BFC2FZ(4@+F5'#&G/V24HT2>$-J[V4;M.> ?5%T;Z@PB_1O
M6\%0Z#;>G!"Y&V'T#/27)Q*6'M[>;.**+7+B&_N_?SD:0=KZ/5%(>]E=L( 1
M:*[4'6Z.MKI%0(;?G#F6>:VT#/7 I,M6MJDU#.**5EIW%M4F(G% >-/:Y@2E
MJ!82,H\H6]#*-!L(M:%K>L%0[SK5L%,$ U''FQ2 &'$IP".F5'%!&>H-"2G(
M (=JAT(X\X80 #KX0A;UK6M[W@J'2WV[.79"D<VJ@)\YMJ].4K0N#?-Z*6H5
MJ4\&C"5*16FM<Q.I3G WK81@$((M;Z=;P5#V>)MD_ERLKZW4C^*>"H\6-.N6
M9)EP&Q10TY3N1J<"HIO.G=#E+3$IJU.VEJ2T@[8">,@QQ5E)PCT'J[.- #6^
ML+6MBH=!5X2@]&TN!%'S$Y _'DI6-<585!F(WE2H*./(3M2D%M")<3SR4Q@P
M )$,0@EBWK6]!WT"H9GQ-LG\N5E?6ZD?Q4P5'BAT5Y(*9V:[D0BJWJ9'1]4%
M"_DQ6U..\A-9%H]G! C=RVBX5@VU4,2<S6BSM 'O98O1\'?0*2PZT["3@T8?
MQXL4@ C2" C.F5'%@$<I.+3)B="':H=;-4*#0E@#^D8Q:#KIWO6L%0BJ;D<K
M6NZ&/(ZI>U;^Z(2G-M8TUI\=SW=Q;3QN)1+@A;2K@&M5H3C&=6$)I8!%B$E.
MUK?24/JBDO\ $VR?RY65];J1_%/!4>+I)M2PE(-FI^/%BJ"]&'$[,)F5'&@T
M:G.,3J"MC!:H@]H0H*$ 8?TA&'8=]&];U@J/%W>)MD_ERLKZW4C^*>"H\3Q-
MLG\N5E?6ZD?Q3P5'B\15OSA0M6MA% ST]R;BDAS@WDSBBC%R EPT?M :L2 M
M?9Z4I;I*;V(AA#HSLQ=7IZN^@5 1;\X4K5S:FH&>J'!LTE$Y(")Q11JQO"N+
M&:BVN2EVN(])I846(16S A[0(=[#TZUO!4!]OSA*K0-ZF@9ZF7N@E(6Q"?.*
M))6.(D9/>%FD"8RUPG*]I4^NT,T6$74!\(71K!4>+V^)MD_ERLKZW4C^*>"H
M\7A<K?F[.A4N;O04]:FU$7LY8X.4XHI"A2$ZWH.S5*M3:Y2<@O6Q:UUA"UKI
MW@J'N\3;)_+E97UNI'\4\%1XO(&W)T-<>U@X_P _&YIDB5>I;@S>BQ+DZ%<<
ML3HEIZ35K;4%)%BAO4%E&"#H!@R# AWO8!:T*AZ_$VR?RY65];J1_%/!4>)X
MFV3^7*ROK=2/XIX*CQ/$VR?RY65];J1_%/!4>+P^,$W]9;9O *>^M](=.>VK
MWYHGUEIMV?M+IPVA\5^]:0[5!V7VO5[/M-=7IZ?1@J'UNM^<.Z,EP::!GKHW
MJ.T[!<W3BBEJ,_9)IA!VB5*:US23.R/*$ 70+?5&'>M^G6]8*A[?$VR?RY65
M];J0_%3!4>)XFV3^7*ROK=2/XJ8*CQ>93;$^1@"8LX^6$D+&/LP#4S2C" ",
MZ@S.H$1MK!"(?9EB%T:]/5#O?Z-;P5'BZF^X)N[)BUC504\<TAI:<XI4WSFB
M5J8PI8D3KTAI9Z:US"AEJD*LHXL6M] R30##TA%K>Q4/05:M@G[."1QYL0X2
M8[:=0$J9T<9LA0$ #!$':!:N]E'!+-"+81= M!%K?1T;U@J/%W>)MD_ERLKZ
MW4C^*>"H\3Q-LG\N5E?6ZD?Q3P5'B\2"WIRZIN^-E 3YR2=NL2]Z03BBEB;O
M+>K/;UZ?MT]KF%=NA7I32#@=/6*.+$ 6M"#O6A4/;XFV3^7*ROK=2/XIX*CQ
M/$VR?RY65];J1_%3!4>+QIK=G2TQ<2CX_P _5G-BOU>Y%)9O11YC>O[JE7Z1
M+@%6N,:17M"N(.[,S01]D< ?1U1AWL5#N)M6P5.C!)^/-B'A*.-3F[)F=&FZ
M+4$#V6>09L%JBT XDP.PC#OX0=ZZ-ZZ<%1XN[Q-LG\N5E?6ZD?Q3P5'B>)MD
M_ERLKZW4C^*F"H\3Q-LG\N5E?6ZD?Q3P5'B>)MD_ERLKZW4C^*>"H\3Q-LG\
MN5E?6ZD?Q3P5'B>)MD_ERLKZW4C^*>"H\3Q-LG\N5E?6ZD?Q3P5'B>)MD_ER
MLKZW4C^*>"H\3Q-LG\N5E?6ZD?Q4P5'B>)MD_ERLKZW4A^*F"H\3Q-LG\N5E
M?6ZD/Q4P5'B>)MD_ERLKZW4C^*F"H\3Q-LG\N5E?6ZD?Q3P5'B>)MD_ERLKZ
MW4C^*>"H\3Q-LG\N5E?6ZD?Q3P5'B>)MD_ERLKZW4C^*>"H\3Q-LG\N5E?6Z
MD?Q3P5'B>)MD_ERLKZW4C^*>"H\3Q-LG\N5E?6ZD?Q4P5'BED0ETKD*U6F?Z
MKED"3$)='D.,@>Z^=$RX_9P2]HB"8?,I(M+/"6+9G6-*+*ZNMZZ_6Z-;"P<(
MI+D/4ZJ[*G?:\1*XVC6.#E$WE(;+6-T?F+:R(RQDEJ$)Y+!(HC)VA>%:R%C0
MN[2Z('5E7A)7I#='IP!$6)J;:-*_+ID<J;W);.K?*<I>&&WVS0!U+02QY7U/
M)+==Z+=XS)&&=R.9K+(F#M7RVFC%)3H^N*IY-.=NR*4IDB1.1AK5_)Y!^75/
M7ZSI),YK>2%TC$NF#>]S.%M46=VAJGS.U<D6&[T+?*$J24)R%&_<YN4Q$T"O
M;GHU$L-%LSN9NVT U154PI/EJ3TANL! IOUSD7O*YDK$YSR=*TQTK+)MM=9B
M!581#:_@C[N\1MI4EL*':YM>T&T!8P&).Z#+0$#5'@_3*H8<^U[5==0.324F
M92"&0N-QAWE2=H"P$2!<QM*5M.="F4*UQ"V%J]INMHGMS>IK?1UMX9F;FUBX
M0P& P*IO.$2ZR:@L6!P*<+*WF,KBSFS1Z;H.]A51]Q5%=4I2 YN5(71(6?K6
MR3#T9Y"U.6:(U.86> L>BQTFY:GTYP\E,1O.(7?.)"SJO<Q!?;9"H @DT\F;
M=5[+;J7CZD0QJ)2R9')7-[:BEE3O[JM$K1)@EK)-LA(260F!L19RN*5*^^7=
M+W*<7+-&>P&Z+/$G7<HI-5LBCTCLEG?HU.[]?>/LKC<F? M#PWD!U GJH%I8
MDI!BA(K*4D&Z*+%VI6BZNE?DO7C_ ,;+LK"]+"LB?W6[S^,28RTQ(FQ1(7,\
M+P&<6:GF<(];Q ]A1LD:-J.'D[C;:-&N7:.1C$( 4A0MIL),Q,4JATX@\D#V
MZ1-2>THVY&/MB'/\GE;O/;F+DMG1!18$TER%G<F@*YQKBMUD38WML:$Q25BD
M"-:C;=E=5&0).2F+JQ\%2PKA5S&%MXC4ONM2%7'89 H>TW2JLBQG=TFI#;Q;
M<JREK4DKPQV5L;=')':+T2[N#BN$2\"6-FU("CU.T:Y,-6/X_-[)EY?O)4U/
M/FNL[NC<((F$VE]E(Y0WR2SFJ4H+$DL1I!G;Y>N3DB=6=8./N-;.Q8$Z?2-6
M:0Z%F@7IP]Z1*1JCO;:2#C+.C>-$FIB-S0EID[S=%C6>0]L;V]0D@;/.^2LL
MN\49-=D+3(S"0C8)+IL7!4M;FW+A!- >C-3F[#HEQ=M;VO@G?+2\ZE"^QX=,
M')Z8J.(LQD]\;E@+5:;C5=6VC6P6N0O[.Z2.4(FED7RUFD*%46::8XN38:%2
MF3]9,<F+J@?^!G(640290"6W\FG+K+8+%8R&Z9*^V-[X,^F*MZ\B:QB;ZP"Y
M+:J7(#IU$%LK*=7<EW4C<',6E",]5K;B(:HNVSBGCC93SQSB=&R.TUZU[9+0
MA+M+;&02.=,\FLVMHS=#9-I*DDCRV/*.0-<PLZ (CFYZ+0K"VG2Q:>!*6G;A
M%(R27%VU,DW#'E@Q!L=QC]T/MB#E$[CFVYC4VI+X@3(X.Z\LJSL94WRO;6C9
MU<-05?1+(YQ8L;2Z.:MS:C3BBR@!4;0F%U8_C\DP6\&;[<8Q,@CY%/S5*ET0
MC+%721LF]D'1VNT)/(VR+:F]?)%;DN4&.T?DU1R9GKXN1*VX]](:VS9H2@E!
M*0Z&J/!YVGA3R@:WZMG9OY'KFHR.-TG;7-:X3"93,N+MD@E-H.Z9LBD:4L\9
M:I&NC[)-FU$WN"DYG2@"T$%K6QQ2)D29,-6/@\<&X$7LGC33&[%Y"21X;4JQ
M4J>FIOLNRCD[^Z%T-)ZW32P3JVE0AV1.+Q9+VEE"M :)820K;23]*5*[6U6Q
MJCP1B0>7SR0/#(3H[?Y;8NEKZ.5R]8UR^<19=,)ZZ<:Z-IO=E/3F4S20\B25
M_-JG='IH(3 + N+DH]C/0*D1!PQJCOAL-6G$NT8IR;8KJFEAMT[;XPGY )D\
MD=GZ;+)O)&VXW6M5\585<05&[KN'(:O;(.8UE'-6MB<DVR3>R2F"5!/).454
M*4?N'%^0'Q[F=?3%Q*<G^0<D+-A#'5TTE:603RQ;4MR.VM3266QV:R!@KF-M
M-3/S*(MR$C6:+?V]Q7$& (*4*BEQ=4=[9&1<99_,>/E+P>62]!)[8@UTTUR
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MM?KU%_G3!4GC-3_VKUK]>HO\Z8*D\9J?^U>M?KU%_G3!4GC-3_VKUK]>HO\
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M(B":JWB51V6G&UY-6R)3>CX60MJ.3IJB<12PAS4709HXXXE*0C71IR2A&I"
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M]=&]:WK^+^# ^]&NGIZ/3^CI_AZ/XNG ='_W_P!/]W 8# ='\/\ #^CI_O\
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MH)C%]U2O<U3LO5.J*LSH,:\!=%30! ] 'H.@Z[?8"QE]*%7E$N5:">RR&U!
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MFD"5HIV<EQ ]%$$HP$C)&5+"K3BQ*(9;,>L-4_PQO;F4IN&-!&&5>E>U"9!
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M,+$XUVMO\,F P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MVR2-B((Z>J6'J_!#Z,AC_FC\VY=>_P"@,'_U/C7_ (*BPD]J880P& P& P&
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M P& P& P& P& P&!^?/EM?[&;H_XZO, _P#6'<F&L^V/RC_!^@V&3 8# 8#
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MM*2%,*J1RZ7)(BZ110<YQ9%%'5PEQQVDCZ2X#&:C0G$&%C;T.TQK5EX+QC/
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M\H_P?H-ADP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P&!I3YDW_ +>/.G_A#Y&?[HY;A<?\T?FVFKW_ $!@_P#J
M?&O_  5%@GM3#"& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P/SY\MK_ &,W1_QU>8!_ZP[DPUGVQ^4?X/T&PR8# 8# 8# 8# 8# 8#
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ME@D9';N:HXPLG0QBZPMZT3*;EL]A# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# IY?>]:-MZQKC>K?]:MR65M*+;:(
MR2D4G[]PXC((]%W5Y<%I8!)&WKO4E3E)BSA!&KZAVRM"T0;U7DM=+[EPX0_3
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@?DI9/&/R>Y9RD5PVQX?QU>^7UI+7!R7QE9,5:BXWT]:E4R=7I<UM\E]>
M-B-2A*-6EIS0)T^R0[&4#J]&\SZ>QJ\ZOK2.WMQ0\E[B^W-CSR%B''NFT;J,
M0F44]L)]CZUVVF-+"<<T-BJ8!='(A(:8#1QA!(RRNMKK[UTZZ;4+'N9=ER_7
M]L$A$VMXFL18VP2)*)N&2+8B1(1$%[2"*%O>]B*$GV'8=_PZRL/=@,!@,#&N
M3PULY0#G1<F0EF#V66)08$OM!Z#L8@EAW\(?4!K8A=&M]4.NG?1K \@)/'C5
M):,IY;CE)H21EE$JBS=B I)"H('H18A ZIQ ]##OIZ-AWK>O1BI[%J:N>QUH
MY;&7!0!(A?6M6J,,[(I.0M(,-.'U#!_R  CWLX'4)'OK Z0_!WZ<%3WOFY=%
MPJ=HQ/[5I2$W1 B=K2=" =LX:8)0^D?0 P2@L0-:WO6]CUO6O3CM*EZ5,A8T
M:!.ZJG5"0VJM!$G7F*"PI#@B (P(@'[WV>P[ '>^GIZ,%3/3O< 2:/F%&' >
M&_996D6S!;4EAZOK$W9"#I"+>A?ST_74*]'PQ>C73O%P5,=K**E:9$0)2K/*
M3)P"+",XX>BRPB.- 24'8A;UK6S#3 AU_'O>M82(F70>Z-J91W10N2D*M(SG
M#NYIY8#NXIQ:">K[,0M"VG)%OH&+] ?X<+4U?<P^II$]]IU9 U"[(O1P]A5E
MBUV6]@ULP.P[WHP -F!ZVP].@=.NMT9:E'W<SB@24Z@4@:]$*PG#3&[5%]F>
M!/V7;F%BZ>@11/; ZPO\'76UZ<5,#W^OV3:<*OULW]U$H,2!5=[([OM226,T
MTC1W7[/M"RBQ"WKI] =;WD6K[&*U.X=O6M^\K1Z1:#K6UA6A=(M] /@;WH70
M;OT WT= ]_X/3EHJ;JI2 EQ0J *#"5:<PM)O058PF@ZJ86R"U70HWT]!.])S
M@CWUNCH"+6_T9FX*F&*2RV,+3R4J1^:CU*DWL$Q %I&SE!O9C-T%.7L>AGZ$
M66+>MAUL.]:WT;R^?<G9TER(E,;5*BT2=\;#U9I@B2R"U9(QB.#L81$:Z!;U
MWCI+%_)]/7WT;]&)Z=JQ$S%QV,_A# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M".&=N635<?A!E+63:-E335>LD#>5<G>79NMV+-#<W%)YD8I6%HV=6<G1H#!
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ML;G5Q_H@U?Z<_I6?[1_]+_\ KA__ 'K_ '/_ ,#_ /:>KECL9GM3G 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# @]C_Z'
MNO\ IQ_A(?\ 9Q_IA_U]-_W5_P#H_P#X?_\ A^OA8:0VQ_LJL[_[LS_9U./^
5O?\ 5/\ 1=U_ZQ_]K_CR-1V]S__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
